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Abstract
Synthetic efforts directed at preparing certain target molecules highlight
deficiencies in the synthetic technology currently available to chemists.  Enolates are
among the most important synthetic intermediates for synthesis, but general means for
enolate functionalizations are not available for many transformations.  In order to address
these limitations in synthetic technology, novel enantioselective transformations are
developed and applied to total syntheses of biologically active natural products.
First, to address the challenge of generating all-carbon quaternary stereocenters,
a palladium-catalyzed allylic alkylation reaction is discovered and optimized for allyl
enol carbonate and silyl enol ether substrate classes.  Certain enolate precursors are not
accessible using these substrates, and therefore a method employing racemic allyl β-
ketoester substrates is developed.  In addition to solving the problem of regiospecific
enolate generation, these transformations are conceptually interesting due to the
stereoablative enantioconvergent mechanism.
Studies of the mechanism of the above transformation suggest the intermediacy
of a chiral palladium enolate.  Since enolate functionalization reactions are valuable to
synthetic chemistry and general protocols are rare, different electrophiles are explored in
addition to the allyl electrophiles used in quaternary center formation.  These studies lead
to the discovery of enantioselective protonation reactions generating tertiary
stereocenters.
To demonstrate the importance of enantioselective enolate functionalization
reactions in synthesis, the allylic alkylation reaction is applied in the total synthesis of
cassiol and the formal synthesis of platencin.
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CHAPTER 1 
Natural Products and Pharmaceuticals as Inspiration 
for the Development of Enantioselective Catalysis† 
1.1 INTRODUCTION 
Biologically active natural products and pharmaceuticals often contain particularly 
challenging structural features and functionalities in terms of synthesis.  Perhaps the 
greatest difficulties are those caused by issues of stereochemistry.  A useful strategy for 
synthesizing such molecules is to devise methods of bond formation that provide 
opportunities for using enantioselective catalysis.  In using this tactic, the desire for a 
particular target structure ultimately drives the development of catalytic methods.  New 
enantioselective catalytic methods contribute to a greater fundamental understanding of 
how bonds can be constructed and lead to valuable synthetic technologies that are useful 
for a variety of applications.  The lack of methods available for installing functionalities 
or structural motifs during chemical synthesis can at first be frustrating.  However, 
retrosynthetic analysis,1 a way of viewing the target molecule as a series of structurally 
                                                
† This review was written in collaboration with Michael R. Krout and a similar version has been published.  
See: Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Nature 2008, 455, 323–332. 
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simpler precursors, can greatly aid in planning how to generate a valuable chemical 
substance.  Despite this, difficulties in preparing materials enriched in a particular 
enantiomer persist because of the limited number of catalytic enantioselective 
transformations available.2  One fruitful strategy is to design a synthesis that depends on a 
bond-forming reaction for which there is no known enantioselective variant.  This 
approach thus provides the impetus for developing novel transformations and leads to a 
greater understanding of methods of bond construction and catalysis.  Herein, several 
recent examples of novel catalytic enantioselective transformations are described in order 
to illustrate the effectiveness of this strategy for preparing important structural motifs 
found in biologically active molecules.  Each of these transformations has contributed not 
only an effective means of generating a particular target structure but also a useful new 
tool for a variety of applications in synthetic chemistry. 
 
1.2 HISTORICAL OVERVIEW OF ENANTIOSELECTIVE METHODS 
To provide an overview of established catalytic enantioselective methods that have 
been developed for total synthesis, several notable examples of enantioselective reactions 
in total synthesis are highlighted in Scheme 1.1 through Scheme 1.4.  In each of these 
cases, the target molecules posed particular challenges that had yet to be solved by 
enantioselective catalysis.  Although, in some instances (e.g., the Diels–Alder reaction, 
Scheme 1.1), the methods were developed before their first application in total synthesis, 
the demonstrated value of the transformation highlighted the need for enantioselective 
variants.  Following the development of the [4 + 2] cycloaddition reaction in the 1920s,3 
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studies of this transformation elucidated several key facets of the stereochemical outcome 
of the reaction (e.g., the “endo rule,” regioselectivity, and diastereoselectivity).  These 
intrinsic stereochemical control elements proved useful when the Diels–Alder reaction 
was first featured in a total synthesis with Stork’s stereocontrolled synthesis of 
cantharidin4 in 1951.  Subsequently, the thermal Diels–Alder reaction was used for 
several total syntheses, perhaps most famously in Woodward’s landmark synthesis of 
reserpine.5  Enantioselectivity in this transformation remained elusive, however, and 
perhaps was considered unattainable at the time.  
Scheme 1.1.  Enantioselective Diels–Alder cycloaddition and enantioselective ketone reduction en 
route to prostaglandins 
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One key practical improvement in the Diels–Alder reaction was the discovery that 
Lewis acids markedly increased the reaction rate.6  Many laboratories sought to exploit 
this and to develop asymmetric versions of the Diels–Alder reaction catalyzed by chiral 
Lewis acids, culminating in a report of the first highly enantioselective catalytic Diels–
Alder reaction in 1979.7  The interface between reaction development, study of the 
mechanism, and synthesis is readily apparent from the multitude of chiral Diels–Alder 
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catalysts and accompanying enantioselective total syntheses that have been reported.8  
These successes validate the extensive efforts directed at realizing this important goal.   
Other methods were developed to address more general problems in synthesis (e.g., 
synthesis of chiral alcohols by means of enantioselective ketone reduction, Scheme 1.1); 
however, the key structures are embedded in a variety of important natural products and 
pharmaceutical compounds.  In the case of Corey’s approach to the synthesis of 
prostaglandins,9 first reported in the 1960s, control of the configuration of the side chain 
allylic alcohol at C15 required stoichiometric chiral reducing agents until a solution to 
this long-standing problem was found in the 1980s.10  Interestingly, the oxazaborolidine 
catalyst discovered in these explorations has had other varied applications in synthesis 
and catalysis,11 demonstrating the versatility of privileged molecular frameworks12 for 
enantioselective catalysis. 
The practical application of enantioselective catalysis is apparent in myriad industrial 
applications (e.g., Scheme 1.2), for which the limits of catalysis must be examined to 
minimize costs.  Important industrial applications include the synthesis of chiral building 
blocks (e.g., amino acids13 (10)), novel biologically active pharmaceuticals (e.g., 
Crixivan14 (indinavir sulfate, 13)), and commodity chemicals (cheap chemicals sold in 
bulk) with various important uses (e.g., menthol15 (17)).  Only the most efficient methods 
are feasible for large-scale industrial synthesis, and in many ways these protocols 
represent the pinnacle of modern enantioselective catalysis.16  A viable commercial 
operation must account for more than simply effective asymmetric induction; factors 
including turnover frequency, catalyst availability, catalyst recovery, catalyst toxicity, 
and feasible large-scale handling procedures must all be considered for industrial 
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applications.  These daunting challenges underscore the demand for increasingly efficient 
catalyst systems.  
Scheme 1.2.  a) Enantioselective enamide hydrogenation toward α-amino acids;  b) Enantioselective 
alkene epoxidation toward Crixivan®;  c) Enantioselective isomerization of an allyl amine toward 
menthol 
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To maximize the usefulness of the stereochemistry attained by these key asymmetric 
transformations, subsequent diastereoselective reactions may be used to control the 
formation of many stereocenters based on a single enantioselective transformation (e.g., 
Scheme 1.3).  The Hajos–Parrish ketone (19), first prepared in the context of steroid 
synthesis, has been used extensively in other synthetic efforts and has proved to be a 
versatile chiral-pool starting material.17  The amino acid catalyst system developed for 
this intramolecular aldol condensation provided a sound basis for the recent use of 
organic molecules as catalysts for a variety of enantioselective transformations (see 
subsection 1.3.4).   
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Scheme 1.3.  Enantioselective intramolecular aldol condensation toward steroids 
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The use of several different enantioselective reactions to prepare enantioenriched 
fragments of complex molecules improves efficiency through convergency.  The 
importance of this strategy is shown by the variety of extraordinarily complex polyketide 
natural products that have been prepared through asymmetric intermolecular aldol 
reactions (e.g., phorboxazole B18 (27), Scheme 1.4).  The challenging structure of these 
molecules has required the development of several related protocols to address the subtle 
differences in substitution patterns and functionality present in substrates, and, despite 
many successes, studies are ongoing.19 
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Scheme 1.4.  Convergent application of various enantioselective methods toward the synthesis of 
phorboxazole B 
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1.3 RECENT DEVELOPMENTS IN ENANTIOSELECTIVE CATALYSIS 
In this section, recent representative developments made by using this approach — 
that is, by using target structures to inspire the development of enantioselective catalysts 
— for the construction of biologically important target molecules are described.  Most of 
these methods involve the formation of a carbon–carbon bond, the fundamental structure 
of organic molecules.  These cases were selected to illustrate some of the latest 
developments in enantioselective catalysis for complex molecule synthesis.  Special 
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attention has been given to reactions that address some of the most important challenges 
in synthetic chemistry today: increasing functional-group tolerance, generating new 
carbocyclic and heterocyclic rings, and forming all-carbon quaternary stereocenters.  The 
examples are also intended to show the important symbiosis between total synthesis and 
method development, and to show that improvements in one branch of synthetic 
chemistry have an impact on the others. 
 
1.3.1 β-ENAMINO AMIDE HYDROGENATIONS—JANUVIA® 
Catalytic enantioselective hydrogenation has become one of the most effective and 
powerful methods for the synthesis of chiral α-amino acids for numerous applications.13  
Over the past decade, the usefulness of the homologous building blocks, β-amino acids, 
in pharmaceutical, agrochemical, β-peptide, and natural substances has become evident, 
highlighting the need for a general and effective means for their preparation.20  
Undoubtedly, the implementation of a catalytic asymmetric hydrogenation of N-acyl-β-
enamino esters seemed to be the most efficient pathway toward their synthesis, although 
initial investigations achieved poor selectivities.21  Additional syntheses using the chiral 
pool, auxiliaries, and more recently the catalytic asymmetric generation of C–C and C–N 
bonds have been successful in satisfying the increased demand for β-amino acids.20b  
These valuable methods allow flexible strategies for the synthesis of a variety of analogs; 
however, most examples are limited by the requirement for further chemical 
manipulation that is often necessary to produce the functionality of the desired β-amino 
acids. 
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Despite initial difficulties, the asymmetric hydrogenation of N-acyl-β-enamino esters 
has been developed into a useful method over the past 15 years.22  This fruitful endeavor 
has demonstrated that several transition metal and ligand combinations are competent for 
preparing N-acyl-β-amino acids with good-to-excellent enantioselectivities.  A notable 
drawback to this strategy, however, is the requirement for the seemingly indispensable N-
acyl group on the β-enamino esters; this group is needed for metal chelation, which 
improves reactivity and selectivity.  The introduction of this moiety often produces 
enamine alkene isomers that can be difficult to separate, and, importantly, the individual 
isomers are typically hydrogenated with differing rates and selectivities.  Moreover, these 
difficulties are magnified by the necessary removal of this group, a seemingly 
cumbersome artifact of an otherwise powerful strategy.  Nonetheless, this advance has 
allowed a variety of β-amino acids to be prepared.20b  
An innovative solution to this problem was demonstrated by a group at Merck en 
route to synthesizing Januvia (sitagliptin phosphate; 40, Scheme 1.5), which has recently 
been approved by the United States Food and Drug Administration for the treatment of 
type II diabetes.23  The optimal target contains an unfunctionalized β-amino amide.  A 
strategy was sought to install this moiety directly by asymmetric hydrogenation of 
unsubstituted β-enamino ester and amide derivatives24 (e.g., 36).  A traditional 
hydrogenation route for the production of amino acids is a proven, cost-effective method 
for the synthesis of chiral building blocks.  The industrial infrastructure is already in 
place to realize this goal; however, in this case, the reduction of unprotected β-enamino 
acids was not effective with existing chiral catalysts.  A crucial component in addressing 
such limitations was Merck’s high-throughput screening facility, which allowed rapid 
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screening of catalyst structures and reaction conditions (an essential component for the 
success of any asymmetric catalytic process).25  One potential complication for this 
hydrogenation strategy was avoided when it was observed that the preparation of the β-
enamino ester and amide substrates (e.g., 35 → 36) proceeded with complete selectivity 
for the Z-isomer, presumably owing to hydrogen bonding in the products. 
Scheme 1.5.  Enantioselective hydrogenation of a β-enamino amide toward the synthesis of Januvia® 
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During the screening, a survey of transition metals and ligands revealed that rhodium 
complexes of the Josiphos (e.g., 37, Scheme 1.5) family of ligands efficiently catalyze the 
hydrogenation of a variety of substrates to give high yields with excellent 
enantioselectivities.  The remarkable functional-group tolerance of this catalyst allowed 
the strategic implementation of this asymmetric transformation as the penultimate step of 
the synthesis, thereby maximizing the usefulness of the process and materials.  Thus, 
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phenylacetic acid derivative 32 was converted into β-ketoamide 35 in a one-pot 
procedure via acylation of Meldrum’s acid (33), followed by treatment with triazole salt 
34.26  Exposure to ammonium acetate converted this into β-enamino amide 36 as a single 
enamine isomer.  Hydrogenation of amide 36 in the presence of 0.30 mol% of rhodium(I) 
and ligand 37 provided β-amino amide 39 in >95% conversion and 95% enantiomeric 
excess.  Subsequent recrystallization and salt formation with phosphoric acid gave 
Januvia® (40).  Efforts to optimize efficiency and examine the mechanism of the 
asymmetric process revealed that reactivity and selectivity were dependent on the pH of 
the reaction solution.27  It was found that ~1 mol% of a mild acid (i.e., ammonium 
chloride) was essential for the reaction to proceed reproducibly on a large scale.  In 
addition, it was observed that hydrogenation of a related substrate under identical 
conditions with a deuterium gas atmosphere resulted in deuterium incorporation at the β-
position only, suggesting that an imine is an intermediate (38) and that an enamine–imine 
tautomerization process plays an important part in the mechanism.24  Interestingly, 
intermediates such as 38 have a striking similarity to asymmetric β-carbonyl 
hydrogenations pioneered by Noyori and co-workers.28   
This example demonstrates the development of asymmetric catalysis into a state-of-
the-art science through maximizing the efficiency by minimizing unnecessary 
functionality, by using atom economy, and by using extremely active catalysts.  
Moreover, the development of the catalyst system for the synthesis of Januvia 
exemplifies the continued need for subtly different catalysts to meet new synthetic 
demands.  Building on the experience obtained during the development of a highly 
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efficient enamide reduction toward α-amino acids, such large-scale industrial synthesis of 
important β-amino acids has been a relatively rapid process. 
 
1.3.2 C(sp3)–C(sp3) CROSS-COUPLINGS—FLUVIRUCININE A1 
Transition metal-catalyzed cross-coupling reactions have been used extensively for 
constructing C–C bonds and, consequently, have had a substantial effect on the field of 
complex molecule synthesis.29  The predominance of palladium and nickel catalysts in 
cross-coupling technologies and their extraordinary functional-group tolerance increases 
the efficiency of this process by allowing a large degree of functionalization before 
coupling.  Moreover, the efficacy of this cross-coupling strategy for streamlining 
synthesis has allowed retrosynthetic analyses that had been thought impossible with 
standard, nonmetal reactions.  Until recently, however, most cross-coupling methods 
involved C(sp2)–C(sp2) or C(sp2)–C(sp) centers, limiting the application potential.  Two 
crucial issues associated with expanding the substrate scope to include C(sp3)–C(sp3) 
couplings are the relatively low reactivity of alkyl halides toward oxidative addition and 
the propensity of σ-alkyl organometallic complexes to undergo rapid β-hydrogen 
elimination reactions.30  Practical solutions to this problem were first presented by Suzuki 
and Knochel, followed more recently by Fu.30b,31  In general, the reaction scope now 
encompasses a variety of primary and secondary halides and pseudohalides as the 
electrophilic component, with organoboranes, boronic acids, alkylmagnesium halides, 
and alkylzinc halides as the nucleophilic component.30b  Although perhaps not developed 
in the context of a particular target molecule, progress in these cross-coupling methods 
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has allowed retrosynthetic disconnections that were not practical previously.  
Asymmetric cross-coupling protocols could, in turn, allow the direct formation of remote 
stereocenters in relatively unfunctionalized molecules. 
Early examples of catalytic asymmetric cross-coupling reactions involving C(sp3)–
C(sp2) centers were explored by Kumada and co-workers in the late 1970s and produced 
moderate enantioselectivities.32  Despite these initial reports and the subsequent evolution 
of cross-coupling methods and asymmetric catalysis, a deficiency in the development of 
catalytic asymmetric methods for C(sp3)–C(sp3) couplings existed until Fu and co-
workers33 reported an asymmetric Negishi coupling in 2005.  Before this report, 
researchers in the Fu laboratory observed the proficiency of tridentate pybox ligands 
(e.g., 48, Scheme 1.6) at enabling the room temperature nickel-catalyzed Negishi 
coupling of symmetric secondary alkyl bromides and iodides.34  It was postulated that the 
tridentate nature of pybox ligands prevented the undesired β-hydrogen-elimination 
pathway, which would require a vacant coordination site.  Reaction optimization 
facilitated the development of several asymmetric variations that generate challenging 
stereocenters applicable to complex molecule synthesis, as demonstrated in Fu’s formal 
total synthesis of fluvirucinine A1 (49), the aglycon of the macrolactam antibiotic 
fluvirucin A1 (50).35  A key nickel(II)-catalyzed asymmetric cross-coupling of racemic 
allylic chloride 41 and alkylzinc reagent 42 in the presence of (S,S)-48 generated γ-
disubstituted enone 43 in an excellent yield and 96% enantiomeric excess.  Elaboration 
over two steps to a bromide (44), followed by conversion to the alkylzinc form and a 
second nickel(II)-catalyzed asymmetric Negishi cross-coupling with racemic allylic 
chloride 45, provided the ester 46 in a good yield and with >98% enantiomeric excess 
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and a 15:1 ratio of diastereomers.  A subsequent two-step conversion to the aldehyde 47 
intersected Suh’s synthesis of fluvirucinine A1 (49).36  This method exemplifies the 
efficiency of the C(sp3)–C(sp3) cross-coupling and presents a creative solution to the 
particularly difficult challenge of remote stereochemical control. 
Scheme 1.6.  Enantioselective C(sp3)–C(sp3) cross-couplings toward fluvirucinine A1 
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At present, most examples of this technology require a stabilizing group adjacent to 
the site of the putative carbon-centered radical.  Eliminating this condition would further 
improve the utility of this asymmetric cross-coupling method.  In addition, stereogenic 
organometallic coupling partners (e.g., secondary alkylzinc reagents) have not yet been 
reported in this asymmetric transformation.  A potential goal for this synthetic method 
would be the combination of a racemic secondary alkyl halide and a racemic secondary 
alkylmetal reagent to form vicinal stereocenters along an alkyl chain with high levels of 
enantioselectivity and diastereoselectivity. 
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1.3.3 INTRAMOLECULAR HECK CYCLIZATIONS—MINFIENSINE 
The enantioselective generation of all-carbon quaternary stereocenters is a 
considerable challenge for synthetic chemists.37  As quaternary stereocenters are found in 
many natural product structures, convenient enantioselective methods for their formation 
would be useful.  One such method is the Heck reaction,38 in which a palladium(0) 
catalyst promotes the vinylation of an aryl halide, vinyl halide, or trifluoromethane 
sulfonate.  The large body of literature on palladium catalysis and mechanisms,29 as well 
as an ever-growing collection of chiral ligands for transition-metal catalysis, greatly 
increased the potential of using this method to carry out asymmetric catalysis.  In 
addition, many synthetic endeavors using diastereoselective or nonstereoselective 
intramolecular Heck reactions have been reported,39 increasing the significance of an 
enantioselective process.  In 1989, the laboratories of Shibasaki40 and Overman41 
independently reported the first variants of an intramolecular catalytic asymmetric Heck 
reaction.  Initial levels of enantioselectivity were moderate; however, subsequent 
optimizations realized good-to-excellent selectivities in the generation of tertiary and all-
carbon quaternary stereocenters.42 
Indole alkaloids encompass a large number of natural and pharmaceutical substances 
with a wide range of biological activities.43  The plant alkaloid minfiensine (54, Scheme 
1.7) is a compelling example of the all-carbon quaternary stereocenter motif in biologically 
active natural products.  Minfiensine and related alkaloids have been used in traditional 
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medicines and have promising anticancer activity.44  The intriguing polycyclic structure 
and biological relevance of minfiensine prompted the Overman laboratory45 to explore a 
catalytic enantioselective Heck reaction to generate the sole quaternary stereocenter at 
C9a.  It was discovered that the palladium-catalyzed intramolecular Heck reaction of 
dienyl aryl trifluoromethane sulfonate 51 in the presence of the phosphinooxazoline 
ligand (S)-55 under microwave conditions produced indoline 52 in good yield and with 
99% enantiomeric excess.  Subsequent acid-promoted carbamate cyclization produced the 
tricyclic core of minfiensine (53), which was then converted to the natural product.  The 
efficiency and selectivity of the catalytic asymmetric Heck reaction facilitated completion 
of the target, where the remaining stereocenters are derived from this initial 
transformation. 
Scheme 1.7.  Enantioselective intramolecular Heck reaction toward minfiensine 
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Despite numerous examples of the asymmetric Heck reaction in total synthesis,42 
there are several features that could be improved.  Reactions typically require high 
temperatures and relatively high catalyst loadings, and the development of chiral ligands 
that greatly increase the reactivity of the transition metal while maintaining an adequate 
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asymmetric environment would be greatly beneficial.  As most enantioselective Heck 
reactions use an sp2-hybridized organohalide component, another frontier lies in the 
application of unactivated alkyl carbon electrophiles that have β-hydrogens in both 
intramolecular and intermolecular cases, an area currently in its infancy.46 
1.3.4 INDOLE FRIEDEL–CRAFTS ALKYLATIONS—FLUSTRAMINE B 
Numerous methods have been developed for the generation of substituted indoles;47 
however, enantioselective indole functionalization has been far less explored.  To address 
the deficiencies in the indole functionalization literature, Jørgensen48 and MacMillan49 
independently developed strategies for asymmetric Friedel–Crafts alkylation of conjugate 
acceptors with electron-rich heteroaromatics.  MacMillan’s method uses a secondary 
amine catalyst (61, Scheme 1.8) that facilitates the LUMO-lowering activation of α,β-
unsaturated aldehydes for a variety of transformations.50  Although imidazolidinone 61 
was a sufficient catalyst for the Friedel–Crafts alkylation of pyrroles, generating good 
yields and excellent enantioselectivities,49 application of less-activated indole substrates 
resulted in sluggish reactivity with considerably diminished selectivities.51  Kinetic 
investigations of iminium-catalyzed reactions revealed that the overall reaction rate was 
influenced by the efficiency of formation for both the iminium ion and the C–C bond, 
prompting the development of a modified imidazolidinone catalyst (62).  This refinement 
minimized the steric bulk around one face of the catalyst, thereby exposing the lone pair 
of electrons on the secondary amine nitrogen.  This structural change translated into 
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increased reactivity that enabled the asymmetric Friedel–Crafts alkylation of a variety of 
indoles with good-to-excellent yields and very high enantioselectivities.51  
Scheme 1.8.  Enantioselective Friedel–Crafts alkylation toward flustramine B 
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Pyrroloindoline alkaloids are a family of polyindole alkaloids of diverse structural 
complexity and biological relevance.52  Diastereoselective syntheses of the core of these 
compounds have focused on the control of the C3a all-carbon quaternary stereocenter as a 
key design element.53  With a powerful and mild indole alkylation method in hand, 
MacMillan and co-workers54 devised a cascade strategy for the catalytic asymmetric 
preparation of the C3a stereocenter and the pyrroloindoline core of the potassium-
channel blocker (–)-flustramine B (60, Scheme 1.8) in one step.  In this key 
transformation, tryptamine derivative 56 and 2-propenal (acrolein, 57), in the presence of 
catalyst 62, underwent the asymmetric Friedel–Crafts alkylation to provide iminium 
intermediate 58.  Subsequent carbamate cyclization and hydrolysis to regenerate the 
catalyst provided the core (59) with a good yield and 90% enantiomeric excess.  
Importantly, this allowed completion of (–)-flustramine B (60) in just six steps and with 
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good overall yield, highlighting the efficiency of this cascade approach.  It is noteworthy 
that this strategy also has the potential to be applied to the synthesis of various 
polycyclic indolines such as the diazonamide family of cytotoxic alkaloids.54  It is also 
interesting to note that both the intramolecular Heck reaction (see subsection 1.3.3) and 
the indole Friedel–Crafts alkylation can generate similar indoline structural motifs despite 
the markedly different bond-connecting strategies of these reactions.  The success of these 
dissimilar strategies allows a great deal of flexibility in the planning of syntheses.   
Iminium-activation methods with chiral amine catalysts have been successful for 
numerous transformations, but catalyst loading, turnover frequency, and excesses of 
certain reagents limit the large-scale industrial application of these methods.  In addition, 
in some cases, the organic catalyst may be more difficult to remove from the reaction 
products than a metal catalyst.  However, the typically air- and moisture-stable reaction 
conditions, low cost of some catalysts, and often metal-free conditions are attractive.  The 
variety of asymmetric transformations (some proceeding through substantially different 
reaction pathways) that have been realized with chiral amine catalysts so far indicates a 
burgeoning field in which there are many useful enantioselective catalysts.  
 
1.3.5 PICTET–SPENGLER CYCLIZATIONS—HARMICINE 
Since the intramolecular cyclization of an aromatic ring onto an iminium species was 
reported by Pictet and Spengler in 1911,55 this transformation has been of great use in the 
synthesis of many important alkaloid natural products.56  Indeed, the need for asymmetric 
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variants of this reaction was recognized, and several diastereoselective protocols have 
been devised.56  A common approach to diastereoselective Pictet–Spengler cyclization 
has been to use tryptophan derivatives to control the stereochemistry of the cyclization.  
However, using this type of technique for the synthesis of a natural product such as 
harmicine (68, Scheme 1.9), which is active against the disease leishmaniasis, 
necessitates the removal of the stereocontrol element at C5, following the 
diastereoselective cyclization.  Nonetheless, Allin and co-workers57 proved this to be a 
viable method in 2007.  This particular structure, however, highlighted a challenge for 
enantioselective catalysis and an opportunity to improve synthetic efficiency. 
Scheme 1.9.  Enantioselective Pictet–Spengler cyclization toward harmicine 
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When considering prospects for asymmetric induction, Jacobsen and Taylor 
considered activated N-acyl-iminium ions as a template and reasoned that a chiral 
thiourea derivative might be effective in promoting cyclization.58  In practice, these 
Brønsted acids,58 as well as other Brønsted acids investigated later by other groups,59 
proved to be excellent catalysts for enantioselective indole annulations with in situ-
generated N-acyl-iminium species (e.g., 66, Scheme 1.9).  In later studies by Jacobsen 
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and co-workers, it was found that hydroxylactams (e.g., 64) are convenient precursors to 
N-acyl-iminium ions, which in turn enable access to various polycyclic structures.60  
Given this effective protocol, an efficient catalytic asymmetric synthesis of harmicine 
(68) was realized in four steps from tryptamine (63).  Several mechanistic experiments 
have suggested that asymmetric induction is controlled by a complex of the Brønsted acid 
catalyst (65) and a chloride counterion closely associated with the iminium ion (e.g., 66) 
that effectively blocks approach to one face of the electrophile, providing annulated 
products (e.g., 67) with excellent enantiomeric excesses.  This insight into the remarkable 
mechanism of this transformation has led to a related C–C bond-forming process using 
oxocarbenium ions.61  Further exploitation of this unusual proposed catalyst–anion 
interaction could lead to a variety of other asymmetric addition reactions, such as 
intermolecular alkylation of N-acyl-iminium ions.  In common with the history of the 
Diels–Alder reaction (see section 1.2), the exploration of the Pictet–Spengler cyclization 
has provided a useful method to access many heterocyclic structures embedded in alkaloid 
natural products using a classical reaction with well-established synthetic applications. 
 
1.3.6 PHASE TRANSFER ALKYLATIONS—INDACRINONE 
Enolate alkylations exemplify the fundamental usefulness of the carbonyl group for 
C–C bond formation.  Strategies to induce asymmetry in these reactions have included 
chiral auxiliaries and chiral ligands, although few examples are catalytic.  A particularly 
challenging class of product targets are all-carbon quaternary stereocenters adjacent to 
carbonyl groups.  One example of an important target bearing this motif is the diuretic 
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drug candidate indacrinone (73, Scheme 1.10).62  Given the lack of efficient methods for 
synthesizing this structure, researchers at Merck envisaged an enantioselective phase-
transfer alkylation method based on a quaternary ammonium salt derived from a naturally 
occurring cinchona alkaloid (e.g., 70).  In the event, readily prepared indanone 69 was 
methylated, producing ketone 72 with 95% yield and 92% enantiomeric excess, and 72 
was then converted to indacrinone (73) in three additional steps.  
Scheme 1.10.  Phase-transfer alkylation toward indacrinone 
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Although successful in achieving enantioselective enolate alkylation, the mechanism 
for this process seems to be complex;63 however, enantiofacial selectivity in the 
alkylation event may be rationalized through the hypothetical transition state 71 (Scheme 
1.10).  Three key interactions are thought to control selectivity: a hydrogen bond between 
the enolate oxygen and the catalyst hydroxyl group, and two π-system stacking 
interactions between the four aromatic rings.  Perhaps as a consequence of the complex 
mechanism, the range of substrates for enolate alkylation is limited, and other solutions to 
this problem are still needed.  However, these initial results have led to several related 
catalytic enantioselective reactions using cinchoninium salts or related organic 
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ammonium complexes as catalysts.64  The discovery of these useful catalysts has 
provided not only an alternative to related transformations using metal catalysts but also a 
means of accessing chiral environments that are simply not possible with metal-based 
catalysts.  Moreover, eliminating metal waste materials is attractive from an industrial 
and environmental standpoint.  Ultimately, the studies directed toward an 
enantioselective synthesis of indacrinone demonstrate the versatility of privileged 
catalysts developed for the synthesis of target molecules for a range of other applications. 
1.3.7 PD-CATALYZED ENOLATE ALKYLATION—CYANTHIWIGIN F 
A recent case of enantioselective enolate alkylation is the synthesis of cyanthiwigin F 
(83, Scheme 1.11), a cytotoxic natural product from a sea sponge.  The cyanthiwigin 
family is composed of more than 30 diterpenoids, most of which bear two quaternary 
stereocenters, at C6 and C9, and a syn relationship of the methyl groups in the central 
ring.  These core stereochemical elements are a complicating factor for a convergent 
strategy that might seek to couple the five- and seven-membered ring portions and 
subsequently form the six-membered ring.  To avoid this difficulty, Enquist and Stoltz 
chose instead to address these two central stereocenters at an early stage and append the 
five- and seven-membered rings to the assembled cyclohexane.65  Accordingly, a 
synthetic strategy was devised that involved a one-pot double-enantioselective enolate 
alkylation reaction to form both quaternary stereocenters simultaneously.  Although such 
enantioselective alkylations have proved difficult, recent studies have identified 
palladium catalysts that might provide a solution to this problem and enable the synthesis 
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of a variety of targets containing quaternary carbon stereocenters, including the 
cyanthiwigins.66 
Scheme 1.11.  Pd-catalyzed enolate alkylations toward cyanthiwigin F 
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The implementation of this retrosynthetic strategy began with a Claisen–Dieckmann 
sequence that converted diallyl succinate (74, Scheme 1.11) to bis(β-ketoester) 75 as a 
1:1 mixture of racemic and meso diastereomers.  On exposure to the catalyst derived 
from Pd(dmdba)2 and phosphinooxazoline ligand (S)-55,66 each stereoisomer of 75 was 
transformed to bis(allylated) ketone 76 with 75% yield and 99% enantiomeric excess as a 
4.4:1 mixture of diastereomers.  With both quaternary centers in place, elaboration of this 
stereochemically rich core structure to the natural product was achieved in six further 
steps.  Enol triflate formation and Negishi coupling (76 + 77 → 78) preceded a tandem 
ring-closing metathesis–cross-metathesis sequence with Grubbs’ ruthenium catalyst 79.67  
Aldehyde–alkene radical cyclization generated the final ring of the cyanthiwigin core (81 
→ 82), and enol triflate formation and palladium-catalyzed cross-coupling formed (–)-
cyanthiwigin F (83), together with reduction product 84.  Choosing to confront the 
difficult stereochemical elements of the cyanthiwigin structure at an early stage led to a 
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direct synthetic route proceeding in nine steps from diallyl succinate.  This strategy was 
made possible by the intriguing reaction mechanism of the enantioselective 
decarboxylative allylation, in which all three stereoisomers of bis(β-ketoester) 75 were 
converted to a specific stereoisomer of product (76) with high selectivity, through a 
stereoablative process.68  In addition, of the nine steps required for the synthesis, seven 
form C–C bonds, and four form multiple C–C bonds.  Directly addressing the carbon 
framework of the target molecule and the stereochemical challenges embedded within 
ultimately led to an efficient synthetic sequence for this important molecule.   
Recently, the proposed chiral palladium enolate was shown to be intercepted by allyl 
or proton electrophiles (the development of this reaction will be a major component of 
this thesis; see Chapters 6 and 7).66,69  Although the synthesis of cyanthiwigin F 
demonstrates the versatility of allyl moieties for further derivatization, the direct use of 
alternative electrophiles would provide a more general and direct method for transition 
metal-mediated enolate functionalization.70 
 
1.3.8 TRIMETHYLENEMETHANE CYCLIZATIONS—MARCFORTINE B 
Of the many fundamental approaches to the formation of five-membered rings from 
acyclic precursors, the [3 + 2] cycloaddition is among the most convergent strategies.  A 
useful method of achieving such a cyclization is via a trimethylenemethane (TMM) 
intermediate.71  This interesting non-Kekulé molecule was first prepared and studied 
through photolytic decomposition of a cyclic diazene precursor.  However, the free diyl is 
prone to several undesired reaction pathways and does not lend itself to asymmetric 
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catalysis.  Despite this, intramolecular diyl-trapping reactions are valuable methods of 
cyclopentane formation.71  Recognizing the synthetic utility of TMM, Trost and 
coworkers developed an array of 2-(trimethylsilyl)-2-propenyl acetate reagents that 
generate a metal•TMM complex when exposed to a palladium catalyst.72  A recent 
application of this transformation in total synthesis is the approach to marcfortine B (90, 
Scheme 1.12a), a member of a family of antiparasitic agents.73  The strategy used sought 
to forge the [2.2.2]bicycle via an intramolecular radical cyclization and install the spiro 
all-carbon quaternary stereocenter by the cycloaddition of oxindole 85 with TMM 
precursor 86.  In the event, an excellent yield was observed for the annulation reaction 
yielding spirooxindole 87 as a 1:1 mixture of diastereomers.  Over the course of nine 
additional steps, spirocycle 87 was transformed into amide 88.  Preparation of the 
xanthate derivative of alcohol 88 allowed radical cyclization, generating the challenging 
[2.2.2]bicycle 89.  Seven further steps produced (±)-marcfortine B (90). 
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Scheme 1.12.  a) Pd-catalyzed TMM-[3 + 2]-cycloaddition toward marcfortine B  b) Enantioselective 
TMM-cyclization 
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Although this strategy demonstrated several intriguing ring-forming reactions, an 
asymmetric synthesis of 90 would require an enantioselective variant of the key TMM-[3 
+ 2] cycloaddition, a goal that has remained elusive.74  The first asymmetric palladium-
catalyzed [3 + 2] cycloaddition with various bis(phosphine) ligands was reported by Ito 
and co-workers,75 but with only moderate enantiomeric excess (up to 78%) and 
diastereomeric ratio (up to 4:1 trans:cis).  Thereafter, Trost and co-workers explored 
bulky monodentate phosphoramidite ligands (e.g., (R,R,R)-94, Scheme 1.12b) for the 
transformation and observed very high enantioselectivity for the first time.76  Of 
particular interest is the enantioselective addition of substituted TMM reagents to 
functionalized oxindole derivatives.76b  The use of oxindole 91 and TMM-precursor 92 in 
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the palladium-catalyzed cyclization with ligand (R,R,R)-94 yielded spirooxindole 93 with 
14:1 diastereomeric ratio and 96% enantiomeric excess for the major diastereomer.  
Although a completed asymmetric synthesis of marcfortine B (90) from intermediate 93 
has not been reported, many of the key functional groups are in place and the challenging 
spiroquaternary stereocenter has been installed (cf. 87 and 93).  The development of this 
valuable asymmetric transformation highlights the ongoing efforts to devise new and 
useful techniques for the construction of important molecules. 
 
1.4 OUTLOOK 
The representative synthetic efforts presented here demonstrate the crucial interplay 
between target-directed synthesis and the development of novel reaction methods.  
Although many useful asymmetric technologies are currently available, the specific 
challenges posed by important natural products and pharmaceutical compounds highlight 
deficiencies in the current technology.  Envisaging strategies to construct these relevant 
molecules through means beyond the current arsenal of enantioselective transformations 
will aid the evolution of both synthetic planning and reaction development.  The 
symbiotic relationship between total synthesis and method development can continue to 
expand the understanding of synthetic strategy and catalysis on both fundamental and 
practical levels. 
Despite the substantial advances that have been made so far, significant challenges 
remain for both multistep synthesis and catalysis.  In addition to improvements to 
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efficiency and selectivity, better reactivity and handling stability are constantly required 
to implement and improve industrial processes for existing methods.  Exceptionally 
reliable methods will aid in the discovery of new biologically active compounds by using 
high-throughput combinatorial screening techniques that are well established in the 
pharmaceutical industry, although these techniques are limited by the number of readily 
accessible chiral building blocks.  Existing methods may be improved by identifying 
systems with better functional-group tolerances that might obviate the need for protecting 
and masking groups.  Similarly, known privileged chiral frameworks may be modified to 
control chiral space more effectively for especially challenging transformations, a 
technique conspicuously successful for Trost’s TMM cyclizations (see subsection 1.3.8). 
Overall, creative solutions are required to address specific organic transformations 
that remain significant impediments to efficient syntheses, namely forming multiple 
stereocenters and rings, forming multiple C–C bonds, generating vicinal quaternary 
stereocenters, and achieving C–H and C–C functionalization reactions.  Cyclic structures 
often present particular challenges owing to the unique strain and steric elements 
imparted by their connectivity.  As a result, many highly strained or complex polycyclic 
structures are daunting targets for synthesis.  Finally, the discovery of new natural 
products will undoubtedly result in new challenges for synthetic chemistry and catalysis.  
In this thesis, examples of the development of useful enantioselective transformations 
for the synthesis of natural products will be presented.  These reactions were initially 
conceived as solutions to synthetic problems in the context of total synthesis efforts and 
have led to various derivative applications and methodologies with broad utility. 
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CHAPTER 2 
Enantioselective Allylic Alkylations of Ketone 
Enolates: Catalyst Development and Allyl Enol 
Carbonate and Silyl Enol Ether Substrates† 
2.1 INTRODUCTION 
The catalytic asymmetric synthesis of all-carbon quaternary stereocenters stands as a 
significant challenge in synthetic chemistry.1  Despite the demanding sterics of 
quaternary stereocenter formation, a number of useful catalytic transformations, 
including Diels–Alder,2 Heck,3 cyclopropanation,4 alkylation,5 acylation,6 
desymmetrization,7 and pericyclic8 reactions, have been successful in generating these 
moieties.  Although palladium-catalyzed enantioselective allylic alkylation chemistry has 
long been an important tool for organic synthesis, only relatively recently has 
palladium(II) π-allyl chemistry been used for the formation of quaternary stereocenters.9  
The vast majority of palladium-catalyzed allylic alkylations studied by Trost, Helmchen, 
Pfaltz, and others form tertiary stereocenters by the attack of stabilized (e.g., malonate) 
                                                
† This work was performed in collaboration with Douglas C. Behenna, John A. Enquist, Jr., Andrew M. 
Harned, Akihiko Iwashita, Michael R. Krout, Samantha R. Levine, Sandy Ma, Smaranda C. Marinescu, 
Ryan M. McFadden, Zoltán Novák, Krastina V. Petrova, Jennifer L. Roizen, Masaki Seto, Nathaniel H. 
Sherden, Kousuke Tani, Scott C. Virgil, and David E. White.  Portions of this work have been published as 
indicated by references in the text. 
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anions on prochiral 1,3-disubstituted allyl fragments.9  Helmchen has shown that such 
reactions with palladium phosphinooxazoline (PHOX) complexes typically occur via an 
outer-sphere malonate attack at the allyl termini.10  Although allylic alkylation mediated 
by other metals, especially copper,11 has successfully generated quaternary centers on 
prochiral allyl groups, to our knowledge this mode of reactivity has not been realized 
with palladium.12 
An alternative, less common strategy in allylic alkylation is the use of prochiral 
nucleophiles.  A quaternary stereocenter may be formed on the prochiral nucleophile 
when it possesses three distinct substituents.  Such reactions require a remote chiral 
ligand to discriminate between the prochiral faces of an incoming nucleophile, and thus 
may seem a more challenging strategy.  However, Hayashi,13 Ito,14 and Trost15 have 
demonstrated the asymmetric allylation of prochiral enolates derived from 1,3-dicarbonyl 
compounds.  Trost and co-workers demonstrated that diamine-derived ligands 103 and 
103, which were designed to project bulk forward of the allyl fragment due to their large 
bite angle, are able to favor one face of the in situ-generated ketone enolate (Scheme 
2.1).16,17,18  These reactions represented a significant advance in asymmetric allylation 
technology by forming quaternary stereocenters with excellent yield and good ee.  
However, the substrate scope of these reactions was limited by the restriction that the 
ketones must contain either a single acidic site (e.g., ketone 95 and tetralone 97) or two 
α-sites that have a large difference in acidity (e.g., β-ketoester 99 and α-phenyl ketone 
101).1d  These limitations prevented direct access to simple α-quaternary ketones, such as 
2-allyl-2-methylcyclohexanone (106), a cyclohexanone derivative not known as a single 
enantiomer prior to our work.19 
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Scheme 2.1.  Trost’s allylic alkylation with prochiral nucleophiles 
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We were confronted by these limitations during studies toward the synthesis of 
several natural products.20  A survey of the literature revealed that the nonenantioselective 
alkylation reactions developed by Tsuji in the early 1980s had the proper reactivity and 
selectivity to form quaternary stereocenters in the presence of less substituted ketone α-
sites of similar acidity.  Allyl enol carbonate and allyl β-ketoester substrates contain both 
the latent enolate and allyl fragments (Scheme 2.2a and b).21  Alternatively, enol acetates 
and silyl enol ethers may serve as enolate precursors in intermolecular reactions with 
allyl carbonates (Scheme 2.2c and d).22  These alkylations have the advantage that the 
reaction occurs under nearly neutral conditions and often at mild temperatures.  Despite 
these advantages, these alkylation reactions had been utilized rarely during the 
intervening twenty years between 1983 and the time we began research in 2003.23,24 
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Scheme 2.2.  Tsuji’s allylic alkylation methods 
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Our analysis of Tsuji’s alkylation reaction showed it to be an ideal candidate for 
asymmetric catalysis.  These high yielding alkylation methods are a clear case of ligand-
accelerated catalysis, occurring only in the presence of phosphine ligands.25  Of 
additional interest was the regiochemical fidelity observed in the alkylation reactions 
(Scheme 2.3).  Tsuji demonstrated that both the tetrasubstituted allyl enol carbonate 
isomer 105 and the trisubstituted allyl enol carbonate isomer 112 undergo reaction to give 
allylated ketones 106 and 113 in ratios essentially unchanged from that of the 
substrates.21a  These reactions were believed to proceed via oxidative addition of Pd to the 
allyl fragment followed by loss of CO2 to give [Pd(II)(allyl)] complex 114 and enolate 
115.  However, the details involving the recombination of the ion pair to give 
cyclohexanone 106 and Pd(0) were unclear at the time of Tsuji’s original reports.26,27  
Coupled with the ability to purify the stable enolate precursors, we believed that the 
regiochemical fidelity afforded in the palladium-catalyzed reaction would provide direct 
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access to enantioenriched α-quaternary ketones if a suitable chiral ligand could be 
found.28 
Scheme 2.3.  Regiochemical fidelity in Tsuji’s palladium-catalyzed alkylation 
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2.2 SCREENING AND OPTIMIZATION 
2.2.1 INITIAL SCREENING OF CHIRAL LIGANDS 
Our initial goal was to show that a chiral ligand could transmit useful levels of 
asymmetric induction in the reaction while maintaining the important property of enolate 
regiochemical fidelity found in the nonenantioselective system.  We chose allyl enol 
carbonate 105 as a test substrate to evaluate the effect of various ligands (Table 2.1).  
Although allyl enol carbonates are less common than the other enolate precursors 
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explored by Tsuji, they allowed us to add a single, achiral reagent to our catalyst system 
without extraneous initiators or counterions that might affect enantioselectivity, whereas 
silyl enol ether, enol acetate, and β-ketoester substrates did not.  In accord with Tsuji’s 
reports, we performed our initial trials in dioxane.  Due to the prevalence of 
bis(phosphine) ligands in asymmetric catalysis, we began with several privileged 
bis(phosphine) ligands, but found that only Trost’s ligand 103 gave significant ee.  
However, commercially available (R)-QUINAP (120), a chelating N/P-type ligand,29 
gave more uniform ee with other ethereal solvents (cf. entries 5 and 6 in dioxane and 
THF).  Encouraged, we quickly found that the phosphinooxazoline (PHOX) class of N/P-
type ligands also provided excellent reactivity and promising levels of enantioselectivity.  
The ready availability of numerous amino acid-derived PHOX ligands30 allowed us to 
rapidly identify that bulkier aliphatic groups on the oxazoline provided higher levels of 
enantioinduction, with (S)-t-Bu-PHOX (55) providing α-quaternary ketone 106 in 86% 
ee when dioxane was used as solvent.  Additionally, we observed slightly higher ee in 
reactions with (R)-i-Pr-PHOX (122) and (S)-t-Bu-PHOX (55) when THF was used as 
solvent (83% and 88% ee, respectively).31  Having attained satisfying levels of 
enantioselectivity and selectivity in forming ketone 106, we began a more thorough 
investigation of reaction conditions. 
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Table 2.1.  Initial ligand screen 
(R)-MOP (119)
OMe
PPh2
(R)-BINAP (116) (R,R)-Me-DUPHOS (117) (R,R)-DIOP (118)
(R)-QUINAP 
(120)
(R,R)-Trost ligand 
(103)
R = Bn
(S)-Bn-PHOX (123)
R = Ph
(R)-Ph-PHOX (121)
entry ligand time (h) % yielda % eeb
5 (R,R)-Trost ligand (103) 5 92 64c
1 (R)-BINAP (116) 5 76 2c
2 (R,R)-Me-DUPHOS (117) 5 66 0
3 (R,R)-DIOP (118) 2 59 2c
4 (R)-MOP (119) 3 47 13
6 (R)-QUINAP (120) 2 97 61
7 (R)-Ph-PHOX (121) 2 95 65c
8 (S)-Bn-PHOX (122) 5 94 63
9 (R)-i-Pr-PHOX (123) 2 95 83c
10 (S)-t-Bu-PHOX (55) 2 96 88
O O
O
Oligand (12.5 mol%)
Pd2(dba)3 (5 mol%)
solvent (0.033 M), 25 °C
R = i-Pr
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CO2
105 (S)-106
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time (h) % yielda % eeb
2 97 46c
5 92 5c
5 61 0
2 91 2c
3 93 18
2 98 61
2 95 62c
3 96 65
3 96 82c
2 95 86
NH HN
O O
PPh2 Ph2P
PPh2
PPh2
P P
O
O PPh2
PPh2
N
PPh2
Ph2P N
O
R
Ph2P N
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R
 
a GC yield of 106 relative to internal standard (tridecane).  b Enantiomeric excess measured by 
chiral GC.  c (R)-106 produced as the major product. 
 
2.2.2 OPTIMIZATION OF REACTION PARAMETERS 
The straightforward experimental procedure for asymmetric alkylation provided 
several opportunities to optimize the reaction.  One important experimental parameter 
was found to be complexation time for the (S)-t-Bu-PHOX (55) and 
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3).  A 30 min complexation time 
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resulted in a balance between short complexation times (e.g., 5 min), in which lower 
yields but complete consumption of the substrate were observed, and longer 
complexation times (e.g., 1–3 h) in which poor conversion was observed.  Long 
complexation times seemed to be complicated by adventitious amounts of O2 that readily 
oxidized the ligated PHOX molecule at phosphorus, thereby preventing significant 
consumption of the starting material.27  We have independently synthesized (S)-t-Bu-
PHOX oxide (125) and found that when used as a ligand for the conversion of tetralone-
derived allyl enol carbonate 124 to ketone 98 no reaction was observed (Scheme 2.4).32   
Scheme 2.4.  Inactivity of (S)-t-Bu-PHOX oxide as an allylation catalyst 
O O
O
Ph2P N
O
t-Bu
O
125
Pd2(dba)3 (5 mol%)
dioxane, 25 °C, 24 h
(12.5 mol%)
124
O
(S)-98
(not observed)  
We also investigated the effect of concentration on the reaction (Table 2.2).  At 
higher concentrations, significantly lower yields were observed, as well as slightly 
decreased ee.  No further increase in enantioselectivity was observed below 0.03 M. 
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Table 2.2.  Effect of concentration on asymmetric allylation 
O O
O
O
(S)-t-Bu-PHOX (12.5 mol%)
Pd2(dba)3 (5 mol%)
dioxane, 25 °C
0.1 mmol scale
105 106
entrya concentration (M) time (h) % yieldb % eec
1 0.500 3 81 82
2 0.250 2 90 84
3 0.125 2 94 84
4d 0.063 2 99 85
5 0.031 2 95 86  
a Data reported are the average of three trials.  b GC yield relative to internal standard (tridecane).    
c Enantiomeric excess measured by chiral GC.  d Data reported are the average of two trials. 
Encouraged by our initial discovery that reactions in THF gave better levels of 
enantioinduction than those in dioxane, we undertook a more thorough study of solvent 
effects on the reaction (Table 2.3).  Many of the ethereal solvents investigated gave good 
results.  Diethyl ether, t-butyl methyl ether (TBME), and diisopropyl ether all provided 
good yields and slightly higher ee than reactions in THF with allyl enol carbonate 105 
(entries 3–5).  However, the methyl tetralone-derived allyl enol carbonate 124 yielded 
products with substantially lower ee in diethyl ether and TBME.  The poor solubility of 
the catalyst system in these less-coordinating ethereal solvents occasionally led to 
incomplete conversion, a disadvantage that outweighed the slight increase in ee.  
Interestingly, several non-ethereal solvents also performed well in the reaction.  
Reactions in benzene and toluene gave similar yield and enantioselectivity to those in 
THF (entries 8 and 9).  The reaction tolerated carbonyl-containing solvents: ethyl acetate 
(entry 10) provided good yields and enantioselectivity in the asymmetric allylation, while 
acetone (entry 11) afforded inferior yield and enantioinduction.  Interestingly, 
triethylamine produced a level of enantioselectivity equal to that observed with the best 
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ethereal solvents, albeit with lower yield (entry 12).  Halogenated solvents fared poorly in 
the reaction, suffering from low conversion and yield (entries 13–15).  Overall, we were 
intrigued by the variety of solvents with vastly different properties that performed equally 
well. 
Table 2.3.  Effect of solvent on asymmetric allylation 
O O
O
O(S)-t-Bu-PHOX (12.5 mol%)
Pd2(dba)3 (5 mol%)
solvent (0.031 M), 25 °C
0.1 mmol scale
106 or 98
entry solvent time (h) % yieldc % eed time (h) % eee
1 dioxane 1 872 95 86
98a,b
2 1 882 96 88tetrahydrofuran
3 1 802 98 89diethyl ether
4 1 782 98 89t-butyl methyl ether
5 diisopropyl ether 2 95 89
6 3 82 81anisole
7 2 72 561,2-dimethoxyethane
8 1 892 99 88benzene
9 1 872 99 88toluene
10 2 97 86ethyl acetate
11 acetone 3 26 60
12 2 72 89triethylamine
13 3 58 51fluorobenzene
106a
14 3 42 13dichloromethane
15 6 0 NAchloroform
105 or 124
– –
– –
– –
– –
– –
– –
– –
– –
– –  
a Data reported are the average of three trials.  b All reactions proceeded to complete conversion 
except entries 13–15.  c GC yield relative to internal standard (tridecane).  d Enantiomeric excess 
measured by chiral GC.  e Enantiomeric excess measured by chiral HPLC. 
 
2.2.3 FINE TUNING OF PHOSPHINOOXAZOLINE LIGANDS 
A substantial effort was undertaken to improve the enantioselectivity of the reaction 
by modifying the PHOX ligand structure (Table 2.4).33  Hoping to continue the trend of 
increasing enantioselectivity initially noted in moving from i-Pr- to t-Bu-PHOX (entries 2 
and 4), we undertook the synthesis of numerous PHOX ligands with varied sterics and 
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evaluated these ligands in the reaction of allyl enol carbonates 105 and 124.  In general, 
ligands bearing saturated substituents performed better than those with aryl groups in 
terms of ee.  Moving the steric bulk away from the oxazoline framework by inserting a 
methylene group (i.e., ligand 127, entry 6) substantially lowered enantioselectivity.  Of 
particular note are the L-serine-derived ligands 131 and 132 (entries 10 and 11),34 which 
allowed access to the enantiomeric R product series with nearly the same level of 
enantioselectivity as that observed with (S)-t-Bu-PHOX (55), but without the need for 
more costly (R)-tert-leucine.35  The known cis-1-amino indan-2-ol-derived ligand 133 
and borneol-derived ligand 134, both with uniquely shaped substituents, gave slightly 
lower enantioselectivity relative to t-Bu-PHOX (55).36  It is noteworthy that regardless of 
the shape or type of the substituent on the PHOX ligand, the ketone products contained 
quaternary stereocenters with a consistent sense of configuration (e.g., (S)-PHOX ligands 
provide (S)-106).  With t-Bu-PHOX (55) established as the optimal steric framework, we 
next considered the electronics of the ligand.37 
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Table 2.4.  Effect of phosphinooxazoline sterics on asymmetric allylation 
(S)
O O
O
O
Ligand (12.5 mol%)
Pd2(dba)3 (5 mol%)
THF (0.031 M), 25 °C
0.1 mmol scale
106 or 98
entry ligand % eebproducta
Ph2P N
(S)
O
R
Ph2P N
O
R
123, R = Bn
55, R = t-Bu
126, R = 1-Adamantyl
127, R = CH2-t-Bu
128, R = CH2-1-Naphthyl
121, R = Ph
129, R = Cy
122, R = i-Pr
130, R = CHPh2
131, R = C(Me)2OBn
132, R = C(Me)2OTBS
Ph2P N
O
133
Ph2P N
O
134
1 65 (R)121 106
2 83 (R)122 106
3 63 (S)123 106
4 88 (S)55 106
5c 78 (S)126 98
6 59 (S)127 98
7 41 (S)128 106
(R)
(R)(R)
(S)
entry ligand % eebproducta
8 83 (R)129 106
9 69 (R)130 106
10 85 (R)131 98
11 85 (R)132 98
12 79 (S)133 98
13 81 (S)134 98
105 or 124
 
a All reactions proceeded to complete conversion.  b Enantiomeric excess measured by chiral HPLC 
or GC.  c Reaction run at 0.2 M in dioxane. 
A number of t-Bu-PHOX derivatives were synthesized to probe the importance of 
phosphine electronics (Table 2.5).  We investigated ligands ranging from electron rich to 
electron poor phosphines with allyl enol carbonates 124 and 105 (entries 1–7 and 8–14, 
respectively).  The electronic perturbation had no significant effect on reaction yield, but 
ligands bearing electron withdrawing groups (especially CF3 groups) gave a significant 
increase in the rate of reaction with allyl enol carbonate substrates.33a  Further, electron 
releasing para substituents on the phenyl rings tended to lower the ee of the product 
relative to that observed with (S)-t-Bu-PHOX (entries 1 and 8).  When tetralone-derived 
allyl enol carbonate 124 was used as the substrate, a slight increase in enantioselectivity 
was observed with electron withdrawing substitution at the p-phenyl positions (entries 3–
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5).  However, enantioselectivity decreased significantly with extremely electron poor 
PHOX ligands (entries 6 and 7).  This trend was not apparent in the enantioselectivity 
with cyclohexyl-derived allyl enol carbonate 105 (entries 8–14).  These results suggest a 
subtle interplay between ligand and substrate electronics. 
Table 2.5.  Effect of phosphine electronics on asymmetric allylationa 
O O
O
O
Ligand (12.5 mol%)
Pd2(dba)3 (5 mol%)
solvent (0.031 M), 25 °C
0.1 mmol scale
entry ligand
1 81
% eebsolvent
135 dioxane
2 8755 dioxane
3 88136 dioxane
4 89137 dioxane
5 90138 dioxane
6 83142 dioxane
7 81143 dioxane
124
entry ligand % eedsolvent % yield
c
8 86139 THF 99
9 8855 THF 96
10 89140 THF 99
11 88136 THF 95
12e 87137 THF 97
13e 88138 THF 89
14 87141 THF 99
electron rich
electron poor
electron rich
electron poor
98
O O
O
O
Ligand (12.5 mol%)
Pd2(dba)3 (5 mol%)
solvent (0.031 M), 25 °C
0.1 mmol scale105 106
PH N
O
t-Bu
R1
135, R1 = Me, R2 = H
55, R1 = H, R2 = H
136, R1 = F, R2 = H
137, R1 = CF3, R2 = H
138, R1 = H, R2 = NO2
P N
O
t-BuAr
Ar
142, Ar = m-(CF3)2C6H3
143, Ar = C6F5139, R1 = H, R2 = OMe
140, R1 = H, R2 = CF3
P N
O
t-BuAr
Ar
141, Ar = p-(CF3)C6H4
CF3
Ph2P N
O
t-Bu
R2
2
 
a All reactions proceeded to complete conversion.  b Enantiomeric excess measured by chiral 
HPLC.  c GC yield relative to internal standard (tridecane).  d Enantiomeric excess measured by 
chiral GC.  e Data reported are the average of two trials. 
As a final investigation into the PHOX ligand structure, we prepared a number of 
non-N/P mixed chelates based on the phenyl oxazoline skeleton of the PHOX ligands.  
As mentioned above, the phosphine oxide of t-Bu-PHOX (125) was inactive as a catalyst 
(Scheme 2.4).  A sulfur analogue (144) also failed to catalyze the reaction (Table 2.6, 
entry 1).38  Moving down the periodic table from phosphorus, the arsenic analogue of t-
Bu-PHOX (145) had excellent activity as a catalyst, but gave tetralone 98 in only 
moderate ee (entry 2).  A nitrogen analogue (146) showed little catalytic activity, and the 
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small amount of product produced was nearly racemic (entry 3).  As a final derivative 
that maintains the six-membered chelation, but changes the hybridization of the backbone 
atoms involved, a known phosphinite ligand, SimplePHOX (147), was found to give only 
moderate ee (entry 4).39 
Table 2.6.  Effect of varied heteroatom chelates on asymmetric allylation 
O
Ph2P N
O
t-Bu
O O
O
OLigand (12.5 mol%)
Pd2(dba)3 (5 mol%)
dioxane (0.2 M), 25 °C
0.1 mmol scale
entry ligand % eeb
PhS N
O
t-Bu
98124
% conversion
1 0a ND
522 99a
Ph2N N
O
t-Bu
NO2
Ph2As N
O
t-Bu
entry ligand % eeb% conversion
3 <5a 7
564 87c
144
145
146
147  
a Conversion estimated by TLC analysis.  b Enantiomeric excess measured by chiral HPLC.  c Trial 
performed with allyl enol carbonate 105.  Conversion measured by GC relative to internal standard 
(tridecane).  Enantiomeric excess measured by chiral GC. 
Although some electron deficient derivatives of t-Bu-PHOX did provide slightly 
better enantioselectivity with certain substrates, ultimately this slight improvement did 
not offset the added difficulty in synthesizing substituted PHOX ligands.33  Our studies 
clearly showed that N/P chelates were particularly effective at inducing high levels of 
asymmetry in the allylation.  As a result, we retained the use of (S)-t-Bu-PHOX (55) in 
our optimized conditions for exploring the scope of the reaction. 
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2.3 SUBSTRATE SCOPE 
2.3.1 ASYMMETRIC ALLYLATION OF ALLYL ENOL CARBONATES 
We have successfully employed a variety of allyl enol carbonates in our asymmetric 
Tsuji allylation (Table 2.7).40  The allyl group may be substituted at the internal position 
resulting in slightly higher levels of asymmetric induction (entry 4).  The cyclic portion 
may be unsaturated (entry 5), substituted (entries 6–11), appended (entries 12 and 13), or 
enlarged (entries 14 and 15).  Among these variations, several are particularly 
noteworthy: the presence of a conjugate acceptor enone (entry 5) does not lead to 
Michael addition products, highlighting the essentially neutral reaction conditions; 
quaternary stereocenters may be synthesized vicinal to preexisting fully substituted 
carbons (entry 8); the temperature may be lowered in order to improve enantioselectivity 
when highly reactive substrates are employed (entries 12 and 13), although the reaction 
time increases significantly.41  Overall, we were pleased to find that a wide range of 
functionalized enantioenriched cycloalkanones were accessible by this method. 
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Table 2.7.  Substrate scope for asymmetric allylation of allyl enol carbonates 
entry producta % yieldb % eec
O
O
O
R
151, R = CH2CH3
152, R = t-Bu
153, R = CH2Ph
154, R = (CH2)3OBn
O
O
R
98, R = H
156, R = OCH3
O
O O
O
n
O
1 7
8g
9
10
5 12i
13i
157, n = 1
158, n = 2
85 87
2d 85 88 (96)e
3f 90 89
96 92
55h 82
96 85
87 88
91 89 87 91
94 91
81 87
90 79
2
% yieldb % eecentry producta
11 94 92
6 87 86
4g 89 91
14
15
R'
O O
O
O
R'
Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX (55)
(12.5 mol%)
THF, 25 °C
R''
R''R
R
106
148
149
150
155
 
a Reactions were performed using 1.0 mmol of substrate in THF (0.033 M in substrate) at 25 °C 
with 2.5 mol% Pd2(dba)3 and 6.25 mol% (S)-t-Bu-PHOX (55), unless otherwise noted.  Each 
reaction is complete in 1–10 h.  b Isolated yields.  c Measured by chiral GC or HPLC.  d Performed 
on 5.1 mmol scale.  e In parentheses is the % ee after one recrystallization of the corresponding 
semicarbazone.  f Reaction performed at 12 °C (GC yield).  g Performed with 5 mol% Pd2(dba)3 and 
12.5 mol% (S)-55.  h Isolated yield after conversion to the corresponding diketone via Wacker 
oxidation.  i Performed at 10 °C. 
At the time of our investigations, 2-allyl-2-methylcyclohexanone (106) was not 
known in enantioenriched form.  Consequently, we wished to determine the absolute 
stereochemistry for several of our substrates (Scheme 2.5).  To definitively assign the 
absolute stereochemistry of the newly formed quaternary stereocenter, we prepared the 
corresponding semicarbazone 159.  This derivative is highly crystalline, and 
recrystallization from EtOH/H2O or toluene produced material of near enantiopurity 
(>98% ee).42,43  Treatment of the semicarbazone with amine 160 of known absolute 
stereochemistry in refluxing xylenes gave the substituted semicarbazone 161.  Amino-
substituted semicarbazone 161 also proved to be crystalline and amenable to single-
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crystal X-ray analysis when recrystallized from acetone.44  As the absolute 
stereochemistry of the isopinocampheylamine portion of semicarbazone 161 was known, 
the quaternary stereocenter set during the alkylation could be assigned S configuration.  
An analogous sequence was performed to prepare ethyl quaternary semicarbazone 162, 
which confirmed that it, too, is of S configuration.44  Having established the absolute 
configuration of the parent alkylation product, ketone (S)-106 could be transformed in a 
straightforward manner to trimethyl ketone 155 and enone 149 (Scheme 2.5b), 
compounds also available directly by asymmetric alkylation (see Table 2.7).  These 
transformations confirmed that the alkylation reaction forms ketone 155 and enone 149 
with the same sense of absolute configuration.  Finally, the S configuration of tetralone 
98 was confirmed by comparison with literature data.16b  Based on the consistent sense of 
enantiofacial selectivity, the stereochemistries of the remaining allylation products in 
Table 2.7 were inferred by analogy. 
Scheme 2.5.  Determination of absolute stereochemistry 
O
R
1. semicarbazide•HCl
    pyridine, MeOH, H2O
    105 °C, 15 min
       
2. Recrystalization from
    EtOH/H2O to 95% ee
N
R
61% yield
HN
106, R = CH3
xylenes, reflux
2 h
88% yield
R
N
HN
NHO
(S)
(S)
(S)
(R)
H2N
160
(S)
O
106
(S)
O
155
(S)
O
149
1. TMSCl, Et3N
    NaI, CH3CN
2. Pd(OAc)2 
    O2, DMSO
1.  LDA, THF
     then MeI
2.  LDA, THF
     then MeI
81% yield
a)
b)
11% yield
O NH2
159, R = CH3
161, R = CH3
162, R = CH2CH3
X-ray structures
(S)
84% yield
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Our use of allyl enol carbonates enabled direct access to α-quaternary ketones with 
multiple acidic sites.  However, allyl enol carbonates are rarely encountered in the 
literature, and the synthesis of isomerically pure enol carbonates45 often required the 
synthesis of silyl enol ethers. Since Tsuji had used silyl enol ethers in his non-
enantioselective allylation, we contemplated adapting our conditions such that silyl enol 
ethers could be employed directly. 
 
2.3.2 ASYMMETRIC ALLYLATION OF SILYL ENOL ETHERS 
Silyl enol ethers are commonly encountered enolate equivalents.  Unlike allyl enol 
carbonates, silyl enol ethers render the alkylation reaction intermolecular, with the 
enolate precursor and allyl fragment introduced separately.  We discovered in our initial 
studies that silyl enol ethers were not sufficiently nucleophilic to react with the 
[Pd(II)(allyl)] fragment under our reaction conditions at 25 °C.  However, we found that 
the reaction could be initiated in the presence of tetra-n-butylammonium 
difluorotriphenylsilicate (TBAT), a commercially available dry fluoride source. 
The use of TBAT as an initiator complicated the proposed catalytic cycle (Scheme 
2.6).  In the case of allyl enol carbonates, the oxidative addition to allyl carbonate 105 
and rapid decarboxylation led directly to the enolate/[Pd(II)(allyl)] ion pair, which could 
collapse directly to the product (Scheme 2.3).  For the intermolecular reaction, we 
primarily used diallyl carbonates as allyl precursors, although mixed carbonates were also 
effective.  Oxidative addition of allyl carbonates occurred readily at 25 °C to give 
[Pd(II)(allyl)] species 114, CO2, and an alkoxide.  The addition of TBAT immediately 
generated the enolate, which we imagined would react with palladium complex 114 by 
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the same enantioselective mechanism observed with allyl enol carbonates.  A 
substoichiometric amount of TBAT was sufficient, as the alkoxide formed in the reaction 
is also capable of providing the enolate in situ.  In principle, it should be possible for the 
small amount of allyl alkoxide generated from oxidative addition to initiate the reaction.46  
In practice, we found that 35 mol% TBAT was usually sufficient to ensure complete 
conversion of the silyl enol ether (110).  Having developed an effective means of silyl 
enol ether activation, we attempted asymmetric alkylation with a range of tetrasubstituted 
silyl enol ethers. 
Scheme 2.6.  General catalytic cycle for silyl enol ether alkylation 
or
Pd0Ln*
O OR
O
CO2
PdIILn*OR
114
OTMS
110
ORF
TMSF
or
TMSOR
PdIILn*
114
O
O
106
115
 
Gratifyingly, alkylation of the silyl enol ether substrates occurred with levels of 
enantioinduction similar to those observed for the allyl enol carbonate substrates and over 
a similar range of substrates (Table 2.8).  Specifically, methyl- and ethyl-substituted 
quaternary ketones were produced with the same ee observed in the allyl enol carbonate 
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reactions (entries 1 and 2).  Tertiary ether stereocenters were accessible from an α-
oxygenated silyl enol ether, albeit with moderate enantioselectivity (entry 3).  In addition 
to diallyl carbonate, dimethallyl carbonate served as a suitable allyl fragment precursor 
(entries 4 and 5).  Interestingly, 2-allyl-2-methallylcyclohexanone (164), bearing only a 
remote methyl group to engender chirality, formed in 91% ee.  As with the reactions of 
allyl enol carbonates, substitution about the ring and larger ring sizes were tolerated as 
well (entries 6–8).47 
Table 2.8.  Substrate scope for asymmetric allylation of silyl enol ethers 
R'
OTMS O
R'
Pd2(dba)3 (2.5 mol%)
(S)-t-Bu-PHOX (55)
(6.25 mol%)
TBAT (35 mol%)
THF, 25 °C
R''
R R
entry % yieldb % eecproducta
O
R
106, R = CH3
151, R = CH2CH3
O
O O
O
n
O
R
1
2
4d
6
157, n = 1
158, n = 2
7
8
95 87
96 92
79 91
99 81
94 86
96 79
163, R = OBn3 83 59
148, R = CH3
5d 82 91164, R = allyl
entry % yieldb % eecproducta
O O
O
R'' R''
150
 
a Reactions were performed using 1.0 mmol of substrate in THF (0.033 M in substrate) at 25 °C 
with 2.5 mol% Pd2(dba)3, 6.25 mol% (S)-t-Bu-PHOX (55), diallyl carbonate (1.05 equiv), and 
TBAT (35 mol%) unless otherwise noted.  Each reaction was complete in 2–5 h.  b Isolated yields.  
c Measured by chiral GC or HPLC.  d Reaction performed with dimethallyl carbonate (1.05 equiv). 
In addition to the flexibility afforded by the intermolecular reaction of silyl enol 
ethers and diallyl carbonates, the use of silyl enol ethers as a means to generate enolates 
independent of the allyl fragment allowed the catalytic cycle to commence at the stage of 
a [Pd(II)(allyl)] complex 165 (Scheme 2.7).  Upon mixing (S)-t-Bu-PHOX, 
[Pd(allyl)Cl]2, and NH4PF6 in ethanol,48 [Pd(II)(allyl)PHOX]+[PF6]– salt 165 readily 
precipitated and this solid could be recrystallized and characterized crystallographically 
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as a partial EtOH adduct.49  The complex (165) served as an active catalyst in the enol 
silane variant of our enantioselective alkylation reaction, giving good yield and nearly 
identical product ee compared to that observed with the in situ-generated catalyst.  The 
Pd(II)PF6 salt 165 has several practical advantages: it is an air stable, nonhygroscopic 
solid that may be stored indefinitely.  Moreover, using the preformed [Pd(allyl)PHOX] 
catalyst obviated the introduction of dibenzylideneacetone (dba), which often 
complicated the purification of the α-quaternary ketone products.50 
Scheme 2.7.  Allylation with Pd(II)PF6 salt 165 
165 (10 mol%)
OOTMS
106
Ph2P N
O
t-Bu
[Pd(allyl)Cl]2
NH4PF6
EtOH, 22 °C
99% yield
55
diallyl carbonate
TBAT (37 mol%)
THF, 25 °C, 1 h
79% yield, 86% ee
X-ray structure of 165•(EtOH)
N
O
t-Bu
P
Ph
Ph
Pd
PF6
•EtOH
165
110  
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2.4 SYNTHETIC APPLICATIONS 
The α-quaternary cycloalkanones produced in the asymmetric Tsuji alkylation are 
highly useful chiral building blocks.  Each substrate contains at least two functional 
groups, a ketone and an olefin, for further manipulation.  Moreover, the preceding section 
has demonstrated these allylation reactions to be highly functional group tolerant.  The 
application of this suite of allylation reactions to the catalytic asymmetric synthesis of 
natural products is an ongoing topic of research in our laboratories.24 
To further demonstrate the utility of these products, we transformed ketone (S)-106 
into several familiar cyclic frameworks (Scheme 2.8a).  Wacker oxidation of (S)-106 
followed by aldol condensation gave enone 166 in good yield.  Another functionalized 
[6-5] skeleton was formed in a three-step sequence by olefin cross-metathesis with 
methyl vinyl ketone catalyzed by Grubbs’ second-generation Ru-complex 167,51 olefin 
hydrogenation, and aldol condensation under basic conditions to afford exocyclic enone 
168.  Carbocyclic [6-6] ring systems were accessible as well; multistep elaboration of the 
allyl group afforded an intermediate diketone, which underwent aldol condensation to 
enone 169 in 42% overall yield.  Enone 169, which has been classically produced by 
Robinson annulation, has been used extensively in synthesis.52  As a final transformation 
of (S)-106, we executed a Baeyer–Villiger oxidation with peracetic acid to give 
caprolactone 170.  This transformation demonstrates the conversion of our 
enantioenriched quaternary stereocenter into a latent tertiary alcohol with defined 
absolute stereochemistry and entry into acyclic systems.47 
Carbocyclic spiro compounds represent a particularly challenging subclass of 
quaternary stereocenters.  In addition to the fused cyclic skeletons above, allyl methallyl 
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ketone 164 was used as an entry into the synthesis of ring systems containing spiro 
quaternary stereocenters.  Ketone 164 could be treated with Grubbs’ second generation 
catalyst (167) in dichloromethane to give a good yield of the spiro[4.5]ketone 171 
(Scheme 2.8b).  Spiro[5.5]enone 173 was produced in modest yield by treatment of 
ketone 164 with standard ketal protection conditions, followed by ozonolysis, and 
exposure to base (Scheme 2.8c). 
Scheme 2.8.  Useful derivatives of enantioenriched cyclic ketones 
O
(–)-106
98% ee
O
O
(+)-170
O
(+)-168(–)-166
O
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3.  KOH, EtOH
     65 °C
63% yield, 3 steps
1.  PdCl2, O2
     Cu(OAc)2•H2O
     DMA, H2O
2.  KOH, EtOH
     60 ! 80 °C
73% yield, 2 steps
1.  ethylene glycol, PPTS
2.  BH3•THF; NaBO3•4H2O
3.  (COCl)2, DMSO, Et3N
4.  MeMgBr, THF
5.  (COCl)2, DMSO, Et3N
6.  TsOH•H2O, acetone, H2O
7.  KOH, EtOH, 60 °C
42% yield overall from 106
a)
O
O
(+)-164
O
(+)-164
O
(–)-171
OO
(+)-173
OO
CH2Cl2, 40 °C
85% yield
ethylene glycol
PhH, Dean-Stark
57% isolated yield
87% yield based
on recovered 
starting material
1.  O3, CH2Cl2
     –78 °C
     then Me2S
2.  KOH, EtOH
     75 °C
16% yield
b)
c)
167
(3 mol%)Ru
Cy3P
Cl
Cl
Ph
NMesMesN
Ru
Cy3P
Cl
Cl
Ph
NMesMesN
167
O
(+)-172  
Similar tactics have enabled the use of the enantioselective Tsuji allylation in a 
number of synthetic efforts.24  Ketone (S)-155 (Scheme 2.9a) was readily converted to 
enone 174, which could be recrystallized via the semicarbazone derivative to 97% ee.  
Enantioenriched enone 174 was then elaborated to the natural product dichroanone (175) 
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in seven additional steps.24a  A strategy comprising enantioselective allylation and ring-
closing metathesis was employed to synthesize the spirocyclic natural products 
laurencenone B (177) and elatol (178) from vinylogous ester 176 (Scheme 2.9b).24c  An 
ongoing effort toward the preparation of the marine alkaloid zoanthenol (180) featured α-
quaternary ketone 150 as a key synthon for the preparation of the ABC tricyclic 
substructure (179) of the target molecule (Scheme 2.9c).24b 
Scheme 2.9.  Enantioenriched cyclic ketones in the synthesis of natural products 
O
O
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a)
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97% ee91% ee
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O
O
HO
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11 total steps
O
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i-BuO
Cl
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O
Cl
(+)-Elatol (178)
9 total steps
HO
Cl
Br
c)
O
O
O
OMe
OMe O
OH
O
O
O
(–)-150
86% ee
O O
(–)-179
21 total steps Zoanthenol (180)  
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2.5 MISCELLANEOUS ALKYLATIONS USING THE PD•PHOX SYSTEM 
2.5.1 SYNTHESIS OF TERTIARY STEREOCENTERS FROM ACYCLIC 
ENOLATE PRECURSORS 
Although we have principally employed our asymmetric allylation for the synthesis 
of fully substituted stereocenters, the mild and nearly neutral conditions of the reaction 
are well suited for the synthesis of tertiary stereocenters α to carbonyls (Table 2.9).40d,40g  
Such stereocenters are prone to epimerization and over alkylation under the strongly 
basic conditions traditionally used for enolate generation.53  We found that the allyl enol 
carbonate 182 underwent allylation to form phenyl ketone (R)-181 in 67% ee (entry 1).  
In analogy to the results of Hou and co-workers,18d we found that the addition of AgBr 
gave a significant increase in the ee of the product (entry 2).  Both TMS (183)54 and TBS 
(184)55 enol ethers were competent enolate precursors when TBAT was used as an 
initiator (entries 3 and 4).  Unlike the tetrasubstituted silyl enol ethers, CsF proved to be 
the optimal fluoride source for the less-substituted silyl enol ethers, resulting in 
noticeably higher ee (entry 5).  Unfortunately, the use of AgBr in the presence of CsF 
greatly reduced reactivity and only slightly increased enantioselectivity (entry 6).  
Similarly, the use of ethyl ether as a solvent increased enantioselectivity at the cost of 
lowered yield (entry 7).  Although our allylation methods have provided tertiary 
stereocenters in only moderate ee, we have recently disclosed a decarboxylative 
protonation of quaternary allyl β-ketoesters based on a similar catalyst system that 
provides access to tertiary stereocenters α to ketones in excellent ee.56 
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Table 2.9.  Enantioselective allylation of enol carbonates and silyl enol ethers not contained in a ring 
entry % yielda % eeb
1
2
4d
79 67
75 79
82 73
3d 60 62
CO2allyl (182)
CO2allyl (182)
TMS (183)
additive
OR O
Pd2(dba)3 (2.5 mol%)
(S)-t-BuPHOX (6.25 mol%)
THF, 22 °C
AgBrc
TBATe
TBATe
(R)-181
none
CsFf
entry % yielda % eeb
7d,g 8238
5d 79 77
TMS (183)
TMS (183)
additive
CsFf
6d 20 79TMS (183)
CsFf
AgBrc
R
TBS (184)
R
 
a Isolated yield from reactions with 0.092 mmol of substrate in THF (0.092 M) with 2.5 mol% 
Pd2(dba)3 and 6.25 mol% (S)-t-Bu-PHOX (55), unless otherwise noted.  b Measured by chiral 
HPLC.  c Reaction with 40 mol% additive.  d Reaction performed with diallyl carbonate (1.05 
equiv).  e Reaction with 35 mol% additive.  f Reaction with 48 mol% additive.  g Performed in Et2O 
solvent. 
 
2.5.2 APPLICATION OF THE PD•PHOX CATALYST SYSTEM TO 
PROPARGYLATION 
In addition to allylation, we also explored propargylation of enol carbonates with the 
Pd•PHOX catalyst system (Table 2.10).57  Our preliminary studies found that 
propargylation of enol carbonate 185 required significantly higher temperatures than are 
needed for allylation.58  Additionally, the optimal structure of the PHOX ligand is 
significantly different for propargylation than for allylation.  Moving the bulk of the t-Bu 
group away from the oxazoline by insertion of a methylene group gave (S)-186 with 
higher ee (entries 1 and 2).  Unlike allylation (cf. Table 2.4), PHOX ligands prepared 
from phenylalanine derivatives gave higher enantioselectivity than those prepared from 
saturated amino acids, with the 9-anthracenylalanine derivative (189) giving the highest 
level of enantioselectivity (entry 7, Table 2.10).  Although still preliminary, these studies 
suggest that the Pd•PHOX catalyst system may find use outside allylation reactions.56 
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Table 2.10.  Enantioselective propargylation 
O O
O
O
Pd2(dba)3 (5 mol%)
THF (0.033 M), 70 °C
0.1 mmol scale
entry ligand % eeb% yielda
Ph2P N
O
R
1 1255, R = t-Bu 84
2 32127, R = CH2-t-Bu 83
3 2654
(S)
185 (S)-186
123, R = CH2Ph
Ligand
(12.5 mol%)
189, R = CH2-9-Anthracenyl
188, R = CH2-(3,5-di-t-Bu-Ph)
entry ligand % eeb% yielda
5 2671
6 2594
7 4480
187, R = CH2-2-Naphthyl
4 3757128, R = CH2-1-Naphthyl
 
a GC yield relative to internal standard (tridecane).  b Enantiomeric excess measured by chiral GC.  
In all cases, (S)-186 was the major enantiomer. 
 
2.5.3 SUBSTRATES PROCEEDING VIA WEAKLY BASIC ENOLATES 
The alkylation of substrates derived from ketones of unusually low pKa (i.e., 
stabilized enolates) as a group gave by far the lowest levels of enantioselectivity we have 
observed with the Pd•PHOX catalyst system (Table 2.11).  Despite the low selectivity, 
these substrates gave consistently excellent chemical yields of the allylated products.  It is 
noteworthy that the β-ketoester (entries 1 and 2) and α-phenyl ketone (entries 3 and 4) 
derived enolates that gave excellent enantioselectivity with Trost’s earlier asymmetric 
allylation reactions15,16b failed to give useful levels of enantioinduction under our 
conditions.  An oxazole (196), designed with the intention of executing an 
enantioselective synthesis of α,α-disubstituted amino acids, also underwent allylation 
with little enantioselectivity, presumably due to the stability of the intermediate aromatic 
enolate (entry 5).  The orthogonality of the substrate scope, in terms of asymmetric 
induction, between our method and Trost’s early reports may be indicative of 
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fundamentally different mechanisms underlying the two allylation reactions as has been 
an important piece of evidence in our mechanistic hypothesis.26,59 
Table 2.11.  Asymmetric alkylation via stabilized allyl enol carbonates 
entry % yielda % eeb
3 99 11c
substrate
OCO2allyl
Ph
O
Ph
product entry % yielda % eeb
5 89 2
substrate product
N
O
Ph
OCO2allyl
N
O
Ph
O
O
OCO2allyl
O
O
O O
OCO2allyl
CO2Et
O
CO2Et OCO2allyl O
4 93 0
2 87 2
1 89 24c
190 100
191 192
193 102 196 197
194 195
 
a Isolated yield from reactions with 1.0 mmol of substrate in THF (0.033 M) at 25 °C with 2.5 
mol% Pd2(dba)3 and 6.25 mol% (S)-t-Bu-PHOX (55).  Each reaction was complete in 2 h.  
b Measured by chiral GC or HPLC.  c Absolute stereochemistry of products assigned by analogy. 
 
2.6 SUMMARY 
In order to address a significant deficiency in the asymmetric alkylation literature, we 
have developed a strategy to prepare enantioenriched cycloalkanones in high yield.  This 
work provides direct access to valuable enantioenriched α-quaternary ketones from 
readily accessible enolate precursors.  Critical to our success was the use of enolate 
precursors, which can be converted to enolates under mild conditions, and the use of a 
chiral catalyst that exhibited the enolate isomeric fidelity found in Tsuji’s non-
enantioselective system.  The reactivity and enantioselectivity of the alkylation reactions 
have proven to be quite general with respect to substrate steric bulk, ring size, 
unsaturation, and diverse functional groups.  We have demonstrated the relevance of the 
α-quaternary ketones produced in the reaction by their conversion to a number of 
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carbocyclic chiral building blocks, including several spiro quaternary motifs, as well as in 
the asymmetric synthesis of the natural products dichroanone, laurencenone B, and elatol 
and an approach to zoanthenol.24  Studies directed toward further development of the 
scope of this reaction and catalyst system are ongoing.26,56  Additionally, the continued 
application of our asymmetric alkylation as a key enantiodetermining step in natural 
products synthesis will be reported in due course.24 
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2.8 EXPERIMENTAL SECTION 
2.8.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.  Tetrabutylammonium 
difluorotriphenylsilicate (TBAT) was purchased from Sigma-Aldrich and azeotropically 
dried five times from acetonitrile prior to use.  Bis(di(3,5-
dimethoxybenzylidene)acetone)palladium(0) (Pd(dmdba)2), alkyl halides, triethylsilyl 
chloride, diallyl carbonate, Select-fluor®, pimelic acid, and all other ketone starting 
materials were purchased from Sigma-Aldrich and used as received, unless otherwise 
noted.  Commercial 3-methylcyclohex-2-en-1-one, cyclohex-2-en-1-one, and NaH (60% 
dispersion in mineral oil) were purchased from Acros and used as received.  Dimethallyl 
carbonate was purchased from Alfa Aesar and used as received.  Trimethylsilyl chloride 
(TMSCl) and triethylamine were purchased from Sigma-Aldrich and distilled from 
sodium hydride immediately prior to use.  Sodium iodide was dried by heating at 90 °C 
(2 torr) for 12 h.  Molecular sieves were purchased from Aldrich as activated 5 µm 
powder and stored in a 120 °C drying oven until immediately prior to use unless 
otherwise noted.  Ligands (R,R)-Trost Ligand (103), (R)-BINAP (116), (R,R)-Me-
DUPHOS (117), (R,R)-DIOP (118), (R)-MOP (119), (R)-QUINAP (120), (R)-i-Pr-PHOX 
(122), (1S,2R)-cis-1-amino-indan-2-ol, and tris(dibenzylideneacetone)dipalladium(0) 
(Pd2(dba)3) were purchased from Strem and stored in a glovebox until immediately before 
use.  (R)-Ph-PHOX (121) and (S)-Bn-PHOX (123) were prepared by the method of 
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Helmchen.60  (S)-tert-Leucine was purchased from Aldrich or Degussa and used as 
received.  Other chiral amino acids were purchased from Chem-Impex International and 
reduced to the corresponding amino alcohols according to literature precedent,61 unless 
otherwise noted.  Methallyl chloroformate was prepared by the method of Kirby.62  
Ruthenium olefin metathesis catalysts were generously donated by Materia and stored 
under argon in a dessicator jar at –20 °C until just prior to use. 
Reaction temperatures were controlled by an IKAmag temperature modulator.  Thin-
layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, p-anisaldehyde, KMnO4 
or CAM staining.  ICN Silica gel (particle size 0.032–0.063 mm) was used for flash 
chromatography. Analytical chiral HPLC was performed with an Agilent 1100 Series 
HPLC utilizing chiralcel AD, OD-H, or OJ columns (4.6 mm × 25 cm) obtained from 
Daicel Chemical Industries, Ltd., with visualization at 254 nm.  Analytical chiral GC was 
performed with an Agilent 6850 GC utilizing a Chiraldex G-TA (30.0 m x 0.25 mm) 
column (1.0 mL/min He carrier gas flow).  Analytical achiral GC was performed with an 
Agilent 6850 GC utilizing an Agilent DB-WAX (30.0 m × 0.25 mm) column (1.0 
mL/min He carrier gas flow).  Optical rotations were measured with a Jasco P-1010 
polarimeter at 589 nm. 1H and 13C NMR spectra were recorded on a Varian Mercury 300 
(at 300 MHz and 75 MHz, respectively) or a Varian Inova 500 (at 500 MHz and 125 
MHz, respectively) and are reported relative to Me4Si (δ 0.0).  Data for 1H NMR spectra 
are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows:  s = singlet, d = doublet, t = triplet, q 
= quartet, sept. = septet, m = multiplet, comp. m = complex multiplet, app. = apparent, br 
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s = broad singlet.  Data for 13C NMR spectra are reported in terms of chemical shift 
relative to Me4Si (δ 0.0).  19F NMR spectra were recorded on a Varian Mercury 300 
spectrometer at 282 MHz, and are reported relative to the external standard F3CCO2H (δ 
–76.53 ppm) or CFCl3 (δ 0.0 ppm).  31P NMR spectra were recorded on a Varian Mercury 
300 spectrometer at 121 MHz, and are reported relative to the external standard H3PO4 (δ 
0.0 ppm).  Temperature controlled 1H NMR kinetic experiments were performed on a 
Varian Inova 500 MHz.  IR spectra were recorded on a Perkin Elmer Paragon 1000 
spectrometer and are reported in frequency of absorption (cm–1). High-resolution mass 
spectra were obtained from the Caltech Mass Spectral Facility.  Crystallographic data 
have been deposited at the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, and copies 
can be obtained on request, free of charge, by quoting the publication citation and the 
deposition number. 
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2.8.2 SYNTHESIS OF PHOX LIGANDS 
2.8.2.1 GENERAL PROCEDURES FOR SYNTHESIS OF PHOX LIGANDS 
PHPh2, CuI
N,N'-dimethylethylenediamine
Cs2CO3, toluene, 110 °C
81% yield
Br
Cl
O NaHCO3
H2O, DCM
90% yield
Br
N
H
O
205
Ph2P N
O
Br N
O
TsCl, Et3N
CH2Cl2, reflux
81% yield
206 (S)-55
H2N OH
OH
204203
 
Amide 205:  To a solution of (S)-t-leucinol (203)61 (3.57 g, 30.5 mmol, 1.0 equiv) in 
CH2Cl2 (100 mL) was added a solution of Na2CO3 (9.70 g, 91.5 mmol, 3.0 equiv) in 
water (75.0 mL).  To the vigorously stirred biphasic mixture was added 2-bromobenzoyl 
chloride (204, 4.58 mL, 35.1 mmol, 1.15 equiv) in a dropwise manner.  After 12 h 
ambient temperature, the layers were separated, and aqueous layer extracted with CH2Cl2 
(2 x 50 mL).  The combined organics were treated with KOH (15 mL of a 1 M 
methanolic solution) for 15 min, neutralized with 3 M HCl, and water (50 mL) was 
added. The layers were separated, and the aqueous layer extracted with CH2Cl2 (2 x 50 
mL).  The combined organics were dried (Na2SO4), evaporated, and the residue 
chromatographed (25→35% acetone in hexanes on SiO2) to give amide 205 (8.19 g, 
89.5% yield): mp 50–51 °C from acetone/hexanes; 1H NMR (300 MHz, CDCl3) δ 7.58 
(dd, J = 7.8, 0.9 Hz, 1H), 7.54 (dd, J = 7.5, 1.8 Hz, 1H), 7.34 (app. dt, J = 7.4, 1.1 Hz, 
1H), 7.26 (app. dt, J = 7.7, 1.8 Hz, 1H), 6.24 (bd, J = 8.1 Hz, 1H), 4.05 (m, 1H), 3.93 (dd, 
J = 11.4, 3.6 Hz, 1H), 3.66 (dd, J = 11.4, 7.5 Hz, 1H), 2.68 (br s, 1H), 1.03 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 168.7, 137.9, 133.3, 131.2, 129.7, 127.6, 119.0, 62.9, 60.2, 
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33.8, 27.1; IR (Neat Film NaCl) 3245, 3070, 2963, 1640, 1557 cm–1; HRMS (FAB) m/z 
calc'd for C13H19NO2Br [M + H]+:  300.0599, found 300.0590; [α]D29 +20.19 (c 2.38, 
methanol). 
Phenyloxazoline 206:60  A solution of amide 205 (8.10 g, 27.0 mmol, 1.0 equiv), 
tosyl chloride (6.69 g, 35.1 mmol, 1.3 equiv), triethylamine (18.7 mL, 135.0 mmol, 5.0 
equiv) in CH2Cl2 (200 mL) in a rb flask equipped with a reflux condenser was heated at 
55 °C for 22 h.  Water (28 mL) was added and heating was continued at 75 °C for 2 h.  
The reaction mixture was cooled, the layers separated, and the aqueous layer extracted 
with CH2Cl2 (2 x 25 mL).  The combined organics were dried (Na2SO4), evaporated, and 
the residue chromatographed (5% EtOAc in Hexanes on SiO2) to give phenyloxazoline 
206 (6.19 g, 81.2% yield): 1H NMR (300 MHz, CDCl3) δ 7.64 (app. dt, J = 8.7, 1.7 Hz, 
2H), 7.33 (app. dt, J = 7.7, 1.5 Hz, 1H), 7.26 (m, 1H), 4.38 (dd, J = 10.5, 8.9 Hz, 1H), 
4.25 (app. t, J = 8.3 Hz, 1H), 4.10 (dd, J = 10.2, 8.1 Hz, 1H), 1.00 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 162.8, 133.6, 131.4, 131.2, 130.2, 127.0, 121.8, 76.6, 69.0, 34.0, 25.9; IR 
(Neat Film NaCl) 2956, 1661, 1478, 1354, 1099, 1022, 963 cm–1; HRMS (FAB) m/z 
calc'd for C13H17NOBr [M + H]+: 282.0493, found 282.0488; [α]D29 –48.32 (c 3.77, 
hexane). 
(S)-t-Bu-PHOX (55):  A mixture of CuI (338.3 mg, 1.77 mmol, 0.125 equiv), 
diphenylphosphine (4.64 mL, 26.7 mmol, 1.88 equiv), N,N'-dimethylethylenediamine 
(1.32 mL, 12.4 mmol, 0.875 equiv) in toluene (60 mL) was stirred for 20 min at ambient 
temperature.  At this point, phenyloxazoline 206 (4.00 g, 14.2 mmol, 1.0 equiv), cesium 
carbonate (17.4 g, 53.3 mmol, 3.75 equiv), and toluene (60 mL) were added, the flask 
sealed and heated to 110 °C with stirring.  The reaction mixture became deep red after 
Chapter 2 – Enantioselective Allylic Alkylations of Enolates from Enol Carbonates and Silanes 83 
~15 min of heating.  After 6 h, the reaction mixture was allowed to cool to ambient 
temperature, filtered, and washed with CH2Cl2 (2 x 50 mL).  Evaporation of the solvent 
and chromatography (3→7% Et2O in Hexanes on SiO2) afforded the known60 (S)-t-Bu-
PHOX (4.48 g, 81.4% yield). 
 
2.8.2.2 CHARACTERIZATION DATA FOR NEW PHOX LIGANDS 
Ph2P N
O
O
125  
(S)-t-Bu-PHOX oxide (125, Scheme 2.4):  To a solution of (S)-t-Bu-PHOX (150 mg, 
0.387 mmol, 1.00 equiv) in THF (2.5 mL) was added a 5% aqueous H2O2 solution (1.94 
mL).  After 15 min the reaction mixture was diluted with EtOAc (5 mL) and brine (5 
mL), washed with 10% aqueous Na2CO3 (5 mL) and brine (5 mL), dried (MgSO4), and 
purified by flash chromatography on silica gel (5% MeOH in CH2Cl2) to give (S)-t-Bu-
PHOX oxide 125 (149.3 mg, 96% yield) as a white foam:  Rf  0.47 (10% MeOH in 
CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.95 (ddd, J = 7.5, 3.9, 1.2 Hz, 1H), 7.81-7.33 
(comp. m, 7H), 7.52-7.31 (comp. m, 7H), 3.84 (dd, J = 8.1, 8.1 Hz, 1H), 3.57 (dd, J = 
9.9, 9.9 Hz, 1H), 3.41 (dd, J = 9.9, 8.4 Hz, 1H), 0.77 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 163.1, 135.0 (d, J = 10.1 Hz), 133.7 (d, J = 107.1 Hz), 133.3 (d, J = 107.1 Hz), 132.6, 
132.4-131.0 (7 lines), 130.8 (d, J = 8.6 Hz), 130.3 (d, J = 11.7 Hz), 138.2 (app. dd, J = 
12.3, 1.4 Hz), 75.9, 68.8, 33.6, 25.8; 31P NMR (121 MHz, CDCl3) δ 30.3; IR (Neat Film 
NaCl) 3057, 2957, 2903, 2868, 2217, 1664, 1589, 1565, 1477, 1438, 1356, 1337, 1307, 
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1248, 1201, 1119, 1108, 1067, 1028, 963, 930, 905 cm–1; HRMS (FAB) m/z calc'd for 
C25H27O2NP [M]+: 404.1779, found 404.1799; [α]D27.6 –69.3 (c 1.96, CH2Cl2). 
 
Ph2P N
O
126  
(S)-(Adamant-1-yl)-PHOX (126, Table 2.4, entry 5):  Prepared by general 
procedure 1 from 2-(1-adamantyl)-glycine63 in 71% yield as a white solid; mp 163–164 
ºC; Rf = 0.59 (5:1 Hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.93 (m, 1H), 7.40-
7.20 (m, 12H), 6.85 (m, 1H), 4.11 (t, J = 9.0 Hz, 1H), 4.03 (t, J = 9.0 Hz, 1H), 3.73 (t, J = 
9.0 Hz, 1H), 1.85 (m, 3H), 1.68-1.46 (m, 6H), 1.44-1.34 (m, 3H), 1.24-1.14 (m, 3H); 13C 
NMR (75 MHz, CDCl3) δ 162.4 (d, JCP = 3 Hz), 138.8-138.3 (6 lines), 134.4 (d, JCP = 21 
Hz), 134.1, 133.4 (d, JCP = 20 Hz), 132.0 (d, JCP = 20 Hz), 130.3, 129.7 (d, JCP = 3 Hz), 
128.5-128.0 (7 lines), 76.8, 66.8, 38.2, 37.0, 35.3, 28.1; 31P NMR (121 MHz, CDCl3) δ –
5.67; IR (Neat Film NaCl) 3053, 2902, 2848, 1651, 1586, 1477, 1434, 1346, 1248, 1089, 
1044, 1026, 963, 744, 696 cm–1; HRMS (FAB) m/z calc’d for C31H33NOP [M + H]+: 
466.2300, found 466.2309; [α]D27 –31.8 (c 0.48, CHCl3). 
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Ph2P N
O
127  
(S)-Neopentyl-PHOX (127, Table 2.4, entry 6; Table 2.10, entry 2):  Prepared by 
general procedure 1 from D-neopentyl-glycine in 73% yield as a white solid; mp 83-86 
ºC; Rf = 0.52 (5:1 Hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.85 (ddd, J = 7.8, 3.6, 
1.5 Hz, 1H), 7.38-7.23 (m, 12H), 6.84 (ddd, J = 7.8, 4.5, 1.5 Hz, 1H), 4.25 (dd, J = 9.3, 
8.1 Hz, 1H), 4.03 (m, 1H), 3.58 (t, J = 8.1 Hz, 1H), 1.52 (dd, J = 14.1, 4.5 Hz, 1H), 0.93 
(dd, J = 14.1, 8.1 Hz, 1H), 0.84 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 163.0 (d, JCP = 3 
Hz), 138.7 (d, JCP = 25 Hz), 137.9 (d, JCP = 12 Hz), 137.8 (d, JCP = 10 Hz), 134.3 (d, JCP = 
21 Hz), 133.9 (d, JCP = 21 Hz), 133.5 (d, JCP = 2 Hz), 131.8 (d, JCP = 18 Hz), 130.3, 129.8 
(d, JCP = 3 Hz), 128.6-128.3 (6 lines), 127.9, 73.9, 64.0, 49.7, 30.0, 29.8; 31P NMR (121 
MHz, CDCl3) δ –3.95; IR (Neat Film NaCl) 3054, 2955, 1652, 1586, 1476, 1434, 1355, 
1248, 1089, 1035, 968, 742, 697 cm–1; HRMS (FAB) m/z calc’d for C26H29NOP [M + 
H]+: 402.1987, found 402.2002; [α]D26 –6.9 (c 1.03, CHCl3). 
 
Ph2P N
O
128  
(S)-(Naphth-1-ylmethyl)-PHOX (128, Table 2.4, entry 7; Table 2.10, entry 4):  
Prepared by general procedure 1 (S)-3-(1-napthyl)-alanine in 54% yield as a white 
amorphous solid; Rf = 0.29 (25% Et2O in Hexanes); 1H NMR (300 MHz, CDCl3) δ 8.00 
(m, 1H), 7.91 (m, 1H), 7.85 (m, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.56-7.45 (m, 2H), 7.42-
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7.28 (m, 13H), 7.16 (m, 1H), 6.87 (m, 1H), 4.55 (m, 1H), 3.97 (t, J = 8.4 Hz, 1H), 3.86 
(dd, J = 8.4, 7.2 Hz, 1H), 3.44 (dd, J = 14.4, 4.2 Hz, 1H), 2.39 (dd, J = 14.4, 10.2 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 164.1 (d, JCP = 3 Hz), 138.9 (d, JCP = 25 Hz), 137.84 
(d, JCP = 10 Hz), 137.79 (d, JCP = 12 Hz), 134.5 (d, JCP = 21 Hz), 134.0, 133.82 (d, JCP = 
21 Hz), 133.80, 133.5 (d, JCP = 3 Hz), 131.9, 131.3 (d, JCP = 17 Hz), 130.6, 130.0 (d, JCP = 
3 Hz), 128.8-128.4 (6 lines), 127.9, 127.2, 126.6, 126.0, 125.6, 125.4, 123.8, 71.7, 66.7, 
38.2; 31P NMR (121 MHz, CDCl3) δ –3.59; IR (Neat Film NaCl) 3052, 2962, 1651, 1585, 
1511, 1476, 1434, 1354, 1216, 1089, 1037, 963, 745, 697 cm–1; HRMS (FAB) m/z calc’d 
for C32H27NOP [M + H]+: 472.1830, found 472.1835; [α]D24 +29.7 (c 0.50, CHCl3). 
 
Ph2P N
O
129  
(S)-Cyclohexyl-PHOX (129, Table 2.4, entry 8):  Prepared by general procedure 1 
from (R)-cyclohexyl-glycine64 in 68% yield as a white solid; mp 122-124 ºC; Rf = 0.57 
(20% EtOAc in Hexanes); 1H NMR (300 MHz, CDCl3) δ 7.87 (ddd, J = 7.7, 4.1, 1.7 Hz, 
1H), 7.27 (m, 13H), 6.82 (ddd, J = 7.7, 4.1, 1.1 Hz, 1H), 4.12 (ddd, J = 14.6, 9.1, 1.4 Hz, 
1H), 3.85 (t, J = 8.3 Hz, 1H), 3.81 (t, J = 8.5 Hz, 1H), 1.60 (m, 4H), 1.28 (d, J = 13.5 Hz, 
1H), 1.05 (m, 4H), 0.80 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 162.7 (d, JCP = 3 Hz), 
139.0-138.0 (6 lines), 134.5 (d, JCP = 21 Hz), 133.8, 133.7 (d, JCP = 20 Hz), 131.8 (d, JCP 
= 19 Hz), 130.4, 129.8 (d, JCP = 3 Hz), 128.6-128.0 (7 lines), 71.2, 70.1, 42.7, 29.4, 29.0, 
26.4, 26.1, 26.0; 31P NMR (121 MHz, CDCl3) δ –4.21; IR (Neat Film NaCl) 3053, 2923, 
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2852, 1651, 1478, 1434, 1356, 1089, 1044, 964, 908 cm–1; HRMS (EI) m/z calc’d for 
C27H28NOP [M+]: 413.1909, found 413.1923; [α]D25 +47.9 (c 0.175, CHCl3). 
 
Ph2P N
O
130
Ph
Ph
 
(R)-Benzhydryl-PHOX (130, Table 2.4, entry 9):  Prepared by general procedure 1 
from (R)-3,3-diphenyl-alanine in 89% yield as a white amorphous solid; Rf = 0.45 (5:1 
Hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.79 (m, 1H), 7.38-7.13 (m, 22H), 6.88 
(m, 1H), 4.92 (q, J = 9.0 Hz, 1H), 4.13 (dd, J = 9.3, 9.0 Hz, 1H), 3.79 (t, J = 9.0 Hz, 1H), 
3.72 (d, J = 9.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 164.2, 142.2, 142.1, 138.8 (d, JCP 
= 25 Hz), 138.0-137.7 (3 lines), 134.1 (d, JCP = 21 Hz), 133.9 (d, JCP = 21 Hz), 133.7 (d, 
JCP = 2 Hz), 131.7 (d, JCP = 19 Hz), 130.5, 130.0 (d, JCP = 3 Hz), 128.7-128.2 (9 lines), 
128.0, 126.5, 126.2, 71.1, 70.1, 56.1; 31P NMR (121 MHz, CDCl3) δ –5.22; FTIR (Neat 
Film NaCl) 3056, 3026, 2895, 1649, 1598, 1584, 1494, 1477, 1451, 1434, 1356, 1091, 
1029, 909, 741 cm–1; HRMS (FAB) m/z calc’d for C34H29NOP [M + H]+: 498.1987, found 
498.1963; [α]D24 +10.4 (c 1.00, CHCl3). 
 
Ph2P N
O
OBn
131  
(S)-(2-(Benzyloxy)propan-2-yl)-PHOX (131, Table 2.4, entry 10):  The aryl 
bromide was prepared from L-serine using the analogous procedure reported by 
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Helmchen.60  Coupling was achieved by general procedure 1 in 75% yield as a colorless 
viscous oil; Rf = 0.45 (5:1 Hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.95 (ddd, J = 
7.5, 3.6, 1.2 Hz, 1H), 7.41-7.19 (m, 17H), 6.88 (ddd, J = 7.5, 4.2, 0.9 Hz, 1H), 4.43-4.23 
(m, 4H), 4.15 (dd, J = 9.6, 7.8 Hz, 1H), 1.21 (s, 3H), 0.88 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 163.8 (d, JCP = 3 Hz), 139.5, 139.1-138.3 (5 lines), 134.4 (d, JCP = 21 Hz), 
134.2, 133.5 (d, JCP = 20 Hz), 131.6 (d, JCP = 19 Hz), 130.5, 129.9 (d, JCP = 3 Hz), 128.6-
128.1 (6 lines), 127.14, 127.12, 76.9, 74.9, 68.5, 63.9, 23.9, 19.5; 31P NMR (121 MHz, 
CDCl3) δ –5.51; IR (Neat Film NaCl) 3067, 2973, 2905, 1649, 1586, 1478, 1434, 1352, 
1248, 1155, 1091, 1065, 1027, 964, 743, 697 cm–1; HRMS (FAB) m/z calc’d for 
C31H31NO2P [M + H]+: 480.2092, found 480.2078; [α]D26 –2.0 (c 1.03, CHCl3). 
 
Ph2P N
O
OTBS
132  
(S)-(2-(tert-Butyldimethylsilyloxy)propan-2-yl)-PHOX (132, Table 2.4, entry 11):  
The aryl bromide was prepared from L-serine using the analogous procedure reported by 
Helmchen.60  Coupling was achieved by general procedure 1 in 84% yield as a white 
solid; mp 104-106 ºC; Rf = 0.62 (5:1 HexanesEtOAc); 1H NMR (300 MHz, CDCl3) δ 
7.92 (ddd, J = 7.5, 3.6, 1.2 Hz, 1H), 7.40-7.20 (m, 12H), 6.88 (ddd, J = 7.5, 3.9, 0.9 Hz, 
1H), 4.32 (dd, J = 7.5, 6.6 Hz, 1H), 4.09 (dd, J = 10.2, 7.5 Hz, 1H), 4.02 (dd, J = 10.2, 
6.6 Hz, 1H), 1.15 (s, 3H), 0.86 (s, 3H), 0.78 (s, 9H), 0.03 (s, 3H), 0.01 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 163.6, 139.0-138.3 (6 lines), 134.3 (d, JCP = 21 Hz), 134.2, 133.5 (d, 
JCP = 20 Hz), 131.9 (d, JCP = 19 Hz), 130.4, 129.8 (d, JCP = 3 Hz), 128.5-128.0 (5 lines), 
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76.8, 74.9, 68.7, 28.7, 25.7, 23.9, 17.9, –2.2, –2.3; 31P NMR (121 MHz, CDCl3) δ –5.99; 
IR (Neat Film NaCl) 3054, 2955, 2929, 2856, 1652, 1586, 1472, 1434, 1353, 1251, 1162, 
1091, 1058, 835, 774, 743, 696 cm–1; HRMS (FAB) m/z calc’d for C30H39NO2PSi [M + 
H]+: 504.2488, found 504.2469; [α]D26 +19.8 (c 1.16, CHCl3). 
 
P N
O
Me
Me
135  
(S)-4-tert-Butyl-2-(2-(di-p-tolylphosphino)phenyl)-4,5-dihydrooxazole (135, Table 
2.5, entry 1):  Prepared by general procedure 1 using (p-Tol)2PH in 73% yield as a 
colorless viscous oil; Rf = 0.39 (10% EtOAc in Hexanes); 1H NMR (300 MHz, CDCl3) δ 
7.91 (ddd, J = 7.5, 3.6, 1.5 Hz, 1H), 7.33 (m, 1H), 7.26 (m, 1H), 7.23-7.05 (m, 8H), 6.89 
(ddd, J = 7.5, 4.2, 1.5 Hz, 1H), 4.06 (dd, J = 10.2, 8.4 Hz, 1H), 3.98 (t, J = 8.3 Hz, 1H), 
3.85 (dd, J = 10.2, 7.8 Hz, 1H), 2.33 (s, 3H), 2.32 (s, 3H), 0.75 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 163.0 (d, JCP = 3 Hz), 139.3 (d, JCP = 25 Hz), 138.4, 138.1, 135.0-134.7 
(4 lines), 134.3 (d, JCP = 21 Hz), 133.9, 133.6 (d, JCP = 20 Hz), 131.9 (d, JCP = 20 Hz), 
130.2, 129.9 (d, JCP = 3 Hz), 129.2 (d, JCP = 7 Hz), 129.0 (d, JCP = 7 Hz), 127.8, 76.5, 
68.3, 33.6, 25.7, 21.3, 21.2; 31P NMR (121 MHz, CDCl3) δ –6.98; IR (Neat Film NaCl) 
2953, 1653, 1496, 1476, 1394, 1353, 1306, 1248, 1185, 1134, 1089, 1024, 967, 805, 743 
cm–1; HRMS (EI) m/z calc’d for C27H30NOP [M+]: 415.2065, found 415.2065; [α]D25 –
58.8 (c 2.23, CHCl3). 
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P N
O
F
F
136  
(S)-2-(2-(bis(4-fluorophenyl)phosphino)phenyl)-4-tert-butyl-4,5-dihydrooxazole 
(136, Table 2.5, entries 3 and 11):  Prepared by Helmchen’s Grignard method60 in 14% 
yield as a colorless oil; Rf = 0.50 (5% Et2O in hexanes developed twice); 1H NMR (500 
MHz, CDCl3) δ 7.95 (ddd, J = 7.0, 3.0, 1.0 Hz, 1H), 7.39 (ddd, J = 8.0, 8.0, 1.5 Hz, 1H), 
7.31 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.26-7.14 (comp. m, 4H), 7.01 (app. dt, J = 13.0, 8.5 
Hz, 4H), 6.83 (ddd, J = 7.5, 4.0, 1.0 Hz, 1H), 4.12 (dd, J = 10.0, 8.5 Hz, 1H), 4.03 (dd, J 
= 8.0, 8.0 Hz, 1H), 3.90 (dd, J = 10.0, 8.0 Hz, 1H), 0.74 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 163.3 (d, JC-F = 247.5 Hz), 163.1 (d, JC-F = 246.5 Hz), 162.3, 138.6 (d, JC-P = 
25.3 Hz), 136.1 (dd, JC-P = 22.5 Hz, JC-F = 8.1 Hz), 135.3 (dd, JC-P = 21.9 Hz, JC-F = 8.1 
Hz), 134.1 (dd, JC-P = 12.5, JC-F = 4.1 Hz), 134.0 (dd, JC-P = 10.4 Hz, JC-F = 4.0 Hz), 133.9, 
131.7 (d, JC-P = 20.0 Hz), 130.5, 130.0 (d, JC-P = 2.9 Hz), 128.3, 115.6 (dd, JC-F = 18.6 Hz, 
JC-P = 7.6 Hz), 115.5 (dd, JC-F = 18.6 Hz, JC-P = 7.6 Hz) 76.8, 68.3, 33.6, 25.7; 31P NMR 
(121 MHz, CDCl3) δ –8.2 (app. t, J = 3.8 Hz); 19F NMR (282 MHz, CDCl3) δ –113.6, –
114.1; IR (Neat Film NaCl) 2955, 2904, 2868, 1653, 1587, 1494, 1392, 1354, 1336, 
1225, 1159, 1091, 1039, 1025, 966, 827, 744 cm–1; HRMS (FAB) m/z calc'd for 
C25H25ONPF2 [M + H]+: 424.1642, found 424.1622; [α]D26.4 –17.7 (c 0.53, CH2Cl2). 
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P N
O
F3C
CF3
137  
(S)-2-(2-(Bis(4-(trifluoromethyl)phenyl)phosphino)phenyl)-4-tert-butyl-4,5-
dihydrooxazole (137, Table 2.5, entries 4 and 12):  Prepared by general procedure 1 
using (p-CF3Ph)2PH in 75% yield as a white amorphous powder; Rf = 0.44 (10% EtOAc 
in Hexanes); 1H NMR (300 MHz, CDCl3) δ 8.00 (ddd, J = 7.5, 3.9, 1.2 Hz, 1H), 7.62-
7.50 (m, 4H), 7.44 (m, 1H), 7.40-7.28 (m, 5H), 6.82 (ddd, J = 7.5, 3.9, 0.9 Hz, 1H), 4.20 
(dd, J = 10.2, 8.4 Hz, 1H), 4.06 (t, J = 8.4 Hz, 1H), 3.93 (dd, J = 10.2, 8.4 Hz, 1H), 0.69 
(s, 9H); 13C NMR (75 MHz, CDCl3) δ 161.8 (d, JCP = 3 Hz), 143.4-143.2 (m), 136.7 (d, 
JCP = 24 Hz), 134.4 (d, JCP = 21 Hz), 134.2, 133.7 (d, JCP = 20 Hz), 132.0 (d, JCP = 20 Hz), 
130.74, 130.65 (q, JCF = 32 Hz), 130.5 (q, JCF = 32 Hz), 129.9 (d, JCP = 3 Hz), 128.9, 
125.3-124.9 (m), 124.1 (q, JCF = 271 Hz,), 77.0, 68.4, 33.6, 25.6; 31P NMR (121 MHz, 
CDCl3) δ –7.29; 19F NMR (282 MHz, CDCl3) δ –63.23, –63.28; IR (Neat Film NaCl) 
2958, 1653, 1606, 1480, 1396, 1324, 1166, 1128, 1106, 1061, 1017, 831, 700 cm–1; 
HRMS (EI) m/z calc’d for C27H24NOPF6 [M+]: 523.1500, found 523.1494; [α]D25 –21.1 (c 
2.26, CHCl3). 
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NO2
Ph2P N
O
138  
(S)-4-tert-Butyl-2-(2-(diphenylphosphino)-5-nitrophenyl)-4,5-dihydrooxazole 
(138, Table 2.5, entries 5 and 13):  Prepared by a modification of Andreas’ method65 in 
8% yield as a red oil; Rf = 0.57 (25% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 
8.77 (dd, J = 3.0, 3.0 Hz, 1H), 8.07 (dd, J = 8.0, 2.0 Hz, 1H), 7.40-7.29 (comp. m, 6H), 
7.29-7.18 (comp. m, 4H), 7.04 (dd, J = 8.5, 3.0 Hz, 1H), 4.15 (dd, J = 10.0, 8.5 Hz, 1H), 
4.04 (dd, J = 9.0, 8.0 Hz, 1H), 3.90 (dd, J = 9.5, 8.0 Hz, 1H), 0.72 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 160.7 (d, J = 3.8 Hz), 148.6 (d, J = 33.0 Hz), 147.4, 137.2 (d, J = 12.0 
Hz), 136.9 (d, J = 8.5 Hz), 135.1 (d, J = 1.4 Hz), 134.3 (d, J = 21.5 Hz), 133.6 (d, J = 
20.5 Hz), 132.7 (d, J = 18.6 Hz), 129.2-128.6 (6 lines), 124.4 (d, J = 1.9 Hz), 124.1, 77.2, 
68.6, 33.6, 25.7; 31P NMR (121 MHz, CDCl3) δ –3.4; IR (Neat Film NaCl) 3071, 2956, 
2904, 2868, 1656, 1522, 1478, 1434, 1346, 1118, 1086, 1026, 970, 913, 742, 696 cm–1; 
HRMS (FAB) m/z calc'd for C25H26O3N2P [M + H]+: 433.1681, found 433.1702; [α]D26.4 –
16.2 (c 0.87, CHCl3). 
 
OMe
Ph2P N
O
139  
(S)-4-tert-Butyl-2-(2-(diphenylphosphino)-5-methoxyphenyl)-4,5-dihydrooxazole 
(139, Table 2.5, entry 8): Prepared by general procedure 1 using 2-bromo-5-
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methoxybenzoyl chloride66 in 72% yield as a white amorphous powder; Rf = 0.61 (25% 
EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.48 (t, J = 2.9 Hz, 1H), 7.34-7.18 (m, 
10H), 6.84 (ddd, J = 8.7, 2.4, 0.6 Hz, 1H), 6.78 (ddd, J = 8.7, 3.3, 0.6 Hz, 1H), 4.13 (dd, J 
= 10.2, 8.4 Hz, 1H), 4.03 (t, J = 8.1 Hz, 1H), 3.92 (dd, J = 10.2, 8.1 Hz, 1H), 3.82 (s, 3H), 
0.73 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 162.5 (d, JCP = 3 Hz), 159.4, 139.0 (d, JCP = 13 
Hz), 138.7 (d, JCP = 10 Hz), 135.8, 134.1 (d, JCP = 20 Hz), 133.41 (d, JCP = 33 Hz), 133.36 
(d, JCP = 20 Hz), 129.3 (d, JCP = 22 Hz), 128.3-128.0 (6 lines), 116.5, 114.9 (d, JCP = 4 
Hz), 76.7, 68.3, 55.3, 33.6, 25.7; 31P NMR (121 MHz, CDCl3) δ –10.1; IR (Neat Film 
NaCl) 3069, 2956, 2903, 1654, 1594, 1561, 1479, 1434, 1354, 1336, 1297, 1224, 1181, 
1093, 1050, 1022, 973, 744, 697 cm–1; HRMS (EI) m/z calc’d for C26H28NO2P [M+]: 
417.1858, found 417.1844; [α]D25 –48.8 (c 2.11, CHCl3). 
 
CF3
Ph2P N
O
140  
(S)-4-tert-Butyl-2-(2-(diphenylphosphino)-5-(trifluoromethyl)phenyl)-4,5-
dihydrooxazole (140, Table 2.5, entry 10):  Prepared by general procedure 1 from 2-
bromo-5-trifluoromethylbenzoyl chloride67 in 77% yield as a white powder; mp 98-100 
ºC; Rf = 0.45 (10% EtOAc in Hexanes); 1H NMR (300 MHz, CDCl3) δ 8.20 (m, 1H), 7.51 
(dd, J = 8.1, 1.8 Hz, 1H), 7.38-7.18 (m, 10H), 6.99 (dd, J = 8.1, 3.3 Hz, 1H), 4.12 (dd, J = 
10.2, 8.4 Hz, 1H), 4.03 (t, J = 8.4 Hz, 1H), 3.90 (dd, J = 10.2, 8.4 Hz, 1H), 0.72 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ 161.4 (d, JCP = 3 Hz), 144.2 (d, JCP = 30 Hz), 137.7 (d, JCP = 
12 Hz), 137.3 (d, JCP = 9 Hz), 134.6, 134.3 (d, JCP = 21 Hz), 133.6 (d, JCP = 20 Hz), 132.2 
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(d, JCP = 19 Hz), 130.1 (q, JCF = 33 Hz), 128.9-128.4 (6 lines), 126.6-126.3 (m), 123.7 (q, 
JCF = 271 Hz), 77.0 (d, JCP = 1 Hz), 68.4, 33.6, 25.7; 31P NMR (121 MHz, CDCl3) δ –6.55 
(JPF = 2 Hz); 19F NMR (282 MHz, CDCl3) δ –63.36; IR (Neat Film NaCl) 3071, 2957, 
1655, 1478, 1434, 1407, 1357, 1343, 1326, 1302, 1262, 1244, 1174, 1131, 1080, 969, 
744, 696 cm–1; HRMS (EI) m/z calc’d for C26H25NOPF3 [M+]: 455.1626, found 455.1646; 
[α]D25 –36.3 (c 2.39, CHCl3). 
 
P N
O
F3C
CF3
141
CF3
 
(S)-2-(2-(Bis(4-(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-4-
tert-butyl-4,5-dihydrooxazole (141, Table 2.5, entry 14):  Prepared by general 
procedure 1 using (p-CF3Ph)2PH in 74% yield as a white amorphous powder; Rf = 0.63 
(10% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 8.26 (m, 1H), 7.64-7.54 (m, 5H), 
7.39-7.27 (m, 4H), 6.95 (dd, J = 7.8, 3.0 Hz, 1H), 4.25 (dd, J = 10.2, 8.7 Hz, 1H), 4.09 (t, 
J = 8.7 Hz, 1H), 3.95 (dd, J = 10.2, 8.7 Hz, 1H), 0.69 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 160.7 (d, JCP = 4 Hz), 142.6-141.7 (6 lines), 134.7-133.6 (5 lines), 132.4 (d, JCP = 20 
Hz), 131.1 (q, JCF = 32 Hz), 130.9 (q, JCF = 32 Hz), 127.0 (q, JCF = 3 Hz), 126.7-126.4 (6 
lines), 125.6-125.1 (8 lines), 123.9 (q, JCF = 271 Hz), 123.5 (q, JCF = 271 Hz), 77.3 (d, JCP 
= 1 Hz), 68.6, 33.5, 25.6; 31P NMR (121 MHz, CDCl3) δ –6.57; 19F NMR (282 MHz, 
CDCl3) δ –63.33, –63.39, –63.53; IR (Neat Film NaCl) 2960, 1657, 1606, 1479, 1397, 
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1324, 1169, 1129, 1107, 1082, 1061, 1017, 832, 700 cm–1; HRMS (FAB) m/z calc’d for 
C28H24F9NOP [M + H]+: 592.1452, found 592.1480; [α]D24 –16.0 (c 2.56, CHCl3). 
 
P N
O
F3C
F3C
F3C CF3
142  
(S)-2-(2-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphino)phenyl)-4-tert-butyl-4,5-
dihydrooxazole (142, Table 2.5, entry 6):  Prepared by Helmchen’s Grignard method60 
in 6% yield as a colorless oil; Rf = 0.29 (5% Et2O in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 8.04 (ddd, J = 7.5, 4.0, 1.5 Hz, 1H), 7.86 (app. d, J = 11.0 Hz, 2H), 7.64 (app. 
dd, J = 21.0, 6.0 Hz, 4H), 7.53 (ddd, J = 7.0, 7.0, 1.0, 1H), 7.42 (ddd, J = 7.5, 7.5 1.0 Hz, 
1H), 6.77 (ddd, J = 7.5, 3.5, 1.0 Hz, 1H), 4.28 (dd, J = 10.0, 8.5 Hz, 1H), 4.12 (dd, J = 
9.0, 9.0 Hz, 1H), 3.91 (dd, J = 10.5, 9.0 Hz, 1H), 0.68 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 161.4 (d, J = 3.4 Hz), 141.9 (d, J = 13.9 Hz), 141.8 (d, J = 11.9 Hz), 134.8 (d, J 
= 23.9 Hz), 134.0, 133.7 (d, J = 19.1 Hz), 133.2 (d, J = 21.5 Hz), 131.8 (app. dq, J = 
31.5, 4.8 Hz), 131.3, 130.0 (d, J = 2.9 Hz), 129.8, 123.1 (q, J = 271.8 Hz), 122.7 (app. d 
of septets, J = 25.3, 3.3 Hz), 77.1, 68.7, 33.4, 25.5; 31P NMR (121 MHz, CDCl3) δ –6.8; 
19F NMR (282 MHz, CDCl3) δ –63.9 (2 peaks); HRMS (FAB) m/z calc'd for 
C29H23ONPF12 [M + H]+: 660.1325, found 660.1328; [α]D26.2 –5.0 (c 0.35, CHCl3). 
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P N
O
C6F5
C6F5
143  
(S)-4-tert-Butyl-2-(2-(diperfluorophenylphosphino)phenyl)-4,5-dihydrooxazole 
(143, Table 2.5, entry 7): Prepared by Helmchen’s Grignard method60 in 13% yield as a 
colorless oil; Rf = 0.39 (2.5% Et2O in hexanes developed twice); 1H NMR (300 MHz, 
CDCl3) δ 8.00 (ddd, J = 7.4, 4.8, 1.3 Hz, 1H), 7.51 (app. tt, J = 7.5, 1.3 Hz, 1H), 7.41 
(app. tt, J = 7.7, 1.3 Hz, 1H), 7.16 (dd, J = 7.7, 3.5 Hz, 1H), 4.35 (dd, J = 10.1, 8.8 Hz, 
1H), 4.18 (dd, J = 8.8, 8.8 Hz, 1H), 3.93 (dd, J = 10.1, 8.8 Hz, 1H), 0.75 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 162.3 (d, J = 5.0 Hz), 132.5, 130.9, 129.7 (2 peaks), 129.6, 
77.3, 69.1, 33.6, 25.7; 31P NMR (121 MHz, CDCl3) δ –54.7 (app. quintet, J = 38.1 Hz); 
19F NMR (282 MHz, CDCl3) δ –130.6 (app. t, J = 27.5 Hz), –131.1 (app. t, J = 27.5 Hz), 
–151.9 (app. t, J = 18.6 Hz), –152.4 (app. t, J = 21.2 Hz), –161.8 (app. t, J = 18.0 Hz), –
162.0 (app. t, J = 15.0 Hz); IR (Neat Film NaCl) 2962, 2908, 2872, 1654, 1516, 1476, 
1382, 1360, 1287, 1139, 1087, 1052, 978, 908, 834, 740 cm–1; HRMS (FAB) m/z calc'd 
for C25H17ONPF10 [M + H]+: 568.0888, found 568.0868; [α]D26.2 –6.3 (c 0.56, CH2Cl2). 
 
Ph2As N
O
145  
(S)-4-tert-Butyl-2-(2-(diphenylarsino)phenyl)-4,5-dihydrooxazole (145, Table 2.6, 
entry 2):  Prepared by Helmchen’s SNAr method60 in 40% yield using lithium 
diphenylarsine generated by lithium reduction of triphenylarsine as a colorless oil; Rf = 
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0.42 (5% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.97 (dd, J = 8.0, 1.5 Hz, 
1H), 7.37 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.34-7.23 (comp. m, 10H), 7.01 (dd, J = 8.0, 
1.0, 1H), 4.15 (dd, J = 9.5, 8.0 Hz, 1H), 4.04 (dd, J = 8.5, 8.5 Hz, 1H), 3.88 (dd, J = 10.5, 
9.0 Hz, 1H), 0.75 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 162.7, 141.9 (2 peaks), 141.5, 
134.6, 134.0, 133.7, 131.8, 130.6, 129.5, 128.4 (2 peaks), 128.0, 127.9, 76.7, 68.3, 33.6, 
25.7; IR (Neat Film NaCl) 3066, 3052, 2955, 2903, 2867, 1652, 1480, 1433, 1354, 1336, 
1306, 1253, 1132, 1088, 1024, 967, 903, 736, 696 cm–1; HRMS (FAB) m/z calc'd for 
C25H27ONAs [M + H]+: 432.1309, found 432.1290; [α]D25.6 –33.8 (c 1.47, CHCl3). 
 
NO2
Ph2N N
O
146  
(S)-4-tert-Butyl-2-(2-(diphenylamino)-5-nitrophenyl)-4,5-dihydrooxazole (146, 
Table 2.6, entry 3):  Prepared by a modification of Zhu’s method68 in 18% yield as a red 
oil; Rf = 0.45 (10% Et2O in hexanes developed thrice); 1H NMR (500 MHz, CDCl3) δ 8.58 
(d, J = 3.0 Hz, 1H), 8.13 (dd, J = 8.5, 2.5 Hz, 1H), 7.28 (app. t, J = 7.5 Hz, 4H), 7.09 
(app. t, J = 7.5, 2H), 7.09 (d, J = 9.0 Hz, 1H), 7.03 (app. d, J = 7.5 Hz, 4H), 3.77 (dd, J = 
8.5, 8.5 Hz, 1H), 3.59 (dd, J = 10.0, 8.5 Hz, 1H), 3.24 (dd, J = 10.0, 8.0 Hz, 1H), 0.80 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 162.3, 151.8, 146.6, 141.8, 129.4, 128.6, 126.6, 
126.5, 124.6, 124.3, 123.3, 75.0, 68.7, 33.6, 25.9; IR (Neat Film NaCl) 2958, 2904, 2868, 
1647, 1588, 1574, 1518, 1490, 1333, 1299, 1278, 1116, 968, 912, 860, 751, 695 cm–1; 
HRMS (FAB) m/z calc'd for C25H26O3N3 [M + H]+: 416.1974, found 416.1969; [α]D25.6 
+203.9 (c 0.55, CHCl3). 
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Ph2P N
O
187  
(S)-(Napth-2-ylmethyl)-PHOX (187, Table 2.10, entry 5): Prepared by general 
procedure 1 from 3-(2-napthyl)-alanine in 71% yield as a white amorphous solid; Rf = 
0.24 (25% Et2O in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.88 (m, 1H), 7.82-7.72 (m, 
3H), 7.53 (br s, 1H), 7.49-7.27 (m, 14H), 7.23 (m, 1H), 6.88 (m, 1H), 4.46 (m, 1H), 4.05 
(dd, J = 9.0, 8.7 Hz, 1H), 3.83 (dd, J = 9.0, 7.5 Hz, 1H), 3.08 (dd, J = 14.1, 5.1 Hz, 1H), 
2.30 (dd, J = 14.1, 9.3 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 164.0 (d, JCP = 3?Hz), 
138.9 (d, JCP = 25 Hz), 137.0-137.7 (3 lines), 135.6, 134.4 (d, JCP = 21?Hz), 133.8 (d, JCP 
= 21 Hz), 133.5 (d, JCP = 2 Hz), 133.4, 132.1, 131.4 (d, JCP = 18 Hz), 130.5, 129.9 (d, JCP 
= 3 Hz), 128.7-127.4 (12 lines), 125.9, 125.4, 71.4, 67.7, 41.2; 31P NMR (121 MHz, 
CDCl3) δ –4.05; FTIR (Neat Film NaCl) 3052, 1651, 1508, 1476, 1434, 1354, 1217, 
1090, 1027, 964, 817, 743, 697 cm–1; HRMS (FAB) m/z calc’d for C32H27NOP [M + H]+: 
472.1830, found 472.1845; [α]D25 +42.7 (c 0.50, CHCl3). 
 
Ph2P N
O
188 t-Bu
t-Bu
 
(R)-(3,5-Di-tert-butylbenzyl)-PHOX (188, Table 2.10, entry 6):  Prepared by 
general procedure 1 from (R)-3-(3,5-di-tert-butylphenyl)-alaninol69 in 55% yield as a 
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colorless viscous oil; Rf = 0.52 (5:1 hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.89 
(m, 1H), 7.40-7.28 (m, 13H), 6.92 (d, J = 1.8 Hz, 2H), 6.86 (m, 1H), 4.33 (m, 1H), 4.00 
(t, J = 8.7 Hz, 1H), 3.78 (dd, J = 8.7, 7.5 Hz, 1H), 2.95 (dd, J = 13.8, 4.2 Hz, 1H), 2.01 
(dd, J = 13.8, 10.2 Hz, 1H), 1.30 (s, 18H); 13C NMR (75 MHz, CDCl3) δ 163.9 (d, JCP = 3 
Hz), 150.8, 138.9 (d, JCP = 25 Hz), 137.9 (d, JCP = 12 Hz), 137.8 (d, JCP = 10 Hz), 137.2, 
134.4 (d, JCP = 21 Hz), 134.0 (d, JCP = 21 Hz), 133.4 (d, JCP = 3 Hz), 131.5 (d, JCP = 17 
Hz), 130.5, 130.0 (d, JCP = 3 Hz), 128.8-128.4 (6 lines), 127.9, 123.3, 120.3, 71.6, 68.1, 
41.6, 34.7, 31.5; 31P NMR (121 MHz, CDCl3) δ –3.60; IR (Neat Film NaCl) 2963, 1649, 
1598, 1477, 1434, 1361, 1248, 1090, 1027, 965, 742, 696 cm–1; HRMS (FAB) m/z calc’d 
for C36H41NOP [M + H]+: 534.2926, found 534.2905; [α]D25 –49.3 (c 0.36, CHCl3). 
 
Ph2P N
O
189  
(S)-(Anthracen-9-ylmethyl)-PHOX (189, Table 2.10, entry 7):  Prepared by 
general procedure 1 from 3-(9-anthracenyl)-alanol69 in 42% yield as a yellow powder; mp 
165-169 ºC; Rf = 0.38 (5:1 Hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.34 (s, 
1H), 8.16 (m, 2H), 7.99 (m, 2H), 7.94 (m, 1H), 7.55-7.29 (comp. m, 16H), 6.88 (m, 1H), 
4.63 (m, 1H), 3.92 (dd, J = 9.0, 6.3 Hz, 1H), 3.77 (dd, J = 14.7, 4.5 Hz, 1H), 3.68 (t, J = 
9.0 Hz, 1H), 3.17 (dd, J = 14.7, 10.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 164.3 (d, JCP 
= 3 Hz), 138.9 (d, JCP = 25 Hz), 138.1 (d, JCP = 10 Hz), 137.8 (d, JCP = 13 Hz), 134.6 (d, 
JCP = 21 Hz), 133.8 (d, JCP = 21 Hz), 133.5 (d, JCP = 3 Hz), 131.5, 130.7, 130.2, 130.0, 
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129.2, 128.9-128.5 (6 lines), 128.0, 126.5, 125.8, 124.9, 124.5, 71.2, 67.8, 32.1; 31P NMR 
(121 MHz, CDCl3) δ –3.57; IR (Neat Film NaCl) 3051, 2961, 1648, 1476, 1434, 1353, 
1092, 1032, 956, 742, 696 cm–1; HRMS (EI) m/z calc’d for C36H29NOP [M+]: 521.1909, 
found 521.1905; [α]D26 –5.1 (c 0.20, CHCl3). 
 
2.8.3 SYNTHESIS OF ALLYL ENOL CARBONATES 
2.8.3.1 GENERAL PROCEDURES FOR THE SYNTHESIS OF ALLYL ENOL 
CARBONATES 
General Procedure 2: 
OCO2allyl
105
O
KOt-Bu
DMF, 0!25 °C
Cl O
O
208
207  
Allyl 2-methylcyclohex-1-enyl carbonate (105, Table 2.7, entries 1–3):70 To a 
solution of potassium t-butoxide (5.88 g, 52.5 mmol, 1.05 equiv) in DMF (100 mL) was 
added 2-methylcyclohexanone (207, 6.13 mL, 50 mmol, 1.0 equiv).  After 12 h, the 
reaction mixture was cooled in an ice bath and allyl chloroformate (208, 6.4 mL, 60 
mmol, 1.2 equiv) was added in a dropwise fashion.  After an additional 30 min in the ice 
bath and 15 min at 25 °C, the reaction mixture was quenched into water (250 mL), 
extracted with 2:1 CH2Cl2:hexanes (4 x 125 mL), dried (MgSO4), and evaporated.  
Chromatography (2.5→4% Et2O in hexanes on SiO2) afforded the allyl enol carbonate 
105 (4.49 g, 46% yield) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.94 (ddt, J = 
17.4, 10.5, 5.6 Hz, 1H), 5.36 (dq, J = 17.1, 1.5 Hz, 1H), 5.26 (dq, J = 10.2, 1.2 Hz, 1H), 
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4.63 (dt, J = 5.7, 1.4 Hz, 2H), 2.13 (m, 2H), 2.02 (m, 2H), 1.70 (m, 2H), 1.59 (m, 2H), 
1.55 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.1, 142.2, 131.5, 120.8, 118.8, 68.5, 30.0, 
26.6, 23.1, 22.3, 15.7; IR (Neat Film NaCl) 3936, 1755, 1275, 1239, 1037 cm–1; HRMS 
(EI) m/z calc'd for C11H16O3 [M]+: 196.1100, found 196.1092. 
 
General Procedure 3: 
OCO2allyl
124
O LiHMDS
THF 0 °C
then
Cl O
O
–78!25 °C97
208
 
Allyl 2-methyl-3,4-dihydronaphthalen-1-yl carbonate (124, Table 2.7, entry 12):71  
To a cooled (0 °C) solution of LiHMDS (17.16 mmol, 1.1 equiv) in THF (37 mL) was 
added 2-methyl-1-tetralone (97, 2.37 mL, 15.6 mmol, 1.0 equiv) in a dropwise manner 
over 15 min.  After an additional 1.5 h at 0 °C, the enolate solution was added dropwise 
over 15 min to a –78 °C solution of allyl chloroformate (208, 2.0 mL, 18.7 mmol, 1.2 
equiv) in THF (80 mL).  The reaction mixture was allowed to warm to 25 °C in a Dewar 
vessel over 8 h.  At which time, the reaction was quenched into CH2Cl2 (100 mL) and 
half-saturated aq NH4Cl (100 mL). The layers were separated and the aqueous layer 
extracted with CH2Cl2 (2 x 50 mL).  The organic fractions were washed with brine (100 
mL), and dried (Na2SO4). Evaporation of the solvents under reduced pressure, and 
chromatography (2→5% Et2O in Hexanes on SiO2) afforded the allyl enol carbonate 124 
(3.34 g, 88% yield) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 7.20-7.08 (m, 4H), 
6.01 (ddt, J = 17.7, 10.4, 5.6 Hz 1H), 5.41 (dq, J = 17.3, 1.5 Hz, 1H), 5.32 (dd, J = 10.2, 
1.0 Hz, 1H), 4.72 (dt, J = 6.3, 1.4 Hz, 2H), 2.87 (t, J = 8.0 Hz, 2H), 2.40 (t, J = 8.0 Hz, 
2H), 1.83 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.1, 140.6, 135.2, 131.3, 130.8, 127.3, 
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127.0, 126.4, 124.4, 119.9, 119.1, 68.9, 28.8, 27.4, 16.5; IR (Neat Film NaCl) 2935, 
2833, 1760, 1239 cm–1; HRMS (EI) m/z calc'd for C15H16O3 [M]+:  244.1100, found 
244.1098. 
 
General Procedure 4: 
OCO2allylOTMS
KOt-Bu, THF
–78! –60 °C
Cl O
O
209 210
208
 
Allyl 2-ethylcyclohex-1-enyl carbonate (210, Table 2.7, entry 7):72  To a solution 
of (2-ethylcyclohex-1-enyloxy)trimethylsilane (209, vide infra) (1.50 g, 7.56 mmol, 1.0 
equiv) in THF (14 mL) cooled to –78 °C was added a solution of potassium t-butoxide 
(0.933 g, 8.32 mmol, 1.1 equiv) in THF (8 mL) in a dropwise fashion over 2 min.  The 
reaction mixture was maintained at –60 °C for 2.5 h, at which time allyl chloroformate 
(208, 847 µL, 7.93 mmol, 1.05 equiv) in THF (3 mL) was added.  After 1 h at –50 °C, the 
reaction mixture was poured into a mixture of CH2Cl2 (20 mL) and half-saturated 
aqueous NH4Cl (20 mL). The layers were separated and the aqueous layer extracted with 
CH2Cl2 (3 x 10 mL).  The organic fractions were washed with water (50 mL), brine (50 
mL), and dried (Na2SO4). Evaporation of the solvents under reduced pressure followed by 
chromatography on (2% Et2O in Hexanes on SiO2) and heating (room temperature to 105 
°C) at 2 torr in a kugelrohr distillation apparatus afforded the allyl enol carbonate (210, 
0.944 g, 59% yield) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.95 (ddt, J = 17.4, 
10.5, 5.6 Hz, 1H), 5.37 (dq, J = 17.2, 1.5 Hz, 1H), 5.27 (dq, J = 10.5, 1.2 Hz, 1H), 4.64 
(dt, J = 5.7, 1.5 Hz, 2H), 2.16 (m, 2H), 2.05 (m, 2H), 1.99 (q, J = 7.8, 2H), 1.70 (m, 2H), 
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1.61 (m, 2H), 0.4 (t, J = 7.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 153.3, 141.7, 131.5, 
126.3, 118.8, 68.5, 27.2, 26.6, 23.0, 22.9, 22.3, 11.9; IR (Neat Film NaCl) 2936, 1754, 
1239 cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+:  210.1256, found 210.1255. 
 
2.8.3.2 CHARACTERIZATION DATA FOR ALLYL ENOL CARBONATES 
O
O
O
211  
2-Methylallyl 2-methylcyclohex-1-enyl carbonate (211, Table 2.7, entry 4):  
Prepared by general procedure 4 from 2-methylcyclohexanone and methallyl 
chloroformate62 in 16% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.03 (s, 
1H), 4.96 (s, 1H), 4.57 (s, 2H), 2.16 (m, 2H), 2.034 (br s, 2H), 1.79 (s, 3H), 1.77-1.58 (m, 
4H), 1.58 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.2, 142.2, 139.4, 120.9, 113.4, 71.1, 
30.1, 26.6, 23.1, 22.3, 19.3, 15.8; IR (Neat Film NaCl) 2926, 1755, 1236 cm–1; HRMS 
(EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1259. 
 
212
OCO2allyl
 
Allyl 2-methylcyclohexa-1,5-dienyl carbonate (212, Table 2.7, entry 5):  Prepared 
by general procedure 3 from 6-methyl-cyclohex-2-en-1-one73 in 45% yield as a colorless 
oil; 1H NMR (300 MHz, CDCl3) δ 5.90 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H), 5.75 (m, 2H), 
5.39 (dq, J = 17.1, 1.5 Hz, 1H), 5.29 (d, J = 10.5, 1.2 Hz, 1H), 4.67 (app. dt, J = 5.7, 1.5 
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Hz, 2H), 2.42 (br s, 4H), 1.69 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.2, 140.4, 131.3, 
126.1, 122.7, 120.0, 119.1, 68.8, 28.2, 22.4, 15.7; IR (Neat Film NaCl) 2933, 1760, 1260 
cm–1; HRMS (EI) m/z calc'd for C11H14O3 [M]+: 194.0943, found 194.0938. 
 
213
OCO2allyl
O O
 
Allyl 7-methyl-1,4-dioxaspiro[4.5]dec-7-en-8-yl carbonate (213, Table 2.7, entry 
6):  Prepared by general procedure 4 from 2-methyl-1,4-cyclohexanedione monoethylene 
ketal74 in 31% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.95 (ddt, J = 17.1, 
10.5, 5.7 Hz, 1H), 5.41 (dq, J = 17.1, 1.5 Hz, 1H), 5.28 (dq, J = 10.5, 1.2 Hz, 1H), 4.65 
(app. dt, J = 5.7, 1.5 Hz, 2H), 3.97 (m, 4H), 2.37 (m, 2H), 2.30 (br s, 2H), 1.87 (app. t, J 
= 6.6 Hz, 2H), 1.58 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 152.9, 141.3, 131.4, 119.0, 
118.5, 107.3, 68.6, 64.5, 39.9, 31.3, 25.3, 15.8; IR (Neat Film NaCl) 2919, 1756, 1250 
cm–1; HRMS (EI) m/z calc'd for C13H19O5 [M + H]+: 255.1232, found 255.1227. 
 
OCO2allyl
t-Bu
214  
Allyl 2-tert-butylcyclohex-1-enyl carbonate (214, Table 2.7, entry 8):  Prepared by 
general procedure 4 from 2-tert-butylcyclohexanone in 18% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 5.95 (ddt, J = 17.3, 10.4, 5.7 Hz, 1H), 5.38 (d, J = 17.4 Hz, 
1H), 5.27 (d, J = 10.5 Hz, 1H), 5.65 (app. dt, J = 5.7, 1.2 Hz, 2H), 2.19 (m, 2H), 2.10 (m, 
2H), 1.63 (m, 4H), 1.10 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 153.1, 142.1, 131.6, 130.7, 
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118.9, 68.4, 34.8, 29.4, 28.1, 26.4, 23.1, 22.7; IR (Neat Film NaCl) 2926, 1754, 1241 cm–
1; HRMS (EI) m/z calc'd for C14H22O3 [M]+:  238.1569, found 238.1566. 
 
OCO2allyl
215  
Allyl 2-benzylcyclohex-1-enyl carbonate (215, Table 2.7, entry 9):  Prepared by 
general procedure 2 from 2-benzylcyclohexanone in 52% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 7.30-7.16 (m, 5H), 5.95 (ddt, J = 17.3, 10.4, 5.7 Hz, 1H), 5.38 
(dq, J = 17.3, 1.5 Hz, 1H), 5.28 (dq, J = 10.2,1.2 Hz, 1H), 4.66 (app. dt, J = 5.7, 1.2 Hz, 
2H), 3.35 (s, 2H), 2.27 (app. t, J = 6.3 Hz, 2H), 1.95 (m, 2H), 1.73 (m, 2H), 1.58 (m, 2H); 
13C NMR (75 MHz, CDCl3) δ 153.2, 143.1, 139.3, 131.4, 128.8, 128.3, 126.0, 123.9, 
119.0, 68.6, 36.0, 27.5, 26.7, 23.0, 22.2; IR (Neat Film NaCl) 2937, 1754, 1702, 1648, 
1600, 1239 cm–1; HRMS (EI) m/z calc'd for C17H20O3 [M]+:  272.1413, found 272.1416. 
 
OCO2allyl
OBn
216  
Allyl 2-(3-(benzyloxy)propyl)cyclohex-1-enyl carbonate (216, Table 2.7, entry 
10):  Prepared by general procedure 2 from 2-(3-(benzyloxy)propyl)cyclohexanone75 in 
48% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 7.34-7.26 (comp. m, 5H), 
5.92 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H), 5.35 (app. dq, J = 17.1, 1.5 Hz, 1H), 5.25 (app. dq, 
J = 10.5, 1.1 Hz, 1H), 4.60 (app. dt, J = 5.7, 0.9 Hz, 2H), 4.49 (s, 2H), 3.44 (t, J = 6.6 Hz, 
2H), 2.11 (comp. m, 6H), 1.64 (comp. m, 6H); 13C NMR (75 MHz, CDCl3) δ 153.2, 
142.6, 138.7, 131.5, 128.3, 127.6, 127.4, 124.3, 118.8, 72.7, 70.0, 68.5, 27.7, 27.3, 26.6, 
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26.5, 23.0, 22.3; IR (Neat Film NaCl) 2924, 1754, 1240 cm–1; HRMS (FAB) m/z calc'd 
for C20H27O4 [M + H]+: 331.1909, found 331.1907. 
 
OCO2allyl
217  
Allyl 2,6,6-trimethylcyclohex-1-enyl carbonate (217, Table 2.7, entry 11):  
Prepared by general procedure 3 from 2,2,6-trimethylcyclohexanone in 59% yield as a 
colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.96 (m, 1H), 5.38 (d, J = 17.4 Hz, 1H), 5.28 
(d, J = 10.5 Hz, 1H), 4.65 (d, J = 6.9 Hz, 2H), 2.05 (t, J = 5.4 Hz, 2H), 1.56 (m, 4H), 1.49 
(s, 3H), 1.04 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 153.3, 147.9, 131.6, 120.7, 118.8, 
68.5, 39.2, 34.9, 31.1, 26.7, 19.1, 16.5; IR (Neat Film NaCl) 2935, 1759, 1238 cm–1; 
HRMS (EI) m/z calc'd for C13H20O3 [M]+: 224.1413, found 224.1418. 
 
OCO2allyl
MeO
218  
Allyl 6-methoxy-2-methyl-3,4-dihydronaphthalen-1-yl carbonate (218, Table 2.7, 
entry 13):  Prepared by general procedure 3 from 2-methyl-6-methoxy-1-tetralone76 in 
88% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 7.04 (m, 1H), 6.70 (m, 2H), 
5.98 (ddt, J = 17.1, 10.4, 5.7 Hz 1H), 5.42 (dq, J = 17.1, 1.5 Hz, 1H), 5.32 (dq, J = 10.5, 
1.2 Hz, 1H), 4.71 (dt, J = 5.7, 1.2 Hz, 2H), 3.78 (s, 3H), 2.84 (t, J = 7.8 Hz, 2H), 2.38 (t, J 
= 8.1 Hz, 2H), 1.80 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 158.7, 153.1, 140.4, 137.2, 
131.3, 123.9, 121.4, 121.1, 119.1, 113.7, 110.9, 68.9, 55.2, 28.8, 27.8, 16.3; IR (Neat 
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Film NaCl) 2933, 1758, 1237 cm–1; HRMS (EI) m/z calc'd for C16H18O4 [M]+: 274.1205, 
found 274.1213. 
 
OCO2allyl
219  
Allyl 2-methylcyclohept-1-enyl carbonate (219, Table 2.7, entry 14):  Prepared by 
general procedure 4 from 2-methylcycloheptanone in 36% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 5.95 (ddt, J = 17.1, 10.5, 5.7 Hz 1H), 5.37 (dq, J = 17.1, 1.5 
Hz, 1H), 5.28 (dq, J = 10.5, 1.2 Hz, 1H), 4.65 (app. dt, J = 6.0, 1.5 Hz, 2H), 2.33 (m, 2H), 
2.10 (m, 2H), 1.70-1.54 (m, 6H), 1.63 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.4, 
146.2, 131.5, 125.5, 118.8, 68.5, 32.8, 32.5, 31.0, 25.7, 25.3, 18.3; IR (Neat Film NaCl) 
2925, 1753, 1255, 1226 cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 
210.1253. 
 
OCO2allyl
220  
Allyl 2-methylcyclooct-1-enyl carbonate (220, Table 2.7, entry 15):  Prepared by 
general procedure 4 from 2-methylcyclooctanone in 28% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 5.95 (m, 1H), 5.39 (d, J = 16.5 Hz, 1H), 5.29 (d, J = 10.5 Hz, 
1H), 4.66 (d, J = 5.4 Hz, 2H), 2.34 (app. t, J = 5.7 Hz, 2H), 2.15 (app. t, J = 5.4 Hz, 2H), 
1.59 (s, 3H), 1.64-1.48 (m, 8H); 13C NMR (75 MHz, CDCl3) δ 153.4, 143.7, 131.5, 123.0, 
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118.8, 68.5, 31.4, 29.7, 28.7, 28.4, 26.6, 25.6, 15.5; IR (Neat Film NaCl) 2927, 1754, 
1227 cm–1; HRMS (EI) m/z calc'd for C13H20O3 [M]+: 224.1413, found 224.1419. 
 
OCO2allyl
182  
(Z)-Allyl 1-phenylprop-1-enyl carbonate (182, Table 2.9, entries 1–2):  Prepared 
by general procedure 3 from propiophenone in 69% yield as a colorless oil; 1H NMR 
(300 MHz, CDCl3) δ 7.46-7.43 (m, 2H), 7.37-7.26 (m, 3H), 6.04-5.85 (m, 2H), 5.44-5.28 
(m, 2H), 4.71 (dt, J = 5.7, 1.5 Hz, 2H), 1.80 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 152.6, 150.7, 147.2, 134.6, 131.1, 128.4, 128.1, 119.0, 68.9, 11.2; IR (Neat 
Film NaCl) 3061, 2920, 1760, 1673, 1496, 1446, 1366, 1227, 1186, 966, 765, 693 cm–1; 
HRMS (EI) m/z calc'd for C13H14O3 [M]+: 218.0943, found 218.0938. 
 
O O
O
185  
2-Methylcyclohex-1-enyl prop-2-ynyl carbonate (185, Table 2.10):  A 50 mL flask 
equipped with a septum was flame-dried under vacuum and cooled under dry nitrogen.  
To this was added methyllithium in Et2O (1.6 M, 7.5 mL, 12.0 mmol, 1.10 equiv) 
followed by dry Et2O (10 mL).  To this solution was added a solution of trimethyl(2-
methylcyclohex-1-enyloxy)silane?(vide infra) (2.003 g, 10.9 mmol, 1.00 equiv) in Et2O 
(5 mL) at 0 ºC and the resulting colorless solution was stirred for 1.5 h at ambient 
temperature to afford a solution of lithium enolate in Et2O. 
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To a solution of propargyl chloroformate (1.18 mL, 12.0 mmol, 1.10 equiv) in Et2O 
(10 mL) was added the above lithium enolate solution at 0 ºC.  The resulting mixture was 
stirred and warmed to 10 ºC over 1 h.  The resulting mixture was poured into saturated aq 
NH4Cl and extracted with Et2O twice.  The combined organic layers were washed with 
water, brine, dried over MgSO4, filtered, and concentrated under reduced pressure to give 
a crude oil.  The crude residue was purified by SiO2 chromatography (2 → 10% Et2O in 
hexanes) to give propargyl enol carbonate 185 (733 mg, 35% yield) as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 4.75 (d, J = 2.4 Hz, 2H), 2.53 (t, J = 2.4 Hz, 1H), 2.20-2.11 
(m, 2H), 2.07-2.00 (m, 2H), 1.76-1.66 (m, 2H), 1.66-1.56 (m, 2H), 1.57 (m, 3H); 13C 
NMR (75 MHz, CDCl3) δ 152.7, 142.3, 121.1, 76.9, 75.7, 55.4, 30.0, 26.5, 23.1, 22.3, 
15.8; IR (Neat Film NaCl) 3295, 2937, 2862, 2130, 1756, 1709, 1439, 1376, 1275, 1250, 
1220, 1045 cm–1; HRMS (EI) m/z calc’d for C11H14O3 [M]+: 194.0943, found 194.0939. 
 
OCO2allyl
CO2Et
190  
Ethyl 2-(allyloxycarbonyloxy)cyclohex-1-enecarboxylate (190, Table 2.11, entry 
1):  Prepared by general procedure 2 from ethyl 2-oxocyclohexanecarboxylate in 78% 
yield as a light yellow oil; 1H NMR (300 MHz, CDCl3) δ 5.96 (ddt, J = 17.1, 10.5, 5.7 Hz, 
1H), 5.39 (ddt, J = 17.1, 1.5, 1.5 Hz, 1H), 5.28 (ddt, J = 10.5, 1.5, 1.2 Hz, 1H), 4.67 (ddd, 
J = 5.7, 1.2, 1.2 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 2.44-2.34 (m, 2H), 2.32-2.24 (m, 2H), 
1.80-1.58 (comp. m, 4H), 1.24 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 165.6, 
154.8, 152.2, 131.2, 119.2, 118.3, 69.0, 60.5, 28.6, 25.1, 21.9, 21.5, 14.0; IR (Neat Film 
NaCl) 3087, 1983, 2942, 2866, 1760, 1715, 1666, 1449, 1368, 1233, 1189, 1081, 1056, 
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1035, 994, 946, 767 cm–1; HRMS (EI) m/z calc'd for C13H18O5 [M]+: 254.1154, found 
254.1153. 
 
O
O OCO2allyl
191  
Allyl 4-methyl-5-oxo-2,5-dihydrofuran-3-yl carbonate (191, Table 2.11, entry 2):  
Prepared by a modification of general procedure 2 from 3-methyltetronic acid using Et3N 
as the base and THF as solvent in 79% yield as a colorless oil; 1H NMR (300 MHz, 
CDCl3) δ 5.95 (ddt, J = 17.1, 10.2, 6.0 Hz, 1H), 4.93 (ddt, J = 17.1, 2.7, 1.2 Hz, 1H), 5.37 
(ddt, J = 10.2, 2.1, 0.9 Hz, 1H), 5.07 (q, J = 1.8 Hz, 2H), 4.74 (ddd, J = 6.0, 1.2, 0.9 Hz, 
2H), 1.81 (t, J = 1.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 172.6, 163.4, 150.2, 130.0, 
120.8, 109.4, 70.3, 67.5, 6.9; IR (Neat Film NaCl) 3089, 2958, 2931, 1774, 1702, 1446, 
1392, 1360, 1330, 1240, 1132, 1079, 1025, 945, 889, 775, 754 cm–1; HRMS (EI) m/z 
calc'd for C9H11O5 [M + H]+: 199.0606, found 199.0600. 
 
OCO2allyl
Ph
193  
Allyl 2-phenylcyclohex-1-enyl carbonate (193, Table 2.11, entry 3):  Prepared by 
general procedure 2 from 2-phenylcyclohexanone in 43% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 7.35-7.18 (comp. m, 5H), 5.80 (ddt, J = 17.4, 10.5, 5.4 Hz, 
1H), 5.20 (ddt, J = 17.4, 1.8, 1.2 Hz, 1H), 5.18 (ddt, J = 10.5, 1.5, 1.2 Hz, 1H), 5.02 (ddd, 
J = 5.7, 1.5, 1.5 Hz, 2H), 2.46-2.38 (m, 2H), 2.37-2.30 (m, 2H), 1.90-1.72 (comp. m, 4H); 
13C NMR (75 MHz, CDCl3) δ 152.8, 143.4, 138.8, 131.3, 128.1, 127.6, 126.8, 125.9, 
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118.4, 68.4, 30.1, 27.1, 22.8, 22.5; IR (Neat Film NaCl) 3081, 3057, 3024, 2938, 2862, 
1753, 1687, 1601, 1492, 1444, 1367, 1238, 1178, 1091, 1036, 941, 784, 760, 700 cm–1; 
HRMS (EI) m/z calc'd for C16H18O3 [M]+: 258.1256, found 258.1256. 
 
OCO2allyl
194  
Allyl 1-methyl-3,4-dihydronaphthalen-2-yl carbonate (194, Table 2.11, entry 4):  
Prepared by general procedure 2 from 2-tetralone in 59% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 7.29-7.11 (comp. m, 4H), 6.00 (ddt, J = 17.1, 10.2, 6.0 Hz, 
1H), 5.43 (ddt, J = 17.1, 1.8, 1.2 Hz, 1H), 5.33 (ddt, J = 10.2, 1.5, 1.2 Hz, 1H), 4.72 (ddd, 
J = 6.0, 1.5, 1.2 Hz, 2H), 2.97 (t, J = 7.8 Hz, 2H), 2.55 (tq, J = 8.1, 1.5 Hz, 2H), 2.00 (t, J 
= 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 152.7, 145.9, 135.0, 134.1, 131.2, 127.1, 
126.6, 126.5, 123.4, 119.7, 119.2, 68.9, 28.7, 26.0, 10.9; IR (Neat Film NaCl) 3021, 
2993, 2944, 2891, 2836, 1757, 1674, 1488, 1451, 1365, 1304, 1279, 1246, 1217, 1181, 
1157, 1031, 1018, 986, 943, 782, 760 cm–1; HRMS (EI) m/z calc'd for C15H16O3 [M]+: 
244.1100, found 244.1095. 
 
O
N
OCO2allyl
196  
Allyl 4-methyl-2-phenyloxazol-5-yl carbonate (196, Table 2.11, entry 5):  
Prepared by a modification of Leplawy’s procedure77 in 96% yield as a colorless oil that 
solidifies on standing; mp 37.5-39 °C; 1H NMR (300 MHz, CDCl3) δ 7.97-7.90 (m, 2H), 
7.45-7.38 (comp. m, 3H), 5.99 (ddt, J = 17.4, 10.5, 5.7 Hz, 1H), 5.45 (ddt, J = 17.4, 1.5, 
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1.2 Hz, 1H), 5.36 (ddt, J = 10.5, 1.2, 1.2 Hz, 1H), 4.78 (ddd, J = 6.0, 1.2, 1.2 Hz, 2H), 
2.14 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 155.3, 155.0, 151.6, 146.2, 130.5 (2C), 128.9, 
127.3, 126.1, 120.6, 70.7, 10.5; IR (Neat Film NaCl) 3066, 2930, 1786, 1669, 1554, 
1490, 1450, 1367, 1213, 1082, 1069, 1026, 992, 939, 774, 711, 692 cm–1; HRMS (EI) m/z 
calc'd for C14H13O4N [M]+: 259.0845, found 259.0855. 
 
2.8.4 SYNTHESIS OF SILYL ENOL ETHERS 
2.8.4.1 GENERAL PROCEDURE FOR THE SYNTHESIS OF SILYL ENOL 
ETHERS FROM CYCLOALKANONES 
General Procedure 5: 
OTMSO 1. TMSCl, Et3N
    NaI, CH3CN
2. Pd(OAc)2, O2
    DMSO
209221  
(2-Ethylcyclohex-1-enyloxy)trimethylsilane (209, Table 2.8, entry 2):78  To a 
solution of NaI (15.0 g, 100 mmol, 1.25 equiv) in CH3CN (125 mL) were added 2-
ethylcyclohexanone (221, 10.1 g, 80 mmol, 1.0 equiv), Et3N (14.0 mL, 100 mmol, 1.25 
equiv), and finally TMSCl (11.6 mL, 91.2 mmol, 1.14 equiv) in a dropwise fashion.  
After 1 h, pentane (75 mL) was added, the biphasic mixture was stirred for 2 min, and the 
pentane decanted.  After additional pentane extractions (5 x 75 mL), the combined 
pentane fractions were washed with water (2 x 50 mL) and brine (1 x 50 mL), and then 
dried (Na2SO4). Evaporation under reduced pressure gave the crude silyl enol ether (12.0 
g) as an 80:20 mixture (NMR) of isomers favoring the tetrasubstituted silyl enol ether.  
An oxygen balloon was affixed to a flask containing a solution of the crude silyl enol 
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ether (6.0 g) and Pd(OAc)2 (338.9 mg, 1.51 mmol) in DMSO (250 mL).  The reaction 
mixture darkened and became heterogeneous.  After 48 h, 1H NMR analysis of an aliquot 
indicated less than 2% of the undesired isomer, and the reaction mixture was poured into 
a separatory funnel containing pentane (300 mL), water (300 mL), and ice (200 g).  The 
layers were separated and the aqueous layer extracted with pentane (3 x 200 mL).  The 
pentane fractions were washed with water (2 x 100 mL) and brine (100 mL), and then 
dried (Na2SO4). Evaporation and chromatography (2% Et2O in Hexanes on SiO2) afforded 
the pure silyl enol ether (209, 3.21 g, 41% yield) as a colorless oil; 1H NMR (300 MHz, 
CDCl3) δ 2.08-1.90 (comp. m, 6H), 1.62 (m, 2H), 1.54 (m, 2H), 0.92 (t, J = 7.8 Hz, 3H), 
0.16 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 142.2, 117.4, 30.4, 27.0, 23.7, 23.1, 22.9, 
12.2, 0.7; IR (Neat Film NaCl) 2961, 2933, 1680, 1252, 922, 843 cm–1; HRMS (EI) m/z 
calc'd for C11H22OSi [M]+: 198.1440, found 198.1436. 
 
2.8.4.2 CHARACTERIZATION DATA FOR CYCLOALKANONE SILYL ENOL 
ETHERS 
OTMS
110  
Trimethyl(2-methylcyclohex-1-enyloxy)silane (110, Table 2.8, entries 1 and 4):  
Prepared by general procedure 5 from 2-methylcyclohexanone.  The initial 10:1 mixture 
favoring the tetrasubstituted isomer was purified by fractional distillation with a spinning 
band column79 to give silyl enol ether 110 (84% yield) as a colorless oil; 1H NMR (300 
MHz, CDCl3) δ 2.00 (m, 2H), 1.94 (m, 2H), 1.64 (m, 2H), 1.58-1.49 (comp. m, 5H), 0.16 
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(s, 9H); 13C NMR (75 MHz, CDCl3) δ 142.9, 111.8, 30.3, 30.1, 23.8, 23.0, 16.3, 0.7; IR 
(Neat Film NaCl) 2930, 1688, 1252, 1185, 843 cm–1; HRMS (EI) m/z calc'd for 
C10H20OSi [M]+: 184.1284, found 184.1275. 
 
OTMS
O
222  
(2-(Benzyloxy)cyclohex-1-enyloxy)trimethylsilane (222, Table 2.8, entry 3):  
Prepared by general procedure 5 from 2-(benzyloxy)cyclohexanone80 in 11% yield as a 
colorless oil; 1H NMR (300 MHz, C6D6) δ 7.40 (d, J = 7.2 Hz, 2H), 7.19 (dd, J = 7.2, 7.2 
Hz, 2H), 7.09 (t, J = 7.5 Hz, 1H), 4.77 (s, 2H), 2.12-1.98 (comp. m, 4H), 1.39 (app. 
quintet, J = 3.3 Hz, 4H), 0.25 (s, 9H); 13C NMR (75 MHz, C6D6) δ 139.9, 136.9, 135.5, 
128.8, 128.2, 128.0, 71.3, 30.8, 27.1, 23.9, 23.7, 1.2; IR (Neat Film NaCl) 3065, 3032, 
2934, 2860, 2841, 1694, 1497, 1454, 1343, 1250, 1245, 1195, 1122, 1017, 930, 860, 844, 
750, 698 cm–1; HRMS (EI) m/z calc'd for C16H24O2Si [M]+: 276.1546, found 276.1545. 
 
OTMS
223  
(2-Allylcyclohex-1-enyloxy)trimethylsilane (223, Table 2.8, entry 5):  Prepared by 
general procedure 5 from 2-allylcyclohexanone in 59% yield as a colorless oil; 1H NMR 
(300 MHz, CDCl3) δ 5.72 (ddt, J = 16.8, 9.9, 6.9 Hz, 1H), 4.99 (ddt, J = 16.5, 2.1, 1.8 Hz, 
1H), 4.95 (ddt, J = 9.6, 2.1, 1.5 Hz, 1H), 2.77 (app. d, J = 6.6 Hz, 2H), 2.14-1.88 (comp. 
m, 4H), 1.75-1.42 (comp. m, 4H), 0.17 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 144.7, 
136.9, 114.6, 113.5, 34.8, 30.4, 27.5, 23.7, 23.0, 0.7; IR (Neat Film NaCl) 3077, 2931, 
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2838, 1682, 1638, 1448, 1433, 1355, 1252, 1204, 1168, 948, 905, 888, 844, 753 cm–1; 
HRMS (EI) m/z calc'd for C12H22OSi [M]+: 210.1440, found 210.1449. 
 
224
OTMS
O O
 
Trimethyl(7-methyl-1,4-dioxaspiro[4.5]dec-7-en-8-yloxy)silane (224, Table 2.8, 
entry 6):  Prepared by general procedure 5 from 2-methyl-1,4-cyclohexanedione 
monoethylene ketal74 in 51% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 3.96 
(br s, 4H), 2.21 (comp. m, 4H), 1.79 (app. t, J = 6.9 Hz, 2H), 1.54 (s, 3H), 0.17 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ 142.2, 108.9, 108.0, 64.4, 39.9, 31.7, 28.7, 16.2, 0.7; IR 
(Neat Film NaCl) 2956, 1691, 1252 cm–1; HRMS (EI) m/z calc'd for C12H22O3Si [M]+: 
242.1338, found 242.1334. 
 
OTMS
225  
Trimethyl(2-methylcyclohept-1-enyloxy)silane (225, Table 2.8, entry 7):  Prepared 
by general procedure 5 from 2-methylcycloheptanone in 39% yield as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 2.23 (app. t, J = 5.4 Hz, 2H), 2.01 (app. t, J = 5.1 Hz, 2H), 
1.66 (m, 2H), 1.59 (s, 3H), 1.56-1.45 (comp. m, 4H), 0.16 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 147.9, 116.9, 35.1, 32.7, 31.6, 26.5, 25.5, 18.7, 0.6; IR (Neat Film NaCl) 2921, 
1678, 1251, 1171, 892, 842 cm–1; HRMS (EI) m/z calc'd for C11H22OSi [M]+: 198.1440, 
found 198.1439. 
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OTMS
226  
Trimethyl(2-methylcyclooct-1-enyloxy)silane (226, Table 2.8, entry 8):  Prepared 
by general procedure 5 (pyridine substituted for Et3N) from 2-methylcyclooctanone in 
29% yield as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 2.21 (m, 2H), 2.05 (m, 2H), 
1.61-1.44 (comp. m, 8H), 1.57 (s, 3H), 0.18 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 145.1, 
113.5, 31.7, 28.9, 28.8, 26.7, 26.3, 15.8, 0.8; IR (Neat Film NaCl) 2924, 1678, 1251 cm–1; 
HRMS (EI) m/z calc'd for C12H24OSi [M]+: 212.1597, found 212.1590. 
 
2.8.5 ENANTIOSELECTIVE ALLYLIC ALKYLATION METHODS 
2.8.5.1 GENERAL PROCEDURES FOR ASYMMETRIC TSUJI ALLYLATION 
General Procedure 9:  0.1 mmol Optimization Reactions of Allyl Enol Carbonates 
O O
O
O
ligand (12.5 mol%)
Pd2(dba)3 (5 mol%)
solvent (0.033 M), 25 °C
105 106  
A 1 dram vial equipped with a magnetic stir bar was flame dried under vacuum.  
After cooling under dry argon, Pd2(dba)3 (4.6 mg, 0.005 mmol, 0.05 equiv) and ligand 
(0.0125 mmol, 0.125 equiv) were added.  After the vial was flushed with argon, solvent 
(3.0 mL) was added, and the contents were stirred at 25 °C for 30 min, at which time 
tridecane (12.25 µL) and allyl enol carbonate 105 (19.6 mg, 0.1 mmol, 1.0 equiv) were 
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added by syringe.  When the reaction was complete by TLC, the reaction mixture was 
diluted with hexanes (5 mL), filtered through a small plug of silica gel and analyzed by 
GC.  GC yield determined on DB-WAX column (70 °C initial temp, 5 °C/min ramp to 
180 °C), tridecane retention time = 7.000 min, ketone 106 retention time = 12.309 min. 
 
General Procedure 10:  1.0 mmol Preparative Reactions of Allyl Enol 
Carbonates 
O O
O
O
(S)-t-Bu-PHOX (6.25 mol%)
Pd2(dba)3 (2.5 mol%)
THF (0.033 M), 25 °C
105 (S)-106  
A 50 mL round-bottom flask equipped with a magnetic stir bar was flame dried under 
vacuum.  After cooling under dry argon, Pd2(dba)3 (22.9 mg, 0.025 mmol, 0.025 equiv) 
and (S)-t-Bu-PHOX (55, 24.2 mg, 0.0625 mmol, 0.0625 equiv) were added.  After the 
flask was flushed with argon, THF (30 mL) was added, and the contents were stirred at 
25 °C for 30 min, at which time allyl enol carbonate 105 (196.2 mg, 1.0 mmol, 1.0 equiv) 
was added by syringe in one portion.  When the reaction was complete by TLC (2 h), the 
reaction mixture was evaporated under reduced pressure and the residue 
chromatographed (2→3% Et2O in pentane on SiO2) to afford (S)-2-allyl-2-
methylcyclohexanone ((S)-106) (129.6 mg, 85.1% yield, 87% ee) as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 5.75–5.61 (m, 1H), 5.05 (s, 1H), 5.01 (m, 1H), 2.40–2.31 
(comp. m, 3H), 2.21 (dd, J = 13.8, 7.5 Hz, 1H), 1.78 (comp. m, 5H), 1.56 (m, 1H), 1.06 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 215.4, 133.7, 117.9, 48.4, 41.9, 38.8, 38.5, 27.4, 
22.6, 21.0; IR (Neat Film NaCl) 2934, 2865, 1707, 1451, 912 cm–1; HRMS (EI) m/z 
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calc'd for C10H16O [M]+: 152.1201, found 152.1204; [α]D21 –49.64 (c 2.38, hexane, 98% 
ee). 
 
General Procedure 11:  1.0 mmol Preparative Reactions of Cycloalkanone Silyl 
Enol Ethers 
(S)-t-Bu-PHOX (6.25 mol%)
Pd2(dba)3 (2.5 mol%), TBAT (35 mol%)
OOTMS
(S)-106
O
O O
THF (0.033 M), 25 °C
110
111
 
A 50 mL round-bottom flask equipped with a magnetic stir bar was flame dried under 
vacuum.  After cooling under dry argon, Pd2(dba)3 (22.9 mg, 0.025 mmol, 0.025 equiv), 
(S)-t-Bu-PHOX (55, 24.2 mg, 0.0625 mmol, 0.0625 equiv), and TBAT (189 mg, 0.35 
mmol, 0.35 equiv) were added.  After the flask was flushed with argon, THF (30 mL) 
was added, and the contents were stirred at 25 °C for 30 min, at which time diallyl 
carbonate (111, 150.6 µL, 1.05 mmol, 1.05 equiv) and trimethyl(2-methylcyclohex-1-
enyloxy)silane (110, 184.35 mg, 1.0 mmol, 1.0 equiv) were added sequentially by syringe 
in one portion.  When the reaction was complete by TLC (2 h), the reaction mixture was 
evaporated under reduced pressure and the residue chromatographed (2→3% Et2O in 
pentane on SiO2) to afford ketone (S)-106 (144.3 mg, 94.8% yield, 87% ee). 
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2.8.5.2 CHARACTERIZATION DATA FOR KETONES PREPARED BY 
ENANTIOSELECTIVE ALKYLATION 
O
148  
2-Methyl-2-(2-methylallyl)cyclohexanone (148, Table 2.7, entry 4; Table 2.8, 
entry 4): Reaction time: from allyl enol carbonate, 8 h, performed with 5 mol% 
Pd2(dba)3, 12.5 mol% (S)-55; from silyl enol ether, 4 h, performed with dimethallyl 
carbonate and 2.5 mol% Pd2(dba)3, 6.25 mol% (S)-55.  1H NMR (300 MHz, CDCl3) δ 
4.81 (s, 1H), 4.64 (s, 1H), 2.52 (m, 1H), 2.48 (d, J = 13.5 Hz, 1H), 2.36 (app. dt, J = 
14.7, 6.0 Hz, 1H), 2.25 (d, J = 13.8 Hz, 1H), 1.94-1.53 (comp. m, 6H), 1.65 (s, 3H), 1.06 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 215.8, 142.2, 114.7, 48.7, 45.4, 40.0, 38.9, 27.6, 
24.3, 23.3, 21.1; IR (neat) 2927, 1707 cm–1; HRMS (EI) m/z calc'd for C11H18O [M]+: 
166.1358, found 166.1358; [α]D27 –26.42 (c 1.85, hexane, 90% ee). 
 
O
(S)-149  
(S)-6-Allyl-6-methylcyclohex-2-enone (149, Table 2.7, entry 5): Reaction time: 
from allyl enol carbonate, 1 h.  1H NMR (300 MHz, CDCl3) δ 6.87 (app. dt, J = 10.2, 4.2 
Hz, 1H), 5.91 (app. dt, J = 10.2, 2.1 Hz, 1H), 5.72 (m, 1H), 5.07 (m, 1H), 5.02 (d, J = 9.3 
Hz, 1H), 2.35 (m, 3H), 2.16 (dd, J = 13.8, 7.5, Hz, 1H), 1.91 (dt, J = 13.8, 6.0 Hz, 1H), 
1.74 (dt, J = 13.8, 6.0 Hz, 1H), 1.07 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 203.7, 148.8, 
134.0, 128.4, 118.0, 44.4, 40.9, 32.9, 23.1, 21.6; IR (Neat Film NaCl) 2927, 1673 cm–1; 
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HRMS (EI) m/z calc'd for C10H14O [M]+: 150.1045, found 150.1039; [α]D26 +14.62 (c 
1.56, hexane, 89% ee). 
 
O
O O
150  
7-Allyl-7-methyl-1,4-dioxaspiro[4.5]decan-8-one (150, Table 2.7, entry 6; Table 
2.8, entry 6; Scheme 2.9c):  Reaction time: from allyl enol carbonate, 1 h; from silyl 
enol ether, 2 h.  1H NMR (300 MHz, CDCl3) δ 5.67 (ddt, J = 17.1, 10.5, 7.2 Hz, 1H), 5.07 
(br s, 1H), 5.02 (app. d, J = 9.3 Hz, 1H), 3.99 (app. d, J = 1.5 Hz, 4H), 2.57 (app. t, J = 
6.3 Hz, 1H), 2.42 (m, 2H), 2.00 (d, J = 13.8 Hz, 1H), 1.98 (app. t, J = 7.2 Hz, 1H), 1.75 
(d, J = 14.1 Hz, 1H), 1.12 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 213.9, 133.7, 118.4, 
107.6, 64.4, 64.3, 47.5, 44.3, 42.7, 35.7, 34.5, 23.9; IR (Neat Film NaCl) 2964, 1710, 
1116 cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1255; [α]D29 –
7.99 (c 2.41, hexane, 86% ee). 
 
O
151  
(S)-2-allyl-2-ethylcyclohexanone (151, Table 2.7, entry 7; Table 2.8, entry 2):  
Reaction time: from allyl enol carbonate, 2 h; from silyl enol ether, 3 h.  1H NMR (300 
MHz, CDCl3) δ 5.66 (m, 1H), 5.02 (m, 2H), 2.47-2.18 (m, 4H), 1.90-1.60 (m, 7H), 1.46 
(ddd, J = 21.6, 15.0, 7.2 Hz, 1H), 0.75 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
215.0, 134.2, 117.6, 51.6, 39.2, 38.5, 36.0, 27.2, 27.1, 20.7, 7.8; IR (Neat Film NaCl) 
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2937, 1703 cm–1; HRMS (EI) m/z calc'd for C11H18O [M]+: 166.1358, found 166.1362; 
[α]D28 +28.58 (c 1.51, hexane, 92% ee). 
 
O
t-Bu
152
O
t-Bu
O
PdCl2
Cu(OAc)2•H2O 
O2 (1 atm)
DMA, H2O
227  
2-tert-Butyl-2-(2-oxopropyl)cyclohexanone (227, Table 2.7, entry 8):  Allylation 
reaction time: from allyl enol carbonate, 10 h.  Isolated yield determined by Wacker 
oxidation (vide infra) of ketone 152 and isolation of 227.  1H NMR (300 MHz, CDCl3) δ 
3.29 (d, J = 18.0 Hz, 1H), 2.58 (app. dt, J = 16.2, 4.8 Hz, 1H), 2.34 (d, J = 17.7 Hz, 1H), 
2.23 (dd, J = 11.1, 6.0 Hz, 1H), 2.18-2.00 (m, 2H), 2.07 (s, 3H), 1.92-1.60 (comp. m, 
4H), 0.94 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 214.5, 207.6, 53.0, 51.3, 43.2, 36.6, 31.6, 
30.5, 27.7, 24.0, 23.9; IR (Neat Film NaCl) 2955, 1716, 1692, 1372, 1171 cm–1; HRMS 
(EI) m/z calc'd for C13H22O2 [M]+: 210.1620, found 210.1615; [α]D28 +132.01 (c 1.38, 
hexane, 81% ee). 
 
O
153  
2-Allyl-2-benzylcyclohexanone (153, Table 2.7, entry 9):  Reaction time: from allyl 
enol carbonate, 2 h.  1H NMR (300 MHz, CDCl3) δ 7.24 (comp. m, 3H), 7.12 (comp. m, 
2H), 5.74 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H), 5.12-5.03 (m, 2H), 2.91 (s, 2H), 2.46 (m, 2H), 
2.28 (d, J = 7.2 Hz, 2H), 1.86-1.65 (comp. m, 6H); 13C NMR (75 MHz, CDCl3) δ 214.1, 
137.5, 133.7, 130.6, 127.9, 126.3, 118.2, 52.5, 40.8, 39.6, 39.2, 35.5, 26.8, 20.8; IR (Neat 
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Film NaCl) 2937, 1704, 1638, 1602 cm–1; HRMS (EI) m/z calc'd for C16H20O [M]+: 
228.1514, found 228.1514; [α]D28 –12.34 (c 2.07, hexane, 85% ee). 
 
O OBn
154  
2-Allyl-2-(3-(benzyloxy)propyl)cyclohexanone (154, Table 2.7, entry 10): 
Reaction time: from allyl enol carbonate, 2 h.  1H NMR (300 MHz, CDCl3) δ 7.35–7.26 
(comp. m, 5H), 5.68 (m, 1H), 5.06 (s, 1H), 5.01 (m, 1H), 4.84 (s, 2H), 3.44 (app. t, J = 
6.3 Hz, 2H), 2.32 (comp. m, 4H), 1.88-1.24 (comp. m, 10H); 13C NMR (75 MHz, CDCl3) 
δ 214.8, 138.5, 133.9, 128.3, 127.5, 127.5, 117.8, 72.8, 70.5, 51.2, 39.2, 39.0, 36.4, 31.2, 
27.1, 23.8, 20.7; IR (Neat Film NaCl) 2926, 1703, 1102 cm–1; HRMS (FAB) m/z calc'd 
for C19H27O2 [M + H]+: 287.2011, found 287.2001; [α]D27 +24.19 (c 2.73, hexane, 88% 
ee). 
 
O
(S)-155  
(S)-2-Allyl-2,6,6-trimethylcyclohexanone (155, Table 2.7, entry 11; Scheme 2.9a):  
Reaction time: from allyl enol carbonate, 1 h.  1H NMR (300 MHz, CDCl3) δ 5.63 (m, 
1H), 5.01 (m, 2H), 2.33 (dd, J = 13.8, 6.9 Hz, 1H), 2.18 (dd, J = 13.8, 7.8 Hz, 1H), 1.82-
1.53 (comp. m, 6H), 1.11 (s, 3H), 1.09 (s, 3H), 1.08 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 219.8, 134.6, 117.9, 47.6, 44.4, 43.9, 39.7, 36.8, 27.8, 27.2, 25.5, 17.7; IR (Neat Film 
NaCl) 2933, 1697, 1463 cm–1; HRMS (EI) m/z calc'd for C12H20O [M]+: 180.1514, found 
180.1521; [α]D27 –35.69 (c 2.15, hexane, 92% ee). 
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O
(S)-98  
(S)-2-Allyl-2-methyl-3,4-dihydronaphthalen-1(2H)-one (98, Table 2.7, entry 12):  
Reaction time: from allyl enol carbonate, 2 h, 10 °C.  1H NMR (300 MHz, CDCl3) δ 8.04 
(dd, J = 8.0, 1.2 Hz, 1H), 7.45 (dt, J = 7.7, 1.5 Hz, 1H), 7.29 (app. t, J = 7.2 Hz, 1H), 
7.21 (app. d, J = 7.5 Hz, 1H), 5.85–5.71 (m, 1H), 5.10 (s, 1H), 5.05 (s, 1H), 2.97 (t, J = 
6.3 Hz, 2H), 2.46 (dd, J = 13.8, 7.5 Hz, 1H), 2.27 (ddt, J = 14.0, 7.5, 1.2 Hz, 1H), 2.07 
(ddd, J = 13.4, 7.2, 6.0 Hz 1H), 1.89 (ddd, J = 14.0, 6.9, 5.7 1H), 1.18 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 202.0, 143.2, 133.9, 133.0, 131.5, 128.6, 127.9, 126.5, 118.1, 44.5, 
41.0, 33.2, 25.3, 21.8; IR (Neat Film NaCl) 3073, 2930, 1682, 1455, 1220, 916, 742 cm–1; 
HRMS (EI) m/z calc'd for C14H16O [M]+: 200.1201, found 200.1194; [α]D27 –18.59 (c 2.08, 
hexane, 88% ee). 
 
O
MeO
156  
2-Allyl-6-methoxy-2-methyl-3,4-dihydronaphthalen-1(2H)-one (156, Table 2.7, 
entry 13): Reaction time: from allyl enol carbonate, 8 h, 10 °C.  1H NMR (300 MHz, 
CDCl3) δ 8.01 (d, J = 8.7 Hz, 1H), 6.82 (dd, J = 8.7, 2.4 Hz, 1H), 6.66 (d, J = 2.4 Hz, 
1H), 5.78 (m, 1H), 5.09 (s, 1H), 5.04 (m, 1H), 3.84 (s, 3H), 3.93 (app. t, J = 6 Hz, 2H), 
2.45 (dd, J = 13.8, 7.5 Hz, 1H), 2.25 (dd, J = 13.8, 7.5 Hz, 1H), 2.05 (m, 1H), 1.87 (m, 
1H), 1.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 200.9, 163.3, 145.7, 134.1, 130.4, 125.1, 
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118.0, 113.2, 112.2, 55.4, 44.3, 41.3, 33.4, 25.7, 22.0; IR (Neat Film NaCl) 2931, 1672, 
1601, 1256 cm–1; HRMS (EI) m/z calc'd for C15H18O2 [M]+: 230.1307, found 230.1313; 
[α]D26 –13.71 (c 1.5, hexane, 89% ee). 
 
O
157  
2-Allyl-2-methylcycloheptanone (157, Table 2.7, entry 14; Table 2.8, entry 7): 
Reaction time: from allyl enol carbonate, 6 h; from silyl enol ether, 2 h.  1H NMR (300 
MHz, CDCl3) δ 5.70 (ddt, J = 16.8, 10.2, 7.5, 1H), 5.02 (m, 2H), 2.59 (app. dt, J = 11.1, 
2.7 Hz, 1H), 2.42 (app. t, J = 9.0 Hz, 1H), 2.24 (dd, J = 13.8, 7.5 Hz, 1H), 2.16 (dd, J = 
13.8, 7.8 Hz, 1H), 1.78-1.30 (comp. m, 8H), 1.03 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
217.4, 133.8, 117.9, 50.8, 43.6, 40.6, 36.6, 30.6, 26.4, 24.4, 22.3; IR (Neat Film NaCl) 
2930, 1702, 1458 cm–1; HRMS (EI) m/z calc'd for C11H18O [M]+: 166.1358, found 
166.1360; [α]D28 –34.70 (c 1.52, hexane, 87% ee). 
 
O
158  
2-Allyl-2-methylcyclooctanone (158, Table 2.7, entry 15; Table 2.8, entry 8): 
Reaction time: from allyl enol carbonate, 2 h; from silyl enol ether, 3 h.  1H NMR (300 
MHz, CDCl3) δ 5.67 (m, 1H), 5.04 (app. d, J = 1.2 Hz, 1H), 5.00 (app. d, J = 8.1 Hz, 
1H), 2.59 (m, 1H), 2.29 (m, 2H), 2.12 (dd, J = 14.1, 7.7 Hz, 1H), 2.01 (m, 1H), 1.83-1.70 
(comp. m, 3H), 1.61-1.32 (comp. m, 5H), 1.18 (m, 1H), 1.01 (s, 3H); 13C NMR (75 MHz, 
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CDCl3) δ 220.3, 133.9, 117.8, 50.1, 42.0, 36.8, 33.5, 30.4, 25.9, 24.8, 24.3, 19.8; IR (Neat 
Film NaCl) 2929, 1699 cm–1; HRMS (EI) m/z calc'd for C12H20O [M]+: 180.1514, found 
180.1508; [α]D26 –21.22 (c 1.56, hexane, 79% ee). 
 
O
OBn
163  
2-Allyl-2-(benzyloxy)cyclohexanone (163, Table 2.8, entry 3):  Reaction time: from 
silyl enol ether, 3 h.  1H NMR (300 MHz, CDCl3) δ 7.39-7.25 (comp. m, 5H), 5.83 (dddd, 
J = 16.5, 10.8, 6.9, 6.9 Hz, 1H), 5.15 (app. ddd, J = 16.5, 3.0, 1.5 Hz, 1H), 5.13 (app. d, J 
= 10.8 Hz, 1H), 4.54 (d, J = 11.1 Hz, 1H), 4.16 (d, J = 11.1 Hz, 1H), 2.85-2.68 (m, 2H), 
2.42-2.24 (comp. m, 3H), 2.13-1.95 (comp. m, 2H), 1.76-1.44 (comp. m, 3H); 13C NMR 
(75 MHz, CDCl3) δ 212.5, 138.2, 132.8, 128.4, 127.5, 127.3, 118.3, 82.1, 65.3, 39.5, 
37.8, 36.0, 27.9, 20.6; IR (Neat Film NaCl) 3068, 3032, 2942, 2864, 1715, 1640, 1498, 
1454, 1433, 1384, 1311, 1254, 1157, 1121, 1085, 1060, 1028, 997, 970, 915, 735, 696 
cm–1; HRMS (EI) m/z calc'd for C16H20O2 [M]+: 244.1463, found 244.1455; [α]D28.3 +47.3 
(c 2.38, hexanes, 59% ee). 
 
O
164  
2-Allyl-2-(2-methylallyl)cyclohexanone (164, Table 2.8, entry 5; Scheme 2.8b & 
c):  Reaction time: from silyl enol ether, 5 h, performed with dimethallyl carbonate.  1H 
NMR (300 MHz, CDCl3) δ 5.69 (dddd, J = 16.5, 10.8, 7.5, 7.2 Hz, 1H), 5.00 (dddd, J = 
16.5, 2.1, 1.2, 1.2 Hz, 1H), 5.01 (dddd, J = 10.2, 2.1, 1.5, 1.5 Hz, 1H), 4.82 (app. ddd, J = 
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2.7, 1.2, 1.2 Hz, 1H), 4.66 (app. ddd, J = 3.0, 0.9, 0.9 Hz, 1H), 2.56-2.28 (comp. m, 6H), 
1.91-1.66 (comp. m, 6H), 1.64 (app. ddd, J = 0.9, 0.9, 0.6 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 214.5, 142.1, 134.1, 118.0, 115.0, 51.5, 43.0, 39.9, 39.5, 36.5, 27.1, 24.3, 20.9; 
IR (Neat Film NaCl) 3075, 2938, 2865, 1704, 1640, 1453, 1376, 1312, 1206, 1124, 1062, 
997, 913, 894 cm–1; HRMS (EI) m/z calc'd for C13H20O [M]+: 192.1514, found 192.1514; 
[α]D29.3 +3.9 (c 3.52, hexanes, 91% ee). 
 
O
(R)-181  
(R)-2-Methyl-1-phenylpent-4-en-1-one (181, Table 2.9):81  Purified by preparative 
TLC.  1H NMR (300 MHz, CDCl3) δ 7.94 (d, J = 7.2 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 
7.45 (t, J = 7.5 Hz, 1H), 5.77 (m, 1H), 5.00 (m, 2H), 3.52 (app. sextet, J = 6.9 Hz, 1H), 
2.54 (m, 1H), 2.19 (m, 1H), 1.21 (d, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
203.6, 136.4, 135.9, 133.0, 128.5, 116.7, 40.5, 37.7, 17.1; IR (Neat Film NaCl) 3078, 
2976, 2933, 1682, 1642, 1448, 1209, 976, 917, 704 cm–1; HRMS (EI) m/z calc'd for 
C12H14O [M]+: 174.1045, found 174.1048; [α]D27.0 –38.1 (c 1.73, hexanes, 70% ee). 
 
O
O O
192  
3-Allyl-3-methylfuran-2,4(3H,5H)-dione (192, Table 2.11, entry 2):  Purified by 
flash chromatography (SiO2, 2→12% EtOAc in hexanes).  87% yield, 2% ee.  Rf = 0.20 
(10% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 5.62 (dddd, J = 17.7, 9.6, 7.5, 
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7.2 Hz, 1H), 5.13 (app. ddd, J = 9.6, 1.8, 0.9 Hz, 1H), 5.12 (app. ddd, J = 17.1, 1.5, 0.9 
Hz, 1H), 4.59 (d, J = 17.1 Hz, 1H), 4.44 (d, J = 17.4 Hz, 1H), 2.53-2.37 (m, 2H), 1.28 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 209.9, 176.6, 130.1, 121.1, 72.5, 45.6, 40.2, 19.0; IR 
(Neat Film NaCl) 3543, 3083, 2983, 2939, 2877, 1803, 1758, 1642, 1454, 1436, 1378, 
1341, 1231, 1122, 1065, 1043, 998, 912, 664 cm–1; HRMS (EI) m/z calc'd for C8H10O3 
[M]+: 154.0630, found 154.0626. 
 
N
O
O
197  
4-Allyl-4-methyl-2-phenyloxazol-5(4H)-one (197, Table 2.11, entry 5):  Purified by 
flash chromatography (SiO2, 4→7% Et2O in hexanes).  89% yield, 2% ee.  Rf = 0.39 
(25% Et2O in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.99 (ddd, J = 7.2, 1.5, 1.2 Hz, 
2H), 7.57 (tt, J = 7.8, 1.2 Hz, 1H), 7.48 (ddd, J = 7.8, 6.9, 1.5 Hz, 2H), 5.67 (dddd, J = 
17.1, 9.9, 7.5, 6.9 Hz, 1H), 5.18 (dddd, J = 17.1, 1.5, 1.5, 1.5 Hz, 1H), 5.11 (dddd, J = 
10.2, 1.5, 0.9, 0.9 Hz, 1H), 2.64 (dddd, J = 13.8, 6.9, 0.9, 0.9 Hz, 1H), 2.57 (dddd, J = 
13.8, 7.5, 1.2, 1.2 Hz, 1H), 1.53 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 180.2, 159.8, 
132.7, 130.8, 128.7, 127.9, 125.9, 120.4, 69.7, 42.3, 23.2; IR (Neat Film NaCl) 3078, 
2982, 2934, 1819, 1655, 1581, 1493, 1451, 1321, 1293, 1177, 1094, 1071, 1005, 930, 
889, 780, 700 cm–1; HRMS (EI) m/z calc'd for C13H13O2N [M]+: 215.0946, found 
215.0938. 
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2.8.5.3 PROCEDURE FOR ASYMMETRIC PROPARGYLATION 
O
(S)-186  
(S)-2-Methyl-2-(prop-2-ynyl)cyclohexanone (186, Table 2.10):  A 50 mL two-neck 
rb flask containing a stirbar was equipped with a three-way stopcock, flame dried under 
vacuum, and cooled under dry nitrogen.  To this was added Pd2(dba)3 (11.4 mg, 0.0125 
mmol, 0.05 equiv) and (S)-t-Bu-PHOX (55, 12.5 mg, 0.0313 equiv).  The flask was 
evacuated and backfilled with dry nitrogen twice.  THF (15 mL) was then added and the 
mixture was stirred for 30 min at 25 ºC.  To the resulting yellow solution was added 
propargyl enol carbonate 185 (97.1 mg, 0.50 mmol) and then this mixture was stirred at 
70 ºC.  After the reaction was complete (~1 h), the resulting mixture was concentrated in 
vacuo.  Flash chromatography gave propargyl ketone 186 (64.3 mg, 86% yield) as a 
colorless oil.  1H NMR (300 MHz, CDCl3) δ 2.55-2.29 (comp. m, 4H), 1.99 (t, J = 2.7 Hz, 
1H), 1.98-1.65 (comp. m, 6H), 1.22 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 213.9, 81.1, 
70.7, 47.8, 38.5, 37.8, 27.6, 27.3, 22.3, 21.1; IR (Neat Film NaCl) 3292, 2936, 2865, 
2117, 1709, 1451, 1425, 1377, 1314, 1128, 1075 cm–1; HRMS (EI) m/z calc’d for 
C10H14O [M]+: 150.1045, found 150.1044; [α]D25 +0.74 (c 1.50, CHCl3, 31% ee). 
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2.8.5.4 METHODS FOR DETERMINATION OF ENANTIOMERIC EXCESS 
Table 2.12.  Methods used for the determination of enantiomeric excess 
O
entry product compound assayed
retention time
of major
isomer (min)
% ee
1 88
retention time
of minor
isomer (min)
assay
conditions
O
GC, G-TA
100 oC
isotherm
11.13 12.74
5
O
85
O
HPLC
Chiracel OJ
2% EtOH in hexane
isocratic, 1.0 mL/min
19.81 13.82
2 92
O
19.97 21.48
O
HPLC
Chiracel OD-H
0.1% IPA in heptane
isocratic, 0.7 mL/min
3 92
O GC, G-TA
100 oC
isotherm
14.52 13.35
O
t-Bu
4 82
t-Bu GC, G-TA
110 oC
isotherm
63.65 62.01
O O
O
6
O
88
O
HPLC
Chiralpak AD
0.75% IPA in hexane
isocratic, 1.0 mL/min
11.95 13.80
OBn OBn
92
O
GC, G-TA
100 oC
isotherm
15.76 17.65
O
7
92
O
GC, G-TA
80 oC
isotherm
25.48 27.90
O
8
O
86
O
GC, G-TA
120 oC
isotherm
26.90 28.64
O O O O
9
10 90
O
GC, G-TA
100 oC
isotherm
15.31 18.04
O
106 106
98 98
227
155 155
149 149
152
151 228
153 153
154 154
148 148
150 150
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Table 2.12.  (continued) 
entry product compound assayed
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
assay
conditions
11 91
O
11.38 10.16
O HPLC
Chiracel OJ
1% EtOH in hexane
isocratic
1.0 mL/min
MeO MeO
12 87
GC, G-TA
110 oC
isotherm
9.88 10.68
O O
O O
O
13 79
GC, G-TA
110 oC
isotherm
63.25 61.94
14
O
OBn
59
O
OBn HPLC
Chiracel OB-H
0.2% EtOH in hexane
isocratic, 1.0 mL/min
13.56 16.96
OO
15 91
GC, G-TA
95 oC
isotherm
49.77 47.98
164 164
16 7021.63 25.04
HPLC
Chiracel OD-H
0.1% IPA in heptane
isocratic, 0.7 mL/min
181 181
O O
20 117.76 8.59
HPLC
Chiracel OJ
0.1% IPA in hexane
isocratic, 1.0 mL/min
O
Ph
O
Ph
19 219.67 21.64
O
OO
O
OO
GC, G-TA
100 oC
isotherm
18 2415.55 16.66
O
CO2Et
O
CO2Et GC, G-TA
120 oC
isotherm
17 3121.8 23.0
186 186
GC, B-DM
90 oC
isotherm
O O
22 26.61 5.40
O
N
O
O
N
O
HPLC
Chiracel OD-H
2% IPA in hexane
isocratic, 1.0 mL/min
Ph Ph
21 09.03 7.38
HPLC
Chiracel OJ
3% IPA in hexane
isocratic, 1.0 mL/min
OO
156 156
157 157
158 229
163 163
100 100
192 192
102 102
195 195
197 197  
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2.8.6 PREPARATION AND CHARACTERIZATION OF DERIVATIVES 
2.8.6.1 PREPARATION AND CHARACTERIZATION OF SEMICARBAZONE 
DERIVATIVES 
O 1.  semicarbazide•HCl
     pyridine, MeOH, H2O
     105 °C, 15 min
N
2.  Recrystalization from
     EtOH/H2O to 95% ee
61% yield
H
NH2N
O
(S)-106
87% ee 159
O
(S)-106
98% ee
3 M aq HCl
Et2O
99% yield
 
Semicarbazone 159 (Scheme 2.5):82  To a solution of ketone (S)-106 (661.4 mg, 4.34 
mmol, 1.0 equiv) of 88% ee in pyridine (1.22 mL), water (3.0 mL), and MeOH (8.0 mL) 
was added semicarbazide•HCl (848.1 mg, 7.60 mmol, 1.75 equiv).  The reaction mixture 
was heated at 105 °C for 15 min, cooled, diluted with water (10 mL), filtered, and dried 
to give semicarbazone 159 (763 mg, 84% yield).  The semicarbazone 159 (3.10 g, 14.8 
mmol, 87% ee) was suspended in EtOH/water (35/65 v/v 355 mL) and warmed to 90 °C.  
When all the material had dissolved, heating was discontinued, and the flask allowed to 
cool in the heating bath.  After 8 h, crystals were filtered and dried giving the 
enantioenriched semicarbazone (1.894 g, 61% yield, 95% ee).  Recrystalization of this 
material in EtOH/water (30/70 v/v 175 mL) by the same procedure gave semicarbazone 
159 (1.692 g, 89% yield, 98% ee) as white crystals; mp 188–189 °C (EtOH/water); 1H 
NMR (300 MHz, CDCl3) δ 7.93 (br s, 1H), 5.73 (m, 1H), 5.05 (s, 1H), 5.00 (app. d, J = 
3.3 Hz, 1H), 2.40-2.11 (comp. m, 4H), 1.71-1.44 (comp. m, 6H), 1.10 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 158.1, 156.8, 134.6, 117.2, 42.9, 41.5, 38.6, 25.9, 24.5, 22.5, 21.0; IR 
(Neat Film NaCl) 3465, 3195, 1693, 1567, 1478 cm–1; HRMS (CI, CH4) m/z calc'd for 
C11H20N3O [M + H]+:  210.1606, found 210.1599; [α]D28 –50.35 (c 2.60, MeOH). 
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To a biphasic mixture of Et2O (30 mL) and 3 M aq HCl (3.0 mL) was added the 
enriched semicarbazone 159 (1.00 g, 4.77 mmol, 1.0 equiv).  The reaction mixture was 
stirred vigorously for 2 h and then quenched with saturated aq NaHCO3 (40 mL).  The 
layers were separated, and aqueous layer extracted with Et2O (4 x 30 mL).  The combined 
organics were washed with brine (30 mL), dried (MgSO4), and concentrated to give 
ketone 106 (718.2 mg, 98.9% yield). 
 
xylenes, reflux, 2 h
88% yield
H2N
160
N
H
NH2N
O
159
(S)
N
HN
NHO
161  
(isopinocampheylamine)-Semicarbazone 161 (Scheme 2.5):  To a solution of the 
semicarbazone 159 (100 mg, 0.43 mmol, 1.0 equiv) in xylenes (1.0 mL) was added 
(1S,2S,3S,5R)-(+)-isopinocampheylamine (160, 76.2 µL, 0.45 mmol, 1.05 equiv).  The 
reaction mixture was refluxed for 2 h, cooled, and concentrated.  Chromatography 
(10→50% EtOAc in Hexanes on SiO2) afforded the (isopinocampheylamine)-
semicarbazone 161 (130.5 mg, 87.8% yield).  mp 131-133 °C from acetone; 1H NMR 
(300 MHz, CDCl3) δ 7.47 (br s, 1H), 6.08 (bd, J = 8.7 Hz, 1H), 5.77 (m, 1H), 5.06 (s, 
1H), 5.01 (s, 1H), 4.18 (m, 1H), 2.63 (app. tdd, J = 9.9, 3.6, 2.4 Hz, 1H), 2.45-2.13 
(comp. m, 4H), 1.96 (m, 1H), 1.82 (m, 2H), 1.74-1.41 (comp. m, 8H), 1.23 (s, 3H), 1.15 
(d, J = 7.2 Hz, 3H), 1.11 (s, 3H), 1.10 (s, 3H), 0.89 (d, J = 9.9 Hz, 1H); 13C NMR (75 
MHz, CDCl3) δ 156.5, 155.5, 134.9, 117.0, 48.0, 47.8, 46.8, 43.0, 41.6, 41.5, 38.5, 38.3, 
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37.8, 35.3, 28.0, 25.9, 24.5, 23.4, 22.4, 21.0, 20.8; IR (Neat Film NaCl) 3400, 3189, 
3074, 2929, 1672, 1526 cm–1; HRMS (FAB) m/z calc'd for C21H36N3O [M + H]+:  
346.2858, found 346.2874; [α]D27 –18.9 (c 0.53, hexane).  The semicarbazone was 
recrystallized from EtOH/H2O to provide suitable crystals for X-ray analysis (vide infra). 
 
N
HN
NHO
162  
(isopinocampheylamine)-Semicarbazone 162 (Scheme 2.5).  Prepared in an 
analogous manner to 161.  mp 145-146 °C from acetone; 1H NMR (300 MHz, CDCl3) δ 
7.78 (d, J = 21.3 Hz, 1H), 6.07 (d, J = 4.4 Hz, 1H), 5.86-5.72 (m, 1H), 5.08-5.04 (m, 
1H), 5.00 (s, 1H), 4.23-4.12 (m, 1H), 2.68-2.55 (m, 1H), 2.46-2.34 (m, 2H), 2.30 (d, J = 
7.5 Hz, 2H), 2.12-2.00 (m, 1H), 1.98-1.90 (m, 1H), 1.88-1.40 (comp. m, 11H), 1.22 (s, 
3H), 1.15 (d, J = 7.2 Hz, 3H), 1.05 (s, 3H), 0.88 (d, J = 9.6 Hz, 1H), 0.77 (t, J = 7.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 156.8, 154.4, 135.3, 116.7, 48.0, 47.9, 46.8, 44.2, 
41.7, 39.9, 38.3, 37.9, 35.6, 35.3, 28.1, 28.0, 25.6, 23.4, 22.6, 20.8, 20.7, 7.8; IR (Neat 
Film NaCl) 3402, 3194, 3074, 2930, 1672, 1526 cm–1; HRMS (EI) m/z calc'd for 
C22H37N3O [M]+:  359.2937, found 359.2940; [α]D29 –4.43 (c 0.38, hexane).  The 
semicarbazone was recrystallized from acetone to provide suitable crystals for X-ray 
analysis (vide infra). 
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2.8.6.2 X-RAY STRUCTURES OF SEMICARBAZONES 161 AND 162 
Figure 2.1.  Representations of semicarbazones 161 and 162 
N
HN
NHO
161
                 
N
HN
NHO
162
 
Table 2.13.  Crystal data and structure refinement for semicarbazone 161 (CCDC 246585) 
Empirical formula  C21H35N3O 
Formula weight  345.52 
Crystallization solvent  Ethanol/water 
Crystal habit  Fragment 
Crystal size 0.41 x 0.37 x 0.24 mm3 
Crystal color  Colorless  
  
Data Collection 
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 7110 reflections used in  
 lattice determination  2.31 to 24.12° 
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Table 2.13.  (continued) 
Unit cell dimensions a = 23.1170(16) Å 
 b = 13.6467(9) Å β = 90.396(2)° 
 c = 13.2060(9) Å 
Volume 4166.0(5) Å3 
Z 8 
Crystal system  Monoclinic 
Space group  C2 
Density (calculated) 1.102 Mg/m3 
F(000) 1520 
θ range for data collection 1.73° to 33.55° 
Completeness to θ = 33.55° 81.9%  
Index ranges –29 ≤ h ≤ 34, –20 ≤ k ≤ 20, –18 ≤ l ≤17 
Data collection scan type  ω scans at 4 φ settings 
Reflections collected 30377 
Independent reflections 12571 [Rint= 0.0616] 
Absorption coefficient 0.068 mm-1 
Absorption correction None 
Max. and min. transmission 0.9838 and 0.9726 
 
 Structure solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 1990) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 1997) 
Refinement method Full matrix least-squares on F2 
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Table 2.13.  (continued) 
Data / restraints / parameters 12571 / 64 / 486 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 1.972 
Final R indices [I > 2σ(I),  5761 reflections] R1 = 0.0873, wR2 = 0.1490 
R indices (all data) R1 = 0.1657, wR2 = 0.1573 
Type of weighting scheme used Sigma 
Weighting scheme used w = 1 / σ2(Fo2) 
Max shift/error  0.002 
Average shift/error  0.000 
Absolute structure parameter 0.4(16) 
Largest diff. peak and hole 0.630 and –0.361 e.Å-3 
 Special Refinement Details  
The data are weak and the structure is disordered in the allyl of molecule B.  These two factors 
combine to produce a final structure that falls short of the desired quality.  Nevertheless, the quality is 
sufficient to determine the relative stereochemistry around C1 and, given the known stereochemistry of 
another chiral center, the absolute conformation can be deduced.  Care should be taken when including 
these results in a publication.  The allylic fragments were restrained to have similar geometry and the 
anisotropic displacement factors of the B molecule allyl fragment (only) were restrained to tend towards 
isotropic behavior. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
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angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes.  
 
Table 2.14.  Crystal data and structure refinement for semicarbazone 162 (CCDC 248956) 
Empirical formula  C22H37N3O 
Formula weight  359.55 
Crystallization solvent  Acetone 
Crystal habit  Fragment 
Crystal size 0.39 x 0.37 x 0.24 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data collection temperature  100(2) K 
θ range for 13615 reflections used 
in lattice determination  2.25° to 21.58° 
Unit cell dimensions a = 13.4105(11) Å 
 b = 13.4433(11) Å 
 c = 24.353(2) Å 
Volume 4390.4(6) Å3 
Z 8 
Crystal system  Orthorhombic 
Space group  P212121 
Density (calculated) 1.088 Mg/m3 
F(000) 1584 
θ range for data collection 1.67° to 28.34° 
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Table 2.14.  (continued) 
Completeness to θ = 28.34° 94.5%  
Index ranges –17 ≤ h ≤ 17, –17 ≤ k ≤ 17, –32 ≤ l ≤ 30 
Data collection scan type  ω scans at 5 φ settings 
Reflections collected 63444 
Independent reflections 10086 [Rint= 0.0909] 
Absorption coefficient 0.067 mm-1 
Absorption correction None 
Max. and min. transmission 0.9841 and 0.9744 
 Structure solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 1990) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 1997) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 10086 / 447 / 570 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 2.208 
Final R indices [I>2σ(I),  6214 reflections] R1 = 0.0842, wR2 = 0.1195 
R indices (all data) R1 = 0.1330, wR2 = 0.1224 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.000 
Average shift/error  0.000 
Absolute structure parameter 0.6(17) 
Largest diff. peak and hole 0.271 and -0.287 e.Å-3 
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 Special Refinement Details  
The diffraction intensities fall off sharply past 2θ = 40º, presumably because the structure is 
disordered.  The asymmetric unit contains two molecules (hydrogen bonded to each other and of the same 
configuration) disordered in different ways.  Molecule A is disordered about the terminal carbon (C11) of 
the allyl ligand (see figures 1 and 2).  Both orientations were modeled, including riding hydrogen atoms, 
with the only restraint being a total occupancy of 1.0 for C11A and C11C.  Molecule B is disordered in the 
camphene moiety, C13B-C22B.  The disorder manifests as a rotation of the camphene around the N3B-
C13B bond (see figures 3 and 4).  Both orientations were restrained to have geometry similar to the 
corresponding part of the A molecule, using the SAME command.  Additional restraints were imposed in 
this portion of molecule B as follows: 1) SIMU – to restrained bonded atoms to have similar displacement 
parameters, and 2) ISOR – to restrain the anisotropic displacement parameters, Uij, to approximate isotropic 
behavior without placing restraint on the refined value of the isotropic U. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles, and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
 
 
140 Chapter 2 – Enantioselective Allylic Alkylations of Enolates from Enol Carbonates and Silanes 
2.8.6.3 PREPARATION AND CHARACTERIZATION OF α-QUATERNARY 
KETONE DERIVATIVES 
O
(–)-106 (–)-166
1.  PdCl2, Cu(OAc)2•H2O, O2, DMA, H2O
2.  KOH, EtOH, 60!80 °C
73% yield, 2 steps
O
 
(–)-7a-Methyl-5,6,7,7a-tetrahydro-1H-inden-2(4H)-one (166, Scheme 2.8a):83  To 
a solution of ketone 106 (98% ee, 304.4 mg, 2.0 mmol, 2.0 equiv) in dimethylacetamide 
(2.8 mL) and water (0.4 mL) was added PdCl2 (53.1 mg, 1.2 mmol, 0.15 equiv), 
Cu(OAc)2•H2O (217.9 mg, 1.20 mmol, 0.60 equiv).  An oxygen balloon was attached.  
After 24 h of vigorous stirring at 25 °C the reaction mixture was chromatographed 
(5→25 % EtOAc in Hexanes on SiO2).  To a solution of the resulting diketone in EtOH 
(30 mL) was added KOH (3.4 mL of a 50 mg/mL ethanolic solution), and the reaction 
mixture was heated at 60 °C for 6 h.  The temperature was increased to 80 °C and 
additional KOH (200 mg) was added.  After 4 h the reaction was cooled and 
concentrated.  The resulting residue was partitioned between EtOAc (30 mL) and water 
(20 mL) and acidified to pH 2 with 3 M aq HCl.  The layers were separated, and the 
aqueous layer extracted with EtOAc (3 x 20 mL).  The combined organics were washed 
with brine (30 mL), dried (Na2SO4), and concentrated.  Chromatography (10→30% Et2O 
in pentane on SiO2) afforded enone 166 (219.1 mg, 72.9% overall yield ).  1H NMR (300 
MHz, CDCl3) δ 5.74 (s, 1H), 2.62 (br d, J = 12.0 Hz, 1H), 2.35 (dt, J = 13.5, 5.4 Hz, 1H), 
2.27 (dd, J = 18.3, 0.9 Hz, 1H), 2.17 (d, J = 18.6 Hz, 1H), 2.26-1.88 (m, 2H), 1.64 (m, 
2H), 1.36 (m, 2H), 1.22 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 208.2, 188.6, 126.0, 52.1, 
43.1, 40.6, 27.9, 27.8, 24.0, 21.8; IR (Neat Film NaCl) 2934, 1713, 1622, 1221 cm–1; 
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HRMS (EI) m/z calc'd for C10H14O [M]+: 150.1045, found 150.1041; [α]D27 –44.86 (c 3.55, 
hexane, 98% ee). 
 
O
(–)-106
O
(+)-168
1.  
     MVK, CH2Cl2, 40 °C
2.  Pd/C, EtOAc, H2
3.  KOH, EtOH, 65 °C
63% yield, 3 steps
167
(5 mol%)Ru
Cy3P
Cl
Cl
Ph
NMesMesN
 
(+)-1-(7a-Methyl-2,4,5,6,7,7a-hexahydro-1H-inden-3-yl)ethanone (168, Scheme 
2.8a):84,85  To a solution of ketone 106 (98% ee, 152.2 mg, 1.0 mmol, 1.0 equiv) and 
methyl vinyl ketone (208.1 µL, 2.5 mmol, 2.5 equiv) in CH2Cl2 (5 mL) was added 
Grubbs’ 2nd generation catalyst (167)86 (42.4 mg, 0.05 mmol, 0.05 equiv).  The reaction 
mixture was heated at 40 °C for 18 h, cooled to 25 °C, and concentrated.  
Chromatography (20% EtOAc in hexanes on SiO2) gave the enone (152.1 mg 78.3% 
yield), which was dissolved in EtOAc (12 mL) and treated with 10% Pd/C (30 mg) under 
an atmosphere of hydrogen gas for 12 h.  The system was purged with argon, filtered 
through a small pad of silica gel, and concentrated.  To a solution of the crude diketone in 
EtOH (12 mL) was added KOH (2.0 mL of a 50 mg/mL ethanolic solution).  The reaction 
mixture was heated to 65 °C for 8 h, cooled to 25 °C, concentrated, and the residue 
partitioned between EtOAc (10 mL) and 1 M aq HCl (10 mL) The layers were separated, 
the aqueous layer extracted with Et2O (3 x 25 mL), and the combined organics were 
washed with saturated NaHCO3 (25 mL), then brine (25 mL), dried (MgSO4), and 
concentrated.  Flash chromatography (10→15 % Et2O in hexanes on SiO2) gave enone 
168 (112.4 mg, 81% yield).  1H NMR (300 MHz, CDCl3) δ 3.32 (d, J = 14.7 Hz, 1H), 
2.59 (m, 2H), 2.23 (s, 3H), 2.01 (app. t, J = 13.5 Hz, 1H), 1.82 (m, 3H), 1.59 (m, 3H), 
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1.43-1.23 (m, 2H), 1.08 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 199.2, 162.2, 131.9, 48.6, 
41.5, 39.0, 30.9, 30.5, 27.1, 25.2, 22.9, 22.0; IR (Neat Film NaCl) 2931, 1678, 1654, 
1614, 1357 cm–1; HRMS (EI) m/z calc'd for C10H18O [M]+: 178.1358, found 178.1355; 
[α]D27 +82.9 (c 3.26, hexane, 98% ee). 
 
O
(–)-106
O
(+)-169
1.  ethylene glycol, PPTS, PhH, Dean-Stark
2.  BH3•THF, then NaBO3•4H2O
3.  (COCl)2, DMSO, Et3N
4.  MeMgBr, THF
5.  (COCl)2, DMSO, Et3N
6.  TsOH•H2O, acetone, H2O
7.  KOH, EtOH, 60 °C, 4 h
42% yield overall from 106  
(+)-4a-Methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (169, Scheme 2.8a):87  
A solution of ketone 106 (98% ee, 1.23 g, 8.11 mmol, 1.0 equiv), ethylene glycol (1.8 
mL), pyridinium p-toluenesulfonate (PPTS, 0.6 g), and benzene (45 mL) was refluxed for 
22 h in a Dean-Stark apparatus.  The reaction mixture was cooled, poured into saturated 
aq NaHCO3 (50 mL), the aq layer extracted with 1:1 hexanes:Et2O (2 x 20 mL).  The 
combined organics were washed with brine (2 x 15 mL), dried (MgSO4), concentrated, 
and chromatographed to give the ketal (1.59 g).  The ketal in THF (15 mL) was added 
dropwise to a cooled (–25 °C) solution of BH3•THF (20.3 mmol, 2.5 equiv) in THF (100 
mL), and after 4 h was allowed to warm to 25 °C overnight.  The reaction mixture was 
then cooled to –10 °C and water (25 mL) was slowly added, followed by NaBO3•4H2O 
(4.99 g, 32.4 mmol, 4.0 equiv), and the reaction mixture was allowed to warm to 25 °C.  
After 48 h, the reaction mixture was partitioned between water (100 mL) and EtOAc (100 
mL), the layers separated, the aq layer extracted with EtOAc (5 x 75 mL), and the organic 
fractions were dried (Na2SO4). Evaporation of the solvents under reduced pressure, and 
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chromatography (20→40% EtOAc in hexanes on SiO2) gave the primary alcohol (1.50 g, 
87% yield).   
To a cooled (–78 °C) solution of DMSO (479.0 µL, 6.72 mmol, 1.6 equiv) in CH2Cl2 
(45 mL) was added oxalyl chloride (475.2 µL, 5.45mmol, 1.3 equiv).  After 45 min, the 
primary alcohol (900 mg, 4.19 mmol, 1.0 equiv) in CH2Cl2 (5 mL) was added in a 
dropwise manner.  After an additional 30 min, Et3N (2.32 mL, 16.8 mmol, 4.0 equiv) was 
added, the reaction mixture warmed to 25 °C, and quenched with half-saturated aq 
NaHCO3.  The aq layer was extracted with CH2Cl2 (3 x 30 mL), the combined organics 
dried (MgSO4), and solvents evaporated.  This crude aldehyde in THF (45 mL) was 
cooled to –10 °C, treated with methyl magnesium bromide (3 M soln in Et2O, 8.40 mmol, 
2.0 equiv), quenched with water (20 mL) and saturated aq NH4Cl (20 mL), extracted 
CH2Cl2 (4 x 20 mL), dried (MgSO4), and solvents evaporated.  The resulting crude 
secondary alcohol was resubmitted to the Swern oxidation conditions described above to 
give a crude methyl ketone.  A solution of the methyl ketone in acetone (45 mL) and 
water (0.7 mL) was treated with TsOH•H2O (60 mg), and heated at 50 °C for 4 h.  The 
reaction mixture was then concentrated and chromatographed (7.5→20% EtOAc in 
hexanes on SiO2) to give the diketone (515.8 mg, 68% yield for 4 steps). 
To a solution of KOH (300 mg 5.36 mmol, 1.91 equiv) in EtOH (40 mL) was added 
the diketone (510.0 mg, 2.80 mmol, 1.0 equiv) dissolved in EtOH (15 mL), and the 
reaction mixture heated at 60 °C for 4 h.  The reaction was quenched with acetic acid 
(306 µL, 5.36 mmol, 1.91 equiv), concentrated and chromatographed (5→20% Et2O in 
hexanes on SiO2) to give enone 169 (334.2 mg, 73% yield, 42% overall yield for 7 steps): 
1H NMR (300 MHz, CDCl3) δ 5.71 (s, 1H), 2.56-2.22 (m, 4H), 1.92-1.64 (m, 6H), 1.44-
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1.30 (m, 2H), 1.23 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 199.6, 170.5, 124.1, 41.5, 38.0, 
35.9, 34.0, 32.7, 27.1, 22.0, 21.7; IR (Neat Film NaCl) 2930, 1678 cm–1; HRMS (EI) m/z 
calc'd for C11H16O [M]+: 164.1201, found 164.1196; [α]D28 +216.2 (c 1.05, EtOH, 98% 
ee). 
 
O
(–)-106
O
O
(+)-170
peracetic acid, Na2CO3
CH2Cl2, 0!25 °C
75% yield  
(+)-7-Allyl-7-methyloxepan-2-one (170, Scheme 2.8a):88  To a cooled (0 °C) 
solution of ketone 106 (98% ee, 152.2 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (20 mL) was 
added Na2CO3 (593.6 mg, 5.6 mmol, 5.6 equiv) and peracetic acid (800 µL of a 32% 
solution in acetic acid).  The reaction mixture was maintained at 0 °C for 9 h, then 
allowed to warm to 25 °C for an additional 12 h, diluted with saturated aq NaHCO3, and 
the organic layer dried (Na2SO4).  Chromatography (5→20% EtOAc in hexanes on SiO2) 
afforded lactone 170 (125.6 mg, 75% yield).  1H NMR (300 MHz, CDCl3) δ 5.85 (m, 
1H), 5.15 (m, 1H), 5.11 (app. d, J = 8.4 Hz, 1H), 2.78-2.61 (m, 2H), 2.51 (dd, J = 13.8, 
7.2 Hz, 1H), 2.42 (dd, J = 14.1, 7.5 Hz, 1H), 1.86-1.62 (m, 6H), 1.43 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 174.7, 132.8, 119.0, 82.7, 46.7, 38.4, 37.3, 24.8, 23.8, 23.3; IR (Neat 
Film NaCl) 2936, 1717, 1172 cm–1; HRMS (EI) m/z calc'd for C10H16O2 [M]+: 168.1150, 
found 168.1154; [α]D27 +20.58 (c 3.46, hexane, 98% ee). 
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O
(+)-164
O
(–)-171
CH2Cl2, 40 °C
85% yield
167
(3 mol%)Ru
Cy3P
Cl
Cl
Ph
NMesMesN
 
(–)-2-methylspiro[4.5]dec-2-en-6-one (171, Scheme 2.8b):  To a sparged (Ar, 5 
min) solution of ketone 164 (91% ee, 526 mg, 2.73 mmol, 1.00 equiv) in CH2Cl2 (56 mL) 
was added the 2nd generation Grubbs catalyst (167)86 (69.6 mg, 0.082 mmol, 0.03 equiv) 
and the reaction was heated at 40 °C for 10 h.  The reaction mixture was cooled to 
ambient temperature, concentrated, and the residue purified by flash chromatography 
(1→2% Et2O in hexanes on SiO2) to give spiro[4.5]ketone 171 (381 mg, 85% yield).  1H 
NMR (300 MHz, CDCl3) δ 5.14 (m, 1H), 2.86-2.71 (m, 2H), 2.44-2.35 (m, 2H), 2.17 
(dddd, J = 16.2, 5.4, 4.2, 2.1 Hz, 1H), 2.02 (ddd, J = 16.5, 3.0, 1.2 Hz, 1H), 1.88-1.68 
(comp. m, 6H), 1.67-1.64 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 213.3, 137.5, 121.1, 
56.3, 45.7, 41.9, 40.3, 39.4, 27.2, 22.2, 16.4; IR (Neat Film NaCl) 3042, 2930, 2860, 
1710, 1666, 1438, 1338, 1312, 1207, 1129, 1056, 1019, 899, 853, 838, 807 cm–1; HRMS 
(EI) m/z calc'd for C11H16O [M]+: 164.1201, found 164.1201; [α]D27.1 –21.7 (c 2.65, 
CH2Cl2, 91% ee). 
 
O
(+)-164
OO
(+)-173
OO
ethylene glycol
PhH, Dean-Stark
57% isolated yield
87% yield based
on recovered 
starting material
1.  O3, CH2Cl2
     –78 °C
     then Me2S
2.  KOH, EtOH
     75 °C
16% yield
O
(+)-172  
(+)-6-Allyl-6-(2-methylallyl)-1,4-dioxaspiro[4.5]decane (172, Scheme 2.8c):  A 
solution of ketone 164 (91% ee, 1.27 g, 6.60 mmol, 1.0 equiv), ethylene glycol (1.8 mL), 
pyridinium p-toluenesulfonate (PPTS, 0.600 g), and benzene (80 mL) was refluxed for 15 
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h in a Dean-Stark apparatus.  The reaction mixture was cooled, poured into saturated aq 
NaHCO3 (20 mL), and diluted with H2O (30 mL) and CH2Cl2 (30 mL).  The aqueous 
layer extracted with CH2Cl2 (3 x 30 mL).  The combined organics were dried (Na2SO4), 
concentrated, and purified by flash chromatography (1→2% Et2O in hexanes on SiO2) to 
give ketal 172 (889 mg, 57% yield) plus recovered 164 (433.3 mg, 34% recovery).  1H 
NMR (300 MHz, CDCl3) δ 6.02 (dddd, J = 16.2, 11.1, 7.2, 7.2 Hz, 1H), 4.95 (app. ddd, J 
= 15.9, 1.8, 1.8 Hz, 1H), 4.95 (app. ddd, J = 11.1, 1.2, 1.2 Hz, 1H), 4.85 (app. ddd, J = 
4.2, 2.4, 1.5 Hz, 1H), 4.78-4.71 (m, 1H), 3.98-3.84 (comp. m, 4H), 2.43-2.17 (comp. m, 
4H), 1.82 (s, 3H), 1.67-1.40 (comp. m, 8H); 13C NMR (75 MHz, CDCl3) δ 143.7, 136.9, 
114.9, 114.8, 112.9, 64.4, 64.1, 45.0, 39.4, 38.1, 33.1, 30.5, 25.6, 23.4, 20.7; IR (Neat 
Film NaCl) 3073, 2936, 2882, 1638, 1452, 11374, 1275, 1215, 1173, 1089, 1060, 1026, 
957, 892 cm–1; HRMS (EI) m/z calc'd for C15H24O2 [M]+: 236.1776, found 236.1779; 
[α]D26.7 +5.0 (c 2.71, CH2Cl2, 91% ee).   
(+)-Spiro[5.5]ketone 173 (Scheme 2.8c):  Through a cooled (–78 °C) solution of 
ketal 172 (441 mg, 1.86 mmol, 1.00 equiv) in CH2Cl2 (40 mL) was bubbled a stream of 
ozone until the reaction mixture turned blue.  The reaction mixture was quenched with 
dimethyl sulfide (0.50 mL), allowed to warm to ambient temperature, and concentrated to 
an oil.  This residue was dissolved in EtOH (35 mL), treated with an ethanolic KOH 
solution (3.0 mL of 50 mg/mL), and heated to 75 °C for 3 h.  The reaction mixture was 
cooled to ambient temperature, neutralized with acetic acid, concentrated, and purified by 
flash chromatography (5→25% EtOAc in hexanes on SiO2) to give spiro[5.5]ketone 173 
(65.7 mg, 16% yield): 1H NMR (300 MHz, CDCl3) δ 6.84 (ddd, J = 10.2, 5.7, 2.7 Hz, 
1H), 5.98 (app. dd, J = 9.9, 3.0 Hz, 1H), 4.02-3.87 (comp. m, 4H), 2.66 (ddd, J = 19.2, 
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2.7, 2.7 Hz, 1H), 2.64 (d, J = 16.2 Hz, 1H), 2.46 (d, J = 15.9 Hz, 1H), 2.33 (ddd, 19.2, 
6.0, 1.5 Hz, 1H) 1.68-1.50 (comp. m, 6H), 1.48-1.34 (comp. m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 199.9, 148.1, 128.5, 111.1, 65.0 (2C), 44.7, 43.3, 31.5, 31.1, 30.1, 23.1, 20.4; IR 
(Neat Film NaCl) 2935, 2865, 1677, 1448, 1389, 1346, 1253, 1179, 1142, 1101, 1063, 
1022, 961, 909, 885, 736 cm–1; HRMS (FAB) m/z calc'd for C13H17O3 [(M + H) – H2]+: 
221.1178, found 221.1185; [α]D28.1 +27.9 (c 1.13, CH2Cl2, 91% ee).  
 
For conversion of ketone (–)-155 to (+)-dichroanone (175), see ref 89. 
For preparation of ketone (–)-176 and conversion to the natural products 
laurencenone B (177) and (+)-elatol (178), see ref 90. 
For conversion of ketone (–)-150 to the ABC tricycle (179) toward the natural 
product zoanthenol (180), see ref 91. 
 
2.8.7 PREPARATION AND CHARACTERIZATION OF 
[(PHOX)PD(ALLYL)][PF6] SALT 
Ph2P N
O
Pd
165
PF6
 
[Pd(allyl)PHOX]•PF6 salt 165 (Scheme 2.7).  Prepared using Zehnder’s method92 
with (S)-t-Bu-PHOX as a mixture of endo- and exo-isomers (ca. 60:40 ratio) in 
quantitative yield as a light yellow powder.  mp (EtOH) 152-154 °C (decomp.); 1H NMR 
(300 MHz, CDCl3) δ 8.30 (app. ddd, J = 7.7, 4.1, 1.1 Hz, 0.6H), 8.24 (app. ddd, J = 7.7, 
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4.4, 1.1 Hz, 0.4H), 7.74-7.42 (comp. m, 8H), 7.39-7.11 (comp. m, 4H), 7.04-6.87 (comp 
m, 1H), 5.96-5.82 (m, 0.4H), 5.82-5.67 (m, 0.6H), 4.96-4.86 (comp. m, 1H), 4.68 (app. q, 
J = 9.9 Hz, 1H), 4.49 (app. dt, J = 11.3, 3.9 Hz, 1H), 4.19 (app. dt, J = 10.2, 4.4 Hz, 1H), 
4.03 (app. dd, J = 14.3, 9.4 Hz, 0.6H), 3.63-3.48 (comp. m, 1H), 3.32 (app. d, J = 6.6 Hz, 
0.4H), 3.16 (app. d, J = 12.7 Hz, 0.4H), 2.77 (app. d, J = 12.1 Hz, 0.6H), 0.64 (s, 3.5H), 
0.56 (s, 5.5H); 13C NMR (75 MHz, CDCl3) δ 164.9-164.8 (3 peaks), 134.9, 134.8, 134.0-
133.3 (7 peaks), 132.9-132.6 (4 peaks), 132.2-132.1 (3 peaks), 131.8 (app. d, J = 2.3 Hz), 
130.2-128.8 (13 peaks), 128.5-127.8 (5 peaks), 127.3, 122.4 (app. d, J = 6.0 Hz), 122.4, 
83.3-79.4 (6 peaks), 69.8, 69.7, 58.6, 54.1, 54.0, 34.3, 25.2; 31P NMR (121 MHz, CDCl3) 
δ 22.7 (d, J = 118.1 Hz), –143.8 (sept., JP-F = 711.0 Hz); IR (Neat Film from CDCl3, 
NaCl) 3062, 2964, 2872, 2271, 1971, 1899, 1826, 1621, 1584, 1568, 1482, 1437, 1372, 
1315, 1249, 1211, 1145, 1121, 1100, 1060, 1028, 958, 913, 836, 778, 732, 697, 678 cm–1; 
HRMS (EI) m/z calc'd for C28H31ONPPd [M]+: 534.1178, found 534.1182; [α]D27.1 +256.6 
(c 3.72, CH2Cl2). 
 
Figure 2.2.  Representation of [Pd(II)(allyl)PHOX]•PF6 salt 165 
   
Ph2P N
O
Pd
165
PF6
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Figure 2.3.  Representation of the unit cell of [Pd(II)(allyl)PHOX]•PF6 salt 165 
 
 
Table 2.15.  Crystal data and structure refinement for [Pd(II)(allyl)PHOX]•PF6 (CCDC 245187) 
Empirical formula  [C28H31NOPPd]+ PF6¯ • ½C2H5OH 
Formula weight  702.91 
Crystallization solvent  Ethanol 
Crystal habit  Fragment 
Crystal size 0.35 x 0.34 x 0.23 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 15322 reflections used in  
lattice determination  2.31° to 41.00° 
Unit cell dimensions a = 17.5183(6) Å 
 b = 15.7792(5) Å β = 107.0990(10)° 
 c = 11.3736(4) Å 
150 Chapter 2 – Enantioselective Allylic Alkylations of Enolates from Enol Carbonates and Silanes 
Table 2.15.  (continued) 
Volume 3004.98(18) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  C2 
Density (calculated) 1.554 Mg/m3 
F(000) 1428 
θ range for data collection 1.77 to 42.31° 
Completeness to θ = 42.31° 85.0 %  
Index ranges –32 ≤ h ≤ 32, –28 ≤ k ≤ 29, –20 ≤ l ≤ 15 
Data collection scan type  ω scans at 3 φ settings of 2θ = –28º and 2 at 2θ = –59º 
Reflections collected 28501 
Independent reflections 15572 [Rint= 0.0351] 
Absorption coefficient 0.787 mm-1 
Absorption correction SADABS 
Max. and min. transmission 0.8397 and 0.7702 
 Structure solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 1990) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 1997) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 15572 / 1 / 408 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 1.343 
Final R indices [I > 2σ(I),  13582 reflections] R1 = 0.0373, wR2 = 0.0725 
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Table 2.15.  (continued) 
R indices (all data) R1 = 0.0459, wR2 = 0.0748 
Type of weighting scheme used Sigma 
Weighting scheme used w = 1 / σ2(Fo2) 
Max shift/error  0.004 
Average shift/error  0.000 
Absolute structure parameter –0.019(13) 
Largest diff. peak and hole 1.422 and –0.710 e.Å-3 
 Special Refinement Details  
The propyl ligand, C26-C27-C28, is disordered in two alternate orientations, differing by “up-
down” positions for C27.  Additional disorder is observed in one PF6 counterion and an included solvent 
molecule, modeled as ethanol hydrogen bonded to a fluorine of one counterion. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles, and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
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Figure A1.2  IR of compound 125 (NaCl/film) 
Figure A1.3  13C NMR of compound 125 (75 MHz, CDCl3) 
158 Appendix 1 – Spectra of Compounds Relevant to Chapter 2 
 
Fi
gu
re
 A
1.
4 
 1
H
 N
M
R
 o
f c
om
po
un
d 
12
6 
(3
00
 M
H
z,
 C
D
C
l 3)
 
 
P
h
2
P
N
O
1
2
6
Appendix 1 – Spectra of Compounds Relevant to Chapter 2 159 
 
Figure A1.5  IR of compound 126 (NaCl/film) 
Figure A1.6  13C NMR of compound 126 (75 MHz, CDCl3) 
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Figure A1.9  13C NMR of compound 127 (75 MHz, CDCl3 
Figure A1.8 IR of compound 127 (NaCl/film) 
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Figure A1.11  IR of compound 128 (NaCl/film) 
Figure A1.12  13C NMR of compound 128 (75 MHz, CDCl3) 
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Figure A1.14  IR of compound 129 (NaCl/film) 
Figure A1.15  13C NMR of compound 129 (75 MHz, CDCl3) 
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Figure A1.17  IR of compound 130 (NaCl/film) 
Figure A1.18  13C NMR of compound 130 (75 MHz, CDCl3) 
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Figure A1.20  IR of compound 131 (NaCl/film) 
Figure A1.21  13C NMR of compound 131 (75 MHz, CDCl3) 
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Figure A1.23  IR of compound 132 (NaCl/film) 
Figure A1.24  13C NMR of compound 132 (75 MHz, CDCl3) 
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Figure A1.26  IR of compound 135 (NaCl/film) 
Figure A1.27  13C NMR of compound 135 (75 MHz, CDCl3) 
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Figure A1.30  13C NMR of compound 136 (125 MHz, CDCl3) 
Figure A1.29  IR of compound 136 (NaCl/film) 
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Figure A1.32  IR of compound 137 (NaCl/film) 
Figure A1.33  13C NMR of compound 137 (75 MHz, CDCl3) 
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Figure A1.35  IR of compound 138 (NaCl/film) 
Figure A1.36  13C NMR of compound 138 (125 MHz, CDCl3) 
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Figure A1.38  IR of compound 139 (NaCl/film) 
Figure A1.39  13C NMR of compound 139 (75 MHz, CDCl3) 
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Figure A1.41  IR of compound 140 (NaCl/film) 
Figure A1.42  13C NMR of compound 140 (75 MHz, CDCl3) 
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Figure A1.44  IR of compound 141 (NaCl/film) 
Figure A1.45  13C NMR of compound 141 (75 MHz, CDCl3) 
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Figure A1.48  13C NMR of compound 142 (125 MHz, CDCl3) 
Figure A1.47  IR of compound 142 (NaCl/film) 
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Figure A1.50  IR of compound 143 (NaCl/film) 
Figure A1.51  13C NMR of compound 143 (75 MHz, CDCl3) 
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Figure A1.53  IR of compound 145 (NaCl/film) 
Figure A1.54  13C NMR of compound 145 (125 MHz, CDCl3) 
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Figure A1.56  IR of compound 146 (NaCl/film) 
Figure A1.57  13C NMR of compound 146 (125 MHz, CDCl3) 
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Figure A1.59  IR of compound 187 (NaCl/film) 
Figure A1.60  13C NMR of compound 187 (75 MHz, CDCl3) 
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Figure A1.63  13C NMR of compound 188 (75 MHz, CDCl3) 
Figure A1.62  IR of compound 188 (NaCl/film) 
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Figure A1.65  IR of compound 189 (NaCl/film) 
Figure A1.66  13C NMR of compound 189 (75 MHz, CDCl3) 
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Figure A1.68  IR of compound 105 (NaCl/film) 
Figure A1.69  13C NMR of compound 105 (75 MHz, CDCl3) 
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Figure A1.71  IR of compound 124 (NaCl/film) 
Figure A1.72  13C NMR of compound 124 (75 MHz, CDCl3) 
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Figure A1.74  IR of compound 210 (NaCl/film) 
Figure A1.75  13C NMR of compound 210 (75 MHz, CDCl3) 
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Figure A1.77  IR of compound 211 (NaCl/film) 
Figure A1.78  13C NMR of compound 211 (75 MHz, CDCl3) 
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Figure A1.81  13C NMR of compound 212 (75 MHz, CDCl3) 
Figure A1.80  IR of compound 212 (NaCl/film) 
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Figure A1.84  13C NMR of compound 213 (75 MHz, CDCl3) 
Figure A1.83 IR of compound 213 (NaCl/film) 
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Figure A1.86  IR of compound 214 (NaCl/film) 
Figure A1.87  13C NMR of compound 214 (75 MHz, CDCl3) 
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Figure A1.89  IR of compound 215 (NaCl/film) 
Figure A1.90  13C NMR of compound 215 (75 MHz, CDCl3) 
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Figure A1.93  13C NMR of compound 216 (75 MHz, CDCl3) 
Figure A1.92  IR of compound 216 (NaCl/film) 
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Figure A1.95  IR of compound 217 (NaCl/film) 
Figure A1.96  13C NMR of compound 217 (75 MHz, CDCl3) 
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Figure A1.99  13C NMR of compound 218 (75 MHz, CDCl3) 
Figure A1.98  IR of compound 218 (NaCl/film) 
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Figure A1.101  IR of compound 219 (NaCl/film) 
Figure A1.102  13C NMR of compound 219 (75 MHz, CDCl3) 
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Figure A1.105  13C NMR of compound 220 (75 MHz, CDCl3) 
Figure A1.104  IR of compound 220 (NaCl/film) 
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Figure A1.108  13C NMR of compound 182 (75 MHz, CDCl3) 
Figure A1.107  IR of compound 182 (NaCl/film) 
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Figure A1.111  13C NMR of compound 185 (75 MHz, CDCl3) 
Figure A1.110  IR of compound 185 (NaCl/film) 
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Figure A1.113  IR of compound 190 (NaCl/film) 
Figure A1.114  13C NMR of compound 190 (75 MHz, CDCl3) 
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Figure A1.116  IR of compound 191 (NaCl/film) 
Figure A1.117  13C NMR of compound 191 (75 MHz, CDCl3) 
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Figure A1.120  13C NMR of compound 193 (75 MHz, CDCl3) 
Figure A1.119  IR of compound 193 (NaCl/film) 
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Figure A1.122  IR of compound 194 (NaCl/film) 
Figure A1.123  13C NMR of compound 194 (75 MHz, CDCl3) 
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Figure A1.125  IR of compound 196 (NaCl/film) 
Figure A1.126  13C NMR of compound 196 (75 MHz, CDCl3) 
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Figure A1.128  IR of compound 209 (NaCl/film) 
Figure A1.129  13C NMR of compound 209 (75 MHz, CDCl3) 
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Figure A1.132  13C NMR of compound 110 (75 MHz, CDCl3) 
Figure A1.131  IR of compound 110 (NaCl/film) 
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Figure A1.135  13C NMR of compound 222 (75 MHz, C6D6) 
Figure A1.134  IR of compound 222 (NaCl/film) 
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Figure A1.137  IR of compound 223 (NaCl/film) 
Figure A1.138  13C NMR of compound 223 (75 MHz, CDCl3) 
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Figure A1.140  IR of compound 224 (NaCl/film) 
Figure A1.141  13C NMR of compound 224 (75 MHz, CDCl3) 
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Figure A1.143  IR of compound 225 (NaCl/film) 
Figure A1.144  13C NMR of compound 225 (75 MHz, CDCl3) 
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Figure A1.146  IR of compound 226 (NaCl/film) 
Figure A1.147  13C NMR of compound 226 (75 MHz, CDCl3) 
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Figure A1.149  IR of compound 106 (NaCl/film) 
Figure A1.150  13C NMR of compound 106 (75 MHz, CDCl3) 
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Figure A1.152  IR of compound 148 (NaCl/film) 
Figure A1.153  13C NMR of compound 148 (75 MHz, CDCl3) 
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Figure A1.156  13C NMR of compound 149 (75 MHz, CDCl3) 
Figure A1.155  IR of compound 149 (NaCl/film) 
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Figure A1.158  IR of compound 150 (NaCl/film) 
Figure A1.159  13C NMR of compound 150 (75 MHz, CDCl3) 
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Figure A1.161  IR of compound 151 (NaCl/film) 
Figure A1.162  13C NMR of compound 151 (75 MHz, CDCl3) 
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Figure A1.164  IR of compound 227 (NaCl/film) 
Figure A1.165  13C NMR of compound 227 (75 MHz, CDCl3) 
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Figure A1.168  13C NMR of compound 153 (75 MHz, CDCl3) 
Figure A1.167  IR of compound 153 (NaCl/film) 
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Figure A1.171  13C NMR of compound 154 (75 MHz, CDCl3) 
Figure A1.170  IR of compound 154 (NaCl/film) 
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Figure A1.174  13C NMR of compound 155 (75 MHz, CDCl3) 
Figure A1.173  IR of compound 155 (NaCl/film) 
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Figure A1.176  IR of compound 98 (NaCl/film) 
Figure A1.177  13C NMR of compound 98 (75 MHz, CDCl3) 
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Figure A1.179  IR of compound 156 (NaCl/film) 
Figure A1.180  13C NMR of compound 156 (75 MHz, CDCl3) 
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Figure A1.182  IR of compound 157 (NaCl/film) 
Figure A1.183  13C NMR of compound 157 (75 MHz, CDCl3) 
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Figure A1.185  IR of compound 158 (NaCl/film) 
Figure A1.186  13C NMR of compound 158 (75 MHz, CDCl3) 
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Figure A1.188  IR of compound 163 (NaCl/film) 
Figure A1.189  13C NMR of compound 163 (75 MHz, CDCl3) 
282 Appendix 1 – Spectra of Compounds Relevant to Chapter 2 
 
Fi
gu
re
 A
1.
19
0 
 1
H
 N
M
R
 o
f c
om
p
ou
nd
 1
64
 (
30
0 
M
H
z,
 C
D
C
l 3)
 
 
O
1
6
4
Appendix 1 – Spectra of Compounds Relevant to Chapter 2 283 
 
Figure A1.191  IR of compound 164 (NaCl/film) 
Figure A1.192  13C NMR of compound 164 (75 MHz, CDCl3) 
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Figure A1.194  IR of compound 192 (NaCl/film) 
Figure A1.195  13C NMR of compound 192 (75 MHz, CDCl3) 
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Figure A1.198  13C NMR of compound 197 (75 MHz, CDCl3) 
Figure A1.197  IR of compound 197 (NaCl/film) 
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Figure A1.201  13C NMR of compound 186 (75 MHz, CDCl3) 
Figure A1.200  IR of compound 186 (NaCl/film) 
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Figure A1.204  13C NMR of compound 159 (75 MHz, CDCl3) 
Figure A1.203  IR of compound 159 (NaCl/film) 
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Figure A1.206  IR of compound 161 (NaCl/film) 
Figure A1.207  13C NMR of compound 161 (75 MHz, CDCl3) 
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Figure A1.210  13C NMR of compound 162 (75 MHz, CDCl3) 
Figure A1.209  IR of compound 162 (NaCl/film) 
296 Appendix 1 – Spectra of Compounds Relevant to Chapter 2 
 
Fi
gu
re
 A
1.
21
1 
 1
H
 N
M
R
 o
f c
om
p
ou
nd
 1
66
 (
30
0 
M
H
z,
 C
D
C
l 3)
 
 
 
O
1
6
6
Appendix 1 – Spectra of Compounds Relevant to Chapter 2 297 
 
Figure A1.213  13C NMR of compound 166 (75 MHz, CDCl3) 
Figure A1.212  IR of compound 166 (NaCl/film) 
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Figure A1.216  13C NMR of compound 168 (75 MHz, CDCl3) 
Figure A1.215  IR of compound 168 (NaCl/film) 
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Figure A1.218  IR of compound 169 (NaCl/film) 
Figure A1.219  13C NMR of compound 169 (75 MHz, CDCl3) 
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Figure A1.221  IR of compound 170 (NaCl/film) 
Figure A1.222  13C NMR of compound 170 (75 MHz, CDCl3) 
304 Appendix 1 – Spectra of Compounds Relevant to Chapter 2 
 
Fi
gu
re
 A
1.
22
3 
 1
H
 N
M
R
 o
f c
om
p
ou
nd
 1
71
 (
30
0 
M
H
z,
 C
D
C
l 3)
 
 
O
1
7
1
Appendix 1 – Spectra of Compounds Relevant to Chapter 2 305 
 
Figure A1.224  IR of compound 171 (NaCl/film) 
Figure A1.225  13C NMR of compound 171 (75 MHz, CDCl3) 
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Figure A1.227  IR of compound 172 (NaCl/film) 
Figure A1.228  13C NMR of compound 172 (75 MHz, CDCl3) 
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Figure A1.231  13C NMR of compound 173 (75 MHz, CDCl3)
Figure A1.230  IR of compound 173 (NaCl/film)
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Figure A1.233  IR of compound 165 (NaCl/film) 
Figure A1.234  13C NMR of compound 165 (75 MHz, CDCl3) 
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CHAPTER 3 
Enantioselective Allylic Alkylations of Ketone 
Enolates: β-Ketoester Substrates† 
3.1 INTRODUCTION 
In the preceding chapter,1 we reported the discovery and development of a novel 
system for the catalytic enantioselective synthesis of all-carbon quaternary stereocenters 
in order to address this significant challenge in synthetic chemistry.2,3  Despite the 
multitude of approaches to the synthesis of these formidable stereocenters,2 we identified 
a specific scarcity of methods for the generation of quaternary stereocenters from 
unstabilized ketone enolates bearing multiple acidic sites.4,5  We reasoned that the 
powerful Pd-catalyzed enantioselective allylic alkylation reactions6 developed by Trost, 
Helmchen, Pfaltz, and others could provide a valuable solution to this synthetic problem, 
although few examples had been reported with prochiral nucleophiles prior to our 
investigations.7,8  Notably, none of the previous examples demonstrated allylation of an 
enolate with multiple sites of similar acidity, since this often led to enolate scrambling 
                                                
† This work was performed in collaboration with Douglas C. Behenna, John A. Enquist, Jr., Andrew M. 
Harned, Akihiko Iwashita, Michael R. Krout, Samantha R. Levine, Sandy Ma, Smaranda C. Marinescu, 
Ryan M. McFadden, Zoltán Novák, Krastina V. Petrova, Jennifer L. Roizen, Masaki Seto, Nathaniel H. 
Sherden, Kousuke Tani, Scott C. Virgil, and David E. White.  Portions of this work have been published as 
indicated by references in the text. 
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and allylation at multiple sites.3e  These limitations prevented direct access to simple α-
quaternary ketones, such as 2-allyl-2-methylcyclohexanone (106), a cyclohexanone 
derivative not known as a single enantiomer prior to our work. 
We successfully adapted Tsuji’s nonenantioselective protocols9 for enolate alkylation 
with allyl enol carbonates (e.g., 105, Scheme 3.1) and silyl enol ethers (e.g., 110) to 
asymmetric variants capable of providing many substituted α-quaternary cyclic 
ketones.1,10,11,12  We found that high yield and product ee was obtained with the catalyst 
generated in situ from tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) and the (S)-t-
Bu phosphinooxazoline (PHOX) ligand (55).13,14  Importantly, we demonstrated that the 
regiochemical fidelity for ketone enolates with multiple acidic sites was maintained in 
our enantioselective system, and we were pleased to report the first preparation of 2-allyl-
2-methylcyclohexanone (106) in enantioenriched form.1,10,15 
Scheme 3.1. Enantioselective allylation of allyl enol carbonates and silyl enol ethers 
O O
O
OTMSO
Pd2(dba)3
(2.5 mol%)
THF, 25 °C
Pd2(dba)3
(2.5 mol%)
t-Bu-PHOX (55)
(6.25 mol%)
85% yield
87% ee
95% yield
87% ee
105 (–)-106 110
Ph2P N
O
t-But-Bu-PHOX (55)
(6.25 mol%)
TBAT (35 mol%)
diallyl carbonate
THF, 25 °C
 
Encouraged by our leading results, we sought to exploit this technology for the 
preparation of a variety of interesting synthetic targets.  In one such effort, we 
encountered difficulty in the preparation of the requisite enol carbonate or silyl enol ether 
(Scheme 3.2).  A variety of conditions for enolate formation and trapping led to 
inseparable mixtures of enol isomers.  As a consequence of the high degree of 
regiochemical fidelity in the allylation reaction,9 corresponding mixtures of allylated 
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products were obtained.  To address this problem, we sought a different class of 
substrates that would afford an alternative method of enolate generation that did not rely 
on extraneous bases. 
Scheme 3.2.  Non-selective enolization leads to product mixtures 
O CO2t-Bu
silyl enol
ether
formation
allyl enol
carbonate
formation
TMSO CO2t-Bu TMSO CO2t-Bu allylO2CO CO2t-Bu allylO2CO CO2t-Bu
O CO2t-BuO CO2t-Bu
236
ca. 20% yield
235
ca. 20% yield
ca. 81% ee
(S)-55
Pd2(dba)3
(S)-55
Pd2(dba)3
230
231 232 233 234
 
 
3.2 ASYMMETRIC ALKYLATION WITH RACEMIC ALLYL β-
KETOESTERS 
3.2.1 INITIAL EXPLORATIONS 
β-Ketoesters represent a classical solution to the problem of regioselective ketone 
alkylation (e.g., the acetoacetic ester synthesis).  In 1980, Tsuji and Saegusa reported 
allyl β-ketoesters as substrates in nonenantioselective Pd-catalyzed enolate alkylations.16  
We reasoned that an allyl β-ketoester might solve the problem of selective enolate 
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formation in the course of an enantioselective allylation reaction.  However, as 
stereogenic racemic substrates for a catalytic asymmetric reaction, allyl β-ketoesters 
presented some unique challenges: the catalyst must deallylate the substrate 
nonselectively to avoid kinetic resolution of the substrate, the C–C bond must break at a 
reasonable temperature in the decarboxylation step to prevent loss of selectivity in the 
subsequent bond-forming step, and the stereogenic intermediates must not experience 
diastereomeric transition states that are detrimental to the selectivity of the process.17  
Nonetheless, we prepared the appropriate substrate (237, Scheme 3.3) using standard 
methods (see Scheme 3.5) and exposed racemate (±)-237 to our standard reaction 
conditions (Pd2(dba)3, (S)-t-Bu-PHOX, THF, 25 °C).  Unfortunately, no conversion was 
observed (by TLC) under these conditions after 24 h.  However, we were delighted to 
find that elevating the temperature to 30 °C and carrying out the reaction in Et2O restored 
reactivity, providing enone (–)-235 in 73% yield and 86% ee after 9 h (Scheme 3.3).  
This experiment provided a key proof of concept for an enantioconvergent reaction using 
a racemic allyl β-ketoester. 
Scheme 3.3.  Asymmetric decarboxylative allylation with an allyl β-Ketoester 
O
Pd2(dba)3 (2.5 mol%)
Et2O, 30 °C, 9 h
73% yield
86% ee
(±)-237 (–)-235
Ph2P N
O
t-Bu(S)-55
(6.25 mol%)
O
O
O
O
O
O
O
 
When further exploring this pivotal reaction, we noted that no significant kinetic 
resolution of the allyl β-ketoesters was observed.18  In fact, this facet of the reaction was 
critical in order to obtain high yield in a reasonable reaction time.  The similar levels of 
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enantioselectivity observed with the allyl β-ketoester substrates and the other substrate 
classes (compare this work with Scheme 3.1 and Chapter 2) suggest that the 
enantiodetermining transition state of the reaction remains unchanged.  Although the 
extent to which decarboxylation slowed at ambient temperature varied from substrate to 
substrate, β-ketoesters were uniformly more sluggish in decarboxylation than allyl enol 
carbonates.19  However, the rate of reaction increased greatly at slightly higher 
temperatures, and thus reasonable reaction times (~2 h) could be achieved by increasing 
the reaction temperature by ca. 5 °C, which had a negligible effect on enantioselectivity 
(Table 3.1). 
Table 3.1.  Temperature effects in decarboxylative allylation of allyl β-ketoesters 
entry time (h) % yielda % eeb
O
O
O O
Pd2(dba)3
(2.5 mol%)
(S)-t-Bu-PHOX (55)
(6.25 mol%)
THF, Temperature
temperature (°C)
1 48 018
2 7.5 85 8825
3 2.25 82 8730
4 1.25 85 8635
5 0.67 86 8540
6 0.15 82 8360
ND
(–)-106(±)-107
 
a Isolated yield from reaction of 1.0 mmol substrate at 0.033 M.  b Determined by chiral GC. 
This enantioconvergent reaction is unusual due to the use of quaternary β-ketoesters 
(Scheme 3.4).  Typical stereomutative enantioconvergent processes (e.g., dynamic kinetic 
resolution) involve a pre-equilibrium epimerization of the starting material, A, followed 
by enantioselective conversion to product B (Pathway I).20  However, quaternary 
stereocenters are not typically epimerizable, and we believe that both enantiomers of the 
starting material, A, convert irreversibly to a prochiral intermediate, C,21 which 
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preferentially forms one enantiomer of the product, B, under the influence of the chiral 
catalyst (Pathway II).  We have termed such transformations as stereoablative 
enantioconvergent catalysis.22,23  As a result of this interesting reaction pathway and the 
facile synthesis of quaternary β-ketoester substrates, we have been able to expand the 
substrate scope of the asymmetric alkylation greatly. 
Scheme 3.4.  Stereoablative enantioconvergent catalysis 
(–)-A
(+)-A
(–)-B
(+)-B
(–)-A
(+)-A
(–)-B
(+)-B
k1
k2
k3
k1
k2
k3
k4
!
stereomutative
enantioconvergent
catalysis
k1!k-1>>k2>k3
!!
stereoablative
enantioconvergent
catalysis
k1!k2 and k3>k4
C
(achiral)k-1
stereomutation stereoablation  
 
3.2.2 SUBSTRATE SYNTHESES 
During the course of our studies, several practical methods for the synthesis of 
quaternary β-ketoesters have been employed (Scheme 3.5).  The Dieckmann cyclization 
of pimelic acid diallyl ester (239) gives an intermediate cyclized sodium salt 240, that can 
be alkylated directly in one pot to give quaternary β-ketoesters, such as benzylated 
compound 241.24  Alternatively, sodium salt 240 can be protonated to give 2-
carboxyallylcyclohexanone (242) and then alkylated in a separate step.  Cyclic ketones, 
such as 1,4-cyclohexanedione monoethylene ketal (243), may be treated with base and 
diallyl carbonate to effect acylation.  Mild alkylation conditions (MeI and K2CO3 in 
acetone) lead to the C-methylated β-ketoester (244) in 74% yield over two steps with a 
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single chromatographic purification.  Both of these methods are inexpensive and can be 
readily carried out on relatively large scale (e.g., 50 g of pimelic acid (238)).25  In cases 
where O-acylation or multiple sites of C-acylation are problematic, such as enone 245, 
treatment with LDA under kinetic conditions and then the allyl version of Mander’s 
reagent, allyl cyanoformate (246), frequently gives selective C-acylation.26,27 
Scheme 3.5.  Methods for the synthesis of racemic quaternary β-ketoesters 
244
OH
O
OH
O Oallyl
O
Oallyl
O
Pimelic Acid (238) 239
O O
O
O O
O
O
O
243
O O
245
p-TSA
PhH, !
Dean-Stark
NaH, PhMe
95 °C
1.  NaH, THF,
O
O O
2.  MeI, K2CO3, acetone, 50 °C
74% yield, 2 steps
1 purification
1.  LDA, THF, –78 °C, then
O
NC O
246
Br
Ot-Bu
O
2.  K2CO3, acetone, 50 °C,
OH
OH
c) Mander's Reagent Method
b) Diallyl Carbonate Method
a) Dieckmann Cyclization Method
O
R
BnBr or HCl
THF
241, R = Bn, 70% yield
242, R = H, 75% yield
1 purification
ONa
240
60% yield, 2 steps
2 purifications
(±)-237
O
O
O
O
O
O
O
O
30
30
247
111
 
 
3.2.3 RESULTS OF ENANTIOSELECTIVE KETONE ALKYLATION WITH 
ALLYL β-KETOESTER SUBSTRATES 
A number of α-substituted 2-carboxyallylcyclohexanones were readily prepared by 
the above methods and successfully underwent enantioconvergent decarboxylative 
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allylation (Table 3.2).  The system was permissive of an array of functionality and 
substitution, and formed products in excellent yield and high ee.  Remarkably, the 
presumed enolate intermediate tolerated both enolizable (entries 4 and 5) and β-
heteroatom (entry 9) substituents without side products corresponding to enolate 
scrambling or β-elimination.28  Our conditions also allowed for incorporation of a 
fluorine atom for the high-yielding synthesis of a stereodefined tertiary fluoride (entry 
10).  Subsequent to our initial disclosure, others have utilized this chemistry to prepare a 
range of tertiary fluoride-containing compounds that could be of interest as non-
epimerizable pharmaceutical analogues.15c,15e,15h,15j,29 
Table 3.2.  Enantioconvergent decarboxylative allylation of α-Substituted 2-
carboxyallylcyclohexanones 
entry time (h) yielda eeb
O
R
O
O O
R
CO2
Pd2(dba)3 (2.5 mol%)
(S)-t-Bu-PHOX (6.25 mol%)
THF or Et2O, 25–30 °C
R
1 7.5 85 88CH3
2c 4.75 89 88CH3
3c,d 6 97 91prenyl
4c 6.5 97 88CH2CH2CN
5c,e 6 96 90CH2CH2CO2Et
racemic
entry time (h) yielda eebR
6 0.5 99 85CH2C6H5
7 10 80 86CH2(4-CH3OC6H4)
8 0.5 99 82CH2(4-CF3C6H4)
9e 5 86 81CH2OTBDPS
10c,d 3.5 80 91F
substrate
107
107
248
250
252
product
106
106
249
251
253
substrate
241
254
256
258
260
product
153
255
257
259
261  
a Isolated yield (%) from reaction of 1.0 mmol substrate with 2.5 mol% Pd2(dba)3 and 6.25 mol% 
(S)-t-Bu-PHOX (55) at 0.033 M in THF at 25 °C, unless otherwise noted.  b Enantiomeric excess 
(%) determined by chiral GC or HPLC.  c Performed in Et2O solvent.  d Performed at 30 °C.  e 4 
mol% Pd2(dba)3, 10 mol% (S)-55, 0.021 M. 
In addition to modifications at the α-position of the substrate, the decarboxylative 
asymmetric allylation of β-ketoesters was also amenable to a wide variety of 
modification to the carbocycle and allyl fragment (Table 3.3).  In particular, the reaction 
was exceptionally tolerant to the steric demands of substitution at the 3-, 4-, 5-, and 6-
positions of the cyclohexane ring: each position can be fully substituted without 
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significantly affecting yield or enantioselectivity (entries 1–4).   Unsaturated substrates 
(entries 5 and 6) as well as seven-membered ring containing substrates (entries 7 and 8) 
performed well in the reaction.  As with the previous substrate classes (i.e., allyl enol 
carbonates and silyl enol ethers),1 substitution at the central position of the allyl fragment 
had a beneficial effect on the enantioselectivity of the reaction (entries 9–11).  The 
incorporation of a chlorine atom on the allyl fragment (entry 10) provided both another 
functional group handle for further manipulation and a higher oxidation state.  Inclusion 
of a phenyl group on the allyl fragment (entry 11) produced the highest ee product we 
have observed to date.  Heterocyclic compounds were also accessible by this method 
(entry 12).  Vinylogous esters were competent in the reaction, but elevated temperatures 
(up to 80 °C) were required in some cases to achieve high conversion and the ee was 
somewhat decreased (entry 13).  Employing a vinylogous thioester lowered the required 
temperature and permitted the isolation of highly enantioenriched product (entry 14).  
This particular vinylogous thioester (268, Scheme 3.6) was employed in the 
enantioselective syntheses of (+)-carissone (269)12e and (+)-cassiol (270).12f 
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Table 3.3.  Enantioconvergent decarboxylative allylation of β-ketoesters with substituted carbocycles 
and allyl fragments 
entry % yielda % eebproduct
O
1
5d,e N
Bn
O
12 91 92
O
9d,e 87 92
R10
d,e 87 91
3
4
2c
148, R = CH3
264, R = Cl
6d
O
8f 98 90
% yielda % eebproduct
O
O
O O
85
77 90
94
O
89 90
O
90 85
8694
O
97 92
entry
O
Ph
11g 96 94
Ph
7 83 87
O
13h 86 75
i-BuO
O
14i 85 92
PhS
150
155
262
149
98
157
263
265
266
267
268
 
a Isolated yield from reaction of 1.0 mmol substrate, 2.5 mol% Pd2(dba)3 and 6.25 mol% (S)-t-Bu-
PHOX (55) at 0.033 M in THF at 25–35 °C, unless otherwise noted.  Each reaction was complete 
in 1.5-12 h.  b Determined by chiral GC or HPLC.  c 25 mmol substrate, 1.5 mol% Pd2(dba)3, and 
3.75 mol%  (S)-55, 24 h reaction time.  d Performed in Et2O.  e 4 mol% Pd2(dba)3, and 10 mol% (S)-
55 at 0.021 M.  f Reaction performed with 3.17 mmol substrate, 3 mol% Pd(dmdba)2, and 3.8 mol% 
(S)-55 at 0.060 M.  g 2.5 mol% Pd(dmdba)2, 2.5 mol% (S)-55.  h Performed with 2.5 mol% 
Pd2(pmdba)3 and 6.25 mol% (S)-55 in PhMe at 80 °C.  i Performed with 2.5 mol% Pd2(pmdba)3 and 
6.25 mol% (R)-55 in PhMe at 50 °C. 
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Scheme 3.6.  Conversion of ketone 268 to the natural products (+)-carissone (269)12e and (+)-
cassiol (270).12f 
O
PhS
268
92% ee
O
OH
(+)-Cassiol (270)
8 total steps
(+)-Carissone (269)
13 total steps
O
OH
OH
OH
 
 
3.2.4 CASCADE REACTIONS GENERATING MULTIPLE QUATERNARY 
STEREOCENTERS 
In an effort to construct more than one quaternary stereocenter in a single 
transformation, we designed substrate 271 (Scheme 3.7a), which contained a latent allyl 
β-ketoester moiety to be revealed by the reaction of the allyl enol carbonate portion of the 
molecule.  To our delight, cascade allylation occurred to afford C2-symmetric ketone 272 
as the predominant product in 92% ee with 4:1 dr.  Similarly, bis(β-ketoester) substrates 
may be employed in a stereoconvergent process where each of the three stereoisomeric 
starting materials are converted to enantioenriched products with excellent stereocontrol 
(e.g., 273 → 272, Scheme 3.7b and 75 → 76, Scheme 3.7c).  We have successfully 
employed the double enantioselective decarboxylative allylation strategy in the total 
synthesis of the cyathin diterpenoid cyanthiwigin F (83, Scheme 3.7c).30  The further 
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application of this allylation reaction to the catalytic asymmetric synthesis of natural 
products is an ongoing topic of research in our laboratories.12 
Scheme 3.7.  Enantioselective cascade allylations generating two quaternary centers 
OO
Pd2(dba)3 (4 mol%)
THF, 40 °C, 6 h
76% yield, 4:1 dr
(–)-272
92% ee
(±)-271
Ph2P N
O
t-Bu(S)-55
(10 mol%)
O
O
O
O
O
(–)-272
94% ee
O
273
either pure diastereomer
O
O
a)
b)
O
(–)-76
99% ee
O
O
75
1:1 dr
O
O
O
O
O
O
H
(–)-Cyanthiwigin F (83)
9 total steps
c)
(S)-55
Pd(dmdba)2
Et2O
Pd2(pmdba)3 
THF, 25 °C
58–61% yield, 4.3:1 dr
(S)-55
O
O
75% yield
4.4:1 dr
 
 
3.2.5 SUBSTRATES CONTAINING FIVE-MEMBERED RINGS 
Although enolate precursors contained in six-membered rings composed the bulk of 
our substrates, we have demonstrated that seven- and eight-membered rings are tolerated 
with only slight loss in enantioselectivity.1  Allyl β-ketoesters constructed on five-
membered rings provided modest to useful levels of enantioselectivity (Table 3.4).  These 
substrates generally produced α-quaternary ketone products in good yields with 
enantiomeric excesses about 10% lower than that observed with the cyclohexanone 
analogue.  Ethyl substituted cyclopentenone (274) was formed in 86% ee, only 6% lower 
than observed with the corresponding cyclohexanone (entry 1).  Indanones were 
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produced in good yield and with useful ee (entries 4 and 5).  Benzyl appended 
cyclopentanone substrates gave consistent yields, but electron deficient aromatic rings 
decreased enantioselectivity more significantly than in the reactions of six-membered β-
ketoesters (entries 6–8). 
Table 3.4.  Enantioconvergent decarboxylative allylation of β-ketoesters containing five-membered 
rings 
entry yielda eebproduct
1
2 6
84
c
5
84 73
83 60
3
279, R = OMe
7 84 73280, R = Me
281, R = CF3
O
R
O
racemic
CO2
O O
R
Pd2(dba)3 (2.5 mol%)
(S)-t-Bu-PHOX (55)
(6.25 mol%)
THF, 25 °C
O
R
O
R
O
R
yielda eeb
274, R = CH2CH3
275, R = CH(CH3)2
277, R = Me
278, R = Bn
82 86
77 84
82 80
93 71
276, R = CH2NPhth 67 48
entry product
 
a Isolated yield (%) from reaction of 1.0 mmol of substrate in THF (0.033 M) with 2.5 mol% 
Pd2(dba)3 and 6.25 mol% (S)-t-Bu-PHOX (55), unless otherwise noted.  Each reaction was 
complete in 1-3 h.  b Enantiomeric excess (%) measured by chiral GC or HPLC.  c Performed on 0.1 
mmol scale with 5 mol% Pd2(dba)3 and 12.5 mol% (S)-55. 
 
3.3 MECHANISTIC INSIGHTS 
3.3.1 THE OUTER-SPHERE MECHANISM PROPOSED BY HELMCHEN 
Although we have not fully elucidated the fine mechanistic details of 
enantiodiscrimination with the Pd•PHOX catalyst, an intriguing picture of the reaction’s 
general mechanism has emerged from our experimental studies.  A number of 
experimental observations suggest that the mechanism of our allylation of prochiral 
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nucleophiles differs substantially from that of Pd•PHOX-catalyzed malonate alkylation of 
prochiral allyl fragments, which has been studied in detail by Helmchen.31 
Helmchen’s model for the asymmetric allylic alkylation of prochiral allyl 
electrophiles (R ≠ H, Scheme 3.8) with Pd•PHOX catalysts involves attack at one allyl 
terminus of a (PHOX)Pd-π-allyl complex by an outer-sphere malonate anion.  The allyl 
group isomers 282 and 283 are in rapid equilibrium such that the nucleophile’s preferred 
attack (283), from the open quadrant at the allyl terminus trans to phosphorus, is the 
nearly exclusive reaction pathway.  The resulting Pd(0)•olefin complexes (e.g., 284) have 
been observed at low temperature.31  Notably, stereoinduction in such alkylation reactions 
suffered when the steric bulk of the allyl substituents was reduced (e.g., 96% ee when R 
= i-Pr, 71% ee when R = Me).32  It was difficult to rationalize the high levels of 
stereoinduction observed in our allylation by this outer-sphere mechanism in that our 
substrates typically have unsubstituted allyl termini.  Additionally, formation of the new 
stereocenter on the enolate would require the chiral Pd complex to differentiate the 
prochiral faces of the unassociated enolate, where steric and electronic interactions 
between the nucleophile and the distant chiral backbone would be minimal.  Moreover, a 
gearing effect through the allyl ligand is unlikely given the lack of sterically large groups 
(R = H). 
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Scheme 3.8.  Helmchen’s outer-sphere mechanism for asymmetric allylation of prochiral allyl 
electrophiles 
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3.3.2 EXPERIMENTAL EVIDENCE CONSISTENT WITH AN INNER-
SPHERE MECHANISM 
In addition to these hypothetical arguments, we have made several experimental 
observations that do not correlate well to an outer-sphere enolate attack mechanism.  The 
high enantioselectivity under our conditions appears to correspond with circumstances 
that would keep ion pairs tightly associated.  The range of effective solvents found during 
our optimization studies demonstrated this trend: ethereal solvents (e.g., THF), aromatic 
solvents (e.g., benzene), ethyl acetate, and triethylamine share few properties other than 
having low dielectric constants in the range of 2 to 8, but each provided products in high 
ee.1  In such low dielectric media, dissociative solvation of ion pairs is difficult.33  In 
conjunction with the lack of other counterions in the reaction, the low dielectric value 
would tend to enforce an inner-sphere mechanism wherein close contact of the enolate 
and the chiral environment would facilitate the discrimination between the prochiral 
enolate faces.34 
Based on our initial reasoning and empirical observations, we developed a working 
model for the course of the reaction via an inner-sphere mechanism (Scheme 3.9).  
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Oxidative addition of Pd(0)•PHOX complex 285 to substrate 107 or 105 leads to 
[Pd(allyl)PHOX] complex 114 and carboxylate 286 or mixed carbonate 287.  We believe 
that an equilibrium exists between the charge-separated form and the coordination 
complex bearing an η1-allyl group (e.g., 288).  We have isolated and characterized the β-
ketocarboxylate analog (288) by X-ray crystallography and found that it can be 
decomposed to deliver enantioenriched ketone 106, and therefore it appears to be an 
important intermediate on the reaction pathway.35  Subsequent loss of CO2, which may be 
assisted by Pd(II), leads to enolate 115 and the Pd-complex 114.  Association of these 
two fragments leads to 5-coordinate intermediate 289, with the enolate bound to the 
sterically less-encumbered apical position of the square-planar metal.  By slightly 
different means, allyl enol carbonate and silyl enol ether substrates may intercept the key 
intermediate 289.  Shifting of the allyl group from an η3- to an η1-binding mode allows 
the enolate fragment to move into the square plane and form intermediate 290 by what is 
essentially an associative ligand substitution mechanism.  From this complex, a standard 
3-centered reductive elimination would require a shift from O- to C-bound Pd-enolate.36  
We reasoned that this isomerization would be unfavorable due to the steric demands of 
the resulting tertiary palladium species.  As an alternative, we postulated an extended 
reductive elimination pathway proceeding through a cyclic 7-membered pericyclic 
transition state (291-boat or 291-chair) similar to a sigmatropic rearrangement.37,38  
Importantly, situating the carbocyclic ring of the enolate fragment away from the bulky t-
Bu group of the oxazoline provides a plausible predictive model for the observed 
absolute sense of enantiofacial selectivity.1  Liberation of the product ketone (106) from 
complex 292 regenerates the catalytic Pd(0) species 285. 
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Scheme 3.9.  Proposed inner-sphere mechanism for asymmetric alkylation of prochiral enolate 
nucleophiles 
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Typically, inner- and outer-sphere processes may be differentiated by 
stereochemically labeling the allyl fragment and evaluating the relative stereochemistry 
of the products.39  However, in the present case, these experiments could not be 
performed since the necessary cyclic carbonates suffered from very poor reactivity and 
enantioselectivity.  In fact, even simple substitution of the termini of acyclic allyl groups 
(e.g., crotyl carbonates) severely impacted reactivity and perhaps suggests that for such 
substrates a different mechanism is operative.40  Given these substrate limitations, we 
were obliged to seek out other forms of mechanistic evidence to evaluate our proposal. 
Since it is conceivable that multiple ion pairs could be involved in the transition state 
(e.g., an enolate bound to one [Pd(allyl)PHOX] fragment could attack the Pd-bound allyl 
fragment associated with another enolate), we conducted simple kinetics experiments that 
support a single metal site pathway (Figure 3.1 through Figure 3.4).41  Varying the 
concentration of Pd•PHOX gives a proportional change in reaction rate, suggesting the 
reaction is first-order in Pd•PHOX (Figure 3.1) and supporting the notion that a single 
metal center is involved in the mechanism.  Additionally, the lack of an observed non-
linear effect is also consistent with the action of a single metal center in the 
enantiodetermining step (Figure 3.2).42  Interestingly, kinetic studies also found zero-
order dependence on substrate concentration in the allyl enol carbonate (Figure 3.3) and 
β-ketoester (Figure 3.4) cases.  Based on these results, we suspect that the rate-limiting 
step is either loss of CO2 from a Pd-carboxylate intermediate (e.g., 288 → 114 + 115, 
Scheme 3.9), or C–C bond formation (e.g., 290 → 292, Scheme 3.9).  The isolation of the 
relatively stable Pd-carboxylate complex 288 is indicative of a slow decarboxylation step.  
The longer reaction times observed with β-ketoester substrates relative to the 
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corresponding allyl enol carbonates is also more consistent with decarboxylation as the 
rate determining step, as the rate difference would be attributed to the difference in 
breaking a C–C bond (β-ketoester) compared to a C–O bond (enol carbonate).  However, 
we cannot rule out the possibility that different substrate classes may have different rate-
determining steps. 
Figure 3.1. Plot of kobs vs. concentration of Pd(PHOX) complex for allyl enol carbonate 
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Figure 3.2.  Plot of i-Pr-PHOX ee vs. product ee43 
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Figure 3.3.  Plot of allyl enol carbonate 1H NMR integral vs. time (s) 
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Figure 3.4.  Plot of allyl β-ketoester 1H NMR integral vs. time (s) 
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In addition to these studies, we designed other experiments to differentiate our 
proposed mechanism from that elucidated by Helmchen.31  Enolates where charge is 
delocalized (e.g., those derived from β-ketoesters or α-aryl ketones), and should therefore 
tend to form weak ion pairs, give high yields but extremely low levels of 
enantioselectivity.1,44  This suggests that, in such cases, allylation proceeds primarily via 
the more conventional, although in this case poorly selective, outer-sphere attack.  The 
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reactivity of sterically demanding substrates in our reaction is also inconsistent with an 
outer-sphere, intermolecular nucleophilic enolate attack.  In a nucleophilic bimolecular 
reaction, such as the Helmchen allylation mechanism (Scheme 3.8), steric bulk near the 
site of bond formation typically impedes the rate of the reaction.45  However, in our case 
there is little difference in the reaction time, yield, or enantioselectivity when comparing 
the formation of ketone 106 with more sterically demanding ketones (Figure 3.5).  This 
observation is more consistent with an intramolecular reaction mechanism. 
Figure 3.5.  Comparison of sterically varied products formed at 25 °C in THF 
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Another observation at odds with an external attack mechanism is the unusual 
tolerance to water (Table 3.5).  Multiple equivalents of water introduced into the reaction 
have only a moderate effect on the yield of the reaction.  This contrasts typical enolates, 
which are rapidly quenched by water even at low temperatures, and suggests that the 
intermediate enolate formed in the reaction is tightly associated with its counterion for 
most of its lifetime.46 
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Table 3.5.  Effect of water on asymmetric alkylation 
O O
O
O(S)-t-Bu-PHOX (12.5 mol%)
Pd2(dba)3 (5 mol%)
THF (0.033 M), H2O, 25 °C
0.1 mmol scale
entrya H2O added (equiv)
b % yieldc % eed
1 0 95 86
2 0.55 99 87
3 1.64 88 84
4 8.25 70 61
5 16.5 67 49
6 33.3 63 40
105 (–)-106
 
a Data reported are the average of three trials.  b H2O added after Pd/PHOX complexation, but 
before substrate.  c GC yield relative to internal standard (tridecane).  d Enantiomeric excess 
measured by chiral GC. 
In an effort to trace the fate of the allyl and enolate fragments in the course of the 
reaction, we performed crossover experiments with deuterated allyl enol carbonates 294 
and 295 in THF, dioxane, and benzene (Scheme 3.10).47  Analysis of the products by 
high-resolution mass spectrometry revealed the presence of all four possible product 
masses in nearly equal amounts.48  In conjunction with the water addition experiments, 
this observation suggests that a palladium enol carbonate species (114 + 287 or 114•287) 
may be a long-lived intermediate.  Such an intermediate would not be readily protonated 
by water,49 and this delocalized anion may facilitate crossover by dissociation from the 
metal center.  In the case of β-ketoester substrates, a β-ketocarboxylate intermediate may 
play an analogous role.50 
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Scheme 3.10.  Crossover experiments with deuterated allyl enol carbonates 
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In order to validate our hypothesis regarding the persistence of an intermediate 
carboxylate or mono-alkyl carbonate (286 or 287, respectively), we collected 31P NMR 
data during the reaction.51  Non-ligated t-Bu-PHOX (55) exhibited a 31P resonance at –5.9 
ppm.  When Pd2(dba)3 and t-Bu-PHOX were complexed, a new resonance was observed 
at 18.8 ppm along with excess ligand (Figure 3.6, spectrum A).  When substrate (±)-107 
was added, the resonance at 18.8 ppm disappeared immediately and the only observed 
intermediate was found at 30.9 ppm, which persisted until the end of the reaction (Figure 
3.6, spectrum B).  When the substrate was completely consumed, the initial Pd•PHOX 
complex returned at 18.8 ppm (Figure 3.6, spectrum C).52  Interestingly, similar behavior 
was observed in reactions with allyl carbonate reactions, although the chemical shift of 
the intermediate species differed slightly.  The separately prepared 
[Pd(II)(allyl)(PHOX)]+[PF6]– complex exhibited two 31P resonances (other than those due 
to PF6–) at 23.5 and 22.5 ppm in a 2:1 ratio, presumably due to the mixture of endo- an 
exo-allyl isomers.1,31  The different chemical shifts for this Pd(II) complex relative to that 
observed during the reaction suggest a different ligation environment about the Pd center.  
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To correlate these two different species, n-Bu4NOAc was added to a solution of 
[Pd(II)(allyl)(PHOX)]+[PF6]–, and a new species was observed at 30.9 ppm.  Based on 
these experiments, we believe that the observed catalyst resting state in solution is likely 
the [Pd(II)(allyl)(PHOX)]+/carboxylate ion pair (114 + 286, Scheme 3.9) or the 
coordination complex 288.  Efforts to fully characterize intermediate structures are 
ongoing.35 
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Figure 3.6.  31P NMR collected during the enantioselective allylation reaction:  Spectrum A: 
Pd•PHOX complex (18.8 ppm) and excess PHOX ligand (–5.9 ppm) prior to addition of substrate; 
Spectrum B: After addition of substrate (±)-107, during reaction; Spectrum C: After complete 
consumption of substrate 
A
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O O
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The solid-state structure of independently prepared [Pd(II)(allyl)PHOX]+[PF6]– salt 
165 lends credence to the possibility of an apically bound palladium enolate.1  As shown 
in Figure 3.7, after recrystallization the complex partially co-crystallizes with a molecule 
of ethanol in its unoccupied quadrant.53  We envision this as the likely site of enolate 
coordination (e.g., apically bound enolate complex 289, Scheme 3.9). 
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Figure 3.7.  X-Ray structure of [Pd(II)(allyl)PHOX]+[PF6]
– EtOH adduct 
N
O
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Ph
Ph
Pd
PF6
•EtOH
165
X-ray Structure of 165•EtOH  
Given the body of evidence accrued in these experimental studies and our inability to 
probe the mechanism through classical stereochemical labeling experiments,39 we 
initiated a collaboration with the Goddard group at Caltech in order to investigate the 
details of the mechanism via computational modeling (see Chapter 4).54  The 
computational studies carried out have corroborated our initial hypothesis regarding the 
inner-sphere mechanism, the difficult isomerization of O- to C-bound Pd enolate, and the 
unusual cyclic 7-membered reductive elimination pathway (Scheme 3.9).  Notably, these 
calculations have found that the traditional outer-sphere mechanism (Scheme 3.8) is 
significantly higher in energy than the inner-sphere pathway.  The simulations have not 
yet elucidated the fine details of the origin of enantioselectivity.  Experiments and 
computational studies to better characterize the reaction mechanism are under way with 
the hope of improving the enantioselectivity and scope of the asymmetric alkylation. 
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3.4 SUMMARY 
In order to address a significant problem in asymmetric synthesis, we developed a 
strategy to prepare enantioenriched cycloalkanones in high yield from either allyl enol 
carbonates or enol silanes.  Difficulties in preparing certain substrates led us to explore 
allyl β-ketoesters as alternative enolate precursors.  Racemic allyl β-ketoesters are 
competent in the reaction owing to the enantioconvergent mechanism of the 
transformation, whereby both enantiomers of the starting material are converted to a 
common achiral intermediate and then proceed to an enantioenriched product.  Prompted 
by several empirical observations, we hypothesize an unusual inner-sphere mechanism 
for the reaction, which accurately predicts the absolute stereochemistry of the observed 
products.  Kinetics experiments and computational simulations have corroborated our 
proposed inner-sphere mechanism.  Studies directed toward further development of the 
scope of this reaction and catalyst system, as well as the application of our asymmetric 
allylation as a key enantiodetermining step in natural product synthesis,12 are ongoing.  
 
Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 339 
3.5 NOTES AND REFERENCES FOR TEXT 
 
1. See Chapter 2. 
2. For a review discussing our strategy of using natural product structures to drive the 
development of enantioselective catalysis, see: Mohr, J. T.; Krout, M. R.; Stoltz, B. M. 
Nature 2008, 455, 323–332. 
3. For excellent general reviews on the catalytic enantioselective generation of 
quaternary stereocenters, see: (a) Cozzi, P. G.; Hilgraf, R.; Zimmermann, N. Eur. J. Org. 
Chem. 2007, 36, 5969–5994.  (b) Trost, B. M.; Jiang, C. Synthesis 2006, 369–396.  
(c) Quaternary Stereocenters: Challenges and Solutions for Organic Synthesis, 
Christoffers, J., Baro, A., Eds.; Wiley: Weinheim, 2005.  (d) Christoffers, J.; Baro, A. 
Adv. Synth. Catal. 2005, 347, 1473–1482.  (e) Douglas, C. J.; Overman, L. E. Proc. Natl. 
Acad. Sci. U.S.A. 2004, 101, 5363–5367.  (f) Denissova, I.; Barriault, L. Tetrahedron 
2003, 59, 10105–10146.  (g) Christoffers, J.; Mann, A. Angew. Chem., Int. Ed. 2001, 40, 
4591–4597.  (h) Corey, E. J.; Guzman-Perez, A. Angew. Chem., Int. Ed. 1998, 37, 388–
401.  (i) Fuji, K. Chem. Rev. 1993, 93, 2037–2066.  (j) Martin, S. F. Tetrahedron 1980, 
36, 419–460. 
4. For selected alternate methods, see: (a) Linton, E. C.; Kozlowski, M. C. J. Am. 
Chem. Soc. 2008, 130, 16162–16163.  (b) Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 
2008, 130, 9228–9229.  (c) Doyle, A. G.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2007, 
46, 3701–3705.  (d) Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 62–63.  
(e) Yamashita, Y.; Odashima, K.; Koga, K. Tetrahedron Lett. 1999, 40, 2803–2806.  
(f) Bhattacharya, A.; Dolling, U.-H.; Grabowski, E. J. J.; Karady, S.; Ryan, K. M.; 
Weinstock, L. M. Angew. Chem., Int. Ed. 1986, 25, 476–477.  
 
340 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
 
5. For recent reviews of allylic alkylation of ketone enolates, see: (a) Braun, M.; 
Meier, T. Angew. Chem., Int. Ed. 2006, 45, 6952–6955. (b) You, S.-L.; Dai, L.-X. 
Angew. Chem., Int. Ed. 2006, 45, 5246–5248. (c) Braun, M.; Meier, T. Synlett 2006, 661–
676.  (d) Kazmaier, U. Curr. Org. Chem. 2003, 7, 317–328. 
6. (a) Lu, Z.; Ma, S. Angew. Chem., Int. Ed. 2008, 47, 258–297. (b) Trost, B. M. J. 
Org Chem. 2004, 69, 5813–5837.  (c) Graening, T.; Schmalz, H.-G. Angew. Chem., Int. 
Ed. 2003, 42, 2580–2584.  (d) Trost, B. M.; Lee, C. In Catalytic Asymmetric Synthesis, 
2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York, 2000; pp 593–649.  (e) Pfaltz, A.; 
Lautens, M. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., 
Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 2, pp 833–884.  (f) Trost, B. M. 
Chem. Pharm. Bull. 2002, 50, 1–14. (g) Helmchen, G. J. Organomet. Chem. 1999, 576, 
203–214.  (h) Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395–422.  (i) Trost, 
B. M. Acc. Chem. Res. 1996, 29, 355–364.   
7. For examples with prochiral nucleophiles, see: (a) Trost, B. M.; Schroeder, G. M. 
Chem. Eur. J. 2005, 11, 174–184.  (b) Kuwano, R.; Uchida, K.-i.; Ito, Y. Org. Lett. 2003, 
5, 2177–2179.  (c) Trost, B. M.; Schroeder, G .M.; Kristensen, J. Angew. Chem., Int. Ed. 
2002, 41, 3492–3495.  (d) You, S.-L.; Hou, X.-L.; Dai, L.-X.; Zhu, X.-Z. Org. Lett. 2001, 
3, 149–151.  (e) Kuwano, R.; Ito, Y. J. Am. Chem. Soc. 1999, 121, 3236–3237.  (f) Trost, 
B. M.; Schroeder, G. M. J. Am. Chem. Soc. 1999, 121, 6759–6760.  (g) Trost, B. M.; 
Radinov, R.; Grenzer, E. M. J. Am. Chem. Soc. 1997, 119, 7879–7880.  (h) Sawamura, 
M.; Sudoh, M.; Ito, Y. J. Am. Chem. Soc. 1996, 118, 3309–3310.  (i) Sawamura, M.; 
Nagata, H.; Sakamoto, H.; Ito, Y. J. Am. Chem. Soc. 1992, 114, 2586–2592.  (j) Hayashi, 
T.; Kanehira, K.; Hagihara, T.; Kumada, M. J. Org. Chem. 1988, 53, 113–120. 
8. Significant progress has also been made for the Pd-catalyzed alkylation of 
pregenerated, unstabilized enolates to generate tertiary stereocenters.  For examples, see: 
(a) Zhao, X.; Liu, D.; Xie, F.; Zhang, W. Tetrahedron 2009, 65, 512–517.  (b) Braun, M.; 
 
Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 341 
 
Meier, T.; Laicher, F.; Meletis, P.; Fidan, M. Adv. Synth. Catal. 2008, 350, 303–314.  
(c) Zheng, W.-H.; Zheng, B.-H.; Zhang, Y.; Hou, X.-L. J. Am. Chem. Soc. 2007, 129, 
7718–7719.  (d) Yan, X.-X.; Liang, C.-G.; Zhang, Y.; Hong, W.; Cao, B.-X.; Dai, L.-X.; 
Hou, X.-L. Angew. Chem., Int. Ed. 2005, 44, 6544–6546.  (e) Braun, M.; Laicher, F.; 
Meier, T.; Angew. Chem., Int. Ed. 2000, 39, 3494–3497. 
9. (a) For enol carbonate substrates, see: Tsuji, J.; Minami, I.; Shimizu, I. 
Tetrahedron Lett. 1983, 24, 1793–1796.  For silyl enol ether substrates, see: (b) Tsuji, J.; 
Minami, I.; Shimizu, I. Chem. Lett. 1983, 1325–1326.  (c) Tsuji, J. Tetrahedron 1986, 42, 
4361–4401. 
10. For our initial communications concerning this chemistry, see: (a) Behenna, D. 
C.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045.  (b) Mohr, J. T.; Behenna, 
D. C.; Harned, A. M.; Stoltz, B. M. Angew. Chem., Int. Ed. 2005, 44, 6924–6927.  
(c) Seto, M.; Roizen, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2008, 47, 6873–6876.  
(d) We have recently reviewed the development of the enantioselective variants of these 
reactions to date by our lab and others.  See: Mohr, J. T.; Stoltz, B. M. Chem.–Asian J. 
2007, 2, 1476–1491. 
11. For examples of non-enantioselective Tsuji allylations in synthesis, see: 
(a) Ohmori, N. J. Chem. Soc., Perkin Trans. 1 2002, 755–767.  (b) Nicolaou, K. C.; 
Vassilikogiannakis, G.; Mägerlein, W.; Kranich, R. Angew. Chem., Int. Ed. 2001, 40, 
2482–2486.  (c) Herrinton, P. M.; Klotz, K. L.; Hartley, W. M. J. Org. Chem. 1993, 58, 
678–682.  (e) Burns, A. C.; Forsyth, C. J. Org. Lett. 2008, 10, 97–100. 
12. For examples of enantioselective Tsuji allylations in synthesis, see: 
(a) McFadden, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 7738–7739.  
(b) Behenna, D. C.; Stockdill, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2007, 46, 4077–
4080.  (c) White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz, B. M. J. Am. Chem. Soc. 
 
342 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
 
2008, 130, 810–811.  (d) Enquist, J. A., Jr.; Stoltz, B. M. Nature 2008, 453, 1228–1231.  
(e) Levine, S. R.; Krout, M. R.; Stoltz, B. M. Org. Lett. 2009, 11, 289–292.  (f) Petrova, 
K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2009, 11, 293–295.  (g) Varseev, G. N.; 
Maier, M. E. Angew. Chem., Int. Ed. 2009, 48, 3685–3688. 
13. For the development of the PHOX ligands, see: (a) Helmchen, G.; Pfaltz, A. Acc. 
Chem. Res. 2000, 33, 336–345.  (b) Williams, J. M. J. Synlett 1996, 705–710, and 
references therein.   
14. We have developed a convenient scaleable procedure for the preparation of a 
variety of PHOX ligands via a Cu-catalyzed C–P coupling reaction, see: (a) Tani, K.; 
Behenna, D. C.; McFadden, R. M.; Stoltz, B. M. Org. Lett. 2007, 9, 2529–2531.  
(b) Krout, M. R.; Mohr, J. T.; Stoltz, B. M. Org. Synth. 2009, 86, 181–193. 
15. Subsequent to our initial report on asymmetric allylation, several related reports 
have appeared:  (a) For a collected review see ref 10d.  (b) Trost, B. M.; Xu, J. J. Am. 
Chem. Soc. 2005, 127, 2846–2847.  (c) Nakamura, M.; Hajra, A.; Endo, K.; Nakamura, 
E. Angew. Chem., Int. Ed. 2005, 44, 7248–7251.  (d) Trost, B. M.; Xu, J. J. Am. Chem. 
Soc. 2005, 127, 17180–17181.  (e) Burger, E. C.; Barron, B. R.; Tunge, J. A. Synlett 
2006, 2824–2826.  (f) Trost, B. M.; Bream, R. N.; Xu, J. Angew. Chem., Int. Ed. 2006, 
45, 3109–3112.  (g) Trost, B. M.; Xu, J.; Reichle, M. J. Am. Chem. Soc. 2007, 129, 282–
283.  (h) Bélanger, É.; Cantin, K.; Messe, O.; Tremblay, M.; Paquin, J.-F. J. Am. Chem. 
Soc. 2007, 129, 1034–1035.  (i) Schulz, S. R.; Blechert, S. Angew. Chem., Int. Ed. 2007, 
46, 3966–3970.  (j) Bélanger, É.; Houzé, C.; Guimond, N.; Cantin, K.; Paquin, J.-F. 
Chem. Commun. 2008, 3251–3253.  (k) Bélanger, É.; Pouliot, M.-F.; Paquin, J.-F. Org. 
Lett. 2009, 11, 2201–2204. 
 
Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 343 
 
16. (a) Shimizu, I.; Yamada, T.; Tsuji, J. Tetrahedron Lett. 1980, 21, 3199–3202.  
(b) Tsuda, T.; Chujo, Y.; Nishi, S.-i.; Tawara, K; Saegusa, T. J. Am. Chem. Soc. 1980, 
102, 6381–6384.  (c) Tsuji, J.; Minami, I. Acc. Chem. Res. 1987, 20, 140–145. 
17. For a discussion of double stereodifferentiation, see: Eliel, E. L.; Wilen, S. H.; 
Mander, L. N. In Stereochemistry of Organic Compounds, Wiley: New York, 1994; pp 
965–971. 
18. Aliquots taken during the reaction with β-ketoester (±)-107 at 30 °C in THF show 
the starting material reaches a maximum of 5% ee at 83% conversion for a krel of 1.1. 
19. Presumably, this is the result of the cleavage of a C–C bond during 
decarboxylation, rather than C–O bond found in carbonates.  The exact nature of the rate-
determining step of the reaction has not yet been elucidated. 
20. For reviews, see: (a) Noyori, R.; Tokunaga, M.; Kitamura, M. Bull. Chem. Soc. 
Jpn. 1995, 68, 36–56.  (b) Stecher, H.; Faber, K. Synthesis 1997, 1–16.  (c) Huerta, F. F.; 
Minidis, A. B. E.; Bäckvall, J.-E. Chem. Soc. Rev. 2001, 30, 321–331.  (d) Pellissier, H. 
Tetrahedron 2003, 59, 8291–8327.  (e) For representative stereomutative examples, see: 
Pfaltz, A.; Lautens, M. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, 
A., Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 2, pp 833–884.  (f) Trost, B. 
M.; Bunt, R. C.; Lemoine, R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968–5976. 
21. This hypothesis has been experimentally supported for non-enantioselective 
systems, see: (a) Tsuji, J.; Yamada, T.; Minami, I.; Yuhara, M.; Nisar, M.; Shimizu, I. J. 
Org. Chem. 1987, 52, 2988–2995.  (b) Detalle, J.-F.; Riahi, A.; Steinmetz, V.; Hénin, F.; 
Muzart, J. J. Org. Chem. 2004, 69, 6528–6532. 
22. For a highlight of recent approaches to catalytic enantioselective stereoablative 
reactions, see: Mohr, J. T.; Ebner, D. C.; Stoltz, B. M. Org. Biomol. Chem. 2007, 5, 
3571–3576. 
 
344 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
 
23. For representative examples of stereoablative enantioconvergent catalysis, see: 
(a) Hamada, T.; Chieffi, A.; Åhman, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 
1261–1268.  (b) Mase, N.; Tanaka, F.; Barbas, C. F., III. Angew. Chem., Int. Ed. 2004, 
43, 2420–2423.  (c) Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594–4595.  
(d) Raheem, I. T.; Thiara, P. S.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007, 
129, 13404–13405.  (e) Nishimura, T.; Katoh, T.; Takatsu, K.; Shintani, R.; Hayashi, T. 
J. Am. Chem. Soc. 2007, 129, 14158–14159.  (f) Enders, D.; Narine, A. A.; Toulgoat, F.; 
Bisschops, T. Angew. Chem., Int. Ed. 2008, 47, 5661–5665. 
24. This is an adaptation of a procedure by Tsuji and co-workers, see: Tsuji, J.; Nisar, 
M.; Shimizu, I,; Minami, I. Synthesis 1984, 12, 1009. 
25. For an optimized large-scale procedure, see: Mohr, J. T.; Krout, M. R.; Stoltz, B. 
M. Org. Synth. 2009, 86, 194–211. 
26. (a) Mander, L. N.; Sethi, S. P. Tetrahedron Lett. 1983, 24, 5425–5428. 
(b) Donnely, D. M. X.; Finet, J.-P.; Rattigan, B. A. J. Chem. Soc. Perkin Trans. 1 1993, 
1729–1735. 
27. Recently, an alternate, cyanide-free reagent has been developed for the 
preparation of allyl enol carbonates or allyl β-ketoesters.  Selective O- or C-acylation 
may achieved by addition of a Lewis acid to the reaction, see: Trost, B. M.; Xu, J. J. Org. 
Chem. 2007, 72, 9372–9375. 
28. Although only trace β-elimination was observed with this substrate, substrates 
with better leaving groups (e.g., OAc) predominantly underwent β-elimination to the α,β-
unsaturated compounds. 
29. Fluorinated compounds have gained frequent use in medicinal chemistry, see: 
(a) Zoute, L.; Audouard, C.; Plaquevent, J.-C.; Cahard, D. Org. Biomol. Chem. 2003, 1, 
 
Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 345 
 
1833–1834.  (b) Nagai, K.; Davies, T. A.; Dewasse, B. E.; Jacobs, M. R.; Appelbaum, P. 
C. J. Antimicrob. Chemother. 2001, 48, 365–374. 
30. Enquist, J. A., Jr.; Stoltz, B. M. Nature 2008, 453, 1228–1231. 
31. (a) Steinhagen, H.; Reggelin, M.; Helmchen, G. Angew. Chem., Int. Ed. Engl. 
1997, 36, 2108–2110.  (b) Helmchen, G.; Steinhagen, H.; Reggelin, M.; Kudis, S. In 
Selective Reactions of Metal-Activated Molecules; Werner, H., Schreier, P., Eds.; Vieweg 
Verlag: Wiesbaden, 1998; pp 205–215.  (c) Kollmar, M.; Goldfuss, B.; Reggelin, M.; 
Rominger, F.; Helmchen, G. Chem. Eur. J. 2001, 7, 4913–4927.  (d) Kollmar, M.; 
Steinhagen, H.; Janssen, J. P.; Goldfuss, B.; Malinovskaya, S. A.; Vázquez, J.; Rominger, 
F.; Helmchen, G. Chem.–Eur. J. 2002, 8, 3103–3114. 
32. von Matt, P.; Pfaltz, A. Angew. Chem., Int. Ed. Engl. 1993, 32, 566–568. 
33. For Trost’s related system, a solvent-caged ion pair has been proposed based on a 
lack of crossover between enolate and alkyl fragments (ref 15b).  However, we observe 
very different results from crossover experiments (Scheme 3.10), suggesting that the 
details of the mechanism between these two systems may be substantially different. 
34. Unusual patterns in enantioselectivity in a different asymmetric allylation system 
have led other researchers to consider enolate associated allylation mechanisms as well, 
see:  (a) ref 15b.  (b) Trost, B. M.; Zhang, Y. J. Am. Chem. Soc. 2006, 128, 4590–4591. 
35. The crystals are composed of two diastereomeric carboxylate complexes.  For 
clarity, only one of these is shown in Scheme 3.9.  See: Sherden, N. H.; Behenna, D. C.; 
Virgil, S. C.; Stoltz, B. M. Angew. Chem., Int. Ed. 2009, 48, 6840–6843. 
36. For representative examples of O- and C-bound Pd-enolates, see: (a) Burkhardt, 
E. R.; Bergman, R. G.; Heathcock, C. H. Organometallics 1990, 9, 30–44.  
(b) Balegroune, F.; Grandjean, D.; Lakkisb, D.; Matt, D. J. Chem. Soc., Chem. Commun. 
1992, 1084–1085.  (c) Byers, P. K.; Canty, A. J.; Skelton, B. W.; Traill, P. R.; Watson, A. 
 
346 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
 
A.; White, A. H. Organometallics 1992, 11, 3085–3088.  (d) Veya, P.; Floriani, C.; 
Chiesi-Villa, A.; Rizzoli, C. Organometallics 1993, 12, 4899–4901.  (e) Sodeoka, M.; 
Tokunoh, R.; Miyazaki, F.; Hagiwara, E.; Shibasaki, M. Synlett 1997, 463–466.  
(f) Kawatsura, M.; Hartwig, J. F. J. Am. Chem. Soc. 1999, 121, 1473–1478.  (g) Albéniz, 
A. C.; Catalina, N. M.; Espinet, P.; Redón, R. Organometallics 1999, 18, 5571–5576.  
(h) Vicente, J.; Arcas, A.; Fernández-Hernández, J. M.; Bautista, D. Organometallics 
2001, 20, 2767–2774.  (i) Culkin, D. A.; Hartwig, J. F. J. Am. Chem. Soc. 2001, 123, 
5816–5817.  (j) Tian, G.; Boyle, P. D.; Novak, B. M. Organometallics 2002, 21, 1462–
1465.  (k) Culkin, D. A.; Hartwig, J. F. Organometallics 2004, 23, 3398–3416. 
37. Similar transition states have been proposed previously for C–C bond formation, 
see: (a) Kitching, W.; Sakakiyama, T.; Rappoport, Z.; Sleezer, P. D.; Winstein, S.; 
Young, W. G. J. Am. Chem. Soc. 1972, 94, 2329–2335.  (b) Méndez, M.; Cuerva, J. M.; 
Gómez-Bengoa, E.; Cárdenas, D. J.; Echavarren, A. M. Chem. Eur. J. 2002, 8, 3620–
3628. 
38. Similar transition states have been proposed previously for C–O bond formation, 
see: (a) Bäckvall, J.-E.; Nordberg, R. E.; Björkman, E. E.; Moberg, C. J. Chem. Soc., 
Chem. Commun. 1980, 943–944.  (b) Bäckvall, J.-E.; Nordberg, R. E.; Wilhelm, D. J. 
Am. Chem. Soc. 1985, 107, 6892–6898.  (c) Grennberg, H.; Langer, V.; Bäckvall, J.-E. J. 
Chem. Soc., Chem. Commun. 1991, 1190–1192. 
39. For representative examples, see: (a) Trost, B. M.; Verhoeven, T. R. J. Org. 
Chem. 1976, 41, 3215–3216.  (b) Trost, B. M.; Verhoeven, T. R. J. Am. Chem. Soc. 1980, 
102, 4730–4743.  (c) Bäckvall, J.-E.; Nordberg, R. E. J. Am. Chem. Soc. 1981, 103, 
4959–4960.  (d) Bäckvall, J.-E.; Nordberg, R. E.; Vågberg, J. Tetrahedron Lett. 1983, 24, 
411–412.  (e) Keinan, E.; Roth, Z. J. Org. Chem. 1983, 48, 1769–1772.  (f) Sheffy, F. K.; 
Stille, J. K. J. Am. Chem. Soc. 1983, 105, 7173–7175.  (g) Sheffy, F. K.; Godschalx, J. P.; 
Stille, J. K. J. Am. Chem. Soc. 1984, 106, 4833–4840.  (h) Tsuji, Y.; Funato, M.; Ozawa, 
 
Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 347 
 
M.; Ogiyama, H.; Kajita, S.; Kawamura, T. J. Org. Chem. 1996, 61, 5779–5787.  
(i) Rayabarapu, D. K.; Tunge, J. A. J. Am. Chem. Soc. 2005, 127, 13510–13511.  
40. A representative experiment with a cyclic carbonate is shown below. 
O
H
Ph2P N
O
t-Bu
OOTMS
Pd2(dba)3 (5 mol%)
TBAT (35 mol%)
THF, 25 °C 4% GC yield, 1.5:1 d.r.
8% and 31% ee, respectively
(S)-55
(12.5 mol%)
301
1.05 equiv
OEt
O
110
302
 
For the preparation of carbonate 301, see: Genêt, J.-P.; Jugé, S.; Achi, S.; Mallart, S.; 
Ruiz-Montès, J.; Levif, G. Tetrahedron 1988, 44, 5263–5275. 
41. See the experimental section (section 3.6) for details of the kinetics experiments. 
42. For discussions of non-linear effects, see: (a) Guillaneux, D.; Zhao, S.-H.; 
Samuel, O.; Rainford, D.; Kagan, H. B. J. Am. Chem. Soc. 1994, 116, 9430–9439.  
(b) Avalos, M.; Babiano, R.; Cintas, P.; Jiménez, J. L.; Palacios, J. C. Tetrahedron: 
Asymmetry 1997, 8, 2997–3017.  (c) Girard, C.; Kagan, H. B. Angew. Chem., Int. Ed. 
1998, 37, 2922–2959.  (d) Kagan, H. B. Synlett 2001, 888–899.  (e) Satyanarayana, T.; 
Abraham, S.; Kagan, H. B. Angew. Chem., Int. Ed. 2009, 48, 456–494. 
43. For these experiments, i-Pr-PHOX was used because of the availability of both 
enantiomers of valine at approximately the same cost. 
44. Substrates that would lead to highly basic enolate intermediates, such as lactone 
303 and lactam 304, have been problematic, presumably because decarboxylation is slow.   
O
O
O
O
N
O
O
O
Bn
303 304  
45. For example, replacement of the CH2 group of the malonate nucleophile with 
CH(NHAc) increased reaction time from 1 h to 3–4 days.  See ref 32. 
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46. Also consistent with the intermediacy of a Pd-bound enolate, stronger acids (e.g., 
formic acid) may be employed in order to achieve an enantioselective protonation 
reaction.  However, empirical observations indicate that the mechanism of C–H bond 
formation differs significantly from that of C–C bond formation, see:  (a) Mohr, J. T.; 
Nishimata, T.; Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 11348–11349.  
(b) Marinescu, S. C.; Nishimata, T.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2008, 10, 1039–
1042. 
47. A separate reaction with dideuterio allyl enol carbonate 294 confirms that the allyl 
termini are scrambled during the course of the reaction.  See the experimental section 
(section 3.6) for details. 
O O
O DD
294
Pd2(dba)3
(S)-t-Bu-PHOX
THF, 25 °C, 2 h
88% yield, 87% ee
of combined D isomers
O
D
D O D D
1.00 : 1.07
296 297
 
48. Although the total ion counts are not rigorously quantitative, they are consistent 
with the presence of all four masses in nearly equal proportions.  The slight excess of the 
155 m/z ion is likely due to the natural abundance of 13C present in the dideuterio 
product. 
49. The pKa of related monomethyl carbonic acid has been estimated at 2.92 (H2O 
solvent, 25 °C), see: Guthrie, J. P. Can. J. Chem. 1978, 56, 2342–2354. 
50. Saegusa suggested similar crossover pathways in a related, non-enantioselective 
system using a Pd(PPh3)4 catalyst.  See ref 16b. 
51. For details and other control experiments, see the experimental section (section 
3.6). 
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52. If the reaction mixture is exposed to air, t-Bu-PHOX is cleanly converted to the 
corresponding phosphine oxide.  Pd catalyzes this conversion.  See the experimental 
section (section 3.6) for details. 
53. PF6– counterions removed for clarity.  Two out of four of the crystallographically 
unique [Pd(allyl)PHOX] complexes in the unit cell crystallized with a molecule of 
ethanol.  The endo- and exo-allyl isomers were present in equal electron density and are 
modeled as a superposition of the two isomers. 
54. For an initial report of our computational studies in collaboration with the W. A. 
Goddard group at Caltech, see: Keith, J. A.; Behenna, D. C.; Mohr, J. T.; Ma, S.; 
Marinescu, S. C.; Oxgaard, J.; Stoltz, B. M.; Goddard, W. A., III J. Am. Chem. Soc. 2007, 
129, 11876–11877. 
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3.6 EXPERIMENTAL SECTION 
3.6.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.  Tetrabutylammonium 
triphenyldifluorosilicate (TBAT) was purchased from Sigma-Aldrich and azeotropically 
dried five times from acetonitrile prior to use.  Bis(3,5-
dimethoxybenzylideneacetone)palladium(0) (Pd(dmdba)2), alkyl halides, diallyl 
carbonate, Select-fluor®, pimelic acid, and all other ketone starting materials were 
purchased from Sigma-Aldrich and used as received, unless otherwise noted.  
Commercial 3-methylcyclohex-2-en-1-one, cyclohex-2-en-1-one, and NaH (60% 
dispersion in mineral oil) were purchased from Acros and used as received.  Dimethallyl 
carbonate was purchased from Alfa Aesar and used as received.  Trimethylsilyl chloride 
(TMSCl) and triethylamine were distilled from sodium hydride immediately prior to use.  
Sodium iodide was dried by heating at 90 °C (2 torr) for 12 h.  
Tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) was purchased from Strem and 
stored in a glovebox until immediately before use.  (S)-tert-Leucine was purchased from 
Aldrich or Degussa, used as received, and reduced to the corresponding amino alcohol 
according to literature precedent.55  (R)-i-PrPHOX (122) and (S)-t-BuPHOX (55) were 
prepared according to our previously reported methods.56  Allyl cyanoformate was 
prepared by known methods.57  Ruthenium olefin metathesis catalysts were generously 
donated by Materia and stored under argon in a dessicator jar at –20 °C until just prior to 
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use.  Preparations of (S)-t-Bu-PHOX oxide (125) and [Pd(allyl)PHOX]•PF6 salt (165) are 
found in Chapter 2. 
Reaction temperatures were controlled by an IKAmag temperature modulator.  Thin-
layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, p-anisaldehyde, KMnO4 
or CAM staining.  ICN Silica gel (particle size 0.032–0.063 mm) was used for flash 
chromatography.  Analytical chiral HPLC was performed with an Agilent 1100 Series 
HPLC utilizing Chiralpak AD, Chiracel OD-H, or Chiracel OJ columns (4.6 mm x 25 
cm) obtained from Daicel Chemical Industries with visualization at 254 nm.  Analytical 
chiral supercritical fluid chromatography was performed with a Berger Analytix SFC 
(Thar Technologies) utilizing a Chiralpak AD-H column (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries with 2 mL/min flow rate at 30 °C and visualization at 244 
nm.  Analytical chiral GC was performed with an Agilent 6850 GC utilizing a Chiraldex 
G-TA (30.0 m x 0.25 mm) column (1.0 mL/min He carrier gas flow).  Analytical achiral 
GC was performed with an Agilent 6850 GC utilizing an Agilent DB-WAX (30.0 m x 
0.25 mm) column (1.0 mL/min He carrier gas flow).  Optical rotations were measured 
with a Jasco P-1010 polarimeter at 589 nm. 1H and 13C NMR spectra were recorded on a 
Varian Mercury 300 (at 300 MHz and 75 MHz, respectively) or a Varian Inova 500 (at 
500 MHz and 125 MHz, respectively) and are reported relative to Me4Si (δ 0.0).  Data for 
1H NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling 
constant (Hz), integration).  Multiplicities are reported as follows:  s = singlet, d = 
doublet, t = triplet, q = quartet, sept. = septet, m = multiplet, comp. m = complex 
multiplet, app. = apparent, br s = broad singlet.  Data for 13C NMR spectra are reported in 
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terms of chemical shift relative to Me4Si (δ 0.0).  19F NMR spectra were recorded on a 
Varian Mercury 300 spectrometer at 282 MHz, and are reported relative to the external 
standard F3CCO2H (δ –76.53 ppm) or CFCl3 (δ 0.0 ppm).  31P NMR spectra were 
recorded on a Varian Mercury 300 spectrometer at 121 MHz, and are reported relative to 
the external standard H3PO4 (δ 0.0 ppm).  Temperature controlled 1H NMR kinetic 
experiments were performed on a Varian Inova 500 MHz.  IR spectra were recorded on a 
Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of absorption 
(cm–1). High-resolution mass spectra were obtained from the Caltech Mass Spectral 
Facility.  
 
3.6.2 SUBSTRATE COMPOUNDS 
3.6.2.1 GENERAL PROCEDURES FOR THE SYNTHESIS OF ALLYL β-
KETOESTERS 
General Procedure 1:  Dieckmann Cyclization Method58,59 
Oallyl
O
Oallyl
O
239
Oallyl
OONa
240
O
241
CO2allyl
Ph
allyl alcohol
(30)
NaH, 95 °C
then BnBr
THF, 50 °C
 
Allyl 1-benzyl-2-oxocyclohexanecarboxylate (241, Table 3.2, Entry 6).  To a 
suspension of NaH (166.4 mg, 4.16 mmol, 1.0 equiv) in toluene (2 mL) was added allyl 
alcohol (30, 79.2 µL, 1.17 mmol, 0.28 equiv).  Once gas evolution ceased, pimelic acid 
diallyl ester (239, 1.00 g, 4.16 mmol, 1.0 equiv) was added slowly and the resulting 
mixture heated to 95 °C for 1 h.  Additional toluene (~2 mL) was added during this time 
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to maintain a fluid reaction mixture.  The reaction mixture was cooled to room 
temperature and the solvent removed by rotary evaporation in vacuo.  The resulting solid 
salt was placed under dry N2 and dissolved in THF (9 mL).  Benzyl bromide (643.2 µL, 
5.4 mmol, 1.3 equiv) was then added dropwise.  The resulting mixture was warmed to 50 
°C for 2.5 h, cooled to ambient temperature, and quenched with saturated aq NH4Cl (5 
mL) followed by H2O (5 mL).  The phases were separated and the aqueous phase was 
extracted with EtOAc (3 x 5 mL).  The combined organic extracts were washed with 
brine (1 x 10 mL), then dried (Na2SO4), filtered, and concentrated in vacuo.  The resulting 
oil was purified by flash chromatography (5 x 18 cm SiO2, 10% Et2O in pentane) to 
afford the quaternary compound 241 as a colorless oil (781.4 mg, 70% yield).  Rf = 0.30 
(10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.33-7.23 (comp. m, 3H), 7.20-
7.13 (comp. m, 2H), 5.86 (dddd, J = 17.2, 10.3, 5.9, 5.9 Hz, 1H), 5.29 (m, 2H), 4.57 (m, 
2H), 3.38 (d, 1H, J = 13.8 Hz), 2.94 (d, J = 13.8 Hz, 1H), 2.60-2.39 (comp. m, 3H), 2.14-
1.97 (m, 1H), 1.83-1.60 (comp. m, 3H), 1.59-1.45 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 
206.8, 170.5, 136.3, 131.2, 130.2, 127.9, 126.5, 119.0, 65.6, 62.1, 41.1, 40.3, 35.7, 27.4, 
22.3; IR (Neat Film NaCl) 3029, 2942, 1713, 1452, 1179, 1085 cm–1; HRMS (EI) m/z 
calc'd for C17H20O3 [M]+: 272.1412, found 272.1425. 
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General Procedure 2:  Diallyl Carbonate Method 
244
O O
O
O O
O
Oallyl
O
243
1.  NaH, diallyl carbonate, THF
2.  MeI, K2CO3, acetone, 50 °C
74% yield, 2 steps
 
Allyl 7-methyl-8-oxo-1,4-dioxaspiro[4.5]decane-7-carboxylate (244, Table 3.3, 
entries 1 and 2): 
Part A, Acylation: 
To a cooled (0 °C) suspension of NaH (9.22 g, 240.1 mmol, 2.5 equiv) in THF (125 
mL) was added a solution of 1,4-cyclohexanedione monoethylene ketal (243, 15.0 g, 96 
mmol, 1.0 equiv) in THF (30 mL) dropwise over 15 min.  The reaction mixture was 
warmed to room temperature and diallyl carbonate (111, 20.65 mL, 144.0 mmol, 1.5 
equiv) was added and the reaction mixture stirred for 16 h.  The reaction was quenched 
with saturated aq NH4Cl and 1 N aq HCl until a pH of 4 was reached.  The phases were 
separated and the aq phase was extracted with EtOAc (7 x 150 mL).  The combined 
organic extracts were dried (Na2SO4), filtered, concentrated, redissolved in CH2Cl2, dried 
(MgSO4), filtered, and concentrated. 
Part B, Alkylation: 
The resulting oil was added to a suspension of anhydrous K2CO3 (26.5 g, 192.0 
mmol, 2.0 equiv) in acetone (128 mL).  To the reaction mixture was added iodomethane 
(12.0 mL, 192.0 mmol, 2.0 equiv) and the reaction mixture was then heated to 50 °C for 
14 h.  The mixture was then cooled, filtered, and the solids washed with acetone.  The 
filtrate was concentrated and the resulting oil purified by flash chromatography (SiO2, 5 
→ 40% Et2O in hexanes) to afford the desired quaternary quaternary β-ketoester 244 as a 
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colorless oil (18.0 g, 74% yield).  Rf = 0.28 (30% Et2O in pentane); 1H NMR (300 MHz, 
CDCl3) δ 5.90 (dddd, J = 17.4, 10.5, 5.7, 5.7 Hz, 1H), 5.26 (m, 2H), 4.60 (m, 2H), 3.97 
(comp. m, 4H), 3.02 (dt, J = 14.8, 10.2 Hz, 1H), 2.68 (dt, J = 14.0, 2.0 Hz, 1H), 2.49 (dt, 
J = 14.8, 4.4 Hz, 1H), 2.00 (comp. m, 2H), 1.72 (d, J = 14.1 Hz, 1H), 1.29 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 207.0, 172.9, 131.6, 118.5, 106.5, 65.9, 64.8, 64.3, 54.6, 43.6, 
37.4, 35.2, 21.7; IR (Neat Film NaCl) 2939, 2891, 1733, 1717, 1304, 1141 cm–1; HRMS 
(EI) m/z calc'd for C13H18O5 [M]+: 254.1154, found 254.1153. 
 
General Procedure 3:  Mander’s Reagent Method57 
O O
(±)-237
CO2allyl
CO2t-Bu
245
1.  LDA, THF, –78 °C, then
O
NC O
24670% yield
86% yield
Br
Ot-Bu
O
2.  K2CO3, acetone, 50 °C,
247  
Allyl 1-(2-tert-butoxy-2-oxoethyl)-4-methyl-2-oxocyclohex-3-enecarboxylate (237, 
Scheme 3.3):  To a cooled (–78 °C) solution of LDA (18.70 mmol, 1.05 equiv) in THF 
(90 mL) was added 3-methylcyclohex-2-enone (245) (2.02 mL, 17.81 mmol, 1.0 equiv) 
in a dropwise fashion.  The resulting solution was stirred at –78 °C for 30 min and then 
allyl cyanoformate (246)57 (2.00 g, 18.17 mmol, 1.02 equiv) was added dropwise.  The 
dry ice bath was removed and the reaction mixture slowly warmed to room temperature 
and stirred for 8 h.  The reaction mixture was quenched with saturated aq NH4Cl (15 mL) 
followed by H2O (15 mL).  The phases were separated and the aq phase was extracted 
with EtOAc (3 x 15 mL).  The combined organic extracts were washed with brine (1 x 30 
mL), dried (Na2SO4), filtered, and concentrated in vacuo.  The resulting oil was purified 
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by flash chromatography (5 x 24 cm SiO2, 50% EtOAc in hexanes) to afford the 
intermediate β-ketoester as a yellow oil (2.4152 g, 70% yield). 
A portion of this β-ketoester (500.0 mg, 2.57 mmol, 1.0 equiv) was added to a 
suspension of anhydrous K2CO3 (711.8 mg, 5.15 mmol, 2.0 equiv) in acetone (2.5 mL).  
To the reaction mixture was added t-butyl bromoacetate (247, 760.5 µL, 5.15 mmol, 2.0 
equiv).  The reaction mixture was then warmed to 50 °C and stirred for 48 h.  The 
reaction mixture was then cooled, filtered, and the solids washed with acetone.  The 
filtrate was concentrated and purified by flash chromatography (3 x 20 cm SiO2, 
10→30% EtOAc in hexanes) to afford the desired quaternary β-ketoester 237 as a 
colorless oil (684.7 mg, 86% yield; 60% overall yield for 2 steps).  Rf = 0.28 (30% Et2O 
in pentane); 1H NMR (300 MHz, CDCl3) δ 5.93 (s, 1H), 5.87 (dddd, J = 17.3, 10.5, 5.4, 
5.4 Hz, 1H), 5.23 (m, 2H), 4.61 (m, 2H), 2.83 (d, J = 16.4 Hz, 1H), 2.73 (d, J = 16.4 Hz, 
1H), 2.58-2.36 (comp. m, 2H), 2.31-2.16 (comp. m, 2H), 1.94 (s, 3H), 1.42 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 194.2, 169.8, 161.9, 131.7, 125.6, 118.2, 81.1, 65.8, 54.2, 39.8, 
30.5, 28.7, 28.0, 24.2; IR (Neat Film NaCl) 2979, 1733, 1677, 1368, 1153 cm–1; HRMS 
(EI) m/z calc'd for C17H24O5 [M]+: 308.1624, found 308.1609. 
 
3.6.2.2 CHARACTERIZATION DATA FOR β-KETOESTER SUBSTRATES 
O
O
O
242  
Allyl 2-oxocyclohexanecarboxylate  (242, Scheme 3.5): Prepared by general 
procedure 1.  The reaction was quenched with 10% HCl.  The product was isolated by 
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bulb-to-bulb distillation once at 150-155 °C (bath temp, 2 torr), then at 136 °C (bath 
temp, 2 torr).  75% yield.  Rf = 0.53 (10:1 Hexane:EtOAc); 1H NMR (300 MHz, CDCl3, 
mixture of keto and enol tautomers) δ 12.14 (s, 0.7H), 5.99 (dddd, J = 5.7, 5.7, 10.8, 17.1 
Hz, 0.7H), 5.96 (dddd, J = 5.7, 5.7, 10.2, 17.1 Hz, 0.3H), 5.38 (dddd, J = 1.5, 1.5, 1.5, 
17.1 Hz, 0.3H), 5.37 (dddd, J = 1.5, 1.5, 1.5, 17.1 Hz, 0.7H), 5.24 (dddd, J = 1.5, 1.5, 1.5, 
10.5 Hz, 1H), 4.72-4.55 (m, 2H), 3.41 (ddd, J = 1.5, 6.6, 9.6 Hz, 0.3H), 2.52 (dddd, J = 
1.5, 5.4, 5.4, 14.1 Hz, 0.3H), 2.37 (m, 0.3H), 2.26 (m, 2.7H), 2.22-2.10 (m, 0.6H), 2.04-
1.78 (m, 0.9H), 1.75-1.55 (m, 3.3H); 13C NMR (75 MHz, CDCl3) δ 205.9, 172.4, 172.2, 
169.6, 132.3, 131.8, 118.4, 117.7, 97.5, 65.6, 64.6, 57.2, 41.5, 29.9, 29.1, 27.0, 23.3, 22.3, 
22.3, 21.9; IR (Neat Film NaCl) 3086, 2941, 1746, 1716, 1659, 1617, 1299, 1259, 1217, 
1176, 831 cm–1; HRMS (EI) m/z calc'd for C10H14O3 [M]+: 182.0943, found 182.0941. 
 
O
O
O
107  
Allyl 1-methyl-2-oxocyclohexanecarboxylate (107, Table 3.1; Table 3.2, entries 1 
and 2):  Prepared by general procedure 1.  62% yield.  Rf = 0.38 (10:1 Hexane:EtOAc); 
1H NMR (300 MHz, CDCl3) δ 5.85 (dddd, J = 17.1, 10.2, 5.9, 5.9 Hz, 1H), 5.24 (m, 2H), 
4.59 (d, J = 5.7 Hz, 2H), 2.58-2.34 (comp. m, 3H), 2.08-1.88 (m, 1H), 1.80-1.54 (comp. 
m, 3H), 1.52-1.37 (m, 1H), 1.27 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 207.9, 172.6, 
131.4, 118.7, 65.6, 57.1, 40.5, 38.1, 27.4, 22.5, 21.1; IR (Neat Film NaCl) 3086, 2939, 
2867, 1715, 1452, 1259, 1211, 1159, 1084, 976 cm–1; HRMS (EI) m/z calc'd for C11H16O3 
[M]+: 196.1099, found 196.1096. 
 
358 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
O
O
O
248  
Allyl 1-(3-methylbut-2-enyl)-2-oxocyclohexanecarboxylate (248, Table 3.2, entry 
3):  Prepared by general procedure 2 part B from ketoester 242 and prenyl bromide.  
Flash chromatography (SiO2, 2→12% Et2O in pentane).  20% yield.  Rf = 0.24 (10% Et2O 
in pentane); 1H NMR (300 MHz, CDCl3) δ 5.87 (dddd, J = 17.1, 10.4, 5.8, 5.8 Hz, 1H), 
5.31 (d, J = 17.1 Hz, 1H), 5.24 (d, J = 10.1 Hz, 1H), 5.06 (t, J = 7.7 Hz, 1H), 4.59 (d, J = 
5.7 Hz, 2H), 2.65-2.27 (comp. m, 5H), 2.07-1.93 (m, 1H), 1.79-1.69 (m, 1H), 1.68 (s, 
3H), 1.66-1.59 (m, 1H), 1.58 (s, 3H), 1.54-1.39 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
207.7, 171.4, 134.8, 131.6, 118.8, 118.5, 65.7, 61.3, 41.2, 35.5, 33.2, 27.5, 26.0, 22.5, 
17.8; IR (Neat Film NaCl) 2938, 2863, 1714, 1451, 1438, 1210, 1178, 989 cm–1; HRMS 
(EI) m/z calc'd for C15H22O3 [M]+: 250.1569, found 250.1574. 
 
250
O
O
O
N
 
Allyl 1-(cyanomethyl)-2-oxocyclohexanecarboxylate (250, Table 3.2, entry 4):  
Prepared by general procedure 2 part B from ketoester 242 and acrylonitrile.  Flash 
chromatography (SiO2, 10% Et2O in pentane).  55% yield.  Rf = 0.27 (CH2Cl2); 1H NMR 
(300 MHz, CDCl3) δ 5.91 (dddd, J = 17.6, 10.2, 6.0, 6.0 Hz, 1H), 5.41-5.25 (m, 2H), 4.68 
(d, J = 6.0 Hz, 2H), 2.64-2.38 (comp. m, 4H), 2.37-2.13 (comp. m, 2H), 2.13-1.86 (comp. 
m, 2H), 1.85-1.40 (comp. m, 4H); 13C NMR (75 MHz, CDCl3) δ 207.0, 170.6, 130.9, 
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120.0, 119.3, 66.4, 59.7, 40.9, 36.7, 30.8, 27.4, 22.4, 13.0; IR (Neat Film NaCl) 2945, 
2868, 2248, 1713, 1450, 1192, 1136, 941 cm–1; HRMS (EI) m/z calc'd for C13H17NO3 
[M]+: 235.1208, found 235.1218. 
 
252
O
O
O
O
EtO
 
Allyl 1-(3-ethoxy-3-oxopropyl)-2-oxocyclohexanecarboxylate (252, Table 3.2, 
entry 5):  Prepared by general procedure 2 part B from ketoester 242 and ethyl acrylate.  
Flash chromatography (SiO2, 10% Et2O in pentane).  81% yield.  Rf = 0.37 (30% Et2O in 
pentane); 1H NMR (300 MHz, CDCl3) δ 5.89 (dddd, J = 17.3, 10.3, 5.9, 5.9 Hz, 1H), 5.33 
(dd, J = 17.3, 1.1 Hz, 1H), 5.26 (dd, J = 10.4, 1.3 Hz, 1H), 4.63 (app. t, J = 14.9 Hz, 2H), 
4.11 (q, J = 7.2 Hz, 2H), 2.51-2.31 (comp. m, 4H), 2.31-2.11 (comp. m, 2H), 2.08-1.85 
(comp. m, 2H), 1.84-1.57 (comp. m, 3H), 1.55-1.40 (m, 1H), 1.24 (t, J = 7.2 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 207.4, 173.0, 171.4, 131.3, 119.3, 65.9, 60.4, 60.1, 41.0, 36.2, 
29.6, 29.5, 27.5, 22.5, 14.2; IR (Neat Film NaCl) 2943, 2868, 1734, 1715, 1456, 1181 
cm–1; HRMS (EI) m/z calc'd for C15H22O5 [M]+: 282.1467, found 282.1474. 
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O
O
O O
O
O
OH
O
O
O
OMe
254305242  
Allyl 1-(4-methoxybenzyl)-2-oxocyclohexanecarboxylate (254, Table 3.2, entry 
7):  To a cooled (0 °C) solution of ketoester 242 (4.00 g, 22.0 mmol, 1.0 equiv) in THF 
(40 ml) was added 35% aqueous formaldehyde (11.3 mL) and KHCO3 (5.93 g, 65.9 
mmol, 3.0 equiv).  After 30 min at 0 °C the reaction mixture was allowed to warm to 
ambient temperature.  After an additional 90 min, the reaction was quenched with water 
(100 mL) and CH2Cl2 (100 mL).  After the layers were separated, the aqueous layer was 
extracted with CH2Cl2 (4 x 50 mL), the combined organics dried (Na2SO4) and 
evaporated.  The oil obtained was treated with THF (40 mL) and 3 M aq HCl (4 drops) 
for 60 min, concentrated, and purified by flash chromatography (SiO2, 10→45% EtOAc 
in hexanes) to give 305 (3.75 g, 81% yield).   
To a cooled (0 °C) suspension of 60% NaH (251 mg, 6.28 mmol, 1.1 equiv) in DMF 
(20 mL) was added 305 (1.20g, 5.71 mmol, 1.0 equiv) in a dropwise manner over 2 min.  
Once gas evolution had ceased (10 min), Bu4NI (527 mg, 1.43 mmol. 0.25 equiv) and 
PMB-Cl (930 µL, 6.85 mmol, 1.2 equiv) were added, and the reaction mixture slowly 
allowed to warm to ambient temperature.  After 12 h, the reaction mixture was quenched 
with water (50 mL) and 2:1 CH2Cl2:hexanes (50 mL), the aqueous layer extracted with 
2:1 CH2Cl2:hexanes (3 x 50 mL), dried (Na2SO4), evaporated, and purified by flash 
chromatography (SiO2, 10→20% Et2O in hexanes) to give the desired compound 306 
(485 mg, 28% yield).  Rf = 0.30 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 
7.03 (d, J = 8.7 Hz, 2H), 6.77 (d, J = 8.7 Hz, 2H), 5.89-5.76 (m, 1H) 5.31-5.21 (m, 2H), 
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4.59-4.47 (m, 2H), 3.76 (s, 3H), 3.25 (d, J = 14.1 Hz, 1H), 2.84 (d, J = 14.1 Hz, 1H), 
2.51-2.35 (m, 3H), 2.04-1.96 (m, 1H), 1.76-1.54 (m, 3H), 1.50-1.40 (m, 1H); 13C NMR 
(75 MHz, CDCl3) δ 207.2, 170.8, 158.4, 131.4, 131.3, 128.4, 119.1, 113.4, 65.8, 62.3, 
55.1, 41.3, 39.5, 35.8, 27.5, 22.5; IR (Neat Film NaCl) 2943, 1713, 1612, 1513, 1247, 
1179 cm–1; HRMS (EI) m/z calc'd for C18H22O4 [M]+: 302.1518, found 302.1514. 
 
256
O
O
O
CF3
 
Allyl 2-oxo-1-(4-(trifluoromethyl)benzyl)cyclohexanecarboxylate (256, Table 3.2, 
entry 8):  Prepared by general procedure 1 with 4-(trifluoromethyl)benzyl bromide.  
Flash chromatography (SiO2, 2→12% Et2O in pentane).  56% yield.  mp 40–41 ºC; Rf = 
0.63 (30% Et2O in pentane); 1H NMR (300 MHz, C6D6) δ 7.29 (d, J = 8.1 Hz, 2H), 7.02 
(d, J = 8.1 Hz, 2H), 5.45 (dddd, J = 17.3, 10.4, 6.0, 6.0 Hz, 1H), 4.91 (m, 2H), 4.18 (m, 
2H), 3.34 (d, J = 13.7 Hz, 1H), 2.78 (d, J = 13.7 Hz, 1H), 2.37-2.15 (comp. m, 3H), 1.57-
1.38 (comp. m, 2H), 1.32-1.11 (comp. m, 2H), 1.09-0.94 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ 206.7, 170.4, 140.8 (q, JCF = 1.2 Hz), 131.0, 130.7, 129.0 (q, JCF = 32.3 Hz), 
124.9 (q, JCF = 3.9 Hz), 124.2 (q, JCF = 271.7 Hz), 119.4, 65.9, 62.2, 41.2, 40.2, 36.2, 
27.5, 22.5; 19F NMR (282 MHz, CDCl3) δ -63.0; IR (Neat Film NaCl) 2945, 1715, 1326, 
1164, 1123, 1068 cm–1; HRMS (EI) m/z calc'd for C18H19F3O3 [M]+: 340.1286, found 
340.1277. 
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Allyl 1-((tert-butyldiphenylsilyloxy)methyl)-2-oxocyclohexanecarboxylate (258, 
Table 3.2, entry 9):  To a solution of 305 (vide supra) (1.20 g, 5.71 mmol. 1.0 equiv), 
imidazole (583 mg, 8.57 mmol, 1.5 equiv), and DMAP (1.04 g, 8.57 mmol, 1.5 equiv) in 
DMF (20 mL) was added TBDPS-Cl (1.75 mL, 6.85 mmol, 1.2 equiv).  After 24 h at 
ambient temperature, the reaction mixture was poured into water (75 mL) and 2:1 
CH2Cl2:hexanes (150 mL), extracted with 2:1 CH2Cl2:hexanes (4 x 30 mL), dried 
(Na2SO4), and evaporated.  Flash chromatography (SiO2, 2.5→12% EtOAc in hexanes) 
gave the desired compound (1.85 g, 72% yield).  mp 59-60 °C; Rf = 0.24 (10% Et2O in 
pentane); 1H NMR (300 MHz, CDCl3) δ 7.72-7.68 (m, 4H), 7.48-7.37 (m, 6H), 6.00-5.86 
(m, 1H), 5.38-5.31 (m, 1H), 5.28-5.23 (m, 1H), 4.74-4.59 (m, 2H), 4.24 (d, J = 9.9 Hz, 
1H), 3.82 (d, J = 9.9 Hz, 1H), 2.78 (dq, J = 13.4, 3.3 Hz, 1H), 2.53-2.38 (m, 2H), 2.10-
1.99 (m, 1H), 1.88-1.54 (m, 4H) 1.07 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 206.4, 169.8, 
135.6, 135.5, 133.1, 132.9, 131.5, 129.6, 127.6 (2C), 118.8, 66.4, 65.8, 62.9, 41.2, 33.6, 
27.3, 26.6, 22.1, 19.2; IR (Neat Film NaCl) 3072, 2933, 2858, 1715, 1428, 1200, 1112, 
703 cm–1; HRMS (EI) m/z calc'd for C27H33O4Si [M – H]+: 449.2148, found 449.2165. 
 
260
O
F
O
O
 
Allyl 1-fluoro-2-oxocyclohexanecarboxylate (260, Table 3.2, entry 10):  To a 
solution of ketoester 242 (946.4 mg, 5.19 mmol, 1 equiv) in 50 mL CH3CN, was added 
TiCl4 (50 µL, 0.456 mmol, 0.09 equiv).  Select-fluor® (2.2224 g, 6.27 mmol, 1.2 equiv) 
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was added after 10 min and the mixture stirred at room temperature for 2 h and 40 min, 
over which time the orange color disappeared.  The mixture was partitioned between H2O 
(200 mL) and Et2O (50 mL).  The aqueous layer was separated and washed with Et2O (30 
mL).  The combined organic layers were dried (MgSO4), concentrated to about 30 mL, 
passed through a pad of silica that was washed with Et2O (5 x 10 mL), and evaporated in 
vacuo.  The residue was then bulb-to-bulb distilled at 180–190 °C (bath temp, 2 torr) to 
afford the title compound as a colorless oil (947.6 mg, 91% yield).  Rf = 0.19 (10:1 
Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.93 (dddd, J = 5.7, 5.7, 10.5, 17.1 Hz, 
1H), 5.37 (dddd, J = 1.5, 1.5, 1.5, 17.4 Hz, 1H), 5.29 (dddd, J = 1.5, 1.5, 1.5, 10.5 Hz, 
1H), 4.73 (bd, J = 5.7 Hz, 2H), 2.80-2.67 (m, 1H), 2.66-2.38 (m, 2H), 2.24-2.10 (m, 1H), 
1.98-1.80 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 201.5 (d, JC-F = 19.8 Hz), 166.4 (d, JC-F 
= 24.8 Hz), 130.8, 119.2, 96.2 (d, JC-F = 196.9 Hz), 66.5, 39.4, 35.8 (d, JC-F = 21.8 Hz), 
26.4, 20.7 (d, JC-F = 6.0 Hz); IR (Neat Film NaCl) 3087, 2952, 1759, 1735, 1650, 1452, 
1281, 1223, 1150, 1097, 990 cm–1; HRMS (EI) m/z calc'd for C10H13O3F [M]+: 200.0849, 
found 200.0858. 
 
306
O
O
O
 
Allyl 1,3,3-trimethyl-2-oxocyclohexanecarboxylate (306, Table 3.3, entry 3):  To a 
cooled (–78 °C) solution of LDA (13.5 mmol, 1.12 equiv) in THF (30 mL) was added 
2,2,6-trimethylcyclohexanone (1.6938 g, 12.08 mmol, 1.0 equiv) dropwise.  The resulting 
solution was warmed to 0 °C for 1 h, cooled to –78 °C and HMPA (2.2 mL, 12.6 mmol, 
1.04 equiv) was added.  After 5 min, allyl cyanoformate (246)57 (1.5014 g, 13.5 mmol, 
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1.12 equiv) was added dropwise.  The reaction was warmed to room temperature and 
allowed to stir overnight.  The reaction was then quenched with 50% saturated aq NH4Cl 
(40 mL).  The aqueous layer was separated and washed with EtOAc (3 x 20 mL).  The 
combined organic extracts were washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo.  The resulting oil was purified by flash chromatography (SiO2, 3% 
Et2O in hexanes) to afford the β-ketoester as a colorless oil (585.6 mg, 22%), along with 
the known enol carbonate (vide supra, Rf = 0.53, 10:1 hexane:EtOAc) as a colorless oil 
(1.3117 g, 48%).  Rf = 0.50 (10:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.87 
(dddd, J = 5.7, 5.7, 10.2, 16.8 Hz, 1H), 5.30 (dddd, J = 1.2, 1.2, 1.2, 17.1 Hz, 1H), 5.22 
(dddd, J = 0.9, 0.9, 0.9, 10.2 Hz, 1H), 4.62 (dddd, J = 1.2, 1.2, 5.7, 13.2 Hz, 1H), 4.51 
(dddd, J = 1.2, 1.2, 5.7, 13.2 Hz, 1H), 2.54 (dddd, J = 2.4, 3.9, 3.9, 13.8 Hz, 1H), 1.98 
(ddddd, J = 3, 4.2, 12, 14.1, 15.6 Hz, 1H), 1.77-1.68 (m, 1H), 1.66-1.52 (m, 2H), 1.42 
(ddd, J = 4.2, 12.3, 13.8, 1H), 1.32 (s, 3H), 1.09 (s, 3H), 1.06 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 211.4, 172.4, 131.5, 118.8, 65.7, 55.1, 46.1, 40.6, 36.8, 26.8, 25.5, 23.6, 18.5; 
IR (Neat Film NaCl) 3089, 2938, 1736, 1707, 1649, 1456, 1377, 1243, 1209, 1174, 1150, 
972 cm–1; HRMS (EI) m/z calc'd for C13H20O3 [M]+: 224.1413, found 224.1413. 
 
307
O
O
O
 
Allyl 1,2,2,4,4-pentamethyl-6-oxocyclohexanecarboxylate (307, Table 3.3, entry 
4):  Prepared by a modification of general procedure 2.  Part A:  Reaction of 3,3,5,5-
tetramethylcyclohexanone in benzene (1 M) at 80 °C for 40 h using NaH (2 equiv) and 
diallylcarbonate (3 equiv) gave an ~1:1 mixture of mono- and bis-acylated material after 
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flash chromatography (SiO2, 1 → 8% Et2O in hexanes).  Part B:  Reaction in acetone 
(0.42 M) at 75 °C in a sealed flask for 24 h using Cs2CO3 (3 equiv) and MeI (4 equiv).  
Flash chromatography (SiO2, 1→4% Et2O in hexanes) gave the desired compound.  25% 
overall yield.  Rf = 0.60 (25% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 5.87 
(dddd, J = 17.4, 10.5, 6.0, 6.0 Hz, 1H), 5.29 (d, J = 17.1 Hz, 1H), 5.22 (d, J = 10.5 Hz, 
1H), 4.55 (d, J = 6.0 Hz, 2H), 2.78 (d, J = 13.5 Hz, 1H), 2.23-2.12 (comp. m, 2H), 1.33 
(d, J = 14.4 Hz, 1H), 1.26 (s, 3H), 1.11 (s, 3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.92 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 208.9, 171.5, 131.5, 118.8, 65.5, 62.6, 51.7, 49.4, 40.9, 
34.8, 34.5, 29.6, 27.7, 26.9, 14.7; IR (Neat Film NaCl) 3087, 2959, 1715, 1456, 1371, 
1216, 1101, 979 cm–1; HRMS (EI) m/z calc'd for C15H24O3 [M]+: 252.1725, found 
252.1719. 
 
308
O
O
O
 
Allyl 1-methyl-2-oxocyclohex-3-enecarboxylate (308, Table 3.3, entry 5):  
Prepared by general procedure 2 from cyclohex-2-en-1-one.  Flash chromatography 
(SiO2, CH2Cl2).  23% yield.  Rf = 0.38 (30% Et2O in pentane); 1H NMR (300 MHz, 
CDCl3) δ 6.92 (m, 1H), 6.06 (dt, J = 10.1, 2.1 Hz, 1H), 5.86 (dddd, J = 17.3, 10.4, 5.6, 5.6 
Hz, 1H), 5.24 (m, 2H), 4.61 (m, 2H), 2.57-2.41 (m, 2H), 2.41-2.27 (m, 1H), 1.97-1.82 
(m, 1H), 1.41 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.8, 172.3, 149.4, 131.6, 128.9, 
118.3, 65.7, 53.4, 33.3, 23.6, 20.3; IR (Neat Film NaCl) 2936, 1733, 1678, 1249, 1192, 
1110 cm–1; HRMS (EI) m/z calc'd for C11H14O3 [M]+: 194.0943, found 194.0941. 
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Allyl 2-methyl-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (293, Table 
3.3, entry 6):  Prepared by general procedure 2 from 1-tetralone.  Flash chromatography 
(SiO2, 10% Et2O in pentane).  60% yield.  Rf = 0.61 (30% Et2O in pentane); 1H NMR 
(300 MHz, CDCl3) δ 8.06 (d, J = 7.8 Hz, 1H), 7.47 (app. t, J = 7.5 Hz, 1H), 7.31 (app. t, J 
= 8.1 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 5.79 (dddd, J = 17.1, 10.7, 5.4, 5.4 Hz, 1H), 5.19-
5.09 (m, 2H), 4.58 (m, 2H), 3.12-2.87 (m, 2H), 2.68-2.57 (m, 1H), 2.13-2.01 (m, 1H), 
1.52 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 195.9, 172.5, 143.1, 133.4, 131.7, 131.5, 
128.7, 128.0, 126.8, 118.0, 65.6, 53.9, 33.9, 26.0, 20.6; IR (Neat Film NaCl) 3071, 2982, 
2938, 1736, 1690, 1602, 1456, 1377, 1308, 1228, 1189, 1112, 979, 743 cm–1; HRMS (EI) 
m/z calc'd for C15H16O3 [M]+: 244.1099, found 244.1094. 
 
O
O
O
309  
Allyl 1-methyl-2-oxocycloheptanecarboxylate (309, Table 3.3, entry 7):  Prepared 
by general procedure 2 from cycloheptanone.  Flash chromatography (SiO2, 25→100% 
CH2Cl2 in pentane).  30% yield.  Rf = 0.60 (30% Et2O in pentane); 1H NMR (300 MHz, 
CDCl3) δ 5.88 (dddd, J = 17.3, 10.4, 5.6, 5.6 Hz, 1H), 5.26 (m, 2H), 4.61 (m, 2H), 2.81-
2.67 (m, 1H), 2.57-2.45 (m, 1H), 2.25-2.11 (m, 1H), 1.91-1.70 (comp. m, 3H), 1.69-1.49 
(comp. m, 4H), 1.36 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 173.2, 131.6, 118.5, 65.6, 
58.8, 42.0, 35.4, 30.1, 25.8, 24.7, 21.5; IR (Neat Film NaCl) 2936, 1740, 1710, 1229, 
1151, 1105 cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1249. 
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Allyl 1-methyl-2-oxocyclohept-3-enecarboxylate (310, Table 3.3, entry 8):  To a 
cooled (–78 °C) solution of LHMDS (1.0 M soln in THF, 10 mL, 10 mmol, 1.5 equiv) in 
THF (20 mL) was added cyclohept-2-enone (759 µL, 6.73 mmol, 1.0 equiv).  After 30 
min, allyl cyanoformate (246)57 (813 mg, 7.32 mmol, 1.1 equiv) was added.  The reaction 
was allowed to stir at –78 °C for 30 min and was then quenched with 50% saturated aq 
NH4Cl (40 mL) and allowed to thaw.  The aqueous layer was separated and extracted 
with Et2O (3 x 30 mL).  The combined organic extracts were washed with brine, dried 
(Na2SO4), filtered, and concentrated in vacuo.  The resulting oil was dissolved in 10 mL 
CH3CN, then Cs2CO3 (3.3271 g, 10.21 mmol, 1.5 equiv) and MeI (2.1 mL, 33.73 mmol, 
5.0 equiv) were added.  The mixture was then heated to 80 °C for 4 h and then cooled to 
ambient temperature.  The mixture was diluted with ~10 mL EtOAc and filtered through 
a 3 x 3 cm plug of silica gel which was then washed with 3 x 25 mL EtOAc.  
Evaportation in vacuo gave an oil that was purified by flash chromatography (3 x 24 cm, 
15:1 hexanes:EtOAc) to afford the title compound as a colorless oil (735.2 mg, 52%). Rf 
= 0.20 (10:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 6.38 (ddd, J = 4.8, 4.8, 12.6 
Hz, 1H), 6.03 (ddd, J = 2.4, 2.4, 12.9 Hz, 1H), 5.86 (dddd, J = 5.4, 5.4, 10.8, 17.1 Hz, 
1H), 5.29 (dddd, J = 1.5, 1.5, 1.5, 17.4 Hz, 1H), 5.21 (dddd, J = 1.2, 1.2, 1.2, 10.5 Hz, 
1H), 4.65-4.59 (m, 1H), 4.59-4.52 (m, 1H), 2.44-2.30 (m, 3H), 2.10 (m, 1H),  1.82-1.65 
(m, 2H), 1.42 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 201.6, 173.3, 143.2, 131.6, 130.9, 
118.2, 65.6, 59.9, 34.2, 31.5, 23.3, 23.1; IR (Neat Film NaCl) 3080, 3018, 2937, 1737, 
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1686, 1454, 1377, 1232, 1171, 1113, 978, 931, 820 cm–1; HRMS (EI) m/z calc'd for 
C12H16O3 [M]+:  208.1100, found 208.1109. 
 
O
O
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2-Methylallyl 1-methyl-2-oxocyclohexanecarboxylate (311, Table 3.3, entry 9):  
Prepared by general procedure 2 from cyclohexanone with dimethyallyl carbonate in part 
A.  Flash chromatography (SiO2, 10% Et2O in pentane).  46% yield.  Rf = 0.24 (10% Et2O 
in pentane); 1H NMR (300 MHz, CDCl3) δ 4.94 (m, 2H), 4.54 (s, 2H), 2.58-2.42 (comp. 
m, 3H), 2.08-1.93 (m, 1H), 1.80-1.57 (comp. m, 6H), 1.55-1.40 (m, 1H), 1.32 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 208.1, 172.8, 139.4, 113.5, 68.4, 57.2, 40.6, 38.2, 27.5, 22.6, 
21.3, 19.5; IR (Neat Film NaCl) 2940, 2867, 1715, 1452, 1260, 1211, 1160, 1086, 907 
cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1256. 
 
O
O
O
Cl
312  
2-Chloroallyl 1-methyl-2-oxocyclohexanecarboxylate (312, Table 3.3, entry 10):  
Prepared by general procedure 2 from cyclohexanone with 1.25 equiv of 2-chloroallyl 
carbonate60,61 in part A.  Flash chromatography (SiO2, 10% Et2O in pentane).  62% yield.  
Rf = 0.20 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 5.45 (m, 2H), 4.71 (m, 
2H), 2.62-2.41 (comp. m, 3H), 2.10-1.93 (m, 1H), 1.81-1.62 (comp. m, 3H), 1.57-1.41 
(m, 1H), 1.34 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 207.8, 172.3, 135.4, 115.8, 66.5, 
57.2, 40.6, 38.2, 27.4, 22.5, 21.2; IR (Neat Film NaCl) 2942, 2868, 1716, 1640, 1453, 
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1248, 1221, 1153, 1084, 903 cm–1; HRMS (EI) m/z calc'd for C11H15O3Cl [M]+: 230.0710, 
found 230.0711. 
 
315
O
317
Bn
NaH, 100 °C
then NH4Cl
NaH
BnBr
THF
50 °C
O
O
Ph
Br
Ph
Mg, THF
(CH2O)n Ph
OH
PhO
O
Ph
O
O
Phpimelic acid
DIC, DMAP
CH2Cl2, 0 °C
O
316
H
O
O
Ph
314
OH
313
(238) 314
 
2-Phenylallyl alcohol (314).62  A 250 mL two-neck round-bottomed flask equipped 
with an addition funnel, a condenser, a stir bar, and two septa was charged with Mg 
turnings (1.71 g, 70.3 mmol), cutting several turnings during addition.  The system was 
then flame dried under vacuum.  After refilling with Ar, anhydrous THF (50 mL) and 
bromoethane (300 µL, 4.02 mmol) were added via syringe.  The flask was opened and 
iodine (110.9 mg, 0.437 mmol) was added under positive Ar pressure.  The flask was 
then sealed and flushed with Ar.  After stirring at 23 °C for 15 min, the reaction turned a 
greenish color.  α-Bromostyrene (313, 8.4 mL, 64.7 mmol) in anhydrous THF (15 mL) 
was then added dropwise over 1 h via the addition funnel, during which time a significant 
exotherm was observed.  The reaction was then placed in an oil bath and heated at reflux 
for 41 min.  After cooling to 23 °C, the flask was opened, and paraformaldehyde (3.00 g, 
99.9 mmol) was added.  The flask was then sealed and flushed with Ar.  After stirring at 
23 °C for 1.5 h, saturated NH4Cl (aq) (40 mL) and H2O (40 mL) were added to quench 
the reaction and dissolve all solids.  The mixture was extracted with Et2O (3 x 40 mL), 
and the combined organic layers were washed with H2O (2 x 50 mL) and brine (50 mL).  
After drying over MgSO4, solvent was removed under reduced pressure.  The crude 
product was then distilled under high vacuum to provide 2-phenylallyl alcohol (314) 
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(6.542 g, 75%) as a colorless liquid containing minor unidentified impurities by 1H NMR 
spectroscopy. 1H NMR (500 MHz, CDCl3) δ 7.48-7.43 (m, 2H), 7.39-7.33 (m, 2H), 7.31-
7.28 (m, 1H), 5.48 (dt, J = 0.9, 0.7 Hz, 1H), 5.36 (dt, J = 1.3, 1.2 Hz, 1H), 4.56 (ddd, J = 
6.1, 1.3, 0.7 Hz, 2H), 1.58-1.52 (m, 1H). 
Bis(ester) 315.  A flame-dried 250 mL round-bottomed flask equipped with a stir bar 
and a septum was charged with 2-phenylallyl alcohol (314) (98.6% pure by mass 
(contained 1.4% CH2Cl2 by mass), 5.42 g, 39.8 mmol), pimelic acid (3.35 g, 20.9 mmol), 
and DMAP (1.95 g, 16.0 mmol).  The flask was evacuated under high vacuum and 
refilled with Ar.  Anhydrous CH2Cl2 (80 mL) was added via syringe, and the reaction was 
cooled to 0 °C in an ice bath.  N,N’-Diisopropylcarbodiimide (6.4 mL, 41.3 mmol) was 
added in one portion via syringe, and the reaction was stirred for 5 min at 0 °C.  The ice 
bath was removed, and the reaction was allowed to warm to 23 °C as it was stirred for 
10.75 h.  A white precipitate formed during this time.  The reaction was filtered through 
filter paper and then diluted with CH2Cl2 (200 mL).  The solution was washed with 0.1 M 
HCl (aq) (200 mL), saturated NaHCO3 (aq) (100 mL), and brine (100 mL).  After drying 
over MgSO4, solvent was removed under reduced pressure.  Flash chromatography over 
silica gel (10 x 5 cm silica, 20% Et2O/pentane eluent) then provided bis(ester) 315 (6.251 
g, 80%) as a colorless oil containing <1% Et2O by mass.  Rf 0.28 (20% Et2O/pentane); 1H 
NMR (300 MHz, acetone-d6) δ 7.53-7.44 (m, 4H), 7.43-7.27 (m, 6H), 5.60-5.55 (m, 2H), 
5.37 (dt, J = 1.2, 1.1 Hz, 2H), 5.02-4.98 (m 4H), 2.28 (t, J = 7.4 Hz, 4H), 1.59-1.47 (m, 
4H), 1.32-1.18 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 173.2, 142.6, 138.0, 128.4, 128.0, 
126.0, 115.2, 65.5, 34.0, 28.4, 24.5; IR (Neat film, NaCl) ν 3084, 3057, 3031, 2938, 
2864, 1736, 1633, 1601, 1575, 1496, 1462, 1445, 1417, 1383, 1320, 1309, 1227, 1167, 
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1083, 1027, 1014, 987, 911, 779, 708 cm–1; HRMS (EI+) m/z calc’d. for C25H28O4 [M]+: 
392.1988, found 392.1998. 
β-ketoester 316.  A flame-dried 100 mL round-bottomed flask equipped with a stir 
bar and a septum was charged with NaH (60% dispersion in mineral oil, 679 mg, 17.0 
mmol) and evacuated under high vacuum.  After refilling with Ar, anhydrous toluene (50 
mL) was added via syringe.  2-Phenylallyl alcohol (314) (182 mg, 1.36 mmol) in 
anhydrous toluene (1 mL) was added via syringe, washing the original flask with 
anhydrous toluene (1 mL).  Bis(ester) 315 (6.079 g, 15.5 mmol) in anhydrous toluene (4 
mL) was added via syringe, washing the original flask with anhydrous toluene (4 mL).  
The reaction was then placed in an oil bath and stirred at 100 °C for 15.7 h.  After cooling 
to 23 °C, saturated  NH4Cl (aq) (50 mL) and 1 M HCl (aq) (25 mL) were added to quench 
the reaction.  The mixture was extracted with Et2O (2 x 50 mL), and the combined 
organic layers were washed with 50% H2O/50% brine (150 mL) and brine (150 mL).  
After drying over MgSO4, solvent was removed under reduced pressure.  Flash 
chromatography over silica gel (10 x 5 cm silica, 10% Et2O/pentane eluent) then 
provided β-ketoester 316 (3.172 g, 78%) as a colorless oil containing 2.2% pentane by 
mass.  A 2.7:1 ratio of enol:ketone tautomer was observed by 1H NMR spectroscopy.  Rf 
0.19-0.60 (10% Et2O/pentane, appears as a streak on TLC plate); 1H NMR (300 MHz, 
CDCl3) δ 12.1 (s, 0.73 H), 7.48-7.40 (m, 2H), 7.40-7.28 (m, 3H), 5.58-5.55 (m, 1H), 
5.41-5.36 (m, 1H), 5.15-5.00 (m 2H), 3.43-3.35 (m, 0.27H), 2.52-1.52 (m, 8H); 13C NMR 
(75 MHz, CDCl3) δ 206.0, 172.6, 172.2, 169.7, 142.5, 142.2, 138.1, 137.8, 128.47, 
128.45, 128.06, 128.03, 126.02, 125.95, 115.7, 114.7, 97.6, 66.3, 65.2, 57.2, 41.4, 29.9, 
29.1, 27.0, 23.2, 22.31, 22.28, 21.8; IR (Neat film, NaCl) ν 3084, 3057, 2938, 2859, 
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1744, 1715, 1655, 1614, 1576, 1496, 1446, 1421, 1396, 1357, 1334, 1294, 1258, 1216, 
1175, 1108, 1080, 1059, 1028, 973, 909, 830, 815, 778, 708 cm–1; HRMS (EI+) m/z 
calc’d. for C16H18O3 [M]+: 258.1256, found 258.1250. 
β-ketoester 317 (Table 3.3, entry 11).  A flame-dried 1 dram screw-cap vial 
equipped with a stir bar and a septum-bearing cap was charged with NaH (60% 
dispersion in mineral oil, 31.7 mg, 0.793 mmol) and evacuated under high vacuum.  After 
refilling with Ar, anhydrous THF (0.4 mL) was added via syringe.  β-Ketoester 316 (200 
mg, 0.774 mmol) in anhydrous THF (0.5 mL) was added dropwise via syringe, washing 
the original flask with anhydrous THF (0.5 mL).  Benzyl bromide (120 µL, 1.01 mmol) 
was then added in one portion via syringe.  The vial cap was wrapped in Teflon tape, and 
the Ar inlet was removed.  The reaction was then placed in an oil bath and stirred at 55 
°C for 5.25 h.  After cooling to 23 °C, saturated NH4Cl (aq) (0.5 mL) and H2O (0.5 mL) 
were added to quench the reaction.  The organic layer was separated, and the aqueous 
layer was extracted with EtOAc (3 x 5 mL).  The combined organic layers were washed 
with 50% H2O/50% brine (15 mL), and brine (15 mL), then dried over MgSO4.  Solvent 
was removed under reduced pressure.  Flash chromatography over silica gel (7 x 2 cm 
silica, 20% Et2O/pentane eluent) then provided β-ketoester 317 (199 mg, 73%) as a thick 
yellow syrup containing <1% Et2O by mass.  Rf 0.45 (20% Et2O/pentane); 1H NMR (300 
MHz, CD3OD) δ 7.42-7.24 (m, 5H), 7.26-7.11 (m, 3H), 7.08-7.01 (m, 2H), 5.53 (d, J = 
1.1 Hz, 1H), 5.32 (ddd, J = 1.1 Hz, 1H), 5.05 (dd, J = 12.8, 1.1 Hz, 1H), 4.90 (dd, J = 
12.9, 0.9 Hz, 1H), 3.18 (d, J = 13.6 Hz, 1H), 2.78 (d, J = 13.6 Hz, 1H), 2.34-1.98 (m, 
3H), 1.91-1.73 (m, 1H), 1.68-1.34 (m, 4H); 13C NMR (75 MHz, CD3OD) δ 208.5, 172.0, 
144.3, 139.3, 137.8, 131.4, 129.6, 129.2, 129.0, 127.7, 127.3, 117.0, 67.6, 63.4, 42.0, 
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41.4, 36.8, 28.6, 23.3; IR (Neat film, NaCl) ν 3086, 3060, 3029, 2941, 2866, 1714, 1634, 
1603, 1575, 1496, 1453, 1442, 1309, 1264, 1248, 1216, 1175, 1133, 1086, 1053, 1030, 
1003, 987, 963, 913, 804, 779, 743, 702 cm–1; HRMS (EI+) m/z calcd. for C23H24O3 [M]+: 
348.1726, found 348.1712. 
 
N
Bn
O
O
O
318  
Allyl 1-benzyl-3-ethyl-4-oxopiperidine-3-carboxylate (318, Table 3.3, entry 12):  
Prepared by general procedure 2 from 1-benzylpiperidin-4-one (part A) and iodoethane 
(part B).  Flash chromatography (SiO2, 2.5→20% EtOAc in hexanes).  55% yield.  Rf = 
0.50 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.33-7.25 (m, 5H), 5.90 
(dddd, J = 17.4, 10.7, 5.7, 5.7 Hz, 1H), 5.33 (dq, J = 17.1, 1.5 Hz, 1H), 5.24 (dq, J = 
10.4, 1.5 Hz, 1H), 4.70 (ddt, J = 13.0, 6.0, 1.4 Hz, 1H), 4.62 (ddt, J = 13.0, 6.0, 1.4 Hz, 
1H), 3.62 (d, J = 13.2 Hz, 1H), 3.56 (d, J = 13.2 Hz, 1H), 3.42 (dd, J = 11.4, 2.7 Hz, 1H), 
3.04-2.80 (m, 2H), 2.45-2.35 (m, 2H), 2.25 (d, J = 11.7 Hz, 1H), 1.94-1.82 (m, 1H), 1.65-
1.53 (m, 1H), 0.87 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.9, 171.3, 137.9, 
131.7, 128.8, 128.2, 127.3, 118.7, 65.6, 61.8, 61.5, 61.0, 53.5, 40.6, 25.2, 9.1; IR (Neat 
Film NaCl) 2966, 2939, 1719, 1224, 1139, 699 cm–1; HRMS (EI) m/z calc'd for C18H23O3 
[M]+:  301.1678, found 301.1691. 
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i-BuO
i-BuOH
p-TsOH•H2O
PhH, reflux
Dean–Stark
(92% yield)
319 320  
Vinylogous Ester 320.63  Diketone 319 (3.000 g, 23.78 mmol, 1.0 equiv) was 
partially dissolved in PhH (42.5 mL, 0.56 M), and i-BuOH (12.75 mL, 137.9 mmol, 5.8 
equiv) and p-TsOH•H2O (226 mg, 1.19 mmol, 0.05 equiv) were added with vigorous 
stirring.  The flask was affixed with a Dean–Stark adapter and a water-cooled condenser 
and warmed to reflux in a 104 °C oil bath.  Upon consumption of 319 by TLC analysis 
(ca. 3.5 h), the reaction was cooled to ambient temperature, diluted with Et2O (50 mL), 
and poured into saturated aq NaHCO3 (20 mL).  The layers were separated and the 
aqueous was extracted with Et2O (3 x 15 mL).  The organics were combined, washed 
with brine, dried with Na2SO4, filtered, and concentrated in vacuo to afford a pale brown 
oil.  To this oil was added PhMe (ca. 10 mL) followed by further concentration in vacuo.  
Purification by bulb-to-bulb distillation yielded vinylogous ester 320 (3.988 g, 21.88 
mmol, 92% yield) as a clear, colorless oil.  Rf = 0.48 (2:1 EtOAc-hexanes); bp =135–140 
°C at 0.8 torr; 1H NMR (300 MHz, CDCl3):  δ 3.76 (d, J = 6.5 Hz, 2H), 2.54 (ddd, J = 
6.1, 1.5, 1.5 Hz, 2H), 2.34 (t, J = 7.1 Hz, 2H), 2.08-1.90 (comp m, 3H), 1.72 (app t, J = 
1.5 Hz, 3H), 0.99 (d, J = 6.7 Hz, 6H).  All other data were consistent with reported 
values. 
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O
i-BuO
O
i-BuO
1. LDA, PhMe, –78 °C
    then ClCO2allyl (208)
    –78 ! 23 °C
2. MeI, Cs2CO3
    MeCN, 80 °C
    
       (55% yield)320 (±)-321
O
O
 
(±)-β-Ketoester 321 (Table 3.3, entry 13).  To a –78 °C solution of i-Pr2NH (425 
 µL, 3.03 mmol, 1.9 equiv) in PhMe (10 mL) was added dropwise n-BuLi (2.55 M in 
hexanes, 1.16 mL, 2.96 mmol, 1.85 equiv).  The reaction vessel was placed in an 
ice/water bath and allowed to stir for 10 min, and then cooled to –78 °C.  A solution of 
vinylogous ester 320 (291 mg, 1.60 mmol, 1.0 equiv) in PhMe (1.4 mL) was added 
dropwise via cannula to the reaction vessel, and the resulting solution was allowed to stir 
for 30 min.  Allyl chloroformate (208, 173 µL, 1.63 mmol, 1.02 equiv) was added 
dropwise, and the reaction vessel was allowed to warm to 23 °C over 1 h.  After stirring 
for 4 h, the reaction was slowly quenched with aq KHSO4 (1 N, 4 mL) and the resulting 
biphasic mixture was allowed to stir for 10 min. The phases were separated, and the aq 
phase was extracted with Et2O (2 x 10 mL). The combined organic extracts were washed 
with brine (10 mL), dried over MgSO4, filtered, and concentrated in vacuo.  The isolated 
crude yellow oil was used in the next step without further purification. 
The resulting crude yellow oil was dissolved in MeCN (5.9 mL, 0.27 M), and Cs2CO3 
(603 mg, 1.85 mmol, 1.16 equiv), and MeI (276 µL, 4.44 mmol, 2.8 equiv) were added.  
The flask was affixed a water-cooled condenser and resulting suspension was warmed to 
reflux in an 80 °C oil bath with vigorous stirring.  After 10 h, the reaction was cooled to 
room temperature, diluted with EtOAc (25 mL).  The organics were dried with MgSO4, 
filtered, and the solvent was evaporated in vacuo.  Purification by flash chromatography 
(15:1 → 9:1 → 4:1 hexanes-EtOAc) afforded β-ketoester (±)-321 as pale yellow oil (246 
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mg, 55% yield over two steps).  Rf = 0.27 (2:1 hexanes-EtOAc); 1H NMR (500 MHz, 
CDCl3): δ 5.82 (dddd, J = 17.2, 10.7, 5.4, 5.4 Hz, 1H), 5.22 (dddd, J = 17.2, 1.6, 1.6, 1.6 
Hz, 1H), 5.15 (dddd, J = 10.5, 1.2, 1.2, 1.2 Hz, 1H), 4.56 (dddd, J = 13.5, 5.4, 1.5, 1.5 
Hz, 2H), 3.72 (ddd, J = 9.2, 6.6, 3.2 Hz, 2H), 2.69-2.62 (m, 1H), 2.53-2.44 (comp m, 
2H), 1.95 (app septuplet, J = 6.6 Hz, 1H), 1.85-1.80 (m, 1H), 1.70 (dd, J = 1.5, 1.5 Hz, 
3H), 1.36 (s, 3H), 0.95 (dd, J = 6.7, 0.8 Hz, 6H); 13C NMR (126 MHz, CDCl3): δ 195.8, 
172.6, 170.3, 131.9, 117.8, 113.8, 73.9, 65.5, 51.6, 31.2, 28.8, 23.0, 20.8, 19.1, 19.0, 8.0; 
IR (Neat Film NaCl) 2961, 2935, 2875, 1733, 1649, 1618, 1460, 1382, 1354, 1237, 1176, 
1103, 983 cm–1; HRMS (FAB+) m/z: calc’d for C16H25O4 [M + H]+: 281.1753, found 
281.1740. 
 
O
O
1. MsCl, Et3N
    CH3CN
    0 ! 23 °C
2. PhSH, Et3N
    0 ! 23 °C
O
PhS
319 322(82% yield)  
Vinylogous Thioester 322.64 To a solution of diketone 319 (5.00 g, 39.82 mmol, 1.00 
equiv) in CH3CN (44 mL) was added Et3N (6.2 mL, 44.40 mmol, 1.12 equiv), and the 
solution was allowed to stir for 5 min, then cooled to 0 °C.  Methanesulfonyl chloride 
(3.26 mL, 42.00 mmol, 1.06 equiv) was added, and the reaction was warmed to 23 °C 
over 2 h.  Stirring was continued for 5 h, and the reaction was cooled to 0 °C.  
Triethylamine (6.2 mL, 44.40 mmol, 1.12 equiv) was added, followed by benzenethiol 
(4.2 mL, 40.80 mmol, 1.03 equiv).  The reaction was allowed to warm to 23 °C over 2 h 
and stirring was continued for 9 h.  Saturated aq Na2CO3 (70 mL) was added, the phases 
were separated, and the aq phase was extracted with Et2O (3 x 120 mL).  The combined 
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organic extracts were dried over Na2SO4, filtered, and the solvent was evaporated in 
vacuo.  Purification by flash chromatography (18% EtOAc in hexanes) afforded 
vinylogous thioester 322 (7.15 g, 82% yield) as a white crystalline solid.  Rf = 0.33 (20% 
EtOAc in hexanes); mp 85 °C; 1H NMR (500 MHz, CDCl3) δ 7.51-7.49 (m, 2H), 7.44-
7.37 (comp m, 3H), 2.38 (t, J = 6.5 Hz, 2H), 2.18 (tq, J = 6.5, 2.0 Hz, 2H), 1.97 (t, J = 2.0 
Hz, 3H), 1.87 (app pentuplet, J = 6.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 195.6, 
157.9, 130.3(2C), 129.6, 129.5, 37.3, 30.5, 22.9, 12.4; IR (Neat Film NaCl) 2944, 1655, 
1578, 1339, 1296 cm–1; HRMS (FAB+) m/z: calc’d for C13H14OS [M + H]+: 219.0844, 
found 219.0843. 
 
O
PhS
322
1. LDA, PhMe, –78 °C
2. MeI, Cs2CO3
    CH3CN, 80 °C
(78% yield, two steps)
Cl
O
O
O
PhS
(±)-323
O
O
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β-Ketoester 323 (Table 3.3, entry 14).65  To a –78 °C solution of diisopropylamine 
(2.63 mL, 18.78 mmol, 2.00 equiv) in toluene (70 mL) was added dropwise n-BuLi (2.53 
M in hexanes, 7.24 mL, 2.00 equiv).  The reaction vessel was warmed to 0 °C, allowed to 
stir for 10 min, and cooled to –78 °C.  A solution of thioester 322 (2.00 g, 9.16 mmol, 
1.00 equiv) in toluene (15 mL) was added dropwise via cannula to the reaction vessel, 
and the resulting solution was allowed to stir for 30 min.  Allyl chloroformate (1.02 mL, 
9.62 mmol, 1.05 equiv) was added dropwise, and the reaction vessel was allowed to 
warm to 23 °C over 1 h.  Stirring was continued for 4 h, then aq KHSO4 (1 N, 70 ml) was 
added, and the resulting solution was allowed to stir for 10 min.  The phases were 
separated, and the aq phase was extracted with Et2O (3 x 30 mL).  The combined organic 
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extracts were washed with brine (1 x 30 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo.  The isolated crude yellow oil was used in the next step without 
further purification. 
To a solution of the crude yellow oil (3.32 g) in CH3CN (40 mL) was added cesium 
carbonate (4.48 g, 13.74 mmol, 1.50 equiv), and iodomethane (1.71 mL, 27.48 mmol, 
3.00 equiv).  The resulting suspension was refluxed at 80 °C for 5 h, and then MeI (1.00 
mL, 16.06 mmol, 1.75 equiv) was added.  The reaction was refluxed at 80 °C for 2 h, 
cooled to room temperature, filtered through Celite (EtOAc eluent), dried over Na2SO4, 
filtered, and the solvent was evaporated in vacuo.  Purification by flash chromatography 
(18% EtOAc in hexanes) afforded β-ketoester (±)-323 (2.26 g, 78% yield over two steps) 
as white solid.  Rf = 0.35 (30% EtOAc in hexanes); mp 34 °C; 1H NMR (300 MHz, 
CDCl3) δ 7.51-7.35 (comp m, 5H), 5.87 (app ddt, J = 10.5, 17.1, 5.4 Hz, 1H), 5.27 (app 
ddt, J = 17.1, 1.7, 1.8 Hz, 1H), 5.22 (app ddt, J = 9.9, 1.7, 1.2 Hz, 1H), 4.65 (dddd, J = 
1.5, 1.8, 5.7, 13.5 Hz, 1H), 4.55 (dddd, J = 1.5, 1.8, 5.7, 13.5 Hz, 1H), 2.41-2.32 (m, 1H), 
2.30-2.21 (m, 1H), 2.16-2.06 (1H), 2.00 (t, J = 1.8 Hz, 3H), 1.78 (ddd, J = 4.5, 8.1, 13.2 
Hz, 1H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 193.0, 172.6, 156.7, 135.6, 131.9, 
129.7, 129.5, 128.9, 118.1, 65.7, 52.3, 33.1, 27.4, 20.7, 12.9; IR (Neat Film NaCl) 2936, 
1733, 1656, 1580, 1314, 1254, 1238, 1174, 985, 752, 693 cm–1; HRMS (FAB+) m/z: 
calc’d for C18H20O3S [M + H]+: 317.1211, found 317.1211. 
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Allyl 1,3-dimethyl-2-oxocyclohexanecarboxylate (325): To a cooled (–78 °C) 
solution of LDA (8.0 mmol, 1.09 equiv) in THF (24 mL) was added 2,6-
dimethylcyclohexanone (324, 1 mL, 7.33 mmol, 1.0 equiv) dropwise.  The resulting 
solution was warmed to 0 °C for 1 h, cooled to –78 °C and HMPA (1.3 mL, 7.47 mmol, 
1.02 equiv) was added.  After 15 min, allyl cyanoformate (246)57 (845.3 mg, 7.61 mmol, 
1.04 equiv) was added dropwise.  The reaction was warmed to ambient temperature for 
30 min and then quenched with 50% saturated aq NH4Cl.  The aq layer was separated and 
extracted with EtOAc (3 x 20 mL).  The combined organic extracts were washed with 
brine, dried (Na2SO4), filtered, and concentrated in vacuo.  The resulting oil was purified 
by flash chromatography (3 x 20 cm, SiO2, 4% Et2O in hexanes, then 8% Et2O in 
hexanes) to afford β-ketoester 325 as a colorless oil (629.1 mg, 41%), along with the 
corresponding enol carbonate as a colorless oil (187.1 mg, 12%); Rf = 0.43 (10:1 
hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.86 (dddd, J = 6.0, 6.0, 10.5, 17.4 Hz, 
1H), 5.28 (dddd, J = 1.5, 1.5, 1.5, 17.1 Hz, 1H), 5.22 (dddd, J = 1.2, 1.2, 1.2, 10.5 Hz, 
1H), 4.63 (dddd, J = 1.2, 1.2, 5.4, 13.2 Hz, 1H), 4.56 (dddd, J = 1.5, 1.5, 5.7, 13.2 Hz, 
1H), 2.61-2.46 (m, 2H), 2.01 (dddd, J = 3.2, 3.2, 6.3, 16.2 Hz, 1H), 1.85-1.63 (m, 2H), 
1.45-1.31 (m, 2H), 1.28 (s, 3H), 1.03 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
209.1, 172.9, 131.5, 118.7, 65.6, 57.1, 44.3, 38.9, 36.7, 22.8, 21.5, 14.7; IR (Neat Film 
NaCl) 3087, 2936, 1743, 1715, 1649, 1452, 1377, 1253, 1214, 1161, 976 cm–1; HRMS 
(EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1249. 
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Allyl 2-(allyloxycarbonyloxy)-1,3-dimethylcyclohex-2-enecarboxylate (271, 
Scheme 3.7a):  To a suspension of KH (155.9 mg, 3.89 mmol, 1.2 equiv, from a ~30% 
dispersion in mineral oil, oil removed by washing with hexane) in 10 mL THF was added 
325 (680.9 mg, 3.24 mmol, 1 equiv) dropwise.  The mixture was stirred at room 
temperature for 2.5 h, at which time it was cooled to –78 °C.  Allyl chloroformate (208, 
420 µL, 3.95 mmol, 1.2 equiv) was added and the mixture stirred 30 min at –78 °C, then 
30 min at room temperature.  The reaction was quenched with 50% saturated aq NH4Cl 
(10 mL).  Et2O (5 mL) was added and the organic layer separated.  The aqueous layer 
was extracted with Et2O (3 x 10 mL). The combined organic layers were dried (Na2SO4) 
and evaporated in vacuo.  Silica gel chromatography (2 x 16 cm, 20:1 hexanes:EtOAc) 
afforded the title compound 271 as a colorless oil (883 mg, 93% yield).  Rf = 0.29 (10:1 
Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.94 (dddd, J = 5.7, 5.7, 10.2, 17.1 Hz, 
1H), 5.90 (dddd, J = 5.7, 5.7, 10.5, 17.1 Hz, 1H), 5.37 (dddd, J = 1.2, 1.2, 1.2, 17.1 Hz, 
1H), 5.31 (dddd, J = 1.2, 1.2, 1.2, 17.1 Hz, 1H), 5.27 (dddd, J = 1.2, 1.2, 1.2, 10.2 Hz, 
1H), 5.20 (dddd, J = 1.5, 1.5, 1.5, 10.5 Hz, 1H), 4.66-4.58 (m. 3H), 4.55 (dddd, J = 1.2, 
1.2, 5.4, 13.5 Hz, 1H), 2.25-2.10 (m, 3H), 1.80-1.52 (m, 3H), 1.58 (s, 3H), 1.35 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 174.6, 152.9, 142.0, 132.2, 131.5, 124.7, 118.9, 117.7, 
68.7, 65.5, 46.7, 35.8, 30.6, 22.4, 19.2, 17.0; IR (Neat Film NaCl) 3087, 2942, 1760, 
1732, 1649, 1452, 1366, 1235, 1168, 992 cm–1; HRMS (EI) m/z calc'd for C16H22O5 [M]+: 
294.1467, found 294.1464. 
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O
O
O
273
O
O
 
Diallyl 1,3-dimethyl-2-oxocyclohexane-1,3-dicarboxylate (273, Scheme 3.7b): 
Prepared by general procedure 2 using (±)-107.  First diastereomer: 1H NMR (500 MHz, 
CDCl3) δ 5.88 (dddd, J = 5.7, 5.7, 10.4, 17.0 Hz, 2H), 5.30 (dddd, J = 1.4, 1.4, 3.1, 17.0 
Hz, 2H), 5.23 (dddd, J = 1.4, 1.4, 2.7, 10.4 Hz, 2H), 4.65 (dddd, J = 1.4, 1.4, 5.6, 13.4 
Hz, 2H), 4.44 (dddd, J = 1.4, 1.4, 5.6, 13.4 Hz, 2H), 2.55-2.50 (m, 2H), 2.23 (dtt, J = 4.1, 
12.3, 14.5 Hz, 1H), 1.67 (dtt, J = 4.4, 4.4, 14.5 Hz, 1H), 1.54–1.47 (m, 2H), 1.39 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 203.9, 171.7, 131.9, 118.4, 66.1, 57.1, 37.3, 23.6, 19.6; IR 
(Neat Film NaCl) 3086, 2937, 1726, 1710, 1648, 1456, 1378, 1240, 1183, 1149, 975 cm–
1; HRMS (EI) m/z calc'd for C16H22O5 [M + H]+: 295.1540, found 295.1538.  Second 
diastereomer: 1H NMR (500 MHz, CDCl3) δ 5.90 (dddd, J = 6.1, 6.1, 10.4, 17.1 Hz, 2H), 
5.32 (dddd, J = 1.6, 1.6, 1.6, 17.1 Hz, 2H), 5.24 (dddd, J = 1.3, 1.3, 1.3, 10.4 Hz, 2H), 
4.63-4.60 (comp. m, 4H), 2.44 (ddd, J = 6.0, 6.0, 13.0 Hz, 2H), 1.82 (dtt, J = 6.8, 6.8, 0.5 
Hz, 2H), 1.85–1.80  (m, 2 H), 1.73–1.67 (m, 2H), 1.36 (s, 6H); 13C NMR (125 MHz, 
CDCl3) δ 206.1, 172.4, 131.7, 118.9, 66.1, 56.9, 35.3, 22.3, 17.9; IR (Neat Film NaCl) 
2984, 2940, 2877, 1734, 1709, 1647, 1458, 1378, 1234, 1150, 1119, 9780 cm–1; HRMS 
(EI) m/z calc'd for C16H22O5 [M + H]+: 295.1540, found 295.1535. 
 
O
O
O
326  
Allyl 1-ethyl-2-oxocyclopentanecarboxylate (326, Table 3.4, entry 1):  Prepared by 
general procedure 2 part B from allyl 2-cyclopentanonecarboxylate66 and using ethyl 
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iodide as the electrophile.  Flash chromatography (3 x 25 cm SiO2, 10% Et2O in hexanes) 
afforded the title compound as a colorless oil (1.5335 g, 85% yield). Rf = 0.27 (10:1 
hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.88 (dddd, J = 5.7, 5.7, 10.5, 17.4 Hz, 
1H), 5.30 (dddd, J = 1.6, 1.6, 1.6, 17.1 Hz, 1H), 5.23 (dddd, J = 1.4, 1.4, 1.4, 10.5 Hz, 
1H), 4.60 (dddd, J = 1.4, 1.4, 1.4, 5.7 Hz, 2H), 2.57-2.36 (m, 2H), 2.31-2.19 (m, 1H), 
2.08-1.86 (m, 4H), 1.64 (dddd, J = 7.5, 7.5, 7.5, 21 Hz, 1H), 0.89 (dd, J = 7.2, 7.2 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 214.6, 170.6, 131.5, 118.1, 65.5, 60.7, 37.9, 32.0, 
26.6, 19.4, 9.0; IR (Neat Film NaCl) 3085, 2971, 1752, 1726, 1225, 1142 cm–1; HRMS 
(EI) m/z calc'd for C11H16O3 [M]+: 196.1100, found 196.1099. 
 
O
i-Pr
CO2allyl
327  
Allyl 1-isopropyl-2-oxocyclopentanecarboxylate (327, Table 3.4, entry 2):  
Prepared by general procedure 2 part B from allyl 2-cyclopentanonecarboxylate66 and 
using 2-iodopropane as the electrophile.  Flash chromatography (3 x 25 cm SiO2, 
10%→30% Et2O in hexane) afforded the title compound as a colorless oil (1.5521 g, 82% 
yield).  Rf = 0.32 (10:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.88 (dddd, J = 
5.7, 5.7, 10.5, 17.1 Hz, 1H), 5.30 (dddd, J = 1.6, 1.6, 1.6, 17.4 Hz, 1H), 5.22 (dddd, J = 
1.4, 1.4, 1.4, 10.5 Hz, 1H), 4.59 (dddd, J = 1.4, 1.4, 1.4, 5.7 Hz, 2H), 2.59 (qq, J = 6.9, 
6.9 Hz, 1H), 2.51-2.34 (m, 2H), 2.19-2.06 (m, 1H), 1.99-1.83 (m, 3H), 0.87 (d, J = 6.9 
Hz, 3H), 0.83 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 214.4, 169.8, 131.5, 
118.3, 65.6, 65.3, 38.9, 31.9, 27.2, 19.5, 18.3, 17.6; IR (Neat Film NaCl) 3085, 2967, 
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1752, 1723, 1228, 1130 cm–1; HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 
210.1255. 
 
O
CO2allyl
NPhth
328  
Allyl 1-((1,3-dioxoisoindolin-2-yl)methyl)-2-oxocyclopentanecarboxylate (328, 
Table 3.4, entry 3):  Prepared by general procedure 2 part B from allyl 2-
cyclopentanonecarboxylate66 and using (N-chloromethyl)phthalimide as the electrophile.  
Purified by flash chromatography (SiO2, 20 → 30% EtOAc in hexanes).  54% yield.  mp 
56-57 °C; Rf = 0.27 (30% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 7.84 (dd, J = 
5.6, 3.2 Hz, 2H), 7.73 (dd, J = 5.6, 3.2 Hz, 2H), 5.92 (dddd, J = 17.0, 10.6, 5.9, 5.9 Hz, 
1H), 5.32 (app. ddd, J = 17.0, 2.9, 1.6 Hz, 1H), 5.23 (app. ddd, J = 10.6, 2.7, 1.3 Hz, 1H), 
4.65 (app. ddt, J = 5.9, 4.5, 1.3 Hz, 2H), 4.34 (d, J = 14.4 Hz, 1H), 3.99 (d, J = 14.4 Hz, 
1H), 2.59-2.47 (m, 1H), 2.46-2.25 (comp. m, 2H), 2.11-1.84 (comp. m, 3H); 13C NMR 
(75 MHz, CDCl3) δ 212.0, 169.0, 168.3, 134.3, 131.9, 131.6, 123.7, 118.8, 66.8, 60.5, 
41.0, 37.7, 32.1, 19.5; IR (Neat Film NaCl) 2953, 1774, 1752, 1718, 1467, 1457, 1428, 
1395, 1359, 1256, 1231, 1170, 991, 722 cm–1; HRMS (EI) m/z calc'd for C18H17O5N [M]+: 
327.1107, found 327.1106. 
 
O
O
O
329  
Allyl 2-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (329, Table 3.4, entry 
4):  Prepared by general procedure 2 from 1-indanone and using methyl iodide as the 
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electrophile.  Purified by flash chromatography (SiO2, 10% Et2O in pentane).  30% yield.  
Rf = 0.55 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.79 (d, J = 7.7 Hz, 1H), 
7.63 (dd, J = 7.6, 7.3 Hz, 1H), 7.48 (d, J = 7.7 Hz, 1H), 7.41 (dd, J = 7.6, 7.3 Hz, 1H), 
5.83 (dddd, J = 17.2, 10.6, 5.6, 5.6 Hz, 1H), 5.21 (dddd, J = 17.2, 2.7, 1.6, 1.1 Hz, 1H), 
5.16 (dddd, J = 10.5, 2.4, 1.3, 1.3 Hz, 1H), 4.58 (ddd, J = 5.6, 2.7, 1.1 Hz, 1H), 4.58 (ddd, 
J = 5.6, 2.7, 1.1 Hz, 1H), 3.73 (d, J = 17.1 Hz, 1H), 3.01 (d, J = 17.1 Hz, 1H), 1.54 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 203.5, 171.8, 152.7, 135.5, 134.9, 131.7, 128.0, 126.6, 
125.2, 118.3, 66.0, 56.2, 40.2, 21.2; IR (Neat Film NaCl) 3080, 2982, 2935, 1745, 1715, 
1608, 1495, 1282, 1184, 967, 747 cm–1; HRMS (EI) m/z calc'd for C14H14O3 [M]+: 
230.0943, found 230.0936. 
 
O
CO2allyl
330  
Allyl 2-benzyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (330, Table 3.4, entry 
5):  Prepared by general procedure 2 from 1-indanone and using benzyl bromide as the 
electrophile.  Purified by flash chromatography (SiO2, 20% Et2O in pentane).  78% yield.  
mp 49-50 °C; Rf = 0.18 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 
8.1 Hz, 1H), 7.53 (dd, J = 8.0, 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.33 (dd, J = 7.7, 7.7 
Hz, 1H), 7.23-7.06 (comp. m, 5H), 5.84 (dddd, J = 17.3, 10.4, 5.6, 5.3 Hz, 1H), 5.22 
(app. ddd, J = 17.3,, 2.9, 1.6 Hz, 1H), 5.18 (dddd, J = 10.4, 2.4, 1.3, 1.1 Hz, 1H), 4.65-
4.57 (m, 2H), 3.63 (d, J = 17.6 Hz, 1H), 3.50 (d, J = 13.8 Hz, 1H), 3.31 (d, J = 14.1 Hz, 
1H), 3.18 (d, J = 17.3 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 202.2, 170.6, 153.3, 136.4, 
135.5, 135.3, 131.6, 130.2, 128.4, 127.8, 127.0, 126.4, 124.8, 118.5, 66.3, 61.9, 39.8, 
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35.5; IR (Neat Film NaCl) 3031, 2929, 1744, 1711, 1606, 1589, 1496, 1464, 1454, 1432, 
1277, 1244, 1210, 1178, 1051, 1028, 930, 752, 703 cm–1; HRMS (EI) m/z calc'd for 
C20H18O3 [M]+: 306.1256, found 306.1259. 
 
O
CO2allyl
OMe
331  
Allyl 1-(4-methoxybenzyl)-2-oxocyclopentanecarboxylate (331, Table 3.4, entry 
6):  Prepared by general procedure 2 part B from allyl 2-cyclopentanonecarboxylate66 and 
using 4-methoxybenzyl chloride as the electrophile.  Flash chromatography (3 x 25 cm 
SiO2, 10:1 hexanes:EtOAc) afforded the title compound as a colorless oil (2.5584 g, 95% 
yield). Rf = 0.17 (10:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.05 (d, J = 8.7 Hz, 
2H), 6.79 (d, J = 8.7 Hz, 2H), 5.87 (dddd, J = 5.7, 5.7, 10.8, 17.1 Hz, 1H), 5.31 (dddd, J 
= 1.5, 1.5, 1.5, 17.1 Hz, 1H), 5.24 (dddd, J = 1.2, 1.2, 1.2, 10.5 Hz, 1H), 4.61 (dddd, J = 
1.4, 1.4, 1.4, 5.7 Hz, 2H), 3.77 (s, 3H), 3.15 (d, J = 13.8 Hz, 1H), 3.09 (d, J = 13.8 Hz, 
1H), 2.45-2.31 (m, 2H), 2.08-1.81 (m, 3H), 1.67-1.53 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ 214.7, 170.5, 158.3, 131.5, 131.0, 128.2, 118.3, 113.6, 65.8, 61.4, 55.0, 38.3, 
38.0, 31.5, 19.3; IR (Neat Film NaCl) 2958, 1751, 1726, 1611, 1513, 1249 cm–1; HRMS 
(EI) m/z calc'd for C17H20O4 [M]+: 288.1362, found 288.1369. 
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O
CO2allyl
332  
Allyl 1-(4-methylbenzyl)-2-oxocyclopentanecarboxylate (332, Table 3.4, entry 7):  
Prepared by general procedure 2 part B from allyl 2-cyclopentanonecarboxylate66 and 
using 4-methylbenzyl bromide as the electrophile.  Purified by flash chromatography 
(SiO2, 10% Et2O in pentane).  89% yield.  Rf = 0.20 (10% Et2O in pentane); 1H NMR 
(300 MHz, CDCl3) δ 7.06 (d, J = 8.0 Hz, 2H), 7.01 (d, J = 8.3 Hz, 2H), 5.89 (dddd, J = 
17.3, 10.5, 5.5, 5.5 Hz, 1H), 5.31 (app. ddd, J = 17.3, 3.0, 1.7 Hz, 1H), 5.24 (app. ddd, J 
= 10.5, 2.4, 1.1 Hz, 1H), 4.61 (app. ddd, J = 6.9, 2.8, 1.4 Hz, 1H), 4.61 (app. ddd, J = 6.9, 
2.8, 1.4 Hz, 1H), 3.17 (d, J = 13.8 Hz, 1H), 3.10 (d, J = 13.8 Hz, 1H), 2.52-2.32 (m, 2H), 
2.30 (s, 3H), 2.12-1.81 (comp. m, 3H), 1.68-1.52 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 
215.1, 170.9, 136.6, 133.5, 131.7, 130.2, 129.2, 118.7, 66.1, 61.6, 38.7, 38.6, 31.8, 21.2, 
19.6; IR (Neat Film NaCl) 2963, 2925, 1752, 1724, 1652, 1515, 1456, 1404, 1264, 1220, 
1184, 1158, 1141, 1116, 992, 924, 813 cm–1; HRMS (EI) m/z calc'd for C17H20O3 [M]+: 
272.1412, found 272.1412. 
 
O
CO2allyl
CF3
333  
Allyl 2-oxo-1-(4-(trifluoromethyl)benzyl)cyclopentanecarboxylate (333, Table 
3.4, entry 8):  Prepared by general procedure 2 part B from allyl 2-
cyclopentanonecarboxylate66 and using 4-(trifluoromethyl)benzyl bromide as the 
electrophile. Purified by flash chromatography (SiO2, 10:1 hexanes:EtOAc) to afford the 
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title compound as a colorless oil (1.9312 g, 65% yield).  Rf = 0.24 (10:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3) δ 7.51 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 7.8 Hz, 2H), 5.87 
(dddd, J = 6.0, 6.0, 10.5, 17.4 Hz, 1H), 5.30 (dddd, J = 1.7, 1.7, 1.7, 17.4 Hz, 1H), 5.25 
(dddd, J = 1.1, 1.1, 1.1, 10.5 Hz, 1H), 4.61 (bd, J = 6 Hz, 2H), 3.29 (d, J = 13.5 Hz, 1H), 
3.15 (d, J = 13.5 Hz, 1H), 2.50-2.33 (m, 2H), 2.13-1.86 (m, 3H), 1.73-1.62 (m, 1H); 13C 
NMR (75 MHz, CDCl3) δ 214.1, 170.3, 140.7, 131.3, 130.6, 142.0, 133.1, 130.6, 129.2 
(q, JC-F = 32.2 Hz), 125.3 (q, JC-F = 3.8 Hz), 124.1 (q, JC-F = 271.5 Hz), 118.8, 66.2, 61.3, 
38.6, 38.1, 31,8, 19.4; 19F NMR (282 MHz, CDCl3) δ –62.54; IR (Neat Film NaCl) 3080, 
2966, 1754, 1728, 1619, 1326, 1164, 1116, 1068 cm–1; HRMS (EI) m/z calc'd for 
C17H17O3F3 [M]+: 326.1130, found 326.1129. 
 
3.6.3 ENANTIOSELECTIVE ALKYLATIONS 
3.6.3.1 GENERAL PROCEDURE FOR ENANTIOSELECTIVE 
DECARBOXYLATIVE ALKYLATION 
O
O
O Pd2(dba)3 (2.5 mol%)
(S)-t-BuPHOX (6.25 mol%)
THF, 25 °C
(±)-107
O
(S)-106  
A 100 mL round-bottom flask was equipped with a magnetic stir bar and flame dried 
under vacuum.  After cooling under dry nitrogen, Pd2(dba)3 (22.9 mg, 0.025 mmol, 0.025 
equiv) and (S)-t-Bu-PHOX (55, 24.2 mg, 0.0625 mmol, 0.0625 equiv) were added.  The 
flask containing the solids was evacuated for 15 min and then refilled with dry nitrogen.  
Dry THF (30 mL) was then added and the resulting solution stirred at 25 ºC for 30 min.  
At this point, allyl 1-methyl-2-oxocyclohexanecarboxylate ((±)-107) was added via 
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syringe in one portion.  When the reaction was complete by TLC (7.5 h), the reaction 
mixture was evaporated under reduced pressure and the residue purified by column 
chromatography (SiO2, 1.5 → 2.5% Et2O in pentane) to afford ketone (S)-106 (129.6 mg, 
85% yield, 88% ee). 
 
3.6.3.2 CHARACTERIZATION DATA FOR KETONE PRODUCTS 
Absolute configuration is noted for product compounds where the configuration has 
been established (crystallographically or by comparison with literature data, see 
preceding publication).  All other configurations shown are inferred by analogy. 
 
O CO2t-Bu
235  
tert-Butyl 2-(1-allyl-4-methyl-2-oxocyclohex-3-enyl)ethanoate (235, Scheme 3.3):  
Reaction time: from β-ketoester, 9 h, performed in Et2O at 30 ºC.  Flash chromatography 
(SiO2, 3% Et2O in pentane).  73% yield.  Rf = 0.45 (30% Et2O in pentane); 1H NMR (300 
MHz, CDCl3) δ 5.84 (s, 1H), 5.70 (dddd, J = 16.8, 10.2, 7.3, 7.3 Hz, 1H), 5.12-5.11 (m, 
2H), 2.71 (d, J = 15.6 Hz, 1H), 2.48-2.13 (comp. m, 6H), 1.93 (s, 3H), 1.91-1.81 (m, 1H), 
1.40 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 201.0, 170.8, 160.3, 133.3, 125.4, 118.7, 80.5, 
45.4, 40.5, 39.0, 29.8, 28.1, 27.8, 24.1; IR (Neat Film NaCl) 2978, 1728, 1670, 1367, 
1213, 1152 cm–1; HRMS (EI) m/z calc'd for C16H25O3 [M + H]+: 265.1804, found 
265.1803; [α]D25.4 –39.22 (c 1.05, CH2Cl2, 86% ee). 
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O
249  
2-Allyl-2-(3-methylbut-2-enyl)cyclohexanone (249, Table 3.2, entry 3):  Reaction 
time: from β-ketoester, 6 h, performed in Et2O at 30 ºC.  Flash chromatography (SiO2, 1.5 
→ 2.5% Et2O in pentane).  97% yield.  Rf = 0.38 (10% Et2O in pentane); 1H NMR (300 
MHz, CDCl3) δ 5.67 (dddd, J = 16.5, 10.6, 7.2, 7.2 Hz, 1H), 5.07-4.93 (comp. m, 3H), 
2.44-2.24 (comp. m, 5H), 2.16 (dd, J = 14.6, 7.2 Hz, 1H), 1.89-1.64 (comp. m, 9H), 1.60 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 214.7, 134.2, 134.1, 119.0, 117.7, 52.1, 39.4, 39.3, 
35.9, 33.3, 27.1, 26.0, 20.9, 18.0; IR (Neat Film NaCl) 3075, 2934, 2863, 1706, 1446, 
1124, 914 cm–1; HRMS (FAB) m/z calc'd for C14H23O [M + H]+: 207.1749, found 
207.1744; [α]D26.0 +1.95 (c 1.29, CH2Cl2, 91% ee). 
 
O
N
251  
3-(1-Allyl-2-oxocyclohexyl)propanenitrile (251, Table 3.2, entry 4):  Reaction 
time: from β-ketoester, 6.5 h, performed in Et2O.  Flash chromatography (SiO2, 25% Et2O 
in pentane).  97% yield.  Rf = 0.32 (CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 5.60 (dddd, J 
= 16.7, 10.4, 7.4, 7.4 Hz, 1H), 5.17-5.07 (m, 2H), 2.53-2.16 (comp. m, 6H), 2.03-1.62 
(comp. m, 8H); 13C NMR (75 MHz, CDCl3) δ 213.2, 131.9, 120.0, 119.3, 50.8, 39.0, 38.9, 
35.4, 30.6, 26.9, 20.5, 12.1; IR (Neat Film NaCl) 3081, 2939, 2863, 2246, 1702, 1453, 
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1126, 921 cm–1; HRMS (EI) m/z calc'd for C12H17NO [M]+: 191.1310, found 191.1307; 
[α]D25.6 –27.00 (c 1.56, CH2Cl2, 88% ee). 
 
O
OEtO
253  
Ethyl 3-(1-allyl-2-oxocyclohexyl)propanoate (253, Table 3.2, entry 5): Reaction 
time: from β-ketoester, 6 h, performed in Et2O.  Flash chromatography (SiO2, 5 → 14% 
Et2O in pentane).  96% yield.  Rf = 0.44 (30% Et2O in pentane); 1H NMR (300 MHz, 
CDCl3) δ 5.66 (dddd, J = 16.2, 10.9, 7.7, 7.2 Hz, 1H), 5.11-5.07 (m, 1H), 5.07-5.02 (m, 
1H), 4.11 (app. q, J = 7.1 Hz, 2H), 2.48-2.18 (comp. m, 5H), 2.16-1.94 (comp. m, 2H), 
1.90-1.65 (comp. m, 7H), 1.24 (app. t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
214.2, 173.5, 133.3, 118.3, 60.4, 50.8, 39.1, 39.0, 36.2, 29.7, 28.8, 27.0, 20.7, 14.2; IR 
(Neat Film NaCl) 3076, 2937, 2866, 1735, 1704, 1454, 1377, 1309, 1181, 917 cm–1; 
HRMS (EI) m/z calc'd for C14H22O3 [M]+: 238.1569, found 238.1574; [α]D25.8 +9.60 (c 
1.13, CH2Cl2, 90% ee). 
 
O
153  
2-Allyl-2-benzylcyclohexanone (153, Table 3.2, entry 6):  Reaction time: from allyl 
enol carbonate, 2 h; from β-ketoester, 0.5 h.  1H NMR (300 MHz, CDCl3) δ 7.24 (comp. 
m, 3H), 7.12 (comp. m, 2H), 5.74 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H), 5.12-5.03 (m, 2H), 
2.91 (s, 2H), 2.46 (m, 2H), 2.28 (d, J = 7.2 Hz, 2H), 1.86-1.65 (comp. m, 6H); 13C NMR 
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(75 MHz, CDCl3) δ 214.1, 137.5, 133.7, 130.6, 127.9, 126.3, 118.2, 52.5, 40.8, 39.6, 
39.2, 35.5, 26.8, 20.8; IR (Neat Film NaCl) 2937, 1704, 1638, 1602 cm–1; HRMS (EI) 
m/z calc'd for C16H20O [M]+: 228.1514, found 228.1514; [α]D28 –12.34 (c 2.07, hexane, 
85% ee). 
 
O
OMe
255  
2-Allyl-2-(4-methoxybenzyl)cyclohexanone (255, Table 3.2, entry 7):  Reaction 
time: from β-ketoester, 10 h.  Flash chromatography (SiO2, 3% Et2O in pentane).  80% 
yield.  Rf = 0.54 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.02 (d, J = 9.0 
Hz, 2H), 6.79 (d, J = 8.4 Hz, 2H), 5.72 (dddd, J = 17.1, 9.8, 7.0, 7.0 Hz, 1H), 5.12-4.98 
(m, 2H), 3.78 (s, 3H), 2.84 (s, 2H), 2.53-2.34 (m, 2H), 2.33-2.17 (m, 2H), 1.91-1.70 
(comp. m, 4H), 1.70-1.61 (comp. m, 2H); 13C NMR (75 MHz, CDCl3) δ 214.3, 158.1, 
133.9, 131.5, 129.5, 118.1, 113.4, 55.2, 52.6, 40.1, 39.6, 39.3, 35.4, 26.8, 20.8; IR (Neat 
Film NaCl) 3076, 2935, 2863, 2361, 1702, 1611, 1513, 1456, 1249, 1179, 1036, 834 cm–
1; HRMS (EI) m/z calc'd for C17H22O2 [M]+: 258.1620, found 258.1627; [α]D25.9 +3.60 (c 
1.05, CH2Cl2, 86% ee). 
 
O
CF3
257  
2-Allyl-2-(4-(trifluoromethyl)benzyl)cyclohexanone (257, Table 3.2, entry 8):  
Reaction time: from β-ketoester, 0.5 h.  Flash chromatography (SiO2, 8 → 14% Et2O in 
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pentane).  99% yield.  Rf = 0.85 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) 
δ 7.50 (d, J = 7.7 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 5.71 (dddd, J = 17.0, 10.1, 7.4, 6.9 
Hz, 1H), 5.17-5.04 (m, 2H), 3.01 (d, J = 13.8 Hz, 1H), 2.88 (d, J = 13.8 Hz, 1H), 2.50-
2.31 (comp. m, 3H), 2.29-2.17 (m, 1H), 1.97-1.82 (m, 1H), 1.82-1.69 (comp. m, 3H), 
1.70-1.59 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 213.3, 142.0 (q, JCF = 1.2 Hz), 133.0, 
130.9, 128.4 (q, JCF = 32.3 Hz), 124.7 (q, JCF = 3.9 Hz), 124.2 (q, JCF = 271.7 Hz), 118.5, 
52.5, 40.4, 39.3, 39.3, 35.5, 26.6, 20.6; 19F NMR (282 MHz, CDCl3) δ –62.9; IR (Neat 
Film NaCl) 3076, 2940, 2867, 1705, 1618, 1418, 1326, 1164, 1123, 1068, 852 cm–1; 
HRMS (EI) m/z calc'd for C17H19 F3O [M]+: 296.1388, found 296.1402; [α]D26.6 –16.31 (c 
1.17, CH2Cl2, 82% ee). 
 
O OTBDPS
259  
2-Allyl-2-((tert-butyldiphenylsilyloxy)methyl)cyclohexanone (259, Table 3.2, 
entry 9):  Reaction time: from β-ketoester, 5 h.  Flash chromatography (SiO2, 1 → 2.5% 
EtOAc in hexanes).  92% yield.  Rf = 0.32 (5% EtOAc in hexanes); 1H NMR (300 MHz, 
CDCl3) δ 7.68-7.64 (m, 4H), 7.46-7.36 (m, 6H), 5.69-5.55 (m, 1H), 5.38-5.31 (m, 1H), 
5.08-4.99 (m, 2H), 3.84 (d, J = 10.2 Hz, 1H), 3.66 (d, J = 10.2 Hz, 1H), 2.48 (d, J = 7.5 
Hz, 2H), 2.40-2.20 (m, 2H), 1.90-1.60 (m, 6H), 1.06 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 213.4, 135.7, 133.8, 133.3 (2C), 129.7, 129.6, 127.6 (2C), 117.9, 66.4, 53.8, 39.7, 37.3, 
34.0, 26.9 (2C), 21.0, 19.3; IR (Neat Film NaCl) 3072, 2933, 2858, 1708, 1428, 1113, 
703 cm–1; HRMS (FAB) m/z calc'd for C26H35O2Si [M + H]+: 407.2406, found 407.2398; 
[α]D25 –3.96 (c 5.00, CHCl3, 81% ee). 
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O
F
261  
2-Allyl-2-fluorocyclohexanone (261, Table 3.2, entry 10):  Reaction time: from β-
ketoester, 3.5 h, performed in Et2O at 30 ºC.  Flash chromatography (SiO2, 2% Et2O in 
pentane).  80% yield.  Rf = 0.36 (10:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 
5.88-5.71 (m, 1H), 5.20-5.10 (m, 2H), 2.76-2.31 (m, 4H), 2.16-2.02 (m, 1H), 1.99-1.78 
(m, 4H), 1.75-1.60 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 207.2 (d, JC-F = 20.0 Hz), 130.7 
(d, JC-F = 3.8 Hz), 119.2, 97.7 (d, JC-F = 184.3 Hz), 39.4, 38.7 (d, JC-F = 22.7 Hz), 37.3 (d, 
JC-F = 22.2 Hz), 27.2, 21.4 (d, JC-F = 6.6 Hz); 19F NMR (282 MHz, CDCl3) δ –158.15; IR 
(Neat Film NaCl) 3080, 2946, 1729, 1642, 1453, 1433, 1126, 923 cm–1; HRMS (EI) m/z 
calc'd for C9H13OF [M]+: 156.0950, found 156.0946; [α]D24.4 –74.65 (c 1.05, CH2Cl2, 91% 
ee). 
 
O
O O 150  
7-Allyl-7-methyl-1,4-dioxaspiro[4.5]decan-8-one (150, Table 3.3, entries 1 and 2):  
Reaction time: from allyl enol carbonate, 1 h; from silyl enol ether, 2 h; from β-ketoester, 
1.5 h (1 mmol scale), 24 h (25 mmol scale) with 1.5 mol% Pd2(dba)3, 3.75 mol% (S)-5, in 
Et2O.  1H NMR (300 MHz, CDCl3) δ 5.67 (ddt, J = 17.1, 10.5, 7.2 Hz, 1H), 5.07 (br s, 
1H), 5.02 (app. d, J = 9.3 Hz, 1H), 3.99 (app. d, J = 1.5 Hz, 4H), 2.57 (app. t, J = 6.3 Hz, 
1H), 2.42 (m, 2H), 2.00 (d, J = 13.8 Hz, 1H), 1.98 (app. t, J = 7.2 Hz, 1H), 1.75 (d, J = 
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14.1 Hz, 1H), 1.12 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 213.9, 133.7, 118.4, 107.6, 
64.4, 64.3, 47.5, 44.3, 42.7, 35.7, 34.5, 23.9; IR (Neat Film NaCl) 2964, 1710, 1116 cm–1; 
HRMS (EI) m/z calc'd for C12H18O3 [M]+: 210.1256, found 210.1255; [α]D29 –7.99 (c 2.41, 
hexane, 86% ee). 
 
O
155  
(S)-2-Allyl-2,6,6-trimethylcyclohexanone (155, Table 3.3, entry 3):  Reaction time: 
from allyl enol carbonate, 1 h; from β-ketoester, 9 h, performed at 30 °C.  1H NMR (300 
MHz, CDCl3) δ 5.63 (m, 1H), 5.01 (m, 2H), 2.33 (dd, J = 13.8, 6.9 Hz, 1H), 2.18 (dd, J = 
13.8, 7.8 Hz, 1H), 1.82-1.53 (comp. m, 6H), 1.11 (s, 3H), 1.09 (s, 3H), 1.08 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 219.8, 134.6, 117.9, 47.6, 44.4, 43.9, 39.7, 36.8, 27.8, 27.2, 
25.5, 17.7; IR (Neat Film NaCl) 2933, 1697, 1463 cm–1; HRMS (EI) m/z calc'd for 
C12H20O [M]+: 180.1514, found 180.1521; [α]D27 –35.69 (c 2.15, hexane, 92% ee). 
 
O
262  
2-Allyl-2,3,3,5,5-pentamethylcyclohexanone (262, Table 3.3, entry 4):  Reaction 
time: from β-ketoester, 5 h.  Flash chromatography (SiO2, 1 → 4% Et2O in hexanes).  
90% yield.  Rf = 0.48 (10% Et2O in hexanes); 1H NMR (300 MHz, CDCl3) δ 5.63-5.46 
(m, 1H), 5.10-4.94 (m, 2H), 2.61 (d, J = 13.5 Hz, 1H), 2.34 (d, J = 12.9 Hz, 1H), 2.11 (d, 
J = 12.9 Hz, 1H), 2.02 (d, J = 13.8 Hz, 1H), 1.83 (d, J = 14.6 Hz, 1H), 1.40 (d, J = 14.5 
Hz, 1H), 1.02 (s, 3H), 0.99 (s, 3H), 0.95 (s, 3H), 0.92 (s, 3H), 0.90 (s, 3H); 13C NMR (75 
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MHz, CDCl3) δ 215.5, 134.2, 117.9, 53.8, 51.0, 49.5, 40.5, 39.1, 35.7, 33.7, 29.8, 26.9, 
26.3, 15.4; IR (Neat Film NaCl) 3077, 2957, 1708, 1639, 1460, 1392, 1370, 913 cm–1; 
HRMS (EI) m/z calc'd for C14H24O [M]+: 208.1827, found 208.1837; [α]D22.5 –4.14 (c 
2.705, hexane, 85% ee). 
 
149
O
 
(S)-6-Allyl-6-methylcyclohex-2-enone (149, Table 3.3, entry 5): Reaction time: 
from allyl enol carbonate, 1 h; from β-ketoester, 4 h, performed with 4 mol% Pd2(dba)3, 
10 mol% (S)-5, in Et2O.  1H NMR (300 MHz, CDCl3) δ 6.87 (app. dt, J = 10.2, 4.2 Hz, 
1H), 5.91 (app. dt, J = 10.2, 2.1 Hz, 1H), 5.72 (m, 1H), 5.07 (m, 1H), 5.02 (d, J = 9.3 Hz, 
1H), 2.35 (m, 3H), 2.16 (dd, J = 13.8, 7.5, Hz, 1H), 1.91 (dt, J = 13.8, 6.0 Hz, 1H), 1.74 
(dt, J = 13.8, 6.0 Hz, 1H), 1.07 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 203.7, 148.8, 
134.0, 128.4, 118.0, 44.4, 40.9, 32.9, 23.1, 21.6; IR (Neat Film NaCl) 2927, 1673 cm–1; 
HRMS (EI) m/z calc'd for C10H14O [M]+: 150.1045, found 150.1039; [α]D26 +14.62 (c 
1.56, hexane, 89% ee). 
 
O
98  
(S)-2-Allyl-2-methyl-3,4-dihydronaphthalen-1(2H)-one (98, Table 3.3, entry 6):  
Reaction time: from allyl enol carbonate, 2 h, 10 °C; from β-ketoester, 10 h, performed in 
Et2O.  1H NMR (300 MHz, CDCl3) δ 8.04 (dd, J = 8.0, 1.2 Hz, 1H), 7.45 (dt, J = 7.7, 1.5 
Hz, 1H), 7.29 (app. t, J = 7.2 Hz, 1H), 7.21 (app. d, J = 7.5 Hz, 1H), 5.85-5.71 (m, 1H), 
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5.10 (s, 1H), 5.05 (s, 1H), 2.97 (t, J = 6.3 Hz, 2H), 2.46 (dd, J = 13.8, 7.5 Hz, 1H), 2.27 
(ddt, J = 14.0, 7.5, 1.2 Hz, 1H), 2.07 (ddd, J = 13.4, 7.2, 6.0 Hz 1H), 1.89 (ddd, J = 14.0, 
6.9, 5.7 1H), 1.18 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 202.0, 143.2, 133.9, 133.0, 
131.5, 128.6, 127.9, 126.5, 118.1, 44.5, 41.0, 33.2, 25.3, 21.8; IR (Neat Film NaCl) 3073, 
2930, 1682, 1455, 1220, 916, 742 cm–1; HRMS (EI) m/z calc'd for C14H16O [M]+: 
200.1201, found 200.1194; [α]D27 –18.59 (c 2.08, hexane, 88% ee). 
 
157
O
 
2-Allyl-2-methylcycloheptanone (157, Table 3.3, entry 7): Reaction time: from 
allyl enol carbonate, 6 h; from silyl enol ether, 2 h; from β-ketoester, 9.5 h.  1H NMR 
(300 MHz, CDCl3) δ 5.70 (ddt, J = 16.8, 10.2, 7.5, 1H), 5.02 (m, 2H), 2.59 (app. dt, J = 
11.1, 2.7 Hz, 1H), 2.42 (app. t, J = 9.0 Hz, 1H), 2.24 (dd, J = 13.8, 7.5 Hz, 1H), 2.16 (dd, 
J = 13.8, 7.8 Hz, 1H), 1.78-1.30 (comp. m, 8H), 1.03 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 217.4, 133.8, 117.9, 50.8, 43.6, 40.6, 36.6, 30.6, 26.4, 24.4, 22.3; IR (Neat Film NaCl) 
2930, 1702, 1458 cm–1; HRMS (EI) m/z calc'd for C11H18O [M]+: 166.1358, found 
166.1360; [α]D28 –34.70 (c 1.52, hexane, 87% ee). 
 
O
263  
7-Allyl-7-methylcyclohept-2-enone (263, Table 3.3, entry 8):  A 100 mL round-
bottom flask equipped with a magnetic stir bar was flame dried under vacuum and cycled 
into a N2-filled glovebox.  Pd(dmdba)2 (78.3 mg, 0.096 mmol, 3 mol%) and (S)-t-Bu-
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PHOX (46.2 mg, 0.119 mmol, 3.76 mol%) were added, followed by THF (40 mL).  The 
contents were stirred at 25 °C for 30 min, at which time allyl 1-methyl-2-oxocyclohept-3-
enecarboxylate (660.1 mg, 3.17 mmol, 1.0 equiv) was added with a total of 10 mL of 
THF.  The reaction was stirred for 3 h at which time TLC indicated complete reaction.  
The reaction mixture was cycled out of the glovebox, concentrated in vacuo, and the 
residue subjected to flash chromatography (2 x 16 cm, 25:1 hexane:EtOAc) to afford the 
title compound as a colorless oil (510 mg, 98% yield).  Rf = 0.34 (10:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3) δ 6.26 (ddd, J = 4.2, 4.2, 12.6 Hz, 1H), 5.91 (ddd, J = 2.1, 
2.1, 12.6 Hz, 1H), 5.71 (dddd, J = 7.5, 7.5, 10.5, 17.1 Hz, 1H), 5.07-5.04 (m, 1H), 5.01 
(dddd, J = 0.9, 0.9, 2.1, 9.9 Hz, 1H), 2.40-2.32 (m, 2H), 2.30 (m, 1H), 2.21 (dddd, J = 
0.9, 0.9, 7.2, 13.5 Hz, 1H),  1.88-1.53 (m, 4H), 1.13 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 209.2, 141.8, 133.9, 130.3, 117.9, 52.3, 44.4, 35.1, 33.2, 24.1, 22.0; IR (Neat Film 
NaCl) 3075, 3013, 2929, 1662, 1455, 1419, 1396, 1375, 1199, 995, 915 cm–1; HRMS (EI) 
m/z calc'd for C11H16O [M]+: 164.1201, found 164.1201; [α]D24.6 –63.58 (c 1.015, CHCl3, 
90% ee). 
 
148
O
 
2-Methyl-2-(2-methylallyl)cyclohexanone (148, Table 3.3, entry 9): Reaction time: 
from allyl enol carbonate, 8 h, performed with 5 mol% Pd2(dba)3, 12.5 mol% (S)-55; 
from silyl enol ether, 4 h, performed with dimethallyl carbonate; from β-ketoester, 6.5 h 
performed with 5 mol% Pd2(dba)3, 12.5 mol% (S)-3, in Et2O at 35 °C.  1H NMR (300 
MHz, CDCl3) δ 4.81 (s, 1H), 4.64 (s, 1H), 2.52 (m, 1H), 2.48 (d, J = 13.5 Hz, 1H), 2.36 
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(app. dt, J = 14.7, 6.0 Hz, 1H), 2.25 (d, J = 13.8 Hz, 1H), 1.94-1.53 (comp. m, 6H), 1.65 
(s, 3H), 1.06 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 215.8, 142.2, 114.7, 48.7, 45.4, 40.0, 
38.9, 27.6, 24.3, 23.3, 21.1; IR (neat) 2927, 1707 cm–1; HRMS (EI) m/z calc'd for 
C11H18O [M]+: 166.1358, found 166.1358; [α]D27 –26.42 (c 1.85, hexane, 90% ee). 
 
264
O
Cl
 
2-(2-Chloroallyl)-2-methylcyclohexanone (264, Table 3.3, entry 10):  Reaction 
time: from β-ketoester, 2.5 h, performed in Et2O at 35 ºC with 4 mol% Pd2(dba)3 (45.8 
mg, 0.040 mmol), and 10 mol% (S)-t-BuPHOX (48.4 mg, 0.10 mmol).  Flash 
chromatography (SiO2, 1 → 2.5% Et2O in pentane).  87% yield.  Rf = 0.63 (30% Et2O in 
pentane); 1H NMR (300 MHz, CDCl3) δ 5.27 (app. d, J = 1.2 Hz, 1H), 5.15-5.09 (m, 1H), 
2.80 (d, J = 14.4 Hz, 1H), 2.61 (d, J = 14.4 Hz, 1H), 2.56-2.37 (m, 2H), 1.94-1.61 (comp. 
m, 6H), 1.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 214.4, 138.7, 116.3, 48.4, 46.5, 39.2, 
38.8, 27.4, 22.7, 21.1; IR (Neat Film NaCl) 2936, 2868, 1708, 1630, 1456, 1126, 887 cm–
1; HRMS (EI) m/z calc'd for C10H16ClO [M + H]+: 187.0890, found 187.0884; [α]D26.6 –
5.40 (c 3.21, CH2Cl2, 91% ee). 
 
O Ph
Ph
265  
2-Benzyl-2-(2-phenylallyl)cyclohexanone (265, Table 3.3, entry 11):  Reaction 
time: from β-ketoester, 12.25 h, performed at 30 ºC with 2.5 mol% Pd(dmdba)2 (20.4 mg, 
0.025 mmol), and 2.5 mol% (S)-t-BuPHOX (9.6 mg, 0.025 mmol).  Flash 
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chromatography (SiO2, 15% Et2O in petroleum ether).  96% yield.  Rf = 0.44 (15% Et2O 
in petroleum ether); 1H NMR (300 MHz, CD3OD) δ 7.36-7.10 (m, 8H), 7.07-7.00 (m, 
2H), 5.25 (d, J = 1.9 Hz, 1H), 5.11-5.08 (m, 1H), 3.04 (d, J = 13.8 Hz, 1H), 2.90-2.85 (m, 
2H), 2.63 (d, J = 13.6 Hz, 1H), 2.42-2.17 (m, 2H), 1.82-1.46 (m, 6H); 13C NMR (75 
MHz, CD3OD) δ 216.6, 147.6, 144.6, 139.3, 131.9, 129.3, 128.9, 128.4, 127.9, 127.3, 
118.0, 54.8, 42.9, 42.4, 40.8, 36.2, 27.2, 21.8; IR (neat film, NaCl) ν 3082, 3058, 3027, 
2938, 2864, 1702, 1624, 1601, 1574, 1494, 1453, 1444, 1315, 1198, 1126, 1080, 1075, 
1055, 1030, 968, 905, 778, 754, 744, 702 cm–1; HRMS (EI+) m/z calc’d. for C22H24O 
[M]+: 304.1827, found 304.1841; [α]D24 –13.67 (c 1.005, CHCl3, 94% ee). 
 
N
Bn
O
266  
3-Allyl-1-benzyl-3-ethylpiperidin-4-one (266, Table 3.3, entry 12):  Reaction time: 
from β-ketoester, 2.5 h.  Flash chromatography (SiO2, 5→7% Et2O in pentane).  91% 
yield.  Rf = 0.29 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.39-7.23 (comp. 
m, 5H), 5.62 (dddd, J = 12.3, 9.6, 7.2, 7.2 Hz, 1H), 5.03 (m, 1H), 4.99 (m, 1H), 3.56 (s, 
2H), 2.83-2.69 (m, 1H), 2.65-2.33 (comp. m, 6H), 2.33-2.20 (m, 1H) 1.95 (dq, J = 15.3, 
7.5 Hz, 1H), 1.51 (dq, J = 15.0, 7.5 Hz, 1H), 0.75 (dd, J = 7.5, 7.5 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 212.6, 138.6, 133.8, 128.7, 128.3, 127.2, 117.8, 62.2, 61.8, 53.4, 52.2, 
39.3, 37.3, 26.7, 7.8; IR (Neat Film NaCl) 3065, 3028, 2965, 2801, 1709, 1454, 1352, 
1200, 915, 699 cm–1; HRMS (EI) m/z calc'd for C17H23NO [M]+: 257.1780, found 
257.1772; [α]D26.6 +31.21 (c 1.51, CH2Cl2, 92% ee). 
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O
i-BuO
(±)-321
O
O Pd2(pmdba)3 (2.5 mol%)
 (S)-55 (6.25 mol%)
PhMe, 80 °C
(86% yield)
O
i-BuO
(+)-267  
Ketone (+)-267 from β-ketoester (±)-321 (Table 3.3, entry 13).  A 2-dram vial 
containing a stir bar was charged with Pd2(pmdba)3 (10.6 mg, 0.00968 mmol, 0.025 
equiv) and (S)-55 (9.4 mg, 0.0242 mmol, 0.0625 equiv).  This was connected to a 1-dram 
vial containing a stir bar and β-ketoester (±)-321 (108.6 mg, 0.387 mmol, 1.0 equiv) via a 
cannula, and PhMe (3.9 mL, 0.1 M) was added to the vial containing the Pd/L and 
immediately immersed in liquid N2.  The vials were rigorously degassed by three freeze-
pump-thaw cycles and warmed to 23 °C.  After complexation for 30 min (purple → 
orange color change), the catalyst solution was transferred to the substrate via cannula 
and immersed in an 80 °C oil bath.  The reaction immediately turned yellow in color.  
After 23 h the reaction was cooled to ambient temperature, diluted with Et2O (4 mL), and 
filtered through a small SiO2 plug.  The filtrate was concentrated and purified by flash 
chromatography as above to afford ketone (+)-267 as a colorless oil (78.5 mg, 0.332 
mmol, 86% yield, 75% ee). Rf = 0.49 (4:1 hexanes-EtOAc); 1H NMR (500 MHz, CDCl3) 
δ 5.73 (dddd, J = 16.6, 10.6, 7.4, 7.4 Hz, 1H), 5.06-5.04 (m, 1H), 5.04-5.01 (m, 1H), 3.74 
(dd, J = 9.7, 6.7 Hz, 2H), 2.59-2.47 (comp m, 2H), 2.33 (dd, J = 13.7, 7.2 Hz, 1H), 2.16 
(dddd, J = 13.7, 7.6, 1.0, 1.0 Hz, 1H), 1.98 (app septuplet, J = 6.6 Hz, 1H), 1.90 (ddd, J = 
13.3, 7.2, 5.7 Hz, 1H), 1.72-1.67 (m, 1H), 1.70 (dd, J = 1.6, 1.6 Hz, 3H), 1.06 (s, 3H), 
0.99 (d, J = 6.7 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 202.7, 169.5, 134.8, 117.8, 
113.3, 73.8, 42.5, 41.9, 31.5, 29.0, 22.5, 22.4, 19.2, 8.0; IR (Neat Film NaCl) 3076, 2962, 
2931, 1622, 1463, 1381, 1355, 1229, 1113, 1002, 915 cm-1; HRMS (EI+) m/z: calc’d for 
C15H24O2 [M]+: 236.1776, found 236.1771; [α]D21.2 +13.2° (c 0.20, CH2Cl2, 88% ee). 
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O
PhS
O
O
Pd2(pmdba)3 (2.5 mol%)
PhMe, 60 °C, 0.1 M
O
PhS
(71% yield)
(±)-323 (–)-268
(R)-t-BuPHOX (55) 
(6.25 mol%)
Ph2P N
O
t-Bu
 
Allyl ketone (–)-268 (Table 3.3, entry 14; Scheme 3.6).  A solution of Pd2(pmdba)3 
(0.1306 g, 0.1185 mmol, 0.025 equiv) and (R)-t-BuPHOX (55) (0.1148 g, 0.2964 mmol, 
0.0625 equiv) in toluene (30 mL) was prepared in a glovebox under N2 atmosphere, and 
allowed to stir at 23 °C for 30 min.  A solution of β-ketoester (±)-323 (1.50 g, 4.741 
mmol, 1.00 equiv) in toluene (10 mL) was transferred to the reaction vessel dropwise via 
glass pipette, washing with toluene (7.5 mL) for quantitative transfer.  The reaction vessel 
was sealed with a rubber septum, removed from the glove box, heated in a 60 °C oil bath, 
and the solution was allowed to stir for 24 h.  The reaction vessel was cooled to room 
temperature, and the solvent was evaporated in vacuo.  The resulting residue was purified 
by flash chromatography (5% EtOAc in hexanes) to afford allyl ketone (–)-268 (0.92 g, 
71% yield, 91.6% ee as determined by chiral HPLC using a Chiralpak AD column with 
4% EtOH in hexanes as the eluent) as a colorless oil.  Rf = 0.45 (30% EtOAc in hexanes); 
1H NMR (300 MHz, CDCl3) δ 7.52-7.48 (m, 2H), 7.43-7.35 (comp m, 3H), 5.68 (app ddt, 
J = 10.8, 16.8, 7.5 Hz, 1H), 5.03 (dddd, J = 9.9, 2.4, 0.9, 0.6 Hz, 1H), 5.01 (dddd, J = 
17.4, 2.4, 1.5, 1.2 Hz, 1H), 2.32 (app ddt, J = 13.8, 7.2, 1.2 Hz), 2.19-2.10 (comp m, 3H), 
1.96 (t, J = 1.8 Hz, 3H), 1.86-1.75 (m, 1H), 1.66-1.56 (m, 1H), 1.04 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 199.5, 155.6, 135.6, 134.4 130.3, 129.6, 129.5, 128.8, 118.2, 43.1, 
41.7, 33.1, 26.9, 22.3, 12.9; IR (Neat Film NaCl) 3074, 2964, 2929, 1652, 1582, 1440, 
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1339, 1287, 1228 cm–1; HRMS (FAB+) m/z: calc’d for C17H20OS [M + H]+: 273.1313, 
found 273.1317; [α]D25.4 –57.4 (c 1.00, CH2Cl2). 
 
O
272
OO
O
O
O
271
Pd2(dba)3 (4 mol%)
(S)-t-Bu-PHOX (10 mol%)
THF, 40 °C, 6 h
76% yield, 4:1 dr
O
334  
2,6-diallyl-2,6-dimethylcyclohexanone (272, Scheme 3.7a).  A 50 mL round-bottom 
flask equipped with a magnetic stir bar was flame dried under vacuum.  After cooling 
under nitrogen, Pd2(dba)3 (31.4 mg, 0.0343 mmol, 0.034 equiv) and (S)-t-Bu-PHOX (55) 
(31.3 mg, 0.0808 mmol, 0.080 equiv) were added.  After the flask was evacuated and 
filled with nitrogen three times, THF (32 mL) was added and the contents were stirred at 
25 °C for 30 min, at which time allyl 2-(allyloxycarbonyloxy)-1,3-dimethylcycohex-2-
enecarboxylate (271) (298 mg, 1.012 mmol, 1.0 equiv) was added by syringe in one 
portion.  The reaction was stirred at 40 °C for 6 h at which time TLC indicated complete 
reaction.  The reaction mixture was allowed to cool and then concentrated to ~1 mL 
under reduced pressure and the residue chromatographed (100 mL pentane, then 1 → 2% 
Et2O in pentane on 2 x 14 cm SiO2) to afford the title compound as a colorless, volatile 
oil (157.9 mg, 76% yield).  GC analysis indicated the isolated compound was an 80:20 
mixture (Rf = 0.51, 10:1 hexane:EtOAc) of C2-symmetric:meso diastereomers (272:334). 
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167
(1 mol%)Ru
Cy3P
Cl
Cl
Ph
NMesMesNO
272
O
334
CH2Cl2 (0.02 M)
40 °C
O
272
O
335  
In order to obtain an analytical sample of the C2-symmetric product (272), the 
following reaction was performed on the mixture of diastereomers:  A solution of the 
diastereomeric ketones (50.4 mg, 0.244 mmol, 1.0 equiv) in 15 mL CH2Cl2 was degassed 
by bubbling Ar through the solution for 15 min.  The second generation Grubbs catalyst 
(167)67 (2 mg, 0.00236 mmol, 0.0097 equiv) was added and the mixture heated to 40 °C.  
After 90 min, GC analysis indicated none of the minor diastereomer was present.  The 
reaction mixture was allowed to cool and then concentrated to ~1-2 mL under reduced 
pressure and the residue chromatographed (75 mL pentane, then 2 → 5% Et2O in pentane 
on 1.5 x 24 cm SiO2) to afford the C2-symmetric 272 (31 mg, 62%), the RCM product 
335 (8.3 mg), and 5.8 mg of a mixture of the two compounds. 
 
O
272  
C2-symmetric ketone 272:  Rf = 0.17 (2% Et2O in hexane); 1H NMR (300 MHz, 
CDCl3) δ 5.65 (m, 2H), 5.10-4.95 (m, 4H), 2.33 (dd, J = 6.9, 13.8 Hz, 2H), 2.18 (dd, J = 
7.8, 13.8 Hz, 2H), 1.87-1.68 (m, 4H), 1.59-1.48 (m, 2H), 1.06 (s, 6H); 13C NMR (75 
MHz, CDCl3) δ 218.6, 134.4, 118.0, 47.6, 43.9, 36.4, 25.0, 17.3; IR (Neat Film NaCl) 
3076, 2930, 1694, 1639, 1461, 1374, 992, 914 cm–1; HRMS (EI) m/z calc'd for C14H22O 
[M]+: 206.1671, found 206.1675; [α]D23.6 –54.04 (c 0.95, hexane, 92% ee).  
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O
335  
meso-Ketone 335:  Rf = 0.13 (2% Et2O in hexane); 1H NMR (300 MHz, CDCl3) δ 
5.83-5.72 (m, 2H), 2.53-2.35 (m, 3H), 2.03-1.85 (m, 4H), 1.75-1.62 (m. 2H), 1.48-1.37 
(m, 1H), 1.09 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 217.9, 129.4, 48.5, 41.7, 39.0, 27.2, 
20.0; IR (Neat Film NaCl) 2965, 1735, 1699, 1458, 1378, 1239 cm–1; HRMS (EI) m/z 
calc'd for C12H18O [M]+: 178.1358, found 178.1360. 
 
For details of the preparation of bis(β-ketoester) 75 (Scheme 3.7), conversion to 
diketone 76, and synthesis of cyanthiwigin F (83), see ref 68. 
 
O
274  
2-Allyl-2-ethylcyclopentanone (274, Table 3.4, entry 1):  Reaction time: from β-
ketoester, 3 h.  Flash chromatography (2 x 12 cm SiO2, 3 → 4% Et2O in pentane).  
Colorless oil (125.9 mg, 82% yield).  Rf = 0.44 (10:1 Hexanes:EtOAc); 1H NMR (300 
MHz, CDCl3) δ 5.68 (dddd, J = 7.2, 7.2, 9.3, 12.3 Hz, 1H), 5.09-5.00 (m, 2H), 2.24-2.14 
(m, 4H), 1.90-1.80 (m, 4H), 1.46 (q, J = 7.2 Hz, 1H), 1.46 (q, J = 7.2 Hz, 1H), 0.83 (dd, J 
= 7.2, 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 214.4, 169.8, 131.5, 118.3, 65.6, 38.9, 
31.9, 27.2, 19.5, 18.3, 17.6; IR (Neat Film NaCl) 3077, 2965, 1735, 1640, 1460, 1406, 
1162, 915 cm–1; HRMS (EI) m/z calc'd for C10H16O [M]+: 152.1201, found 152.1195; 
[α]D25.2 –18.55 (c 1.050, CH2Cl2, 86% ee). 
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275  
2-Allyl-2-isopropylcyclopentanone (275, Table 3.4, entry 2):  Reaction time: from 
β-ketoester, 3 h.  Flash chromatography (2 x 13 cm SiO2, 3% Et2O in pentane).  Colorless 
oil (130.4 mg, 77% yield).  Rf = 0.44 (10:1 Hexanes:EtOAc); 1H NMR (300 MHz, 
CDCl3) δ 5.70 (dddd, J = 7.5, 7.5, 9.3, 13.2 Hz, 1H), 5.07-5.00 (m, 2H), 2.30-2.07 (m, 
4H), 2.01-1.69 (m, 5H), 0.87 (d, J = 7.2 Hz, 3H), 0.80 (d, J = 7.2 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 223.6, 134.2, 117.8, 55.1, 39.7, 39.6, 31.8, 29.0, 18.9, 18.2, 17.1; IR 
(Neat Film NaCl) 3077, 2963, 1734, 1640, 1471, 1406, 1388, 1370, 1190, 914 cm–1; 
HRMS (EI) m/z calc'd for C11H18O [M]+:  166.1358, found 166.1359; [α]D24.9 +43.05 (c 
1.085, CH2Cl2, 84% ee). 
 
O NPhth
276  
2-((1-Allyl-2-oxocyclopentyl)methyl)isoindoline-1,3-dione (276, Table 3.4, entry 
3):  Reaction time: from β-ketoester, 2 h.  Flash chromatography (SiO2, 10 → 15% 
EtOAc in hexanes).  67% yield, 48% ee.  Rf = 0.34 (30% EtOAc in hexanes); 1H NMR 
(300 MHz, CDCl3) δ 7.84 (dd, J = 5.9, 3.2 Hz, 2H), 7.72 (dd, J = 5.9, 3.2 Hz, 2H), 5.73 
(dddd, J = 16.8, 9.8, 7.7, 6.4 Hz, 1H), 5.18-5.06 (m, 2H), 3.80 (d, J = 14.1 Hz, 1H), 3.74 
(d, J = 14.1 Hz, 1H), 2.56-2.41 (m, 1H), 2.38-2.10 (comp. m, 3H), 2.10-1.86 (comp. m, 
4H); 13C NMR (75 MHz, CDCl3) δ 220.1, 168.8, 134.2, 133.3, 132.0, 123.6, 119.4, 53.0, 
41.8, 38.7, 38.3, 31.9, 18.9; IR (Neat Film NaCl) 2966, 1773, 1734, 1713, 1429, 1395, 
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1354, 715, 666 cm–1; HRMS (EI) m/z calc'd for C17H17O3N [M]+: 283.1208, found 
283.1209; [α]D26.5 –14.1 (c 1.49, CH2Cl2, 48% ee). 
 
O
277  
2-Allyl-2-methyl-2,3-dihydro-1H-inden-1-one (277, Table 3.4, entry 4):  Reaction 
time: from β-ketoester, 1 h, performed on 0.1 mmol scale.  Purified by flash 
chromatography (SiO2, 10% Et2O in pentane).  82% yield, 80% ee.  Rf = 0.37 (10% Et2O 
in pentane); [α]D26.4 –38.5 (c 0.47, CH2Cl2, 80% ee).  Spectral data matched those reported 
in the literature.69  
 
O
278  
2-Allyl-2-benzyl-2,3-dihydro-1H-inden-1-one (278, Table 3.4, entry 5):  Reaction 
time: from β-ketoester, 1 h.  Purified by flash chromatography (SiO2, 2 → 4% Et2O in 
pentane).  93% yield, 71% ee.  Rf = 0.37 (10% Et2O in pentane); 1H NMR (300 MHz, 
CDCl3) δ 7.84 (d, J = 7.7 Hz, 1H), 7.63 (ddd, J = 7.7, 7.7, 1.1 Hz, 1H), 7.49 (comp. m, 
2H), 7.36-7.20 (comp. m, 5H), 5.74 (dddd, J = 16.7, 10.1, 8.0, 6.6 Hz, 1H), 5.21 (app. d, 
J = 16.8 Hz, 1H), 5.12 (app. d, J = 10.1 Hz, 1H), 3.26 (d, J = 17.3 Hz, 1H), 3.25 (d, J = 
13.3 Hz, 1H), 3.10 (d, J = 17.3 Hz, 1H), 2.96 (d, J = 13.6 Hz, 1H), 2.70 (dd, J = 13.6, 6.4 
Hz, 1H), 2.46 (dd, J = 13.6, 8.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 210.3, 153.0, 
137.3, 136.8, 134.8, 133.4, 130.2, 128.0, 127.2, 126.4, 126.3, 123.8, 118.7, 53.7, 42.7, 
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42.5, 35.3; IR (Neat Film NaCl) 3076, 3029, 2917, 1708, 1608, 1496, 1465, 1436, 1296, 
1210, 1030, 995, 922, 756, 703 cm–1; HRMS (EI) m/z calc'd for C19H18O [M]+: 262.1358, 
found 262.1365; [α]D26.1 +28.4 (c 1.42, CH2Cl2, 71% ee). 
 
O
OMe
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2-Allyl-2-(4-methoxybenzyl)cyclopentanone (279, Table 3.4, entry 6):  Reaction 
time: from β-ketoester, 2 h.  Flash chromatography (2 x 14 cm SiO2, 3% Et2O in 
pentane).  Colorless oil (207.6 mg, 84% yield).  Rf = 0.32 (10:1 Hexanes:EtOAc); 1H 
NMR (300 MHz, CDCl3) δ 7.01 (d, J = 8.7 Hz, 2H), 6.79 (d, J = 8.7 Hz, 2H), 5.71 (dddd, 
J = 7.5, 7.5, 10.2, 14.7 Hz, 1H), 5.14-5.01 (m, 2H), 3.78 (s, 3H), 2.86 (d, J = 13.8 Hz, 
1H), 2.53 (d, J = 13.8 Hz, 1H), 2.26 (dd, J = 7.2, 13.5 Hz, 1H), 2.20-2.09 (m, 2H), 1.99 
(dd, J = 6.6, 8.7 Hz, 1H), 1.95-1.66 (m, 2H), 1.86 (app. dd, J = 7.5, 7.5 Hz, 1H), 1.55-
1.41 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 223.0, 158.2, 133.7, 131.1, 129.6, 118.5, 
113.5, 55.1, 53.2, 40.8, 40.8, 38.9, 30.9, 18.6; IR (Neat Film NaCl) 3075, 2958, 1733, 
1611, 1512, 1248, 1178, 1036 cm–1; HRMS (EI) m/z calc'd for C16H20O2 [M]+: 244.1463, 
found 156244.1465; [α]D25.1 +7.34 (c 1.065, CH2Cl2, 73% ee). 
 
O
280  
2-Allyl-2-(4-methylbenzyl)cyclopentanone (280, Table 3.4, entry 7):  Reaction 
time: from β-ketoester, 2 h.  Flash chromatography (SiO2, 5% Et2O in pentane).  84% 
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yield, 73% ee.  Rf = 0.39 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.06 (d, J 
= 7.7 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 5.72 (dddd, J = 17.0, 10.4, 8.0, 6.9 Hz, 1H), 5.10 
(app. ddd, J = 10.1, 2.1, 1.1 Hz, 1H), 5.06 (app. ddd, J = 16.7, 2.1, 1.3 Hz, 1H), 2.87 (d, J 
= 13.3 Hz, 1H), 2.55 (d, J = 13.3 Hz, 1H), 2.31 (s, 3H), 2.29-2.22 (m, 1H), 2.21-2.07 
(comp. m, 2H), 2.05-1.82 (comp. m, 3H), 1.82-1.65 (m, 1H), 1.56-1.41 (m, 1H); 13C 
NMR (75 MHz, CDCl3) δ 223.2, 136.1, 134.7, 133.9, 130.3, 129.0, 118.8, 53.4, 41.4, 
41.0, 39.1, 31.1, 21.2, 18.8; IR (Neat Film NaCl) 3080, 2961, 2915, 1737, 1515, 1441, 
1157, 921, 810, 666 cm–1; HRMS (EI) m/z calc'd for C16H20O [M]+: 228.1514, found 
228.1505; [α]D26.2 +9.1 (c 2.68, CH2Cl2, 73% ee). 
 
O
CF3
281  
2-Allyl-2-(4-(trifluoromethyl)benzyl)cyclopentanone (281, Table 3.4, entry 8):  
Reaction time: from β-ketoester, 2 h.  Flash chromatography (2 x 14 cm SiO2, 2 → 3% 
Et2O in pentane).  Colorless oil (239.3 mg, 83% yield).  Rf = 0.39 (10:1 Hexane:EtOAc); 
1H NMR (300 MHz, CDCl3) δ 7.51 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 5.73 
(dddd, J = 7.5, 7.5, 10.2, 17.4 Hz, 1H), 5.17-5.05 (m, 2H), 2.97 (d, J = 13.2 Hz, 1H), 2.66 
(d, J = 13.2 Hz, 1H), 2.26 (dd, J = 7.2, 13.5 Hz, 1H), 2.24-2.19 (m, 1H), 2.16 (dd, J = 7.2, 
13.5 Hz, 1H), 2.01-1.70 (m, 3H), 1.59-1.43 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 222.1, 
142.0, 133.1, 130.6, 128.7 (q, JC-F = 32.2 Hz), 125.1 (q, JC-F = 3.8 Hz), 124.2 (q, JC-F = 
269.2 Hz), 119.0, 53.1, 41.0, 40.7, 38.6, 31.0, 18.5; 19F NMR (282 MHz, CDCl3) δ –
63.29; IR (Neat Film NaCl) 3078, 2964, 1736, 1618, 1326, 1163, 1123, 1068 cm–1; 
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HRMS (EI) m/z calc'd for C16H17OF3 [M]+: 282.1232, found 282.1237; [α]D24.8 +5.65 (c 
1.085, CH2Cl2, 60% ee). 
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3.6.3.3 METHODS FOR DETERMINATION OF ENANTIOMERIC EXCESS 
Table 3.6.  Methods used for determining product ee 
O
entry product compound assayed
retention time
of major
isomer (min)
% ee
1 88
retention time
of minor
isomer (min)
assay
conditions
O
GC, G-TA
100 oC
isotherm
11.13 12.74
6
O
85
O
HPLC
Chiracel OJ
2% EtOH in hexane
isocratic, 1.0 mL/min
19.81 13.82
106 106
3
O
4
91
O GC, G-TA
100 oC
isotherm
55.511 52.56
O
88
O GC, G-TA
150 oC
isotherm
18.75 21.06
CN CN
86
O
GC, G-TA
130 oC
isotherm
59.36 61.19
OCO2t-Bu CO2t-Bu
2
235 235
5
O
90
O GC, G-TA
120 oC
isotherm
90.98 94.22
CO2Et CO2Et
O
7 86
O
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
12.87 15.36
O O
8
O
82
O
127.74 126.43
CF3 CF3
GC, G-TA
120 oC isotherm
for 120 mins, then
ramp 3 oC/min
O
F
91
O
F GC, G-TA
110 oC
isotherm
6.27 8.02
9
10
81
O
16.75 23.91
OOTBDPS OTBDPS HPLC
Chiracel OD-H
100%  hexane
isocratic, 1.0 mL/min
O
86
O
GC, G-TA
120 oC
isotherm
26.90 28.64
O O O O
11
249 249
251 251
253 253
153 153
255 255
257 257
259 259
261 235
150 150
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Table 3.6.  (continued) 
entry product compound assayed
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
assay
conditions
13 85
O
GC, G-TA
120 oC
isotherm
49.12 50.57
O
O
17 9010.08 10.61
O O
GC, G-TA
125 oC
isotherm
91
O
GC, G-TA
100 oC
isotherm
44.91 50.06
O
ClCl
19
20 94
O
6.0 6.5
OPh Ph
HPLC
Chiralpak AD
2.5% EtOH in hexane
isocratic, 1.0 mL/min
15 92
O
19.97 21.48
O
HPLC
Chiracel OD-H
0.1% IPA in heptane
isocratic, 0.7 mL/min
Ph Ph
92
O
GC, G-TA
100 oC
isotherm
15.76 17.65
O
18
92
O
GC, G-TA
80 oC
isotherm
25.48 27.90
O
12
14 90
O
GC, G-TA
100 oC
isotherm
15.31 18.04
O
16 87
GC, G-TA
110 oC
isotherm
9.88 10.68
O O
21
N
Bn
92
N
Bn
O
7.95 8.82
O
HPLC
Chiracel OJ
1% EtOH in hexane
isocratic, 1.0 mL/min
155 155
262 336
149 149
98 98
157 157
263 263
148 148
264 264
265 265
266 266
22 75
O
5.175 6.016
O
267 267i-BuO i-BuO
SFC, 244 nm
Chiralpak AD-H
5% IPA, isocratic
2.0 mL/min, 30 °C  
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Table 3.6.  (continued) 
entry product compound assayed
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
assay
conditions
24 92
O
GC, G-TA
75 oC
isotherm
118.51 127.37
O
272 272
25 86
GC, G-TA
110 oC
isotherm
45.22 38.91
O O
O
27 4824.13 18.26
HPLC
Chiracel OD-H
4% IPA in hexane
isocratic, 1.0 mL/min
O NPhth O NPhth
30 7310.07 11.84
HPLC
Chiralpak AD
1% IPA in hexane
isocratic, 1.0 mL/min
O O
OMe OMe
31 7314.88 12.80
HPLC
Chiracel OJ
0.3% EtOH in hexane
isocratic, 1.0 mL/min
O O
32 606.42 7.47
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
O O
CF3 CF3
28 8021.78 23.74
HPLC
Chiracel OD-H
0.1% IPA in hexane
isocratic, 0.7 mL/min
O O
29 7128.93 22.38
HPLC
Chiracel OJ
1% EtOH in hexane
isocratic, 1.0 mL/min
O O
26 84
GC, G-TA
80 oC
isotherm
43.95 49.93
O
i-Pr
O
i-Pr
274 337
275 275
276 276
277 277
278 278
279 279
280 280
281 281
23 92
O
7.243 9.479
O
268 268PhSPhS
HPLC
Chiralpak AD
4% EtOH in hexane
isocratic, 1.0 mL/min
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3.6.3.4 ALLYLATION WITH A SUBSTITUTED ALLYL CARBONATE 
O
H
Ph2P N
O
t-Bu
OOTMS
Pd2(dba)3 (5 mol%)
TBAT (35 mol%)
THF, 25 °C 4% GC yield, 1.5:1 dr
8% and 31% ee, respectively
(S)-55
(12.5 mol%)
301
1.05 equiv
OEt
O
110
302
 
In a flame dried 1 dram vial, Pd2(dba)3 (4.6 mg, 0.005 mmol), (S)-t-BuPHOX (55, 4.7 
mg, 0.0625 mmol), and TBAT (18.9 mg, 0.035 mmol) were combined.  The vial was 
evacuated for 10 min prior to addition of THF (3 mL). The mixture was allowed to stir at 
25 °C for 30 min prior to addition of tridecane (10 µL, 0.4 mmol), silyl enol ether 110 
(18.4 mg, 0.1 mmol), and carbonate 30170 (17.9 mg, 0.105 mmol) via syringe.  GC yield 
was determined by a GC assay with tridecane as the internal standard.  (Isothermal at 80 
°C for 5 min, then ramp from 80 to 115 °C at 10 °C/min, then isothermal at 115°C for 75 
min.  Silyl enol ether: 5.759 min, tridecane: 7.329 min, minor product diastereomer: 
72.223 min, major product diastereomer: 73.434 min).  Enantiomeric excess was 
determined by an Agilent 6850 GC utilizing a G-TA column (30 mm x 0.25 cm) with 1.0 
mL/min carrier gas flow.  The method utilized for enantiomeric excess determination was 
isothermal at 110 °C for 60 min (major product diastereomer: 47.504 min and 53.594 min 
(major enantiomer), minor product diastereomer: 48.282 min (major enantiomer) and 
55.842 min).  Isolation of products as a mixture of diastereomers was accomplished by 
flash chromatography (1 cm x 20 cm SiO2, 2% ether in pentane). 
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O
H
 
2-(Cyclohex-2-enyl)-2-methylcyclohexanone (302): 1H NMR (300 MHz) δ 5.74 
(comp. m, 1H), 5.49 (dddd, 0.7H, J = 11.0, 1.9, 1.9, 1.9 Hz), 5.20 (dddd, 0.3H, J = 10.1, 
2.1, 2.1, 2.1 Hz), 2.84-2.29 (comp. m, 3H), 2.01-1.22 (comp. m, 12H), 0.90 (s, 2.1 H), 
0.89 (s, 0.9 H); 13C NMR (75 MHz, CDCl3) δ 216.7, 216.1, 129.6, 129.5, 128.0, 127.3, 
52.0, 51.7, 39.5, 39.0, 38.6, 37.0, 36.0, 28.0, 27.7, 25.4, 24.0, 23.1, 23.0, 22.9, 21.1, 21.0, 
19.4, 18.6; IR (Neat Film, NaCl) 3023, 2934, 2862, 1705, 1452, 1313, 1121 cm–1; HRMS 
m/z calc’d for C13H24O [M+]: 192.1514, found 192.1519. 
 
3.6.4 MECHANISTIC EXPERIMENTS 
3.6.4.1 NONLINEAR EXPERIMENTS 
General Procedures for Nonlinear Experiments 
O
O
O
Bn
241
Pd2(dba)3 (5 mol%)
i-Pr-PHOX (12.5 mol%)
THF (0.033 M), 25 °C
0.1 mmol scale
O
Bn
153  
THF stock solutions with the desired enantiomeric excess of i-Pr-PHOX (122) were 
freshly prepared prior to each experiment.  The enantiomeric excess of the i-Pr-PHOX 
delivered was confirmed by subsequent chiral HPLC with a Chiracel OJ column using 
1% ethanol in hexanes (1.0 mL/min) as an eluent on the remaining stock solution ((S)-i-
Pr-PHOX (122): 13.16 min and (R)-i-Pr-PHOX: 7.60 min). 
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A 1-dram vial equipped with a stir bar was flame dried twice under vacuum.  After 
cooling under nitrogen, Pd2(dba)3 (4.6 mg, 0.005 mmol) was added.  The vial was 
evacuated for 5 min.  THF (3 mL total) was added and then i-Pr-PHOX (4.8 mg, 0.0125 
mmol) in THF was added via syringe.  Contents were allowed to stir for 30 min at 25 °C 
prior to addition of benzyl β-ketoester 241 (27.2 mg, 0.1 mmol) via syringe.  The reaction 
progress was monitored by TLC.  Upon completion, the reaction was concentrated and 
purified via column chromatography (1 x 11.5 cm SiO2, 20% Et2O in pentane).  
Subsequently, the enantiomeric excess of product was determined by chiral HPLC with a 
Chiracel OJ column using 1% ethanol in hexanes (1.0 mL/min) as an eluent (153: 15.942 
min and 24.345 min). 
Comparison of the enantiomeric excess of the product vs. the enantiomeric excess of 
the i-Pr-PHOX revealed a linear relationship (Figure 3.2).  The absence of a nonlinear 
effect suggests that the active catalyst in our Tsuji allylation system involves one 
molecule of i-Pr-PHOX, thus one palladium metal center.  Furthermore, the absence of a 
nonlinear effect suggests that the rate-determining step does not involve a bimetallic 
system, such as a palladium-enolate and a palladium π-allyl complex. 
 
416 Chapter 3 – Enantioselective Allylic Alkylations of Enolates from β-Ketoesters 
3.6.4.2 KINETICS EXPERIMENTS 
General Procedures for Kinetic Experiments 
Determination of [Pd(PHOX)] Order 
O O
O
Pd2(dba)3 (X mol%)
(S)-t-Bu-PHOX (2.5X mol%)
THF (0.03 M), 25 °C
tridecane 
(internal standard, 0.15 mmol)
0.3 mmol scale
O
105 106  
Asymmetric Tsuji allylation of enol carbonate 105 was carried out in an identical 
manner to general procedure 4, but at different concentrations of the in situ-generated 
[Pd(PHOX)] complex.  Reaction progress was monitored by an achiral GC equipped with 
a DB-WAX column with tridecane as the internal standard.  GC yield was determined by 
using an acquisition method that ramped the temperature from 70 to 175 °C at a rate of 5 
°C/min (tridecane: 6.915 min, cycloalkanone 106: 12.185 min, and enol carbonate 105: 
17.697 min). 
Rate constants (kobs) were determined at 25 °C by GC analysis.  The dependence of 
reaction rate on the concentration of the in situ-generated [Pd(PHOX)] was measured at a 
constant concentration of 105 (0.03 M) and a constant concentration of tridecane 
(0.015M).  Figure 3.1 shows that the reaction is first-order in [Pd(PHOX)] complex. 
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Determination of Substrate Order for Allyl Enol Carbonates 
O
Pd2dba3 (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
THF-d8 (0.1 M), 0 °C
1,4-dimethoxybenzene 
(internal standard, 0.0175 mmol)
0.05 mmol scale
OO
O
124 98  
Solid Pd2(dba)3 (2.3 mg, 0.0025 mmol) and (S)-t-Bu-PHOX (55, 2.4 mg, 0.00625 
mmol) were placed in a NMR tube equipped with a screw cap and a Teflon septum.  The 
NMR tube was then placed under vacuum and backfilled with argon (3 x 1 min).  THF-d8 
(0.2 mL, dried over sodium benzophenone ketyl) was added to the NMR tube via syringe 
under a positive pressure of argon.  The mixture was heated at 40 °C for 30 min.  The 
mixture was then cooled to –78 °C using a CO2/acetone bath.  A THF-d8 solution (0.3 
mL, 0.1 M in substrate total) of allyl enol carbonate 124 (12.2 mg, 0.05 mmol) and 1,4-
dimethoxybenzene (2.4 mg, 0.0175 mmol) were added to the reaction mixture under 
argon.  Before recording the 1H NMR spectrum, the sample was allowed to warm for 5–
10 s and mixed.  Reaction progress was monitored by 1H NMR spectroscopy at 0 ºC, 
where integral areas of the allylic protons of 124 (δ 4.677 ppm, dt, J = 5.5, 1.0 Hz, 2H) 
relative to the phenyl protons of the dimethoxybenzene internal standard (δ 6.795 ppm, s, 
4H) were obtained at 5 min intervals.   The experiment was concluded upon complete 
conversion of 124, which was determined by the disappearance of the allylic protons of 
124.   
Analysis of consumption of 124 over time is consistent with a zero-order dependence 
in allyl enol carbonate (Figure 3.3). 
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Determination of Substrate Order for β-Ketoesters 
O Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
THF-d8 (0.1 M), 25 °C
0.05 mmol scale
O
293
O
O
98  
Solid Pd2(dba)3 (2.3 mg, 0.0025 mmol) and (S)-t-Bu-PHOX (55, 2.4 mg, 0.00625 
mmol) were placed in a NMR tube equipped with a screw cap and a Teflon septum.  The 
NMR tube was then placed under vacuum and backfilled with argon (3 x 2 min).  THF-d8 
(0.2 mL, dried over sodium benzophenone ketyl) was added to the NMR tube via syringe 
under a positive pressure of argon.  The mixture was heated at 40 °C for 30 min.  A THF-
d8 solution (0.3 mL, 0.1 M in substrate total) of allyl β-ketoester 293 (12.2 mg, 0.05 
mmol) was added to the reaction mixture under argon.  Reaction progress was monitored 
by 1H NMR spectroscopy at 25 ºC, where integral areas of the allylic protons of 293 (δ 
4.494-4.574 ppm, m, 2H) relative to the OCH2 protons of the THF (δ 3.58 ppm, s, 4H) 
were obtained at 8 min intervals.  The experiment was concluded upon complete 
conversion of 293, which was determined by the disappearance of the allylic protons of 
293. 
Analysis of consumption of 293 over time is consistent with a zero-order dependence 
in allyl β-ketoester (Figure 3.4). 
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Determination of the Order in (S)-t-Bu-PHOX 
293 98
O Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX 
C6D6 (0.1 M in substrate), 40 °C
1,4-dimethoxybenzene
(internal standard, 0.05 mmol)
0.05 mmol scale
O
O
O
 
Asymmetric Tsuji allylation of allyl  β-ketoester 293 was carried out in C6D6 in a 
similar procedure to the one mentioned above.  Reaction progress was monitored by 1H 
NMR spectroscopy at 40 ºC, where integral areas of the allylic protons of 293 (δ 4.240-
4.380 ppm, m, 2H) relative to the CH3 protons of the internal standard 1,4-
dimethoxybenezene (δ 3.338 ppm, s, 6H) were obtained at 4 min intervals. 
Rate constants (kobs) were determined at 40 °C by 1H NMR spectroscopy.  The 
dependence of reaction rate on the concentration of the (S)-t-Bu-PHOX (55) was 
measured at constant concentrations of 293 (0.1 M), Pd2(dba)3 (0.005 M), and 1,4-
dimethoxybenzene (0.01 M).  Figure 3.8 shows that the reaction is zero-order in (S)-t-Bu-
PHOX. 
Figure 3.8.  Plot of kobs vs. concentration of (S)-t-Bu-PHOX. 
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Based on these preliminary kinetic experiments, we believe that our asymmetric Tsuji 
allylation is zero-order in substrate (for allyl enol carbonate and allyl β-ketoester 
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substrates), zero-order in PHOX ligand, and first-order in in situ palladium(PHOX) 
complex. 
 
3.6.4.3 DEUTERIUM LABELING EXPERIMENTS 
Synthesis of Deuterated Allyl Enol Carbonates 
General Procedure: 
OCO2allyl
105
O
KOt-Bu
DMF, 0!25 °C
Cl O
O
207
208
 
Allyl 2-methylcyclohex-1-enyl carbonate (105):71 To a solution of potassium t-
butoxide (5.88 g, 52.5 mmol, 1.05 equiv) in DMF (100 mL) was added 2-
methylcyclohexanone (207, 6.13 mL, 50 mmol, 1.0 equiv).  After 12 h, the reaction 
mixture was cooled in an ice bath and allyl chloroformate (6.4 mL, 60 mmol, 1.2 equiv) 
was added in a dropwise fashion.  After an additional 30 min in the ice bath and 15 min at 
25 °C, the reaction mixture was quenched into water (250 mL), extracted with 2:1 
CH2Cl2:hexanes (4 x 125 mL), dried (MgSO4), and evaporated.  Chromatography 
(2.5→4% Et2O in Hexanes on SiO2) afforded the allyl enol carbonate 105 (4.49 g, 46% 
yield) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.94 (ddt, J = 17.4, 10.5, 5.6 Hz, 
1H), 5.36 (dq, J = 17.1, 1.5 Hz, 1H), 5.26 (dq, J = 10.2, 1.2 Hz, 1H), 4.63 (dt, J = 5.7, 1.4 
Hz, 2H), 2.13 (m, 2H), 2.02 (m, 2H), 1.70 (m, 2H), 1.59 (m, 2H), 1.55 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 153.1, 142.2, 131.5, 120.8, 118.8, 68.5, 30.0, 26.6, 23.1, 22.3, 15.7; 
IR (Neat Film NaCl) 3936, 1755, 1275, 1239, 1037 cm–1; HRMS (EI) m/z calc'd for 
C11H16O3 [M]+: 196.1100, found 196.1092. 
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O O
O DD
294  
Dideuterio allyl enol carbonate 294 (Scheme 3.10):  Prepared by general procedure 
7 with dideuterioallyl chroroformate, which was synthesized from 1,1-dideuterioallyl 
alcohol72 and 20% phosgene in toluene.  Flash chromatography (SiO2, 1 → 2.5% Et2O in 
hexanes) gave dideuterio allyl enol carbonate 294 (6% yield) as a colorless oil; Rf = 0.82 
(25% Et2O in hexanes); 1H NMR (300 MHz, CDCl3) δ 5.95 (dd, J = 17.0, 10.4 Hz, 1H), 
5.38 (d, J = 17.1 Hz, 1H), 5.28 (d, J = 10.5 Hz, 1H), 2.21-2.09 (comp. m, 2H), 2.08-1.98 
(comp. m, 2H), 1.77-1.66 (comp. m, 2H), 1.65-1.53 (comp. m, 2H), 1.57 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 153.1, 142.2, 131.4, 120.9, 119.0, 30.3, 26.6, 23.1, 22.3, 21.7, 
15.8; IR (Neat Film NaCl) 2935, 2862, 1753, 1710, 1280, 1262, 1078 cm–1; HRMS (EI) 
m/z calc'd for C11H14D2O3 [M]+: 198.1225, found 198.1217. 
 
CD3
O O
O
295  
Trideuterio allyl enol carbonate 295 (Scheme 3.10):  Prepared by general 
procedure 7 with 2-trideuteriomethylcyclohexanone.73.  Flash chromatography (SiO2, 2 → 
2.5% Et2O in hexanes) gave trideuterio allyl enol carbonate 295 (22% yield) as a 
colorless oil; Rf = 0.82 (25% Et2O in hexanes); 1H NMR (300 MHz, CDCl3) δ 5.96 (ddt, J 
= 17.1, 10.8, 6.0 Hz, 1H), 5.38 (d, J = 17.3 Hz, 1H), 5.28 (d, J = 10.5 Hz, 1H), 4.65 (d, J 
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= 5.7 Hz, 2H), 2.21-2.09 (comp. m, 2H), 2.08-1.98 (comp. m, 2H), 1.77-1.66 (comp. m, 
2H), 1.66-1.53 (comp. m, 2H); 13C NMR (75 MHz, CDCl3) δ 153.1, 142.2, 131.5, 120.8, 
118.8, 68.5, 30.0, 26.6, 23.1, 22.3; IR (Neat Film NaCl) 2936, 1755, 1705, 1367, 1276, 
1247, 1216, 1034, 786 cm–1; HRMS (EI) m/z calc'd for C11H13D3O3 [M]+: 199.1288, found 
199.1280. 
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Comparison 1H NMR spectra: 
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Enantioselective Tsuji Allylation of Deuterated Substrates 
O O
O DD
294
Pd2(dba)3
(S)-t-Bu-PHOX
THF, 25 °C, 2 h
88% yield, 87% ee
of combined D isomers
O
D
D O D D
1.00 : 1.07
296 297
 
Dideuterio allyl enol carbonate 294 (39.7 mg, 0.2 mmol, 1.0 equiv) was exposed 
under our standard allylation conditions (see Chapter 2).  After 2 h, the reaction was 
complete by TLC.  GC analysis showed an 88.1% yield and an 87% ee for the mixture of 
products.  Flash chromatography (SiO2, 1 → 2.5% Et2O in pentane) afforded material for 
NMR analysis, which allowed the ratio of products to be quantified (vide infra). 
 
O O
O
CD3
O O
O
O
O
CD3
D
O D
D
Pd2(dba)3
(S)-t-Bu-PHOX
THF, 25 °C, 2 h
88% yield, 87% ee
of combined D isomers294 295
O D
CD3
+ isomer
+ isomer
D
D 106
298
297
300
296
299
 
Dideuterio allyl enol carbonate 294 (19.9 mg, 0.1 mmol, 1.0 equiv) and trideuterio allyl enol 
carbonate 295 (19.8 mg, 0.1 mmol, 1.0 equiv) were simultaneously exposed to our standard 
conditions (see Chapter 2).  After 2 h, the reaction was complete by TLC.  GC analysis showed 
an 88.4% yield and an 87% ee for the mixture of products.  Flash chromatography (SiO2, 1 → 
2.5% Et2O in pentane) afforded material for MS and NMR analysis, which allowed the ratio of 
products to be quantified (vide infra). 
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Mass Spectral Analysis of Crossover Experiments 
 
A Representative MS Scan 
O D DO
D
DO
O CD3
D
DO CD3
D
DO CD3
Exact Mass: 152.1201 Exact Mass: 154.1327
Exact Mass: 157.1515Exact Mass: 155.1389
Exact Mass: 154.1327
Exact Mass: 157.1515
 
 
Relative Abundance of Four Product Masses 
 
Mass Scans Integral % Abundance
152.1183           110-118                459336                      21.23 %
154.1328           110-118                478480                      22.12 %
155.1388           108-118                720536                      33.31 %
157.1522           107-118                504864                      23.34 %
Total      2163216                     100 %  
Although the total ion counts are not rigorously quantitative, they clearly suggest that 
all four masses are present in nearly equal proportions.  This was the case whether the 
reaction was run in THF, dioxane, or benzene. 
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31P NMR study of catalyst resting state.  In a nitrogen atmosphere glove box Pd2(dba)3 
(3.0 mg, 3.3 µmol, 1 equiv, dark red-purple powder) was weighed out in a 1 dram vial.  
Solid (S)-t-Bu-PHOX ligand (55, 3.3 mg, 8.5 µmol, 2.6 equiv, white crystalline solid) 
was weighed out in a second 1 dram vial.  THF (1 mL) that had been dried on an alumina 
column and then stored over 4Å molecular sieves in the glove box was filtered through a 
pipette filter constructed with a 2.4 mm GF/A Whatman glass microfiber filter directly 
into the vial containing the (S)-t-Bu-PHOX ligand.  The solution was mixed manually by 
pipette until all the material had dissolved forming a clear colorless solution.  The 
solution was then moved by pipette and added to the vial containing Pd2(dba)3.  This 
solution was mixed manually by pipette for 1 min during which time a dark red-purple 
solution formed that then lightened to a dark but richly orange color.  This solution was 
then filtered through a pipette filter constructed with a 2.4 mm GF/A Whatman glass 
microfibre filter directly into an NMR tube separating a bright, richly orange filtrate from 
a black amorphous precipitate presumed to be colloidal Pd(0) particles.  The NMR tube 
was then sealed with an appropriately sized septum and removed from the glove box.  
NMR spectrum #1 was taken at this time.  Neat 1-methyl-2-oxo-cyclohexanecarboxylic 
acid allyl ester (107) (12.3 mg, 62.8 µmol, 19.1 equiv) was weighed and added to the 
NMR tube via a 25 µL Hamilton syringe in a single portion.  The NMR tube was shaken 
vigorously for 30 s, and the solution quickly changed color from a rich orange to a lighter 
yellow-green.  NMR spectrum #2 was taken at this time.  The NMR tube was then placed 
in an oil bath regulated at 24 °C and warmed for 3 h, which was 20 min longer than it 
took for the solution’s color to change to a rich orange from a lighter yellow-green.  
NMR spectrum #3 was taken at this time. 
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31P NMR study of catalyst decomposition in ambient air.  In a nitrogen atmosphere 
glove box, Pd2(dba)3 (3.0 mg, 3.3 µmol, 1 equiv, dark red-purple powder) was weighed 
out in a 1 dram vial.  Solid (S)-t-Bu-PHOX ligand (55, 3.3 mg, 8.5 µmols, 2.6 equiv, 
white crystalline solid) was weighed out in a second 1 dram vial.  THF (1 mL) that had 
been dried on an alumina column and then stored over 4 Å molecular sieves in the glove 
box was filtered through a pipette filter constructed with a 2.4 mm GF/A Whatman glass 
microfiber filter directly into the vial containing the (S)-t-Bu-PHOX ligand (55).  The 
solution was mixed manually by pipette until all the material had dissolved forming a 
clear colorless solution.  The solution was then moved by pipette and added to the vial 
containing Pd2(dba)3.  This solution was mixed manually by pipette for 1 min during 
which time a dark red-purple solution formed that then lightened to a dark but richly 
orange solution.  This solution was then filtered through a pipette filter constructed with a 
2.4 mm GF/A Whatman glass microfibre filter directly into an NMR tube separating a 
bright, rich orange filtrate from a black amorphous precipitate presumed to be colloidal 
Pd(0) particles.  The NMR tube was then sealed with a standard appropriately sized 
plastic cap and removed from the glove box.  NMR spectrum #4 was taken at this time.  
The NMR tube was then uncapped on the bench, and quickly flushed with a jet of air to 
purge the inert atmosphere above the solution in the tube.  After 7 h, the solution in the 
tube had faded from a rich orange to lighter yellow color.  NMR spectrum #5 was taken 
at this time.  The tube was left to stand for another 36 h at which point clear crystalline 
masses had formed.  NMR spectrum #6 was taken at this time. 
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31P NMR study of the Pd-catalyzed conversion of (S)-t-Bu-PHOX to (S)-t-Bu-PHOX 
oxide with ambient air as the oxident.  In a nitrogen glove box, (S)-t-Bu-PHOX ligand 
(55, 18.7 mg, 48.3 µmol, 1 equiv, white crystalline powder) followed by Pd2(dba)3 (4.8 
mg, 5.2 µmol, 0.108 equiv, 10.8 mol%, dark red-purple powder) were weighed directly 
into a 1 dram vial.  THF (1 mL) that had been dried on an alumina column and then 
stored over 4 Å molecular sieves in the glove box was filtered through a pipette filter 
constructed with a 2.4 mm GF/A Whatman glass microfiber filter directly into the vial.  
The solution was mixed manually by pipette for 5 min and then left to mix by diffusion 
for another 20 min, during which time an initially dark red-purple solution formed that 
then lightened to a rich orange color.  The solution was then filtered through a pipette 
filter constructed with a 2.4 mm GF/A Whatman glass microfibre filter directly into an 
NMR tube separating a bright, richly orange filtrate from a black amorphous precipitate 
presumed to be colloidal Pd(0) particles.  The NMR tube was then sealed with an 
appropriately sized septum and removed from the glove box.  NMR spectrum #7a was 
taken at this time.  (S)-t-Bu-PHOX oxide (125, 1.97 mg, 4.9 µmol, 0.101 equiv, 10 
mol%, white powder) was weighed out in a 0.5 dram vial.  The vial was then sealed with 
a septum and sparged with argon for 10 s.  Anhydrous THF (0.2 mL) was added to the 
0.5 dram vial by syringe.  The vial was swirled manually until all of its contents dissolved 
forming a clear solution.  The solution in the 0.5 dram vial was then moved by syringe 
and added as a single portion to the NMR tube.  NMR spectrum #8a was taken at this 
time.  The NMR tube was then opened up on the bench and briefly flushed with a jet of 
ambient air to expel the layer of inert atmosphere above the solution in the tube. 
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A second NMR tube was flame dried and backfilled with argon.  (S)-t-Bu-PHOX 
ligand (55, 5.0 mg, 12.9 µmol, white crystalline powder) was weighed out and added to 
the second NMR tube.  Anhydrous THF (1 mL) was added to the second NMR tube via a 
syringe, dissolving the contents of the tube and forming a clear solution.  The second 
NMR tube was then opened on the bench and briefly flushed with a jet of ambient air to 
expel the layer of inert atmosphere above the solution in the tube. 
 
Both NMR tubes were then left opened in an oil bath heated to 25 °C.  After 2 h the 
NMR spectra #9a and #9b were taken of the NMR tube containing the mixture of Pd and 
ligand, and the NMR tube containing only the ligand, respectively.  At 10 h NMR spectra 
#10a and #10b were taken.  At 53 hours NMR spectra #11a and #11b were taken.  At 160 
hours NMR spectra #12a and #12b were taken. 
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31P NMR studies of catalyst decomposition in air from the catalyst’s resting state.  In 
a nitrogen glove box Pd2(dba)3 (8.4 mg, 9.17 µmol, 0.04 equiv, 4.3 mol%, dark red-
purple powder) followed by (S)-t-Bu-PHOX (55, 22.0 mg, 56.8 µmol, 26.8 mol%, white 
crystalline powder) were weighed out neat into a single 1 dram vial.  THF (1 mL) that 
had been dried on an alumina column and then stored over 4 Å molecular sieves in the 
glove box, was filtered through a pipette filter constructed with a 2.4 mm GF/A Whatman 
glass microfiber filter directly into the 1 dram vial.  The solution was mixed manually by 
pipette for 5 min and then left to mix by diffusion for another 10 min, during which time 
an initially dark red-purple solution formed that then lightened to a rich orange color.  
The solution was then filtered through a pipette filter constructed with a 2.4 mm GF/A 
Whatman glass microfibre filter directly into an NMR tube separating a bright, rich 
orange filtrate from a black amorphous precipitate presumed to be colloidal Pd(0) 
particles.  The NMR tube was sealed with an appropriately sized septum and removed 
from the glove box.  NMR spectrum #13 was taken at this time.  Neat 1-methyl-2-oxo-
cyclohexanecarboxylic acid allyl ester (107) (41.5 mg, 211.5 µmol, 1 equiv) was weighed 
out and added in a single portion via a 100 µL Hamilton syringe.  The NMR tube was 
inverted once, and immediately changed color from a rich orange to a lighter yellow-
green.  NMR spectrum #14 was taken at this time.  The NMR tube was then uncapped on 
the bench, and quickly flushed with a jet of air to expel the inert atmosphere above the 
solution in the tube.  The NMR tube was left open and then placed in an oil bath 
regulated to 25 °C.  After 2 h, NMR spectrum #15 was taken.  After 16 h NMR spectrum 
#16 was taken.  After 48 h NMR spectrum #17 was taken.  After 160 h NMR spectrum 
#18 was taken.  The solution had turned a light yellow by this juncture. 
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31P NMR study of acetate then acid addition to the palladium π-allyl cation.   
[Pd(II)(allyl)PHOX]•PF6 salt (165) (12.8 mg, 18.8 µmol, 1 equiv, white powder) was 
weighed out in a 1 dram vial.  Anhydrous THF (0.5 mL) was added to the 1 dram vial via 
syringe.  The vial was sealed, and the solution was mixed manually by swirling until all 
the solids had dissolved leaving a faintly colored solution.  The solution was then 
transferred via pipette into an NMR tube.  NMR spectrum #19 was then collected, 
showing the endo and exo isomers (23.5 ppm and 22.5 ppm, unknown correspondence) 
of the [Pd(II)(allyl)PHOX] cation, and the septuplet of the PF6– anion.  Tetra-n-
butylammonium acetate (8.8 mg, 30.6 µmol, 1.6 equiv, hygroscopic white nuggets) was 
weighed into a separate 1 dram vial.  Anhydrous THF (0.3 mL) was added to the new vial 
via syringe.  The vial was sealed, and the solution was mixed manually by swirling until 
all the solids had dissolved, forming a clear colorless solution.  The solution was 
transferred via pipette in a single portion to the NMR tube.  Upon addition, the solution 
instantly became yellow as the two solutions mixed.  The NMR tube was sealed and 
mixed via a single complete inversion turning the entire solution yellow.  A 31P NMR 
spectrum was collected at this time (not depicted) that showed a broad fluxional 
resonance at 29.9 ppm presumed to be an averaged state of an equilibrium.  An additional 
7.4 mg of tetra-n-butylammonium acetate (25.7 µmol, 1.37 equiv, 3.07 equiv total, 
hygroscopic white nuggets) was weighed out in a third 1 dram vial.  Anhydrous THF (0.2 
mL) was added to the third vial via syringe.  The vial was sealed, and the solution was 
mixed manually by swirling until all the solids had dissolved, forming a clear colorless 
solution.  This solution was transferred via pipette in a single portion to the NMR tube.  
The NMR tube was sealed and mixed via a single complete inversion causing a very 
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subtle color shift in the solutions appearance.  NMR spectrum #20 was collected at this 
time.  Tetrafluoroboric acid diethyl ether adduct (54% weight in diethyl ether, 19.6 mg, 
65.4 µmol, 3.47 equiv, light orange viscous solution) was weighed in a 100 µL Hamilton 
syringe under a blanket of argon, and then added to the NMR tube in a single portion.  
The NMR tube was sealed and mixed via a single complete inversion, causing the color 
to rapidly fade from bright yellow to faint beige.  NMR spectrum #21 was collected at 
this time. 
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Figure A2.2  IR of compound 241 (NaCl/film) 
Figure A2.3  13C NMR of compound 241 (75 MHz, CDCl3) 
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Figure A2.6  13C NMR of compound 244 (75 MHz, CDCl3) 
Figure A2.5  IR of compound 244 (NaCl/film) 
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Figure A2.8  IR of compound 237 (NaCl/film) 
Figure A2.9  13C NMR of compound 237 (75 MHz, CDCl3) 
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Figure A2.13  IR of compound 107 (NaCl/film) 
Figure A2.14  13C NMR of compound 107 (75 MHz, CDCl3) 
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Figure A2.16  IR of compound 248 (NaCl/film) 
Figure A2.17  13C NMR of compound 248 (75 MHz, CDCl3) 
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Figure A2.20  13C NMR of compound 250 (75 MHz, CDCl3) 
Figure A2.19  IR of compound 250 (NaCl/film) 
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Figure A2.22  IR of compound 252 (NaCl/film) 
Figure A2.23  13C NMR of compound 252 (75 MHz, CDCl3) 
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Figure A2.25  IR of compound 254 (NaCl/film) 
Figure A2.26  13C NMR of compound 254 (75 MHz, CDCl3) 
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Figure A2.28  IR of compound 256 (NaCl/film) 
Figure A2.29  13C NMR of compound 256 (75 MHz, CDCl3) 
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Figure A2.31  IR of compound 258 (NaCl/film) 
Figure A2.32  13C NMR of compound 258 (75 MHz, CDCl3) 
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Figure A2.34  IR of compound 260 (NaCl/film) 
Figure A2.35  13C NMR of compound 260 (75 MHz, CDCl3) 
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Figure A2.37  IR of compound 306 (NaCl/film) 
Figure A2.38  13C NMR of compound 306 (75 MHz, CDCl3) 
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Figure A2.40  IR of compound 307 (NaCl/film) 
Figure A2.41  13C NMR of compound 307 (75 MHz, CDCl3) 
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Figure A2.44  13C NMR of compound 308 (75 MHz, CDCl3) 
Figure A2.43  IR of compound 308 (NaCl/film) 
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Figure A2.46  IR of compound 293 (NaCl/film) 
Figure A2.47  13C NMR of compound 293 (75 MHz, CDCl3) 
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Figure A2.49  IR of compound 309 (NaCl/film) 
Figure A2.50  13C NMR of compound 309 (75 MHz, CDCl3) 
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Figure A2.54  IR of compound 311 (NaCl/film) 
Figure A2.55  13C NMR of compound 311 (75 MHz, CDCl3) 
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Figure A2.57  IR of compound 312 (NaCl/film) 
Figure A2.58  13C NMR of compound 312 (75 MHz, CDCl3) 
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Figure A2.63  13C NMR of compound 318 (75 MHz, CDCl3) 
Figure A2.62  IR of compound 318 (NaCl/film) 
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Figure A2.69  IR of compound 271 (NaCl/film) 
Figure A2.70  13C NMR of compound 271 (75 MHz, CDCl3) 
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Figure A2.76  IR of compound 326 (NaCl/film) 
Figure A2.77  13C NMR of compound 326 (75 MHz, CDCl3) 
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Figure A2.80  13C NMR of compound 327 (75 MHz, CDCl3) 
Figure A2.79  IR of compound 327 (NaCl/film) 
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Figure A2.83  13C NMR of compound 328 (75 MHz, CDCl3) 
Figure A2.82  IR of compound 328 (NaCl/film) 
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Figure A2.86  13C NMR of compound 329 (75 MHz, CDCl3) 
Figure A2.85  IR of compound 329 (NaCl/film) 
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Figure A2.89  13C NMR of compound 330 (75 MHz, CDCl3) 
Figure A2.88  IR of compound 330 (NaCl/film) 
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Figure A2.92  13C NMR of compound 331 (75 MHz, CDCl3) 
Figure A2.91  IR of compound 331 (NaCl/film) 
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Figure A2.94  IR of compound 332 (NaCl/film) 
Figure A2.95  13C NMR of compound 332 (75 MHz, CDCl3) 
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Figure A2.98  13C NMR of compound 333 (75 MHz, CDCl3) 
Figure A2.97  IR of compound 333 (NaCl/film) 
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Figure A2.100  IR of compound 106 (NaCl/film) 
Figure A2.101  13C NMR of compound 106 (75 MHz, CDCl3) 
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Figure A2.103  IR of compound 235 (NaCl/film) 
Figure A2.104  13C NMR of compound 235 (75 MHz, CDCl3) 
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Figure A2.106  IR of compound 249 (NaCl/film) 
Figure A2.107  13C NMR of compound 249 (75 MHz, CDCl3) 
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Figure A2.110  13C NMR of compound 251 (75 MHz, CDCl3) 
Figure A2.109  IR of compound 251 (NaCl/film) 
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Figure A2.112  IR of compound 253 (NaCl/film) 
Figure A2.113  13C NMR of compound 253 (75 MHz, CDCl3) 
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Figure A2.116  13C NMR of compound 153 (75 MHz, CDCl3) 
Figure A2.115  IR of compound 153 (NaCl/film) 
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Figure A2.118  IR of compound 255 (NaCl/film) 
Figure A2.119  13C NMR of compound 255 (75 MHz, CDCl3) 
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Figure A2.122  13C NMR of compound 257 (75 MHz, CDCl3) 
Figure A2.121  IR of compound 257 (NaCl/film) 
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Figure A2.124  IR of compound 259 (NaCl/film) 
Figure A2.125  13C NMR of compound 259 (75 MHz, CDCl3) 
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Figure A2.127  IR of compound 261 (NaCl/film) 
Figure A2.128  13C NMR of compound 261 (75 MHz, CDCl3) 
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Figure A2.130  IR of compound 150 (NaCl/film) 
Figure A2.131  13C NMR of compound 150 (75 MHz, CDCl3) 
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Figure A2.134  13C NMR of compound 155 (75 MHz, CDCl3) 
Figure A2.133  IR of compound 155 (NaCl/film) 
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Figure A2.136  IR of compound 262 (NaCl/film) 
Figure A2.137  13C NMR of compound 262 (75 MHz, CDCl3) 
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Figure A2.140  13C NMR of compound 149 (75 MHz, CDCl3) 
Figure A2.139  IR of compound 149 (NaCl/film) 
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Figure A2.142  IR of compound 98 (NaCl/film) 
Figure A2.143  13C NMR of compound 98 (75 MHz, CDCl3) 
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Figure A2.145  IR of compound 157 (NaCl/film) 
Figure A2.146  13C NMR of compound 157 (75 MHz, CDCl3) 
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Figure A2.150  IR of compound 148 (NaCl/film) 
Figure A2.151  13C NMR of compound 148 (75 MHz, CDCl3) 
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Figure A2.153  IR of compound 264 (NaCl/film) 
Figure A2.154  13C NMR of compound 264 (75 MHz, CDCl3) 
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Figure A2.159  13C NMR of compound 266 (75 MHz, CDCl3) 
Figure A2.158  IR of compound 266 (NaCl/film) 
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Figure A2.165  IR of compound 272 (NaCl/film) 
Figure A2.166  13C NMR of compound 272 (75 MHz, CDCl3) 
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Figure A2.170  IR of compound 274 (NaCl/film) 
Figure A2.171  13C NMR of compound 274 (75 MHz, CDCl3) 
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Figure A2.173  IR of compound 275 (NaCl/film) 
Figure A2.174  13C NMR of compound 275 (75 MHz, CDCl3) 
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Figure A2.176  IR of compound 276 (NaCl/film) 
Figure A2.177  13C NMR of compound 276 (75 MHz, CDCl3) 
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Figure A2.179  IR of compound 278 (NaCl/film) 
Figure A2.180  13C NMR of compound 278 (75 MHz, CDCl3) 
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Figure A2.182  IR of compound 279 (NaCl/film) 
Figure A2.183  13C NMR of compound 279 (75 MHz, CDCl3) 
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Figure A2.185  IR of compound 280 (NaCl/film) 
Figure A2.186  13C NMR of compound 280 (75 MHz, CDCl3) 
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Figure A2.189  13C NMR of compound 281 (75 MHz, CDCl3) 
Figure A2.188  IR of compound 281 (NaCl/film) 
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Figure A2.192  13C NMR of compound 294 (75 MHz, CDCl3) 
Figure A2.191  IR of compound 294 (NaCl/film) 
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Figure A2.194  IR of compound 295 (NaCl/film) 
Figure A2.195  13C NMR of compound 295 (75 MHz, CDCl3) 
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CHAPTER 4 
Computational Study of the Mechanism 
of the Enantioselective Tsuji Allylation † 
4.1 INTRODUCTION 
Challenges in natural product and pharmaceutical synthesis have fueled the 
development of asymmetric homogeneous catalysis in organometallic chemistry for 
decades.1  In particular, the synthesis of enantioenriched quaternary stereocenters without 
stoichiometric chiral reagents remains an active area of research.   
Recently, we described a method for the enantioselective preparation of quaternary 
stereocenters (Scheme 4.1)2 based on an enantioselective version of the general Tsuji 
decarboxylative allylation.3a  The general allylation process involves oxidative addition to 
an enol carbonate (e.g., 105) by a Pd(0) complex.  The resulting allylated Pd(II) complex 
then reacts with ketone enolates with high regiochemical fidelity to form enantioenriched 
α-quaternary ketones (e.g., 106). 
                                                
† This work was performed in collaboration with John A. Keith, Douglas C. Behenna, Sandy Ma, Smaranda 
C. Marinescu, Jonas Oxgaard, and William A. Goddard, III.  This study has been published.  See: Keith, J. 
A.; Behenna, D. C.; Mohr, J. T.; Ma, S.; Marinescu, S. C.; Oxgaard, J.; Stoltz, B. M.; Goddard, III, W. A. J. 
Am. Chem. Soc. 2007, 129, 11876–11877. 
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Scheme 4.1.  The enantioselective Tsuji allylation 
O O
O
O
(S)-t-Bu-PHOX (6.25 mol%)
Pd2(dba)3 (2.5 mol%)
THF (0.033 M), 25 °C
105 (S)-106
(PHOX) P N ==
NPh2P
O
t-Bu(S)-55  
We reported a series of Pd catalysts that perform enantioselective allylation to form 
quaternary stereocenters from unstabilized prochiral enolates and non-prochiral allyl 
fragments.2  In general, these 2-alkyl-2-allylcyclohexanone products are distinct from the 
majority of asymmetric allylic alkylation products.  In contrast to previous works,1c,3,4 this 
method has allowed the regiospecific allylic alkylation of hard enolates derived from 
ketones having two or more α-acidic sites.  Furthermore, a variety of enolate precursors 
can be employed in these reactions (i.e., enol carbonates, silyl enol ethers, and β-
ketoesters). 
Using the (S)-t-Bu-phosphinooxazoline (PHOX) ligand (55),5 allylated products form 
in high yields (80–99%) and enantiomeric excess (79–92%) with a variety of hard 
enolates.  These ees are reduced to negligible levels when soft enolates are utilized.  
Solvent effects do not seem to play a crucial role in the enantioselectivity of the reaction.6  
Although this level of enantioselectivity is useful for many applications, it would be 
valuable to achieve ees above 95%.  Substantial efforts have not achieved this, prompting 
us to investigate mechanistic details.7 
The observation that the reaction gives consistent levels of enantioselectivity 
regardless of the enolate precursor utilized to generate a particular product2,8 suggested 
that these variants share a common intermediate.  We obtained an X-ray crystal structure 
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for a synthetic Pd(II)-allyl complex 114•PF6 (i.e., 165) and found that it is a viable 
catalytic precursor to the enantioselective decarboxylative allylation reaction.  This 
suggested to us that the allylated complex (114, Figure 4.1) is a likely intermediate in the 
reaction, and thus 114 + 115 (Scheme 4.2) is an intermediate as well. 
Figure 4.1.  X-ray crystal structure for π-allyl complex 114, with PF6 as the counter ion (i.e., 165) 
N
O
t-Bu
P
Ph
Ph
Pd
PF6
•EtOH
114•PF6 = 165
X-ray Structure of 165  
Scheme 4.2.  The enantioselective Tsuji allylation mechanism studied in this work9 
O O
O
O
105
!E = +25.5 kcal/mol
!E + Esolv = +23.4 kcal/mol
(S)-106
!E = 0.0 kcal/mol
!E + Esolv = 0.0 kcal/mol
Pd0(PHOX)
O
enolate (115)
PdII(PHOX)
114
114 + 115
!E = +84.8 kcal/mol
!E + Esolv = +11.6 kcal/mol
CO2
285
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4.2 MECHANISTIC EXPERIMENTS AND COMPUTATIONS 
Two unpublished experiments within our group suggested that we consider just one 
Pd0(PHOX) complex in our investigation of the mechanism: (1) experiments 
demonstrated a linear relationship between the ee of the catalyst and the ee of the 
product; and (2) simple kinetic studies showed that the reaction was first order in 
Pd0(PHOX) and zero order in starting material.  We used quantum chemistry calculations 
to investigate possible mechanisms for the reaction presented in Scheme 4.2 starting from 
intermediate 114 + 115. 
All calculations10 reported in this study employ the B3LYP hybrid flavor of density 
functional theory (DFT) that has been established to provide the most accurate energetics 
of the common methods using Jaguar version 6.5.11 
The lowest energy conformer for intermediate 114 + 115 is a five-coordinate square 
pyramidal structure, 289 (Figure 4.2).  We found that a multitude of external attack 
pathways lead to similar energetics, and the two lowest in energy are 339 (trans-P attack) 
and 340 (trans-N attack).  Neither stereochemistry nor conformation of the allyl fragment 
(endo or exo) has a significant effect on these barriers.   
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Figure 4.2.  Relevant internal coordinates (Å) and thermodynamic energies of intermediates and 
transition states in this study (some atoms from the enolate and PHOX ligand are omitted from the 
figures for clarity) 
289 338 339
292291290340
 
We also considered an inner-sphere mechanism that converts 289 to the square planar 
intermediate 290 via a trigonal bipyramidal transition state 338.  We presumed that 290 
could then form products through an internal C–C coupling mechanism.   
Most interesting is that we find an inner-sphere mechanism that is 2.6 kcal/mol lower 
than that for the external attack in the gas phase and 1.6 kcal/mol lower in THF solvent 
(Figure 4.2). 
A second interesting result is that reductive elimination can occur from 290 to form 
the η2-coordinated product, 292, through a seven-centered transition state (similar to the 
thermally facile Claisen rearrangement),12 291, rather than the standard three-centered 
elimination analogue.13  Transition state 291 is 7.0 kcal/mol lower than 338 in the gas 
phase and 2.5 kcal/mol lower in THF (Figure 4.2). 
Overall, these results contradict previous asymmetric allylic alkylation results 
involving soft enolate nucleophiles, prochiral allyl fragments, and Pd(PHOX) complexes 
that have been determined to proceed through external attack.3c,i,j  Indeed, this mechanism 
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explains how high ees can be obtained without prochiral allyl fragments.  These 
computational results constitute strong evidence of an inner-sphere mechanism in the 
Tsuji allylation reaction and may shed greater light on the details of similar inner-sphere 
processes already reported in the literature, especially those involving allyl–allyl type 
couplings.  
Thus far, the enantiodetermining step of this reaction has not been identified 
satisfactorily.  The current results suggest that a concerted process forms products 
directly from 289 to 292, but have not ruled out stepwise transition states 338 and 291.  
Figure 4.3 summarizes the calculated data. 
Figure 4.3.  Summary of energy pathway  E + Esolv for the enantioselective Tsuji Allylation reaction 
105
114 + 115
289
338
290
291
341
292 106
339
285
285  
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4.4 EXPERIMENTAL SECTION 
4.4.1 MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under 
argon atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.  
Tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) was purchased from Strem and 
stored in a dessicator under argon atmosphere prior to use.  Ligands (S)-t-Bu-PHOX (55), 
(S)-i-Pr-PHOX (122), (R)-i-Pr-PHOX (122), and all substrates were prepared by our 
previously reported methods.14  Reaction temperatures were controlled by an IKAmag 
temperature modulator.  Thin-layer chromatography (TLC) was performed by using E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence 
quenching or anisaldehyde.  ICN silica gel (particle size 0.032–0.063 mm) was used for 
flash chromatography.  Analytical chiral HPLC was performed with an Agilent 1100 
Series HPLC, utilizing a Chiracel OJ column (4.6 mm x 25 cm) obtained from Daicel 
Chemical Industries with visualization at 254 nm.  Analytical achiral GC was performed 
with an Agilent 6850 GC utilizing a DB-WAX column (30 mm x 0.24 mm with 1.0 
mL/min carrier gas flow).  Temperature controlled 1H NMR kinetic experiments were 
performed on a Varian Inova 500 MHz. 
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4.4.2 EXPERIMENTAL PROCEDURES FOR ALLYLIC ALKYLATION 
General Procedure for the Synthesis of Allyl Enol Carbonates 
OCO2allyl
105
O
KOt-Bu
DMF, 0!25 °C
Cl O
O
208
207  
Allyl 2-methylcyclohex-1-enyl carbonate (105):15 To a solution of potassium t-
butoxide (5.88 g, 52.5 mmol, 1.05 equiv) in DMF (100 mL) was added 2-
methylcyclohexanone (207, 6.13 mL, 50 mmol, 1.0 equiv).  After 12 h, the reaction 
mixture was cooled in an ice bath and allyl chloroformate (208, 6.4 mL, 60 mmol, 1.2 
equiv) was added in a dropwise fashion.  After an additional 30 min in the ice bath and 
15 min at 25 °C, the reaction mixture was quenched into water (250 mL), extracted with 
2:1 CH2Cl2:hexanes (4 x 125 mL), dried (MgSO4), and evaporated.  Chromatography 
(2.5→4% Et2O in hexanes on SiO2) afforded the allyl enol carbonate 105 (4.49 g, 46% 
yield) as a colorless oil; 1H NMR (300 MHz, CDCl3) δ 5.94 (ddt, J = 17.4, 10.5, 5.6 Hz, 
1H), 5.36 (dq, J = 17.1, 1.5 Hz, 1H), 5.26 (dq, J = 10.2, 1.2 Hz, 1H), 4.63 (dt, J = 5.7, 1.4 
Hz, 2H), 2.13 (m, 2H), 2.02 (m, 2H), 1.70 (m, 2H), 1.59 (m, 2H), 1.55 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 153.1, 142.2, 131.5, 120.8, 118.8, 68.5, 30.0, 26.6, 23.1, 22.3, 15.7; 
IR (Neat Film NaCl) 3936, 1755, 1275, 1239, 1037 cm–1; HRMS (EI) m/z calc'd for 
C11H16O3 [M]+: 196.1100, found 196.1092. 
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General Procedures for Asymmetric Tsuji Allylation 
O O
O
O
(S)-t-Bu-PHOX (6.25 mol%)
Pd2(dba)3 (2.5 mol%)
THF (0.033 M), 25 °C
105 (S)-106  
A 50 mL round-bottom flask equipped with a magnetic stir bar was flame dried under 
vacuum.  After cooling under dry argon, Pd2(dba)3 (22.9 mg, 0.025 mmol, 0.025 equiv) 
and (S)-t-Bu-PHOX (55, 24.2 mg, 0.0625 mmol, 0.0625 equiv) were added.  After the 
flask was flushed with argon, THF (30 mL) was added, and the contents were stirred at 
25 °C for 30 min, at which time allyl enol carbonate 105 (196.2 mg, 1.0 mmol, 1.0 equiv) 
was added by syringe in one portion.  When the reaction was complete by TLC (2 h), the 
reaction mixture was evaporated under reduced pressure and the residue 
chromatographed (2→3% Et2O in pentane on SiO2) to afford (S)-2-allyl-2-
methylcyclohexanone ((S)-106) (129.6 mg, 85.1% yield, 87% ee) as a colorless oil; 1H 
NMR (300 MHz, CDCl3) δ 5.75–5.61 (m, 1H), 5.05 (s, 1H), 5.01 (m, 1H), 2.40–2.31 
(comp. m, 3H), 2.21 (dd, J = 13.8, 7.5 Hz, 1H), 1.78 (comp. m, 5H), 1.56 (m, 1H), 1.06 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 215.4, 133.7, 117.9, 48.4, 41.9, 38.8, 38.5, 27.4, 
22.6, 21.0; IR (Neat Film NaCl) 2934, 2865, 1707, 1451, 912 cm–1; HRMS (EI) m/z 
calc'd for C10H16O [M]+: 152.1201, found 152.1204; [α]D21 –49.64 (c 2.38, hexane, 98% 
ee). 
 
For results of Tsuji allylations with stabilized enolates (with low pKa values relative to 
the typical ketone enolates employed in these reactions), see Table 4.1 (identical to Table 
2.11 in Chapter 2).  Despite the low levels of enantioselectivity, chemical yield is very high.  
This may imply that an alternate mechanism is accessible with this low pKa substrate (e.g., 
Chapter 4 – Computational Study of the Mechanism of the Enantioselective Tsuji Allylation 597 
an outer sphere mechanism).  Characterization data for new compounds can be found in 
Chapter 2. 
Table 4.1 Asymmetric allylation via stabilized allyl enol carbonates. 
entry % yielda % eeb
3 99 11c
substrate
OCO2allyl
Ph
O
Ph
product entry % yielda % eeb
5 89 2
substrate product
N
O
Ph
OCO2allyl
N
O
Ph
O
O
OCO2allyl
O
O
O O
OCO2allyl
CO2Et
O
CO2Et OCO2allyl O
4 93 0
2 87 2
1 89 24c
190 100
191 192
193 102 196 197
194 195
 
a Isolated yield from reactions with 1.0 mmol of substrate in THF (0.033 M) at 25 °C with 2.5 
mol% Pd2(dba)3 and 6.25 mol% (S)-t-Bu-PHOX (55).  Each reaction was complete in 2 h.  
b Measured by chiral GC or HPLC.  c Absolute stereochemistry of products assigned by analogy. 
Tsuji Allylation with cyclohexenyl substrates 
Ph2P N
O
t-Bu
BrOTMS
Pd2(dba)3 (5 mol%)
TBAT (35 mol%)
THF, 25 °C 4% GC yield
1.25:1 dr
(12.5 mol%)
342
1.05 equiv
O
H
Ph2P N
O
t-Bu
OOTMS
Pd2(dba)3 (5 mol%)
TBAT (35 mol%)
THF, 25 °C 4% GC yield
1.5:1 dr
8% and 31% ee, respectively
(12.5 mol%)
301
1.05 equiv
OEt
O
O
H
55
55
110
110
302
302
 
Sample Procedure 
In a flame dried 1-dram vial, Pd2(dba)3 (4.6 mg, 0.005 mmol), (S)-t-BuPHOX (55, 4.7 
mg, 0.0625 mmol), and TBAT (18.9 mg, 0.035 mmol) were combined.  The vial was 
evacuated for 10 min prior to addition of THF (3 mL).  The mixture was allowed to stir at 
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25 °C for 30 min prior to addition of tridecane (10 µL, 0.4 mmol), silyl enol ether (110, 
18.4 mg, 0.1 mmol), and bromocyclohexene (342, 16.1 mg, 0.105 mmol) via syringe.  
GC yield was determined by a GC assay with tridecane as the internal standard.  
(Isothermal at 80 °C for 5 min, then ramp from 80 °C to 115 °C at 10 °C/min, then 
isothermal at 115 °C for 75 min.  Silyl enol ether: 5.759 min, tridecane: 7.329 min, 
bromocyclohexene: 8.426 min, minor product diastereomer: 72.223 min, major product 
diastereomer: 73.434 min).  Enantiomeric excess was determined by an Agilent 6850 GC 
utilizing a G-TA column (30 mm x 0.25 cm) with 1.0 mL/min carrier gas flow.  The 
method utilized for enantiomeric excess determination was isothermal at 110 °C for 60 
min (major product diastereomer: 47.504 min and 53.594 min (major enantiomer), minor 
product diastereomer: 48.282 min (major enantiomer) and 55.842 min).  Isolation of 
products as a mixture of diastereomers was accomplished by flash chromatography (1 cm 
x 20 cm SiO2, 2% ether in pentane). 
 
O
H
302  
1H NMR (300 MHz) δ 5.74 (complex multiplet, 1H), 5.49 (dddd, 0.7H, J = 11.0, 1.9, 
1.9, 1.9 Hz), 5.20 (dddd, 0.3H, J = 10.1, 2.1, 2.1, 2.1 Hz), 2.84-2.29 (complex multiplet, 
3H), 2.01-1.22 (complex multiplet, 12H), 0.90 (s, 2.1 H), 0.89 (s, 0.9 H); 13C NMR (75 
MHz, CDCl3) δ 216.7, 216.1, 129.6, 129.5, 128.0, 127.3, 52.0, 51.7, 39.5, 39.0, 38.6, 
37.0, 36.0, 28.0, 27.7, 25.4, 24.0, 23.1, 23.0, 22.9, 21.1, 21.0, 19.4, 18.6; IR (Neat Film, 
NaCl) 3023, 2934, 2862, 1705, 1452, 1313, 1121 cm–1; HRMS m/z calc’d for C13H24O 
[M+]: 192.1514, found 192.1519. 
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Procedures and results of nonlinear and kinetic experiments can be found in Chapter 3.   
Procedures and data for the [(PHOX)Pd(allyl][PF6] salt 165 can be found in Chapter 2. 
Spectra of the relevant compounds can be found in Appendix 1. 
 
4.4.3 ATOMIC COORDINATES FOR CALCULATED COMPLEXES 
Calculation details: 
All calculations were run using Jaguar 6.5 
Geometry optimization was done with a mixed basis set (MIDI! on all atoms except N, 
P, Pd, the six atoms from the allyl fragment and enolate component which were treated with 
LACVP or 6-31G*). 
“Gas Phase Energy” was calculated as single point energy calculations from the above 
geometries with the LACV3P**++ basis set with both B3LYP and PBE. 
“Solvent Phase Energy” was calculated with B3LYP and the LACV3P** basis set.  
Diffuse functions were omitted, as they appear to have adverse effects on Jaguar’s solvation 
model.  Solvent = THF (probe radius = 2.527Å, ε = 7.52). 
“Zero Point Energy” was calculated from analytic vibrational frequencies. 
All transition states were reported were fully optimized and yielded one imaginary 
frequency. 
Contact John Keith for other calculation details (johnk@wag.caltech.edu) 
***************************************************************** 
----------------------------------------------------------------- 
Complex 105 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -654.64331885491      = Eh 
Solvent Phase Energy     = -0.01095745854        = Eh 
Zero Point Energy        = 159.985               = kcal/mol 
 
(PBE) 
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Gas Phase Energy         = -653.82932310282      = Eh 
 
Geometry Coordinates 
  C1            0.0113083798      0.0124257236     -0.0061783496 
  C2           -0.0013818048      0.0086824472      1.3267454073 
  C3            1.2339260089      0.0153211569      2.1717260330 
  O4            1.1429594509     -1.0908202308      3.1072486300 
  C5            2.1186404294     -1.1171196145      4.0385647212 
  O6            3.0180904838     -0.3191945640      4.1324261749 
  O7            2.0035448532     -2.1647199625      4.8809113190 
  C8            0.8991992312     -3.0435401244      4.8363028339 
  C9            1.0771331487     -4.2973061924      4.4017656946 
  H10          -0.9133147377      0.0566512194     -0.5891741503 
  H11           0.9476871255     -0.0189251237     -0.5744052870 
  H12          -0.9534029285      0.0384538672      1.8713083079 
  H13           2.1474818658     -0.0980871386      1.5652816886 
  H14           1.3285573872      0.9488691482      2.7535568736 
  C15          -1.5746866876     -3.4044541922      5.1922740477 
  C16          -0.3551976806     -2.4877409835      5.4538668734 
  C17          -0.0529567564     -5.3043896563      4.4860652339 
  C18          -1.1917306988     -4.8771957822      5.4433840026 
  H19          -1.9051008295     -3.2856823628      4.1486577507 
  H20          -2.4102397826     -3.1039696803      5.8392585659 
  H21          -0.2035478549     -2.3634255284      6.5406674169 
  H22          -0.5522573151     -1.4841068032      5.0483581460 
  H23          -0.4659570753     -5.4740200848      3.4748151872 
  H24           0.3551672995     -6.2753897821      4.8132244080 
  H25          -0.8589056652     -4.9939727985      6.4867831715 
  H26          -2.0626868838     -5.5322187705      5.3021157953 
  C27           2.3661026241     -4.7966479686      3.8064196230 
  H28           2.7491463200     -5.6575604840      4.3802683709 
  H29           2.2066227425     -5.1482417926      2.7722771430 
  H30           3.1442248494     -4.0244807837      3.7932077238 
 
----------------------------------------------------------------- 
Complex 106 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -466.03738555019      = Eh 
Solvent Phase Energy     = -0.00763066733        = Eh 
Zero Point Energy        = 151.022               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -465.41294401844      = Eh 
 
Geometry Coordinates 
  C1           -0.0109108095     -0.0090913358     -0.0039725405 
  C2           -0.0019377287      0.0036042017      1.3311872844 
  C3            1.2380737348     -0.0031750635      2.1857876305 
  C4            1.4287766106     -1.2691160917      3.0695595585 
  C5            2.7189398847     -1.0964231308      3.9031287517 
  O6            3.5264703528     -0.2162058183      3.6688334943 
  C7            0.2197252134     -1.4655974661      4.0267158875 
  C8            0.4425853342     -2.5256322103      5.1342095225 
  C9            1.6991627758     -2.1908086263      5.9645485923 
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  C10           2.9434642135     -2.0867930224      5.0391924948 
  H11          -0.0056320434     -0.5013459258      4.5157686164 
  H12          -0.6675204448     -1.7358556422      3.4339196855 
  H13           0.5474941665     -3.5277876176      4.6914167333 
  H14          -0.4422202193     -2.5569111685      5.7863780637 
  H15           1.5517832876     -1.2318804997      6.4865076425 
  H16           1.8737722150     -2.9553599127      6.7343017634 
  H17           3.8338193270     -1.7655138907      5.5946626836 
  H18           3.1533849642     -3.0833841603      4.6143920855 
  C19           1.6086725483     -2.5137696692      2.1667783431 
  H20           2.4990070331     -2.4061609466      1.5279721473 
  H21           1.7168858220     -3.4408988269      2.7458276242 
  H22           0.7345201419     -2.6209798584      1.5084046329 
  H23           1.2232556197      0.8767106710      2.8575081124 
  H24          -0.9639896574      0.0470791753      1.8593952008 
  H25           0.9176493118     -0.0351836527     -0.5858169872 
  H26          -0.9443975068      0.0188140773     -0.5750236071 
  H27           2.1318023368      0.1153535642      1.5506968142 
       ----------------------------------------------------------------- 
Complex CO2 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -188.64660127352      = Eh 
Zero Point Energy        = 7.282                 = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -188.45726211825      = Eh 
 
Geometry Coordinates 
  C1           -0.8753363139      0.6870813764      3.6403431163 
  O2            0.0327656439      1.4194127886      3.5572223432 
  O3           -1.7834484094     -0.0452538213      3.7234453188 
 
----------------------------------------------------------------- 
Complex Pd(PHOX) (285) 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -1566.71636231574     = Eh 
Solvent Phase Energy     = -0.01365948285        = Eh 
Zero Point Energy        = 282.286               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -1565.11360608546     = Eh 
 
Geometry Coordinates 
  Pd1           0.1771925079      0.0303972044     -0.4792913529 
  N2            0.3026055938     -0.1410796128      2.7832384005 
  P3            2.2198705967      0.1131084513      0.4386177259 
  C4           -1.0038182842     -0.4993172805      3.3625614198 
  C5           -1.3695267186      0.7361541683      4.2307918808 
  O6           -0.3882895714      1.7308207778      3.8622197991 
  C7            0.5365601358      1.0775218072      3.0867538636 
  C8            1.7119479275      1.8758559013      2.6970712247 
  C9            2.5690975521      1.5236726441      1.6174755080 
  H10          -1.2808860521      0.5535120633      5.3074731832 
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  H11          -2.3613727745      1.1431853758      4.0214715692 
  H12          -1.7172300412     -0.5928340006      2.5308864595 
  C13          -0.9841978369     -1.8701715435      4.0945009747 
  C14          -2.3648552261     -2.1070062927      4.7373306520 
  H15          -2.5902874904     -1.3712288252      5.5181278530 
  H16          -3.1649458690     -2.0598774342      3.9887377476 
  H17          -2.4051576939     -3.0976292088      5.2029555345 
  C18           0.1177154570     -1.9123891038      5.1697106313 
  H19          -0.0286262495     -1.1533905905      5.9471385087 
  H20           0.1230764126     -2.8888419941      5.6667758799 
  H21           1.1022823775     -1.7536811771      4.7207186916 
  C22          -0.7141035645     -2.9721399418      3.0521117944 
  H23          -0.6925443510     -3.9577358762      3.5312475708 
  H24          -1.4991625169     -2.9905243568      2.2864005629 
  H25           0.2426939315     -2.8105282874      2.5505088026 
  C26           3.8406411180     -3.7385110338      2.5048718642 
  C27           4.1074926647     -2.4953066171      3.0804314492 
  C28           3.6158390117     -1.3260446596      2.4942467370 
  C29           2.8405525532     -1.3857520540      1.3280198613 
  C30           2.5686003340     -2.6405304324      0.7628757974 
  C31           3.0698671727     -3.8065787580      1.3421728173 
  H32           4.2263028740     -4.6465171258      2.9601381937 
  H33           4.7048511534     -2.4314405374      3.9864012030 
  H34           3.8388033638     -0.3655148675      2.9489214760 
  H35           1.9555010794     -2.6973239457     -0.1333013057 
  H36           2.8521177860     -4.7695353786      0.8877957053 
  C37           5.4861173515      0.6665806808     -2.8578378957 
  C38           4.2062548075      1.2036606991     -3.0082511302 
  C39           3.2507099574      1.0247192022     -2.0079837737 
  C40           3.5613462203      0.3211578322     -0.8338278752 
  C41           4.8523299578     -0.2141929668     -0.6939888728 
  C42           5.8049371963     -0.0441991918     -1.7000423116 
  H43           6.2285709031      0.7952972902     -3.6409822040 
  H44           3.9476943978      1.7523924171     -3.9099742196 
  H45           2.2440352795      1.4175481875     -2.1322906313 
  H46           5.1159062955     -0.7705053528      0.1999946198 
  H47           6.7974292943     -0.4705309077     -1.5784051954 
  C48           3.6692839902      2.3615463383      1.3687018727 
  H49           4.3411402151      2.1287397114      0.5515794144 
  C50           1.9763230183      3.0296087707      3.4539024330 
  H51           1.3009806790      3.2790098495      4.2642189791 
  C52           3.9287604198      3.4947888886      2.1392257713 
  H53           4.7973722597      4.1073788890      1.9123437951 
  C54           3.0767496909      3.8370912632      3.1861609677 
  H55           3.2645320738      4.7206656803      3.7890262267 
----------------------------------------------------------------- 
 
***************************************************************** 
----------------------------------------------------------------- 
Complex 115 
----------------------------------------------------------------- 
 
(B3LYP) 
Gas Phase Energy         = -348.71065236365      = Eh 
Solvent Phase Energy     = -0.08425259124        = Eh 
Zero Point Energy        = 102.902               = kcal/mol 
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(PBE) 
Gas Phase Energy         = -348.25500040654      = Eh 
 
Geometry Coordinates  
  O1           -0.0003410345      0.0018492883     -0.0018906891 
  C2           -0.0012930859     -0.0008335598      1.2724903838 
  C3            1.1061593054     -0.0010872893      2.1166904574 
  C4           -1.4104526170     -0.0319872575      1.9233471036 
  C5            2.4818715361      0.0739164076      1.5196859652 
  C6           -1.4515514456      0.3591684973      3.4170181569 
  C7           -0.3527287552     -0.4105932402      4.1753994277 
  C8            1.0376837131     -0.0101397774      3.6211509483 
  H9           -1.2650581487      1.4419209104      3.5240176167 
  H10          -2.4459585505      0.1554018823      3.8553292856 
  H11          -0.5098798273     -1.4922663929      4.0247324928 
  H12          -0.4093491028     -0.2110971796      5.2604028648 
  H13           1.3059029375      0.9803472051      4.0738041013 
  H14           1.7916277693     -0.7143291969      4.0427607809 
  H15          -1.8367868734     -1.0464439177      1.7975540590 
  H16          -2.0494777870      0.6403990799      1.3261341092 
  H17           2.3821126706      0.0632008815      0.4232794062 
  H18           3.0422779241      0.9968736269      1.8062482500 
  H19           3.1410928032     -0.7749511975      1.8204725621 
***************************************************************** 
----------------------------------------------------------------- 
Complex 114 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -1683.90795339188     = Eh 
Solvent Phase Energy     = -0.05367430515        = Eh 
Zero Point Energy        = 330.264               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -1682.15272185669     = Eh 
 
Geometry Coordinates 
  Pd1           0.0179829299     -0.0676708739     -0.0340612533 
  C2            0.5050195355     -1.1692203769      1.8489587378 
  C3           -0.8985553714     -1.0206510966      1.6545794544 
  C4            1.3163391626     -0.0389784858      1.8956242167 
  H5           -1.5090774567     -1.9019537550      1.4854221069 
  H6            2.3957602772     -0.1371207332      1.8535746508 
  H7           -1.4192523527     -0.1889278914      2.1262357489 
  H8            0.9276249187      0.9130875980      2.2504672281 
  H9            0.9636611927     -2.1435452811      1.6917623608 
  N10           1.1511428117      1.0692029511     -1.4617307199 
  P11          -1.7174002497     -0.1717162380     -1.5812161704 
  C12           2.6446626690      1.1016133800     -1.4946703082 
  C13           2.9128829823      2.4582786137     -2.1982793762 
  O14           1.6458038779      2.7356867692     -2.8905046568 
  C15           0.7042142647      1.9499153489     -2.3012413409 
  H16           3.6970106065      2.4401837791     -2.9562777418 
  C17          -1.0801338212     -3.5570386762     -4.6791348973 
  C18          -0.9045469272     -3.7929162060     -3.3142014391 
  C19          -1.0864813043     -2.7594305492     -2.3980923311 
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  C20          -1.4620964696     -1.4768035670     -2.8390164366 
  C21          -1.6366193894     -1.2479218533     -4.2131459744 
  C22          -1.4431481568     -2.2866855522     -5.1253184971 
  H23          -0.9335313877     -4.3634376384     -5.3934074944 
  H24          -0.6224696672     -4.7828988999     -2.9639494457 
  H25          -0.9402425784     -2.9505439510     -1.3367592315 
  H26          -1.9276546004     -0.2655093506     -4.5751408796 
  H27          -1.5807296881     -2.1020685290     -6.1880005070 
  C28          -6.0108222495     -0.6827395226      0.0847630174 
  C29          -5.5822308034     -1.5014328706     -0.9587416830 
  C30          -4.2929564870     -1.3649872842     -1.4782699849 
  C31          -3.4198230169     -0.4035262947     -0.9472616242 
  C32          -3.8571442232      0.4141129064      0.1112558776 
  C33          -5.1470706008      0.2775924727      0.6174870591 
  H34          -7.0156694884     -0.7918028681      0.4852892341 
  H35          -6.2527440211     -2.2501124139     -1.3737276006 
  H36          -3.9715041448     -2.0086007331     -2.2926869648 
  H37          -3.1922296286      1.1650736918      0.5348615338 
  H38          -5.4801222065      0.9178646759      1.4308987877 
  C39          -2.0917909438      3.8288111183     -3.9397626248 
  C40          -3.1955760773      3.0087813541     -3.7309847663 
  C41          -3.0479854883      1.8169764747     -3.0216946696 
  C42          -1.8029857361      1.4161325566     -2.5147376653 
  C43          -0.6774653169      2.2487612543     -2.7363715505 
  C44          -0.8484695501      3.4481733444     -3.4474833487 
  H45          -2.1943350346      4.7645713961     -4.4827813227 
  H46          -4.1734051120      3.2929850556     -4.1118290136 
  H47          -3.9204699432      1.1932225546     -2.8516287667 
  H48           0.0149971016      4.0830108962     -3.6095204853 
  H49           3.0945447092      3.2781428195     -1.4921063989 
  C50           3.2673196683     -0.1322099069     -2.2290481406 
  C51           4.8097960218      0.0355752320     -2.2321692566 
  H52           5.1372215469      0.8949872402     -2.8338522574 
  H53           5.1986577741      0.1574569696     -1.2094740686 
  H54           5.2753864147     -0.8611778049     -2.6646233451 
  C55           2.7466860750     -0.2452939683     -3.6796940074 
  H56           2.9375390805      0.6699273619     -4.2584065984 
  H57           3.2584862794     -1.0737003009     -4.1902023908 
  H58           1.6679877242     -0.4548105081     -3.7011281686 
  C59           2.9295243491     -1.4292044742     -1.4578823501 
  H60           3.3997035260     -2.2895861753     -1.9559421718 
  H61           3.3142422646     -1.3859212143     -0.4274744391 
  H62           1.8451801419     -1.6056103459     -1.4248356794 
  H63           3.0184804616      1.1146049470     -0.4645288410 
***************************************************************** 
----------------------------------------------------------------- 
Complex 289 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.73911500101     = Eh 
Solvent Phase Energy     = -0.01784563176        = Eh 
Zero Point Energy        = 434.031               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -2030.53944632755     = Eh 
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Geometry Coordinates 
  Pd1           0.1522421755     -0.1116392671     -0.0014489177 
  C2            0.3201673009     -0.1796904055      2.2760129712 
  O3            2.7683828369     -0.1292058406     -0.0509452580 
  C4           -0.3089759399      1.0020591816      1.8725967702 
  C5            0.3572462693      1.8198794116      0.9189059555 
  C6            3.6231836400     -1.0320514691     -0.4454565077 
  C7            4.5645342779     -0.6017701382     -1.5790101993 
  C8            3.7319944213     -2.2986969229      0.0963151434 
  C9            2.9319355116     -2.6638738931      1.3176139803 
  C10           4.7627721980     -3.3113686164     -0.3585935803 
  H11          -0.1635796499      2.6681043577      0.4843450687 
  H12          -0.2222383097     -0.9166488314      2.8606049645 
  H13           1.4435092171      1.8793455997      0.9323271725 
  H14           1.4035149507     -0.2611482144      2.2437892374 
  H15          -1.3662592386      1.1559400314      2.0796270765 
  N16          -0.0964120286     -2.1721913229     -0.6248671759 
  P17           0.1746800925      0.4526738241     -2.2431717911 
  H18           3.9999458625     -0.5790651765     -2.5330843392 
  H19           4.8626842027      0.4444461070     -1.3794720165 
  H20           2.9495855916     -3.7566841867      1.4997009411 
  H21           3.3236753121     -2.1850991038      2.2432746779 
  H22           1.8783429227     -2.3407749381      1.2329248766 
  H23           4.3030634936     -4.3222079238     -0.4201911164 
  H24           5.5694359641     -3.4207278375      0.4055290059 
  C25          -0.7350831020     -3.2196094825      0.2145874496 
  C26           0.0253384366     -4.4963013059     -0.2322589823 
  O27           0.5646050655     -4.1275435673     -1.5433923246 
  C28           0.5490572057     -2.7557291926     -1.5872860900 
  H29          -0.5979310895     -5.3814233610     -0.3767989277 
  C30           1.0751352456     -0.8356551795     -3.2059721504 
  C31           1.1800742899     -2.1879310773     -2.7905657485 
  H32           0.8671385414     -4.7299403361      0.4300132078 
  C33          -2.2861720057     -3.2868486983      0.0078957052 
  C34          -2.8503553237     -4.4322244334      0.8875736219 
  H35          -2.4968156257     -5.4213090582      0.5626847308 
  H36          -2.5704486745     -4.2925639033      1.9434975890 
  H37          -3.9486254196     -4.4383230060      0.8269120766 
  C38          -2.6429574335     -3.5374779809     -1.4747726814 
  H39          -2.1569173063     -4.4433254395     -1.8650556956 
  H40          -3.7310120313     -3.6646211075     -1.5783460509 
  H41          -2.3418826533     -2.6849977453     -2.0990721550 
  C42          -2.9326790960     -1.9607299977      0.4721737948 
  H43          -4.0245459550     -2.0136723051      0.3421425130 
  H44          -2.7256056999     -1.7760957874      1.5377230994 
  H45          -2.5505778966     -1.1091203781     -0.1060660246 
  H46          -0.5403211568     -2.9996832719      1.2703192523 
  C47           2.3860184274      4.3928572056     -3.2837949551 
  C48           1.1849262514      4.1040696560     -3.9307794581 
  C49           0.4990063076      2.9223334720     -3.6431855483 
  C50           1.0156992509      2.0222375547     -2.6982728271 
  C51           2.2242796977      2.3187630128     -2.0406796476 
  C52           2.9016472517      3.4996854342     -2.3422000820 
  H53           2.9179077889      5.3148280951     -3.5105141300 
  H54           0.7783647615      4.7996636351     -4.6623478042 
  H55          -0.4393082329      2.7098002870     -4.1494234414 
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  H56           2.6195443006      1.6088146650     -1.3055510017 
  H57           3.8379878854      3.7243131230     -1.8353142604 
  C58          -4.0140849884      0.8486431113     -4.2294907723 
  C59          -3.0426757843      0.0654841238     -4.8504161246 
  C60          -1.7758545288     -0.0722575192     -4.2781553383 
  C61          -1.4704573260      0.5697076485     -3.0683288784 
  C62          -2.4649169194      1.3419170502     -2.4406972350 
  C63          -3.7217207787      1.4881266566     -3.0229061547 
  H64          -4.9979071726      0.9582920145     -4.6804358217 
  H65          -3.2670363641     -0.4380494793     -5.7884578786 
  H66          -1.0232965470     -0.6749349737     -4.7796770291 
  H67          -2.2502441947      1.8272918150     -1.4903614712 
  H68          -4.4779273956      2.0969750059     -2.5318640115 
  C69           1.6776467046     -0.4539878202     -4.4182651942 
  H70           1.6202426167      0.5839995041     -4.7339037256 
  C71           1.8801960366     -3.0948204178     -3.6107465389 
  H72           1.9634346085     -4.1239615571     -3.2816818655 
  C73           2.3570314890     -1.3677921209     -5.2172415639 
  H74           2.8120335257     -1.0408065248     -6.1494141375 
  C75           2.4586284413     -2.6978214199     -4.8070394514 
  H76           2.9941504587     -3.4227225064     -5.4152182616 
  C77           5.8108451629     -1.4802030793     -1.7353239197 
  H78           6.5162215574     -1.2846717852     -0.9091958086 
  H79           6.3415542060     -1.2405257562     -2.6715555184 
  C80           5.4125045433     -2.9724497525     -1.7051510232 
  H81           6.2936522790     -3.6113461306     -1.8783039381 
  H82           4.7016915621     -3.1642056614     -2.5260393040 
***************************************************************** 
----------------------------------------------------------------- 
Complex 338 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.73488137273     = Eh 
Solvent Phase Energy     = -0.01873037575        = Eh 
Zero Point Energy        = 434.098               = kcal/mol 
Frequency                = -34.91 
  
(PBE) 
Gas Phase Energy         = -2030.53248097952     = Eh 
 
Geometry Coordinates  
  Pd1           0.0000000000      0.0000000000      0.0000000000 
  O2            0.0000000000      0.0000000000      2.4803720451 
  C3            2.3476054165      0.0000000000      0.7367316679 
  P4           -1.8800020861     -0.5618249390     -1.1806220877 
  N5           -0.7195656370      2.0597627224      0.0137173621 
  C6            0.9064332782     -1.8840233523      0.2142974169 
  C7            2.0445691690     -1.0617588596     -0.0915735806 
  C8           -0.7922314100      0.6676829591      3.2821701313 
  C9           -2.2509241518      0.1857639555      3.2879022041 
  C10          -0.4063556970      1.7062882460      4.1018820247 
  C11           1.0425569704      2.0837572704      4.2713044757 
  C12          -1.3793764863      2.4634873294      4.9843006402 
  C13          -3.1383462101      0.7776325158      4.3901106130 
  C14          -2.8397718715      2.2847274286      4.5576714445 
  H15          -2.9358046298      0.2743380753      5.3511223962 
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  H16          -4.2047722555      0.6135394931      4.1628775917 
  H17          -3.5217147132      2.7350407823      5.2969811729 
  H18          -3.0092349046      2.7942325503      3.5925930708 
  H19          -2.7000559021      0.3900064897      2.2954888901 
  H20          -2.2191406357     -0.9177934332      3.3776356079 
  H21           1.2619118657      3.1338681065      3.9709727183 
  H22           1.3566809869      2.0156057803      5.3358840075 
  H23           1.6974826371      1.4175034753      3.6882268715 
  H24          -1.1277811425      3.5473387431      4.9780721229 
  H25          -1.2778659160      2.1626772194      6.0543878341 
  H26           0.6299523797     -2.6735728266     -0.4795275726 
  H27           3.0728822401      0.7458542597      0.4238115325 
  H28           0.6660856868     -2.0624677761      1.2615306105 
  H29           1.9397681570      0.0474465421      1.7466374505 
  H30           2.5138443074     -1.1399840470     -1.0713262590 
  C31           0.1812309612      3.1604316961      0.4629063979 
  C32          -0.7452405288      3.9527408768      1.4154757460 
  O33          -2.0914874689      3.6008132210      0.9327958474 
  C34          -1.9379362622      2.4149678241      0.2662991991 
  H35          -0.6577173350      5.0398267895      1.3699702015 
  C36          -3.3331200492      0.4700475481     -0.6838786444 
  C37          -3.2113039348      1.7446025095     -0.0738916922 
  H38          -0.6625795277      3.5742926563      2.4425828016 
  C39           0.7450457047      3.9829183995     -0.7415342329 
  C40           1.6788928218      5.0867728182     -0.1831908470 
  H41           1.1333993955      5.8178336242      0.4308846595 
  H42           2.4818338428      4.6497621426      0.4300802510 
  H43           2.1453981695      5.6346533982     -1.0152001957 
  C44          -0.3906385962      4.6292424156     -1.5676040534 
  H45          -1.0344233910      5.2700520102     -0.9488046425 
  H46           0.0405812648      5.2509039584     -2.3665418098 
  H47          -1.0170744416      3.8597922931     -2.0401356505 
  C48           1.5760122526      3.0579503875     -1.6615697933 
  H49           1.9939656734      3.6413559812     -2.4962698698 
  H50           2.4117096252      2.6038245279     -1.1088845448 
  H51           0.9573327549      2.2498820850     -2.0736224508 
  H52           1.0163878771      2.7227230956      1.0184537406 
  C53          -3.4086102107     -4.9030843740     -0.5674705694 
  C54          -3.3279831636     -4.3939449216     -1.8624661290 
  C55          -2.8845741818     -3.0871164255     -2.0789992967 
  C56          -2.5132856862     -2.2791085131     -0.9942049296 
  C57          -2.5818701933     -2.8056336904      0.3091561554 
  C58          -3.0355866321     -4.1061042413      0.5169557627 
  H59          -3.7541665409     -5.9212640420     -0.4019386526 
  H60          -3.6090571493     -5.0145894062     -2.7102397005 
  H61          -2.8244554032     -2.7014474119     -3.0935496837 
  H62          -2.2712339676     -2.1974572829      1.1576893747 
  H63          -3.0889145554     -4.5027041241      1.5287555954 
  C64          -1.4395461626      0.0044342230     -5.7793216043 
  C65          -2.6908340590      0.1962592220     -5.1932725625 
  C66          -2.8553650403      0.0399216749     -3.8163992255 
  C67          -1.7630296496     -0.3100851497     -3.0062840665 
  C68          -0.5044470040     -0.4853757023     -3.6055647271 
  C69          -0.3463340711     -0.3368857458     -4.9827212123 
  H70          -1.3153088822      0.1284774518     -6.8528320453 
  H71          -3.5436197597      0.4722026535     -5.8099053953 
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  H72          -3.8341496035      0.2030161266     -3.3744114483 
  H73           0.3526202106     -0.7246791946     -2.9792211061 
  H74           0.6334966583     -0.4780263819     -5.4328751065 
  C75          -4.6206080175     -0.0498147446     -0.9005027928 
  H76          -4.7270762954     -1.0440822164     -1.3251947583 
  C77          -4.3817107142      2.4461824658      0.2675069522 
  H78          -4.2784088137      3.4157065455      0.7403735308 
  C79          -5.7665363634      0.6634457911     -0.5578048907 
  H80          -6.7482084736      0.2304573169     -0.7366032364 
  C81          -5.6440672192      1.9221918765      0.0236956770 
  H82          -6.5282403983      2.4903939387      0.3019617665 
***************************************************************** 
----------------------------------------------------------------- 
Complex 339 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.72926163396     = Eh 
Solvent Phase Energy     = -0.02182969499        = Eh 
Zero Point Energy        = 434.068               = kcal/mol 
Frequency                = -30.63 
 
(PBE) 
Gas Phase Energy         = -2030.52840672257     = Eh 
 
Geometry Coordinates 
  Pd1           0.0000000000      0.0000000000      0.0000000000 
  C2            0.0000000000      0.0000000000      2.4380822781 
  C3            0.6432168078      0.0000000000      5.2288898795 
  C4           -0.9577996270      0.8242757005      1.8292527455 
  C5           -1.9333911447      0.3010441896      0.9393466568 
  C6            1.3920387959     -1.0411775719      4.6521739538 
  O7            2.4038882128     -0.8626009024      3.8926831343 
  C8            0.9582318422     -2.4964169892      4.8908529369 
  C9            1.1490531325      1.4175118987      5.1694290282 
  C10          -0.5291132928     -0.2378446570      6.1606933875 
  H11          -2.6383125028      0.9742306191      0.4606679979 
  H12          -2.2888799627     -0.7201752021      1.0704217078 
  H13          -0.8301103775      1.9037677609      1.8923316849 
  H14           0.9290103527      0.3785585874      2.8291907710 
  H15          -0.1499539666     -1.0723479593      2.4991565056 
  H16           1.0755042597     -3.0454280781      3.9377318532 
  H17           1.6900573488     -2.9549284256      5.5873659314 
  H18           0.3709363831      2.1387011460      4.8407575547 
  H19           1.4785716180      1.7684365765      6.1722558610 
  H20           2.0158725557      1.4938857868      4.4933295049 
  H21          -0.4306748395      0.4183825616      7.0521528150 
  H22          -1.4820690508      0.0839987822      5.6819176663 
  N23           2.2012755411     -0.1770214513     -0.2701657118 
  P24          -0.0746830027     -0.1706195745     -2.3497321554 
  C25           3.1417415294     -0.7281884090      0.7519737679 
  C26           4.3768076860      0.1876453930      0.5678148220 
  O27           4.1972964798      0.7472717266     -0.7857698346 
  C28           2.8740324098      0.5651857183     -1.0812655715 
  C29           2.4219869655      1.2718017843     -2.3027869054 
  C30           1.1917621682      1.0385633280     -2.9727103546 
  H31           5.3405861920     -0.3246122924      0.5811828515 
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  H32           4.3875997254      1.0240633226      1.2786452064 
  H33           2.7148545860     -0.6192644112      1.7585164888 
  C34           3.4375695046     -2.2484693420      0.5347891135 
  C35           4.3907486126     -2.6996420717      1.6737633360 
  H36           5.3864747323     -2.2393179696      1.5824731914 
  H37           3.9597180661     -2.4271499633      2.6491859319 
  H38           4.5280525539     -3.7907324593      1.6299833012 
  C39           4.0695216000     -2.5273875995     -0.8464098140 
  H40           4.9965819577     -1.9542667694     -0.9971420737 
  H41           4.3206008154     -3.5959200446     -0.9286627601 
  H42           3.3723668218     -2.2834327564     -1.6610162573 
  C43           2.1196406902     -3.0445101136      0.6744536143 
  H44           2.3253943365     -4.1224262846      0.5863410312 
  H45           1.6726112849     -2.8563674501      1.6605266346 
  H46           1.4006668427     -2.7668136954     -0.1079690935 
  C47          -3.9164397725      1.0237571877     -4.6834959146 
  C48          -3.1101506713      0.0008040066     -5.1816198066 
  C49          -1.9486547064     -0.3737647815     -4.5042330557 
  C50          -1.5839113122      0.2712736866     -3.3110678713 
  C51          -2.4103528689      1.2928404124     -2.8118376405 
  C52          -3.5634403651      1.6698713517     -3.4973505416 
  H53          -4.8211297859      1.3126888881     -5.2138114521 
  H54          -3.3846515179     -0.5092779083     -6.1026847695 
  H55          -1.3291652504     -1.1724067821     -4.9036477189 
  H56          -2.1491921337      1.7870732624     -1.8782323947 
  H57          -4.1931451028      2.4637717511     -3.1015363532 
  C58           1.0991936356     -4.2519871459     -4.2399010222 
  C59           1.7062582256     -3.0882490547     -4.7107716932 
  C60           1.3797715802     -1.8494949096     -4.1550951219 
  C61           0.4425787059     -1.7645983729     -3.1129760199 
  C62          -0.1530088040     -2.9457673083     -2.6361437772 
  C63           0.1677128116     -4.1780335204     -3.2029527657 
  H64           1.3542028781     -5.2150802439     -4.6763391844 
  H65           2.4354538428     -3.1416090041     -5.5165096608 
  H66           1.8537370634     -0.9495705283     -4.5385949304 
  H67          -0.8712756638     -2.8985923454     -1.8196670867 
  H68          -0.3040158359     -5.0837941180     -2.8285858033 
  C69           3.0096058630      2.9563150416     -3.9655288892 
  C70           3.3081916232      2.2303795607     -2.8181216893 
  C71           0.9155798386      1.7771799082     -4.1331398154 
  C72           1.8088181324      2.7271029623     -4.6278451081 
  H73           3.7131767993      3.6979080775     -4.3358575125 
  H74           4.2418481011      2.3973850102     -2.2929354265 
  H75          -0.0206353150      1.6132140828     -4.6575701994 
  H76           1.5595325253      3.2848774661     -5.5278170572 
  C77          -0.6739835636     -1.6916908541      6.6302127243 
  H78          -1.6635797548     -1.8512185521      7.0878784722 
  H79           0.0799410992     -1.9102276847      7.4059672475 
  C80          -0.4583710845     -2.6651725868      5.4495242864 
  H81          -1.2066190791     -2.4485879632      4.6667337224 
  H82          -0.6270041583     -3.7050178951      5.7739204697 
***************************************************************** 
----------------------------------------------------------------- 
Complex 340 
----------------------------------------------------------------- 
(B3LYP) 
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Gas Phase Energy         = -2032.72448663528     = Eh 
Solvent Phase Energy     = -0.02524726980        = Eh 
Zero Point Energy        = 433.361               = kcal/mol 
Frequency                = -15.07 
  
(PBE) 
Gas Phase Energy         = -2030.52549546915     = Eh 
 
Geometry Coordinates 
  Pd1           0.0000000000      0.0000000000      0.0000000000 
  C2            0.0000000000      0.0000000000      2.3211968669 
  C3            0.8424999870      0.0000000000      5.2512512366 
  C4           -0.6604120923     -1.9348412135      0.9595233626 
  C5            2.0348324454     -0.2310662807      4.5376139376 
  O6            2.6348456752      0.6466958488      3.8354158531 
  C7            2.6662417406     -1.6330421228      4.5701704904 
  C8            0.2961210408      1.3961934591      5.3680717406 
  C9            0.1728499396     -1.0508920472      6.1098325762 
  H10           0.7948244678      0.5765149642      2.7720940497 
  H11          -1.0279369486      0.3229104883      2.4686154440 
  H12           1.2858408351     -1.6542438342      1.8480005605 
  H13          -0.3944955452     -2.8749897192      0.4852676950 
  H14          -1.7244022252     -1.7326377282      1.0634760359 
  H15           3.5597004710     -1.5853182383      5.2270714149 
  H16           3.0593542203     -1.8489673429      3.5582365913 
  H17          -0.7921611092      1.4502644686      5.1542871484 
  H18           0.4156091570      1.7923032950      6.4009815514 
  H19           0.8276757331      2.0791754177      4.6873643011 
  H20          -0.1086039186     -0.6061760141      7.0889316396 
  H21          -0.7975838993     -1.3648843601      5.6603378580 
  N22          -0.2745441670     -0.2905545527     -2.1920555215 
  P23           0.8648308863      2.1113477013     -0.6693151461 
  C24          -1.2509872732     -1.2571523956     -2.7626386475 
  C25          -0.4420654562     -1.9002773930     -3.9231160958 
  O26           0.6345547654     -0.9384740923     -4.1632467737 
  C27           0.6946263401     -0.1464163899     -3.0415768310 
  C28           1.8728726616      0.7334422716     -2.9853464257 
  C29           2.0761494729      1.7610679965     -2.0218505857 
  H30          -0.9906321073     -2.0177097100     -4.8602362182 
  H31           0.0126772887     -2.8586026226     -3.6381708761 
  H32          -1.4950380278     -2.0010319604     -1.9954775416 
  C33           2.4241038645      2.7233170959      1.5561167438 
  C34           1.7400677103      3.2648340468      0.4560900697 
  C35           1.7305566879      4.6604610113      0.2713410300 
  H36           2.4342950681      1.6572310425      1.7657888990 
  C37          -0.1744459942      3.8005104158     -2.7353763444 
  C38          -0.3842402897      3.1941069380     -1.4871547730 
  C39          -1.5873254814      3.4462197271     -0.8046222505 
  H40           0.7497590375      3.6229391528     -3.2795306915 
  C41          -2.5829048012     -0.5723812117     -3.2115703309 
  C42          -3.5226457050     -1.6611799856     -3.7906283054 
  H43          -3.1206050633     -2.1126142666     -4.7095296194 
  H44          -3.6984259948     -2.4631779990     -3.0568533627 
  H45          -4.4954173395     -1.2140115013     -4.0424949399 
  C46          -2.3236751391      0.5166456810     -4.2766675801 
  H47          -1.7994590868      0.1136099881     -5.1557923258 
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  H48          -3.2821669514      0.9339498639     -4.6198067842 
  H49          -1.7273284056      1.3400238101     -3.8615835900 
  C50          -3.2711894530      0.0620790727     -1.9813446505 
  H51          -4.2359934795      0.5002592874     -2.2786198113 
  H52          -3.4654380926     -0.6960811123     -1.2072950761 
  H53          -2.6515770794      0.8562591986     -1.5472490587 
  C54           3.0863060738      3.5602725378      2.4558857286 
  C55           2.4027650897      5.4884113118      1.1684566451 
  H56          -1.7673404030      2.9824138821      0.1636368688 
  C57           3.0798840591      4.9403968382      2.2615620909 
  H58           3.5686606868      3.1019120375      3.3147293051 
  H59           3.5894325554      5.5940185150      2.9665952082 
  H60           2.3898130592      6.5665337320      1.0198503902 
  H61           1.1923191041      5.0998890573     -0.5650727955 
  C62           3.2639293977      2.5054802833     -2.0831420359 
  H63           3.4376797169      3.2834967942     -1.3462185188 
  C64           2.8582121102      0.5133783170     -3.9652365103 
  H65           2.6930188108     -0.2734663361     -4.6926562066 
  C66           4.2268004642      2.2702537433     -3.0626286700 
  H67           5.1353855670      2.8677815670     -3.0804999502 
  C68           4.0213668206      1.2695081458     -4.0094654907 
  H69           4.7664559798      1.0728666145     -4.7766134510 
  C70          -1.1435577183      4.6448497973     -3.2830470551 
  H71          -0.9667010913      5.1117833019     -4.2499459543 
  C72          -2.5469733724      4.2973968449     -1.3506503759 
  H73          -3.4690537648      4.4911595023     -0.8068178154 
  C74          -2.3280888886      4.8971398964     -2.5920592894 
  H75          -3.0784118973      5.5595794610     -3.0183503598 
  C76           1.7313693390     -2.7447299319      5.0553938736 
  H77           2.2909677741     -3.6804210814      5.2200821173 
  H78           0.9637938530     -2.9596843707      4.2909866494 
  C79           1.0289212136     -2.3009106400      6.3589482287 
  H80           0.4080627879     -3.1172395038      6.7609951908 
  H81           1.8016646973     -2.0804973041      7.1152871298 
  C82           0.2694098235     -1.2734770317      1.7771592089 
***************************************************************** 
----------------------------------------------------------------- 
Complex 290 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.75792237478     = Eh 
Solvent Phase Energy     = -0.01322731344        = Eh 
Zero Point Energy        = 434.122               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -2030.55097086362     = Eh 
 
Geometry Coordinates 
  Pd1           0.1915648604     -0.0578528428     -0.0045695048 
  C2            0.7380779138      0.2487995492      1.9995464524 
  C3            0.9177841207     -1.0073451258      2.7347292550 
  C4            2.1009685961     -1.5430077692      3.0837744176 
  C5            2.4878983867     -3.6194572433      0.6346249865 
  O6            1.0583871202     -1.9540125174     -0.2257736421 
  C7            2.2726742622     -2.3890021033      0.0776056574 
  C8            3.4297966073     -1.4751329042     -0.3067694587 
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  C9            1.3453136245     -4.5030156999      1.0554435136 
  C10           3.8735081920     -4.2179363732      0.7748355573 
  H11           1.6597711792      0.8380857605      1.9368195007 
  H12          -0.0661278683      0.8647676841      2.4088914371 
  H13           0.0075837368     -1.5471634442      2.9999230666 
  H14           2.1666842094     -2.4793286188      3.6288899558 
  H15           3.0398243445     -1.0476341725      2.8491588813 
  N16          -0.3151411952     -0.2210320715     -2.2673198189 
  P17          -1.0099909164      1.8893277359     -0.2353169597 
  H18           1.2026386203     -5.3564874568      0.3580888722 
  H19           1.5340795723     -4.9528330440      2.0514005731 
  H20           0.4021506133     -3.9378683602      1.0961707804 
  H21           3.4558833885     -1.3843806675     -1.4135071228 
  H22           3.2005713018     -0.4583710791      0.0668447451 
  H23           4.1612766875     -4.2676650211      1.8487845849 
  H24           3.8539533942     -5.2762285658      0.4391254461 
  C25          -0.1707710001     -1.5388970127     -2.9376804206 
  C26           0.5848833580     -1.1678773667     -4.2428486570 
  O27           0.3965718734      0.2867028847     -4.3570544158 
  C28          -0.0234016542      0.6990763044     -3.1184031584 
  C29          -0.0901801771      2.1649562186     -2.9507016808 
  C30          -0.5336065898      2.8158246961     -1.7713310450 
  H31           0.1849787453     -1.6192735173     -5.1539130856 
  H32           1.6635538895     -1.3603616856     -4.1744656024 
  H33           0.4335428166     -2.1672215716     -2.2734206758 
  C34          -1.5507008039     -2.2342628594     -3.1622908909 
  C35          -1.3000056189     -3.5938690621     -3.8631928080 
  H36          -0.8746059321     -3.4698997206     -4.8704068576 
  H37          -0.6150941371     -4.2177932248     -3.2693802954 
  H38          -2.2505255673     -4.1371046791     -3.9707983782 
  C39          -2.4955577412     -1.3642139207     -4.0210720513 
  H40          -2.0550758561     -1.1204001307     -4.9998245432 
  H41          -3.4376912446     -1.9035547547     -4.2023374903 
  H42          -2.7378972057     -0.4251752261     -3.5037520189 
  C43          -2.2033919921     -2.5068433753     -1.7866159330 
  H44          -3.1236858616     -3.0968506834     -1.9199341474 
  H45          -1.5148537869     -3.0636939639     -1.1349875996 
  H46          -2.4641750329     -1.5673286597     -1.2833208377 
  C47          -0.7351988819      5.1428542117      3.0777342034 
  C48          -1.9902940587      4.7276393083      2.6361133318 
  C49          -2.1006118621      3.7627045552      1.6327710106 
  C50          -0.9499837117      3.1987892116      1.0607850552 
  C51           0.3118483935      3.6159099203      1.5230068995 
  C52           0.4159497924      4.5860115161      2.5170725798 
  H53          -0.6524707600      5.8936163832      3.8605807615 
  H54          -2.8904676073      5.1553437529      3.0726229093 
  H55          -3.0854016586      3.4503657429      1.2964933333 
  H56           1.2147396958      3.1780202374      1.1024854807 
  H57           1.3977544977      4.9010793435      2.8635438565 
  C58          -5.5721822676      1.0976674868     -0.6537203254 
  C59          -4.9793523413      2.0817837082     -1.4447955083 
  C60          -3.6099851672      2.3339098202     -1.3456845603 
  C61          -2.8160674451      1.5952320583     -0.4544319317 
  C62          -3.4200745858      0.5953567211      0.3276738616 
  C63          -4.7910605004      0.3570153269      0.2342728769 
  H64          -6.6399550725      0.9052587831     -0.7322854924 
Chapter 4 – Computational Study of the Mechanism of the Enantioselective Tsuji Allylation 613 
  H65          -5.5846466717      2.6582142658     -2.1414020266 
  H66          -3.1622611951      3.1085298952     -1.9630976861 
  H67          -2.8092648528      0.0016576511      1.0050616425 
  H68          -5.2473410856     -0.4162861624      0.8481598024 
  C69          -0.5766164268      4.2191986417     -1.7623943464 
  H70          -0.9095791948      4.7354282688     -0.8675032058 
  C71           0.3066134829      2.9389340228     -4.0524075135 
  H72           0.6546991590      2.4236847708     -4.9406427424 
  C73          -0.1888534396      4.9709030312     -2.8705946740 
  H74          -0.2348239360      6.0568682123     -2.8287902764 
  C75           0.2606249955      4.3274412581     -4.0192348967 
  H76           0.5763238190      4.9016115004     -4.8869892838 
  C77           4.9562887125     -3.4610120967     -0.0033264612 
  H78           4.8661386095     -3.6803287843     -1.0812050486 
  H79           5.9587135159     -3.7919330880      0.3110557758 
  C80           4.7963226149     -1.9385504327      0.2112779548 
  H81           5.6071565314     -1.3895053766     -0.2934912805 
  H82           4.8835268496     -1.7225425270      1.2893223041 
***************************************************************** 
----------------------------------------------------------------- 
Complex 291 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.74615186694     = Eh 
Solvent Phase Energy     = -0.01150958455        = Eh 
Zero Point Energy        = 434.278               = kcal/mol 
Frequency                = -310.74 
 
(PBE) 
Gas Phase Energy         = -2030.54481985386     = Eh 
 
Geometry Coordinates 
  Pd1          -0.0043666097      0.0634387862      0.0584997996 
  C2            0.0070301491      0.1093603823      2.2104800572 
  C3            1.3809836889      0.0923046314      2.5751574707 
  C4            2.1337719483      1.2231012929      2.9104985345 
  C5            3.2615043957      2.1293264681      1.3058756248 
  O6            1.6508404679      1.4960421691     -0.2819578274 
  C7            2.1093206112      2.3759665974      0.5197675089 
  C8            1.2867406393      3.6483812887      0.7117120749 
  C9            4.1528897960      0.9682068027      0.9203252161 
  C10           3.9828945429      3.2963699640      1.9819053361 
  H11          -0.5402218720      1.0258575014      2.4494500813 
  H12          -0.5664594077     -0.7887870614      2.4359080111 
  H13           1.8911886327     -0.8702890690      2.5576346448 
  H14           3.0695012544      1.0739744176      3.4420746077 
  H15           1.5994052343      2.1238049488      3.2026376188 
  N16           0.0598027013     -0.1507606747     -2.3652811753 
  P17          -1.8988267118     -1.1875206227     -0.3477454845 
  H18           4.8116316350      1.2485030675      0.0735001053 
  H19           4.8134459789      0.6793548089      1.7587925662 
  H20           3.5634789877      0.0919793950      0.6127374514 
  H21           1.2084237611      4.1364644156     -0.2796986047 
  H22           0.2541749651      3.3496393037      0.9756055892 
  H23           3.9873328709      3.1615714475      3.0835539236 
  H24           5.0493474817      3.2771056818      1.6831225435 
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  C25           1.3309108023      0.1810614157     -3.0550807095 
  C26           0.8910225442      1.2580287268     -4.0897827309 
  O27          -0.5680682715      1.1190895635     -4.1437226055 
  C28          -0.9058379715      0.3663336690     -3.0417826594 
  C29          -2.3556196621      0.2503022358     -2.8003711737 
  C30          -2.9294723790     -0.4275592628     -1.6914924094 
  H31           1.2716436199      1.1104281738     -5.1038867802 
  H32           1.1212299331      2.2758671052     -3.7497625271 
  H33           2.0131888195      0.6092412024     -2.3126094410 
  C34           1.9944710527     -1.0877589318     -3.6779034594 
  C35           3.2954968468     -0.6618860827     -4.4036098376 
  H36           3.0945550658     -0.0098999411     -5.2665946508 
  H37           3.9712282665     -0.1305765168     -3.7158460289 
  H38           3.8216624034     -1.5526772970     -4.7781852931 
  C39           1.0427151133     -1.7914018068     -4.6709814172 
  H40           0.7079690166     -1.1106221418     -5.4682127999 
  H41           1.5575815230     -2.6401635697     -5.1462692117 
  H42           0.1565372175     -2.1790632194     -4.1497984629 
  C43           2.3663733904     -2.0656736741     -2.5393859493 
  H44           2.8776872764     -2.9478889243     -2.9550727816 
  H45           3.0424607685     -1.5817340672     -1.8185428345 
  H46           1.4711677153     -2.4015219368     -2.0023770477 
  C47          -4.9857758571     -1.8215422525      3.0822534802 
  C48          -4.6702699354     -2.8969135612      2.2525319378 
  C49          -3.7572341243     -2.7377091227      1.2083770539 
  C50          -3.1437451996     -1.4952556675      0.9828513043 
  C51          -3.4608629400     -0.4212893720      1.8344622973 
  C52          -4.3797126106     -0.5822574108      2.8696882541 
  H53          -5.6966301602     -1.9495905712      3.8958736944 
  H54          -5.1374082326     -3.8659337610      2.4167936563 
  H55          -3.5227954964     -3.5838104971      0.5681301190 
  H56          -2.9803705094      0.5434447887      1.6830382378 
  H57          -4.6170652447      0.2585608854      3.5180215106 
  C58          -1.0423446840     -5.5146784482     -1.8369275927 
  C59          -2.0652162923     -4.7811237959     -2.4378130859 
  C60          -2.3378093279     -3.4776209438     -2.0172885838 
  C61          -1.5817596932     -2.8888154214     -0.9916794829 
  C62          -0.5435110064     -3.6317485021     -0.4041155969 
  C63          -0.2836971483     -4.9382818293     -0.8171342513 
  H64          -0.8345014604     -6.5311394994     -2.1646302183 
  H65          -2.6572510971     -5.2253558197     -3.2355813982 
  H66          -3.1436769655     -2.9204076742     -2.4882240108 
  H67           0.0643119259     -3.1770472487      0.3757621197 
  H68           0.5194360829     -5.5035453497     -0.3491395012 
  C69          -4.3309567383     -0.4629720977     -1.5913714220 
  H70          -4.7900339729     -0.9696964429     -0.7484630146 
  C71          -3.1991766733      0.8608780164     -3.7429400764 
  H72          -2.7407847681      1.3829060717     -4.5756876027 
  C73          -5.1507369355      0.1403645374     -2.5425295950 
  H74          -6.2320589425      0.0880192955     -2.4339354764 
  C75          -4.5818586235      0.8083042804     -3.6235973487 
  H76          -5.2103802919      1.2895048275     -4.3693208260 
  C77           3.3935843916      4.6746888398      1.6482914839 
  H78           3.6828770373      4.9697891388      0.6253733622 
  H79           3.8019437690      5.4363281057      2.3301100420 
  C80           1.8507165035      4.6395234511      1.7395643891 
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  H81           1.4323039335      5.6436565142      1.5706238144 
  H82           1.5613964410      4.3467043411      2.7621993770 
***************************************************************** 
----------------------------------------------------------------- 
Complex 292 
----------------------------------------------------------------- 
(B3LYP) 
Gas Phase Energy         = -2032.79265164845     = Eh 
Solvent Phase Energy     = -0.01320247828        = Eh 
Zero Point Energy        = 436.003               = kcal/mol 
 
(PBE) 
Gas Phase Energy         = -2030.58452882899     = Eh 
 
Geometry Coordinates 
  Pd1           0.0720538868      0.0428463229      0.0099922639 
  C2            0.1823952393      0.0807276368      3.1441744177 
  C3            0.9868244414     -0.0413482100      4.4706878791 
  C4            1.0117446381      0.4512350308      1.9246127186 
  C5            0.8479732080      1.6552857713      1.2186102544 
  C6            1.9459401444     -1.2505665304      4.3933555328 
  O7            1.7797394260     -2.1590009219      3.5946976409 
  C8            3.0834756682     -1.3205780504      5.4113248468 
  C9           -0.0108204601     -0.3537065252      5.6196570138 
  C10           1.7656846439      1.2674364822      4.7784009153 
  H11           1.6760690159      2.0855625627      0.6590397637 
  H12           0.0702612855      2.3606437920      1.5081520885 
  H13           1.9744286139     -0.0554575430      1.8517660042 
  H14          -0.3256968273     -0.8772717915      2.9927053433 
  H15          -0.6035676672      0.8337681560      3.2886683122 
  N16           0.0484820169     -2.2853000136     -0.3976119107 
  P17          -0.7102341132      0.0214395134     -2.2148560190 
  H18           3.7706645397     -2.1220425249      5.0937819529 
  H19           2.6427740306     -1.6388325815      6.3782108942 
  H20           0.4849699728     -0.4715208688      6.5985465661 
  H21          -0.7381239401      0.4726328396      5.7119503953 
  H22          -0.5731314347     -1.2806682257      5.4109840625 
  H23           2.2926459144      1.5902870483      3.8618999508 
  H24           1.0323602254      2.0635735350      5.0074200204 
  C25           0.0609439448     -3.2580504675      0.7255767213 
  C26           1.2631248171     -4.1793755031      0.3705211187 
  O27           1.5050457660     -3.9039475631     -1.0474204185 
  C28           0.8256728704     -2.7365105650     -1.3214621184 
  C29           1.1008358857     -2.1782701010     -2.6615948386 
  C30           0.4890408738     -1.0109593988     -3.1967527048 
  H31           1.0716161971     -5.2510148996      0.4680682596 
  H32           2.1650133576     -3.9099959040      0.9350579742 
  H33           0.2646088251     -2.7222304050      1.6595664200 
  C34          -1.3072661327     -3.9997669336      0.8635278086 
  C35          -1.2098812150     -4.9996551446      2.0435941864 
  H36          -0.4866097167     -5.8042555496      1.8447936330 
  H37          -0.9092094092     -4.4848574196      2.9689330704 
  H38          -2.1899178524     -5.4701321508      2.2140042606 
  C39          -1.6726280358     -4.7520967625     -0.4362427854 
  H40          -0.8854136775     -5.4613605143     -0.7329157546 
  H41          -2.6021536753     -5.3227565150     -0.2879394314 
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  H42          -1.8358339521     -4.0468267949     -1.2624684923 
  C43          -2.4121125123     -2.9666683809      1.1845480490 
  H44          -3.3744282653     -3.4814873145      1.3314558084 
  H45          -2.1726515138     -2.4156799195      2.1068399847 
  H46          -2.5240247405     -2.2441332382      0.3673154852 
  C47          -4.8363112980     -2.0144593546     -2.9723984437 
  C48          -3.7513922214     -2.3705730274     -3.7726248755 
  C49          -2.5015840574     -1.7803920205     -3.5680641511 
  C50          -2.3200197983     -0.8286844618     -2.5522219347 
  C51          -3.4185615847     -0.4875286143     -1.7442527129 
  C52          -4.6674240007     -1.0694183139     -1.9590789706 
  H53          -5.8093280350     -2.4731173374     -3.1356856461 
  H54          -3.8765619927     -3.1077399192     -4.5635379229 
  H55          -1.6666922446     -2.0622871319     -4.2047590342 
  H56          -3.2887940948      0.2376267572     -0.9428108291 
  H57          -5.5094217762     -0.7901086644     -1.3290662510 
  C58          -1.0241618164      3.9357099438     -4.7255940687 
  C59          -0.1324344483      3.8237060081     -3.6579522014 
  C60          -0.0645545666      2.6401959335     -2.9237900966 
  C61          -0.8753936666      1.5430660785     -3.2587200675 
  C62          -1.7745918263      1.6692103634     -4.3306614785 
  C63          -1.8479227101      2.8591134108     -5.0561857332 
  H64          -1.0842297636      4.8625131638     -5.2926029702 
  H65           0.5033051520      4.6649184764     -3.3890527821 
  H66           0.6078759339      2.5615382272     -2.0710561244 
  H67          -2.4238350807      0.8383667700     -4.5961507454 
  H68          -2.5518526350      2.9460398511     -5.8818049236 
  C69           0.8634098162     -0.6036993693     -4.4874960931 
  H70           0.4144613913      0.2885664182     -4.9115175531 
  C71           2.0446382301     -2.8727927175     -3.4370646676 
  H72           2.5050639468     -3.7562853405     -3.0096107953 
  C73           1.8006810884     -1.3079279906     -5.2410127888 
  H74           2.0638814782     -0.9595474772     -6.2377039883 
  C75           2.3948084026     -2.4497335188     -4.7128787974 
  H76           3.1313153560     -3.0074737718     -5.2868418177 
  C77           3.8063600601      0.0213914446      5.6105285093 
  H78           4.5404854526     -0.0664440798      6.4252479976 
  H79           4.3696318528      0.2801472431      4.6984207991 
  C80           2.7902258113      1.1494348280      5.9139507169 
  H81           2.2935087270      0.9442125103      6.8766427542 
  H82           3.3219781402      2.1059402224      6.0322366545 
***************************************************************** 
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CHAPTER 5 
Enantioselective Tsuji Allylations† 
5.1 INTRODUCTION 
Chapters 2–4 have discussed the specific developments of enantioselective enolate 
alkylation from the Stoltz laboratories.  In order to provide a context for these 
transformations, this chapter provides a review of all of the published works dealing 
specifically with the enantioselective Tsuji allylation in both the Stoltz labs and others. 
 
5.1.1 BACKGROUND AND SIGNIFICANCE 
The catalytic enantioselective synthesis of quaternary carbon stereocenters is an 
ongoing challenge to synthetic chemists.1  Any such reaction must forge a new carbon–
carbon bond in the face of significant steric encumbrance to accomplish this goal.  As a 
result, there are relatively few protocols that are both mild and highly enantioselective.  
Methods for the generation of quaternary stereocenters are extremely desirable given the 
prevalence of these stereogenic carbon centers in a wide variety of natural products with 
important structural and biological properties. 
                                                
† An earlier version of this review has been published, see: Mohr, J. T.; Stoltz, B. M. Chem.–Asian J. 2007, 
2, 1476–1491. 
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One important method for the enantioselective synthesis of quaternary stereocenters 
is the Pd-catalyzed allylic alkylation of prochiral stabilized enolates developed by 
Hayashi,2 Ito,3 Trost,4 and Hou and Dai,5 and their co-workers (Scheme 5.1).  These 
reactions are unusual in the field of asymmetric allylic alkylation because the newly 
formed stereocenter resides on the nucleophilic partner instead of the electrophilic allyl 
group.6  Later, Trost,7 Hou and Dai,8 and their co-workers described palladium-catalyzed 
systems capable of generating quaternary stereocenters with high enantiomeric excess 
from unstabilized ketone enolates that contain a single acidic position (e.g., tetralones, 
Scheme 5.1).9,10   Although these systems have proven useful in a number of applications, 
one limitation of this methodology is the requirement that there be only a single acidic 
site or a large pKa difference between two acidic sites to prevent the formation of 
mixtures of allylated products from enolate scrambling in situ.1c  As an example of this 
deficiency in the literature, the seemingly simple compound 2-allyl-2-
methylcyclohexanone (106, Scheme 5.2) had not been prepared in highly enantioenriched 
form prior to the work discussed herein. 11 
Scheme 5.1.  a) Enantioselective allylic alkylation with stabilized enolates  b) Enantioselective allylic 
alkylation with unstabilized enolates 
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5.1.2 HISTORY 
In the 1980s, Professor Jiro Tsuji12 and his co-workers at the Tokyo Institute of 
Technology, and later at Okayama University, developed a series of Pd-catalyzed 
reactions in which unstabilized enolates or enol equivalents were transformed into the 
corresponding allylated ketones under essentially neutral reaction conditions.  Viable 
substrates for these transformations included allyl enol carbonates,13 silyl enol ethers,14 
allyl β-ketoesters,15 and enol acetates16 (Scheme 5.2).  Importantly, each of these Pd-
catalyzed decarboxylative reactions is capable of generating a quaternary carbon center.17  
Tsuji published several accounts of his work in the development of this suite of 
reactions.18 
Scheme 5.2.  Tsuji allylation reactions 
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An important observation was the very high levels of regiochemical fidelity observed 
in these processes (Scheme 5.3).  For example, a mixture of allyl enol carbonates 
enriched in tetrasubstituted enol isomer 105 was converted into α-quaternary ketone 106 
with essentially no leakage of material to the isomeric ketone product 113.  Likewise, a 
mixture enriched in allyl enol carbonate 112 yielded ketone 113 with little trace of the α-
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quaternary isomer.13  Despite this valuable quality, enantioselective variants of these 
transformations were not disclosed in the 20 years since the initial discoveries. 
Scheme 5.3.  Regiochemical fidelity in the Tsuji allylation 
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Over the past three years, significant effort has been underway to develop 
enantioselective variants of the Tsuji reactions to address the limitations of the 
asymmetric allylic alkylation protocols.  Viable methods for synthesizing all-carbon 
quaternary stereocenters adjacent to carbonyl groups have been reported from these 
investigations.  In this chapter, the development and utility of these methods for the 
synthesis of complex molecules will be highlighted.19  For the purposes herein, the Tsuji 
allylation is defined as one of the four representative reactions detailed in Scheme 5.2.  
The enolate intermediate must be revealed in the course of the reaction with CO2 as a by-
product, the enolate must be unstabilized by conjugated electron-withdrawing groups 
(e.g., esters), and the newly formed stereocenter must reside on the nucleophilic fragment 
of the product. 
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5.2 ALLYL ENOL CARBONATES 
5.2.1 SYNTHESIS OF CYCLIC KETONES 
In 2004, Behenna and Stoltz reported an enantioselective Tsuji allylation from allyl 
enol carbonate substrates.20  An initial screening of chiral ligands quickly identified that 
chelating P/N ligands were especially effective in terms of yield and enantioselectivity.  
Specifically, the tert-butyl phosphinooxazoline (t-BuPHOX; 55) ligand framework, 
developed in the 1990s by Pfaltz, Helmchen, and Williams,21 led to the formation of the 
elusive 2-allyl-2-methylcyclohexanone (106) with up to 89% ee, the first reported 
synthesis of this simple enantioenriched ketone. 
The extension of this result to more complex systems proved rewarding.  The mild 
reaction conditions were tolerant of a variety of substituents and functional groups 
(Scheme 5.4).  Remarkably, these adapted enantioselective Tsuji allylation conditions 
were capable of generating a quaternary stereocenter adjacent to another quaternary 
carbon atom in the formation of 2-allyl-2-tert-butylcyclohexanone (152) with little 
degradation in enantioselectivity relative to less sterically demanding substrates.  The 
absolute configuration was established for a number of products and, in all cases 
investigated, the enantiomer shown predominated.  An interesting effect observed in this 
work was that a range of solvents, including ethereal (THF, 1,4-dioxane, Et2O, tert-butyl 
methyl ether, i-Pr2O), aromatic (benzene, toluene), and carbonyl-containing (EtOAc) 
solvents, proved to be nearly equally effective for several substrates. 
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Scheme 5.4.  Enantioenriched cycloalkanones produced from allyl enol carbonates 
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To improve the ee of the cycloalkanone products, straightforward methods of 
derivitization to the corresponding semicarbazone followed by recrystallization and 
hydrolysis were developed.20,22  These protocols allowed the isolation of 106 with 98% ee 
(Scheme 5.5). 
Scheme 5.5.  Enantioenrichment of ketone (–)-106 via the semicarbazone derivative 
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In 2005, Trost disclosed a similar system for enantioselective allylic alkylation from 
allyl enol carbonate substrates.23  Although several P/P chelating ligands performed 
poorly in the work reported by the Stoltz group,20 Trost found that the uniquely shaped 
P/P ligand (R,R)-348 provided high ee in the allylic alkylation of allyl enol carbonate 
substrates in toluene (Scheme 5.6).  Two examples of substrates with multiple sites of 
similar acidity were reported.  Interestingly, besides the enantioselective formation of 
quaternary centers, the use of trisubstituted enol precursors led to the formation of highly 
enantioenriched tertiary stereocenters.  Further optimization of the reaction conditions 
was required in some cases to prevent multiple alkylations at the carbonyl α-position of 
these trisubstituted enol precursors; use of 1,4-dioxane solvent effectively suppressed 
overalkylation for some substrates.  Also included are the first examples of heterocycles 
in allylations of this type.24 
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Scheme 5.6.  Enantioenriched cycloalkanones produced from allyl enol carbonates 
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An important facet of this chemistry is the observation that the major enantiomer of 
the cycloalkanone product is of the opposite sense to that observed in the earlier work of 
Trost’s group with lithium-enolate nucleophiles and a similar ligand in the same 
enantiomeric series.7a  This suggests that the mechanism of the reaction with preformed 
Li-enolate is significantly different from that with Pd-enolate generated in situ. 
 
5.2.2 SYNTHESIS OF ACYCLIC KETONES AND ALDEHYDES 
A significant advance in the development of these protocols is the extension to 
acyclic enolate precursors.  Trost’s group found that many α-tertiary ketones could be 
formed with high ee by using the (R,R)-348/Pd(0) catalyst system (Scheme 5.7).25 
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Scheme 5.7.  Enantioenriched ketones produced from (Z)-enol carbonates 
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Interestingly, the geometry of the enol precursor affected not only the rate of reaction, 
but also the absolute configuration of the product (Scheme 5.8).  This suggests that 
neither the enol carbonate nor the putative Pd–enolate complex undergoes significant 
geometric isomerization.  No speculation regarding the origin of the large rate difference 
between enol isomers was given. 
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Scheme 5.8.  Reactivity differences for (E)- and (Z)-enol carbonates 
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An extension of this chemistry was the incorporation of α-heteroatom-containing 
substrates.  Trost and co-workers found that siloxy-substituted allyl enol carbonates are 
especially useful in this reaction and are particularly important because of the prevalence 
of α-hydroxyketones and aldehydes in natural products and pharmaceuticals.24  
Interestingly, isomeric substrates 378 and 380 each led to product 379, which is derived 
from a probable aldehyde enolate intermediate (383, Scheme 5.9).  This most likely 
occurred by an intramolecular silyl transfer between enolates 381 and 383 followed by 
subsequent allylation. 
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Scheme 5.9.  Allylic alkylation from isomeric silyloxy substituted allyl enol carbonates 
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A variety of α-silyloxy aldehydes were prepared in this manner, including one cyclic 
example of an α silyloxy ketone (Scheme 5.10).  The isomer of the enolate precursor 
employed affected the rate of reaction and, to a small degree, the level of 
enantioselectivity.  This rate difference was especially noticeable when substituted allyl 
fragments were employed.  The ee of the major diastereomer formed in these cases was 
uniformly high, and the dr was typically high as well. 
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Scheme 5.10.  Allylic alkylation to form α-silyloxy aldehydes and ketones 
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In later work, Trost and co-workers26 discovered that a change in the nature of the 
group on oxygen led to a loss of the convergent nature of the reaction.  Specifically, 
acyloxy enol carbonates gave nearly complete regiochemical fidelity depending on the 
starting material isomer (Scheme 5.11).  This result was interpreted as indicating a slow 
equilibrium between the two isomeric acyloxy enolate intermediates relative to the rate of 
C–C bond formation.  The ratio of product isomers was modulated somewhat by the 
ligand on Pd, with naphthyl bis(phosphine) ligand 104 ultimately providing the best 
combination of regioselectivity, yield, and ee for a variety of substrates (Scheme 5.12).  
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Scheme 5.11.  Regiochemical fidelity with acyloxy enol carbonates 
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Scheme 5.12.  Allylic alkylation to form α-acyloxy ketones 
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Allyl enol carbonate substrates provided the first entries to general allylation of 
ketone enolates.  The importance of this class of enolate precursors is highlighted by their 
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use in syntheses of natural products and pharmaceutical intermediates.  Examples of 
these applications are discussed in section 5.5. 
 
5.3 SILYL ENOL ETHERS 
5.3.1 CARBOCYCLIC KETONES 
Apart from allyl enol carbonate substrates, Stoltz and co-workers demonstrated the 
application of the PHOX•Pd(0) catalyst system to a variety of silyl enol ethers.20,27  These 
enol silanes are desirable enolate precursors because, in many cases, they are 
significantly easier to prepare than the corresponding allyl enol carbonates. 
The intermolecular nature of this variant of the Tsuji allylation meant that the 
addition of a diallyl carbonate (e.g., 111, Scheme 5.13) as a coupling partner was 
required.  Although Tsuji and co-workers reported the allylation of silyl enol ethers 
without an exogenous activator,14 it was found that the addition of a substoichiometric 
amount of the fluoride donor tetrabutylammonium difluorotriphenylsilicate (TBAT) was 
necessary for the enantioselective reaction at 25 °C.  Notably, products obtained from 
allyl enol carbonate (Scheme 5.4) and silyl enol ether (Scheme 5.13) substrates had 
nearly identical ee with this catalyst system.  This consistent enantioselectivity suggests 
that the mechanisms of C–C bond formation for both enolate precursors are identical.   
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Scheme 5.13.  Enantioenriched cycloalkanones produced from silyl enol ethers 
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Although this class of substrate has not been developed to the extent of the allyl enol 
carbonate variant, the intermolecular reaction could be an important convergent coupling 
reaction of elaborate fragments toward complex target molecules.  Furthermore, this 
method was recently used in the synthesis of stereodefined tertiary fluorides (see section 
5.5.2.1). 
 
5.3.2 DIOXANONES 
Given the success in preparing α-quaternary cycloalkanones, the direct synthesis of 
enantioenriched α-oxygenated ketones using the Pd•PHOX catalyst was considered as 
another potentially fruitful avenue of study.  Ketones possessing α-oxygenation are 
particularly challenging and appear in a number of biologically active compounds.28  
Preliminary entries into these systems were through Baeyer–Villiger oxidation of an α-
quaternary ketone (see Scheme 5.38a below) or a single example of an oxygenated enol 
silane that provided a tertiary ether in only moderate ee (163, Scheme 5.13).  The latter 
result indicated that an exocyclic heteroatom directly attached to the putative enolate 
intermediate caused significant disruption to the stereocontrol elements of the catalyst.  
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Therefore, a class of substrates with the heteroatom contained within the ring were 
chosen since it would be less likely to interact with the metal center.29  Dioxanone 
substrates have been employed in chiral auxiliary-controlled enolate alkylations, and a 
catalytic enolate alkylation procedure might provide a more efficient entry into these 
oxygenated products.30,31 
The solvent had a relatively larger effect on the yield and ee of the product with this 
class of substrates, and toluene was found to be the preferred solvent.  Efficient 
conversion of the TES enol ethers32 to product required a full equivalent of TBAT.  In the 
optimal case, exposure of dioxanone-derived enol ethers to the complex derived from 
[Pd(dmdba)2] and (S)-55 in the presence of diallyl carbonate and TBAT (1 equiv) in 
toluene at 25 °C led to dioxanone products with high yield and ee (Scheme 5.14).  The 
scope of this transformation was found to include substitutions at the α-position and on 
the allyl group.  These oxygenated products were amenable to a number of subsequent 
transformations that enabled the enantioselective synthesis of several structural motifs 
including tertiary oxygenation (see section 5.5.3). 
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Scheme 5.14.  Enantioselective alkylation using dioxanone derived enol silanes 
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5.4 ALLYL β-KETOESTERS 
Although the above transformations have proven to be very useful, one particular 
shortcoming of these protocols is the need to pregenerate the enol equivalent prior to the 
allylation reaction with an exogenous base (typically an amine or amide base).  In some 
cases, this enolization step provides poor selectivity for the desired enol isomer.  Given 
the high level of regiochemical fidelity demonstrated by Tsuji (Scheme 5.3), these 
mixtures of enol isomers inevitably lead to mixtures of allylated products and, thus, poor 
yield.  An example is shown in Scheme 5.15. 
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Scheme 5.15.  Non-selective enolization leads to mixtures of allylated products 
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When confronted with this problem, Stoltz and co-workers found a possible solution 
in the work of Tsuji and Saegusa and their co-workers: allyl β-ketoesters, like the allyl 
enol carbonate substrates, contain all the necessary components for decarboxylative 
allylation, and the enolate generation is regiospecific.15  However, the extension of this 
substrate class to enantioselective variants was potentially complicated by the intrinsic 
stereochemistry of the allyl β-ketoester, which could result in kinetic resolution or other 
problematic effects of double stereodifferentiation.33  Despite that, substrate kinetic 
resolution was not observed, and the desired products were formed in excellent yield and 
with good ee (Scheme 5.16); this transformation of a racemic substrate into an 
enantioenriched product is an example of an enantioconvergent catalytic reaction.34  The 
reaction probably proceeded through Pd-mediated oxidative addition and deallylation of 
the substrate followed by stereoablative C–C bond cleavage via decarboxylation to form 
an achiral enolate intermediate, then recombination of the fragments through Pd-
mediated stereoselective C–C bond formation. 
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Scheme 5.16.  Enantioselective decarboxylative allylation with an allyl β-ketoester 
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The substrate scope of the β-ketoester variant of the Tsuji allylation was found to be 
quite broad.  Notably, compounds with high steric demands, such as 2-allyl-2,3,3,5,5-
pentamethylcyclohexanone (262), were produced in good yield and with high ee (Scheme 
5.17).  Interestingly, substrates that bear β-leaving groups did not suffer elimination, and 
substrates that contain other acidic functional groups (e.g., nitrile, ester) did not cause 
enolate scrambling.  Furthermore, allyl groups substituted at the central carbon atom 
(e.g., methyl, chloro) led to increased ee.  The ketones produced from allyl β-ketoesters, 
allyl enol carbonates, and silyl enol ethers were formed in nearly identical yield and ee 
with this catalyst system. 
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Scheme 5.17.  Enantioenriched cycloalkanones prepared from allyl β-ketoesters 
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Also demonstrated was the tolerance of a fluorine atom at the α-position of the 
racemic substrate, a concept that was later developed further by Nakamura and others 
(see section 5.5.2.1).  In the work of Nakamura and co-workers, three examples of the 
formation of quaternary stereocenters from allyl β-ketoesters were included as well.35 
Apart from the development of the β-ketoester substrate class, Stoltz and co-workers 
reported the use of a masked β-ketoester moiety to effect a cascade reaction that 
generates two quaternary stereocenters in a single reaction (Scheme 5.18).34  Presumably, 
the allyl enol carbonate functionality of substrate 14 reacted rapidly, thus generating the 
first quaternary stereocenter and revealing allyl β-ketoester 15, which underwent further 
reaction.  Ketone 16 was isolated in 76% yield and with 92% ee as a 4:1 mixture of 
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C2/meso diastereomers.  A similar double-alkylation strategy was successfully applied to 
the total synthesis of cyanthiwigin F (see section 5.5.1.4). 
Scheme 5.18.  Enantioselective cascade allylation generating two quaternary stereocenters 
O
(S)-55 (10 mol%)
Pd2(dba)3
(4 mol%)
THF, 40 °C
O
O
(±)-271
O
O
O O
O
423
O
(–)-272
76% yield
92% ee, 4:1 dr  
Subsequent to this initial report, Trost and co-workers described the application of the 
bis(phosphine)/Pd(0) catalyst to the enantioselective allylic alkylation of vinylogous ester 
and thioester enolates.36  When they were confronted with a similar problem of 
nonselective enolization in enol carbonate formation, the β-ketoester motif was explored.  
Unlike the PHOX system, some variation in product ee was observed depending on the 
nature of the enolate precursor (i.e., allyl enol carbonate vs. allyl β-ketoester).  Notably, 
the level of substrate conversion observed was sensitive to the nature of the substituent of 
the vinylogous ester moiety.  To address this problem, vinylogous thioester substrates 
were examined, and the reactivity was improved.  A variety of substitutions were 
possible, and products with high ee were obtained in many cases (Scheme 5.19).  Details 
of the synthetic utility of these products are shown in section 5.5.3. 
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Scheme 5.19.  Vinylogous thioesters prepared from allyl β-ketoesters 
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Trost and co-workers suggested that substrates that bear Lewis basic groups (e.g., 
alkyne or carbonyl) nearby may cause a decrease in enantioselectivity by chelating to 
palladium in the course of enantiodetermination, thereby leading to decreased ee in the 
product.  This effect contrasts results in Stoltz’ work, whereby neighboring Lewis basic 
groups had little effect (Scheme 5.17). 
Allylation in the presence of an acidic 1,3-diester moiety highlighted the 
regiochemical fidelity of the allylation process in an extreme case, although the ee was 
decreased considerably (Scheme 5.20). 
640 Chapter 5 – Enantioselective Tsuji Allylations 
Scheme 5.20.  Allylation in the presence of a pendent 1,3-diester 
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Stoltz and co-workers have reported alkylation of vinylogous esters and thioesters 
using the Pd•PHOX catalyst system.37  High yields and enantiomeric excess were 
obtained under slightly modified reaction conditions.  The vinylogous thioester 268 was 
employed in the total syntheses of carissone (see section 5.5.1.7) and cassiol (see section 
5.5.1.8).  Enol carbonates could also be used in some cases (see section 5.5.1.5). 
Scheme 5.21.  Alkylation of vinylogous esters and thioesters with the Pd•PHOX catalyst system 
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Allyl β-ketoester substrates are very practical because of the simple substrate 
preparation, the bench-top stability of quaternary β-ketoesters, and the relative ease of 
purification.  These facets have enabled the preparation of ketone products in multi-gram 
quantities.22  The enantioconvergent nature of this reaction is conceptually interesting and 
provides a useful method for the conversion of racemic materials into valuable 
enantioenriched products. 
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5.5 SYNTHETIC APPLICATIONS OF ENANTIOENRICHED 
CYCLOALKANONES 
5.5.1 APPLICATIONS IN TARGET-DIRECTED SYNTHESIS 
5.5.1.1 TOTAL SYNTHESIS OF (+)-DICHROANONE 
Although the Tsuji allylation has seen only sparse use in total synthesis to date,38 the 
prevalence of quaternary carbon stereocenters in natural products provides an ample 
proving ground for the utility of the enantioselective Tsuji allylation protocols described 
above.  One class of compounds that bears this structural motif is a group of structurally 
similar norditerpenoids, which include the tricyclic p-quinone dichroanone (175, Scheme 
5.22).39  Recently, the enantioselective Tsuji allylation played a key role in the 
enantioselective total synthesis of (+)-dichroanone (175) by McFadden and Stoltz.40 
Scheme 5.22.  Enantioselective Tsuji allylation in the total synthesis of (+)-dichroanone 
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The synthesis commenced from allyl enol carbonate 217, which underwent 
enantioselective Tsuji allylation to form ketone (–)-155 with 91% ee.  Attempts to 
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generate the corresponding semicarbazone derivative to improve the ee of this material 
(Scheme 5.5) were negated by the presence of two quaternary centers adjacent to the 
ketone.  However, Wacker oxidation and aldol condensation led to bicyclic enone (–)-
174, which readily formed semicarbazone derivative (–)-440.  Recrystallization of this 
material and hydrolysis of the semicarbazone provided enone (–)-174 with 97% ee.  
Conversion of bicycle (–)-174 into 175 was achieved in eight steps.  The material 
produced by this route was enantiomeric to the natural isolate, which was of unknown 
absolute configuration.  Therefore, this total synthesis unambiguously proved the 
configuration of nat-(–)-(S)-dichroanone (175).  Dichroanone was produced in 11 steps 
from commercially available material in 4% overall yield without the use of protecting 
groups. 
 
5.5.1.2 FORMAL SYNTHESIS OF OXYBUTYNIN 
The reported conversion by Trost’s group of allyl enol carbonates into α-hydroxy 
aldehydes25 was highlighted by the formal synthesis of (S)-oxybutynin (449; Scheme 
5.23), a pharmaceutical compound used to treat various urinary disorders.  Although 
commercial oxybutynin is sold as a racemic mixture, some studies suggest that 
enantiopure (S)-oxybutynin may offer improved pharmaceutical properties.  As a result, 
asymmetric methods of producing (S)-oxybutynin may become valuable.41 
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Scheme 5.23.  Enantioselective formal synthesis of (S)-oxybutynin 
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The synthesis began with the one-step formation of mixed carbonate 443 from 
alcohol 441, CO2, and α-bromoacetophenone (442).  Treatment with base and TBSCl 
initiated a shift of the carbonate group, and the resulting aldehyde enolate was trapped as 
the enol silane (444).  Decarboxylative allylation was effected with Pd(0) supported by 
bis(phosphine) ligand (R,R)-348 to yield α-tertiary aldehyde 445 as an 11:1 mixture of 
diastereomers.  Although the ee of the major diastereomer was 99%, subsequent olefin 
hydrogenation of the diastereomeric mixture led to aldehyde 446 with 84% ee.  Oxidation 
with concomitant silyl ether cleavage formed (S)-448, a known intermediate in the 
synthesis of oxybutynin;42 recrystallization of (S)-448 increased its ee from 84% to over 
99%. 
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5.5.1.3 PROGRESS TOWARD ZOANTHENOL 
The zoanthus alkaloids are a family of polycyclic marine natural products with 
complex molecular architectures and interesting biological properties.  These compounds 
have attracted significant attention from the synthetic community on the basis of their 
challenging structural features and their significant biological activity (antiosteoporotic, 
cytotoxic, antibacterial).43  Despite the large body of work toward these natural products, 
only one member of the class, norzoanthamine, has had its total synthesis achieved.44 
One of the greatest challenges posed by the zoanthus alkaloids is the three quaternary 
carbon stereocenters about the C ring.  The Stoltz group recently reported an approach to 
the synthesis of one member of this class, zoanthenol (180, Scheme 5.24), and addressed 
these difficult stereocenters by an acid-mediated cyclization reaction to form the B ring.45  
The stereochemistry of the two stereocenters generated in this ring-forming reaction 
would ultimately be directed by the configuration of the quaternary stereocenter at C22. 
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Scheme 5.24.  Progress toward the total synthesis of zoanthenol 
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To fully exploit the key diastereoselective steps of this synthetic approach, an 
enantioselective method to form the C22 quaternary carbon center was required.  To this 
end, readily available allyl β-ketoester 244 was treated with catalytic [Pd2(dba)3] and (S)-
tBuPHOX to form ketone (–)-150 in 94% yield and with 86% ee.  Oxidative olefin 
cleavage followed by esterification and methylation formed ketone (+)-450, an 
immediate precursor to enol triflate 451. 
Toward the completion of the tricyclic core, racemic enol triflate 451 was converted 
into enal 453 through an interesting Pd-catalyzed reductive carbonylation.  Highly 
diastereoselective addition of Grignard reagent 454 yielded cyclization precursor 455, 
which, upon exposure to TFA, formed both the B ring and the key C12 quaternary 
stereocenter with good diastereocontrol.  Further elaboration of tricycle 456 over nine 
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steps led to diketone 179, which bears the correct stereochemical triad for the natural 
product (confirmed by X-ray crystallography). 
 
5.5.1.4 TOTAL SYNTHESIS OF CYANTHIWIGIN F 
The cytotoxic marine diterpenoid natural product cyanthiwigin F (83, Scheme 5.25) 
possesses a core structure laden with four contiguous stereocenters, two of which are all-
carbon quaternary centers.  Enquist and Stoltz46 sought to construct both of these 
challenging quaternary carbon stereocenters through a double enantioselective Tsuji 
alkylation reaction.  The requisite substrate (75) was prepared as mixture of rac- and 
meso-diastereomers, but upon exposure to the Pd•PHOX catalyst complex all three 
substrate stereoisomers were selectively converted to (R,R)-76 in 78% yield and a 4.4:1 
dr.  The major diastereomer was formed with 99% enantiomeric excess, likely through a 
Horeau-type enhancement of the overall ee.47  Enantioenriched diketone 76 was 
elaborated to cyanthiwigin F (83) in six additional steps (for a more complete discussion, 
see section 1.3.7).  Owing to the high degree of stereochemical complexity introduced by 
the double enantioselective alkylation reaction, the completion of cyanthiwigin F 
required only nine steps from known starting materials. 
Scheme 5.25.  Total synthesis of cyanthiwigin F via double enantioselective alkylation 
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5.5.1.5 TOTAL SYNTHESIS OF LAURENCENONE B AND ELATOL 
Many naturally occurring halogenated compounds have been identified.48  These 
metabolites often possess interesting biological activities and their structures pose 
unusual challenges to synthetic chemistry.  One specific example is the cytotoxic and 
antifungal chamigrene natural product elatol (178, Scheme 5.26).  From a structural 
standpoint, the spiro quaternary stereocenter is particularly challenging.  Grubbs, Stoltz, 
and their co-workers49 envisioned synthesizing the spiro-[6,6] carbocycle via ring-closing 
metathesis of an α,ω-diene derived from an enantioselective ketone alkylation (i.e., 176).  
To this end, enol carbonate substrate 458 was prepared in four steps and 49% yield from 
dimedone (457).  The decarboxylative alkylation reaction provided modest results (23% 
yield, 81% ee) when ligand 55 was used.  Installation of electron-withdrawing groups on 
the ligand provided a substantial increase in reactivity, and permitted alkylation product 
176 to be isolated in 82% yield and 87% ee.  The challenging ring-closing metathesis 
reaction to form the tetrasubstituted alkene present in the natural product was achieved 
using the highly active Ru-catalyst 79.50  Addition of methyllithium in the presence of 
CeCl3 and subsequent acidic workup formed the natural product (+)-laurencenone B 
(177) in 89% yield.  Bromination of spirocycle 177 with elemental bromine introduced 
the necessary secondary bromide with good diastereoselectivity.  Reduction of dibromide 
460 with DIBAL completed the first total synthesis of (+)-elatol (178). 
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Scheme 5.26.  Total syntheses of laurencenone B and elatol 
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5.5.1.6 FORMAL SYNTHESIS OF QUINIC ACID 
Quinic acid (463) is a common chiral pool starting material used in many synthetic 
efforts,51 including the total synthesis of dragmacidin F reported by Stoltz and co-
workers.52  Dioxanone 421 could be converted to cyclohexene 462 in three steps and 50% 
yield (Scheme 5.27).  Hydroxy acid 462 has previously been employed in the synthesis of 
quinic acid (463).53 
Scheme 5.27.  Formal synthesis of quinic acid 
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5.5.1.7 TOTAL SYNTHESIS OF CARISSONE 
The antibiotic carissone (269, Scheme 5.28) is representative of the eudsmane class of 
sesquiterpenoid natural products.  Stoltz and co-workers37a envisioned a general approach 
to this group of metabolites through a ring-closing strategy.  Toward this goal, 
enantioenriched vinylogous thioester 268 was converted to the vinylogous ester in order 
facilitate addition of allyl Grignard reagent derived from bromide 465.  Following acidic 
workup, substituted cyclohexanone 466 was isolated in excellent yield.  Ring-closing 
metathesis with Grubbs’ second-generation catalyst (167)54 was followed by regio- and 
diastereoselective olefin hydrogenation with heterogeneous Rh.  Cleavage of the silyl 
ether under acidic conditions formed primary alcohol 468.  After oxidation and 
esterification (468 → 469), the enone moiety was reduced diastereoselectively to the 
allylic alcohol.  Addition of methylmagnesium bromide formed diol 470, which is an 
intermediate in Aoyama’s synthesis of (α)-eudesmol (471).55  Alcohol oxidation by 
action of manganese dioxide provided (+)-carissone (269) quantitatively. 
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Scheme 5.28.  Enantioselective synthesis of carissone 
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5.5.1.8 TOTAL SYNTHESIS OF CASSIOL 
The antiulcerogenic sesquiterpenoid cassiol (270, Scheme 5.29) was also targeted by 
Stoltz and co-workers.37b  Toward this target molecule, enantioenriched vinylogous 
thioester 268 was isomerized to (E)-alkene 472 with PdCl2(CH3CN)2 in refluxing 
benzene.  Oxidative cleavage of the disubstituted alkene was challenging, but ultimately 
accomplished by olefin dihydroxylation and diol oxidation with lead tetraacetate.  The 
resulting aldehyde (473) was chemoselectively reduced with a bulky aluminum hydride 
reagent to form alcohol 474.  Addition of thioester 474 to a solution of vinyllithium 
reagent 475 provided (+)-cassiol (270) in 12% overall yield after acidic workup.  For 
further details, see Chapter 9. 
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Scheme 5.29.  Enantioselective total synthesis of cassiol 
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5.5.2 METHODOLOGICAL APPLICATIONS 
5.5.2.1 α-FLUORINATED CYCLOALKANONES 
Stereodefined α-fluoroketones are intriguing compounds for synthetic and medicinal 
chemistry.  The asymmetric synthesis of such compounds, however, has been quite 
challenging.56  The mild reaction conditions and functional-group tolerance of the Tsuji 
allylation protocol are ideal for the incorporation of fluorine atoms.  Moreover, the facile 
fluorination of β-ketoesters with electrophilic reagents, such as Selectfluor®, allows the 
straightforward preparation of fluorine-containing substrates.57 
Stoltz and co-workers reported the first use of the enantioselective Tsuji allylation to 
generate an enantioenriched tertiary fluoride with the preparation of 2-allyl-2-
fluorocyclohexanone (261) with 91% ee (Scheme 5.30).34  Soon after, Nakamura and co-
workers elaborated this concept with a nearly identical catalyst system.35  They found 
high levels of enantioselectivity for a range of cyclic substrates and modest 
enantioselectivity for acyclic β-ketoester substrates. 
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Scheme 5.30.  Enantioenriched α-fluoroketones derived from allyl β-ketoesters 
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Since the appearance of the nearly simultaneous reports above, other related systems 
have emerged.  Tunge and co-workers also chose allyl β-ketoester substrates and found 
that the biaryl P/N chelating ligand QUINAP (120) provided good levels of 
enantioselectivity, although t-BuPHOX (55) was superior in most cases (Scheme 5.31).58  
Notably, (S)-QUINAP ((S)-120) and (S)-t-BuPHOX ((S)-55) provided products in the 
opposite enantiomeric series, an effect also observed by Stoltz for allylation from allyl 
enol carbonates.20  This shift in absolute configuration may be advantageous as (R)-t-
BuPHOX, which is derived from (R)-tert-leucine, is somewhat more expensive than its 
antipode, whereas both enantiomers of QUINAP are commercially available.  In 
agreement with the findings of Stoltz and co-workers and those of Nakamura and co-
workers, P/P and P/O chelating ligands were found to be inferior to P/N ligands in terms 
of ee. 
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Scheme 5.31.  Enantioenriched α-fluorocycloalkanones prepared from allyl β-ketoesters 
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In 2007, Paquin and co-workers reported a system based on the silyl enol ether 
substrates employed by Stoltz (see section 5.3).  The reaction conditions used in Paquin’s 
work were slightly modified: [Pd(allyl)Cl]2, toluene solvent, TES enol ethers in 
preference to TMS enol ethers, and allyl ethyl carbonates (489 and 490) in place of 
diallyl carbonates (Scheme 5.32).59  Paquin and co-workers also found that (S)-55 gave 
α-fluorocycloalkanones with high ee, whereas chelating P/P ligands performed poorly.  
However, their work has no examples of ketone enolates with multiple acidic sites. 
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Scheme 5.32.  Enantioenriched α-fluorocycloalkanones prepared from silyl enol ethers 
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The antipode of (S)-55 has been synthesized, although the (R)-tert-leucine starting 
material is somewhat more expensive.  In order to access the opposite enantiomeric 
series, Paquin and co-workers prepared 5,5-dimethyl-i-PrPHOX (200, Scheme 5.33).60  
Reactions using this ligand gave comparable results to reactions with 55. 
Scheme 5.33.  Alkylation with pseudoenantiomeric ligands 
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Further studies from Paquin and co-workers61 sought to employ fluorinated enol 
carbonates as substrates (Scheme 5.34).  Initial explorations with standard conditions led 
to products with moderate ee (ca. 50%).  Examination of the ligand-to-metal ratio 
revealed that using a substoichiometric amount of ligand relative to metal improved the 
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product ee significantly without affecting yields.  This effect was observed for a range of 
fluorinated enol carbonates, although acyclic cases still provided modest ee. 
Scheme 5.34.  Alkylation using fluorinated enol carbonates 
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Alkylation using fluorinated enol silanes or β-ketoesters was not improved by 
lowering the ligand-to-metal ratio (Scheme 5.35).  Alkylation forming all-carbon 
quaternary centers was similarly unaffected. 
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Scheme 5.35.  Alkylation reactions relatively unaffected by ligand-to-metal ratio 
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5.5.2.2 CASCADE REACTIONS TO GENERATE ENOLATES 
An ingenious application of the allyl enol carbonate version of the Tsuji allylation 
was recently reported by Blechert’s group (Scheme 5.36).62  In this work, [3.2.0]bicycles 
502 were readily synthesized through photocycloaddition from the corresponding allyl 
enol carbonates 499.  Subsequently, a retroaldol fragmentation cascade was initiated by 
decarboxylation of the allyl carbonate, and the resultant enolate underwent 
enantioselective allylation.  As the substrate stereocenters are destroyed in the retroaldol 
step, racemic starting materials may be used, and the reaction is enantioconvergent.  By 
exploiting this ring-expansion method, a variety of seven-membered-ring diketones 503 
were generated with good ee by using the t-BuPHOX/Pd(0) catalyst system.  Attempts to 
generate tertiary stereocenters through this reaction were met with moderate ee, and in 
some cases it was necessary to employ (S)-i-PrPHOX ((S)-122) to obtain reasonable 
yields.  The overall sequence represents an enantioselective variant of the de Mayo 
reaction.63 
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Scheme 5.36.  Asymmetric ring-expanding allylation 
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This method allows access to interesting seven-membered ring compounds that may 
be useful for the synthesis of a variety of natural products.  Important to the development 
of the enantioselective allylation methodology, this work suggests that many distinct 
methods of accessing a Pd-enolate intermediate may be amenable to enantioselective 
reactions by using the ligand complexes discussed herein. 
 
5.5.2.3 INTERCEPTED ALKYLATION WITH CONJUGATE ACCEPTORS 
Stoltz and co-workers hypothesized that it could be possible to intercept the proposed 
Pd-enolate intermediate with other electrophiles.  Explorations of Brønsted acids led to 
successful enantioselective protonation protocols (see Chapters 6 and 7).64  Next, 
conjugate acceptors were investigated.65  Inspired by earlier works from other 
researchers,66 benzylidenemalononitrile (516, Scheme 5.37) was selected as the conjugate 
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acceptor.  Initial screening reactions indicated that electron deficient PHOX ligand 141 
was optimal for capturing the presumed enolate intermediate derived from racemic β-
ketoester substrates.  High yields of the interrupted allylic alkylation products could be 
obtained.  Product dr was somewhat variable with some substrates providing very high dr 
for unknown reasons.  Often both diastereomers of product formed with high ee.  Other 
arenylidenemalononitriles could be used in the reaction as well.  The absolute 
stereochemistry was established via X-ray crystallography and the enantiofacial 
selectivity differs between trapping with an allyl group and interrupted trapping with a 
conjugate acceptor (cf. Scheme 5.17 and Scheme 5.37).  The facial selectivity for 
interrupted alkylation did, however, match that of the enantioselective protonation of 
cyclohexanone-derived enolates.64  This work represents a significant advance toward a 
general catalytic system for enantioselective enolate functionalization. 
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Scheme 5.37.  Interrupted allylic alkylation 
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5.5.3 MISCELLANEOUS APPLICATIONS 
In the initial report from the Stoltz group, several useful transformations of the α-
quaternary cycloalkanone products were carried out (Scheme 5.38a).20  Among these 
were functionalizations of the allyl group followed by aldol condensation to generate 
[6.5] and [6.6] bicycles 166, 168, and 169 in good yields.  Enone 169 is commonly 
produced by Robinson annulation67 and has found many applications in synthesis.68  
Another simple transformation of 2-allyl-2-methylcyclohexanone (106) is the conversion 
into lactone 170 by Baeyer–Villiger oxidation.  This transformation provides an entry to 
enantioenriched tertiary alcohol stereocenters.  Spriocyclic systems were accessed with 
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high ee by employing the Grubbs’ second-generation olefin metathesis catalyst 16754 to 
transform ketone 164 into 171 (Scheme 5.38b).27 
Scheme 5.38.  a) Transformations of ketone (–)-106  b) Ring-closing metathesis to form a spirocycle 
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The vinylogous thioesters produced by Trost and co-workers (Scheme 5.19) were 
amenable to further functionalization by Stork–Danheiser-type manipulations (Scheme 
5.39).69  These transformations provided a valuable route to enantioenriched γ-quaternary 
stereocenters in enone systems.70  Two of these derivatives, (S)-532 and (R)-533, were 
used to establish the absolute configuration of (R)-424.  Related transformations were 
used in the total syntheses of carissone (section 5.5.1.7) and cassiol (section 5.5.1.8) by 
Stoltz and co-workers. 
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Scheme 5.39.  Stork–Danheiser type transformations of vinylogous thioester (R)-51 
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The dioxanone class of substrates provided entries into other important derivatives 
(Scheme 5.40).  Cleavage of the acetal with p-toluenesulfonic acid generated dihydroxy 
ketones (e.g., 415 → 536).  These dihydroxy ketones underwent selective oxidative 
cleavage upon exposure to periodic acid and after esterification the corresponding 
hydroxyesters were isolated (e.g., 537).  Overall yields for the transformation from 
dioxanone to hydroxyester (415 → 537) were 41–81% for three steps.  In the case of 
chlorinated compound 537, subsequent ozonolysis formed citramalic acid dimethyl ester 
(538) that was correlated to literature data to establish the absolute configuration as S.71 
Scheme 5.40.  Useful derivatives of enantioenriched dioxanones 
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5.6 MECHANISM OF ALLYLATION REACTIONS 
To date, there has been relatively little mechanistic evidence presented for these 
reactions.  One important set of experiments that have been reported are crossover 
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experiments.  Both the Trost and Stoltz groups described crossover experiments with enol 
carbonate substrates and their respective catalyst systems (Scheme 5.41).  Trost’s group 
observed minimal crossover between allyl and crotyl carbonates (539 and 540, 
respectively);23 they attributed the lack of crossover with the bis(phosphine)/Pd(0) 
catalyst system to a rate of alkylation that exceeds the rate of ion diffusion from solvent-
caged ion pairs in dioxane.  Further evidence for the importance of these contact ion pairs 
was the importance of the solvent in suppressing overalkylation and enolate scrambling 
when forming tertiary stereocenters.23,25 
Scheme 5.41.  a) Trost's crossover experiment  b) Stoltz' crossover experiment 
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In contrast to the results of Trost’s group, Stoltz and co-workers observed scrambling 
of allyl termini and complete crossover between the two differently deuterated allyl enol 
carbonates 294 and 295 in THF, dioxane, and benzene (Scheme 5.41b).34  Saegusa and 
co-workers also observed crossover in a similar experiment with a non-enantioselective 
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system and allyl β-ketoester substrates in DMF, although crossover was suppressed in 
benzene.15b  At the time, Saegusa and co-workers proposed a catalytic cycle similar to the 
one shown in Scheme 5.42 that accounted for crossover at two stages in the process.  This 
cycle appears to be consistent with the results obtained by Stoltz and co-workers with the 
PHOX/Pd(0) catalyst system.  Additionally, the recent isolation of a (PHOX)Pd-
carboxylate complex72 is suggestive of a long-lived carboxylate intermediate that may 
provide an opportunity for crossover.  Although Stoltz’ crossover results clearly contrast 
with those of Trost’s group, these experiments are not informative as to the mechanism of 
bond formation or the origin of enantioselectivity in these reactions. 
Scheme 5.42.  Possible catalytic cycle for decarboxylative allylation 
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The reversal of enantioselectivity that Trost and co-workers observed between the 
reaction of pregenerated lithium enolates7a and those generated in situ from allyl enol 
carbonates23 indicates that these two processes probably have significantly different 
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mechanisms.  However, the details of these differences have not been elucidated 
experimentally.  The possible intermediacy of an inner-sphere Pd enolate73 rather than the 
outer-sphere nucleophile typical of other π-allyl alkylations74 has been suggested and 
supported by some evidence, although alternates cannot be ruled out at this time.  
Computational studies of the Pd•PHOX system have found that the inner-sphere 
mechanism is lower in energy than outer-sphere attack (see Chapter 4).73  The lack of 
enolate scrambling observed throughout all the studies presented herein, especially in the 
presence of an acidic 1,3-diester moiety (Scheme 5.20), would be consistent with the 
inner-sphere proposal. 
 
5.7 CONCLUSIONS 
The important discoveries made by Professor Tsuji and his co-workers laid the 
groundwork for a multitude of useful processes that will surely find further applications 
in the coming years.  These powerful methods allow for the high-yield synthesis of α-
quaternary cycloalkanones from three distinct substrate motifs.  Apart from quaternary 
centers, several examples of the synthesis of tertiary stereocenters have been reported.  
The versatility of these methods provides valuable inroads toward the ultimate goal of 
general protocols for the enantioselective functionalization of enolates.  The first 
evidence of the impact of these methods is apparent in the applications to total synthesis 
and to the synthesis of other important functionalized molecules described in this chapter.  
The adaptations of other palladium enolate reactions developed by Tsuji to analogous 
enantioselective variants (e.g., enantioselective protonation64) are indicative of the 
ongoing legacy of these contributions.  A multitude of future reports on the utility of 
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these reactions is anticipated.  These will further demonstrate the importance of the 
pioneering discoveries of Professor Tsuji. 
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CHAPTER 6 
Enantioselective Protonations† 
6.1 INTRODUCTION 
Enantioselective protonation is a common process in biosynthetic sequences.  The 
decarboxylase and esterase enzymes that effect this valuable transformation are able to 
control both the steric environment around the proton acceptor (typically an enolate) and 
the proton donor (typically a thiol).  Recently, several chemical methods to achieve 
enantioselective protonation have been developed by exploiting various means of 
enantiocontrol in different mechanisms.  These laboratory transformations have proven 
useful for the preparation of a number of valuable organic compounds. 
A fundamental method to generate a tertiary carbon stereocenter is to deliver a proton 
to a carbanion intermediate.  However, enantioselective transfer of a proton presents 
unusual challenges, specifically, manipulating a very small atom and avoiding product 
racemization at a particularly labile stereocenter.  As a result, the conditions for a 
successful enantioselective protonation protocol may be very specific to a certain 
substrate class.  Tertiary carbon stereocenters are extremely common in valuable 
                                                
† This review was written in collaboration with Allen Y. Hong and a similar version has been accepted for 
publication in Nature: Chemistry. 
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biologically active natural products, and thus the need for synthetically useful 
enantioselective methods to form these stereocenters is vital.1 
In this chapter, several strategic approaches to enantioselective protonation are 
presented.  Emphasis has been placed on recently developed methods and their 
accompanying mechanisms in order to update the most recent prior reviews on this 
topic.2  Each method relies on particular stereochemical control elements based on the 
mechanism of the protonation transformation.  Appreciation of these controlling elements 
may lead to improved methods for preparing valuable chiral materials for a variety of 
synthetic applications. 
 
6.2 IMPORTANT FACTORS IN ACHIEVING ENANTIOSELECTIVE 
PROTONATION 
Several of the most important practical features of enantioselective protonation were 
enumerated in Fehr’s 1996 review.2  Principal among these is the fact that 
enantioselective protonations are necessarily kinetic processes since under 
thermodynamic control racemate would be formed.  Accordingly, it is often necessary to 
match the pKa of the proton donor and the product to prevent racemization before product 
isolation.  It is unfortunate that the same anion stabilizing groups (e.g., ketones) that 
make protonations relatively easy to achieve also impart a degree of instability in the 
product.  This has led some researchers to explore hydrogen atom transfer reactions in 
lieu of Brønsted acid-mediated protonations (see subsection 6.4.4). 
In addition to the obvious challenges of product stability under the reaction 
conditions, the rapid rate of proton exchange in solution often leads to significant levels 
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of background reaction without the intercession of the chiral control element.  As a result, 
typical proton donors are relatively weak acids that react with the proton acceptor in a 
slower and more controlled fashion. 
Since substrates for enantioselective protonation generally involve a prochiral sp2-
hybridized atom, the stereochemistry of the substrate is a concern.  In some cases, the 
ability to generate stereodefined proton acceptors (e.g., a pure E- or Z-enolate) is critical 
to the success of a protonation method.  In other cases, however, the two stereoisomers of 
enolate may in fact lead to the same enantiomer of product.2d  To obviate this concern 
many researchers choose to investigate cyclic substrates; in turn, this may lead to a 
limited substrate scope for a particular system.  The method to access the reactive proton 
acceptor is among the most important facets of each protonation system, and many 
strategies have been explored (e.g., conjugate addition, addition to ketenes, and 
decarboxylation from β-ketoesters). 
Finally, the fine mechanistic details of enantioselective protonations are often not 
well understood.  Since typical proton acceptors are stabilized anions, there are multiple 
Lewis basic sites available for protonation.  It is likely that these sites protonate at 
kinetically different rates dependent on the specific reaction conditions.  Potentially, 
enantioselective protonations may be achieved either by direct protonation to generate the 
desired stereocenter, or by protonation at a different site followed by enantioselective 
tautomerization.  In an important recent report, Fehr3 demonstrated that isolated enol 543 
(Scheme 6.1) could be transformed enantioselectively into ketone 546 (an immediate 
precursor to the rose-smelling fragrance compound (S)-(α)-damascone) via the proposed 
aggregate complex 545, and this mechanistic course seemed to be operative in the 
678 Chapter 6 – Enantioselective Protonations  
analagous protonation of a lithium enolate with the conjugate acid of alkoxide 544.  
Based on these findings, perhaps some protonation protocols are more accurately 
described as enantioselective tautomerization reactions.  Although ultimately 
inconsequential in terms of the products obtained, insights into the specific mechanistic 
course of the reaction are important in order to improve these systems.  However, only 
rarely have these levels of mechanistic understanding been realized. 
Scheme 6.1.  Enantioselective tautomerization of an isolated enol 
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6.3 ENANTIOSELECTIVE PROTONATION IN ENZYMATIC SYSTEMS 
6.3.1 DECARBOXYLASE ENZYMES 
Nature has evolved several efficient enzymes that catalyze enantioselective 
protonation reactions on useful organic building blocks.  In recent reports, 
decarboxylases and esterases have proven to be two popular classes of natural enzymes 
for the construction of α-stereocenters adjacent to ketones.  Esterases release latent 
enolates from prochiral substrates while decarboxylases generate enolates in situ from 
malonic acid derivatives (Scheme 6.2 through Scheme 6.4). 
Ohta and co-workers4 isolated arylmalonate decarboxylase (AMDase) from Gram-
negative bacterium Alcaligenes bronchisepticus and found that it catalyzes the 
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decarboxylative enantioselective protonation of α-aryl-α-methyl-malonates through the 
proposed mechanism in Scheme 6.2.  Yields and enantiomeric excesses were excellent 
for substrates with various α-aryl substitutents (up to 99% yield and 99% ee).  
Experiments have shown that the Cys188 residue is essential for activity, and this site is 
the putative proton donor that stabilizes the enolate intermediate.  A Hammett study5 of 
the reaction found a ρ value of +1.19, which is consistent with a negatively charged 
transition state.4  Recently, preliminary X-ray diffraction experiments and an X-ray 
crystal structure of AMDase were reported.6 
Scheme 6.2.  Enzymatic decarboxylative protonation with wild-type and mutant decarboxylases 
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Accessing the opposite enantiomeric series of products required additional 
investigation.7  Analysis of the enzyme amino acid sequence was carried out to check for 
homology with known enzymes.  The Cys188 residue is conserved in several racemase 
enzymes from other microorganisms.  Glutamate racemase, found in the bacterium 
Lactobacillus fermenti, contains an active site similar to that of AMDase, but with 
cysteine residues (Cys188 and Cys74) on both sides of the substrate.  Presumably, one of 
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the cysteine residues acts as a base and generates an enolate intermediate which can then 
be protonated non-selectively from either cysteine residue to give rise to a racemic 
mixture.  When Ohta and co-workers prepared a G74C mutant of AMDase to mimic 
these racemase enzymes, they found that racemic α-thienylpropionic acid (548, Scheme 
6.2) was formed in 37% yield from the malonic acid substrate (547).  Further 
explorations based on this homology hypothesis led to the preparation of a double mutant 
of AMDase (G74C/C188S) that removed the native cysteine residue while maintaining 
the mutant residue on the opposite face of the substrate.  The opposite enantiomer of 
product was indeed obtained with this new enzyme in 94% enantiomeric excess, although 
yields decreased to 60% and the activity of this mutant was several orders of magnitude 
lower than the wild-type.  Some activity was rescued by performing random mutagenesis 
and identifying more active triple mutants.8 
Decarboxylase-type activity was also observed in the conversion of β-hydroxyacid 
554 to optically active α-arylpropionic acid (R)-558 by Gram-positive bacteria 
Rhodococcus sp. KU1314 (Scheme 6.3).9 In the proposed metabolic pathway, enzymes in 
the microorganism non-selectively oxidize hydroxyacid substrate 554 to aldehyde 555 
and then decarboxylate the corresponding acid to form enolate 556 that undergoes 
enantioselective protonation to generate aldehyde 557.  Subsequent non-selective 
oxidation affords enantioenriched α-arylpropionic acid 558.  Mechanistic experiments 
were consistent with this proposed enantioselective protonation mechanism rather than 
alternative possibilities such as enantioselective oxidation steps.  Enantioselectivity and 
yield varied considerably depending on the aryl and alkyl groups at the α-position in the 
substrate, but enantiomeric excesses up to 85% could be achieved.  Employing an 
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electron poor aryl group appeared to give poor enantioselectivity due to increased acidity 
of the proton in the presumed aldehyde intermediate.  When the alkyl group was changed 
from methyl to ethyl, the reaction yield dropped, suggesting that the enzyme is sensitive 
to sterics. 
Scheme 6.3.  Enzymatic oxidation/decarboxylation/protonation/oxidation cascade 
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6.3.2 ESTERASE ENZYMES 
Several researchers have employed esterases to obtain enantioenriched protonation 
products.  In 1990, Ohta and co-workers10 reported that live Pichia miso IAM 4682 yeast 
cells catalyze the conversion of enol acetates to enantioenriched ketones (e.g., 108 → 
207, Scheme 6.4).  High levels of enantiomeric excess were attained with a variety of 
enol esters.  For larger ring systems, the reaction yield and absolute configuration varied 
unpredictably with ring size.  In an impressive application, this yeast-mediated reaction 
was used to generate an α-stereocenter in a 12-membered ring with 96% ee. 
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Scheme 6.4.  Enzymatic hydrolysis of enol acetates 
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Hirata and co-workers11 reported that liverwort Marchantia polymorpha esterase I 
also catalyzes the same reaction on a variety of substrates with differing alkyl side chains, 
but the facial preference for proton delivery varied for different enolate substitutions.  For 
example, the enzyme delivered (S)-2-methylcyclohexanone (207) and (R)-2-n-
propylcyclohexanone from their respective enol acetates in 99% conversion and 99% ee. 
Lipase PS-C II, originating from Gram-negative bacteria Burkholderia cepacia, may 
also be used for the hydrolysis of 1-acetoxy-2-methylcyclohexene (108).  Sakai and co-
workers12 discovered that the enantiomeric excess of the product ((R)-207) was largely 
dependent on the temperature and the proton source.  The best results were obtained by 
running the reaction at 0 °C with solid-supported enzyme PS-C II and ethanol as proton 
source (82% conversion, 77% ee). 
Among these enzymatic approaches, a general problem appears to be the difficulty of 
enzyme modification to give the unnatural antipode of product.  Another limitation is the 
need for buffers to help stabilize enzymes or cells.  Substrate scope is also limited due to 
the specificity of substrate recognition.  For these reasons, enzymatic reactions do not 
provide a general solution to the synthesis of enantioenriched protonation products.  
Laboratory means for enantioselective protonation may enable a more universal protocol 
due to the ability to tune the structural and electronic features of the catalyst.  These 
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natural systems do, however, demonstrate many of the key controlling elements 
necessary for successful enantioselective protonation. 
 
6.4 STRATEGIC APPROACHES TO NONENZYMATIVE 
ENANTIOSELECTIVE PROTONATION 
6.4.1 GENERAL CONSIDERATIONS 
Using enzymatic systems as a guide to the important factors in achieving 
enantioselective protonation, two distinct factors have been envisioned as opportunities 
for asymmetric induction: the use of a chiral Brønsted acid (see subsection 6.4.2) and 
generation of a chiral proton acceptor intermediate (see subsection 6.4.3).  Whereas the 
enzymatic systems exploit both of these control elements, many laboratory methods have 
sought to use only a single control element not only to minimize the amount of 
enantiopure material required for the transformation, but also to eliminate complicating 
diastereomeric interactions possible in systems with multiple chiral additives.  In 
practice, some of these systems seem to involve protonation through an aggregate 
complex of both proton acceptor and proton donor, typically in a metal complex (e.g., 
Fehr’s tautomerization depicted in Scheme 6.1). 
An additional factor important in improving efficiency of enantioselective 
protonation systems is achieving catalysis.  For example, catalytic generation of a chiral 
metal/enolate complex in situ minimizes the amount of chiral controller required.  
Alternatively, coupling of a catalytic chiral proton donor to a stoichiometric achiral 
proton source achieves a similarly efficient use of chiral information.  In the latter case, 
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however, a specific order of thermodynamic acidity of the reaction components must be 
employed (necessarily in this order of decreasing Brønsted acidity: stoichiometric proton 
source, catalytic chiral protonating agent, and product).  An accompanying balance of 
kinetic rates of proton transfer between all of these components must also be achieved to 
allow a reasonable rate of protonation through the catalyzed pathway while avoiding 
undesired background reaction between the prochiral proton acceptor and the 
stoichiometric achiral proton donor.  Vedejs and co-workers have disclosed a study of 
these factors that is representative of these important issues.13 
 
6.4.2 ENANTIOSELECTIVE PROTONATION BY MEANS OF CHIRAL 
PROTON DONOR 
Perhaps the most fundamental means of achieving an enantioselective protonation is 
to employ a chiral proton donor.  The acidic proton often comes from an oxygen, 
nitrogen, or carbon atom in the proton donor.  Indeed, the earliest enantioselective 
protonation protocols employed this technique. 
Among the most popular substrates for enantioselective protonation are lithium 
enolates, which are often generated from ketones, enol acetates, or silyl enol ethers at low 
temperatures.  This method most closely resembles an esterase approach taken by Nature.  
Kim and co-workers14 have synthesized a family of hydroxyethers as chiral proton 
sources (e.g., 560, Scheme 6.5) capable of protonating lithium enolates of tetralones and 
indanones (prepared in situ from silyl enol ethers such as 559) in up to 97% yield and 
90% ee.  The acidity of the Brønsted acids had a strong correlation to enantioselectivity 
and salt-free conditions were important to selectivity.  A π–π-stacking interaction 
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between the substrate and rigid proton source was proposed as the chiral controlling 
interaction during the protonation event.  Since cyclohexanone-derived enolates lack an 
aryl group to participate in the stacking interaction, poor ee was observed for these 
substrates. 
Scheme 6.5.  Kim's enolate protonation 
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Eames and co-workers15 have developed several strategies for the asymmetric 
protonation of prochiral tetralone enolates based on structurally different chiral proton 
sources.  In one example, tris(sulfonamide) protonating agents with chiral backbones 
(e.g., 562, Scheme 6.6) provided yields of ketone products (e.g., 97) up to 70% and 
enantiomeric excesses of up to 77%.15c  In these systems, it is believed that the enolates 
and proton sources can form an organized transition state that is guided by lithium 
chelation and perhaps more closely resembles a chiral aggregate intermediate than a 
direct enolate protonation.  In some cases it was possible to access the opposite antipode 
of the product ketone by employing an external quench strategy.15 
Scheme 6.6.  Eames's enolate protonation 
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Enolate intermediates can also be accessed through decarboxylation.  Proton donors 
derived from Cinchona alkaloids (e.g., 565, Scheme 6.7) have proven to be especially 
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useful reagents for this enantioselective protonation strategy.  Rouden and co-workers16 
have shown that cyclic and acyclic α-aminomalonate hemiester substrates (e.g., 563) can 
be protonated with high levels of enantioselectivity.  Enantiomeric excesses of product 
esters (e.g., 564) up to 93% could be achieved in cyclic cases and 89% in acyclic cases.  
Products in the opposite enantiomeric series could be generated in comparable ee using 
catalysts prepared from naturally occurring diastereomeric alkaloids.  The alkaloid 
derivatives are believed to serve as dual-purpose reagents: they deprotonate malonate 
hemiester substrates and promote a decarboxylation event.  The intermediate enolate can 
be protonated by the tertiary ammonium salt to give enantioenriched products.  This 
approach is biomimetic and resembles decarboxylase enzymes in Nature. 
Scheme 6.7.  Rouden's decarboxylative protonation 
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Work done by Donohoe and co-workers17 has shown that it is possible to perform 
dissolving metal reductions of pyrrole esters and quench the resulting enolate 
intermediates with a chiral proton source.  Reduction of 2,5-disubstituted pyrroles (e.g., 
566, Scheme 6.8) led to a separable 1:1 mixture of trans- and meso-diasastereomers of 
ester 568, but the asymmetric induction in the chiral trans-product was good when (–)-
ephedrine (567) was used as the chiral proton source.  Based on enantioselectivities of 
reactions with substituted ephedrine derivatives, it was proposed that the hydroxyl group 
provides the proton and that the ephedrine molecule needs to interact with the lithium 
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cation in a bidentate fashion for optimal asymmetric induction.  Considering this 
proposal, this transformation may be more accurately described as protonation through a 
chiral aggregate of Brønsted acid and base.  A related transformation of pyrrole mono-
esters with oxazolidinone proton donors yielded reduced products in up to 68% ee and 
58% yield.  These partially reduced pyrroles could be elaborated to form uncommon 
dihydroxylated amino acids found in the marine mussel Mytilus edulis.17 
Scheme 6.8.  Donohoe's partial pyrrole reduction 
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It is often possible to employ catalytic amounts of chiral protonating agents, provided 
that an appropriate stoichiometric proton source can be identified.  For this purpose, a 
number of chiral organic catalyts have been employed in various transformations.  In 
order to achieve a heterocycle reduction/protonation strategy analogous to that used by 
Donohoe and co-workers (Scheme 6.8), Rueping and co-workers18 were able reduce 
substituted quinolines enantioselectively (Scheme 6.9).  Initial hydride reduction of 
annulated quinoline 569 by a Hantzch dihydropyridine (574) to form enamine 570 was 
followed by enantioselective protonation with a catalytic chiral BINOL-phosphoric acid 
(573).  Terminal hydride reduction of iminium ion 571 yielded optically active 
tetrahydroquinoline 572 as an 8:1 mixture of trans- and cis-diastereomers with the 
diastereomers formed in 94% and 99% enantiomeric excess, respectively.  Up to 84% 
yield and 85% enantiomeric excess could be obtained for mono-substituted quinolines 
using the optimal reaction conditions. 
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Scheme 6.9.  Rueping's quinoline reduction/protonation 
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In a mechanistically different approach, Cheon and Yamamoto19 used a related 
BINOL N-triflyl thiophosphoramide catalyst (577) to directly protonate cyclic silyl enol 
ethers (e.g., 575 → 576, Scheme 6.10).  Regeneration of the chiral proton source was 
made possible by using phenol as the achiral proton source.  With this system, yields up 
to 99% and enantiomeric excesses up to 90% were achieved.  The highest levels of 
enantioselectivity were obtained with substrates bearing an aryl substituent at the α-
position and 7-membered rings performed somewhat better than 6-membered rings.  
Comparable selectivity and yield could be obtained with catalyst loadings as low as 0.05 
mol%.  In control experiments, the protonation reaction did not proceed without an 
achiral proton source, even with stoichiometric chiral Brønsted acid.  This observation 
led to a proposed mechanism that involves pre-association of the chiral and achiral proton 
sources to form an oxonium ion pair (578) that then protonates the silyl enol ether 
substrate. 
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Scheme 6.10.  Yamamoto's enol silane protonation 
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A common approach to enantioselective protonation employs a lithium enolate, 
catalytic chiral proton source, and stoichiometric achiral proton source.  These lithium 
enolates are often prepared from the corresponding enol silanes.  Reports of amino acids 
as catalytic proton sources have appeared in recent literature.  Yanagisawa and co-
workers20 employed commercially available dipeptide 560 (Scheme 6.11) for the 
protonation of lithium enolates of tetralones and cyclohexanones.  The catalytic proton 
source is regenerated through proton transfer from 2,6-di-t-butyl-4-methylphenol (BHT).  
The steric bulk of the phenol is important to suppressing background enolate protonation 
through a non-selective pathway.  The structure of the chiral proton donor is very specific 
to the success of the reaction because isomeric dipeptide aspartame afforded racemic 
product.  Enolates generated from deprotonation of racemic ketone 97 with lithium 
diisopropylamide could also be protonated with comparable yield and enantioselectivity 
using this system. 
Scheme 6.11.  Yanagisawa's lithium enolate protonation 
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In separate work from Yanagisawa and co-workers,21 enol silanes were found to react 
to form ketones in the presence of the complex of AgF and BINAP (116, Scheme 6.12) 
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with methanol as a proton donor.  Excellent enantiomeric excesses were reported for a 
variety of cyclic ketones.  Cyclohexanone-derived enol silanes yielded significantly 
higher ee products than tetralone-derived enol ethers.  The highest levels of ee (up to 
99%) were found for α-arylcyclohexanones.  Although the fine mechanistic details have 
not been elucidated, one possibility is that the chiral Lewis acidic Ag•BINAP complex 
binds methanol to generate a potent chiral Brønsted acid capable of protonating the latent 
enolate.  Taking the fluoride activation component into account, aggregate complex 562 
was proposed as a potential intermediate leading to the observed enantiomer of product 
ketone. 
Scheme 6.12.  Yanagisawa's enol silane protonation 
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Levacher and co-workers22 have reported that catalytic amounts of Cinchona alkaloid 
derivatives can be coupled to latent hydrogen fluoride sources to achieve enantioselective 
protonation of silyl enol ethers of 1-indanones and 1-tetralones (e.g., 563 → 565, Scheme 
6.13).  The hydrogen fluoride, generated in situ from benzoyl fluoride and ethanol, is 
presumed to interact with the alkaloid-derived catalyst to form a cinchonium fluoride.  
The fluoride anion of this active catalyst then activates the silyl group to facilitate proton 
delivery from the ammonium cation (e.g., 564) through a proposed transition state 
reminiscent of the Ag•BINAP protonation protocol described above.  The optimal 
alkaloid catalyt was (DHQ)2(AQN), a common ligand for Sharpless’ enantioselective 
dihydroxylation reactions.23  Yields up to 86% and enantiomeric excesses up to 92% were 
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reported.  Protonation of cyclohexanone-derived enol silanes gave moderate enantiomeric 
excess.  Later work revealed that carboxylic acids (e.g., citric acid) could be used directly 
with the alkaloid-derived catalysts to carry out the enol silane protonation.24  
Enantioselectivity for this variant of the reaction was moderately diminished, however 
(ee up to 75%).  The use of chiral carboxylic acids revealed a moderate, but measureable, 
influence of both the proton donor and the catalyst on enantioselection, with the catalyst 
influence apparently dominating. 
Scheme 6.13.  Levacher's enol silane protonation 
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In a series of reports by Deng and co-workers,25 bifunctional Cinchona alkaloid-
derivatives (e.g., 565, 572–575, Scheme 6.14) were reported to catalyze tandem 
asymmetric conjugate addition/protonation reactions of cyclic and acyclic α-cyanoketone 
nucleophiles (e.g., 566 and 569) to 2-chloroacrylonitrile (567).  The Cinchona alkaloid 
derivative is proposed to serve two functions: activating the Michael acceptor for addition 
and serving as the chiral Brønsted acid for the protonation of the nitrile-stabilized 
carbanion intermediate.  The postulated stereochemical model involves a network of 
hydrogen bonding interactions, and it was found that modification of this network by 
masking the phenolic hydroxyl group and introducing a thiourea moiety led to 
preferential formation of the diastereomeric products in excellent ee.  By virtue of this 
discovery, all four stereoisomeric products of 568 could be prepared with high degrees of 
diastereo- and enantioselectivity.  This method was applied to an enantioselective formal 
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synthesis of (–)-manzacidin A (571) via the intermediate thioester 570, prepared in 93% 
ee from α-cyanothioester 569 and 2-chloroacrylonitrile (567).  A very similar 
transformation was reported by Wu and co-workers26 for the conjugate addition of 
thiophenol to an α-substituted acrylamide with subsequent enantioselective protonation 
in up to 60% ee. 
Scheme 6.14.  Deng's conjugate addition/protonation 
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Organic catalysts other than Cinchona alkaloids have shown promise for catalytic 
asymmetric protonation as well.  Tan and co-workers27 used thiols and phosphine oxides 
as nucleophiles for 1,4-addition into various phthalimidoacrylates and itaconimides (e.g., 
576 → 578, Scheme 6.15).  Subsequent protonation of the intermediate enolates by the 
conjugate acid of chiral bicyclic guanidine catalyst 577 gave up to 99% yield and 94% 
enantiomeric excess.  Interestingly, the presence of water and relatively acidic 
thiophenols did not lead to appreciable amounts of non-selective enolate quenching.  
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Kinetic isotope effects were explored with D2O and a primary kinetic isotope effect of 1.5 
was found, consistent with cleavage or formation of a bond containing H or D in the rate-
determining step. 
Scheme 6.15.  Tan's conjugate addition/protonation 
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An unusual technique to generate an enol in situ was reported by Hénin, Muzart and 
co-workers.28  In this work, a racemic α-quaternary ketone (e.g., 579, Scheme 6.16) was 
exposed to laser photolysis at 366 nm.  This irradiation caused a Norrish type II 
fragmentation (579 → 581) to occur with concomitant loss of isobutylene.  The enol 
(581) then undergoes enantioselective transformation to the corresponding ketone (97) in 
the presence of amino alcohol 582.  Although high ee was realized for this dealkylative 
protonation in some cases, yields were low largely due to undesired fragmentation 
reactions initiated by the photochemical irradiation and decomposition of the resulting 
radical intermediates.  This method represents one of the few enantioselective 
stereoablative transformations29 involving destruction of a quaternary stereocenter. 
Scheme 6.16.  Hénin/Muzart Norrish type II fragmentation/protonation 
h!
(366 nm)
CH3CN
–40 °C
(60% conversion)(±)-579
O
(R)-97
89% ee
O
(10 mol%)
(40% yield)
H
581
OH
CH3 CH3
H
OH
NHi-Pr
582
580  
A variety of transformations catalyzed by planar-chiral heterocycles involve 
protonation as the enantiodetermining step.  In one recent example from Fu and co-
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workers,30 catalyst 584 (Scheme 6.17) was found to promote the addition of HN3 to 
ketenes (e.g., 583).  The resulting acyl azides (e.g., 587) then underwent Curtius 
rearrangement at elevated temperatures.  The carbamate products (e.g., 588) were 
isolated with up to 97% ee, presumably from enantioselective protonation of the amide 
enolate intermediate (585).  Sterically large ketenes performed best since less 
encumbered ketenes suffered from rapid uncatalyzed background reaction even at 
cryogenic temperatures.  In control experiments, hydrazoic acid was found to be readily 
deprotonated by planar-chiral heterocycle catalyst 584.  Since the reaction also proceeded 
with higher selectivity at low substrate concentration, a mechanism involving an ion pair 
585 + 586 was proposed.  This behavior of the catalyst as a chiral Brønsted acid (i.e., 
586) rather than the more typical role of these catalysts as Lewis bases31 is somewhat 
unusual, but also serves as a testament to the privileged nature of these catalysts.32 
Scheme 6.17.  Fu's addition of hydrazoic acid to ketenes followed by Curtius rearrangement 
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Although the particular example in Scheme 6.17 is thought to occur through a 
protonated catalyst molecule as the proton donor, other similar transformations may 
proceed through a different mechanism (see section 6.4.3), however in both examples the 
lack of a nonlinear relationship33 between catalyst ee and product ee suggests that only 
one catalyst molecule is involved in the enantioselective step and therefore a hybrid 
mechanism is unlikely.  Regardless of which of these two mechanistic hypotheses is 
operative, the transformation remains an enantioselective protonation process.  An 
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understanding of the mechanistic details, however, is helpful in order to understand the 
stereochemical control elements important to the success of the transformation. 
 
6.4.3 ENANTIOSELECTIVE PROTONATION BY MEANS OF CHIRAL 
BRØNSTED BASE 
The most common form of chiral Brønsted base employed in enantioselective 
protonations has been chiral metal enolates.  To circumvent the challenge of 
stereoselective generation of acyclic enolates, the majority of methods have focused on 
cyclic enolate precursors.  A variety of techniques for enolate generation have been 
employed including simple deprotonations, pericyclic reactions, decarboxylations, and 
dehalogenations.  The synthesis of the specific enolate precursor required for a 
protonation protocol (e.g., enol silane, acrylate, or β-ketoester) may determine how useful 
the method is for the preparation of specific target molecules.  Although several 
successful chiral Brønsted base protonation protocols have been developed, substrate 
scope remains a significant problem.  Especially lacking are general methods capable of 
protonation of acyclic enolates with high selectivity. 
Planar-chiral heterocycle catalysts have also been employed in the generation of 
chiral Brønsted base intermediates for enantioselective protonation.   Fu and co-workers34 
employed azaferrocene catalyst 590 (Scheme 6.18).  In the proposed reaction mechanism 
the heterocycle catalyst reacts with a ketene (e.g., 589) to form a zwitterionic chiral 
enolate intermediate (591).  Subsequent protonation of the enolate by methanol or an 
achiral pyridinium cocatalyst then forms an acylferrocenium ion (e.g., 592) that goes on 
to form an enantioenriched ester (e.g., 593).  Evidence for this distinct reaction 
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mechanism included the fact that catalyst 590 did not appreciably deprotonate methanol 
in solution.35  However, in the case above (Scheme 6.17) the catalyst 584 does readily 
deprotonate hydrazoic acid.  The remarkable ability of these Lewis base catalysts to 
achieve enantioselective protonation through two different mechanisms highlights the 
importance of understanding the details of the reaction pathways.  The preliminary 
mechanistic evidence does not always provide sufficient information to determine the 
operative mechanism, however.36 
Scheme 6.18.  Fu's Addition of alcohols to ketenes 
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Other organic molecules have been employed for the generation of chiral enolates as 
well.  For example, Rovis and co-workers37 found that treatment of α,α-
dichloroaldehydes such as 594 (Scheme 6.19) with enantiopure triazolium salt catalyst 
595 in the presence of a stoichiometric phenoxide base and phenol led to α-
chloroaldehydes with high enantiomeric excess.  The proposed path of the reaction 
involves addition of the carbene conjugate base of catalyst 595 to the aldehyde substrate.  
Subsequent elimination of HCl then generates a zwitterionic enolate intermediate (596) 
that is subject to protonation to form enantioenriched aldehyde 597.  The precise structure 
of the putative enolate is a matter of conjecture since a number of different strain 
elements are likely in competition in this intermediate.  Nonetheless, this method 
represents a very valuable technique for the preparation of useful, but synthetically 
challenging, chiral synthons. 
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Scheme 6.19.  Rovis' protonation of chloroenolates 
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In a separate application of carbene catalysis, Scheidt and co-workers38 found that 
homoenolate equivalents (e.g., 600, Scheme 6.20), generated in situ from enals such as 
598, could undergo enantioselective protonation when chiral triazolium catalyst 599 was 
employed.  Ester products (e.g., 601) were obtained in up to 58% yield and up to 59% ee, 
although competitive formation of overoxidized enoate byproduct 602 complicated the 
reaction.  Although the degree of enantioselectivity observed for this transformation was 
modest, this represents a significant advance in the type of proton acceptor that can be 
used for enantioselective protonation reactions since the site of protonation is relatively 
distant from the chiral control element. 
Scheme 6.20.  Scheidt's protonation of homoenolate equivalents 
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Metal-catalyzed 1,4-additions of organoboranes or organosilanes to enone systems 
have proven to be a popular strategy for generating chiral enolates for asymmetric 
protonation.  These reactions can employ neutral or cationic rhodium complexes.  
Arylboron, arylstannane, arylsilicon, or arylzinc (and in some cases, vinylboron) reagents 
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can be used for coupling, but yields and enantioselectivities can depend on the type of 
organometallic reagent chosen.  Atropisomeric bis(phosphine) ligands such as BINAP 
(116) and its analogues give excellent enantioselectivities for simple β-unsubstituted 
enone substrates.  Diverse proton sources have been used to enable the formation of α-
stereocenters.  The optimal proton source varies from system to system, but phenols and 
other low-pKa proton sources are common.  Recent examples have mainly explored 
simple β-unsubstituted systems, so issues of diastereoselectivity in the generation of 
multiple stereocenters have not been fully addressed. 
Frost and co-workers39 explored Rh-catalyzed additions of organotrifluoroborate salts 
to itaconate substrates with water as the stoichiometric proton donor (e.g., 603 → 604 → 
605, Scheme 6.21).  The metal-to-ligand ratio was found to be important in the selectivity 
of the reaction.  Equimolar amounts of metal and ligand gave racemic product in high 
yield, but 2.2 equivalents of ligand relative to metal gave product in 82% ee and 56% 
yield.  Interestingly, high reaction temperature was found to be an important factor in this 
reaction; racemic product was obtained when the reaction was carried out at 60 or 80 °C 
instead of 110 °C.  In related work, Frost showed that organosiloxanes are also viable 
nucleophilic components for 1,4-addition, but such systems give poor yields and low 
enantioselectivity.40  In a separate system involving aryl boronic acid organometallic 
components in microwave reactors, Frost and co-workers41 examined whether a chiral 
proton source affected the stereochemical outcome of the reaction.  When (R)-, (S)-, or 
racemic-BINOL was used with a Rh•BINAP catalyst, the yields and enantioselectivities 
were comparable in each of the three scenarios.  This suggests that the chirality of the 
bis(phosphine) ligand is the dominant stereodetermining factor. 
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Scheme 6.21.  Frost’s Rh-catalyzed conjugate addition/protonation 
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Sibi and co-workers42 also investigated rhodium-catalyzed conjugate addition-
protonation as a method for accessing β2-amino esters from enoates (e.g., 606 → 608, 
Scheme 6.22).  Reaction screening revealed that (S)-DifluorPhos ligand (607) and 
phthalimide proton donor provided the best enantioselectivity.  The best substrate 
provided 95% yield and 91% ee.  Notably, lower temperatures could be used to increase 
product ee. 
Scheme 6.22.  Sibi’s Rh-catalyzed conjugate addition/protonation 
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Hayashi and co-workers43 reported a related conjugate addition/protonation sequence 
for an analogous diphenylphosphinylallene (e.g., 609) system with a cationic dimeric 
rhodium µ2-hydroxide  catalyst (Scheme 6.23).  Temperature did not appear to have an 
effect on enantioselectivities, but the choice of THF as solvent instead of dioxane 
improved product ee by more than 20%.  Minimal isomerization of the β,γ-unsaturated 
products (e.g., 610) was observed under the reaction conditions, and excellent yields (up 
to 97%) and enantiomeric excesses (up to 98%) were obtained.  In this case, the 
arylboronic acid appears to be acting as the proton source based on an NMR experiment. 
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Scheme 6.23.  Hayashi’s Rh-catalyzed conjugate addition/protonation 
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Sodeoka and co-workers44 found that this conjugate addition/protonation sequence is 
viable with palladium complexes and heteroatom nucleophiles as well (611 → 612, 
Scheme 6.24).  A bimetallic palladium µ2-hydroxide complex effected the conjugate 
addition of aniline derivatives to acrylamides.  With BINAP ligand (116), the enolate 
intermediate was protonated enantioselectively to give product 612 in 80% yield and 94% 
ee.  Although this is a promising result, the substrate scope has not been fully 
investigated. 
Scheme 6.24.  Conjugate addition/protonation with a nitrogen nucleophile catalyzed by palladium 
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Genet, Darses, and co-workers45 sought to make α-amino esters using a similar 
conjugate addition/protonation strategy (e.g., 613 → 618, Scheme 6.25).  In this system, 
boronic esters, boronic acids, and organosilanes did not provide adequate conversion or 
enantioselectivity.  Organostannanes, however, were reactive under these conditions.  In 
the screening of various proton sources, phenol derivatives appeared to provide the best 
enantioselectivity.  Guaiacol (2-methoxyphenol) was determined to be the best proton 
donor, giving products with up to 91% yield and 88% ee.  Higher temperatures and 
optimized solvents (such as toluene or dioxane) increased conversion and 
enantioselectivity.  As in Frost’s work, the ratio of metal to ligand did have a notable 
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effect on the enantioselectivity of the reaction, with 2.2 equivalents of chiral ligand 
relative to metal being optimal.  Chiral proton sources were also added to see if the chiral 
ligand or chiral proton source was the dominant selectivity factor.  Studies with (R)-
BINAP (116) and both enantiomers of BINOL provided identical enatiomeric excesses, 
implying that the chirality of the enolate is dominant, as in the reports by Frost. 
Scheme 6.25.  Divergent pathway consisting of β-hydride elimination, hydride transfer, and 
protonation 
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Mechanistic studies showed that the hydrogen on the enamide was essential for 
reactivity.  Deuterium labeling studies showed that the reaction did not proceed via a 
direct protonation of the rhodium enolate (614); in a substrate with a labeled carbamate 
proton, deuterium incorporation at the α-carbon was high (41%).  Based on this 
observation, a mechanism involving sequential conjugate addition, β-hydride elimination 
from the carbamate (615 → 616), and intramolecular hydride transfer to the α-carbon 
(616 → 617) was proposed.  This proposed reaction pathway was supported by DFT 
calculations with the B3LYP/BII level of theory.45b  In light of these mechanistic insights, 
a more electron-poor bis(phophine) ligand was chosen to facilitate the postulated β-
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hydride elimination step, and DifluorPhos (607) was experimentally shown to give higher 
enantiomeric excesses. 
A related conjugate addition/enantioselective protonation strategy consisted of a 
Friedel–Crafts-type addition of pyrroles to α-substituted acrylates (e.g., 619 → 622, 
Scheme 6.26).46  Sibi and co-workers employed Zn(NTf2)2 complexed with chiral dbfox 
ligand 620 as a Lewis acid catalyst to achieve up to 98% yield and up to 98% ee.  The 
enolate intermediate (621) generated from the Friedel–Crafts reaction can be quenched 
by a proton from the pyrrole fragment to give a chiral product.  The isoxazolidinone 
auxiliary is believed to be critical for improving reactivity and providing greater enolate 
control during the course of the reaction. 
Scheme 6.26.  Friedel–Crafts-type conjugate addition followed by enantioselective protonation 
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A distinct method of accessing a chiral metal enolate is the use of a pericyclic 
reaction.  In the case of the Nazarov cyclization, the enantioselective reaction would not 
only generate a new stereocenter, but also a new five-membered ring.  However, until 
recently enantioselective variants of this classical reaction were unknown.  In studies 
directed toward the development of a general enantioselective Nazarov cyclization, 
Trauner and co-workers47 discovered that high ee cyclopentenone products could be 
synthesized from electronically activated substrates such as dienone 623 in the presence 
of Sc•PYBOX complex 624 (Scheme 6.27).  Interestingly, this enantioselective 
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protonation protocol requires no external proton source.  Unfortunately, in cases where a 
second stereocenter would be generated at the β-carbon (i.e., 628 where R ≠ H), low 
diastereoselectivity was observed.  This was interpreted as a result of low 
stereoselectivity in the electrocyclization step (625 → 626) followed by high selectivity 
in the protonation step (627 → 628). 
Scheme 6.27.  Trauner's Nazarov cyclization/enantioselective protonation 
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A different strategy for accessing chiral metal enolates is decarboxylation of β-
ketoesters.  The nature of the ester is typically important to enable enolate formation.  In 
the case of palladium-catalyzed protonation reactions, benzyl and allyl esters have been 
the most common enolate precursors.  The first examples of these reactions, developed 
extensively by Hénin, Muzart, and co-workers,48 employed an initiation step such as Pd-
mediated hydrogenolysis to generate an achiral enol (or enolate)49 intermediate that was 
subsequently protonated with a chiral Brønsted acid (typically an amino alcohol).  The 
results of these studies showed a strong dependence on the specific reaction conditions 
(e.g., temperature and source of palladium on carbon).   
More recently, this strategy has been refined to instead generate a chiral Pd-enolate 
intermediate from allyl β-ketoester substrates (e.g., 629 and 631, Scheme 6.28) in the 
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hopes that chirality at the metal might impart improved stereocontrol in the protonation 
step and obviate the need for heterogeneous Pd catalysts.  Stoltz and co-workers50 found 
that the catalyst derived from Pd(OAc)2 and phosphinooxazoline (PHOX) ligand 55 was 
capable of achieving enantioselective protonation in the presence of formic acid and 
molecular sieves (MS).  High enantiomeric excesses were obtained for a range of cyclic 
ketone products including tetralone- and cyclohexanone-derived ketones (e.g., 630 and 
221).  Attempts to track the source of the proton incorporated in the product with 
isomeric mono-deuterated formic acids (DCO2H and HCO2D) led to inconclusive results: 
with DCO2H the formyl deuteron was not incorporated into the product, but with HCO2D 
only 35% D incorporation was observed in the product, suggesting that another 
unidentified proton donor is also participating in the reaction.   
Scheme 6.28.  Stoltz' palladium-catalyzed decarboxylative protonation reactions 
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The heterogeneous additive (MS) in the reaction is important to the selectivity for 
protonation in preference to the competitive allylation reaction also catalyzed by the 
Pd•PHOX complex,51 and the specific amount required varied somewhat depending on 
the substrate.  To address this issue, a related homogeneous protonation system was 
developed by Stoltz and co-workers52 employing Meldrum’s acid (33, Scheme 6.28) as 
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the achiral proton donor and a Pd•PHOX catalyst.  Similar substrate scope and 
enantioselectivity was observed with this system, but without the need to optimize the 
amounts of additives to achieve optimal results.  Initial mechanistic studies found zero-
order kinetic dependence in substrate, which suggests a fast initial reaction between 
catalyst and substrate and a slow subsequent step, presumably either decarboxylation or 
protonation of the putative enolate intermediate common to both the protonation and 
allylic alkylation reactions with this catalyst system.53  However, in the protonation 
reaction opposite enolate facial preference was observed for tetralone- and 
cyclohexanone-derived enolates, whereas in the alkylation reaction consistent 
enantiofacial selectivity was observed.51  This unexpected result suggests a substantial 
difference in the bond-forming portion of the mechanism. 
Kanai, Shibasaki, and co-workers54 recently reported the use of a chiral gadolinium 
complex for the enantioselective protonation of Gd-enolates generated in situ (Scheme 
6.29).  The Gd-enolates were accessed by two means: transmetallation from enol silane 
(e.g., 559) or conjugate addition of cyanide to N-acryloyl pyrroles (e.g., 633).  Based on 
optimization studies, a polymetallic enolate intermediate was proposed.  The optimal 
ligand-to-metal ratio is consistent with a 5:6 complex.  The lack of reactivity in the 
absence of ligand 632 was also interpreted as the necessity of polynuclear Gd complexes 
for the success of the reaction.  Kinetic studies also suggested that the reaction proceeds 
via transmetallation from Si to Gd, and that this step is rate limiting.  2,6-Dimethylphenol 
was the preferred proton source, providing indanone and tetralone products in up to 99% 
yield and up to 88% ee.  The same Gd•632 complex was also effective for the conjugate 
addition/protonation of cyanide to N-acryloyl pyrroles (e.g., 633 → 634).  In this case, 
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hydrogen cyanide was the preferred proton source.  This transformation was capable of 
producing N-acyl pyrroles in up to 99% yield and up to 91% ee.  In the case of product 
634, recrystallization could be carried out to provide a 74% yield of material with >99% 
ee.  The versatility of this polynuclear Gd catalyst to effect protonation of considerably 
different enolate intermediates is important to the prospect of a general system for enolate 
protonation. 
Scheme 6.29.  Kanai and Shibasaki’s gadolinium-catalyzed protonation reactions 
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6.4.4 ENANTIOSELECTIVE HYDROGEN ATOM TRANSFER 
An analogous strategy for arriving at protonation products is to exploit radical 
chemistry with a terminal H-atom abstraction step.  Although not explicitly an 
enantioselective protonation reaction, many of the same challenges apply when 
manipulating a hydrogen atom.  A recent example of this tactic by Sibi and co-
workers55,56 has led to new methods for synthesizing β-amino acid derivatives (Scheme 
6.30).  By employing a Lewis acid complex formed from MgI2 and bis(oxazoline) ligand 
635, tributyltin hydride, and triethylborane/O2, alkyl radicals (from alkyl halides) can 
undergo radical conjugate addition followed by enantioselective hydrogen atom transfer 
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to afford optically active products (e.g., 636) in up to 95% yield and up to 98% ee.  The 
reaction is believed to proceed through a bidentate chelate of the substrate to the chiral 
magnesium complex.  The process can be made catalytic in Lewis acid without a 
significant effect on yield, but product ee suffered greatly in some cases due to a rapid 
uncatalyzed background reaction.  These reactions have the benefit of being essentially 
neutral as opposed to the acidic or basic conditions required for the transformations 
described above. 
Scheme 6.30.  Radical conjugate addition followed by enantioselective H-atom transfer 
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6.5 CONCLUSION 
From the enantioselective enzymatic protonation reactions of nature to the variety of 
techniques for achieving enantioselective protonation in laboratories, a great deal of 
energy has been dedicated to understanding this deceptively simple transformation.  
Despite the many systems reported to date, the search for a highly efficient system with a 
broad scope continues.  Moreover, although many of the key parameters needed to create 
a successful system have been enumerated here and elsewhere, the current level of 
mechanistic understanding in nearly all of the enantioselective protonation reactions 
reported to date remains relatively immature.  Nonetheless, these useful transformations 
allow the synthesis of valuable chiral materials including natural products like α- and β-
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amino acids.  Given these preliminary successes and improved understanding of the 
underlying mechanisms, enantioselective protonation reactions should continue to rise to 
prominence as an important tool for synthetic organic chemistry. 
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CHAPTER 7
Catalytic Enantioselective Decarboxylative Protonation†
7.1 INTRODUCTION
Enantioselective protonation represents a direct method for generating tertiary carbon
stereocenters from an achiral enolate or an enol equivalent.  Several distinct approaches
toward effecting this process have been reported, including the use of achiral enolates
with chiral Brønsted acids, chiral metal enolates with an achiral proton source, and the
combination of chiral enolates and chiral Brønsted acids.1  Of the existing methods, most
are limited in scope, few are catalytic, and together they have not provided a general
solution to this deceptively simple goal.1e  This chapter comprises our studies directed
toward developing a highly enantioselective general catalytic system for the facile
synthesis of tertiary stereocenters by protonation adjacent to ketones.
Recently, we disclosed a series of catalytic enantioselective allylation reactions that
deliver cyclic ketones bearing all-carbon quaternary stereocenters at the α-position with
high efficiency and enantioselectivity.2  Crucial to the success of these transformations
                                                 
† This work was performed in collaboration with Toyoki Nishimata, Smaranda C. Marinescu, and Douglas
C. Behenna.  Portions of this work have been published, see: (a) Mohr, J. T.; Nishimata, T.; Behenna, D.
C.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 11348–11349.  (b) Marinescu, S. C.; Nishimata, T.; Mohr, J.
T.; Stoltz, B. M. Org. Lett. 2008, 10, 1039–1042.
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was the use of catalysts derived from Pd(0) and a chiral phosphinooxazoline (PHOX)
supporting ligand (e.g., 55).3,4  Included in this effort was our exploration of racemic allyl
β-ketoesters as substrates for a novel stereoablative enantioconvergent decarboxylative
allylic alkylation reaction (e.g., (±)-293 →  98, Scheme 7.1).2b,5  We believe that in the
course of this reaction a chiral Pd-enolate (637) likely is generated in solution, and that
the high degree of organization about the palladium center is responsible for the levels of
enolate facial selectivity observed in the alkylation.6  Interestingly, if this were the case,
the catalytic generation and utilization of such chiral enolate complexes by this method
would have the potential to be more broadly applicable than we previously recognized.
Thus, in an effort to exploit this valuable chiral synthon, we chose to intercept this
intermediate with an alternative electrophile, namely, a proton.7,8
Scheme 7.1.  Interception of the putative Pd-enolate intermediate
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7.2 ENANTIOSELECTIVE PROTONATION WITH FORMIC ACID AS
PROTON DONOR
7.2.1 DISCOVERY AND OPTIMIZATION OF REACTION CONDITIONS
Our first attempts to achieve an enantioselective protonation consisted of exposure
racemic β-ketoesters 329, 241, and 293 to Pd(OAc)2 in the presence of (S)-t-Bu-PHOX
(55) with triethylamine and HCO2H, resulting in smooth conversion to the corresponding
ketones (638, 639, and 97, respectively) with low, but measurable enantiomeric excess
(Scheme 7.2).7
Scheme 7.2.  Initial attempts at enantioselective protonation
O O
O
329
O
H
638
11% ee
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H, Et3N
THF, 45 °C
O
O
293 977% ee
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
5:2 HCO2H/Et3N (0.5 equiv)
THF, 40 °C
O
H
O
Bn
O
O
241 63931% ee
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H (2.5 equiv)
Et3N (3 equiv)
THF, 40 °C
O
Bn
H
O
We suspected that an ammonium species was behaving as the proton donor, and
therefore modification of amine base additive would serve to modulate the acidity and
perhaps improve enantioselectivity.  Examination several basic additives did indeed show
a significant influence on product ee (Table 7.1).  As a control experiment we also carried
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out the reaction in the absence of base and were surprised to find that ketone 639 was
formed in 53% ee (entry 9).
Table 7.1.  Effect of basic additives on enantioselecitve protonationa
Bn
O
O
241 639
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H (2.5 equiv)
additive
THF, 40 °C
O
Bn
H
O
additive amount(equiv) %ee of 639 additive
amount
(equiv) %ee of 639
3 31 2,6-lutidine 3 42
3 41 3 47
3 27 5 52
DABCO 3 1 none – 53
Et3N
i-Pr2NEt
i-Pr2NH Na2SO4
entry entry
6
7
4 9
1
2
3 8
pyridine 3 575
K2CO3
a Reactions performed with 0.1 mmol of 241. Each reaction proceeded to complete conversion.
In order to sequester the small amount of water present in commercially available
formic acid, we next examined additives that might remove adventitious moisture (Table
7.2).9  Whereas many common additives had little effect on the ee of product 97, oven-
dried molecular sieves (MS) dramatically increased enantiopurity (entries 8, 10, and 11).
Table 7.2.  Effect of other additives on enantioselective protonationa
O
O
293 97
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H (2.5 equiv)
additive
p-dioxane, 40 °C
O
H
O
additive amount %ee of 97 additive amount %ee of 97
1 equiv 7b Celite 90 mg 39
– 24b 90 mg 79
90 mg 33 90 mg 67
activated carbon 90 mg 8 4ÅMS 88
Et3N
none
activated SiO2 4ÅMSc
entry entry
7
8
4 10
1
2
3 9
3ÅMS
5 equiv 34 90 mg 85
5 equiv 30 13X MS 90 mg 58
MgSO4 5ÅMS
6 12
5 11
HC(OEt)3
90 mg
a Reactions performed with 0.1 mmol of 293.  Solid additives were oven dried prior to use.  Each
reaction proceeded to complete conversion.  b Reaction performed with THF as solvent.  c Used as
received without drying in an oven.
A brief examination of the Pd source indicated that Pd(OAc)2 was preferred and that
the metal was required for the reaction to occur (Table 7.3).
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Table 7.3.  Effect of palladium source on enantioselective protonation
O
O
293 97
Pd source (10 mol% Pd)
(S)-t-BuPHOX (12.5 mol%)
HCO2H (2.5 equiv)
O
H
O
Pd source %ee of 97
72
41
49
none –b
Pd(OAc)2
[Pd(allyl)Cl]2
Pd2(dba)3
entry
4
1
2
3
3ÅMS (90 mg)
THF, 40 °C
a Reactions performed with 0.1 mmol of 293.  3ÅMS were oven-dried prior to use.  Each reaction
proceeded to complete conversion, unless otherwise noted.  b No conversion was observed.
Solvent was found to influence the enantioselectivity of the protonation reaction
significantly (Table 7.4).  This contrasts the results for the related alkylation reaction that
performed well in a variety of solvents.2  Ethereal solvents gave mixed results, but p-
dioxane proved to be superior to all others tested (entry 3).
Table 7.4.  Effect of solvent on enantioselective protonationa
O
O
293 97
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H (2.5 equiv)
O
H
O
solvent %ee of 97 solvent %ee of 97
72 anisole 21
63 39
79 53
1,2-dimethoxyethane 27 ethyl acetate 56
tetrahydrofuran
tetrahydropyran
p-dioxane toluene
entry entry
7
8
4 10
1
2
3 9
benzene
68 4
58 1,2-dichloroethane –b
t-butyl methyl ether pinacolone
6 12
5 11
diisopropyl ether
3ÅMS (90 mg)
solvent, 40 °C
a Reactions performed with 0.1 mmol of 293.  3ÅMS were oven dried prior to use.  Each reaction
proceeded to complete conversion, unless otherwise noted.  b No conversion was observed.
At this point, we also examined the behavior of other chiral ligands in this reaction
(Table 7.5).  As in our earlier studies,2 we found chelating P–N ligands to be the most
effective, while bis(phosphine)-type ligands (entries 1–3) provided only trace asymmetric
induction.  Several PHOX-type ligands were tested with good results (entries 5–11),
however, none of these was significantly superior to t-BuPHOX (55).  Finally, we found
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that when the solvent was freshly distilled and the 4ÅMS were rigorously flame-dried
immediately prior to use, the enantiomeric purity was further enhanced, providing 97 in
92% ee (entry 12).
Table 7.5.  Ligand screen for enantioselective protonationa
O
O
293 97
Pd(OAc)2 (10 mol%)
ligand (12.5 mol%)
HCO2H (2.5 equiv)
O
H
O
ligand %ee of 97
–1
3
(S)-QUINAP (120)
(R)-BINAP (116)
(R,R)-DIOP (118)
(R,R)-Trost ligand (103)
entry
4
1
2
3
4ÅMS (90 mg)
p-dioxane, 40 °C
3b
–20
–65
87 (S)-tBuPHOX (55)
(R)-PhPHOX (121)
(S)-iPrPHOX (122)
(S)-tBuPHOX (55)
12c
5
6
11 88
92
5
–89
(S)-SimplePHOX (147)
(R)-132
(S)-187
7
8
9 86
90(S)-14010
ligand %ee of 97entry
(R)-BINAP (116) (R,R)-DIOP (118) (R)-QUINAP (120)(R,R)-Trost ligand (103)
121, R = Ph, (R)-Ph-PHOX
122, R = i-Pr, (R)-i-Pr-PHOX
132, R = C(Me)2OTBS
187, R = 2-napthyl, R' = H
140, R = t-Bu, R' = CF3
55, R = t-Bu, R' = H
     (S)-t-Bu-PHOX
NH HN
O O
PPh2 Ph2P
PPh2
PPh2 O
O PPh2
PPh2
N
PPh2
Ph2P N
O
R
Ph2P N
O
R
O
Ph2P N
O
t-Bu
(S)-SimplePHOX 
(147)
R'
a Reactions performed with 0.1 mmol of 293.  4ÅMS were oven dried prior to use.  Each reaction
proceeded to complete conversion, unless otherwise noted.  b The ee was measured after 72 hours at
approximately 60% conversion.  c MS were flame dried under vacuum and p-dioxane was freshly
distilled from Na.
Attempts to optimize the amount of HCO2H and 4ÅMS in the reaction indicated that
the balance of these two components was intimately related to both enantio- and
chemoselectivity (i.e., the ratio of protonated to allylated products 97/98).  In general, an
excess of HCO2H led to decreased enantioselectivity while smaller quantities afforded
greater amounts of allylated product 98.  Alternatively, small amounts of 4ÅMS
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produced 97 in decreased ee, while large quantities led to increased allylation.  Specific
results for substrate 293 are shown in Table 7.6.  The optimal amount of HCO2H was
found to be 6.0 equiv with a 4ÅMS quantity of 1.80 g/mmol substrate.
Table 7.6.  Optimization of relative amounts of HCO2H and 4ÅMS
a
2.5 3 3.5 4
90 mg
n.d.
88% ee
82/18
90% ee
96/4
92% ee
100/0
90% ee
100/0
69% ee
135 mg
86/14
86% ee
61/39
82% ee
89/11
91% ee
90/10
92% ee
95/5
92% ee
180 mg – – –
96/4
92% ee
–
225 mg – – –
83/17
92% ee
–
270 mg –
54/46b
78% ee
– – –
O O
O
Pd(OAc)2 (10 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
HCO2H 
4ÅMS
p-dioxane, 40 °C
O
(±)-293 97
amount of HCO2H (equiv)
am
ou
nt
 o
f 4
ÅM
S 
(fo
r 0
.1
 m
m
ol
 o
f 2
93
 )
O
98
+
4.5
100/0
93% ee
99/1
93% ee
ratio 
97/98
%ee of 97
Entries
report:5 5.5 6 8 10
100/0
46% ee
– – – –
99/1
93% ee
99/1
90% ee
100/0
86% ee
– –
95/5
91% ee
–
100/0
93% ee
– –
91/9
89% ee
–
96/4
93% ee
99/1
93% ee
100/0
69% ee
93/7c
91% ee
–
91/9
92% ee
100/0
93% ee
100/0
92% ee
a Reactions performed with 0.1 mmol of 293.  4ÅMS were flame dried under vacuum prior to use.
Each reaction proceeded to complete conversion.  Data in the table are the ratio of protonation to
allylation products (97/98) and the ee of protonation product 97.  b Isolated 98 was found to be 86%
ee.  c Isolated 98 was found to be 87% ee.
7.2.2 RESULTS OF ENANTIOSELECTIVE PROTONATION
We next explored the generality of the reaction.  Under the optimized conditions
determined in Table 7.6, (S)-(–)-2-methyl-1-tetralone (97) was produced in 88% yield
and 94% ee with no observable allylation (Table 7.7, entry 1).  It was necessary to
slightly vary the relative amounts of formic acid and MS in order to obtain optimal
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results for other substrates.  A variety of substitution is tolerated at the ketone α-position
(entries 1–3) and various positions about the aromatic ring (entries 4–8) of 1-tetralone
derivatives.  Enantioenriched (S)-(+)-2-methyl-1-indanone (638) can also be produced
from the corresponding β-ketoester (entry 9).  Additionally, monocyclic compounds
(entries 10–13) and a heterocycle (entry 14) were easily accessed under similar reaction
conditions.
Table 7.7.  Enantioconvergent decarboxylative protonations with formic acid
O
CO2allyl
R
O
CO2allyl
R
O
Entry Substrate Product Time (h) Yield (%)a ee (%)b
1 10 88 94 (S)
2 4 88 85 (R)
3 5 79 88 (S)
4 5 91 95
5 6 81 88
N
Bn
O
CO2allyl14 3 81 84
9c 22 83 81 (S)
O
CO2allyl
O
CO2allyl
O
7 8.5 62 94
O
O
CO2allyl
8 8 75 92
R = Me
R = allyl
R = F
R = Me
R = allyl
O
CO2allyl
R
12e 4.5 91 92 (S)
13 5 69 74
n = 1, R = Bn
n = 2, R = Bn
O
R
O
R
O
N
Bn
O
O
O
O
O
O
O
R = Bn 5 786 95
R
10 4 63 60
11 4.5 99d 85 (R)
n = 0, R = Bn
n = 1, R = Me
n n
293
640
498
629
643
318
329
646
648
241
652
644
650
107
97
641
642
630
541
654
638
647
649
639
653
645
651
207
a Isolated yield from reaction of 0.3 mmol substrate at 0.033 M in p-dioxane with 10 mol%
Pd(OAc)2, 12.5 mol% (S)-t-Bu-PHOX, 5–8 equiv HCO2H, and 405–810 mg 4ÅMS at 40 °C (ref
10). b Determined by chiral HPLC or GC; where noted, the absolute configuration was determined
by comparing the sign of optical rotation to literature values (ref 10). c Reaction performed with 5
mol% Pd(OAc)2 and 6.25 mol% (S)-t-Bu-PHOX. d GC yield using tridecane as internal standard. e
Reaction performed at 35 °C.
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The absolute configuration of a number of products was established by comparison of
the observed sign of optical rotation to literature values (entries 1–3, 9, 11, and 12).10
Interestingly, fused aromatic substrates (i.e., tetralones and indanones) lead to products in
the opposite enantiomeric series compared to the cyclohexanone cases (cf. entries 1–3
and 9 to entries 11–12).  These results are in contrast to the consistent enantiofacial
selectivity observed across multiple substrate types in our asymmetric allylation
chemistry, and suggest stark differences in their corresponding mechanisms.2,6
7.2.3 ENANTIOSELECTIVE PROTONATION WITH OTHER ENOLATE
PRECURSORS
We were interested in whether the other enolate precursors we have employed for
enantioselective allylation chemistry would be competent substrates for the protonation
reaction.  In order to investigate this possibility, allyl enol carbonate 124 was subjected to
our optimized reaction conditions for the formation of 97.  Contrasting the result when
(±)-293 was used (Table 7.2, entry 1), in this case ketone 97 was produced in 74% ee
with a 66/44 ratio of 97/98 on a 0.1 mmol scale (100% conversion).  When enol silane
559 was used, low conversion (<5%) was observed, however, the ee of isolated 97 was
84%.  Although these results highlight the advantage of β-ketoester precursors to the
reactive enolate intermediate, it is uncertain why the reactivity and selectivity of these
substrates is so different.11
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Scheme 7.3.  Enantioselective protonation with allyl enol carbonate and silyl enol ether substrates
O Pd(OAc)2 (10 mol%)55 (12.5 mol%)
HCO2H (6 equiv)
4ÅMS (180 mg)
p-dioxane, 40 °C
(100% conversion)124
OTMS Pd(OAc)2 (10 mol%)55 (12.5 mol%)
HCO2H (6 equiv)
4ÅMS (180 mg)
p-dioxane, 40 °C
(< 5% conversion)559
O
O
O
H
97
84% ee
O
98
O
H
97
74% ee
O
98
a)
b)
66:44 ratio
ratio n.d.
7.2.4 DEUTERIUM LABELING EXPERIMENTS
In order to probe the mechanism of the protonation reaction, we carried out deuterium
labeling studies using substrate 293 with mono-deuterio-formic acid isomers HCO2D and
DCO2H.10  We have maximally observed 35% D-incorporation when using HCO2D and
4ÅMS dried under vacuum for three days at 320 °C.  If the MS were not dried in this way
then much lower levels of D-incorporation were observed (ca. 10%).  By contrast, under
otherwise identical conditions, <1% D-incorporation was observed when DCO2H was
employed.  In the absence of MS, 35% D-incorporation was observed when HCO2D was
used, and no detectable D-incorporation was found when DCO2H was used.12  The
detailed mechanism of proton incorporation (e.g., proton transfer, reductive elimination,
or otherwise) remains unclear.
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7.2.5 SUMMARY OF ENANTIOSELECTIVE PROTONATION
METHODOLOGY USING FORMIC ACID
A novel system for the enantioconvergent decarboxylative protonation of racemic β-
ketoesters was developed.  The reaction tolerates a variety of substitution and
functionality and delivers products of high enantiopurity in excellent yield.  The
enantioinduction in the observed protonated products is consistent with the intermediacy
of an enolate that is intimately associated to the chiral Pd complex.  This, in turn,
substantiates our initial hypothesis concerning the nature of the reactive intermediate 637
and opens the door to further applications.  The process capitalizes on the availability and
unique reactivity of racemic α-substituted allyl-β-ketoesters, which are employed directly
in the catalytic enantioselective process and deliver valuable tertiary-substituted products
in highly enantioenriched form.  In general, the overall process (substrate synthesis and
use) represents a catalytic enantioselective variant of classic alkylation/decarboxylation
sequences (e.g., acetoacetic ester synthesis, cf. Scheme 7.4a and b).13  Furthermore, the
asymmetric protonation described here serves to complement our recently developed
asymmetric alkylation methodology that delivers quaternary stereocenters from the same
starting materials via catalytic enantioselective allylation.
Scheme 7.4.  Acetoacetic ester synthesis vs alkylation/decarboxylation sequence
O O
OR
O O
OR
R'
O
R'
O O
OR
O O
OR
O
R'
R'
base, R'X
base, R'X
saponification/
decarboxylation
enantioselective
decarboxylative
protonation *
a)
b)
Chapter 7 – Catalytic Enantioselective Decarboxylative Protonation 725
7.3 HOMOGENEOUS ENANTIOSELECTIVE PROTONATION
7.3.1 BACKGROUND
We first reported a highly enantioselective catalytic system for the decarboxylative
protonation of racemic allyl β-ketoesters in the presence of Pd(OAc)2, (S)-t-Bu-PHOX
(55), 4Å molecular sieves (MS), and HCO2H (Scheme 7.5).14  Although this protocol is
capable of generating cycloalkanones with excellent ee, each substrate required
optimization of the amounts of 4ÅMS and HCO2H in order to suppress competitive
allylation and maximize product ee.  Moreover, the heterogeneous nature of the reaction
hinders investigation of the mechanism of protonation.  In response, we have sought
substantially different protonation conditions to allow further development of a practical
synthetic process.
Scheme 7.5.  Pd-catalyzed enantioselective decarboxylative allylation and protonation of racemic
allyl β-ketoesters
O
CO2allyl
R
Ph2P N
O
t-Bu55
R O
R R
R
up to 99% yield
up to 92% ee
Pd2(dba)3
THF, 25 °C
O
R
R R
55
Pd(OAc)2
HCO2H (6–8 equiv)
4 Å MS (1.35–2.70 g/mmol)
p-dioxane, 40 °C
R
H
up to 95% yield
up to 95% ee
racemic
Enantioselective
Allylation
Enantioselective
Protonation
O
R
R R
*LnPd
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7.3.2 SCREENING OF ALTERNATE PROTON DONORS
To achieve a homogeneous enantioselective protonation, the racemic allyl β-ketoester
(±)-293 was exposed to Pd2(dba)3, (S)-t-Bu-PHOX (55), and a variety of achiral organic
proton donors (Table 7.8).  Gratifyingly, the use of dimethyl malonate did indeed lead to
protonated product 97, although the ee was moderate (entry 1).  Acetoacetic esters
(entries 2 and 3) provided 97 in significantly higher ee than the malonate case, but at the
expense of conversion.  Acetylacetone derivatives (entries 4–6) were very reactive, with
the more acidic analogues providing higher ee products.  Noting that the more acidic
compounds increased the rate of reaction dramatically, we chose next to explore other
highly acidic organic proton donors.  Ketosulfones (entries 7–9) led to protonated product
97 in very high ee, though conversion was sometimes slow.  However, commercially
available Meldrum’s acid15 led to extremely rapid formation of 97  with good
enantioselectivity (entry 10).  Given the fast reaction at 40 °C, we attempted the
transformation at ambient temperature (23 °C) and observed a significant increase in
product ee (entry 11).  Further lowering the temperature required changing the solvent to
THF, and although the ee was excellent, reactivity dropped sharply (entry 12).  Notably,
addition of MS to the reaction had a severe impact on the ee (entry 13).
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Table 7.8.  Screening of achiral proton donorsa
O
CO2allyl
Pd2(dba)3 (5 mol %)
(S)-t-Bu-PHOX (12.5 mol %)
p-dioxane, 40 °C
proton donor (2.5 equiv)
O
(±)-293
entry time (h) conversion (%)b ee (%)c
7 661, R = Me 24 42 89
8 662, R = Ph 24 63 90
2 656, R = H 24 50 80
3 657, R = F 24 55 89
1
4
24 85 62
5
6
97
proton donor
R
S
OO O
O
R
O
OEt
O
O O
O
663, R = p-Tol 5 100 849
OO 24 95 50
R
658, R = H
659, R = Ac 2 100 74
660, R = Ms 3 100 88
O O
O O 0.2 100 8510
0.5 100 9011d
24 50 9512e
1.5 100 4313f
655
33
a Reactions performed with 0.1 mmol of (±)-293 at 0.033 M in p-dioxane.  b Measured by 1H NMR
spectroscopy.  c Measured by chiral HLPC.  d Reaction performed at 23 °C.  e Reaction performed at
0 °C in THF solvent.  f Reaction performed with 90 mg of 4ÅMS.
The combination of reactivity, selectivity, and availability prompted us to choose the
Meldrum’s acid scaffold for our further studies (Table 7.9).  It was found that, in general,
large substituents between the carbonyls of the proton source decrease the enantiopurity
of 97, although smaller groups (e.g., CH3) are tolerated (entries 1–5).  In contrast to the
acyclic case, addition of a third resonance withdrawing group (e.g., acetyl) severely
decreased reactivity and product ee (cf. Table 7.8, entry 9 and Table 7.9, entry 5).
Electronic perturbation by substituting dimedone (457) as the proton source led to only
trace product in low ee (entry 6).  Variation of the acetal portion with sterically diverse
groups had a relatively small effect on ee (entries 7 and 8).  Notably, simple spirocyclic
derivatives of Meldrum’s acid (entries 9 and 10) gave the highest ee, although conversion
728 Chapter 7 – Catalytic Enantioselective Decarboxylative Protonation
to product was sluggish.  Larger bicyclic acetals gave mixed results (entries 11–13).
Interestingly, the enantiopure menthone derived analogue performed equally well with
either antipode of the chiral ligand, indicating that the catalyst directly controls the sense
of enantioinduction (entries 12 and 13).  None of the slight improvements observed with
these various derivatives outweighed the convenience of the commercially available
Meldrum’s acid (33).  Additionally, a screen of other chiral PHOX ligands revealed the
superiority of the original (S)-t-Bu-PHOX (55).10
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Table 7.9.  Screening of Meldrum’s acid derivativesa
O
CO2allyl
Pd2(dba)3 (5 mol %)
(S)-t-Bu-PHOX (12.5 mol %)
p-dioxane, 23 °C
proton donor (2.5 equiv)
O
(±)-293
entry time (h) conversion (%)b ee (%)c
1 33, R = H
O O
O O
R
0.5 100 90
2 664, R = Me 0.2 100 90
3 665, R = Ph 24 86 68
4 666, R = Allyl 1 100 67
O O
O O
R Ph
5 667, R = Ac 24 1 51
7 668, R = H 5 100 85
8 669, R = Me 4 100 84
O O
6 24 8 43
O O
O O
O O
O O
O O
O O
R R
671, R = H 24 86 91
672, R = Me 24 100 76
9 24 25 93
10
11
24 100 9012
97
proton donor
13d 24 100 –90
457
670
673
a Reactions performed with 0.1 mmol of (±)-293 at 0.033 M in p-dioxane.  b Measured by 1H NMR
spectroscopy.  c Measured by chiral HLPC.  d Reaction performed with (R)-t-Bu-PHOX (12.5
mol%).
7.3.3 RESULTS OF HOMOGENEOUS ENANTIOSELECTIVE
PROTONATION
Encouraged by these results, the scope of this enantioselective protonation was
explored (Table 7.10).  The general set of reaction conditions employed in these studies
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were straightforward: racemic allyl β-ketoester was exposed to Pd2(dba)3 (5 mol%), (S)-t-
Bu-PHOX (55, 12.5 mol%), and Meldrum’s acid (33, 2.5 equiv) in p-dioxane (0.033 M)
at room temperature (22 °C).  A variety of substituted cyclohexanone derivatives was
prepared (entries 1–5).  Especially noteworthy is the tolerance of a β-siloxy substituent
(entry 5).  The near quantitative yield and the absence of β-elimination products (i.e.,
enone) highlight the mild, neutral reaction conditions.  1-Tetralone derivatives (entries
6–8) were also accessible in high yield and ee.  Finally, (S)-(+)-2-methyl-1-indanone
(638, entry 9) was prepared in good yield, although the ee was moderate.  When we
attempted to carry out the reaction on larger scale, we observed a slight decrease in
product ee.  The origins of this decrease are unclear at this time.
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Table 7.10.  Homogeneous enantioconvergent decarboxylative protonations with Meldrum’s acida
yield
(%)
86
time
(h)
0.5
product
O
R 97, R = Me
entry
641, R = allyl
6
7
8
0.5 83
O
0.5 77 77
O
0.5 79
O
R
207, R = Me 0.5 99b
639, R = Bn 90
5 87 89
221, R = Et 0.5 99b
0.5 97 80
O
O
OTBDPS
0.5
ee B
(%)
91
85
–
–
1
2
3
4
5
9
O
CO2allyl
R
R
O
R
R
Pd2(dba)3 (5 mol %)
(S)-t-Bu-PHOX (12.5 mol %)
p-dioxane, 22 °C
O O
O O
(2.5 equiv)
77 (R)
77 (S)
61 (S)
86 (R)
78 (S)
89 (R)
88
92
83
90
82
ee A
(%)
674
675
649
638
33
a Reactions were performed on two different scales, A: 0.1 mmol of substrate, and B: 0.3 mmol of
substrate, each at 0.033 M in p-dioxane.  Column ee A reflects results for conditions A; time,
isolated yield, and ee B are reported for conditions B.  Isolated yields from conditions A were
comparable to those with conditions B.  The major enantiomer was the same under either set of
conditions.  Enantiomeric excess was measured following chromatography on silica gel; no erosion
of ee was observed as a result of purification.  b GC yield using tridecane as internal standard.
The absolute configuration of a number of products was established by a comparison
of the observed sign of optical rotation to literature values (entries 1–3, 6, 7, and 9).
Cyclohexanone substrates led to products in the opposite enantiomeric series compared to
that of the tetralone and indanone cases (entries 1–3 vs. entries 6, 7, and 9).  Identical
behavior was observed when the reactions were performed with our heterogeneous
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Pd(OAc)2/HCO2H conditions,14 suggesting that the two enantioselective protonations
proceed through very similar mechanisms.
Under our optimized reaction conditions, products arising from allylation of our
postulated enolate intermediate were not observed.  This contrasts with our previous
work14 where it was necessary to supply an excess of acid (up to 8 equiv) to fully
suppress competitive allylation.  The only by-product isolated under the homogeneous
reaction conditions was 5,5-diallyl-2,2-dimethyl-1,3-dioxane-4,6-dione (676, Figure
7.1).16  Interestingly, we did not detect mono-allylated Meldrum’s acid 666 as a by-
product.
Figure 7.1.  Diallyl Meldrum’s acid by-product of protonation
O O
O O
676
7.3.4 PRELIMINARY KINETIC STUDIES
Since we have been unable to perform detailed mechanistic studies with our
heterogeneous protonation system, we were eager to examine the mechanism with our
new system.  Kinetic studies of the homogeneous enantioselective protonation reaction
were performed via 1H NMR spectroscopy in C6D6 (Figure 7.2).10  A plot of amount of
allyl β-ketoester substrate 293 over time displayed zero-order decay, suggesting that
ketoester 293 reacts very fast and generates an intermediate (possibly a Pd-carboxylate
(e.g., 678) or Pd-enolate(e.g., 637)) that undergoes further reaction in a slower step
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(Scheme 7.6).  Similar zero-order dependence in substrate was observed in the case of
our related enantioselective allylation reaction,2,6 implying that the early stages of both
processes are similar.  Although these results give some information regarding the first
portion of the reaction pathway, further studies are required to elucidate the mechanism
and origin of enantioselectivity.
Figure 7.2.  Plot of substrate 293 1H NMR integral vs time
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Scheme 7.6.  Proposed catalytic cycle for enantioselective protonation
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7.4 SUMMARY
In conclusion, we have developed two novel palladium-catalyzed system for the
enantioconvergent decarboxylative protonation of racemic allyl β-ketoesters.  The
reaction tolerates a variety of substrate substitution and functionality and generates
products with high enantiomeric excess.  The method utilizes readily accessible racemic
α-substituted allyl β-ketoesters and either formic acid or commercially available
Meldrum’s acid as the proton donor.  Using the former proton source, substrate-specific
optimization is required.  Using the latter proton donor one standard set of reaction
conditions was amenable to the synthesis of a variety of α-tertiary cycloalkanones with
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high ee.  The homogeneous conditions developed herein enabled preliminary kinetic
experiments for investigation of the mechanism of this transformation.
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7.6 EXPERIMENTAL SECTION
7.6.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents.  p-Dioxane was distilled
over sodium prior to use unless specifically noted.  Other solvents were dried by passage
through an activated alumina column under argon.  Brine solutions are saturated aqueous
sodium chloride solutions.  Palladium(II) acetate (Pd(OAc)2)  and
Tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) were purchased from Strem and
used as received.  (S)-t-Bu-PHOX (55) was prepared by the method reported in our
previous work.17  Preparations of other PHOX ligands are found in Chapter 2.  Ketone
starting materials, diallyl carbonate, alkyl halides, L-Selectride®, and SelectfluorTM were
purchased from Aldrich and used as received.  Sodium hydride (NaH) was purchased as a
60% dispersion in mineral oil from Acros and used as received. Formic acid (98%) was
purchased from Fluka and used as received.  Deuterated formic acid (HCO2D and
DCO2H) were purchased from Cambridge Isotope Laboratories and used as received.
The HCO2D (≥98% chemical purity) was from lot #PR-15324/06034FA1 and was
assayed by the supplier as containing 99.6% isotopic enrichment and 4% D2O.  The
DCO2H (≥98% chemical purity) was from lot #I1-5333 and was assayed by the supplier
as containing >98% isotopic enrichment and 1608 ppm H2O.  Molecular sieves were
purchased from Aldrich as activated 5 µm powder and stored in a 120 °C drying oven
until immediately prior to use unless otherwise noted; the 4Å molecular sieves (4ÅMS)
used in this work were from batch #13128AD.  Meldrum’s acid (33) was recrystallized
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from ethyl acetate prior to use.  Reaction temperatures were controlled by an IKAmag
temperature modulator.  Thin-layer chromatography (TLC) was performed using E.
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence
quenching, anisaldehyde, KMnO4, or CAM staining.  ICN Silica gel (particle size 0.032-
0.063 mm) was used for flash chromatography.  Analytical chiral HPLC was performed
with an Agilent 1100 Series HPLC utilizing a Chiralcel OD-H or Chiralpak AD column
(4.6 mm x 25 cm) obtained from Daicel Chemical Industries with visualization at 254
nm, unless otherwise stated.  Analytical chiral GC was performed with an Agilent 6850
GC utilizing a G-TA (30 m x 0.25 mm) column (1.0 mL/min carrier gas flow).  Optical
rotations were measured with a Jasco P-1010 polarimeter at 589 nm.  1H and 13C NMR
spectra were recorded on a Varian Mercury 300 spectrometer (at 300 and 75 MHz
respectively), and are reported relative to Me4Si (δ 0.0 ppm).  19F NMR spectra were
recorded on a Varian Mercury 300 spectrometer at 282 MHz, and are reported relative to
the external standard F3CCO2H (δ –76.53 ppm).  2H NMR spectra were recorded on a
Varian Inova 500 spectrometer at 77 MHz, and are reported relative to Me4Si (δ 0.0
ppm).  Temperature controlled 1H NMR kinetic experiments were performed on a Varian
Inova 500 MHz.  Data for 1H NMR spectra are reported as follows: chemical shift (δ
ppm) (multiplicity, coupling constant (Hz), integration).  Data for 13C, 19F, and 2H NMR
are reported in terms of chemical shift.  IR spectra were recorded on a Perkin Elmer
Paragon 1000 spectrometer and are reported in frequency of absorption (cm–1).  Melting
points were determined using a Thomas capillary melting point apparatus and the values
reported are uncorrected.  High-resolution mass spectra were obtained from the Caltech
Mass Spectral Facility.
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7.6.2 EXPERIMENTAL DATA RELEVANT TO THE FORMIC ACID
PROTOCOL
7.6.2.1 OPTIMIZATION OF REACTION CONDITIONS FOR FORMIC ACID
PROTOCOL
Optimization reactions were carried out using the following sample procedure with
variations as indicated in Table 7.1 through Table 7.5.
Sample Procedure for Optimization Reactions
In a 1 dram glass vial, a solution of Pd(OAc)2 (2.2 mg, 0.010 mmol, 0.10 equiv, 10
mol%) and (S)-t-Bu-PHOX (55, 4.8 mg, 0.0125 mmol, 0.125 equiv, 12.5 mol%) in p-
dioxane (1 mL, purchased from Aldrich and used as received) was stirred at 40 °C for 30
min.  To the solution was added oven-dried powdered 3ÅMS (90 mg), followed
immediately by a solution of HCO2H (9.4 µL, 0.25 mmol, 2.5 equiv) in p-dioxane (1 mL)
and a solution of (±)-293 (24.4 mg, 0.10 mmol, 1.0 equiv) in p-dioxane (1 mL).  The vial
was then sealed with a teflon-lined cap and stirred at 40 °C until TLC indicated complete
consumption of the starting material (about 10 h).  The reaction mixture was passed
through a small plug of celite and the filtrate was concentrated in vacuo.  The residue was
purified by flash chromatography on SiO2 using 10% Et2O in pentane as the eluent.  The
ee of the product was determined to be 79% by chiral HPLC using a Chiracel OD-H
column with 1% 2-propanol in hexanes as the eluent.
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Optimization of Amount of Formic Acid and Molecular Sieves
Optimization of amounts of HCO2H and 4ÅMS was carried out using the following
general procedure with the variations indicated in Table 7.6.
General Procedure
Oven-dried 4Å molecular sieves (4ÅMS) were placed in a 1 dram glass vial equipped
with a magnetic stir bar, a screw cap, and a septum.  The vial and 4ÅMS were thoroughly
flame dried under vacuum and backfilled with dry argon gas.  The flame-drying
procedure was carried out twice more, and then the vial cooled to ambient temperature
(20 °C).  To the cooled vial was added Pd(OAc)2 (2.2 mg, 0.010 mmol, 0.10 equiv, 10
mol%), (S)-t-Bu-PHOX (55, 4.8 mg, 0.0125 mmol, 0.125 equiv, 12.5 mol%), and freshly
distilled p-dioxane (1.5 mL).  The mixture was heated to 40 °C for 30 mins, at which
point neat HCO2H was added, followed immediately by addition of a solution of (±)-293
(24.4 mg, 0.10 mmol, 1.0 equiv) in p-dioxane (1.5 mL).  The reaction mixture was stirred
at 40 °C until TLC indicated complete consumption of (±)-293 (about 10 h).  After
cooling to ambient temperature, the reaction mixture was filtered through a pad of celite.
The filtrate was concentrated by rotary evaporation and the residue purified by flash
chromatography on SiO2 using 10% Et2O in pentane as eluent.  The ee of the product was
determined by chiral HPLC with a Chiracel OD-H column using 1% 2-propanol in
hexanes as eluent.  The ratio of 97/98 was determined by 1H NMR integration.
Compound 98 was formed in comparable enantiomeric excess (and with the same
predominant enantiomer) to that from the allylation reaction described in Chapter 3.  The
alkylated product exhibits the following characteristics:
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O
98
(S)-2-Allyl-2-methyl-3,4-dihydronaphthalen-1(2H)-one (98):  1H NMR (300 MHz,
CDCl3) δ 8.04 (dd, J = 8.0, 1.2 Hz, 1H), 7.45 (dt, J = 7.7, 1.5 Hz, 1H), 7.29 (app. t, J =
7.2 Hz, 1H), 7.21 (app. d, J = 7.5 Hz, 1H), 5.85-5.71 (m, 1H), 5.10 (s, 1H), 5.05 (s, 1H),
2.97 (t, J = 6.3 Hz, 2H), 2.46 (dd, J = 13.8, 7.5 Hz, 1H), 2.27 (ddt, J = 14.0, 7.5, 1.2 Hz,
1H), 2.07 (ddd, J = 13.4, 7.2, 6.0 Hz 1H), 1.89 (ddd, J = 14.0, 6.9, 5.7 1H), 1.18 (s, 3H);
13C NMR (75 MHz, CDCl3) δ 202.0, 143.2, 133.9, 133.0, 131.5, 128.6, 127.9, 126.5,
118.1, 44.5, 41.0, 33.2, 25.3, 21.8; IR (Neat Film NaCl) 3073, 2930, 1682, 1455, 1220,
916, 742 cm–1; HRMS (EI) m/z calc'd for C14H16O [M]+: 200.1201, found 200.1194; [α]D27
–18.59 (c 2.08, hexane, 88% ee).
7.6.2.2 SYNTHESES OF SUBSTRATE COMPOUNDS
Substrates were synthesized by the methods reported in our previous work,18 unless
otherwise stated.  The following general procedures are representative.  Further details
and alternate methods may be found in Chapter 3.
General Procedure 1:  Dieckmann Cyclization Method19,20
Oallyl
O
Oallyl
O
239
Oallyl
OONa
240
O
241
CO2allyl
Ph
allyl alcohol
(30)
NaH, 95 °C
then BnBr
THF, 50 °C
Allyl 1-benzyl-2-oxocyclohexanecarboxylate (241, Scheme 7.2, Table 7.1, Table
7.7, entry 12; Table 7.10, entry 3).  To a suspension of NaH (166.4 mg, 4.16 mmol, 1.0
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equiv) in toluene (2 mL) was added allyl alcohol (30, 79.2 µL, 1.17 mmol, 0.28 equiv).
Once gas evolution ceased, pimelic acid diallyl ester (239, 1.00 g, 4.16 mmol, 1.0 equiv)
was added slowly and the resulting mixture heated to 95 °C for 1 h.  Additional toluene
(~2 mL) was added during this time to maintain a fluid reaction mixture.  The reaction
mixture was cooled to room temperature and the solvent removed by rotary evaporation
in vacuo.  The resulting solid salt was placed under dry N2 and dissolved in THF (9 mL).
Benzyl bromide (643.2 µL, 5.4 mmol, 1.3 equiv) was then added dropwise.  The resulting
mixture was warmed to 50 °C for 2.5 h, cooled to ambient temperature, and quenched
with saturated aq NH4Cl (5 mL) followed by H2O (5 mL).  The phases were separated
and the aqueous phase was extracted with EtOAc (3 x 5 mL).  The combined organic
extracts were washed with brine (1 x 10 mL), then dried (Na2SO4), filtered, and
concentrated in vacuo.  The resulting oil was purified by flash chromatography (5 x 18
cm SiO2, 10% Et2O in pentane) to afford the quaternary compound 241 as a colorless oil
(781.4 mg, 70% yield).  Rf = 0.30 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ
7.33-7.23 (comp. m, 3H), 7.20-7.13 (comp. m, 2H), 5.86 (dddd, J = 17.2, 10.3, 5.9, 5.9
Hz, 1H), 5.29 (m, 2H), 4.57 (m, 2H), 3.38 (d, 1H, J = 13.8 Hz), 2.94 (d, J = 13.8 Hz, 1H),
2.60-2.39 (comp. m, 3H), 2.14-1.97 (m, 1H), 1.83-1.60 (comp. m, 3H), 1.59-1.45 (m,
1H); 13C NMR (75 MHz, CDCl3) δ 206.8, 170.5, 136.3, 131.2, 130.2, 127.9, 126.5, 119.0,
65.6, 62.1, 41.1, 40.3, 35.7, 27.4, 22.3; IR (Neat Film NaCl) 3029, 2942, 1713, 1452,
1179, 1085 cm–1; HRMS (EI) m/z calc'd for C17H20O3 [M]+: 272.1412, found 272.1425.
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General Procedure 2:  Diallyl Carbonate Method
244
O O
O
O O
O
Oallyl
O
243
1.  NaH, diallyl carbonate, THF
2.  MeI, K2CO3, acetone, 50 °C
74% yield, 2 steps
Allyl 7-methyl-8-oxo-1,4-dioxaspiro[4.5]decane-7-carboxylate (244):
Part A, Acylation:
To a cooled (0 °C) suspension of NaH (9.22 g, 240.1 mmol, 2.5 equiv) in THF (125
mL) was added a solution of 1,4-cyclohexanedione monoethylene ketal (243, 15.0 g, 96
mmol, 1.0 equiv) in THF (30 mL) dropwise over 15 min.  The reaction mixture was
warmed to room temperature and diallyl carbonate (111, 20.65 mL, 144.0 mmol, 1.5
equiv) was added and the reaction mixture stirred for 16 h.  The reaction was quenched
with saturated aq NH4Cl and 1 N aq HCl until a pH of 4 was reached.  The phases were
separated and the aq phase was extracted with EtOAc (7 x 150 mL).  The combined
organic extracts were dried (Na2SO4), filtered, concentrated, redissolved in CH2Cl2, dried
(MgSO4), filtered, and concentrated.
Part B, Alkylation:
The resulting oil was added to a suspension of anhydrous K2CO3 (26.5 g, 192.0
mmol, 2.0 equiv) in acetone (128 mL).  To the reaction mixture was added iodomethane
(12.0 mL, 192.0 mmol, 2.0 equiv) and the reaction mixture was then heated to 50 °C for
14 h.  The mixture was then cooled, filtered, and the solids washed with acetone.  The
filtrate was concentrated and the resulting oil purified by flash chromatography (SiO2, 5
→ 40% Et2O in hexanes) to afford the desired quaternary quaternary β-ketoester 244 as a
colorless oil (18.0 g, 74% yield).  Rf = 0.28 (30% Et2O in pentane); 1H NMR (300 MHz,
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CDCl3) δ 5.90 (dddd, J = 17.4, 10.5, 5.7, 5.7 Hz, 1H), 5.26 (m, 2H), 4.60 (m, 2H), 3.97
(comp. m, 4H), 3.02 (dt, J = 14.8, 10.2 Hz, 1H), 2.68 (dt, J = 14.0, 2.0 Hz, 1H), 2.49 (dt,
J = 14.8, 4.4 Hz, 1H), 2.00 (comp. m, 2H), 1.72 (d, J = 14.1 Hz, 1H), 1.29 (s, 3H); 13C
NMR (75 MHz, CDCl3) δ 207.0, 172.9, 131.6, 118.5, 106.5, 65.9, 64.8, 64.3, 54.6, 43.6,
37.4, 35.2, 21.7; IR (Neat Film NaCl) 2939, 2891, 1733, 1717, 1304, 1141 cm–1; HRMS
(EI) m/z calc'd for C13H18O5 [M]+: 254.1154, found 254.1153.  Spectra for this compound
may be found in Appendix 2.
7.6.2.3 CHARACTERIZATION DATA FOR SUBSTRATE COMPOUNDS
O
O
O
329
Allyl 2-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (329, Scheme 7.2,
Table 7.7, entry 9; Table 7.10, entry 9):  Prepared by the diallyl carbonate method from
1-indanone using methyl iodide as the electrophile.  Purified by flash chromatography
(SiO2, 10% Et2O in pentane).  30% yield.  Rf = 0.55 (30% Et2O in pentane); 1H NMR (300
MHz, CDCl3) δ 7.79 (d, J = 7.7 Hz, 1H), 7.63 (dd, J = 7.6, 7.3 Hz, 1H), 7.48 (d, J = 7.7
Hz, 1H), 7.41 (dd, J = 7.6, 7.3 Hz, 1H), 5.83 (dddd, J = 17.2, 10.6, 5.6, 5.6 Hz, 1H), 5.21
(dddd, J = 17.2, 2.7, 1.6, 1.1 Hz, 1H), 5.16 (dddd, J = 10.5, 2.4, 1.3, 1.3 Hz, 1H), 4.58
(ddd, J = 5.6, 2.7, 1.1 Hz, 1H), 4.58 (ddd, J = 5.6, 2.7, 1.1 Hz, 1H), 3.73 (d, J = 17.1 Hz,
1H), 3.01 (d, J = 17.1 Hz, 1H), 1.54 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 203.5, 171.8,
152.7, 135.5, 134.9, 131.7, 128.0, 126.6, 125.2, 118.3, 66.0, 56.2, 40.2, 21.2; IR (Neat
Film NaCl) 3080, 2982, 2935, 1745, 1715, 1608, 1495, 1282, 1184, 967, 747 cm–1;
HRMS (EI) m/z calc'd for C14H14O3 [M]+: 230.0943, found 230.0936.
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293
O
O
O
Allyl 2-methyl-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (293, Scheme
7.2, Table 7.2 through Table 7.10):  Prepared by the diallyl carbonate method from 1-
tetralone.  Flash chromatography (SiO2, 10% Et2O in pentane).  60% yield.  Rf = 0.61
(30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 8.06 (d, J = 7.8 Hz, 1H), 7.47 (app.
t, J = 7.5 Hz, 1H), 7.31 (app. t, J = 8.1 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 5.79 (dddd, J =
17.1, 10.7, 5.4, 5.4 Hz, 1H), 5.19-5.09 (m, 2H), 4.58 (m, 2H), 3.12-2.87 (m, 2H), 2.68-
2.57 (m, 1H), 2.13-2.01 (m, 1H), 1.52 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 195.9,
172.5, 143.1, 133.4, 131.7, 131.5, 128.7, 128.0, 126.8, 118.0, 65.6, 53.9, 33.9, 26.0, 20.6;
IR (Neat Film NaCl) 3071, 2982, 2938, 1736, 1690, 1602, 1456, 1377, 1308, 1228, 1189,
1112, 979, 743 cm–1; HRMS (EI) m/z calc'd for C15H16O3 [M]+: 244.1099, found
244.1094.
O
CO2allyl
640
640, Table 7.7, Entry 2: Prepared using the diallyl carbonate method from 1-
tetralone and allyl bromide.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  83% yield.  Rf = 0.77 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3)
δ 8.06 (d, J = 7.7 Hz, 1H), 7.47 (dd, J = 7.7, 7.4 Hz, 1H), 7.31 (dd, J = 7.7, 7.7 Hz, 1H),
7.21 (d, J = 7.4 Hz, 1H), 5.92-5.71 (comp. m, 2H), 5.21-5.06 (comp. m, 4H), 4.58 (app.
d, J = 5.3 Hz, 1H), 4.58 (app. d, J = 5.6 Hz, 1H), 3.08 (ddd, J = 17.3, 10.1, 4.8 Hz, 1H),
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2.93 (ddd, J = 17.3, 5.1, 4.8 Hz, 1H), 2.77 (app. ddd, J = 13.8, 7.2, 1.1 Hz, 1H), 2.70
(app. ddd, J = 13.8, 7.4, 1.1 Hz, 1H), 2.54 (ddd, J = 13.8, 5.1, 4.8 Hz, 1H), 2.16 (ddd, J =
14.1, 10.1, 5.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 195.0, 171.4, 143.3, 133.7, 133.5,
132.1, 131.7, 128.9, 128.2, 126.9, 119.2, 118.4, 65.9, 57.5, 38.7, 30.6, 25.9; IR (Neat
Film NaCl) 3077, 2937, 1734, 1689, 1601, 1455, 1236, 1212, 1188, 922, 743 cm–1;
HRMS (EI+) m/z calc'd for C17H18O3 [M]+: 270.1256, found 270.1249.
O O
O
H
O O
O
FTiCl4 (10 mol%)
Select-fluor
CH3CN, 20 °C
498680
Allyl 2-fluoro-1-tetralone-2-carboxylate (498, Table 7.7, Entry 3):  Neat TiCl4
(45.6 µL, 0.42 mmol, 0.10 equiv, 10 mol%) was added to a 20 °C solution of 68018 (1.00
g, 4.16 mmol, 1.0 equiv) in acetonitrile (40 mL), resulting in an immediate color change
from pale yellow to dark orange-brown.  After 5 min, SelectfluorTM (1.77 g, 4.99 mmol,
1.2 equiv) was added in one portion.  The mixture was stirred vigorously at 20 °C for 2 h,
during which time the dark orange-brown color faded to yellow.  The reaction was
quenched by addition of H2O (120 mL).  The aqueous phase was extracted with Et2O (4 x
30 mL).  The combined organic extracts were washed with brine (1 x 25 mL), dried over
Na2SO4, filtered, and the filtrate concentrated in vacuo to a yellow oil.  Purification by
flash chromatography (SiO2, 20% Et2O in pentane) yielded the title compound (498) as a
colorless oil (879.9 mg, 85% yield).  Rf = 0.41 (30% Et2O in pentane); 1H NMR (300
MHz, CDCl3) δ 8.08 (d, J = 8.0 Hz, 1H), 7.56 (dd, J = 7.4, 7.4 Hz, 1H), 7.37 (dd, J = 7.7,
7.4 Hz, 1H), 7.28 (d, J = 7.7 Hz, 1H), 5.88 (dddd, J = 17.3, 10.4, 5.6, 5.1 Hz, 1H), 5.27
(dd, J = 17.3, 1.3 Hz, 1H), 5.24 (dd, J = 10.4, 1.1 Hz, 1H), 4.73 (app. ddd, J = 5.9, 2.1,
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1.3 Hz, 1H), 4.73 (app. ddd, J = 5.9, 2.1, 1.3 Hz, 1H), 3.20 (ddd, J = 17.3, 6.4, 6.1 Hz,
1H), 3.08 (ddd, J = 17.3, 7.5, 5.1 Hz, 1H), 2.75 (dddd, JH-H = 7.4, 7.2, 6.4 Hz, JH-F = 26.3
Hz, 1H), 2.56 (dddd, JH-H = 7.2, 6.1, 5.3 Hz, JH-F = 21.8 Hz, 1H); 13C NMR (75 MHz,
CDCl3) δ 188.6 (JC-F = 18.6 Hz), 167.2 (JC-F = 26.3 Hz), 143.2, 132.7, 130.9, 130.7, 128.9,
128.6 (JC-F = 0.9 Hz), 127.4, 119.4, 93.4 (JC-F = 194.5 Hz), 66.8, 32.0 (JC-F = 22.1 Hz),
25.0 (JC-F = 7.2 Hz); 19F NMR (282 MHz, CDCl3) δ –165.2 (dd, JF-H = 24.5, 21.4 Hz, 1F);
IR (Neat Film NaCl) 3075, 2945, 1765, 1696, 1602, 1457, 1312, 1277, 1228, 1187, 1138,
1087, 942, 913, 744 cm–1; HRMS (EI+) m/z calc'd for C14H13FO3 [M]+: 248.0849, found
248.0860.
O
O
O
O
629
629, Table 7.7, Entry 4:  Prepared using the diallyl carbonate method from 6-
methoxy-1-tetralone and methyl iodide.  Purified by flash chromatography (SiO2, 5%
Et2O in pentane).  82% yield.  Rf = 0.34 (30% Et2O in pentane); 1H NMR (300 MHz,
CDCl3) δ 8.04 (d, J = 8.8 Hz, 1H), 6.84 (dd, J = 8.8, 2.4 Hz, 1H), 6.66 (d, J = 2.4 Hz,
1H), 5.82 (dddd, J = 17.1, 10.4, 6.0, 5.2 Hz, 1H), 5.23-5.17 (m, 2H), 4.59 (m, 2H), 3.85
(s, 3H), 3.02 (ddd, J = 17.3, 9.6, 4.8 Hz, 1H), 2.89 (ddd, J = 17.0, 5.3, 5.3 Hz, 1H), 2.63
(ddd, J = 13.6, 5.1, 4.8 Hz, 1H), 2.05 (ddd, J = 13.8, 9.6, 5.1 Hz, 1H), 1.51 (s, 3H); 13C
NMR (75 MHz, CDCl3) δ 194.9, 173.0, 163.8, 145.8, 131.8, 130.7, 125.4, 118.2, 113.6,
112.6, 65.8, 55.6, 53.8, 34.1, 26.5, 20.8; IR (Neat Film NaCl) 2938, 1734, 1676, 1600,
1276, 1262, 1230, 1186, 1172, 1099, 978, 668 cm–1; HRMS (EI+) m/z calc'd for C16H18O4
[M]+: 274.1205, found 274.1204.
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O
CO2allyl
O 643
643, Table 7.7, Entry 5: Prepared using the diallyl carbonate method from 6-
methoxy-1-tetralone and allyl bromide.  Purified by flash chromatography (SiO2, 10%
Et2O in pentane).  83% yield.  Rf = 0.45 (30% Et2O in pentane); 1H NMR (300 MHz,
CDCl3) δ 8.03 (d, J = 8.7 Hz, 1H), 6.83 (dd, J = 8.5, 2.4 Hz, 1H), 6.66 (d, J = 2.4 Hz,
1H), 5.91-5.72 (comp. m, 2H), 5.24-5.05 (comp. m, 4H), 4.59 (app. ddd, J = 5.3, 1.6, 1.3
Hz, 1H), 4.59 (app. ddd, J = 5.3, 1.6, 1.3 Hz, 1H), 3.85 (s, 3H), 3.05 (ddd, J = 17.3, 10.1,
4.8 Hz, 1H), 2.88 (ddd, J = 17.3, 5.3, 5.1 Hz, 1H), 2.76 (dd, J = 13.8, 7.2 Hz, 1H), 2.69
(dd, J = 13.8, 7.2 Hz, 1H), 2.52 (ddd, J = 13.8, 5.3, 4.8 Hz, 1H), 2.13 (ddd, J = 13.8, 10.1,
5.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 193.7, 171.5, 163.8, 145.9, 133.7, 131.8,
130.7, 125.6, 119.0, 118.3, 113.6, 112.5, 65.8, 57.2, 55.6, 38.8, 30.5, 26.3; IR (Neat Film
NaCl) 3080, 2942, 1734, 1676, 1600, 1447, 1353, 1272, 1254, 1214, 925 cm–1; HRMS
(EI+) m/z calc'd for C18H20O4 [M]+: 300.1362, found 300.1374.
O
CO2allyl
Ph
O 644
644, Table 7.7, Entry 6: Prepared using the diallyl carbonate method from 6-
methoxy-1-tetralone and benzyl bromide.  Purified by flash chromatography (SiO2, 10%
Et2O in pentane).  80% yield.  Rf = 0.56 (30% Et2O in pentane); 1H NMR (300 MHz,
CDCl3) δ 8.06 (d, J = 8.8 Hz, 1H), 7.29-7.14 (comp. m, 5H), 6.82 (dd, J = 8.8, 2.5 Hz,
1H), 6.60 (d, J = 2.2 Hz, 1H), 5.80 (dddd, J = 17.3, 10.7, 5.5, 5.5 Hz, 1H), 5.17 (app. ddd,
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J = 17.6, 3.0, 1.4 Hz, 1H), 5.15 (app. ddd, J = 10.5, 2.5, 1.4 Hz, 1H), 4.57 (app. ddd, J =
5.5, 2.5, 1.4 Hz, 1H), 4.57 (app. ddd, J = 5.5, 2.5, 1.4 Hz, 1H), 3.83 (s, 3H), 3.46 (d, J =
13.8 Hz, 1H), 3.31 (d, J = 13.8 Hz, 1H), 3.06 (ddd, J = 17.3, 11.6, 4.4 Hz, 1H), 2.79 (ddd,
J = 17.3, 4.4, 4.4 Hz, 1H), 2.46 (ddd, J = 13.8, 4.4, 4.4 Hz, 1H), 1.97 (ddd, J = 13.5, 11.6,
5.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 193.1, 171.4, 163.8, 145.9, 136.8, 131.6,
130.9, 130.8, 128.2, 126.8, 125.9, 118.4, 113.6, 112.4, 65.9, 58.6, 55.6, 40.2, 30.5, 26.6;
IR (Neat Film NaCl) 2935, 1708, 1688, 1607, 1595, 1497, 1310, 1277, 1244, 1196, 1144,
1080, 1029, 992, 698 cm–1; HRMS (EI+) m/z calc'd for C22H22O4 [M]+: 350.1518, found
350.1503.
O
O
O
O
O 646
646, Table 7.7, Entry 7: Prepared using the diallyl carbonate method from 6,7-
dimethoxy-1-tetralone and methyl iodide.  Purified by flash chromatography (SiO2, 20%
EtOAc in hexanes).  18% yield. Rf = 0.14 (30% Et2O in pentane); mp 78–80 °C; 1H NMR
(300 MHz, CDCl3) δ 7.54 (s, 1H), 6.23 (s, 1H), 5.83 (dddd, J = 17.3, 10.4, 5.6, 5.1 Hz,
1H), 5.19 (dddd, J = 17.3, 3.2, 1.6, 1.6 Hz, 1H), 5.16 (dddd, J = 10.6, 2.7, 1.3, 1.3, 1H),
4.60 (dddd, J = 8.2, 5.3, 2.7, 1.3 Hz, 1H), 4.60 (dddd, J = 8.2, 5.3, 2.7, 1.3 Hz, 1H), 3.93
(s, 3H), 3.91 (s, 3H), 2.99 (ddd, J = 17.0, 9.3, 4.8 Hz, 1H), 2.86 (ddd, J = 17.3, 5.6, 5.3
Hz, 1H), 2.61 (ddd, J = 13.3, 5.8, 4.8 Hz, 1H), 2.06 (ddd, J = 13.3, 9.3, 4.8 Hz, 1H), 1.51
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 195.0, 172.9, 153.8, 148.2, 138.1, 131.8, 124.9,
118.2, 110.2, 109.3, 65.8, 56.2, 56.1, 53.5, 34.4, 25.9, 20.9; IR (Neat Film NaCl) 3079,
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2938, 2836, 1732, 1672, 1600, 1513, 1454, 1368, 1269, 1239, 1183, 1105, 1018, 790
cm–1; HRMS (EI+) m/z calc'd for C17H20O5 [M]+: 304.1311, found 304.1299.
O
O
O
648
648, Table 7.7, Entry 8: Prepared using the diallyl carbonate method from 5,7-
dimethyl-1-tetralone and methyl iodide.  Purified by flash chromatography (SiO2, 10 →
15% Et2O in pentane).  40% yield.  Rf = 0.67 (30% Et2O in pentane); 1H NMR (300 MHz,
CDCl3) δ 7.75 (br s, 1H), 7.19 (br s, 1H), 5.79 (dddd, J = 16.5, 10.1, 5.6, 5.6 Hz, 1H),
5.15 (dd, J = 16.5, 1.6 Hz, 1H), 5.14 (dd, J = 10.1, 1.6 Hz, 1H), 4.57 (app. ddd, J = 5.6,
2.1, 1.3 Hz, 1H), 4.57 (app. ddd, J = 5.6, 2.1, 1.3 Hz, 1H), 2.93-2.73 (m, 2H), 2.64 (ddd,
J = 13.6, 5.3, 5.3 Hz, 1H), 2.33 (s, 3H), 2.25 (s, 3H), 2.03 (ddd, J = 13.8, 8.5, 5.9 Hz,
1H), 1.50 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 196.7, 172.7, 138.6, 136.3, 136.1 (2C),
131.8 (2C), 126.1, 118.1, 65.7, 53.5, 33.3, 23.1, 21.0, 20.7, 19.3; IR (Neat Film NaCl)
2982, 2937, 1736, 1688, 1477, 1453, 1318, 1251, 1197, 1165, 1110, 1051, 984, 928, 874
cm–1; HRMS (EI+) m/z calc'd for C17H20O3 [M]+: 272.1412, found 272.1413.
O
CO2allyl
Ph
650
650, Table 7.7, Entry 10: Prepared using the Dieckmann cyclization method from
diallyl adipate and benzyl bromide.  Purified by flash chromatography (SiO2, 10% Et2O
in pentane).  36% yield.  Rf = 0.17 (10% Et2O in pentane); 1H NMR (300 MHz, CDCl3)
δ 7.31-7.18 (comp. m, 3H), 7.17-7.09 (comp. m, 2H), 5.89 (dddd, J = 17.3, 10.6, 5.6, 4.8
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Hz, 1H), 5.31 (dd, J = 17.3, 1.3 Hz, 1H), 5.24 (dd, J = 10.4, 1.3 Hz, 1H), 4.61 (app. dd, J
= 5.6, 2.7, 1.6 Hz, 1H), 4.61 (dd, J = 5.6, 2.7, 1.6 Hz, 1H), 3.21 (d, J = 13.8 Hz, 1H), 3.14
(d, J = 13.8 Hz, 1H), 2.51-2.29 (m, 2H), 2.12-1.80 (comp. m, 3H), 1.70-1.51 (m, 1H); 13C
NMR (75 MHz, CDCl3) δ 215.0, 170.8, 136.6, 131.7, 130.4, 128.5, 127.0, 118.8, 66.2,
61.6, 39.2, 38.5, 31.8, 19.6; IR (Neat Film NaCl) 3029, 2963, 1751, 1728, 1496, 1454,
1266, 1220, 1187, 1158, 1141, 1102, 991, 925, 703 cm–1; HRMS (EI+) m/z calc'd for
C16H18O3 [M]+: 258.1256, found 258.1268.
O
O
O
107
Allyl 1-methyl-2-oxocyclohexanecarboxylate (107, Table 7.7, entry 11; Table
7.10, entry 1):  Prepared by the Dieckmann cyclization method.  62% yield.  Rf = 0.38
(10:1 Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.85 (dddd, J = 17.1, 10.2, 5.9, 5.9
Hz, 1H), 5.24 (m, 2H), 4.59 (d, J = 5.7 Hz, 2H), 2.58-2.34 (comp. m, 3H), 2.08-1.88 (m,
1H), 1.80-1.54 (comp. m, 3H), 1.52-1.37 (m, 1H), 1.27 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 207.9, 172.6, 131.4, 118.7, 65.6, 57.1, 40.5, 38.1, 27.4, 22.5, 21.1; IR (Neat
Film NaCl) 3086, 2939, 2867, 1715, 1452, 1259, 1211, 1159, 1084, 976 cm–1; HRMS
(EI) m/z calc'd for C11H16O3 [M]+: 196.1099, found 196.1096.
O
CO2allyl
Ph
652
652, Table 7.7, Entry 13: Prepared using the diallyl carbonate method from
cycloheptanone and benzyl bromide.  Purified by flash chromatography (SiO2, 20 → 60%
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CH2Cl2 in hexane).  44% yield.  Rf = 0.35 (15% EtOAc in hexanes); 1H NMR (300 MHz,
CDCl3) δ 7.34-7.19 (comp. m, 3H), 7.19-7.07 (comp. m, 2H), 5.89 (dddd, J = 17.3, 10.4,
5.6, 5.6 Hz, 1H), 5.33 (dddd, J = 17.3, 2.9, 1.3, 1.3 Hz, 1H), 5.27 (dddd, J = 10.4, 2.7,
1.3, 1.3 Hz, 1H), 4.62 (dddd, J = 5.6, 5.6, 1.3, 1.3 Hz, 1H), 4.62 (dddd, J = 5.6, 5.6, 1.3,
1.3 Hz, 1H), 3.41 (d, J = 13.6 Hz, 1H), 3.03 (d, J = 13.8 Hz, 1H), 2.65 (ddd, J = 12.5, 9.0,
3.7 Hz, 1H), 2.36 (ddd, J = 12.8, 8.8, 2.9 Hz, 1H), 2.10 (app. dd, J = 13.8, 9.3 Hz, 1H),
1.94-1.62 (comp. m, 5H), 1.62-1.37 (comp. m, 2H); 13C NMR (75 MHz, CDCl3) δ 209.4,
171.7, 136.8, 131.6, 130.6, 128.3, 126.9, 119.0, 66.0, 64.4, 42.5, 40.9, 31.7, 29.9, 25.5,
24.6; IR (Neat Film NaCl) 3028, 2932, 2860, 1734, 1711, 1454, 1195, 1172, 1145, 991,
941, 702 cm–1; HRMS (EI+) m/z calc'd for C18H22O3 [M]+: 286.1569, found 286.1571.
N
Bn
O
O
O
318
Allyl 1-benzyl-3-ethyl-4-oxopiperidine-3-carboxylate (318, Table 7.7, entry 14):
Prepared by the diallyl carbonate method from 1-benzylpiperidin-4-one (part A) and
iodoethane (part B).  Flash chromatography (SiO2, 2.5→20% EtOAc in hexanes).  55%
yield.  Rf = 0.50 (30% Et2O in pentane); 1H NMR (300 MHz, CDCl3) δ 7.33-7.25 (m, 5H),
5.90 (dddd, J = 17.4, 10.7, 5.7, 5.7 Hz, 1H), 5.33 (dq, J = 17.1, 1.5 Hz, 1H), 5.24 (dq, J =
10.4, 1.5 Hz, 1H), 4.70 (ddt, J = 13.0, 6.0, 1.4 Hz, 1H), 4.62 (ddt, J = 13.0, 6.0, 1.4 Hz,
1H), 3.62 (d, J = 13.2 Hz, 1H), 3.56 (d, J = 13.2 Hz, 1H), 3.42 (dd, J = 11.4, 2.7 Hz, 1H),
3.04-2.80 (m, 2H), 2.45-2.35 (m, 2H), 2.25 (d, J = 11.7 Hz, 1H), 1.94-1.82 (m, 1H), 1.65-
1.53 (m, 1H), 0.87 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.9, 171.3, 137.9,
131.7, 128.8, 128.2, 127.3, 118.7, 65.6, 61.8, 61.5, 61.0, 53.5, 40.6, 25.2, 9.1; IR (Neat
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Film NaCl) 2966, 2939, 1719, 1224, 1139, 699 cm–1; HRMS (EI) m/z calc'd for C18H23O3
[M]+:  301.1678, found 301.1691.
7.6.2.4 ENANTIOCONVERGENT DECARBOXYLATIVE PROTONATION
USING FORMIC ACID AS THE PROTON SOURCE
Sample Procedure for Enantioconvergent Protonation
(S)
OO O
O
(±)-293 (S)-97
Pd(OAc)2 (10 mol%)
(S)-t-BuPHOX (12.5 mol%)
HCO2H, 4ÅMS
p-dioxane, 40 °C
(S)-(–)-2-Methyl-1-tetralone (97, Table 7.7, Entry 1):21  A glass tube (2.5 x 10 cm
with a ground glass joint) equipped with a magnetic stir bar was charged with powdered
4Å molecular sieves (540 mg) and then thoroughly flame dried under vacuum (3x,
backfill with dry argon).  After cooling to ambient temperature under dry argon,
Pd(OAc)2 (6.7 mg, 0.030 mmol, 0.10 equiv, 10 mol%), (S)-t-Bu-PHOX (55, 14.5 mg,
0.0375 mmol, 0.125 equiv, 12.5 mol%), and freshly distilled p-dioxane (4.5 mL) were
added, and the resulting slurry was stirred vigorously at 40 ºC for 30 min.  At this point,
neat HCO2H (68 µL, 1.80 mmol, 6.0 equiv) was added to the reaction mixture, followed
immediately by addition of a solution of (±)-293 (73.3 mg, 0.30 mmol, 1.0 equiv) in p-
dioxane (4.5 mL).  When the reaction was complete by TLC, the reaction mixture was
cooled to ambient temperature and then filtered through a pad of SiO2.  The filtrate was
concentrated under reduced pressure and the residue purified by flash chromatography on
SiO2 using 10% Et2O in pentane as eluent to afford (S)-97 (42.1 mg, 88% yield).  The
material was determined to be of 94% ee, measured by chiral HPLC using a Chiracel
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OD-H column with 1% 2-propanol in hexanes as the eluent. [α]D25 –44.4 (c 1.06, p-
dioxane, 94% ee).
The absolute configuration was determined by comparison of the observed optical
rotation to a literature value for (S)-2-methyl-1-tetralone (97): [α]D22 –51.2 (c 2.5, p-
dioxane).22
Data for product compounds:
Products were prepared using the above procedure, unless specifically stated
otherwise.
(R)
O
641
(R)-(–)-2-Allyl-1-tetralone (641, Table 7.7, Entry 2):23 Reaction performed with 5.0
equiv of HCO2H (56.6 µL, 1.50 mmol) and 405 mg (1.35 g/mmol of substrate) of
powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  88% yield, 85% ee.  [α]D25 –22.2 (c 0.63, MeOH, 85% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(–)-2-allyl-1-tetralone: [α]D23 –29.7 (c 1.21, MeOH, 97% ee).23
(S)
O
F
642
(S)-(–)-2-Fluoro-1-tetralone (642, Table 7.7, Entry 3):24 Reaction performed with
8.0 equiv of HCO2H (90.6 µL, 2.40 mmol) and 810 mg (2.70 g/mmol of substrate) of
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powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  79% yield, 88% ee.  [α]D25 –56.9 (c 1.01, p-dioxane, 88% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(+)-2-fluoro-1-tetralone: [α]D +64.9 (c 0.43, p-dioxane, >95%
ee).24
O
MeO 630
(–)-2-Methyl-6-methoxy-1-tetralone (630, Table 7.7, Entry 4):25 Reaction
performed with 6.0 equiv of HCO2H (67.9 µL, 1.80 mmol) and 540 mg (1.80 g/mmol of
substrate) of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2,
10% Et2O in pentane).  91% yield, 95% ee.  [α]D25 –62.6 (c 1.02, CHCl3, 95% ee).
O
O 541
(–)-2-Allyl-6-methoxy-1-tetralone (541, Table 7.7, Entry 5):23 Reaction performed
with 5.0 equiv of HCO2H (56.6 µL, 1.50 mmol) and 405 mg (1.35 g/mmol of substrate)
of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  81% yield, 88% ee.  [α]D24.9 –50.28 (c 2.03, CH2Cl2, 88% ee).
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O
MeO 645
(+)-2-Benzyl-6-methoxy-1-tetralone (645, Table 7.7, Entry 6):26 Reaction
performed with 7.0 equiv of HCO2H (79.2 µL, 2.10 mmol) and 675 mg (2.25 g/mmol of
substrate) of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2,
10% Et2O in pentane).  95% yield, 78% ee.  [α]D25 +8.6 (c 0.79, CHCl3, 78% ee).
O
O
O 647
(–)-2-Methyl-6,7-dimethoxy-1-tetralone (647, Table 7.7, Entry 7):27 Reaction
performed with 5.0 equiv of HCO2H (56.6 µL, 1.50 mmol) and 405 mg (1.35 g/mmol of
substrate) of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2,
40% Et2O in pentane).  62% yield, 94% ee.  [α]D25.9 –86.88 (c 1.09, CH2Cl2, 94% ee).
O
649
(–)-2,5,7-Trimethyl-1-tetralone (649, Table 7.7, Entry 8):28 Reaction performed
with 5.0 equiv of HCO2H (56.6 µL, 1.50 mmol) and 405 mg (1.35 g/mmol of substrate)
of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  75% yield, 92% ee.  [α]D25.8 –29.97 (c 1.00, CH2Cl2, 92% ee).
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(S)
O
638
(S)-(+)-2-Methyl-1-indanone (638, Table 7.7, Entry 9):21 Reaction performed with
5 mol% Pd(OAc)2 (3.4 mg, 0.015 mmol, 0.050 equiv), 6.25 mol% (S)-t-Bu-PHOX (7.3
mg, 0.0188 mmol, 0.0625 equiv), 5.0 equiv of HCO2H (56.6 µL, 1.50 mmol) and 405 mg
(1.35 g/mmol of substrate) of powdered 4Å molecular sieves.  Purified by flash
chromatography (SiO2, 10% Et2O in pentane).  83% yield, 81% ee.  [α]D26.3 +35.73 (c
1.50, p-dioxane, 81% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-2-methyl-1-indanone: [α]D22 –42 (c 1.72, p-dioxane).22
651
O
(–)-2-Benzylcyclopentanone (651, Table 7.7, Entry 10):29 Reaction performed with
6.0 equiv of HCO2H (67.9 µL, 1.80 mmol) and 675 mg (2.25 g/mmol of substrate) of
powdered 4Å molecular sieves.  63% yield, 60% ee.  [α]D27 –116.6 (c 1.11, CHCl3, 60%
ee).
(R)
O
207
(R)-(–)-2-Methylcyclohexanone (207, Table 7.7, Entry 11):21 Reaction performed
with 6.0 equiv of HCO2H (67.9 µL, 1.80 mmol) and 675 mg (2.25 g/mmol of substrate)
of powdered 4Å molecular sieves.  Yield determined by GC using tridecane (30.0 µL) as
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an internal standard.  99% GC yield, 85% ee.  Material for optical rotation was obtained
by filtering the reaction mixture through a pad of SiO2, concentrating the filtrate,
dissolving the residue in 10% Et2O in pentane, passing through a short plug of SiO2, and
concentrating the filtrate.  [α]D26.2 –6.4 (c 0.87, MeOH, 85% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (S)-(+)-2-methylcyclohexanone: [α]D +12.2 (c 4, MeOH, 87%
ee).30
(S)
O
639
(S)-(–)-2-Benzylcyclohexanone (639, Table 7.7, Entry 12):21 Reaction performed
with 7.0 equiv of HCO2H (79.2 µL, 2.10 mmol) and 675 mg (2.25 g/mmol of substrate)
of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  91% yield, 92% ee.  [α]D25.5 –42.2 (c 1.66, MeOH, 92% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(+)-2-benzylcyclohexanone: [α]D +41.4 (c 5, MeOH, 88%
ee).30  This assignment was confirmed by reduction of the ketone to the corresponding
syn alcohol 681.
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639
(S)
(S)
OHO
L-Selectride
THF, –78 °C
681
(1S,2S)-(+)-2-benzylcyclohexanol (681):31 To a cooled (–78 °C) solution of (–)-2-
benzylcyclohexanone (43.9 mg, 0.23 mmol, 1.0 equiv) in THF (2.3 mL) was added a
1.0M solution of L-Selectride® in THF (303.1 µL, 0.30 mmol, 1.3 equiv).  After 30 min,
the reaction was quenched with H2O (500 µL) and then warmed to 25 °C.  Additional
H2O (3 mL) and EtOAc (5 mL) were added and the phases separated.  The aqueous phase
was extracted with EtOAc (3 x 4 mL).  The combined organics were then washed with
brine (1 x 5 mL), dried over anhydrous Na2SO4, filtered, and concentrated to a colorless
oil.  Flash chromatography (SiO2, 15% EtOAc in hexanes) provided the title compound
as a white crystalline solid that was isolated as one diastereomer (14.1 mg, 32% yield).
1H NMR data matched that previously reported for the syn diastereomer.31  R f  = 0.18
(15% EtOAc in hexanes); mp 66–68 °C (lit.31 67–70 °C); [α]D26.7 +30.7 (c 0.50, CHCl3).
The absolute configuration was confirmed by comparison of the optical rotation to the
literature value for (1S,2S)-(+)-2-benzylcyclohexanol: [α]D20 +28.2 (c 1, CHCl3).31
O
653
(–)-2-Benzylcycloheptanone (653, Table 7.7, Entry 13):32 Reaction performed with
6.0 equiv of HCO2H (67.9 µL, 1.80 mmol) and 540 mg (1.80 g/mmol of substrate) of
powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 30% CH2Cl2 in
pentane).  69% yield, 74% ee.  [α]D27 –43.7 (c 1.08, MeOH, 74% ee).
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N
Bn
O
654
(–)-1-Benzyl-3-ethyl-4-piperidone (654, Table 7.7, Entry 14):33 Reaction performed
with 6.0 equiv of HCO2H (67.9 µL, 1.80 mmol) and 600 mg (2.00 g/mmol of substrate)
of powdered 4Å molecular sieves.  Purified by flash chromatography (SiO2, 10% Et2O in
pentane).  83% yield, 84% ee.  [α]D25 –19.6 (c 1.03, CHCl3, 84% ee).
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Table 7.11. Methods for the determination of enantiomeric excess (formic acid conditions)
97
641
649
Entry Product
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
Assay
Conditions
5
O
O
8812.796 11.807
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
7
O
O
9432.596 36.115
HPLC
Chiracel AD
1% i-PrOH in hexane
isocratic, 1.0 mL/min
O
8
O
927.104 7.598
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
4 9516.768 15.855
3
94
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
9.076 8.2851
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
(S)
O
F 8815.860 17.707
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
2 (R)
O
8521.732 19.414
HPLC
Chiracel OD-H
0.1% i-PrOH in heptane
isocratic, 1.0 mL/min
(S)
O
O
O
6 7825.940 23.992
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
O
MeO
642
630
541
645
647
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Table 7.11.  (continued)
207
639
638
81
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
9.381 8.6639
O
12 (S)
O
929.989 8.453
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
11 (R)
O
8519.225 17.610
GC
G-TA
70 ° isotherm
14
N
Bn
O
8411.578 10.420
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
Entry Product
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
Assay
Conditions
13 748.893 8.286
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
UV detection at 210 nm
O
10 6016.384 13.558
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
O
651
653
654
7.6.2.5 DEUTERIUM LABELING EXPERIMENTS
General Procedure for Deuterium Labeling Experiments:
Prior to use, powdered 4ÅMS were dried under vacuum (~1 torr) for 3 days at 320
°C.34  Subsequently, these 4ÅMS were cooled to 25 °C under dry N2 and then
immediately transferred to a glove box containing an atmosphere of dry N2.  In the
labeling experiments below, the powdered 4ÅMS were weighed in the glove box,
transferred to a 1 dram glass vial containing a magnetic stir bar and sealed with a screw
cap and a septum.  The vial was then removed from the glove box and thoroughly flame
dried under vacuum, backfilling with dry N2 (three cycles).  The contents were then
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cooled to ambient temperature (25 °C).  Once cool, Pd(OAc)2 (2.2 mg, 0.010 mmol, 0.10
equiv, 10 mol%), (S)-t-Bu-PHOX (55, 4.8 mg, 0.0125 mmol, 0.125 equiv, 12.5 mol%),
and freshly distilled p-dioxane (1.5 mL) were added and the resulting suspension stirred
at 40 °C for 30 min.  At this point, a solution of (±)-293 (24.4 mg, 0.10 mmol, 1.0 equiv)
in p-dioxane (1.5 mL) was added, followed immediately by addition of neat formic acid
(labeled as shown below).  This mixture was stirred at 40 °C until TLC indicated
complete consumption of (±)-293.  After cooling to ambient temperature, the reaction
mixture was passed through a pad of SiO2 and the filtrate concentrated by rotary
evaporation.  The residue was then purified by flash chromatography on SiO2 using 5%
Et2O in pentane as eluent.  The ee of the isolated material was determined by chiral
HPLC with a Chiracel OD-H column using 1% 2-propanol in hexanes as eluent.  The
amount of deuterium incorporation was determined by 1H NMR integration and
deuteration was confirmed by 2H NMR.
Deuterium Labeling Experiment 1:
O
O
O Pd(OAc)2 (10 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
HCO2D (6.0 equiv)
4ÅMS (180 mg)
p-dioxane, 40 °C
O
H(D)
35% D incorporation
(±)-293 (S)-97
Reaction performed using HCO2D (23.1 µ L, 0.60 mmol, 6.0 equiv).  Flash
chromatography on SiO2 with 5% Et2O in pentane as eluent provided 10.2 mg of product
with 89% ee.  1H NMR integration indicates 35% deuterium incorporation at the 2-
position of 2-methyl-1-tetralone (observed at δ 2.06 ppm). 2H NMR detected deuterium
incorporation at only one site.  2H NMR (77 MHz, C6H6) δ 2.05.
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Deuterium Labeling Experiment 2:
(±)-293 (S)-97
O
O
O Pd(OAc)2 (10 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
DCO2H (6.0 equiv)
4ÅMS (180 mg)
p-dioxane, 40 °C
O
H(D)
<1% D incorporation
Reaction performed using DCO2H (22.6 µL, 0.60 mmol, 6.0 equiv). Flash
chromatography on SiO2 with 5% Et2O in pentane as eluent provided 13.1 mg of product
with 91% ee.  1H NMR integration indicates <1% deuterium incorporation at the 2-
position of 2-methyl-1-tetralone.  2H NMR detected no deuterium in the product material.
Deuterium Labeling Experiment 3 (Control):
(±)-293 (S)-97
O
O
O Pd(OAc)2 (10 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
HCO2H (6.0 equiv)
4ÅMS (180 mg)
p-dioxane, 40 °C
O
H(D)
<1% D incorporation
Reaction performed using HCO2H (22.6 µL, 0.60 mmol, 6.0 equiv). Flash
chromatography on SiO2 with 5% Et2O in pentane as eluent provided 12.9 mg of product
(81% yield) with 93% ee. 1H NMR integration indicates <1% deuterium incorporation at
the 2-position of 2-methyl-1-tetralone.  2H NMR detected no deuterium in the product
material.
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7.6.3 EXPERIMENTAL DATA RELEVANT TO THE MELDRUM’S ACID
PROTOCOL
7.6.3.1 SCREENING OF ALTERNATE PROTON DONORS
3-(Methylsulfonyl)pentane-2,4-dione (Table 7.8, entry 6) was prepared according to
the literature method.35  Meldrum’s acid derivatives in entries 436, 837, 12, and 1338 (Table
7.9) were prepared by literature methods.
Sample Procedure for Screening of the Achiral Proton Donors (Table 7.8)
(±)-293 97
O
CO2allyl
Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
p-dioxane, 40 °C
proton donor (2.5 equiv)
O
A 10 mL Schlenk tube equipped with a magnetic stir bar and a teflon stopcock was
flame dried under vacuum (3x, backfill with dry argon).  After cooling to ambient
temperature under dry argon, Pd2(dba)3 (4.5 mg, 0.005 mmol, 0.05 equiv, 5 mol%), (S)-t-
Bu-PHOX (55, 4.6 mg, 0.0125 mmol, 0.125 equiv, 12.5 mol%), and freshly distilled p-
dioxane (1 mL) were added, and the resulting mixture was stirred vigorously at 40 ºC for
30 min.  A p-dioxane solution (2 mL) of allyl β-ketoester 293 (24.4 mg, 0.1 mmol, 1.0
equiv) and achiral proton donor (0.25 mmol, 2.5 equiv) was added to the reaction mixture
at 40 °C.  When the reaction was complete by TLC, the reaction mixture was filtered
through a pad of SiO2 and the filtrate was concentrated under reduced pressure.  The
residue was purified by flash chromatography on SiO2 using 5% Et2O in petroleum ether
as the eluent.  The ee of the product 97 was determined by chiral HPLC using a Chiracel
OD-H column with 1% 2-propanol in hexanes as the eluent.
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Sample Procedure for Screening of Meldrum’s Acid Derivatives (Table 7.9):
(±)-293 97
O
CO2allyl
Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
p-dioxane, 23 °C
AH (2.5 equiv)
O
A 1 dram glass vial equipped with a magnetic stir bar, a screw cap, and a septum was
flame dried under vacuum (3x, backfill with dry argon).  After cooling to ambient
temperature under dry argon, Pd2(dba)3 (4.5 mg, 0.005 mmol, 0.05 equiv, 5 mol%), (S)-t-
Bu-PHOX (55, 4.6 mg, 0.0125 mmol, 0.125 equiv, 12.5 mol%), and freshly distilled p-
dioxane (1 mL) were added, and the resulting mixture was stirred vigorously at 40 ºC for
30 min.  A p-dioxane solution (2 mL) of allyl β-ketoester 239 (24.4 mg, 0.1 mmol, 1.0
equiv) and Meldrum’s acid derivative (AH) (0.25 mmol, 2.5 equiv) was added to the
reaction mixture at 23 °C.  When the reaction was complete by TLC, the reaction mixture
was filtered through a pad of SiO2 and the filtrate was concentrated under reduced
pressure.  The residue was purified by flash chromatography on SiO2 using 5% Et2O in
petroleum ether as the eluent.  The ee of the product 97 was determined by chiral HPLC
using a Chiracel OD-H column with 1% 2-propanol in hexanes as the eluent.
Sample Procedure for Ligand Optimization Reactions (Table 7.12)
O O
O
Pd2(dba)3 (5 mol%)
chiral ligand (12.5 mol%)
p-dioxane, 23 °C
O
(±)-293 97O O
O O
2.5 equiv
33
A 1 dram glass vial equipped with a magnetic stir bar, a screw cap, and a septum was
flame dried under vacuum (3x, backfill with dry argon).  After cooling to ambient
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temperature under dry argon, Pd2(dba)3 (4.5 mg, 0.005 mmol, 0.05 equiv, 5 mol%), chiral
ligand (0.0125 mmol, 0.125 equiv, 12.5 mol%), and freshly distilled p-dioxane (1 mL)
were added, and the resulting mixture was stirred vigorously at 40 ºC for 30 min.  A p-
dioxane solution (2 mL) of β-ketoester 239 (24.4 mg, 0.1 mmol, 1.0 equiv) and
Meldrum’s acid (33, 36 mg, 0.25 mmol, 2.5 equiv) was added to the reaction mixture at
23 °C.  When the reaction was complete by TLC, the reaction mixture was filtered
through a pad of SiO2 and the filtrate was concentrated under reduced pressure.  The
residue was purified by flash chromatography on SiO2 using 5% Et2O in petroleum ether
as the eluent.  The ee of the product was determined by chiral HPLC using a Chiracel
OD-H column with 1% 2-propanol in hexanes as the eluent.
Table 7.12.  Optimization of chiral ligand (Meldrum’s acid conditions)a
Ph2P N
O
Ph2P N
O
Ph
90
–77
ee (%)b of 97chiral ligand chiral ligand
Ph2P N
O
–82
Ph2P N
O
67
Ph2P N
O
OTBS
–79
P N
O
CF3
F3C
80
2
entry entry
1
2
3
4
5
6
55
121
132
133
187
141
ee (%)b of 97
aReactions performed with 0.1 mmol of (±)-293 at 0.033 M in solvent. bMeasured by chiral HPLC.
770 Chapter 7 – Catalytic Enantioselective Decarboxylative Protonation
7.6.3.2 ENANTIOCONVERGENT DECARBOXYLATIVE PROTONATION
USING MELDRUM’S ACID AS THE PROTON SOURCE
Characterization Data for Substrate Compounds
O O
O
242
Ketoester 242 was prepared using the Dieckmann Cyclization method from our
previous work.18
CO2allyl
O
631
631, Table 7.10, Entry 2: Prepared from 242 by general alkylation method (EtI,
K2CO3, acetone, reflux).18  Purified by flash chromatography (SiO2, 2.5 →  5% Et2O in
hexane).  36% yield.  Rf = 0.24 (10% Et2O in hexane); 
1H NMR (300 MHz, CDCl3) δ 5.88
(dddd, J = 17.4, 10.8, 6.0, 6.0 Hz, 1H), 5.31 (dddd, J = 17.4, 3.0, 1.8, 1.8 Hz, 1H), 5.23
(dddd, J = 10.2, 2.4, 0.9, 0.9 Hz, 1H), 4.62 (app. ddd, J = 6.0, 1.5, 1.5 Hz, 1H), 4.62 (app.
ddd, J = 6.0, 1.5, 1.5 Hz, 1H), 2.55-2.37 (comp. m, 3H), 1.96 (app. q, J = 7.5 Hz, 1H),
1.92 (app. q, J = 7.8 Hz, 1H), 1.80-1.54 (comp. m, 4H), 1.48-1.36 (m, 1H), 0.84 (app. t, J
= 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.9, 171.6, 131.5, 118.9, 65.6, 61.2, 41.1,
35.5, 27.6, 22.5, 8.7; IR (Neat Film NaCl) 3087, 2943, 2867, 1714, 1649, 1452, 1439,
1234, 1203, 1153, 1100, 992, 974, 934 cm–1; HRMS (EI+) m/z calc'd for C12H18O3 [M]+:
210.1256, found 210.1258.
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O
CO2allyl
682
682, Table 7.10, Entry 4:  Prepared from 242 by general alkylation method (3-
chloro-2-methyl propene, K2CO3, acetone, reflux).2  Purified by flash chromatography
(SiO2, 5 → 10% Et2O in pentane).  67% yield.  Rf = 0.25 (10% Et2O in pentane); 1H NMR
(300 MHz, CDCl3) δ 5.89 (dddd, J = 17.1, 10.2, 5.7, 5.7 Hz, 1H), 5.32 (dddd, J = 17.1,
3.0, 1.5, 1.5 Hz, 1H), 5.25 (dddd, J = 10.5, 2.7, 1.2, 1.2 Hz, 1H), 4.82 (app. dd, J = 1.8,
1.2 Hz, 1H), 4.66 (app. t, J = 0.8 Hz, 1H), 4.64-4.51 (comp. m, 2H), 2.75 (d, J = 14.0 Hz,
1H), 2.36 (d, J = 14.0 Hz, 1H), 2.62-2.29 (comp. m, 4H), 2.09-1.95 (m, 1H), 1.84-1.72
(m, 2H), 1.66 (s, 3H), 1.52-1.39 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 207.3, 171.4,
141.4, 131.6, 119.3, 115.6, 66.0, 61.0, 42.4, 41.3, 36.2, 27.8, 24.0, 22.7; IR (Neat Film
NaCl) 2946, 1716, 1646, 1452, 1377, 1186, 1086, 989, 898 cm–1; HRMS (EI+) m/z calc'd
for C14H20O3 [M]+: 236.1412, found 236.1401.
O
O
O
OH
305 258
O
O
O
OTBDPS
258, Table 7.10, entry 5):  To a solution of 305 (see Chapter 3) (1.20 g, 5.71 mmol.
1.0 equiv), imidazole (583 mg, 8.57 mmol, 1.5 equiv), and DMAP (1.04 g, 8.57 mmol,
1.5 equiv) in DMF (20 mL) was added TBDPS-Cl (1.75 mL, 6.85 mmol, 1.2 equiv).
After 24 h at ambient temperature, the reaction mixture was poured into water (75 mL)
and 2:1 CH2Cl2:hexanes (150 mL), extracted with 2:1 CH2Cl2:hexanes (4 x 30 mL), dried
(Na2SO4), and evaporated.  Flash chromatography (SiO2, 2.5→12% EtOAc in hexanes)
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gave the desired compound (1.85 g, 72% yield).  mp 59-60 °C; Rf = 0.24 (10% Et2O in
pentane); 1H NMR (300 MHz, CDCl3) δ 7.72-7.68 (m, 4H), 7.48-7.37 (m, 6H), 6.00-5.86
(m, 1H), 5.38-5.31 (m, 1H), 5.28-5.23 (m, 1H), 4.74-4.59 (m, 2H), 4.24 (d, J = 9.9 Hz,
1H), 3.82 (d, J = 9.9 Hz, 1H), 2.78 (dq, J = 13.4, 3.3 Hz, 1H), 2.53-2.38 (m, 2H), 2.10-
1.99 (m, 1H), 1.88-1.54 (m, 4H) 1.07 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 206.4, 169.8,
135.6, 135.5, 133.1, 132.9, 131.5, 129.6, 127.6 (2C), 118.8, 66.4, 65.8, 62.9, 41.2, 33.6,
27.3, 26.6, 22.1, 19.2; IR (Neat Film NaCl) 3072, 2933, 2858, 1715, 1428, 1200, 1112,
703 cm–1; HRMS (EI) m/z calc'd for C27H33O4Si [M – H]+: 449.2148, found 449.2165.
General Procedure for the Enantioconvergent Protonation (Table 7.10)
O
CO2allyl
R
R
O
R
R
Pd2(dba)3 (5 mol%)
(S)-t-Bu-PHOX (12.5 mol%)
p-dioxane, 22 °C
O O
O O
(2.5 equiv)
33
A 25 mL round-bottom flask equipped with a magnetic stir bar, and a septum was
flame dried under vacuum (3x, backfill with dry argon).  After cooling to ambient
temperature under dry argon, Pd2(dba)3 (13.7 mg, 0.015 mmol, 0.05 equiv, 5 mol%), (S)-
t-Bu-PHOX (55, 14.5 mg, 0.0375 mmol, 0.125 equiv, 12.5 mol%), and freshly distilled p-
dioxane (4.5 mL) were added, and the resulting mixture was stirred vigorously at 40 ºC
for 30 min.  A p-dioxane solution (4.5 mL) of β-ketoester (0.30 mmol, 1.0 equiv) and
Meldrum’s acid (33, 108.1 mg, 0.75 mmol, 2.5 equiv) was added to the reaction mixture
at 22 °C.  When the reaction was complete by TLC, the reaction mixture was filtered
through a pad of SiO2 and the filtrate was concentrated under reduced pressure.
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Data for product compounds
Products were prepared using the above procedure, unless specifically stated
otherwise.
O
207
(R)-(–)-2-Methylcyclohexanone (Table 7.10, Entry 1):21 Yield determined by GC
using tridecane (30.0 µL) as an internal standard.  99% GC yield.  Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether). 86% ee. [α]D20.8 –9.0 (c 0.50,
MeOH, 86% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (S)-(+)-2-methylcyclohexanone: [α]D +12.2 (c 4, MeOH, 87%
ee).30
O
221
(R)-(–)-2-Ethylcyclohexanone (Table 7.10, Entry 2):21 Yield determined by GC
using tridecane (30.0 µL) as an internal standard.  99% GC yield.  Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether). 89% ee. [α]D23.7 –22.4 (c 0.30,
MeOH, 88% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(–)-2-ethylcyclohexanone: [α]D25 –23.6 (c 4.31, MeOH).30
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O
639
(S)-(–)-2-Benzylcyclohexanone (639, Table 7.10, Entry 3):21 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  90% yield, 78% ee.  [α]D23.6 –37.6
(c 1.36, MeOH, 78% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(+)-2-benzylcyclohexanone: [α]D +41.4 (c 5, MeOH, 88%
ee),30 and has been correlated to (1S,2S)-(+)-2-benzylcyclohexanol to confirm assignment
(see section 0 above).
O
674
(–)-2-(2-Methylallyl)cyclohexanone (674, Table 7.10, Entry 4):39 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  87% yield, 89% ee.  [α]D21.2 –31.1
(c 0.25, CH2Cl2, 82% ee).
O
OTBDPS
675
(–)-2-((tert-butyldiphenylsilyloxy)methyl)cyclohexanone (675, Table 7.10, Entry
5):40 Purified by flash chromatography (SiO2, 5% Et2O in petroleum ether).  97% yield,
80% ee. mp 67–69 °C. Rf = 0.23 (10% Et2O in petroleum ether); 1H NMR (300 MHz,
CDCl3) δ 7.71-7.63 (comp. m, 4H), 7.46-7.34 (comp. m, 6H), 4.01 (dd, J = 10.4, 4.8 Hz,
1H), 3.67 (dd, J = 10.4, 7.8 Hz, 1H), 2.62-2.48 (m, 1H), 2.43-2.21 (comp. m, 3H), 2.12-
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1.97 (m, 1H), 1.96-1.82 (m, 1H), 1.75-1.61 (m, 2H), 1.53-1.40 (m, 1H), 1.05 (s, 9H); 13C
NMR (75 MHz, CDCl3) δ 212.2, 135.8 (2C), 133.9, 133.8, 129.8, 127.8, 63.2, 53.0, 42.3,
31.1, 27.8, 27.1, 24.8, 19.5; IR (Neat Film NaCl) 2932, 2858, 1709, 1472, 1428, 1390,
1113, 1054, 823, 740, 702 cm–1; HRMS (EI+) m/z calc'd for C23H30SiO2 [M]+: 366.2015,
found 366.2001. [α]D23.8 –15.2 (c 1.05, CH2Cl2, 80% ee).
O
97
(S)-(–)-2-Methyl-1-tetralone (97, Table 7.10, Entry 6):21 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  86% yield, 77% ee.  [α]D23.6 –38.4
(c 0.54, p-dioxane, 77% ee).
The absolute configuration was determined by comparison of the observed optical
rotation to a literature value for (S)-2-methyl-1-tetralone: [α]D22 –51.2 (c 2.5, p-dioxane).22
O
641
(R)-(–)-2-Allyl-1-tetralone (641, Table 7.10, Entry 7):23 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  83% yield, 77% ee.  [α]D23.6 –24.1
(c 1.02, MeOH, 77% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-(–)-2-allyl-1-tetralone: [α]D23 –29.7 (c 1.21, MeOH, 97% ee).23
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O
649
(–)-2,5,7-Trimethyl-1-tetralone (649, Table 7.10, Entry 8):28 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  77% yield, 77% ee.  [α]D23.7 –23.2
(c 1.05, CH2Cl2, 77% ee).
O
638
(S)-(+)-2-Methyl-1-indanone (638, Table 7.10, Entry 9):21 Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).  79% yield, 61% ee.  [α]D23.6 +21.2
(c 0.23, p-dioxane, 61% ee).
The absolute configuration was established by comparison of the optical rotation to
the literature value for (R)-2-methyl-1-indanone: [α]D22 –42 (c 1.72, p-dioxane).22
O O
O O
676
5,5-Diallyl-2,2-dimethyl-1,3-dioxane-4,6-dione36 (Figure 7.1): Purified by flash
chromatography (SiO2, 5% Et2O in petroleum ether).
Chapter 7 – Catalytic Enantioselective Decarboxylative Protonation 777
Table 7.13.  Methods for the determination of enantiomeric excess (Meldrum’s acid conditions)
Entry Product
retention time
of major
isomer (min)
% ee
retention time
of minor
isomer (min)
Assay
Conditions
1
O
8619.406 18.306
GC
G-TA
70 ° isotherm
2
O
8936.643 34.987
GC
G-TA
70 ° isotherm
3
O
7811.637 9.885
HPLC
Chiralpak AD
1% EtOH in hexane
isocratic, 1.0 mL/min
4
O
8917.133 18.672
GC
G-TA
100 ° isotherm
5
O
805.553 6.217
HPLC
Chiralpak AD
1% i-PrOH in hexane
isocratic, 1.0 mL/min
OTBDPS
77
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
8.723 8.0756
O
7
O
7724.007 20.561
HPLC
Chiracel OD-H
0.1% i-PrOH in heptane
isocratic, 1.0 mL/min
8
O
777.283 7.787
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
61
HPLC
Chiracel OD-H
1% i-PrOH in hexane
isocratic, 1.0 mL/min
10.239 9.4469
O
207
221
639
674
675
97
641
649
638
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7.6.4 KINETIC STUDIES FOR THE ENANTIOCONVERGENT
PROTONATION WITH MELDRUM’S ACID
Determination of Substrate Order (Figure 7.2)
O
CO2allyl
Pd2(dba)3 (5 mol%)
(S)-t-BuPHOX (12.5 mol%)
C6D6 (0.1 M), 23 °C
 1,4-dimethoxybenzene (0.35 equiv)
0.05 mmol scale
O
(±)-293 97
O O
O O
(2.5 equiv)33
Solid Pd2(dba)3 (2.3 mg, 0.0025 mmol, 0.05 equiv, 5 mol%) and (S)-t-Bu-PHOX (55,
2.4 mg, 0.00625 mmol, 0.125 equiv, 12.5 mol%) were placed in a NMR tube equipped
with a screw cap and a Teflon septum.  The NMR tube was then placed under vacuum
and backfilled with argon (3x).  C6D6 (0.2 mL, dried over sodium benzophenone ketyl)
was added to the NMR tube via syringe under a positive pressure of argon.  The mixture
was heated at 40 °C for 30 min.  A C6D6 solution (0.3 mL total) of allyl β-ketoester 293
(0.05 mmol, 1.0 equiv), 1,4-dimethoxybenzene (2.4 mg, 0.0175 mmol, 0.35 equiv), and
Meldrum’s acid (33, 18 mg, 0.125 mmol, 2.5 equiv) was added to the reaction mixture at
23 °C under argon. Reaction progress was monitored by 1H NMR spectroscopy at 23 ºC,
where integral areas of the allylic protons of 2 (δ 4.30 ppm, m, 2H) relative to the phenyl
protons of the 1,4-dimethoxybenzene internal standard (δ 3.34 ppm, s, 6H) were obtained
at 2 minute intervals.  The experiment was concluded upon complete conversion of 293,
which was determined by the disappearance of the allylic protons of 293.
Analysis of consumption of 293 over time is consistent with a zero-order dependence
in allyl β-ketoester (Figure 7.2).
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M.; Shimizu, I,; Minami, I. Synthesis 1984, 12, 1009.
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Figure A3.3  13C NMR of compound 329 (75 MHz, CDCl3)
Figure A3.2  IR of compound 329 (NaCl/film)
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Figure A3.5  IR of compound 241 (NaCl/film)
Figure A3.6  13C NMR of compound 241 (75 MHz, CDCl3)
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Figure A3.8  IR of compound 293 (NaCl/film)
Figure A3.9  13C NMR of compound 293 (75 MHz, CDCl3)
Appendix 3 – Spectra of Compounds Relevant to Chapter 7 789
Fi
gu
re
 A
3.
10
  
H
 N
M
R
 o
f c
om
po
un
d 
98
 (
30
0 
M
H
z,
 C
D
C
l 3
)
O 98
790 Appendix 3 – Spectra of Compounds Relevant to Chapter 7
Figure A3.11  IR of compound 98 (NaCl/film)
Figure A3.12  13C NMR of compound 98 (75 MHz, CDCl3)
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Figure A3.15  13C NMR of compound 640 (75 MHz, CDCl3)
Figure A3.14  IR of compound 640 (NaCl/film)
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Figure A3.18  13C NMR of compound 498 (75 MHz, CDCl3)
Figure A3.17  IR of compound 498 (NaCl/film)
Appendix 3 – Spectra of Compounds Relevant to Chapter 7 795
Fi
gu
re
 A
3.
19
   
H
 N
M
R
 o
f c
om
po
un
d 
62
9 
(3
00
 M
H
z,
 C
D
C
l 3)
O
O
O
O 62
9
796 Appendix 3 – Spectra of Compounds Relevant to Chapter 7
Figure A3.21  13C NMR of compound 629 (75 MHz, CDCl3)
Figure A3.20  IR of compound 629 (NaCl/film)
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Figure A3.24  13C NMR of compound 643 (75 MHz, CDCl3)
Figure A3.23  IR of compound 643 (NaCl/film)
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Figure A3.27  13C NMR of compound 644 (75 MHz, CDCl3)
Figure A3.26  IR of compound 644 (NaCl/film)
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Figure A3.30  13C NMR of compound 646 (75 MHz, CDCl3)
Figure A3.29  IR of compound 646 (NaCl/film)
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Figure A3.33  13C NMR of compound 648 (75 MHz, CDCl3)
Figure A3.32  IR of compound 648 (NaCl/film)
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Figure A3.36  13C NMR of compound 650 (75 MHz, CDCl3)
Figure A3.35  IR of compound 650 (NaCl/film)
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Figure A3.38  IR of compound 107 (NaCl/film)
Figure A3.39  13C NMR of compound 107 (75 MHz, CDCl3)
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Figure A3.42  13C NMR of compound 318 (75 MHz, CDCl3)
Figure A3.41  IR of compound 318 (NaCl/film)
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Figure A3.48  IR of compound 258 (NaCl/film)
Figure A3.49  13C NMR of compound 258 (75 MHz, CDCl3)
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CHAPTER 8
Catalytic Enantioselective Stereoablative Reactions†
8.1 INTRODUCTION
Since the inception of enantioselective catalytic methodology, the prevailing strategic
approach has relied on inducing chirality into a prochiral atom by the generation of new
asymmetric centers or axes (Scheme 8.1).  Although this tactic has proven extremely
effective, the number of viable prochiral functional groups is relatively limited.  An
alternative approach to the production of enantioenriched materials is to begin with a
racemic mixture and subsequently eliminate the intrinsic stereochemistry from a portion
or all of this mixture.  The scope of this approach to enantioselective catalysis is as wide
as the number of chiral molecules in existence.  Although inherently a complexity
minimizing process, this approach has proven to be valuable in the synthesis of chiral
building blocks and more complex synthetic targets.
                                                 
† This review was written in collaboration with David C. Ebner and a similar version has been published.
See: Mohr, J. T.; Ebner, D. C.; Stoltz, B. M. Org. Biomol. Chem. 2007, 5, 3571–3576.
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Scheme 8.1. Strategies for enantioselective catalysis
A
(achiral)
(–)-B
(enantioenriched)
enantioselective
catalyst
(±)-A
(racemic)
(–)-A
(enantioenriched)
enantioselective
catalyst
stereoablation
(±)-A
(racemic)
B
(achiral)
catalyst
stereoablation
B
(achiral)
enantioselective
catalyst (–)-C
(enantioenriched)
a)
b)
c)
In 2005, the term “stereoablation” was defined in the context of an enantioconvergent
reaction.1  Our initial definition was “the conversion of a chiral molecule to an achiral
molecule,” based on the Oxford English Dictionary definition for ablation: “the action or
process of carrying away or removing; removal.”2  Upon further consideration of the
importance of such methods in enantioselective chemical transformations, we have seen
fit to expand the scope of this definition to include reactions where an existing
stereocenter in a molecule is destroyed, but the intermediate molecule need not be wholly
achiral.3  This revised definition thereby includes many other important advances.  To
date, few stereoablative strategies have been exploited for enantioselective catalysis,
although notable exceptions include metal π-allyl alkylations4 and many dynamic kinetic
resolutions.5  In this chapter, recent examples of novel approaches to asymmetric
catalytic methods for stereoablation will be discussed.  These chemistries will
demonstrate that this is an important, though underutilized, method of asymmetric
synthesis.6
When considering catalytic enantioselective stereoablative reactions, two possible
regimes arise: one in which the stereoablative step is the enantioselective step (Scheme
8.1b), and one in which stereoablation precedes the enantioselective step (Scheme 8.1c).
In the first case, a catalyst must selectively react with one enantiomer or enantiotopic
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group of the substrate to provide enantioenrichment.  In the second case, a nonselective
stereoablation is required before the enantioselective step.
8.2 EXAMPLES OF STEREOABLATIVE ENANTIOSELECTIVE REACTIONS
8.2.1 KINETIC RESOLUTIONS
8.2.1.1 OXIDATION OF RACEMIC ALCOHOLS
Kinetic resolution is of the former type, selectively transforming one enantiomer of a
racemic mixture to product (cf. Scheme 8.1b).  In addition to making enantiomer
isolation a trivial process, stereoablative approaches often have the added capability of
converting the achiral product back into a racemic starting material mixture by a
relatively straightforward procedure.  Recycling this material minimizes the waste
common to many kinetic resolutions due to discard of the undesired enantiomer.
Recently, the Stoltz laboratory has reported an oxidative kinetic resolution (OKR) of
secondary alcohols (Scheme 8.2).7,8,9,10  Utilizing molecular oxygen as the terminal
oxidant, [Pd(nbd)Cl2] and (–)-sparteine (685) catalyze the oxidation of alcohol (±)-683 to
achiral ketone 684, leaving unreacted alcohol (–)-683 of high ee.  Selective stereoablation
by β-hydride elimination of a Pd-alkoxide to form product ketone has been shown to be
enantiodetermining by extensive mechanistic7d,8 and computational7f studies.  To date, a
wide variety of secondary alcohols have been successfully resolved with this catalyst
system.
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Scheme 8.2.  Stoltz’ oxidative kinetic resolution of secondary alcohols
OH
[Pd(nbd)Cl2] (5 mol%)
(–)-sparteine (12 mol%)
O2 (1 atm), CHCl3
Cs2CO3 (0.4 equiv)
3ÅMS, 23 °C
48 h, 60% conv.
OH O
(±)-683 (–)-683
99% ee
684
s = 31
(–)-sparteine (685)
NN
Additionally, ketone 687, obtained in the resolution of alcohol (±)-686, can be
recycled by reduction to racemic (±)-686 in quantitative yield, allowing greater than 50%
overall yield of the enantioenriched alcohol after a second resolution (Scheme 8.3).
Scheme 8.3.  Stoltz’ stereoablative kinetic resolution with recycle
OH O[Pd(nbd)Cl2] (5 mol%)
(–)-sparteine (20 mol%)
O2 (1 atm), 3ÅMS
PhMe, 80 °C
OH
(±)-686 (–)-686687
NaBH4, MeOH (99% yield)
1st cycle: 5.0 g
2nd cycle: 2.7 g
1st: 2.7 g
2nd: 1.4 g
1st: 2.2 g, 99% ee
2nd: 1.2 g, 99% ee
total: 3.4 g, 99% ee
68% total yield
55% conversion
55% conversion
s = 47
When other stereocenters are present in the alcohol, enantioenriched ketones can be
obtained.  In the Stoltz synthesis of (+)-amurensinine (690), racemic alcohol (±)-688 was
resolved successfully using the [(sparteine)PdCl2] catalyst system (Scheme 8.4).11  I n
addition to highly enantioenriched alcohol (–)-688, diketone (–)-689a was obtained in
79% ee.  This diketone presumably arises from overoxidation of the initial ketone product
((+)-689b, R = H2) in the presence of O2.  In fact, the monoketone (+)-689b could be
isolated with 77% ee at shorter reaction times, albeit with lower ee of alcohol (–)-688.
Importantly, the products (–)-689a and (+)-689b have the opposite configuration at C5,
potentially providing access to (–)-amurensinine (690).  In general, OKR of alcohols with
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multiple stereocenters can provide enantioenriched product ketones as well as alcohols,
opening the door to enantiodivergent synthetic strategies.12
Scheme 8.4.  OKR in the Stoltz synthesis of (+)-amurensinine
O
O
5
OTIPS
HO
(±)-688
[(sparteine)PdCl2] (20 mol%)
(–)-sparteine (20 mol%)
O2 (1 atm), Cs2CO3
2-methyl-2-butene
CHCl3, 3ÅMS
O
O
OTIPS
HO
(–)-688
O
O
5
OMe
OMe
OMe
OMe
OMe
OMe
N Me
(+)-Amurensinine (690)
7 steps
(–)-688
O
O 11
5
OTIPS
O
(–)-689a, R = O
OMe
OMe
47% yield
>99% ee
s > 47
46% yield
79% ee
R
8.2.1.2 OXIDATION OF SULFOXIDES AND SULFIDES
Oxidative resolution of sulfoxides has also been demonstrated.  Unlike alcohol
oxidation, in which C–H bond cleavage is stereoablative, in sulfoxide oxidation S–O
bond formation leads to stereoablation.  Of particular note is an example by Jackson and
co-workers.  It was found that a racemic mixture of sulfoxides was effectively resolved
with a vanadium catalyst and diiodide ligand (R)-692 (Scheme 8.5).13  The high
selectivity in sulfoxide oxidative kinetic resolution led them to investigate a tandem
enantioselective sulfide oxidation followed by sulfoxide resolution.  Treatment of sulfide
694 with their oxidative conditions provided sulfoxide (R)-691 in 70% yield and >99.5%
ee, along with achiral sulfone 693.  The combined effect of the two processes allows the
synthesis of highly enantioenriched sulfoxides with higher yields than a typical kinetic
Chapter 8 – Catalytic Enantioselective Stereoablative Reactions 833
resolution.  Additionally, coupling two enantioselective reactions has the potential to
bring poorly selective methods into the synthetically useful range because of the
enhanced yield and product enantiopurity relative to the individual steps.
Scheme 8.5.  Jackson’s oxidation of sulfoxides and sulfides
+[VO(acac)2] (1 mol%)
H2O2 (1.2 equiv)
CHCl3, 0 °C
S
O
S
O
S
OO
+
(R)-692 (1.5 mol%)
[VO(acac)2] (1 mol%)
H2O2 (1.2 equiv)
CHCl3, 0 °C
S S
O
S
OO
(±)-691 693(R)-691
41% yield
98% ee
694 (R)-691
70% yield
>99.5% ee
693
I
I
HO
N
t-Bu
OH
(R)-692
(1.5 mol%)
s = 28
8.2.1.3 HYDROGENATION OF ALKENES
An unusual example of stereoablative kinetic resolution has been reported by Noyori
and co-workers.14  Hydrogenation of allylic alcohols with chiral catalyst [((S) -
BINAP)Ru(OAc)2] results in kinetic resolution by symmetrizing one enantiomer of
substrate (Scheme 8.6).  This reductive kinetic resolution (RKR) is capable of resolving
racemic alcohols such as (±)-441 with exceptionally high selectivity factors, providing
achiral alcohol 695 as the by-product.  Although (R)-441 is obtained in high ee, there is
currently no simple, direct method for recycling 695 back to (±)-441.  Nonetheless, this
RKR process provides a complementary method to the previously described OKR, using
a reductive gas instead of an oxidative gas.
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Scheme 8.6.  Noyori’s reductive kinetic resolution
OH
(±)-441
OH OH
695(R)-441
48% yield
96% ee
[((S)-BINAP)Ru(OAc)2]
(0.3 mol%)
H2 (1 atm)
MeOH, 30 °C
s = 62
8.2.2 DESYMMETRIZATIONS
In addition to by-product recycling, greater than 50% yield in a stereoablative process
can be achieved by performing a desymmetrization.  Such reactions utilize substrates that
contain two enantiotopic functional groups, one of which selectively reacts with a chiral
catalyst.  Stoltz and Ferreira have reported a desymmetrization of meso diol 696 using
their Pd-catalyzed oxidation conditions to obtain ketoalcohol (+)-697 in 72% yield with
95% ee (Scheme 8.7).7a  A similar desymmetrization strategy has been employed in the
synthesis of lobeline.7i
Scheme 8.7.  Stoltz’ desymmetrization of meso diol 696
[Pd(nbd)Cl2] (5 mol%)
(–)-sparteine (20 mol%)
O2 (1 atm), 3ÅMS
PhMe, 80 °C
(+)-697
72% yield
95% ee
OH
OH
696
O
OH
Catalytic enantioselective processes have also been employed in the
desymmetrization of epoxides.  Andersson and Södergren have reported the use of chiral
diamine 699 in the rearrangement of epoxides to allylic alcohols.15  Treatment of
cyclohexene oxide (698) with 5 mol% 699 in the presence of LDA as the stoichiometric
base provided (R)-2-cyclohexenol (441) in 96% ee (Scheme 8.8).  Selective removal of
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one of the enantiotopic protons in the starting material accompanies destruction of one of
the stereocenters of the epoxide in the elimination step.  Although there have been several
other examples of catalytic asymmetric epoxide desymmetrization, this system has the
largest reported substrate scope, with five allylic alcohols formed with good to excellent
ee.
Scheme 8.8.  Andersson’s epoxide desymmetrization
OH
O
NH
N699 
(5 mol%)
LDA (2 equiv)
THF/DBU (95:5)
0 °C, 24 h
91% yield
96% ee
(R)-441698
8.2.3 ENANTIOCONVERGENT REACTIONS
A second type of stereoablative enantioselective catalysis consists of stereoablation
followed by enantioselective bond formation.  In these enantioconvergent processes, both
enantiomers of a racemic mixture are converted to an achiral intermediate, which is
converted subsequently to an enantioenriched product in a separate process (Scheme
8.1c).  It is critical to avoid kinetic resolution in the stereoablative step in order to ensure
good yield in a reasonable time.
8.2.3.1 DYNAMIC KINETIC RESOLUTION
A prominent type of enantioconvergent catalysis is dynamic kinetic resolution (DKR)
of racemic alcohols.  A particularly elegant system was developed by Bäckvall and co-
workers, wherein an achiral metal catalyst (700) capable of rapid stereomutation via the
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corresponding ketone was coupled with selective acylating enzyme CALB (Scheme
8.9).16  The rates of these two simultaneous reactions are critical to the success of the
process.  The rate of stereomutation must be considerably greater than the rate of
acylation in order to maintain an optimal 1:1 mixture of alcohol enantiomers for the
enzymatic resolution.  Although kinetic resolution by acylation is a common approach to
obtaining enantioenriched alcohols, the pairing of the stereoablative Ru catalyst and the
acylation enzyme increases the overall efficiency of the reaction, as it allows yields
greater than 50%.  However, systems such as this are rare because the two concurrent
catalytic reactions must tolerate one another.
Scheme 8.9.  Bäckvall’s dynamic kinetic resolution of alcohols
RuOC
OC
Cl
Ph
Ph
Ph
Ph
Ph
OH
OH
CALB
isopropenyl acetate
KOt-Bu (5 mol%)
Na2CO3, PhMe
700
(5 mol%)
O
O
O
(R)-701
92% yield
>99% ee
O
stereomutation
via ketone
kinetic resolution(R)-683
(S)-701(S)-683
8.2.3.2 DERACEMIZATION
To avoid catalyst incompatibility, it is desirable to identify a single catalyst system
capable of both the stereoablative step and enantioselective bond-forming step.  In the
realm of alcohol oxidation, Williams and Adair recently reported a deracemization of
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secondary alcohols utilizing a bifunctional Ru catalyst (Scheme 8.10).17  This system uses
a single catalyst to perform a nonselective stereoablative oxidation followed by an
enantioselective reduction.  Exposure of racemic alcohol mixture (±)-702 to a catalyst
formed in situ from [RuCl2(benzene)]2, phosphine 704, and (R,R)-DPEN (705) with
cyclohexanone as a hydrogen acceptor produces achiral ketone 703.  Pressurization of the
reaction with H2 promotes enantioselective hydrogenation to the enantioenriched alcohol
(S)-702.  Although the demonstrated substrate scope of this reaction is still limited, the
system overcomes the shortcoming of low yields of kinetic resolution processes,
providing benzylic alcohols in 82–97% yield.  The unique ability of the Ru catalyst to
operate via two distinct mechanisms is critical to the success of this method.  According
to the principle of microscopic reversibility, the nonselective transfer dehydrogenation
must also be nonselective in the reverse reaction, and therefore cannot complete the
deracemization.  However, introduction of an atmosphere of H2 opens a different, highly
selective mechanistic pathway leading to alcohols of high ee.
Scheme 8.10.  Williams’ deracemization of benzylic alcohols
MeO
C5H11
OH
[RuCl2(benzene)]2 (1 mol%)
(R)-704 (2 mol%), (R,R)-705 (2 mol%)
cyclohexanone (2.4 equiv)
110 °C, 1 h
then (±)-702
cyclohexanone (0.6 equiv)
t-BuOK (8 mol%), THF
60 °C, 24 h
MeO
C5H11
OH
(±)-702
(S)-702
94% yield
99% ee
H2 (10 bar)
20 °C, 16 h
MeO
C5H11
O
703
H2N
Ph
Ph
H2N
(R,R)-DPEN (705)
PAr2
PAr2
(R)-xylyl-BINAP (704)
Ar = 3,5-xylyl
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8.2.3.3 DESTRUCTION/CONSTRUCTION SEQUENCES
Recently, Stoltz and co-workers established that racemic mixtures of allyl β-
ketoesters are efficiently converted to enantioenriched α-quaternary cycloalkanones in an
enantioconvergent process mediated by Pd and phosphinooxazoline (PHOX) ligands
(Scheme 8.11).1  The mechanism is presumed to proceed through a Pd-enolate (637)
formed by deallylation and stereoablative loss of CO2 from (±)-293.  No significant
kinetic resolution of the racemic starting materials was observed, and, coupled with the
high chemical yield and enantioselectivity, these reactions represent an efficient method
for the generation of enantioenriched building blocks for synthesis.18
Scheme 8.11.  Stoltz’ stereoablative enantioconvergent ketone alkylation
O
Me
O
O
O
Me
O
Me
[Pd2(dba)3]
(2.5 mol%)
Et2O, 25 °C, 10 h (S)-9897% yield
92% ee
(±)-293
Ph2P N
O
t-Bu
(S)-t-BuPHOX (55)
(6.25 mol%)
637
Pd
N P
*
An interesting extension of this enantioconvergent method is the combination of a
reactive allyl enol carbonate moiety with a latent allyl β-ketoester (271, Scheme 8.12).  In
the course of this reaction, a new stereocenter is first generated via decomposition of the
allyl enol carbonate to reveal a Pd-enolate that undergoes enantioselective allylation.  It is
important that the catalyst be able to effectively overcome the inherent stereochemical
preference of the substrate since the starting material is a racemic mixture.  If the catalyst
is unable to overcome the substrate preference, then a poor product dr will result.
Notably, in this reaction, a 7:3 dr was obtained with Ph3P as ligand, while an enhanced dr
of 4:1 was observed with (S)-t-BuPHOX (55) as ligand.  In the second step of this
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double-alkylation reaction, the newly revealed ketone in 423 activates the allyl ester
toward decarboxylation and formation of Pd-enolate 706.  Catalyst control over the
configuration of the second stereocenter leads to a Horeau-type enhancement19 of the
overall ee of the product.  In this case, product (–)-272 forms in 92% ee.  A similar
double-alkylation technique was applied to the total synthesis of cyanthiwigin F.20
Scheme 8.12.  Stoltz’ cascade asymmetric allylation generating two quaternary stereocenters
O
O
O
O
O O
O
O O
Pd
N P
*
[Pd2(dba)3] 
(4 mol%)
THF, 40 °C
Ph2P N
O
t-Bu(S)-55
(10 mol%)
(±)-271 423 706
O
(–)-272
76% yield
92% ee, 4:1 dr
A second stereoablative reaction has been reported with the Pd•PHOX catalyst
system.  In this case, the putative Pd-enolate (637) is trapped with an alternate
electrophile: a proton (Scheme 8.13).21  Again, the enantiopure catalyst is involved in
both the bond-breaking and bond-forming steps, although the exact mechanistic course of
the reaction remains unclear.22  The divergent reactivity of the enolate intermediate
toward different electrophiles highlights the effectiveness and convenience of these
stereoablative reactions.  Although the stereoablative step in both reactions is likely
identical, two different structural motifs (α-quaternary and α-tertiary ketones) are both
available from a common starting material.23  Recently, conjugate acceptors were also
found to intercept the putative enolate intermediate providing different α-quaternary
cycloalkanones in high ee (see section 5.5.2.3).24
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Scheme 8.13.  Stoltz’ stereoablative enantioconvergent protonation
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*
Å
Catalyst design in catalytic enantioconvergent processes is especially important in
cases such as the enantioselective decarboxylative allylation and protonation reactions
described above.  Since the catalyst is intimately involved in both the stereoablative (C–C
bond-breaking) and enantioselective (C–C or C–H bond-forming) steps, it is critical that
the first step be insensitive to substrate stereochemistry.
Analogous enolate methods are known in which stoichiometric reagents are used in
the stereoablative step.25  Importantly, kinetic resolution of the starting material is
avoided by employing an achiral reagent (e.g., sec-BuLi) for this process.  Among these
is the enantioselective Li-enolate protonation method of Vedejs and Kruger, wherein a
catalytic amount of a chiral amine (708) coupled with slow addition of stoichiometric
phenylacetic acid derivative 709 leads to amide (R)-707 in high ee (Scheme 8.14).26
Scheme 8.14.  Vedejs’ enantioselective enolate protonation
MeO
N(i-Pr)2
O
1. sec-BuLi, –78 °C
2.
3.
NH
NHMe
Cl
Me2N
OEt
O
MeO
N(i-Pr)2
O
(±)-707 (R)-707
94% yield
92% ee
708
(5 mol%)
709
(2 equiv added over 1 h)
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A unique, metal-free approach to stereoablation was developed by Hénin, Muzart,
and co-workers.27  In this work, a light initiated Norrish Type II fragmentation is
employed to eliminate the stereocenter present in tetralone 579 and access intermediate
enol 581 (Scheme 8.15).  Subsequently, amino alcohol 582 mediates tautomerization to
the enantioenriched product (R)-97.  Other amino alcohols provide higher levels of
conversion and yield at the cost of enantioselectivity.
Scheme 8.15.  Hénin and Muzart’s photolytic stereoablative process
O
Me
(±)-579
OH
Me
hν (366 nm)
CH3CN
–40 °C, 1 h
Norrish Type II
Fragmentation
O
Me
(R)-97
40% yield
89% ee
OH
NHi-Pr
(10 mol%)
582
581
H
(60% conversion)
580
A recent report of a stereoablative enantioconvergent process for cross-coupling was
detailed by Fu and co-workers in 2005.  In the reaction, a racemic α-bromo amide or
benzylic bromide is treated with catalytic Ni, enantiopure (i-Pr)-pybox ligand, and an
alkylzinc reagent to create an enantioenriched tertiary stereocenter (Scheme 8.16).28
Although the mechanistic details have not been fully elucidated, it has been hypothesized
that the racemic bromide (710) initially decomposes to a radical intermediate (711),
negating the stereochemistry of the starting material.  Subsequent combination of the
carbon-centered radical with the Ni catalyst and Negishi-type coupling provides (–)-714
and completes the catalytic cycle.
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Scheme 8.16.  Fu’s enantioconvergent Negishi coupling
Br
(±)-710 711 712
NiLn n-C6H13
(–)-714
89% yield
96% ee
n-H13C6–ZnBr[NiBr2•diglyme]
(10 mol%)
(S)-(i-Pr)-pybox
715
(13 mol%)
N
N N
O O
i-Pr i-Pr
(S)-(i-Pr)-pybox (715)
713
Stoltz and co-workers also used a halide leaving group to develop an
enantioconvergent reaction, albeit through a considerably different mechanism (Scheme
8.17).29  As a strategy to access oxindoles bearing all-carbon quaternary centers at the 3-
position, racemic halooxindoles were envisioned as synthons for an electrophilic o-
azaxylylene intermediate (e.g., 718) that could be trapped by action of a nucleophile such
as a malonate (e.g., 655).  The overall transformation is unusual since oxindoles are
typically nucleophiles, but in this case the stereoablative step of the mechanism leads to
an electrophilic intermediate.  The technique was first demonstrated in a non-
enantioselective version of the reaction, but later studies found that optimization of the
stoichiometric base enabled enantioselective catalysis with a Cu(box) complex (i.e., 717).
Highly enantioenriched C3-quaternary oxindoles (up to 94% ee) were prepared, and the
products were shown to be useful for synthesizing spiro- and fused-pyrrolidinoxindole
architectures found in several families of natural products (e.g., 720 and 722).
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Scheme 8.17.  Stoltz' stereoablative oxindole functionalization
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As a final example, Trost and Ariza have reported an intermolecular system where
both the electrophilic and nucleophilic partners are racemic (723 and 724, Scheme
8.18).30  It is proposed that (±)-723 is converted to an achiral γ3-allyl ligand bound to Pd
(725), which is subsequently attacked by deprotonated azlactone 726, forming product
727 with excellent enantio- and diastereocontrol.  The remarkable stereochemical control
in this work is made possible by two separate stereoablative steps.
Scheme 8.18.  Trost’s doubly-stereoconvergent allylic alkylation
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8.3 CONCLUSIONS
Although to date the primary focus during the development of enantioselective
catalysis has been the creation of new stereocenters on prochiral substrates, asymmetric
catalysis is not limited to the selective construction of new stereocenters.  The selective
destruction of stereogenic elements is also a viable, and increasingly important, technique
that is beginning to show its utility in synthetic applications.  This approach has several
advantages including easily recycled by-products, easily accessible racemic or meso
starting materials, entries into enantioconvergent catalytic processes, and opportunities
for enantiodivergent synthesis.  As these new methods become more prominent and are
further developed by the synthetic community they will surely play a pivotal role in the
construction of enantiopure materials.
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CHAPTER 9
Enantioselective Total Synthesis of (+)-Cassiol†
9.1 INTRODUCTION
In 1988, Fukaya reported the isolation of (–)-cassioside (728) (Figure 9.1) from the
stem bark of Cinnamonum cassia Blume.1  This glycosylated sesquiterpenoid exhibited
potent antiulcerogenic activity in rats.  The aglycon of (–)-cassioside, (+)-cassiol (270),
demonstrated even stronger antiulcerogenic activity than observed with the glycosylated
precursor.  Given this useful biological property, (+)-cassiol (270) has attracted a great
deal of attention from synthetic laboratories.2  Herein, we report an expedient
enantioselective synthesis of (+)-cassiol with a longest linear sequence of eight steps.
Figure 9.1.  Structures of (+)-cassiol and (–)-cassioside
O
OH
HO
HO
OH
O
O
OH
OHCassioside (728)
O
OH
OHCassiol (270)
OH
                                                 
† This work was performed primarily by Krastina V. Petrova as a Amgen Summer Undergraduate Research
Fellow.  Portions we also perfomed in collaboration with Samantha R. Levine and Michael R. Krout.
These works have been published.  See: (a) Petrova, K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2009, 11,
293–295.  (b) Levine, S. R.; Krout, M. R.; Stoltz, B. M. Org. Lett. 2009, 11, 289–292.
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A principal challenge to the synthesis of (+)-cassiol (270) is the presence of an all-
carbon quaternary stereocenter.3 Several total syntheses of cassiol have been reported;
however, most have relied on chiral pool starting materials, or chiral auxiliaries.4,5  Few
of these syntheses addressed the challenge of catalytic enantioselective quaternary carbon
stereocenter generation.  For example, successful catalytic enantioselective approaches
have utilized Diels–Alder,6 intramolecular alkylidine insertion,7 and enzymatic8 reactions
to form the quaternary carbon.
9.2 RETROSYNTHETIC ANALYSIS
We envisioned a different strategy9 wherein the key quaternary stereocenter would be
installed through an enantioselective Pd-catalyzed allylic alkylation method recently
developed in our laboratories.10  Our plan consisted of coupling two complex pieces (474
and 729, Scheme 9.1) in the final step of the synthesis through a Stork–Danheiser-type
addition/rearrangement reaction.11  Precursors 474 and 729 would in turn be available
from known vinylogous thioester 32212 and primary alcohol 730,13 respectively.
Scheme 9.1.  Retrosynthetic analysis of (+)-cassiol (270)
HO
O
OH
OHCassiol (270)
HO
SPh
O
I
O
O
SPh
O
O
O
OH
729 730
474 322
Chapter 9 – Enantioselective Total Synthesis of (+)-Cassiol 851
9.3 TOTAL SYNTHESIS OF (+)-CASSIOL
9.3.1 ENANTIOSELECTIVE ALKYLATION WITH VINYLOGOUS ESTERS
Given the success with enol carbonate substrates derived from vinylogous esters both
in our laboratory14 and others,12 we first pursued enantioselective alkylation with substrate
731 (Table 9.1).  Upon exposure to the catalyst complex derived from Pd2(dba)3 and
phosphinooxazoline (PHOX) ligand (S)-55,15 desired product 267 was isolable, but the
yield and ee were variable (entry 1).  A further complication was the instability of the
enol carbonate.16  To circumvent this complication, the corresponding β-ketoester
substrate 321 was chosen with the hope of improving stability.12b  Although the substrate
proved stable, reactivity with our catalyst was quite low at 50 °C in toluene (entry 2).17
Increasing the reaction temperature led to complete conversion, but the ee of product
ketone 267 was moderate (entry 3).  In order to increase the reactivity of the ester
substrate, vinylogous thioester analog 323 was prepared.  With substrate 323, both high
yield and product ee were obtained with a range of solvents (entries 4–7).  With a suitable
synthesis of 268 in hand, we moved on to the synthesis of (+)-cassiol.18
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Table 9.1.  Enantioselective alkylation of vinylogous esters
CO2allyl
O
R Pd2(pmdba)3
(2.5 mol%)
solvent, temp
Ph2P N
O
t-Bu
O
R
321, R = Oi-Bu
323, R = SPh
(S)-55
(6.25 mol%)
OCO2allyl
i-BuO
731
or
267, R = Oi-Bu
268, R = SPh
entry substrate solvent T (°C) product isolated yield (%) eea (%)
1 731 toluene 25 267 22–61 84–88
2 321 toluene 50 267 19b 79
3 321 toluene 80 267 86 75
4 323 toluene 50 268 86 92
5 323 benzene 50 268 61c 92
6 323 50 268 88 92
7 323 1,4-dioxane 50 268 90 91
THF
a Enantiomeric excess determined by chiral HPLC or SFC.  b β-ketoester (±)-10 was recovered in
69% yield.  c β-ketoester (±)-11 was recovered in 26% yield.
9.3.2 PREPARATION OF THE CYCLOHEXENONE CORE
Our synthesis commenced with the deprotonation of vinylogous thioester 322 with
LDA and acylation of the resulting enolate with allyl chloroformate (Scheme 9.2).
Subsequent position-selective alkylation with iodomethane provided racemic β-ketoester
323 in 78% overall yield from 322.  In the presence of the catalyst complex derived from
Pd2(pmdba)3 and (R)-t-BuPHOX (55), β-ketoester (±)-323 was readily transformed into
allyl ketone (–)-268 in good yield and excellent enantiomeric excess.12a  Isomerization of
the terminal alkene occurred upon exposure to catalytic PdCl2(CH3CN)2 in hot benzene,
resulting in quantitative recovery of an inseparable 13:1 mixture of E-alkene 472 and
starting material 268.
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Scheme 9.2.  Enantioselective synthesis of alcohol (–)-474
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2. CH3I, Cs2CO3
    CH3CN, 80 °C
Cl O
O
(78% yield)
Pd2(pmdba)3 (2.5 mol %)
PhMe, 60 °C
(71% yield)
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O
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O
PhS
(–)-268
92% ee
PdCl2(CH3CN)2
(10 mol %)
PhH, 60 °C
(99% yield)
O
PhS
(–)-472
(–)-268
(13:1 mixture by 1H NMR)
1. OsO4 (10 mol %), DABCO
    K3Fe(CN)6, K2CO3
    t-BuOH/H2O (1:1), 35 °C
2. Pb(OAc)4, PhH, 30 °C
(70% yield)
O
PhS
(–)-473
H Li(O-t-Bu)3AlH
THF, 0 °C
(85% yield)
O O
PhS
(–)-474
(6.25 mol %)
OH
208
In order to convert the propenyl sidechain of 472 into a hydroxymethylene unit, we
sought to carry out an oxidative olefin cleavage reaction.  This transformation, however,
proved challenging.  Competing oxidative reactions of the thioester moiety appeared to
occur rapidly under ozonolysis conditions.  Modified Lemieux–Johnson conditions
(OsO4, NaIO4, 2,6-lutidine, dioxane/water)19 were also investigated, but led to a complex
mixture of products lacking the desired compound.  Both Upjohn dihydroxylation (OsO4,
NMO, acetone)20 and Sharpless asymmetric dihydroxylation conditions (AD-mix-α or
AD-mix-β, t-BuOH/H2O)21 resulted in slow and only partial conversion to the desired
diol product.
Confronted by these difficulties, we considered possible opportunities to improve
reactivity for our system.  We wished to take advantage of the well-precedented rate
acceleration of amine additives in osmium-catalyzed dihydroxylation reactions,22 but we
reasoned that the bulky chiral ligands employed in the Sharpless protocol might hamper
reactivity toward our sterically encumbered, enantiomerically enriched olefin.  Warren,
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Wyatt, and co-workers had found DABCO to be a convenient achiral ligand for non-
enantioselective dihydroxylations,23 and we suspected that the smaller steric size of this
ligand might improve the rate of oxidation in our system.  This proved to be the case, and
dihydroxylation proceeded smoothly with no evidence of undesired vinylogous thioester
oxidation.24  Immediate exposure of the crude diol to Pb(OAc)4 furnished pure aldehyde
(–)-473 in 70% overall yield for the two oxidative transformations.
Treatment of aldehyde (–)-473 with NaBH4 or NaBH(OAc)3 resulted in rapid
reduction of both carbonyl groups present in the substrate.  Fortunately, use of the bulkier
reducing agent Li(O-t-Bu)3AlH circumvented the problem of overreduction and provided
the desired alcohol (–)-474 in good yield.  Chiral HPLC analysis of (–)-474 indicated that
no significant erosion of enantiomeric purity had occured over the course of these steps.
9.3.3 PREPARATION OF THE SIDECHAIN SYNTHON
Turning our attention to the synthesis of vinyl iodide 729, we prepared alcohol 730 in
four known steps from diethyl malonate (732).13,25  Catalytic oxidation of alcohol 730 to
the corresponding aldehyde was accomplished with TEMPO and PhI(OAc)2 as the
stoichiometric co-oxidant (Scheme 9.3).26  Takai olefination27 of the crude aldehyde to
stereoselectively introduce the alkene functionality yielded vinyl iodide 729 in a 5:1 E/Z
ratio.
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Scheme 9.3.  Synthesis of vinyl iodide 729
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O
O
O
OH
729730
1. TEMPO 
    (10 mol %)
    PhI(OAc)2
    CH2Cl2
2. CrCl2, CHI3
    THF, 0 °C
(58% yield)
(5:1 E/Z mixture)
732
EtO
O
OEt
O Ref 13
(4 steps)
9.3.4 FRAGMENT COUPLING
In the final step of the synthesis, lithium–halogen exchange of vinyl iodide 729 (2
equiv) through exposure to t-BuLi (4.25 equiv) in diethyl ether furnished vinyllithium
475.  Addition of a solution of alcohol (–)-474 (1 equiv) to the solution of organolithium
475 and subsequent acid-catalyzed rearrangement and hydrolysis yielded (+)-cassiol
(270).7  The spectroscopic data (1H NMR, 13C NMR, IR, HRMS, optical rotation) were
identical to the reported data for natural 270.
Scheme 9.4.  Preparation of (+)-cassiol (270)
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t-BuLi
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9.4 SUMMARY
In summary, we report a brief and convergent total synthesis of the antiulcerogenic
natural product (+)-cassiol.  Our route requires eight linear steps from vinylogous ester
322 and proceeds in 12% overall yield.  Employing our recently developed enolate
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alkylation technology, the key quaternary carbon stereocenter was generated at an early
stage in high ee.  The versatile reactivity of the allyl group enabled installation of the
hydroxymethylene unit present in the natural product through chemoselective oxidation
and reduction reactions.  Late-stage installation of the diol sidechain via
Stork–Danheiser-type addition/rearrangement completed the synthesis.  Other synthetic
efforts featuring enantioselective enolate functionalization reactions are underway.28
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9.6 EXPERIMENTAL SECTION
9.6.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by
passage through an activated alumina column under argon.  Brine solutions are saturated
aqueous sodium chloride solutions.  Liquids and solutions were transferred via syringe or
cannula.  All the starting materials were purchased from Sigma-Aldrich or Alfa Aesar,
and used as received, unless otherwise stated.  Benzenethiol was distilled under nitrogen
prior to use.  Previously reported methods were used to prepare (R)-t-BuPHOX (55),29
Pd2(pmdba)3,30 and PdCl2(CH3CN)2.31 Osmium tetroxide and Pb(OAc)4 were purchased
from Sigma-Aldrich, and the Pb(OAc)4 was stored under a glovebox atmosphere prior to
use.  Reaction temperatures were controlled by an IKAmag temperature modulator.
Thin-layer chromatography (TLC) was performed using E. Merck silica gel 60 F254
precoated plates (0.25 mm) and visualized by UV fluorescence quenching, anisaldehyde,
or KMnO4 staining.  SiliCycle® SiliaFlash® P60 Academic Silica Gel (particle size 40–63
µ m; pore diameter 60 Å), or Florisil®  (100–200 mesh) were used for flash
chromatography.  Analytical chiral HPLC was performed with an Agilent 1100 Series
HPLC utilizing a Chiralpak AD column (4.6 mm x 25 cm) obtained from Daicel
Chemical Industries with visualization at 254 nm.  Analytical chiral supercritical fluid
chromatography was performed with a Berger Analytix SFC (Thar Technologies)
utilizing a Chiralpak AD-H column (4.6 mm x 25 cm) obtained from Daicel Chemical
Industries, Ltd. with 2 mL/min flow rate at 30 °C and visualization at 244 nm.  Optical
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rotations were measured with a Jasco P-1010 polarimeter at 589 nm.  1H and 13C NMR
spectra were recorded on a Varian Mercury 300 (at 300 and 75 MHz respectively) or a
Varian Inova 500 (at 500 and 125 MHz respectively), and are reported relative to Me4Si
(δ 0.0 ppm).  Data for 1H NMR spectra are reported as follows: chemical shift (δ ppm)
(multiplicity, coupling constant (Hz), integration).  Multiplicity and qualifier
abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m =
multiplet, comp = complex, br = broad, app = apparent.  IR spectra were recorded on a
Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of absorption
(cm–1).  High-resolution mass spectra were obtained from the Caltech Mass Spectral
Facility.
9.6.2 EXPERIMENTAL PROCEDURES AND CHARACTERIZATION DATA
O
O
O
i-BuO
i-BuOH
p-TsOH•H2O
PhH, reflux
Dean–Stark
(92% yield)319 320
Vinylogous Ester 320.32  Diketone 319 (3.000 g, 23.78 mmol, 1.0 equiv) was
partially dissolved in PhH (42.5 mL, 0.56 M), and i-BuOH (12.75 mL, 137.9 mmol, 5.8
equiv) and p-TsOH•H2O (226 mg, 1.19 mmol, 0.05 equiv) were added with vigorous
stirring.  The flask was affixed with a Dean–Stark adapter and a water-cooled condenser
and warmed to reflux in a 104 °C oil bath.  Upon consumption of 319 by TLC analysis
(ca. 3.5 h), the reaction was cooled to ambient temperature, diluted with Et2O (50 mL),
and poured into saturated aq NaHCO3 (20 mL).  The layers were separated and the
aqueous was extracted with Et2O (3 x 15 mL).  The organics were combined, washed
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with brine, dried with Na2SO4, filtered, and concentrated in vacuo to afford a pale brown
oil.  To this oil was added PhMe (ca. 10 mL) followed by further concentration in vacuo.
Purification by bulb-to-bulb distillation yielded vinylogous ester 320 (3.988 g, 21.88
mmol, 92% yield) as a clear, colorless oil.  Rf = 0.48 (2:1 EtOAc-hexanes); bp = 135–140
°C at 0.8 torr; 1H NMR (300 MHz, CDCl3):  δ 3.76 (d, J = 6.5 Hz, 2H), 2.54 (ddd, J =
6.1, 1.5, 1.5 Hz, 2H), 2.34 (t, J = 7.1 Hz, 2H), 2.08-1.90 (comp m, 3H), 1.72 (app t, J =
1.5 Hz, 3H), 0.99 (d, J = 6.7 Hz, 6H).  All other data were consistent with reported
values.
O
i-BuO
O
i-BuO
LDA, THF
0 → – 78 °C
MeI, –78 → 23 °C
(80% yield)
320 736
Methyl Vinylogous Ester 736.32 To a solution of i-Pr2NH (1.12 mL, 7.99 mmol, 1.9
equiv) in THF (26 mL, 0.15 M) at 0 ˚C was added dropwise a solution of n-BuLi (2.55 M
in hexanes, 3.06 mL, 7.80 mmol, 1.85 equiv).  After 15 min, a solution of vinylogous
ester 320 (765.2 mg, 4.198 mmol, 1.0 equiv) in THF (2.0 mL) was added dropwise via
cannula transfer.  The resulting solution was cooled to –78 ˚C and stirred for 45 min, to
which a solution of MeI (485 µL, 7.80 mmol, 1.85 equiv) in THF (5.0 mL) was added
over 30 min via positive-pressure cannula transfer.  The cooling bath was allowed to
expire over ca. 4 h and the reaction was quenched with brine (15 mL).  The phases were
separated and the aqueous phase was extracted with hexanes (3 x 25 mL).  The combined
organics were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo
to a yellow oil.  Purification by flash chromatography (4:1  →  2:1 hexanes-Et2O)
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afforded methyl vinylogous ester 736 (659 mg, 3.36 mmol, 80% yield) as a pale yellow
oil.  Rf = 0.48 (2:1 hexanes-EtOAc); 1H NMR (300 MHz, CDCl3):  δ 3.73 (ddd, J = 15.6,
9.2, 6.5 Hz, 2H), 2.61 (ddd, J = 17.3, 5.3, 1.2 Hz, 1H), 2.55-2.44 (m, 1H), 2.35-2.19 (m,
1H), 2.06 (app dq, J = 8.3, 4.8 Hz, 1H), 1.98 (app septet, J = 6.6 Hz, 1H), 1.71 (dd, J =
1.6, 1.6 Hz, 3H), 1.73-1.60 (m, 1H), 1.14 (d, J = 6.9 Hz, 3H), 0.99 (d, J = 6.7 Hz, 6H).
All other data are consistent with reported values.
O
i-BuO
OCO2allyl
i-BuO
LDA, THF, –78 °C
then TMEDA
then ClCO2allyl
736 731
i-BuO
OCO2allyl
733
208
Enol Carbonate 731.  To a solution of i-Pr2NH (1.56 mL, 11.15 mmol, 1.2 equiv) in
THF (85 mL, 0.11 M) at 0 ˚C was added a solution of n-BuLi (2.55 M in hexanes, 4.0
mL, 10.22 mmol, 1.1 equiv) dropwise.  The reaction mixture was allowed to stir for 30
min and then cooled to –78 ˚C.  A solution of ketone 736 (1.824 g, 9.29 mmol, 1.0 equiv)
in THF (10 mL) was added dropwise via cannula and stirred for 1 h.  TMEDA (1.67 mL,
11.15 mmol, 1.2 equiv) was then added via syringe and the resulting solution stirred for
75 min.  To this solution allyl chloroformate (208, 1.08 mL, 10.13 mmol, 1.09 equiv) was
added via syringe and the reaction mixture was stirred at –78 ˚C for an additional hour.
The reaction was quenched with saturated aq NaHCO3 (40 mL) and H2O (40 mL), and
the flask was transferred to a 23 ˚C water bath and allowed to equilibrate.  The phases
were separated and the aqueous was extracted with Et2O (2 x 200 mL).  The combined
organics were washed with brine, dried over MgSO4, and concentrated in vacuo to afford
enol carbonate 731 as a yellow oil (2.472 g); 1H NMR analysis shows 731 is the major
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product with other impurities present.  Rf = unstable to SiO2; 1H NMR (500 MHz,
CDCl3): δ 5.97 (dddd, J = 16.4, 10.8, 5.8, 5.8 Hz, 1H), 5.42 (app d, J = 17.2 Hz, 1H),
5.33 (app d, J = 10.4 Hz, 1H), 4.72 (dd, J = 5.7, 0.8 Hz, 2H), 3.86 (d, J = 6.7 Hz, 2H),
2.85 (app t, J = 7.9 Hz, 2H), 2.52 (app t, J = 7.9 Hz, 2H), 2.19 (s, 3H), 1.92 (app
septuplet, J = 6.7 Hz, 1H), 1.82 (s, 3H), 0.93 (d, J = 6.7 Hz, 6H); IR (Neat Film NaCl)
2963, 1760, 1736, 1699, 1361, 1248, 1170, 990 cm–1; HRMS (FAB+) m/z: calc’d for
C13H19O4 [M – C3H5]+: 239.1283, found 239.1273.
This material was unstable to various purification attempts (distillation or flash
chromatography using silica gel or Florisil) and storage.  Aromatic carbonate 733 was
identified as a colorless oil from this complex mixture.  Rf = 0.51 (4:1 hexanes-EtOAc);
1H NMR (500 MHz, CDCl3): δ 6.97 (d, J = 8.4 Hz, 1H), 6.65 (d, J = 8.4 Hz, 1H), 6.00
(dddd, J = 17.1, 10.5, 5.7, 5.7 Hz, 1H), 5.43 (dddd, J = 17.2, 1.4, 1.4, 1.4 Hz, 1H), 5.33
(dddd, J = 10.5, 1.2, 1.2, 1.2 Hz, 1H), 4.75 (app dt, J = 5.8, 1.3 Hz, 2H), 3.70 (d, J = 6.4
Hz, 2H), 2.14 (s, 3H), 2.09 (s, 3H), 2.09 (app septuplet, J = 6.6 Hz, 1H), 1.03 (d, J = 6.7
Hz, 6H); 13C NMR (126 MHz, CDCl3): δ 156.3, 153.0, 148.7, 131.4, 127.7, 121.8, 119.5,
119.4, 109.1, 74.9, 69.2, 28.6, 19.5, 15.7, 9.2; IR (Neat Film NaCl) 2960, 2874, 1762,
1620, 1494, 1470, 1365, 1244, 1202, 1172, 1115, 1048, 799 cm–1; HRMS (FAB+) m/z:
calc’d for C16H22O4 [M]+: 278.1518, found 278.1517.
O
i-BuO
O
i-BuO
1. LDA, PhMe, –78 °C
    then ClCO2allyl (208)
    –78 → 23 °C
2. MeI, Cs2CO3
    MeCN, 80 °C
    
       (55% yield)320 (±)-321
O
O
(±)-β-Ketoester 321.  To a –78 °C solution of i-Pr2NH (425  µL, 3.03 mmol, 1.9
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equiv) in PhMe (10 mL) was added dropwise n-BuLi (2.55 M in hexanes, 1.16 mL, 2.96
mmol, 1.85 equiv).  The reaction vessel was placed in an ice/water bath and allowed to
stir for 10 min, and then cooled to –78 °C.  A solution of vinylogous ester 320 (291 mg,
1.60 mmol, 1.0 equiv) in PhMe (1.4 mL) was added dropwise via cannula to the reaction
vessel, and the resulting solution was allowed to stir for 30 min.  Allyl chloroformate
(208, 173 µL, 1.63 mmol, 1.02 equiv) was added dropwise, and the reaction vessel was
allowed to warm to 23 °C over 1 h.  After stirring for 4 h, the reaction was slowly
quenched with aq KHSO4 (1 N, 4 mL) and the resulting biphasic mixture was allowed to
stir for 10 min. The phases were separated, and the aq phase was extracted with Et2O (2 x
10 mL). The combined organic extracts were washed with brine (10 mL), dried over
MgSO4, filtered, and concentrated in vacuo.  The isolated crude yellow oil was used in
the next step without further purification.
The resulting crude yellow oil was dissolved in MeCN (5.9 mL, 0.27 M), and Cs2CO3
(603 mg, 1.85 mmol, 1.16 equiv), and MeI (276 µL, 4.44 mmol, 2.8 equiv) were added.
The flask was affixed a water-cooled condenser and resulting suspension was warmed to
reflux in an 80 °C oil bath with vigorous stirring.  After 10 h, the reaction was cooled to
room temperature, diluted with EtOAc (25 mL).  The organics were dried with MgSO4,
filtered, and the solvent was evaporated in vacuo.  Purification by flash chromatography
(15:1 → 9:1 → 4:1 hexanes-EtOAc) afforded β-ketoester (±)-321 as pale yellow oil (246
mg, 55% yield over two steps).  Rf = 0.27 (2:1 hexanes-EtOAc); 1H NMR (500 MHz,
CDCl3): δ 5.82 (dddd, J = 17.2, 10.7, 5.4, 5.4 Hz, 1H), 5.22 (dddd, J = 17.2, 1.6, 1.6, 1.6
Hz, 1H), 5.15 (dddd, J = 10.5, 1.2, 1.2, 1.2 Hz, 1H), 4.56 (dddd, J = 13.5, 5.4, 1.5, 1.5
Hz, 2H), 3.72 (ddd, J = 9.2, 6.6, 3.2 Hz, 2H), 2.69-2.62 (m, 1H), 2.53-2.44 (comp m,
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2H), 1.95 (app septuplet, J = 6.6 Hz, 1H), 1.85-1.80 (m, 1H), 1.70 (dd, J = 1.5, 1.5 Hz,
3H), 1.36 (s, 3H), 0.95 (dd, J = 6.7, 0.8 Hz, 6H); 13C NMR (126 MHz, CDCl3): δ 195.8,
172.6, 170.3, 131.9, 117.8, 113.8, 73.9, 65.5, 51.6, 31.2, 28.8, 23.0, 20.8, 19.1, 19.0, 8.0;
IR (Neat Film NaCl) 2961, 2935, 2875, 1733, 1649, 1618, 1460, 1382, 1354, 1237, 1176,
1103, 983 cm–1; HRMS (FAB+) m/z: calc’d for C16H25O4 [M + H]+: 281.1753, found
281.1740.
OCO2allyl
i-BuO
731
Pd2(pmdba)3 (2.5 mol%)
 (S)-55 (6.25 mol%)
PhMe, 25 °C
(22-61% yield)
O
i-BuO
(+)-267, 84–88% ee
Ketone (+)-267 from enol carbonate 731.  A 1-dram vial containing a stir bar was
charged with Pd2(pmdba)3 (4.9 mg, 0.0045 mmol, 0.025 equiv) and (S)-55 (4.4 mg,
0.0112 mmol, 0.0625 equiv), sealed with a septum, and the atmosphere was purged by
three evacuate/purge cycles.  To this was added PhMe (0.9 mL) and the complexation
was stirred for 30 min in a 25 °C oil bath, upon which time a solution of enol carbonate
731 (50.2 mg, 0.179 mmol, 1.0 equiv) in PhMe (0.9 mL, 0.1 M total) was added via
cannula.  After 21.5 h at 25 °C, the reaction was diluted with Et2O (2 mL), filtered
through a SiO2 plug, and concentrated in vacuo.  The filtrate was purified by flash
chromatography on SiO2 (15:1 → 4:1 hexanes-EtOAc) to afford ketone (+)-267 as a pale
yellow oil (22-61% yield, 84–88% ee).  Rf = 0.49 (4:1 hexanes/EtOAc); 1H NMR (500
MHz, CDCl3) δ 5.73 (dddd, J = 16.6, 10.6, 7.4, 7.4 Hz, 1H), 5.06-5.04 (m, 1H), 5.04-5.01
(m, 1H), 3.74 (dd, J = 9.7, 6.7 Hz, 2H), 2.59-2.47 (comp m, 2H), 2.33 (dd, J = 13.7, 7.2
Hz, 1H), 2.16 (dddd, J = 13.7, 7.6, 1.0, 1.0 Hz, 1H), 1.98 (app septuplet, J = 6.6 Hz, 1H),
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1.90 (ddd, J = 13.3, 7.2, 5.7 Hz, 1H), 1.72-1.67 (m, 1H), 1.70 (dd, J = 1.6, 1.6 Hz, 3H),
1.06 (s, 3H), 0.99 (d, J = 6.7 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 202.7, 169.5, 134.8,
117.8, 113.3, 73.8, 42.5, 41.9, 31.5, 29.0, 22.5, 22.4, 19.2, 8.0; IR (Neat Film NaCl)
3076, 2962, 2931, 1622, 1463, 1381, 1355, 1229, 1113, 1002, 915 cm-1; HRMS (EI+)
m/z: calc’d for C15H24O2 [M]+: 236.1776, found 236.1771; [α]D21.2 +13.2° (c 0.20, CH2Cl2,
88% ee).  SFC conditions: 5% IPA, AD-H column, tR (min): major = 5.18, minor = 6.02.
O
i-BuO
(±)-321
O
O Pd2(pmdba)3 (2.5 mol%)
 (S)-55 (6.25 mol%)
PhMe, 80 °C
(86% yield)
O
i-BuO
(+)-267, 75% ee
Ketone (+)-267 from β-ketoester (±)-321.  A 2-dram vial containing a stir bar was
charged with Pd2(pmdba)3 (10.6 mg, 0.00968 mmol, 0.025 equiv) and (S)-55 (9.4 mg,
0.0242 mmol, 0.0625 equiv).  This was connected to a 1-dram vial containing a stirbar
and β-ketoester (±)-321 (108.6 mg, 0.387 mmol, 1.0 equiv) via a cannula, and PhMe (3.9
mL, 0.1 M) was added to the vial containing the Pd/L and immediately immersed in
liquid N2.  The vials were rigorously degassed by three freeze-pump-thaw cycles and
warmed to 23 °C.  After complexation for 30 min (purple → orange color change), the
catalyst solution was transferred to the substrate via cannula and immersed in an 80 °C
oil bath.  The reaction immediately turned yellow in color.  After 23 h the reaction was
cooled to ambient temperature, diluted with Et2O (4 mL), and filtered through a small
SiO2 plug.  The filtrate was concentrated and purified by flash chromatography as above
to afford ketone (+)-267 as a colorless oil (78.5 mg, 0.332 mmol, 86% yield, 75% ee).
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O
O
1. MsCl, Et3N
    CH3CN
    0 → 23 °C
2. PhSH, Et3N
    0 → 23 °C
O
PhS
319 322(82% yield)
Vinylogous Thioester 322.33 To a solution of diketone 319 (5.00 g, 39.82 mmol, 1.00
equiv) in CH3CN (44 mL) was added Et3N (6.2 mL, 44.40 mmol, 1.12 equiv), and the
solution was allowed to stir for 5 min, then cooled to 0 °C.  Methanesulfonyl chloride
(3.26 mL, 42.00 mmol, 1.06 equiv) was added, and the reaction was warmed to 23 °C
over 2 h.  Stirring was continued for 5 h, and the reaction was cooled to 0 °C.
Triethylamine (6.2 mL, 44.40 mmol, 1.12 equiv) was added, followed by benzenethiol
(4.2 mL, 40.80 mmol, 1.03 equiv).  The reaction was allowed to warm to 23 °C over 2 h
and stirring was continued for 9 h.  Saturated aq Na2CO3 (70 mL) was added, the phases
were separated, and the aq phase was extracted with Et2O (3 x 120 mL).  The combined
organic extracts were dried over Na2SO4, filtered, and the solvent was evaporated in
vacuo.  Purification by flash chromatography (18% EtOAc in hexanes) afforded
vinylogous thioester 322 (7.15 g, 82% yield) as a white crystalline solid.  Rf = 0.33 (20%
EtOAc in hexanes); mp 85 °C; 1H NMR (500 MHz, CDCl3) δ 7.51-7.49 (m, 2H), 7.44-
7.37 (comp m, 3H), 2.38 (t, J = 6.5 Hz, 2H), 2.18 (tq, J = 6.5, 2.0 Hz, 2H), 1.97 (t, J = 2.0
Hz, 3H), 1.87 (app pentuplet, J = 6.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ  195.6,
157.9, 130.3(2C), 129.6, 129.5, 37.3, 30.5, 22.9, 12.4; IR (Neat Film NaCl) 2944, 1655,
1578, 1339, 1296 cm–1; HRMS (FAB+) m/z: calc’d for C13H14OS [M + H]+: 219.0844,
found 219.0843.
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O
PhS
322
1. LDA, PhMe, –78 °C
2. MeI, Cs2CO3
    CH3CN, 80 °C
(78% yield, two steps)
Cl
O
O
O
PhS
(±)-323
O
O
208
β-Ketoester 323.34  To a –78 °C solution of diisopropylamine (2.63 mL, 18.78 mmol,
2.00 equiv) in toluene (70 mL) was added dropwise n-BuLi (2.53 M in hexanes, 7.24 mL,
2.00 equiv).  The reaction vessel was warmed to 0 °C, allowed to stir for 10 min, and
cooled to –78 °C.  A solution of thioester 322 (2.00 g, 9.16 mmol, 1.00 equiv) in toluene
(15 mL) was added dropwise via cannula to the reaction vessel, and the resulting solution
was allowed to stir for 30 min.  Allyl chloroformate (1.02 mL, 9.62 mmol, 1.05 equiv)
was added dropwise, and the reaction vessel was allowed to warm to 23 °C over 1 h.
Stirring was continued for 4 h, then aq KHSO4 (1 N, 70 ml) was added, and the resulting
solution was allowed to stir for 10 min.  The phases were separated, and the aq phase was
extracted with Et2O (3 x 30 mL).  The combined organic extracts were washed with brine
(1 x 30 mL), dried over Na2SO4, filtered, and concentrated in vacuo.  The isolated crude
yellow oil was used in the next step without further purification.
To a solution of the crude yellow oil (3.32 g) in CH3CN (40 mL) was added cesium
carbonate (4.48 g, 13.74 mmol, 1.50 equiv), and iodomethane (1.71 mL, 27.48 mmol,
3.00 equiv).  The resulting suspension was refluxed at 80 °C for 5 h, and then MeI (1.00
mL, 16.06 mmol, 1.75 equiv) was added.  The reaction was refluxed at 80 °C for 2 h,
cooled to room temperature, filtered through Celite (EtOAc eluent), dried over Na2SO4,
filtered, and the solvent was evaporated in vacuo.  Purification by flash chromatography
(18% EtOAc in hexanes) afforded β-ketoester (±)-323 (2.26 g, 78% yield over two steps)
as white solid.  Rf = 0.35 (30% EtOAc in hexanes); mp 34 °C; 1H NMR (300 MHz,
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CDCl3) δ 7.51-7.35 (comp m, 5H), 5.87 (app ddt, J = 10.5, 17.1, 5.4 Hz, 1H), 5.27 (app
ddt, J = 17.1, 1.7, 1.8 Hz, 1H), 5.22 (app ddt, J = 9.9, 1.7, 1.2 Hz, 1H), 4.65 (dddd, J =
1.5, 1.8, 5.7, 13.5 Hz, 1H), 4.55 (dddd, J = 1.5, 1.8, 5.7, 13.5 Hz, 1H), 2.41-2.32 (m, 1H),
2.30-2.21 (m, 1H), 2.16-2.06 (1H), 2.00 (t, J = 1.8 Hz, 3H), 1.78 (ddd, J = 4.5, 8.1, 13.2
Hz, 1H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 193.0, 172.6, 156.7, 135.6, 131.9,
129.7, 129.5, 128.9, 118.1, 65.7, 52.3, 33.1, 27.4, 20.7, 12.9; IR (Neat Film NaCl) 2936,
1733, 1656, 1580, 1314, 1254, 1238, 1174, 985, 752, 693 cm–1; HRMS (FAB+) m/z:
calc’d for C18H20O3S [M + H]+: 317.1211, found 317.1211.
O
PhS
O
O
Pd2(pmdba)3 (2.5 mol%)
PhMe, 60 °C, 0.1 M
O
PhS
(71% yield)(±)-323 (–)-26892% ee
(R)-t-BuPHOX (55) 
(6.25 mol%)
Ph2P N
O
t-Bu
Allyl ketone (–)-268.  A solution of Pd2(pmdba)3 (0.1306 g, 0.1185 mmol, 0.025
equiv) and (R)-t-BuPHOX (55) (0.1148 g, 0.2964 mmol, 0.0625 equiv) in toluene (30
mL) was prepared in a glovebox under N2 atmosphere, and allowed to stir at 23 °C for 30
min.  A solution of β-ketoester (±)-323 (1.50 g, 4.741 mmol, 1.00 equiv) in toluene (10
mL) was transferred to the reaction vessel dropwise via glass pipette, washing with
toluene (7.5 mL) for quantitative transfer.  The reaction vessel was sealed with a rubber
septum, removed from the glove box, heated in a 60 °C oil bath, and the solution was
allowed to stir for 24 h.  The reaction vessel was cooled to room temperature, and the
solvent was evaporated in vacuo.  The resulting residue was purified by flash
chromatography (5% EtOAc in hexanes) to afford allyl ketone (–)-268 (0.92 g, 71%
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yield, 91.6% ee as determined by chiral HPLC using a Chiralpak AD column with 4%
EtOH in hexanes as the eluent) as a colorless oil.  Rf = 0.45 (30% EtOAc in hexanes); 1H
NMR (300 MHz, CDCl3) δ 7.52-7.48 (m, 2H), 7.43-7.35 (comp m, 3H), 5.68 (app ddt, J
= 10.8, 16.8, 7.5 Hz, 1H), 5.03 (dddd, J = 9.9, 2.4, 0.9, 0.6 Hz, 1H), 5.01 (dddd, J = 17.4,
2.4, 1.5, 1.2 Hz, 1H), 2.32 (app ddt, J = 13.8, 7.2, 1.2 Hz), 2.19-2.10 (comp m, 3H), 1.96
(t, J = 1.8 Hz, 3H), 1.86-1.75 (m, 1H), 1.66-1.56 (m, 1H), 1.04 (s, 3H); 13C NMR (75
MHz, CDCl3) δ 199.5, 155.6, 135.6, 134.4 130.3, 129.6, 129.5, 128.8, 118.2, 43.1, 41.7,
33.1, 26.9, 22.3, 12.9; IR (Neat Film NaCl) 3074, 2964, 2929, 1652, 1582, 1440, 1339,
1287, 1228 cm–1; HRMS (FAB+) m/z: calc’d for C17H20OS [M + H]+: 273.1313, found
273.1317; [α]D25.4 –57.4 (c 1.00, CH2Cl2).
O
PhS
(–)-268
O
PhS
(–)-472
(99% yield)
PdCl2(CH3CN)
(10 mol%)
 
benzene, 60 °C
O
PhS
(–)-268
+
Isomerized alkene (–)-472.  A solution of allyl ketone (–)-268 (0.80 g, 2.94 mmol,
1.00 equiv) and PdCl2(CH3CN)2 (76.3 mg, 0.29 mmol, 0.10 equiv) in benzene (5.8 mL)
was sparged with Ar for 10 min.  The flask was sealed, and heated to 60 °C for 12 h.  The
reaction was cooled to room temperature, the solvent was evaporated in vacuo, and the
resulting residue was purified by flash chromatography (5% EtOAc in hexanes) to afford
an inseparable mixture of isomerized alkene (–)-472 and starting material (–)-268 (0.7951
g, 99% overall yield, ratio of 13:1 of 472:268 by NMR).  Rf = 0.45 (30% EtOAc in
hexanes); 1H NMR (500 MHz, CDCl3) δ (additional peaks correspond to compound 268)
7.52-7.47 (m, 2H), 7.36-7.42 (comp m, 3H), 5.45 (dq, J = 1.5, 15.5 Hz, 1H), 5.33 (dq, J =
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6.0, 15.5 Hz, 1H), 2.26-2.04 (m, 2H), 1.98  (t, J = 1.5 Hz, 3H), 1.83-1.72 (m, 2H), 1.66
(dd, J = 2.0, 6.5 Hz, 3H), 1.14 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 198.1, 155.9, 135.5,
133.7, 130.4, 129.5, 129.4, 129.3, 124.9, 46.2, 35.3, 27.4, 24.3, 18.5, 12.9; IR (Neat Film
NaCl) 2923, 1651, 1588, 1440, 1372, 1339 1287, 1230 cm–1; HRMS (FAB+) m/z: calc’d
for C17H20OS [M + H]+: 273.1313, found 273.1314; [α]D26.0 –34.8 (c 1.00, CH2Cl2).
O
PhS
(–)-472
O
PhS
(–)-473(70% yield)
H
O1. OsO4 (10 mol%), DABCO     K3Fe(CN)6, K2CO3
    1:1 t-BuOH:H2O, 35 °C
2. Pb(OAc)4
    benzene, 30 °C
Aldehyde (–)-473.  To a solution of K3Fe(CN)6 (2.18 g, 6.61 mmol, 3.00 equiv),
K2CO3 (0.91 g, 6.61 mmol, 3.00 equiv), 1,4-diazabicyclo[2.2.2]octane (DABCO) (0.124
g, 1.01 mmol, 0.50 equiv), and 13:1 isomeric mixture of α-vinyl ketone (–)-472 and α-
allyl ketone (–)-268 (0.60 g, 2.20 mmol, 1.00 equiv) was added solid OsO4 (56.0 mg,
0.22 mmol, 0.10 equiv), and the solution was allowed to stir at 35 °C for 12 h.  Saturated
aq Na2SO3 (20 mL) was added, and the solution was allowed to stir for 1 h.  The phases
were separated, and the aq phase was extracted with Et2O (3 x 30 mL), dried over
Na2SO3, filtered, and concentrated.  The isolated white solid was used in the next step
without further purification.
To a solution of the crude white solid (0.64 g) in benzene (17 mL) was added
Pb(OAc)4 (1.02 g, 2.31 mmol, 1.10 equiv), and the solution was allowed to stir at 30 °C
for 1 h.  The solution was concentrated in vacuo, and the resulting residue was purified
by flash chromatography (5% EtOAc in hexanes) to afford aldehyde (–)-473 (0.40 g,
70% yield over two steps) as a white solid.  Rf = 0.60 (30% EtOAc in hexanes); mp 41
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°C; 1H NMR (300 MHz, CDCl3) δ 9.57 (s, 1H), 7.52-7.36 (comp m, 5H), 2.35-2.10 (m,
3H), 1.98 (t, J = 1.5 Hz, 3H), 1.76-1.67 (m, 1H), 1.27 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 201.1, 193.7, 159.2, 135.9, 130.0, 129.7, 129.4, 128.9, 56.4, 29.0, 26.7, 18.9,
12.5; IR (Neat Film NaCl) 2931, 1725, 1642, 1578, 1440, 1339, 1312, 1239, 1025 cm–1;
HRMS (FAB+) m/z: calc’d for C15H16O2S [M + H]+: 261.0949, found 261.0944; [α]D25.6
–30.4 (c 1.00, CH2Cl2).
O
PhS
(–)-473
H
O
Li(O-t-Bu)3AlH
THF, 0 °C
O
PhS
(–)-474
OH
(85% yield)
Alcohol (–)-474.  A solution of lithium tri-tert-butoxy aluminium hydride (1.34 mL,
1.00 M solution in THF, 1.41 mmol, 1.05 equiv) in THF (7 mL) was cooled to 0 °C.  This
solution was then added to a 0 °C solution of aldehyde (–)-473 (0.35 g, 1.35 mmol, 1.00
equiv) in THF (20 mL) in seven equal portions over 2 h.  The reaction was allowed to stir
for an additional 30 min, then H2O (0.3 mL) was added, followed by 15% aq NaOH (0.3
mL), and then H2O (0.9 mL).  The reaction was warmed to 23 °C, and allowed to stir for
30 min.  The solution was filtered through Celite (washing with EtOAc), dried over
Na2SO4, filtered, and concentrated in vacuo to afford alcohol (–)-474 (0.30 g, 85% yield)
as a white solid (90.3% ee as determined by chiral HPLC using a Chiralpak AD column
with 80% EtOH in hexanes as the eluent).  Rf = 0.22 (30% EtOAc in hexanes); mp 49 °C;
1H NMR (500 MHz, CDCl3) δ 7.54-7.49 (m, 2H), 7.46-7.40 (comp m, 3H), 3.51 (dd, J
=11.1, 8.1 Hz, 2H), 2.88 (dd, J = 5.1, 7.8 Hz, 1H), 2.38-2.10 (comp m, 2H), 1.98-1.88
(comp m, 4H), 1.46 (ddd, J = 3.3, 4.8, 13.2 Hz, 1H), 1.11 (s, 3H); 13C NMR (75 MHz,
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CDCl3) δ 201.2, 157.8, 135.8, 129.8, 129.6, 128.4, 69.5, 44.5, 31.1, 26.7, 18.8, 12.5; IR
(Neat Film NaCl) 3433 (br.), 2927, 1642, 1578, 1440, 1339, 1025, 750 cm–1; HRMS
(FAB+) m/z: calc’d for C15H18O2S [M + H]+: 263.1106, found 263.1115; [α]D26.1 –13.3 (c
1.00, CH2Cl2).
I
O
O
O
O
OH
729730
1. TEMPO (10 mol%)
    PhI(OAc)2, CH2Cl2
2. CrCl2, CHI3, THF
    0 °C
(58% yield) (5:1 E/Z mixture)
Vinyl iodide 729.  2,2,6,6-tetramethyl-1-piperidinyloxyl (TEMPO, 0.0424 g, 0.27
mmol, 0.10 equiv) was added to a solution of alcohol 73035 (0.40 g, 2.74 mmol, 1.00
equiv) in CH2Cl2 (8 mL), and the reaction was allowed to stir for 5 min.  To the reaction
vessel was added solid bis(acetoxy)iodobenzene (0.97 g, 3.01 mmol, 1.10 equiv) was
added, and the reaction was allowed to stir for 12 h at 23 °C.  The reaction was diluted
with CH2Cl2 (8 mL), washed with saturated aq Na2S2O3 (1 x 15 mL), and the aq phase
was extracted with CH2Cl2 (3 x 15 mL).  The combined organic extracts were washed
with saturated aq NaHCO3 (1 x 15 mL) and brine (1 x 15 mL), dried over Na2SO4,
filtered through Celite, and concentrated in vacuo to yield a white oil.  The crude product
was used without further purification in the following step.
The crude oil was added to a solution of iodoform (2.15 g, 5.47 mmol, 2.00 equiv) in
THF (7 mL), and then cooled to 0 °C.  The resulting solution was transferred via cannula
to a 0 °C suspension of chromium(II) chloride (2.00 g, 16.27 mmol, 5.95 equiv) in THF
(30 mL), washing with THF (2 mL) to effect quantitative transfer.  The reaction was
allowed to stir for 4 h, and then  H2O (40 mL) was added, the phases were separated, and
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the aq phase was extracted with Et2O (3 x 50 mL).  The combined organic extracts were
washed with H2O (1 x 30 mL), dried over Na2SO4, filtered, and concentrated in vacuo.
Purification by column chromatography (gradient elution of 3% to 10% EtOAc in
hexanes) yielded vinyl iodide 729 (0.42 g, 58% yield, 5:1 E/Z by 1H NMR) as a thick
yellow oil.  Rf = 0.29 (10% EtOAc in hexanes); 1H NMR (500 MHz, C6D6) δ (trans
isomer) 6.02 (dd, J = 8.5, 15.0 Hz, 1H), 5.62 (d, J = 15.0 Hz, 1H), 3.45 (dd, J = 5.0, 12.0
Hz, 2H), 3.25 (dd, J = 9.0, 12.0 Hz, 2H), 2.04 (dtt, J = 9.0, 8.5, 5.0 Hz, 1H), 1.38 (s, 3H),
1.20 (s, 3H); (cis isomer): 5.89 (d, J = 7.5 Hz, 1H), 5.79 (dd, J = 7.5, 8.5 Hz, 1H), 3.67
(dd, J = 4.0, 11.5 Hz, 2H), 3.41 (dd, J = 7.0, 11.5 Hz, 2H), 3.25 (dd, J = 9.0, 11.5 Hz,
2H), 2.66 (dtt, J = 7.0, 8.5, 4.0 Hz, 1H), 1.36 (s, 3H), 1.30 (s, 3H); 13C NMR (75 MHz,
C6D6) δ (trans isomer) 143.6, 98.0, 78.5, 63.2, 42.2, 27.6, 21.2; IR (Neat Film NaCl)
2992, 2940, 2863, 1604, 1478, 1453, 1386, 1371, 1262, 1205, 1153, 1131, 1076, 1036,
949, 830 cm-1; HRMS (FAB+) m/z: calc’d for C8H13O2I [M + H]+: 269.0039, found
269.0040.
I
O
O
729
O
OH
OHCassiol (270)
t-BuLi
Et2O
–78 °C
(36% yield)
O
PhS (–)-474
OH
then aq HCl
t-BuOMe
Li
O
O
475
OH
 (+)-Cassiol (270).36 To a solution of vinyl iodide 729 (0.204 g, 0.76 mmol, 2.00
equiv) in diethyl ether (5 mL) at –78 °C was added dropwise t-BuLi (1.37 M soln in
pentane, 1.18 mL, 1.62 mmol, 4.25 equiv).  The solution was allowed to stir for 1 h, and
then warmed to 0 °C.  A solution of alcohol (–)-474 (0.10 g, 0.38 mmol, 1 equiv) in
diethyl ether (2.5 mL) was cooled to 0 °C, and added to the reaction vessel dropwise via
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cannula, washing with ether (2.5 mL) for quantitative transfer.  The resulting solution
was warmed to 24 °C, and allowed to stir for 72 h.  To the reaction vessel was added
saturated aq NaHCO3 buffered to pH 8 with saturated aq NH4Cl (7 mL).  The phases were
separated, the aq phase was extracted with EtOAc (3 x 10 mL), and the combined organic
extracts were concentrated in vacuo.  The residue was dissolved in t-butyl methyl ether (8
mL), and 10% aq HCl solution (10 mL) was added to the reaction vessel.  The solution
was allowed to stir for 2 h, and solid NaHCO3 (4.0 g) was added in small portions.  The
phases were separated, and the aq phase was extracted with EtOAc  (3 x 20 mL).  The
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo.
Purification by column chromatography on silica gel (10% MeOH in EtOAc), followed
by purification by column chromatography on Florisil (100% EtOAc) afforded (+)-
cassiol (270, 35.0 mg, 36%) as a thick colorless oil.  Rf = 0.10 (10% MeOH in CH2Cl2);
1H NMR (500 MHz, D2O) δ 6.27 (d, J = 16.5 Hz, 1H), 5.66 (dd, J = 8.5, 16.5 Hz, 1 H),
3.77 (d, J = 11.5 Hz, 1H), 3.74 (ddd, J = 3.0, 6.0, 11.0 Hz, 2H), 3.66 (ddd, J = 2.0, 7.0,
11.0 Hz, 2H), 3.43 (d, J =11.5, 1H), 2.68-2.52 (comp m, 3H), 2.17 (ddd, J = 5.5, 11.0,
14.0 Hz, 1H), 1.80 (s, 3H), 1.75 (app dt, J = 13.5, 6.0 Hz, 1H), 1.11 (s, 3H); 13C NMR
(125 MHz, D2O, uncorrected) δ 204.8, 162.4, 136.7, 132.0, 129.0, 68.0, 62.1, 48.0, 40.8,
33.5, 30.8, 20.5, 13.2; IR (Neat Film NaCl) 3369, 2930, 2868, 1643, 1591, 1455, 1358,
1038 cm–1; HRMS (FAB+) m/z: calc’d for C14H22O4 [M + H]+: 255.1596, found 255.1604;
[α]D26.8 +8.2 (c 1.00, MeOH).
NMR data for (+)-cassiol was also collected in CDCl3.  1H NMR (500 MHz, CDCl3) δ
6.23 (d, J = 16.5 Hz, 1H), 5.59 (dd, J = 8.0, 16.5 Hz, 1H), 3.73-3.86 (comp m, 4H), 3.67
(d, J = 11.5 Hz, 1H), 3.38 (d, J = 11.5 Hz, 1H), 2.78-2.58 (comp. m, 3H), 2.58-2.51
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(comp m, 2H), 2.41 (br. s, 1H), 2.21 (ddd, J = 6.5, 10.5, 14.0 Hz, 1H), 1.82 (s, 3H), 1.64
(dt, J = 13.5, 5.5 Hz, 1H), 1.13 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 199.6, 158.4,
135.2, 132.1, 129.6, 69.7, 64.139, 64.131, 47.7, 41.0, 34.0, 32.1, 21.1, 13.7.
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9.6.3 COMPARISON TABLES FOR PROPERTIES OF SYNTHETIC AND
NATURAL CASSIOL
Table 9.2.  Comparison of 1H NMR data for synthetic, literature, and natural (+)-cassiol
Synthetica
(ppm)
Multiplicity Literatureb
(ppm)
Multiplicity Natural
samplec
(ppm)
Multiplicity
6.27
5.66
3.76
3.75
3.66
3.43
2.68–2.52
2.17
1.80
1.75
1.11
d (1H)
dd (1H)
d (1H)
ddd (2H)
ddd (2H)
d (1H)
comp m (3H)
ddd
br s
app dt
s (3H)
6.28
5.67
3.76
3.75
3.66
3.43
2.71–2.55
2.17
1.81
1.74
1.12
d (1H)
dd (1H)
d (1H)
dd (2H)
dd (2H)
d (1H)
m (3H)
ddd (1H)
d (3H)
dt (1H)
s (3H)
6.28
5.67
3.76
3.75
3.66
3.43
2.69–2.51
2.17
1.81
1.75
1.12
dt (1H)
dd (1H)
d (1H)
dd (2H)
dd (2H)
d (1H)
ddd (3H)
ddd (1H)
d (3H)
ddd (1H)
s (3H)
a 1H NMR data measured at 500 MHz in D2O  (this work).
b 1H NMR data measured at 250 MHz in D2O.37
c 1H NMR data measured at 250 MHz in D2O.38
Table 9.3.  Comparison of 13C NMR data for synthetic, literature, and natural (+)-cassiol
Synthetica Literatureb Natural samplec
204.8
162.4
136.7
132.0
129.0
68.0
62.1
48.0
40.8
33.5
30.8
20.5
13.2
207.12
164.87
139.17
134.35
131.37
70.44
64.55
50.30
43.18
35.89
33.28
23.02
15.63
207.1
164.7
139.0
134.2
131.3
70.4
64.5
50.1
43.1
35.8
33.2
22.9
15.5
a 13C NMR data measure at 125 MHz in D2O (this work).
b 13C NMR data measure at 50 MHz in D2O.37
c 13C NMR data measure at 50.3 MHz in 1:1 CDCl3/methanol-d4.38
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Table 9.4.  Comparison of IR data for synthetic, literature, and natural (+)-cassiol
Synthetica Literatureb Natural samplec
3369
2930
2868
1643
1591
1455
1358
1038
975
3368
2930
2876
1644
1594
1456
1044
3400
1650
1600
1340
1040
980
a Thin film (this work).
b Neat.37
c Thin film.38
Table 9.5.  Comparison of HRMS data for synthetic, literature, and natural (+)-cassiol
Synthetic
calculated
Synthetic founda Literature
calculated
Literature
foundb
Natural sample
foundc
255.1596 255.1604 254.1518 254.1519 254
a FAB+, measured [M + H]+ (this work).
b EI-MS, measured [M]+.39
c EI-MS, measured [M]+.38
Table 9.6.  Comparison of optical rotation data for synthetic, literature, and natural (+)-cassiol
Synthetica Literatureb Natural samplec
[α]D26.8 +8.2 [α]D30 +8.3 [α]D28.5 +8.6
a c = 1.00 in MeOH (this work).
b c = 0.35 in MeOH.37
c c = 0.25 in MeOH.38
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CHAPTER 10
Enantioselective Formal Synthesis of Platencin†
10.1 INTRODUCTION
The growing resistance of several pathogenic bacterial strains against commercially
available antibiotics necessitates the rapid and efficient development of novel active
ingredients.  In this quest natural products serve as valuable lead structures.1  Recently,
platencin (737, Figure 10.1)2 and platensimycin (738)3 were isolated by Merck scientists
as highly active in vitro and in vivo antibiotics possessing a novel mode of action.  These
natural products attracted tremendous interest from the synthetic community, and a
number of different approaches to each natural product have been reported.4,5  Herein, we
disclose a short and efficient enantioselective formal synthesis of platencin (737) making
use of enantioconvergent allylation methodology developed in our group.6
Figure 10.1.  Structures of the antibiotics platencin (737) and platensimycin (738)
Platencin (737) Platensimycin (738)
O
O
Me
Me
O
N
H
OH
OH
HO2C
OMe
O
N
H
OH
OH
HO2C
                                                 
† This work was performed in collaboration with Christian Defieber.
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10.2 RETROSYNTHETIC ANALYSIS
We have pursued a research strategy that consists of identifying particular structural
challenges of natural products to guide the development of novel methods in
enantioselective catalysis.7  In accord with this tactic, we have developed a series of Pd-
catalyzed enolate alkylation reactions for the enantioselective synthesis of quaternary
stereocenters and applied these transformations in synthetic studies toward several target
molecules.8,9  The presence of two all-carbon quaternary stereocenters in both platencin
(737) and platensimycin (738) entreated us to explore the synthesis of these molecules
using our method.  We first chose to explore the synthesis of platencin (737) because of
the interesting dual-mode of action in inhibiting bacterial fatty-acid biosynthesis
exhibited by platencin but not platensimycin.  Moreover, we have an ongoing interest in
strained [2.2.2]bicyclic compounds due to their special structural and chemical
properties.10  Since Nicolaou4a and Rawal4b have each reported procedures to introduce
the aromatic portion of the natural product, we targeted tricyclic intermediate 739
(Scheme 10.1) for our synthetic studies.
Initially, our retrosynthetic plan included the assembly of the [2.2.2]bicyclic structure
739 by employing an intramolecular vinyl radical cyclization11 of precursor 740 (Scheme
10.1).  We envisioned constructing dienone 741 through an intramolecular aldol
condensation with cyclohexanone 742.  The absolute stereochemistry of diketone 742
would be controlled via Pd-catalyzed enantioconvergent alkylation using racemic β-
ketoester 743 or 744.
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Scheme 10.1. Retrosynthetic analysis of platencin (737)
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10.3 INITIAL STUDIES TOWARD PLATENCIN
The necessary precursor for the projected Tsuji allylation was readily assembled
through a three-step protocol (Scheme 10.2).  Cyclohexanone (745) was converted to its
corresponding morpholine enamine that then reacted with 2-haloallyl chloroformates
(746 or 747) to afford the allyl β-ketoesters.12  Subsequent alkylation with ethyl vinyl
ketone yielded racemic allylation precursors 743 and 744.  With these substrates in hand,
we next explored enantioconvergent decarboxylative alkylation reactions in the presence
of the complex derived from [Pd2(dba)3] and phosphinooxazoline (PHOX) ligand 55.13,14
Whereas chloro-substituted β-ketoester underwent a clean conversion to provide
cyclohexanone 742 in 85% yield, the corresponding bromo derivative 744 remained
unreactive under identical reaction conditions.  Subsequent experimentation led us to
conclude that the palladium complex inserts oxidatively in the C–Br bond and is
precluded from participation in the allylation chemistry.15
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Scheme 10.2.  Investigations of the Tsuji allylation
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Further synthetic manipulations toward our target intermediate (739) involved
annulation by means of aldol cyclization with Tsuji product 742, followed by
dehydrogenation16  to afford dienone 741 (Scheme 10.2).  Several reaction conditions to
effect the key cyclization to the bicyclo[2.2.2]octane 740 were examined, albeit to no
avail.  Application of radical conditions (Bu3SnH, AIBN, benzene, 80 °C)17 only led to
recovery of starting material; anionic conditions (t-BuLi, CuCN, THF, –78 °C)18 resulted
in the formation of a complex mixture of unidentified products.
10.4 REVISED RETROSYNTHESIS
In order to tackle the challenging synthesis of the chiral bicyclo[2.2.2]octane scaffold,
we reconsidered our retrosynthetic plan and decided to reverse the order of ring assembly
(Scheme 10.3).  Postponing the aldol condensation to a later stage in the synthesis, our
focus shifted entirely toward construction of the chiral bicyclo[2.2.2]octadione 749.  We
envisioned an umpolung strategy in which aldehyde 750 would undergo an
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intramolecular conjugate addition (Stetter cyclization).19  The aldehyde itself would again
be the result of an enantioselective decarboxylative alkylation.
Scheme 10.3.  Revised retrosynthesis of the platencin core
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10.5 IMPLEMENTATION OF THE REVISED STRATEGY—FORMAL
SYNTHESIS OF PLATENCIN
Following our revised strategy, the lithium enolate of cyclohex-2-en-1-one (751) was
treated with allyl diethylphosphonoformate 752,20 an inexpensive alternative to Mander’s
reagent21 (Scheme 10.4).  The intermediate β-ketoester was alkylated with ethyl vinyl
ketone to afford racemic substrate 753.  The subsequent enantioselective decarboxylative
alkylation reaction proceeded smoothly to provide cyclohexenone 754 in good yield
(88%) and enantiomeric excess (83%).  Selective oxidative cleavage of the more
electron-rich double bond in enone 754 was effected by ozone in the presence of
pyridine.22  However, when aldehyde 750 was subjected to Stetter cyclization conditions
promoted by thiazolium- or triazolium-based catalysts,23 only a benzoin-type
condensation product was isolated.24  Given our recent success with an aldehyde/olefin
radical cyclization in another synthetic effort,9c we exposed tricarbonyl compound 750 to
the radical initiator V-40 and t-dodecanethiol in refluxing toluene.  We were pleased to
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find that the radical cyclization conditions provided the desired chiral
bicyclo[2.2.2]octadione 749 in 78% yield.25
Scheme 10.4.  Assembly of the bicyclo[2.2.2]octadione scaffold
O O
O
O
O
O
O
751 754, 83% ee753
O
O
O
750
H O
O
O
749
1. LDA, then
2. ethyl vinyl ketone
    K2CO3, acetone
    50 °C
(88% yield)
O3, Pyr
MeOH, –78 °C
then P(OMe)3
(83% yield)
V-40
t-C12H25SH
toluene, 110 °C
(78% yield)
(59% yield, 2 steps)
752
THF, 30 °C
[Pd2(dba)3]
(2.5 mol%)
55
(6.25 mol%)
(EtO)2P O
O
O
The key bridged bicycle 749 was then subjected to basic conditions (KOH, MeOH,
23 °C, Scheme 10.5).  These conditions promoted an intramolecular aldol cyclization that
appeared to be completely regioselective for formation of the desired tricyclic compound
(751).  Dione 751 was highly crystalline and a single recrystallization from hexanes
allowed us to increase the enantiomeric excess to 99%.  The structure of tricycle 751 was
confirmed by single-crystal X-ray diffraction analysis (Figure 10.2).26
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Scheme 10.5.  Formal synthesis of platencin
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Figure 10.2.  ORTEP plot of dione 751 derived from X-ray crystallographic analysis (nonhydrogen
atoms are shown with ellipsoids at 50% probability)
O
O
751
Chemoselective methylenation of the ketone moiety of 751 was achieved in 89%
yield by action of a Wittig reagent (Scheme 10.5).  Exposure of the resulting alkene (740)
to Li metal led to enone reduction with concomitant formation of a lithium enolate that
was trapped with allyl bromide (752) to provide ketone 753 in 78% yield as a 1:1 mixture
of epimers at C(9).  A three-step protocol was employed to introduce the enone
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functionality present in the target structure (739) in 88% yield.  This compound was an
intermediate in Nicolaou’s total synthesis of platencin (737),4a and therefore this work
constitutes a formal synthesis of the natural product.
10.6 SUMMARY
In conclusion, we have developed a short enantioselective formal synthesis of the
antibiotic platencin (737).  Key features include the enantioconvergent catalytic
alkylation to set the absolute stereochemistry as well as a radical-mediated cyclization to
assemble the core bicyclo[2.2.2]octane structure.  The synthesis and biological evaluation
of platencin analogues is underway and will be reported in due course.
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10.8 EXPERIMENTAL SECTION
10.8.1 MATERIALS AND METHODS
Unless otherwise stated, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by
passage through an activated alumina column under argon. Brine solutions are saturated
aqueous sodium chloride solutions.  Tris(dibenzylideneacetone)dipalladium(0)
[Pd2(dba)3],27 (S)-t-BuPHOX (55),28 and trizaolium salt 75529 were synthesized according
to standard procedures and stored in a desiccator until immediately before use.
Trimethylsilyl chloride (TMSCl) and triethyl amine (TEA) were distilled from sodium
hydride immediately prior to use.  Cyclohex-2-enone and ethyl vinyl ketone were
distilled immediately prior to use. All other commercially obtained reagents were used as
received.  Reaction temperatures were controlled by an IKAmag temperature modulator.
Thin-layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 pre
coated plates (0.25 mm) and visualized by UV fluorescence quenching, p-anisaldehyde,
or KMnO4 staining.  ICN Silica gel (particle size 0.032-0.063 mm) was used for flash
column chromatography.  Analytical chiral HPLC was performed with an Agilent 1100
Series HPLC utilizing Chiralpak AD or Chiralcel OD-H columns (4.6 mm x 25 cm)
obtained from Daicel Chemical Industries, Ltd. with visualization at 254 nm.  Optical
rotations were measured with a Jasco P-1010 polarimeter at 589 nm.  1H NMR spectra
were recorded on a Varian Mercury 300 (at 300 MHz) or a Varian Inova 500 (at 500
MHz) and are reported relative to residual solvent peaks (CDCl3, δ  7.26; DMSO-d6, δ
2.49). Data for 1H NMR spectra are reported as follows: chemical shift (δ  ppm)
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(multiplicity, coupling constant (Hz), integration).  13C NMR spectra were recorded on a
Varian Mercury 300 (at 75 MHz) or a Varian Inova 500 (at 125 MHz) and are reported
relative to residual solvent peaks (CDCl3, δ 77.3; DMSO-d6, δ 39.5).  Data for 13C NMR
spectra are reported in terms of chemical shift.  IR spectra were recorded on a Perkin
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption
(cm-1).  High resolution mass spectra were obtained from the California Institute of
Technology Mass Spectral Facility.
10.8.2 EXPERIMENTAL PROCEDURES AND CHARACTERIZATION DATA
Procedure for the Synthesis of the 2-Haloallyl chloroformates30
Cl O
O
X
HO
X
Cl O
O
NEt3
Et2O
CCl3 +
746, X = Cl
747, X = Br
758, X = Cl
759, X = Br
757
2-Chloroallyl chloroformate 746: A 50 mL three-neck round-bottom flask equipped
with a 25 mL addition funnel, a stir bar, and three septa was flame dried under vacuum.
After refilling with argon, anhydrous Et2O (6 mL) was added via syringe, and the system
was cooled to ca. –10 °C.  Diphosgene (757, 1.0 mL, 8.46 mmol, 1.21 equiv) was added
dropwise via syringe, and the solution was cooled to approx. –20 °C. 2-chloroallyl
alcohol (758, 0.56 mL, 7.0 mmol, 1.0 equiv) in anhydrous Et2O (6 mL) was added
dropwise via the addition funnel, and the solution was stirred at approx. –20 °C for an
additional 15 min.  The reaction was cooled to approx. –30 °C, and triethylamine (1.17
mL, 8.37 mmol, 1.20 equiv) in anhydrous Et2O (6 mL) was added dropwise via the
addition funnel, generating a white precipitate.  The reaction was then cooled to approx.
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–30 °C and stirred for 3 h, at which time it was allowed to warm to 23 °C.  During this
time, the reaction mixture became very thick, anhydrous Et2O (10 mL) was added to
obtain a stirable suspension.  Argon was bubbled through the suspension for 2 h to
remove excess phosgene.  The reaction mixture was filtered via vacuum filtration through
a fritted funnel, and the filtrate was concentrated by rotary evaporation under reduced
pressure.   The title compound 746 (553 mg, 3.57 mmol, 51%) was obtained as a
colorless liquid.  1H NMR (500 MHz, CDCl3): δ 5.58 (dt, J = 2.0, 1.0 Hz, 1H), 5.53 (d, J
= 2.2 Hz, 1H), 4.84 (d, J = 0.7 Hz, 2H).  The other spectroscopic data are in agreement
with the literature data.30b
Cl O
O
Br747
2-Bromoallyl chloroformate 747:  A solution of 2-bromoallyl alcohol31 (759. 1.00 g,
7.30 mmol, 1.0 equiv) in Et2O (6 mL) was added to a –30 °C solution of diphosgene
(757, 898.8 µL, 7.44 mmol, 1.02 equiv) in Et2O (6 mL).  After 15 min, neat Et3N (1.03
mL, 7.37 mmol, 1.01 equiv) was added, causing the immediate formation of a white
precipitate.  After 3.5 h at –30 °C, the mixture was removed from the cooling bath and
then quickly passed through a sintered glass filter.  The filtrate was concentrated carefully
by rotary evaporation.  Distillation of the residue through a short path apparatus into an
receiving flask cooled in an ice/water bath provided the title compound 747 as a clear,
colorless liquid (582.3 mg, 40% yield).  bp 69–71 °C/22 torr; 1H NMR (300 MHz, C6D6)
δ 5.26 (dt, J = 2.5, 1.1 Hz, 1H), 5.17 (dt, J = 2.5, 0.6 Hz, 1H), 4.13 (dd, J = 1.1, 0.6 Hz,
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2H); 13C NMR (75 MHz, C6D6) δ 150.3, 124.0, 121.7, 73.8; IR (Neat Film NaCl) 2954,
1786, 1634, 1439, 1413, 1268, 1148, 1128, 918, 839, 811, 686 cm–1.
Procedure for the Preparation of the β-Ketoesters 743 and 74432
O 1. morpholine, benzene
    Dean-Stark trap
2.
O
O
Cl
X
O
O O
X
O
O O
X
O
Me
ethyl vinyl ketone, 
acetone, 50 °C
746, X = Cl
747, X = Br
745 760, X = Cl
761, X = Br
743, X = Cl
744, X = Br
Cyclohexanone (745, 3.8 mL, 40.8 mmol, 1.0 equiv) and morpholine (6.4 mL, 73.4
mmol, 1.8 equiv) were diluted in dry benzene (12 mL) in a 50 mL round-bottom flask
equipped with a Dean–Stark trap and a reflux condenser. The resulting reaction mixture
was heated to reflux until no further separation of water was observed. The volatiles were
removed by rotary evaporation under reduced pressure. The resulting oily orange residue
is distilled to remove excess morpholine to afford 5.0 g (29.9 mmol, 73%) morpholine
enamine of cyclohexanone as a colorless liquid.
A portion of this intermediate (971 mg, 5.8 mmol, 1.8 equiv) was diluted in benzene
(5 mL). Under a nitrogen atmosphere, 2-chloroallyl chloroformate (746, 500 mg, 3.23
mmol, 1.0 equiv) was slowly added via syringe while the enamine solution was stirred
rapidly. After refluxing for about 10 h, the solution was cooled to 23 °C and filtered, the
precipitate of enamine hydrochloride being washed with dry ether. The combined filtrate
and washings were returned to the reaction flask, ca. 7 mL of 10% aqueous hydrochloride
acid was added, and the mixture was stirred vigorously for 15-30 minutes. The layers
were separated, the aqueous layer was extracted three times with diethyl ether (20 mL x
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3) and the combined organic layers were washed with brine, dried (MgSO4) and
concentrated in vacuo. The crude 2-chloroallyl 2-oxocyclohexanecarboxylate (638 mg,
2.94 mmol, 91%) was analyzed by 1H NMR. The sample possessed sufficient quality to
be used immediately in the next reaction obviating the need for further purification.
The crude β-ketoester (760 , 638 mg, 2.94 mmol, 1.0 equiv) was added to a
suspension of potassium carbonate (814 mg, 5.89 mmol, 2.0 equiv) in acetone (4 mL). At
23 °C, ethyl vinyl ketone (586 µL, 5.89 mmol, 2.0 equiv) was added slowly via syringe.
The resulting heterogeneous mixture was stirred for 7 h at 50 °C, then cooled to 23 °C,
filtered and the filtrate concentrated by rotary evaporation under reduced pressure. The
residue was purified by flash column chromatography (silica, hexanes-EtOAc 15:1 to
3:1) to afford 2-chloroallyl 2-oxo-1-(3-oxopentyl)cyclohexanecarboxylate (676 mg, 2.24
mmol, 76%)  743 as a colorless liquid.
760
O
O
Cl
O
2-Chloroallyl 2-oxocyclohexanecarboxylate (760): Neat 2-chloroallyl
chloroformate33 (746, 257.4 mg, 1.66 mmol, 1.0 equiv) was added to a solution of 1-
morpholinocyclohexene34 (500.0 mg, 2.99 mmol, 1.8 equiv) in dry benzene (2.5 mL).
The mixture was heated to reflux for 9 h, during which time some solids precipitated and
the solution became orange in color.  The mixture was cooled and then filtered through
cotton, rinsing with diethyl ether.  The combined filtrate and washings were treated with
2 N aq hydrochloric acid (2 mL) and the resulting biphasic mixture was stirred vigorously
for 1 h.  The phases were separated and then the aq phase was extracted with diethyl ether
926 Chapter 10 – Enantioselective Formal Synthesis of Platencin
(3 x 2 mL).  The combined organic phases were dried over anhydrous magnesium sulfate,
filtered, and concentrated to an orange-brown oil.  Flash chromatography (silica gel, 2 cm
diameter x 10 cm height, 15% EtOAc in hexanes eluent) yielded a colorless liquid (199.3
mg, 55% yield).  Characterized as a 3.5:1 mixture of enol:keto tautomers in C6D6: 1H
NMR (500 MHz, C6D6) δ 12.50 (s, 0.8H), 5.21 (app. dt, J = 1.7, 1.2 Hz, 0.2H), 5.10 (app.
dt, J = 1.7, 0.7 Hz, 0.2H), 5.06 (dt, J = 1.7, 0.7 Hz, 0.8H), 5.03 (dt, J = 1.7, 1.2 Hz, 0.8H),
4.54 (ddd, J = 13.7, 1.0, 0.5 Hz, 0.2H), 4.50 (ddd, J = 13.7, 1.0, 0.5 Hz, 0.2H), 4.44 (dd, J
= 1.2, 0.7 Hz, 1.6H), 3.00 (ddd, J = 11.0, 5.6, 1.0 Hz, 0.2H), 2.18–2.11 (comp. m, 1.8H),
2.05–2.02 (m, 1.6H), 1.88 (dddd, J = 13.7, 11.2, 11.0, 3.7 Hz, 0.2H), 1.70 (dddd, J =
13.7, 11.2, 5.4 1.0 Hz, 0.2H), 1.67–1.59 (m, 0.2H), 1.31–1.18 (comp. m, 3.6H),
1.18–1.07 (m, 0.2H), 0.96–0.86 (m, 0.2H); 13C NMR (125 MHz, C6D6) δ 204.1, 173.9,
171.8, 169.1, 136.6, 136.2, 115.4, 114.8, 97.3, 66.3, 65.6, 57.2, 41.5, 29.9, 29.4, 26.9,
23.4, 22.6, 22.4, 21.9; IR (Neat Film NaCl) 2941, 2861, 1755, 1717, 1659, 1642, 1614,
1450, 1422, 1396, 1363, 1297, 1259, 1217, 1174, 1082, 1062, 894, 829, 811, 708, 644
cm–1; HRMS (FAB+) m/z calc'd for C10H14O3Cl [M + H]+: 217.0632, found 217.0627.
761
O
O
Br
O
2-Bromoallyl 2-oxocyclohexanecarboxylate (761): Neat 2-bromoallyl
chloroformate (747, 250.0 mg, 1.25 mmol, 1.0 equiv) was added to a solution of 1-
morpholinocyclohexene34 (377.4 mg, 2.26 mmol, 1.8 equiv) in dry benzene (2 mL).  The
mixture was heated to reflux for 9 h, during which time some solids precipitated and the
solution became slightly yellow in color.  The mixture was cooled and then filtered
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through cotton, rinsing with diethyl ether.  The combined filtrate and washings were
treated with 2 N aq hydrochloric acid (1 mL) and the resulting biphasic mixture was
stirred vigorously for 1 h.  The phases were separated and then the aq phase was
extracted with diethyl ether (3 x 2 mL).  The combined organic phases were dried over
anhydrous magnesium sulfate, filtered, and concentrated to a yellow oil.  Flash
chromatography (silica gel, 2 cm diameter x 8 cm height, 10% EtOAc in hexanes eluent)
yielded a colorless liquid (761, 184.1 mg, 56% yield).  Characterized as a 3.7:1 mixture
of enol:keto tautomers in C6D6: Rf = 0.16 (10% EtOAc in hexanes); 1H NMR (500 MHz,
C6D6) δ 12.50 (s, 0.8H), 5.65 (app. dt, J = 1.5, 0.7 Hz, 0.2H), 5.44 (dt, J = 1.2, 0.7 Hz,
0.8H), 5.33 (app. dt, J = 1.2, 0.7 Hz, 0.2H), 5.29 (dt, J = 1.2, 0.7 Hz, 0.8H), 4.60 (ddd, J
= 13.9, 0.7, 0.7 Hz, 0.2H), 4.56 (ddd, J = 13.9, 0.7, 0.7 Hz, 0.2H), 4.49 (app. s, 1.6H),
3.00 (dd, J = 10.7, 5.4 Hz, 0.2H), 2.18–2.11 (comp. m, 1.8H), 2.02 (app. t, J = 5.1 Hz,
1.6H), 1.89 (dddd, J = 13.9, 11.0, 11.0, 3.2 Hz, 0.2H), 1.71 (ddd, J = 13.9, 11.5, 5.4 Hz,
0.2H), 1.67–1.60 (m, 0.2H), 1.31–1.18 (comp. m, 3.6H), 1.18–1.06 (m, 0.2H), 0.97–0.87
(m, 0.2H); 13C NMR (125 MHz, C6D6) δ 204.1, 173.9, 171.7, 168.9, 127.1, 126.6, 119.6,
118.9, 97.3, 67.9, 67.1, 57.2, 41.5, 29.9, 29.4, 26.9, 23.4, 22.6, 22.4, 21.9; IR (Neat Film
NaCl) 2940, 2860, 1753, 1716, 1659, 1613, 1449, 1429, 1394, 1361, 1296, 1258, 1216,
1174, 1143, 1080, 1061, 894, 829, 810, 647 cm–1; HRMS (FAB+) m/z calc'd for
C10H14O3Br [M + H]+: 261.0126, found 261.0118.
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O
O
O
Me
Cl
743
2-chloroallyl 2-oxo-1-(3-oxopentyl)cyclohexanecarboxylate 743: Prepared
according to the representative procedure on a 3.23 mmol scale.  The title compound 743
(676 mg, 2.24 mmol, 69% over 2 steps) was obtained as a colorless liquid. Rf 0.56 (silica,
hexanes/EtOAc 3:1); 1H NMR (500 MHz, CDCl3): δ 5.50 (s, 1H), 5.44 (s, 1H), 4.73 (d, J
= 13.3 Hz, 1H), 4.68 (d, J = 13.3 Hz, 1H), 2.58–2.37 (m, 7H), 2.16 (m, 2H), 2.02–1.98
(m, 1H), 1.91 (m, 2H), 1.79–1.77 (m, 1H), 1.67 (m, 2H), 1.52 (m, 1H), 1.03 (t, J = 7.3
Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 210.4, 207.5, 171.4, 135.3, 116.5, 66.8, 60.1,
40.9, 37.3, 36.5, 35.9, 28.3, 27.4, 22.4, 7.8; IR (neat Film, NaCl): ν 2941, 2868, 1715,
1451, 1239, 1212, 1177, 1134, 1086, 906 cm-1; HRMS (EI+) m/z calc’d for C15H22O4Cl
[M + H]+: 301.1207, found 301.1205.
O
O
O
O
Me
Br
744
2-bromoallyl 2-oxo-1-(3-oxopentyl)cyclohexanecarboxylate 744: Prepared
according to the representative procedure on a 3.46 mmol scale. The title compound 744
(651 mg, 1.89 mmol, 55% over 2 steps) was obtained as a colorless liquid. Rf 0.61 (silica,
hexanes/EtOAc 3:1); 1H NMR (500 MHz, CDCl3): δ 5.94 (s, 1H), 5.44 (s, 1H), 4.79 (d, J
= 13.4 Hz, 1H), 4.73 (d, J = 13.4 Hz, 1H), 2.58–2.34 (m, 7H), 2.16 (m, 2H), 2.01–1.99
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(m, 1H), 1.92 (m, 2H), 1.80–1.77 (m, 1H), 1.72–1.65 (m, 2H), 1.52 (m, 1H), 1.03 (t, J =
7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 210.3, 207.5, 171.3, 125.6, 120.7, 68.4,
60.2, 40.9, 37.3, 36.5, 35.9, 28.3, 27.4, 22.4, 7.8; IR (neat Film, NaCl): ν 2940, 2867,
1714, 1450, 1310, 1177, 1133, 1085, 980, 908 cm-1; HRMS (EI+) m /z calc’d for
C15H22O4Br [M+H]+: 345.0701, found 345.0712.
O
OO
O
Me
762
Allyl 2-oxo-1-(3-oxopentyl)cyclohexanecarboxylate 762: Prepared according to the
representative procedure on a 56.6 mmol scale.  The title compound 762 (4.04 g, 15.1
mmol, 27% over 2 steps) was obtained as a colorless liquid. Rf  0.39 (silica,
hexanes/EtOAc 3:1); 1H NMR (500 MHz, CDCl3): δ 6.08 (m, 1H), 5.33 (dd, J = 1.2, 16.6
Hz, 1H), 5.26 (dd, J = 1.0, 10.6 Hz, 1H), 4.63–4.61 (m, 2H), 2.56–2.30 (m, 6H), 2.12
(dddd, J = 5.1, 5.1, 5.1, 14.3 Hz, 1H), 2.01–1.97 (m, 1H), 1.88 (dddd, J = 5.4, 5.4, 5.4,
14.2 Hz, 1H), 1.77–1.74 (m, 1H), 1.67–1.61 (m, 2H), 1.15–1.50 (m, 1H), 1.03 (t, J = 7.3
Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 210.4, 207.8, 171.4, 131.4, 119.3, 65.9, 60.1,
41.0, 37.4, 36.6, 35.9, 28.4, 27.5, 22.5, 7.8; IR (neat Film, NaCl): ν 3087, 2941, 2868,
1714, 1649, 1452, 1376, 1292, 1240, 1211, 1182, 1136, 1115, 1086, 993, 938, 814 cm-1;
HRMS (EI+) m/z calc’d for C15H23O4 [M + H]+: 267.1596, found 267.1604.
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Representative Procedure for the Enantioconvergent Allylation35
742, X = Cl
763, X = H
O
O O
X
O
Me
O
O
Me
X5 mol% [Pd2(dba)3]THF, 30 °C
(12.5 mol%)
Ph2P N
O
t-Bu
743, X = Cl
762, X = H
55
A 25 mL Schlenk flask was equipped with a magnetic stir bar and flame dried under
vacuum.  After cooling to 23 °C under dry argon, Pd2(dba)3 (4.6 mg, 5 µmol, 5 mol%)
and (S)-t-BuPHOX (55 , 4.8 mg, 12.5 µmol, 12.5 mol%) were added.  The flask
containing the solids was evacuated for 15 min and then refilled with dry argon.  Dry
THF (3 mL) was then added and the resulting solution stirred at 23 °C for 30 min.  At
this point, 2-chloroallyl 2-oxo-1-(3-oxopentyl)cyclohexanecarboxylate 743 (30 mg, 0.1
mmol, 1.0 equiv) was added via syringe in one portion.  The reaction was warmed to
30–35 °C.  When the reaction was complete as judged by TLC, the reaction mixture was
evaporated under reduced pressure and the residue purified by flash column
chromatography (silica, hexanes/EtOAc 10:1) to afford (R)-2-(2-chloroallyl)-2-(3-
oxopentyl)cyclohexanone 742 (21.7 mg, 85 µmol, 85%) as a colorless liquid.  The
enantiomeric excess was determined after the aldol cyclization on compound 748.  Rf
0.42 (silica, hexanes/EtOAc 3:1); [α]D22.5 +20.4° (c 1.04, CHCl3); 1H NMR (500 MHz,
CDCl3): δ 5.28 (app. d, J = 1.2 Hz, 1H), 5.13 (s, 1H), 2.70 (d, J = 14.9 Hz, 1H), 2.63 (d,
J = 14.9 Hz, 1H), 2.51–2.42 (m, 3H), 2.40 (q, J = 7.3 Hz, 2H), 2.18–2.09 (m, 2H),
1.95–1.70 (m, 7H), 1.03 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 213.7,
210.7, 138.5, 116.8, 50.7, 43.4, 39.1, 36.7, 36.7, 36.1, 28.2, 26.9, 20.7, 7.8; IR (neat Film,
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NaCl): ν 2939, 2867, 1706, 1628, 1455, 1374, 1113, 889 cm-1; HRMS (EI+) m/z calc’d
for C14H22O2Cl [M+H]+: 257.1308, found 257.1317.
O
O
Me
763
2-Allyl-2-(3-oxopentyl)cyclohexanone 763: Prepared according to the representative
procedure on a 0.1 mmol scale. The title compound 763 (20.0 mg, 90 µmol, 90%) was
obtained as a colorless liquid.  Rf 0.40 (silica, hexanes/EtOAc 3:1); [α]D22.5 +16.4° (c
1.28, CHCl3); 1H NMR (500 MHz, CDCl3): δ 5.69–5.61 (m, 1H), 5.07–5.02 (m, 2H),
2.43–2.14 (m, 8H), 1.99 (ddd, J = 4.9, 10.7, 15.9 Hz, 1H), 1.88–1.67 (m, 7H), 1.03 (t, J =
7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 214.6, 211.1, 133.4, 118.3, 50.7, 39.2, 39.2,
36.6, 36.3, 36.0, 28.4, 27.0, 20.7, 7.8; IR (neat Film, NaCl): ν 2937, 2866, 1703, 1639,
1455, 1375, 1113, 916 cm-1.
748
Me
O
Cl
KOH, 
MeOH, 23 °C
76% yield,
90% ee
O
O
Me
Cl
742
(R)-4a-(2-Chloroallyl)-1-methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one
748: The 1,5-diketone 742 (210 mg, 0.82 mmol, 1.0 equiv) was added to 1.85 mL 1 M
KOH (1.85 mmol, 3 equiv) in methanol.  The reaction mixture was stirred at 23 °C for 7
h during which time color gradually changes from yellow to orange.  After the reaction
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was complete as judged by TLC, ca. 4 mL Et2O and ca. 4 mL H2O were added.  The
organic phase was separated and the aqueous phase acidified by addition of 10% aq HCl
(ca. 2 mL) before it was extracted three times with Et2O (10 mL x 3). The combined
organic phases were washed with brine, dried (MgSO4) and concentrated in vacuo.  The
residue was purified by flash column chromatography (silica, hexanes/EtOAc 10:1) to
afford 142 mg (0.59 mmol, 73%) of the title compound 748 as a colorless liquid.  The
enantiomeric excess was determined to be 88% ee.  It was measured with HPLC using
chiral stationary phase columns (Chiralcel OD-H, 1% isopropanol in hexanes, flow rate 1
mL/min, 254 nm, 10.9 min (major), 13.2 min (minor)).  Rf 0.39 (silica, hexanes/EtOAc
3:1); [α]D21.0 –70.7° (c 0.99, CHCl3); 1H NMR (500 MHz, CDCl3): δ 5.36 (d, J = 1.0 Hz,
1H), 5.17 (s, 1H), 2.78 (d, J = 14.6 Hz, 1H), 2.77–2.73 (m, 1H), 2.62 (d, J = 14.1 Hz,
1H), 2.62–2.54 (m, 1H), 2.40 (ddd, J = 3.9, 4.6, 17.3 Hz, 1H), 2.18 (ddd, J = 3.9, 5.0,
13.9 Hz, 1H), 2.15–2.07 (m, 1H), 2.02 (ddd, J = 3.2, 5.4, 13.9 Hz, 1H), 1.97–1.92 (m,
1H), 1.78 (s, 3H), 1.73–1.60 (m, 3H), 1.44–1.34 (m, 1H), 1.28 (ddd, J = 4.2, 13.5, 13.5
Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 198.8, 161.2, 138.7, 129.9, 116.7, 42.1, 39.7,
38.1, 33.9, 33.1, 27.7, 26.7, 21.2, 11.1; IR (neat Film, NaCl): ν 2932, 2862, 1665, 1627,
1608, 1456, 1362, 1304, 1163, 1076, 882 cm-1; HRMS (EI+) m/z calc’d for C14H20ClO
[M+H]+: 239.1203, found 239.1209.
Chapter 10 – Enantioselective Formal Synthesis of Platencin 933
Me
O
Cl
Me
O
Cl
1. cat. p-TsOH
   (EtO)3CH
   EtOH, 23 °C
2. DDQ
    aq acetone
55% yield
741748
(R)-4a-(2-Chloroallyl)-1-methyl-4,4a,5,6-tetrahydronaphthalen-2(3H)-one 741:36
The enone 748 (170 mg, 0.71 mmol, 1.0 equiv), triethyl orthoformate (535 µL, 2.85
mmol, 4.0 equiv) and a catalytic amount of p-toluenesulfonic acid monohydrate were
diluted in dry ethanol (4 mL).  The yellow reaction mixture was stirred at 23 °C for 24 h
during which time its color turned dark brown.  The reaction mixture was then poured
into saturated sodium bicarbonate (10 mL) and extracted with hexanes (15 mL x 3).  The
combined organic layers were washed with brine (5 mL), dried (MgSO4) and
concentrated in vacuo.  The crude ethyl dienol ether (173 mg, 0.65 mmol, 92%) is
unstable and therefore it was immediately dissolved in 95% aqueous acetone (4 mL).  A
solution of 2,6-dichloro-5,6-dicyano-p-benzoquinone (188 mg, 0.68 mmol, 1.05 equiv) in
acetone (1 mL) was slowly added to the reaction mixture via syringe.  The mixture turned
black immediately, stirring was continued for 3 h at 23 °C before the solids were
removed by filtration, and the filtrate concentrated in vacuo. The residue was purified by
flash column chromatography (silica, hexanes/EtOAc 10:1) to afford dienone 741 (92
mg, 0.39 mmol, 55% over 2 steps) as a colorless liquid.  1H NMR (500 MHz, CDCl3): δ
6.54–6.41 (m, 1H), 6.21–6.15 (m, 1H), 5.33 (d, J = 1.5 Hz, 1H), 5.14 (d, J = 1.0 Hz, 1H);
2.67–2.57 (m, 1H), 2.52–2.36 (m, 4H), 2.24–2.15 (m, 2H), 2.15–2.10 (m, 1H), 2.03–1.96
(m, 1H), 1.76 (s, 3H), 1.72–1.60 (m, 1H), 1.46–1.30 (m, 1H); 13C NMR (125 MHz,
CDCl3): δ 198.9, 153.6, 138.6, 136, 8, 128.7, 124.5, 116.8, 40.9, 36.9, 33.9, 32.3, 32.2,
23.2, 10.3; HRMS (EI+) m/z calc’d for C14H18OCl [M+H]+: 237.1046, found 237.1045.
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Cl O
O
P(OEt)3+
no solvent, 
exothermic
23 °C
(EtO)2P O
O
O208 752766
Allyl diethylphosphonoformate 752:37 Allyl chloroformate (208, 7.7 mL (72 mmol,
1 equiv) was slowly added to triethyl phosphite (766, 12.4 mL, 72 mmol, 1 equiv) in a
250 mL round-bottom flask.  The reaction was very rapid at 23 °C, creating heat and
emitting bubbles of chloroethane.  After stirring was continued for 20 min at 23 °C, the
progress of the reaction was monitored by 31P NMR (δ –4.2).  When no more starting
material was present, the reaction mixture was diluted with 20 mL THF and used without
further purification.
O O
O
O
751 767
LDA, then
(EtO)2(O)P O
O 752
THF, –78 °C to 23 °C
XX% yield
Allyl 2-oxocyclohex-3-enecarboxylate 767:38 Lithium diisopropylamide was
prepared by slow addition of n-butyllithium (2.5 M solution in hexanes, 26.4 mL, 66
mmol, 1.1 equiv) to a solution of diisopropylamine (10 mL, 72 mmol, 1.2 equiv) in THF
(120 mL) at –78 °C.  The resulting colorless solution was stirred for 1 h at –78 °C before
a solution of freshly distilled cyclohex-2-enone (5.8 mL, 60 mmol, 1.0 equiv) in THF (20
mL) was slowly added via canula.  The resulting yellow reaction mixture was stirred for
1 h at –78 °C. A freshly prepared solution of allyl diethylphosphonoformate 752 (16 g, 72
mmol, 1.2 equiv) in THF (20 mL) was added to the reaction mixture via canula at such a
rate that the reaction temperature did not exceed –70 °C.  The resulting yellow reaction
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mixture was stirred for an additional hour at –78 °C before it was allowed to warm to 23
°C over a period of 4 h.  When the reaction was complete as judged by TLC, the reaction
mixture was quenched by the addition of saturated aqueous NH4Cl (50 mL) at 23 °C.
Most of the organic layer was evaporated by rotary evaporation under reduced pressure.
The mixture was diluted with ca. 70 mL Et2O and the layers were separated.  The
aqueous phase was extracted three times with Et2O (ca. 50 mL x 3).  The combined
organic layers were washed with brine, dried (MgSO4), and concentrated in vacuo. The
residue was purified by flash column chromatography (silica, hexanes/EtOAc (3:1) to
afford the title compound 767 (7.8 g, 43 mmol, 72%) as a colorless liquid.  Rf 0.21 (silica,
hexanes/EtOAc 3:1); 1H NMR (500 MHz, CDCl3): δ 7.01 (ddd, J = 3.7, 3.7, 10.3 Hz,
1H), 6.07 (ddd, J = 1.7, 1.7, 10.0 Hz, 1H), 5.92 (dddd, J = 5.6, 5.6, 11.2, 16.1 Hz, 1H),
5.34 (1.5, 1.5, 1.5, 17.3 Hz, 1H), 5.24 (dd, J = 1.2, 10.5 Hz, 1H), 4.70–4.62 (m, 2H),
3.46–3.43 (m, 1H), 2.54–2.36 (m, 3H), 2.26–2.21 (m, 1H); 13C NMR (125 MHz, CDCl3):
δ 193.7, 169.6, 150.6, 131.7, 129.1, 118.5, 65.7, 53.4, 25.6, 24.3; IR (neat Film, NaCl):
ν 3624, 3084, 3034, 2941, 2878, 1740,  ,  1681, 1650, 1455, 1426, 1373, 1388, 1307,
1232, 1166, 1124, 1078, 1040, 1023, 994, 937, 892 cm-1; HRMS (EI+) m/z calc’d for
C10H12O3 [M]+: 180.0786, found 180.0786.
K2CO3, 
ethyl vinyl ketone, O
O
O
O
Me
O
O
O
acetone, 50 °C
767 753
Allyl 2-oxo-1-(3-oxopentyl)cyclohex-3-enecarboxylate 753: Allyl 2-oxocyclohex-3-
enecarboxylate 767 (4.00 g, 22.2 mmol, 1.0 equiv) was added to a suspension of
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potassium carbonate (6.14 g, 44.4 mmol, 2.0 equiv) in acetone (30 mL). At 23 °C, ethyl
vinyl ketone (4.42 mL, 44.4 mmol, 2.0 equiv) was added slowly via syringe.  The
resulting heterogeneous mixture was stirred for 2.5 h at 50 °C, then cooled to 23 °C,
filtered and the filtrate concentrated by rotary evaporation under reduced pressure.  The
residue was purified by flash column chromatography (silica, hexanes/EtOAc 5:1 to 3:1)
to afford allyl 2-oxo-1-(3-o42xopentyl)cyclohex-3-enecarboxylate (4.77 g, 18.0 mmol,
82%) 753 as a colorless liquid.  Rf 0.19 (silica, hexanes/EtOAc 3:1); 1H NMR (500 MHz,
CDCl3): δ 6.92–6.88 (m, 1H), 6.03 (ddd, J = 1.9, 1.9, 10.0 Hz, 1H), 5.90–5.82 (m, 1H),
5.31–5.27 (m, 1H), 4.64–4.57 (m, 2H), 2.61–2.50 (m, 1H), 2.49–2.37 (m, 6H), 2.20–2.14
(m, 1H), 2.07–2.01 (m, 1H), 1.97–1.92 (m, 1H), 1.04 (t, J = 7.3 Hz, 3H); 13C NMR (125
MHz, CDCl3): δ 210.5, 196.1, 171.3, 149.2, 131.5, 129.1, 118.6, 65.8, 56.2, 37.6, 35.9,
31.0, 27.3, 23.5, 7.8; IR (neat Film, NaCl): ν 3085, 3035, 2975, 2939, 1731, 1716, 1682,
1449, 1452, 1387, 1376, 1354, 1237, 1221, 1188, 1116, 1094, 993, 974, 943 cm-1; HRMS
(EI+) m/z calc’d for C15H20O4 [M]+: 264.1362, found 264.1347.
O
O
O
O
Me
O
O
Me
Ph2P N
O
t-Bu
88% yield,
83% ee
2.5 mol%
[Pd2(dba)3]
THF, 30 °C
(6.25 mol%)
55
753 754
(R)-6-allyl-6-(3-oxopentyl)cyclohex-2-enone 754: A 500 mL round-bottom flask
was equipped with a magnetic stir bar and flame-dried under vacuum.  After cooling to
23 °C under dry argon, Pd2(dba)3 (260 mg, 0.28 mmol, 2.5 mol%) and (S)-t-BuPHOX
(55, 275 mg, 0.71 mmol, 6.25 mol%) were added.  The flask containing the solids was
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evacuated for 15 min and then refilled with dry argon.  Dry THF (3 mL) was then added
and the resulting solution stirred at 23 °C for 30 min.  At this point, allyl 2-oxo-1-(3-
oxopentyl)cyclohex-3-enecarboxylate 753 (3.00 g, 11.4 mmol, 1.0 equiv) was added via
syringe in one portion.  The reaction was warmed to 30-35 °C.  When the reaction was
complete as judged by TLC, the reaction mixture was evaporated under reduced pressure
and the residue purified by flash column chromatography (silica, hexanes/EtOAc 10:1) to
afford (R)-6-allyl-6-(3-oxopentyl)cyclohex-2-enone 754 (2.19 g, 10.0 mmol, 88%) as a
colorless liquid.  The enantiomeric excess was determined to be 83% ee.  It was
measured with SFC using chiral stationary phase columns (Chiralcel OD-H, 5%
isopropanol in hexanes, flow rate 1 mL/min, 244 nm, 5.5 min (minor), 5.8 min (major)).
Rf 0.25 (silica, hexanes/EtOAc 3:1); [α]D20.9 +13.9° (c 1.09, CHCl3, 83% ee); 1H NMR
(500 MHz, CDCl3): δ 6.87 (ddd, J = 3.9, 3.9, 10.0 Hz, 1H), 5.90 (ddd, J = 2.0, 2.0, 10.0
Hz, 1H), 5.73–5.65 (m, 1H), 5.09-5.05 (m, 2H), 2.46–2.27 (m, 7H), 2.20 (dd, J = 7.8,
13.9 Hz, 1H), 1.93–1.75 (m, 4H), 1.03 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3):
δ 211.2, 202.6, 148.9, 133.5, 128.7, 118.4, 46.8, 38.8, 36.7, 36.0, 31.1, 27.6, 22.9, 7.8; IR
(neat Film, NaCl): ν 3075, 3033, 2976, 2935, 1714, 1670, 1449, 1430, 1387, 1221, 1115,
997, 916 cm-1; HRMS (EI+) m/z calc’d for C14H20O2 [M]+: 220.1463, found 220.1487.
754
O
O
O
Me
H
O3, 
pyridine,
83% yield
MeOH, –78 °C
then P(OMe)3
O
O
Me
750
(R)-2-(2-oxo-1-(3-oxopentyl)cyclohex-3-enyl)acetaldehyde 750:39 A 500 mL round-
bottom flask equipped with a stir bar was charged with the enone 754 (2.19 g, 10.0 mmol,
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1.0 equiv), pyridine (899 µL, 11.1 mmol, 1.12 equiv) and methanol (331 mL).  Some
Sudan Red 7B (tip of a spatula) was added as an indicator to determine the end point of
the ozonolysis.  A flow of ozone (125 mL/min oxygen flow, 302 mg/h) was passed
through the solution until there was no starting material left by TLC analysis.  The
reaction flask was purged with nitrogen.  Trimethyl phosphite (7.3 mL, 49.6 mmol, 5.0
equiv) was added via syringe, and the flask was allowed to slowly warm to 23 °C.  After
an additional hour stirring at 23 °C, the reaction mixture was concentrated in vacuo and
the residue was purified by flash column chromatography (silica, hexanes/EtOAc, 5:1) to
afford the title compound 750 (1.83 g, 8.25 mmol, 83%) as a colorless liquid.  Rf 0.18
(silica, hexanes/EtOAc 3:1); [α]D20.9 +36.6° (c 1.04, CHCl3); 1H NMR (500 MHz,
CDCl3): δ 9.73 (m, 1H), 6.94–6.91 (m, 1H), 5.97 (ddd, J = 1.5, 2.4, 10.1 Hz, 1H), 2.83
(dd, J = 1,5, 16.2 Hz, 1H), 2.56–2.49 (m, 1H), 2.45–2.31 (m, 6H), 2.18 (dq, J = 5.4, 13.8
Hz, 1H), 2.00 (dq, J = 5.4, 15.1 Hz, 1H), 1.91–1.81 (m, 2H), 1.03 (t, J = 7.3 Hz, 3H); 13C
NMR (125 MHz, CDCl3): δ 210.2, 201.2, 200.9, 149.4, 128.1, 48.1, 46.1, 36.5, 36.1,
31.7, 27.5, 22.8, 7.8; IR (neat Film, NaCl): ν 2975, 2938, 2737, 1714, 1668, 1455, 1389,
1223, 1112, 940, 807 cm-1; HRMS (EI+) m/z calc’d for C13H18O3 [M]+: 222.1256, found
222.1233.
O
O
O
Me
H O
O
O
Me
V-40
t-C12H25SH
78% yield
toluene, 110 °C
750 749
(1R , 4S )-1-(3-oxopentyl)bicyclo[2.2.2]octane-2,5-dione 749:40 1 , 1 ’ -
Azobis(cyclohexanecarbonitrile) (V-40) (2.47 g, 10.1 mmol, 1.5 equiv) was added to a
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solution of the alkenal 750 (1.50 g, 6.75 mmol, 1.0 equiv) and t-dodecanethiol (4.76 mL,
20.2 mmol, 3.0 equiv) in dry toluene (68 mL).  The solution was degassed three times by
the freeze-thaw procedure. The reaction mixture was then refluxed under argon
atmosphere for 24 h.  After cooling to 23 °C, the solvents were evaporated under reduced
pressure.  The residue was purified by flash column chromatography (silica,
hexanes/EtOAc 3:1 to 1:1) to afford bicyclo[2.2.2]octadione 749 (1.17 g, 5.26 mmol,
78%) as a white solid.  Rf 0.10 (silica, hexanes/EtOAc 3:1); mp 73 °C; [α]D19.7 +29.3° (c
0.99, CHCl3, 83% ee); 1H NMR (500 MHz, CDCl3): δ 2.74 (quint, J = 2.9 Hz, 1H),
2.53–2.33 (m, 8H), 2.09–2.03 (m, 1H), 1.98–1.91 (m, 1H), 1.86–1.69 (m, 4H), 1.05 (t, J
= 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 211.7, 211.0, 210.6, 48.7, 44.8, 44.3,
40.7, 37.0, 35.9, 28.0, 26.8, 22.6, 7.8; IR (neat Film, NaCl): ν 2940, 2879, 1720, 1450,
1399, 1115, 1086, 952 cm-1; HRMS (EI+) m/z calc’d for C13H18O3 [M]+: 222.1256, found
222.1254.
O
O
O
Me
749
O
O
Me
KOH, 
MeOH, 23 °C
77% yield,
recrystallization 
to 99% ee 751
Dione 751: The 1,5-diketone 749 (1.75 g, 7.87 mmol, 1.0 equiv) was added to 11.8
mL 1 M KOH (11.8 mmol, 1.5 equiv) in methanol (33 mL).  The reaction mixture was
stirred at 23 °C for 7 h during which time color gradually changes to orange.  After the
reaction was complete as judged by TLC, the reaction mixture was concentrated in
vacuo.  Subsequently, the residue was redissolved in ca. 30 mL Et2O and ca. 30 mL H2O.
The organic phase was separated and the aqueous phase acidified by addition of 10% aq
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HCl (ca. 12 mL) before it was extracted three times with Et2O (30 mL x 3).  The
combined organic phases were washed with brine, dried (MgSO4) and concentrated in
vacuo.  The residue was purified by flash column chromatography (silica,
hexanes/EtOAc 3:1). The colorless solid material was recrystallized from hexanes to
afford 1.31 g 751 (6.41 mmol, 81%) as colorless crystals suitable for X-ray analysis.  The
enantiomeric excess was determined to be 99% ee (measured by HPLC using a Chiralpak
AD column and 10% isopropanol in hexanes as eluent at a flow rate of 1 mL/min and
detection at 254 nm; retention times: 13.3 min (major), 14.7 min (minor)).  Rf 0.13 (silica,
hexanes/EtOAc 3:1); mp = 110 °C; [α]D20.0 +30.5° (c 1.00, CHCl3, >99% ee); 1H NMR
(500 MHz, CDCl3): δ 2.65 (s, 2H), 2.62 (t, J = 2.7 Hz, 1H), 2.46–2.42 (m, 2H), 2.37 (dd,
J = 2.7, 18.7 Hz, 1H), 2.23 (d, J = 18.5 Hz, 1H), 2.01–1.96 (m, 2H), 1.90–1.84 (m, 3H),
1.72 (s, 3H), 1.64–1.59 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 213.5, 197.3, 157.2,
130.3, 48.4, 43.7, 38.2, 33.5, 32.4, 31.7, 29.9, 23.1, 10.6; IR (neat Film, NaCl): ν 2966,
2952, 2915, 1720, 1660, 1631, 1472, 1402, 1310, 1295, 1124, 889, 867, 709 cm-1; HRMS
(EI+) m/z calc’d for C13H16O2 [M]+: 204.1150, found 204.1114.
O
O
Me
O
Me
KOt-Bu, 
Ph3PCH3Br
THF, 23 °C
89% yield
751 740
Enone 740:  A 25 mL round-bottom flask was charged with
methyltriphenylphosphonium bromide (879 mg, 2.46 mmol, 1.5 equiv) and THF (8 mL).
The solution was cooled to 0 °C and a solution of potassium t-butoxide (221 mg, 1.97
mmol, 1.2 equiv) in THF (2 mL) was slowly added via syringe.  The solution was stirred
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at 0 °C for 15 min before a solution of the dione 751 (335 mg, 1.64 mmol, 1.0 equiv) in
THF (2 mL) was added via syringe.  Upon addition the color of the reaction mixture
changed from yellow to red/brown.  Stirring was continued, first at 0 °C for 30 min, then
at 23 °C for another 30 min.  The reaction was quenched by addition of saturated aqueous
NH4Cl (7 mL) and Et2O (7 mL).  The layers were separated and the aqueous layer was
extracted with Et2O (10 mL x3).  The combined organic layers were washed with brine (5
mL), dried (MgSO4) and concentrated in vacuo.  The residue was purified by flash
column chromatography (silica, hexanes/EtOAc 7:1) to afford the enone 740  (295 mg,
1.45 mmol, 89%) as a colorless liquid.  Rf 0.24 (silica, hexanes/EtOAc 3:1); 1H NMR
(500 MHz, CDCl3): δ 4.85 (dd, J = 2.2, 4.0 Hz, 1H), 4.67 (dd, J = 2.2, 3.8 Hz, 1H), 2.55
(quintet, J = 2.9 Hz, 1H), 2.45 (s, 2H). 2.41–2.38 (m, 3H), 2.24 (dd, J = 2.0, 17.8 Hz,
1H), 1.81–1.74 (m, 4H), 1.67 (s, 3H), 1.66–1.63 (m, 1H), 1.52–1.49 (m, 1H); 13C NMR
(125 MHz, CDCl3): δ 198.2, 182.2, 149.2, 129.0, 106.4, 40.2, 37.0, 36.4, 35.7, 33.8, 32.2,
30.7, 26.4, 10.3; IR (neat Film, NaCl): ν 3069, 2928, 2870, 2823, 1666, 1630, 1449,
1308, 1198, 1082, 881, 754 cm-1; HRMS (EI+) m/z calc’d for C14H18O [M]+: 202.1358,
found 202.1351.
O
O
Me
O
H
O
O
OH
Me
N N
N
F F
F
FF
BF4
Et3N, CH2Cl2, 45 °C
74% yield
750 756
755
(6R)-9-Ethyl-9-hydroxyspiro[5.5]undec-2-ene-1,8-dione 756: A 25 mL round-
bottom flask was charged with a stir bar and CH2Cl2 (5 mL).  The aldehyde 750 (100 mg,
0.45 mmol, 1.0 equiv), triazolium salt (755. 124 mg, 0.45 mmol, 1.0 equiv) and
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triethylamine (63 µL, 0.45 mmol, 1.0 equiv) were added consecutively.  The resulting
yellow mixture was stirred at 45 °C for 2 h.  After cooling to 23 °C, the reaction mixture
was concentrated in vacuo and the residue purified by flash column chromatography
(silica, hexanes/EtOAc 2:1) to afford the title compound 756 (74 mg, 0.33 mmol, 74%) as
a colorless liquid.  Rf 0.18 (silica, hexanes/EtOAc 3:1); 1H NMR (500 MHz, CDCl3): δ
6.96–6.92 (m, 1H), 6.01 (ddd, J = 2.0, 2.0, 10.3 Hz, 1H), 3.89 (s, 1H), 3.15 (d, J = 13.9,
1H), 2.39–2.36 (m, 2H), 2.23–2.16 (m, 2H), 2.03–1.76 (m, 6H), 1.71 (dddd, J = 7.3, 7.3,
7.3, 14.3 Hz, 1H), 0.81 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 213.8, 199.7,
149.5, 128.1, 78.6, 50.0, 43.6, 35.6, 30.2, 29.3, 27.1, 22.6, 7.0; IR (neat Film, NaCl):
ν 3477, 2956, 2938, 2922, 2877, 1710, 1672, 1463, 1386, 1259, 1218, 1155, 1132, 1023,
803 cm-1; HRMS (EI+) m/z calc’d for C13H19O3 [M + H]+: 223.1334, found 223.1336.
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10.8.3 X-RAY STRUCTURE OF DIKETONE 751
Diketone 751
Note: The crystallographic data have been deposited in the Cambridge Database (CCDC) and has been
placed on hold pending further instructions from me.  The deposition number is 686706.  Ideally the
CCDC would like the publication to contain a footnote of the type: "Crystallographic data have been
deposited at the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on
request, free of charge, by quoting the publication citation and the deposition number 686706."
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Table 10.1  Crystal data and structure refinement for diektone 751 (CCDC 686706).
Empirical formula C13H16O2
Formula weight 204.26
Crystallization solvent hexanes
Crystal habit prism
Crystal size 0.42 x 0.15 x 0.11 mm3
Crystal color colorless
Data Collection
Type of diffractometer Bruker KAPPA APEX II
Wavelength 0.71073 Å MoKα
Data Collection Temperature 100(2) K
θ range for 2641 reflections used
in lattice determination 2.33 to 34.42°
Unit cell dimensions a = 12.0658(7) Å
b = 7.1991(4) Å β= 92.724(5)°
c = 12.0987(10) Å
Volume 1049.74(12) Å3
Z 4
Crystal system Monoclinic
Space group P21
Density (calculated) 1.292 Mg/m3
F(000) 440
Data collection program Bruker APEX2 v2.1-0
θ range for data collection 2.44 to 34.55°
Completeness to θ = 34.55° 78.3 %
Index ranges –17 ≤ h ≤ 17, 0 ≤ k ≤ 11, 0 ≤ l ≤ 17
Data collection scan type ω scans; 12 settings
Data reduction program Bruker SAINT-Plus v7.34A
Reflections collected 3732
Independent reflections 3732 [Rint= 0.0000]
Absorption coefficient 0.086 mm-1
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7468 and 0.6368
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 Table 10.1  (cont.)
Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 2008)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Geometric positions
Structure refinement program SHELXL-97 (Sheldrick, 2008)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 3732 / 1 / 274
Treatment of hydrogen atoms Riding
Goodness-of-fit on F2 2.574
Final R indices [I>2σ(I),  3246 reflections] R1 = 0.0659, wR2 = 0.0929
R indices (all data) R1 = 0.0805, wR2 = 0.0943
Type of weighting scheme used Sigma
Weighting scheme used w=1/σ2(Fo2)
Max shift/error 0.002
Average shift/error 0.000
Absolute structure determination Unable to determine reliably
Absolute structure parameter –1.8(16)
Largest diff. peak and hole 0.387 and –0.359 e.Å-3
Special Refinement Details
The structure was refined as a twin with two orientations, BASF=0.452, using an HKLF 5 format
reflection file prepared with TWINABS (see below).  The two orientations were separated using
CELL_NOW as follows.
Rotated from first domain by 179.7 degrees about reciprocal axis  0.000  0.000  1.000  and real
axis  0.042  0.003  1.000. Twin law to convert hkl from first to this domain (SHELXL TWIN matrix):
-1.000   0.007  -0.001
-0.003  -1.000   0.000
 0.085   0.005   1.000
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Saint refined twin law; Twin Law, Sample 1 of 1 transforms h1.1(1)->h1.2(2)
-1.00019  0.00027 -0.00402
-0.00010 -1.00014 -0.00007
 0.09148 -0.00022  1.00008
Twinabs;
 PART 1 - Refinement of parameters to model systematic errors
     2121 data (    819 unique ) involve domain  1 only,  mean I/sigma  18.8
     2180 data (    823 unique ) involve domain  2 only,  mean I/sigma  16.4
    12491 data (   3743 unique ) involve   2 domains,  mean I/sigma  13.2
 HKLF 5 dataset constructed from all observations involving domain 1
    7697 Corrected reflections written to file twin5.hkl
 Reflections merged according to point-group 2/m
 Single reflections that also occur in composites omitted
 Minimum and maximum apparent transmission:  0.636799  0.746793
 Additional spherical absorption correction applied with mu*r =  0.2000
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under
a nitrogen stream at 100K.
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold
expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F,
and R-factors based on ALL data will be even larger.
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances,
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds
involving l.s. planes.
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Figure 10.3  Representations of diketone 751
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Figure 10.3 (continued)
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Table 10.2  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103)
for 751 (CCDC 686706).  U(eq) is defined as the trace of the orthogonalized Uij tensor.
________________________________________________________________________________
x y z Ueq
________________________________________________________________________________
O(1A) 8680(2) 193(3) 8344(2) 34(1)
O(2A) 6770(3) 4232(3) 3573(3) 44(1)
C(1A) 8512(3) 250(4) 7345(3) 24(1)
C(2A) 9440(3) 503(5) 6585(3) 27(1)
C(3A) 9187(3) -422(4) 5456(3) 24(1)
C(4A) 8084(3) 196(4) 4923(3) 17(1)
C(5A) 8115(3) 2139(4) 4372(3) 18(1)
C(6A) 6953(4) 2683(4) 3920(3) 32(1)
C(7A) 6156(3) 1123(4) 3966(3) 27(1)
C(8A) 6042(3) 637(4) 5198(3) 24(1)
C(9A) 7182(3) 315(4) 5760(3) 16(1)
C(10A) 7346(3) 262(4) 6850(3) 18(1)
C(11A) 6440(3) 272(5) 7646(3) 32(1)
C(12A) 7718(3) -1199(4) 4011(3) 26(1)
C(13A) 6617(3) -572(4) 3390(3) 32(1)
O(1B) 779(2) 360(3) 3326(2) 34(1)
O(2B) 3569(2) -3383(3) -872(2) 32(1)
C(1B) 1121(3) 274(4) 2398(3) 21(1)
C(2B) 358(3) -75(4) 1415(3) 22(1)
C(3B) 714(3) 901(4) 388(3) 20(1)
C(4B) 1919(3) 450(4) 129(3) 16(1)
C(5B) 2022(3) -1471(4) -433(3) 20(1)
C(6B) 3247(3) -1894(4) -580(3) 23(1)
C(7B) 3990(3) -237(4) -312(3) 20(1)
C(8B) 3889(3) 213(4) 922(3) 20(1)
C(9B) 2657(3) 388(4) 1167(3) 16(1)
C(10B) 2324(2) 336(4) 2205(3) 17(1)
C(11B) 3100(3) 345(5) 3213(3) 22(1)
C(12B) 2369(3) 1934(4) -650(3) 20(1)
C(13B) 3541(3) 1410(4) -1012(3) 23(1)
950 Chapter 10 – Enantioselective Formal Synthesis of Platencin
Table 10.3 Bond lengths [Å] and angles [°] for 751 (CCDC 686706).
_______________________________________________________________________________
O(1A)-C(1A) 1.217(4)
O(2A)-C(6A) 1.208(4)
C(1A)-C(2A) 1.493(5)
C(1A)-C(10A) 1.502(4)
C(2A)-C(3A) 1.537(5)
C(3A)-C(4A) 1.518(5)
C(4A)-C(9A) 1.523(4)
C(4A)-C(12A) 1.541(5)
C(4A)-C(5A) 1.550(4)
C(5A)-C(6A) 1.531(5)
C(6A)-C(7A) 1.482(5)
C(7A)-C(13A) 1.524(5)
C(7A)-C(8A) 1.543(6)
C(8A)-C(9A) 1.523(4)
C(9A)-C(10A) 1.325(4)
C(10A)-C(11A) 1.491(4)
C(12A)-C(13A) 1.561(5)
O(1B)-C(1B) 1.215(4)
O(2B)-C(6B) 1.199(4)
C(1B)-C(10B) 1.482(4)
C(1B)-C(2B) 1.491(5)
C(2B)-C(3B) 1.508(5)
C(3B)-C(4B) 1.537(4)
C(4B)-C(9B) 1.505(4)
C(4B)-C(12B) 1.540(4)
C(4B)-C(5B) 1.548(4)
C(5B)-C(6B) 1.527(4)
C(6B)-C(7B) 1.518(4)
C(7B)-C(8B) 1.539(5)
C(7B)-C(13B) 1.540(4)
C(8B)-C(9B) 1.535(4)
C(9B)-C(10B) 1.337(5)
C(10B)-C(11B) 1.502(4)
C(12B)-C(13B) 1.546(5)
O(1A)-C(1A)-C(2A) 121.4(3)
O(1A)-C(1A)-C(10A) 120.3(3)
C(2A)-C(1A)-C(10A) 118.0(3)
C(1A)-C(2A)-C(3A) 111.8(3)
C(4A)-C(3A)-C(2A) 112.6(3)
C(3A)-C(4A)-C(9A) 111.9(3)
C(3A)-C(4A)-C(12A) 109.2(3)
C(9A)-C(4A)-C(12A) 108.9(3)
C(3A)-C(4A)-C(5A) 114.1(3)
C(9A)-C(4A)-C(5A) 105.5(2)
C(12A)-C(4A)-C(5A) 107.0(3)
C(6A)-C(5A)-C(4A) 110.1(3)
O(2A)-C(6A)-C(7A) 127.2(4)
O(2A)-C(6A)-C(5A) 120.6(4)
C(7A)-C(6A)-C(5A) 112.2(3)
C(6A)-C(7A)-C(13A) 109.7(3)
C(6A)-C(7A)-C(8A) 107.2(3)
C(13A)-C(7A)-C(8A) 108.1(3)
C(9A)-C(8A)-C(7A) 110.3(3)
C(10A)-C(9A)-C(8A) 122.5(3)
C(10A)-C(9A)-C(4A) 125.7(3)
C(8A)-C(9A)-C(4A) 111.7(3)
C(9A)-C(10A)-C(11A) 124.3(3)
C(9A)-C(10A)-C(1A) 119.3(3)
C(11A)-C(10A)-C(1A) 116.4(3)
C(4A)-C(12A)-C(13A) 111.3(3)
C(7A)-C(13A)-C(12A) 109.4(3)
O(1B)-C(1B)-C(10B) 121.4(3)
O(1B)-C(1B)-C(2B) 121.5(3)
C(10B)-C(1B)-C(2B) 116.8(3)
C(1B)-C(2B)-C(3B) 112.9(3)
C(2B)-C(3B)-C(4B) 112.3(3)
C(9B)-C(4B)-C(3B) 111.3(3)
C(9B)-C(4B)-C(12B) 108.7(3)
C(3B)-C(4B)-C(12B) 110.0(3)
C(9B)-C(4B)-C(5B) 106.4(2)
C(3B)-C(4B)-C(5B) 112.0(2)
C(12B)-C(4B)-C(5B) 108.2(3)
C(6B)-C(5B)-C(4B) 109.1(3)
O(2B)-C(6B)-C(7B) 124.6(3)
O(2B)-C(6B)-C(5B) 122.8(3)
C(7B)-C(6B)-C(5B) 112.5(3)
C(6B)-C(7B)-C(8B) 107.4(3)
C(6B)-C(7B)-C(13B) 107.4(3)
C(8B)-C(7B)-C(13B) 109.2(3)
C(9B)-C(8B)-C(7B) 109.0(3)
C(10B)-C(9B)-C(4B) 126.4(3)
C(10B)-C(9B)-C(8B) 121.0(3)
C(4B)-C(9B)-C(8B) 112.4(3)
C(9B)-C(10B)-C(1B) 119.3(3)
C(9B)-C(10B)-C(11B) 124.0(3)
C(1B)-C(10B)-C(11B) 116.7(3)
C(4B)-C(12B)-C(13B) 110.9(3)
C(7B)-C(13B)-C(12B) 109.6(3)
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Figure 10.4  Anisotropic displacement parameters (Å2 x 104) for 751 (CCDC 686706).  The
anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ]
______________________________________________________________________________
U11 U22 U33 U23 U13 U12
______________________________________________________________________________
O(1A) 469(17) 284(11) 261(15) 12(13) -90(14) 47(14)
O(2A) 573(19) 210(11) 500(19) 80(11) -201(18) -1(13)
C(1A) 380(20) 126(11) 227(19) 59(15) 17(18) 38(16)
C(2A) 200(18) 295(16) 310(20) 100(16) -34(18) 90(16)
C(3A) 210(20) 208(14) 300(20) 64(13) 16(19) 34(13)
C(4A) 169(17) 169(12) 169(16) 25(13) 6(14) -13(15)
C(5A) 163(19) 185(13) 188(19) 24(12) -3(16) -28(12)
C(6A) 520(30) 213(14) 210(20) -26(13) -60(20) 27(16)
C(7A) 230(20) 294(16) 280(20) -21(15) -131(19) 0(16)
C(8A) 130(17) 251(16) 340(20) -42(14) 14(17) -39(13)
C(9A) 183(16) 110(11) 200(17) 10(13) 16(15) 13(15)
C(10A)230(18) 103(12) 204(18) 5(13) 61(16) -15(15)
C(11A)500(20) 240(14) 250(20) -25(17) 230(20) -40(20)
C(12A)410(20) 225(14) 157(18) -5(12) 63(19) 22(16)
C(13A)450(30) 304(16) 200(20) -25(14) -60(20) -135(18)
O(1B) 416(16) 360(12) 255(15) -63(12) 157(14) -73(15)
O(2B) 294(14) 213(10) 450(18) -94(11) 112(14) 24(11)
C(1B) 248(19) 130(12) 250(20) -12(15) 108(17) 33(16)
C(2B) 99(16) 167(14) 410(20) -48(13) 28(17) 11(12)
C(3B) 91(17) 216(14) 300(20) -37(13) 24(17) 26(12)
C(4B) 165(16) 154(12) 161(16) -60(12) 22(15) -5(13)
C(5B) 220(18) 172(13) 190(20) 2(12) -19(17) 14(13)
C(6B) 230(20) 235(14) 230(20) 18(13) 72(18) 20(14)
C(7B) 108(16) 236(14) 270(20) 3(13) 87(17) 4(12)
C(8B) 161(16) 177(12) 264(19) 5(14) -4(15) 20(14)
C(9B) 119(15) 115(12) 255(19) -33(13) 14(15) -14(13)
C(10B)203(17) 118(11) 177(17) -24(13) -35(15) -9(14)
C(11B)252(18) 184(12) 227(18) 30(14) -21(16) 12(17)
C(12B)216(19) 204(14) 160(20) 46(12) -35(17) 11(14)
C(13B)255(19) 228(15) 210(20) 13(13) 37(18) 3(15)
______________________________________________________________________________
952 Chapter 10 – Enantioselective Formal Synthesis of Platencin
10.8.4 NOTES AND REFERENCES FOR EXPERIMENTAL SECTION
27. M. Schlosser, Organometallics in Synthesis, Wiley-VCH, New York, 1996.
28. (a) Tani, K.; Behenna, D. C.; McFadden, R. M.; Stoltz, B. M. Org. Lett. 2007, 9,
2529–2531.  (b) Krout, M. R.; Mohr, J. T.; Stoltz, B. M. Org. Synth. 2009, 86,
29. Kerr, M. S.; Read de Alaniz, J.; Rovis, T. J. Org. Chem. 2005, 70, 5725–5728.
30. (a) M. Apparu, Y. B. Tiba, P.-M. Leo, D. Fagret, Eur. J. Org. Chem. 2000,
1007–1012.  (b) D. E. White, I. C. Stewart, R. H. Grubbs, B. M. Stoltz, J. Am. Chem.
Soc. 2008, 130, 810–811.
31. Snyder, S. A.; Corey, E. J. J. Am. Chem. Soc. 2006, 128, 740–742.
32. G. Stork, A. Brizzolara, H. Landesman, J. Szmuszkovic, R. Terrell, J. Am. Chem.
Soc. 1963, 85, 207–222.
33. White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz, B. M. J. Am. Chem. Soc. 2008,
130, 810–811.
34. Stork, G.; Brizzolara, A.; Landesman, H.; Szmuszkovicz, J.; Terrell, R. J. Am.
Chem. Soc. 1963, 85, 207–222.
35. J. T. Mohr, D. C. Behenna, A. M. Harned, B. M. Stoltz, Angew. Chem. 2005, 117,
7084–7987; Angew. Chem. Int. Ed. 2005, 44, 6924-6927.
36. Wijnberg, J. P. B. A.; Vader, J., de Groot, A. J. Org. Chem. 1983, 48, 4380–4384.
37. C. M. Yamada, D. J. Dellinger, M. H. Carruthers, J. Am. Chem. Soc. 2006, 128,
5251–5261.
38. S. Hanessian, A. M. Griffin, M. J. Rozema, Bioorg. Med. Chem. Lett. 1997, 14,
1857–1862.
Chapter 10 – Enantioselective Formal Synthesis of Platencin 953
39. (a) G. Slomp, Jr., J. L. Johnson, J. Org. Chem. 1958, 80, 915–921; (b) S. A.
Stanton, S. W. Felman, C. S. Parkhurst, S. A. Godleski, J. Am. Chem. Soc. 1983, 105,
1964–1969.
40. (a) K. Yoshikai, T. Hayama, K. Nishimura, K. Yamada, K. Tomioka, J. Org.
Chem. 2005, 70, 681–683; (b) J. A. Enquist, Jr., B. M. Stoltz Nature 2008, 453, 1228-
1231.
954 Appendix 5 – Spectra of Compounds Relevant to Chapter 10
APPENDIX 5
Spectra of Compound Relevant to Chapter 10
Appendix 5 – Spectra of Compounds Relevant to Chapter 10 955
Fi
gu
re
 A
5.
1 
 
H
 N
M
R
 o
f c
om
po
un
d 
74
7  
(3
00
 M
H
z,
 C
6D
6)
Cl
O
O
Br
74
7
956 Appendix 5 – Spectra of Compounds Relevant to Chapter 10
Figure A5.2  IR of compound 747 (NaCl/film)
Figure A5.3  13C NMR of compound 747 (75 MHz, C6D6)
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Figure A5.6  13C NMR of compound 760 (125 MHz, C6D6)
Figure A5.5  IR of compound 760 (NaCl/film)
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Figure A5.8  IR of compound 761 (NaCl/film)
Figure A5.9  13C NMR of compound 761 (125 MHz, C6D6)
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APPENDIX 6
Optimized Large-Scale Procedure for
Preparation of t-Bu-PHOX†
A6.1 PROCEDURE
A6.1.1 2-BROMO-N-[(1S)-1-(HYDROXYMETHYL)-2,2-
DIMETHYLPROPYL]-BENZAMIDE
Caution!  This procedure should be carried out in an efficient fume hood due to the
evolution of hydrogen gas during the reaction.
Scheme A6.1  Amino acid reduction and amide bond formation
H2N OH
O 1. NaBH4, I2, THF
     0 °C → reflux
2. 2-bromobenzoyl chloride
     Na2CO3, CH2Cl2/H2O
H
N
OH
OBr
An oven-dried 500 mL 3-neck flask equipped with a 3.0 cm x 1.4 cm, egg-shaped,
Teflon-coated magnetic stirring bar, pressure-equalizing addition funnel, an internal
                                                 
† This work was carried out in collaboration with Michael R. Krout and the procedures herein have been
published in Org. Synth.  Some of the data contained in this procedure were collected by the Org. Synth.
checkers (A. Schumacher and A. Pfaltz, University of Basel) during the normal Org. Synth. review process.
See: Krout, M. R.; Mohr, J. T.; Stoltz, B. M. Org. Synth. 2009, 86, 181–193.
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thermometer, and a reflux condenser (central neck) equipped with a two-tap Schlenk
adapter connected to a bubbler and an argon/vacuum manifold (Note 1) is assembled hot
and cooled under a stream of argon.  The flask is charged with (L)-tert-leucine (5.00 g,
38.1 mmol, 1.00 equiv, 99% ee) (Note 2) and tetrahydrofuran (100 mL, 0.38 M) (Note 3)
under a positive pressure of argon.  The resulting suspension is cooled to approximately 4
°C in an ice-water bath and sodium borohydride (3.46 g, 91.5 mmol, 2.40 equiv) (Note 2)
is added in one portion (Note 4).  The addition funnel is charged with a solution of iodine
(9.67 g, 38.1 mmol, 1.00 equiv) (Note 2) in tetrahydrofuran (25 mL) (Note 3) via syringe
and added dropwise to the suspension over 30 min.  After complete addition, the bath is
removed, the addition funnel and the thermometer are removed and replaced by glass
stoppers and the reaction is warmed to reflux (80 °C oil bath temperature).  After 18 h the
reaction is allowed to cool to ambient temperature and methanol (50 mL) (Note 3) is
added slowly resulting in an almost clear solution (Note 5).  After stirring for 30 min the
solution is quantitatively transferred to a 500 mL 1-necked flask with methanol (ca. 50
mL) and concentrated on a rotary evaporator under reduced pressure (40 °C, ca. 53 torr)
to a white semi-solid.  The resulting material is dissolved in 20% aqueous potassium
hydroxide (75 mL) and stirred for 5 h at ambient temperature with a 3.0 cm x 1.4 cm egg-
shaped Teflon-coated magnetic stirring bar.  The aqueous phase is extracted with
dichloromethane (6 x 60 mL) and the combined organic extracts are dried over sodium
sulfate (ca. 7 g), filtered, and concentrated on a rotary evaporator under reduced pressure
(40 °C, 38 torr) and dried under vacuum (0.13 mmHg) to yield 4.42–4.45 g (37.7–37.9
mmol, 99% yield) of crude (S)-tert-leucinol as a colorless oil (Note 6).  This material is
used in the following step without purification.
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A 500 mL flask containing a 3.0 cm x 1.4 cm egg-shaped Teflon-coated magnetic
stirring bar is charged with crude (S)-tert-leucinol (4.42 g, 37.7 mmol, 1.00 equiv),
dichloromethane (125 mL, 0.30 M) (Note 3) and then a solution of sodium carbonate
(11.98 g, 113.1 mmol, 3.00 equiv) (Note 2) in distilled water (95 mL) (Note 3) is added at
ambient temperature.  The biphasic mixture is stirred vigorously to emulsify and neat 2-
bromobenzoyl chloride (5.67 mL, 43.3 mmol, 1.15 equiv) (Note 2) is added dropwise via
syringe over approximately 15 min.  The reaction flask is capped with a two-tap Schlenk
adapter connected to a bubbler (Note 1) and stirred for 10 h, after which time the layers
are partitioned in a 500 mL separatory funnel and the aqueous phase is extracted with
dichloromethane (4 x 50 mL).  The combined organic extracts are stirred with 1 N
potassium hydroxide solution in methanol (19 mL) in a 500 mL Erlenmeyer flask with a
3.0 cm x 1.4 cm egg-shaped Teflon-coated magnetic stirring bar for 30 min at ambient
temperature and then acidified to neutral pH with 1 N hydrochloric acid (ca. 16 mL).
Water (25 mL) is added, the phases are partitioned in a 1 L separatory funnel, and the
aqueous phase is extracted with dichloromethane (4 x 35 mL).  The combined organic
extracts are washed with saturated brine (75 mL), dried over sodium sulfate (3.00 g),
filtered, and concentrated on a rotary evaporator under reduced pressure (40 °C, ca. 11
torr) to an off-white solid.  The crude white solid is dissolved in a minimal amount of hot
acetone (ca. 10 mL) (Note 3) and hexanes (Note 3) are added until a cloudy solution is
obtained (ca. 45 mL).  The crystals formed upon cooling and aging for 3 hours at 0 °C are
collected, washed with hexanes, and dried under vacuum to afford 2-bromo-N-[(1S)-1-
(hydroxymethyl)-2,2-dimethylpropyl]-benzamide (9.23–9.61 g, 30.8–32.0 mmol) as
white blocks (Note 7).  The filtrate is concentrated and recrystallized in a similar manner
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(with acetone (ca. 2 mL) and hexanes (10 mL)) to provide additional product (0.62–1.13
g, 2.1–3.76 mmol) as white blocks (Note 8), for a combined yield of 9.85–10.74 g
(32.8–35.77 mmol, 86–94 % yield over two steps).
A6.1.2 2-(2-BROMOPHENYL)-4-(1,1-DIMETHYLETHYL)-4,5-DIHYDRO-
(4S)-OXAZOLE
Scheme A6.2  Oxazoline formation
Br
H
N
OH
OBr
MsCl, Et3N
CH2Cl2, 0 °C → reflux
O
N
An oven-dried 500 mL 3-necked flask equipped with a 3.0 cm x 1.4 cm egg-shaped
Teflon-coated magnetic stirring bar, an internal thermometer, a glass stopper and a reflux
condenser (central neck) equipped with a two-tap Schlenk adapter connected to a bubbler
and an argon/vacuum manifold (Note 1) is assembled hot and cooled under a stream of
argon.  The flask is charged with 2-bromo-N -[(1S)-1-(hydroxymethyl)-2,2-
dimethylpropyl]-benzamide (9.85 g, 32.8 mmol, 1.00 equiv), dichloromethane (170 mL,
0.19 M) (Note 3), and triethylamine (11.0 mL, 78.6 mmol, 2.40 equiv) (Note 2) under a
positive pressure of argon.  The resulting colorless solution is cooled to approximately 4
°C in an ice-water bath and neat methanesulfonyl chloride (2.92 mL, 37.7 mmol, 1.15
equiv) (Note 2) is added dropwise via syringe over 3 min, at which point the solution
turns slightly yellow.  The reaction is warmed to reflux (50 °C oil bath temperature)
while monitoring conversion by TLC (Note 9).  Upon completed cyclization, the reaction
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is allowed to cool to ambient temperature and 60 mL of saturated aqueous sodium
bicarbonate is added with vigorous stirring for 5 min.  The layers are partitioned in a 1 L
separatory funnel, the aqueous phase is extracted with dichloromethane (2 x 35 mL), the
combined organic phases are washed with saturated brine (75 mL), dried over anhydrous
magnesium sulfate (1.50 g), filtered, and concentrated on a rotary evaporator under
reduced pressure (40 °C, 23 mmHg) to afford a red-brown semi-solid.  The residue is
dissolved in a minimal amount of dichloromethane (ca. 35 mL), dry-loaded onto silica
gel (8 g), and purified by silica gel chromatography (Note 10) to afford 8.85–8.86 g (31.4
mmol, 96% yield) of 2-(2-bromophenyl)-4-(1,1-dimethyl-ethyl)-4,5-dihydro-(4S)-
oxazole as a pale yellow oil.  This material solidifies when placed in a –20 °C freezer and
is preferred in this state for the subsequent reaction (Note 11).
A6.1.3 4-(1,1-DIMETHYLETHYL)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-
4,5-DIHYDRO-(4S)-OXAZOLE ((S)-TERT-BUTYLPHOX)
Scheme A6.3  C–P cross-coupling
Ph2P
O
NBr
O
N
CuI, Ph2PH
N,N'-dimethylethylenediamine
Cs2CO3, PhMe, 110 °C
A 150 mL Schlenk flask equipped with a glass valve, a glass stopper, and a 1.7 cm x
0.7 cm egg-shaped teflon-coated magnetic stirring bar is dried with a heat gun under
vacuum and cooled under argon atmosphere.  The glass stopper is removed under a
positive pressure of argon and the flask is charged with copper(I) iodide (19.0 mg, 0.10
994 Appendix 6 – Optimized Large-Scale Procedure for Preparation of t-Bu-PHOX
mmol, 0.005 equiv) (Note 2), diphenylphosphine (4.35 mL, 25.0 mmol, 1.25 equiv) (Note
2), N,N’-dimethylethylenediamine (53 µL, 0.50 mmol, 0.025 equiv) (Note 2) and toluene
(20 mL) (Note 3).  The flask is sealed with the glass stopper and the colorless contents
are stirred at ambient temperature for 20 min.  The glass stopper is then removed under a
positive pressure of argon and the flask is charged with 2-(2-bromophenyl)-4-(1,1-
dimethylethyl)-4,5-dihydro-(4S)-oxazole (5.64 g, 20.0 mmol, 1.00 equiv), cesium
carbonate (9.78 g, 30.0 mmol, 1.50 equiv) (Note 2), and toluene (20 mL, 0.50 M total) to
wash the neck and walls of the flask.  The flask is equipped with a reflux condenser with
a two-tap Schlenk adapter connected to a bubbler and an argon/vacuum manifold (Note
1).  The now yellow heterogeneous reaction is placed in a 110 °C oil bath and vigorously
stirred under argon atmosphere (Note 12).  Following consumption of starting material
(Note 13), the reaction is allowed to cool to ambient temperature, filtered through a pad
of Celite, and the filter cake is washed with dichloromethane (2 x 40 mL) (Note 14).  The
filtrate is concentrated on a rotary evaporator under reduced pressure (40 °C, 15 torr) to a
pale yellow semi-solid.  The residue is dissolved in a minimal amount of
dichloromethane (ca. 40 mL) (Note 15), dry-loaded onto silica gel (10 g), and purified by
silica gel chromatography eluting with 24:1 hexanes/diethyl ether until excess Ph2PH
elutes, then with a 9:1 dichloromethane/diethyl ether mixture until the desired product
elutes (Note 16).  The combined fractions are concentrated on a rotary evaporator under
reduced pressure (40 °C, 14 torr) to a viscous pale yellow oil and layered with acetonitrile
(ca. 5 mL) to facilitate crystallization (Notes 3 and 17).  The flask is swirled while
crystals form within seconds (Note 18).  After approximately 15 min, the flask is placed
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under high vacuum to remove volatiles to afford 6.81 g (17.6 mmol, 88% yield) of (S)-
tert-ButylPHOX as white blocks (Note 19).
A6.2 NOTES
1. A two-tap Schlenk adapter connected to a bubbler and an argon/vacuum
manifold is illustrated in Yu, J.; Truc, V.; Riebel, P.; Hierl, E. and Mudryk, B. Org.
Synth. 2008, 85, 64–71.
2. Submitters and checkers purchased (L)-tert-leucine (99%, 99% ee), sodium
borohydride (98%), cesium carbonate (99%), and N,N’-dimethylethylenediamine (99%)
from Aldrich and used as received.  (2)-Bromobenzoyl chloride (98%) and
methanesulfonyl chloride (99.5%) were purchased from Acros and used as received.
Copper iodide (98%) was purchased from Strem and used as received.  Submitters and
checkers purchased triethylamine (99.5%) from Aldrich and distilled it from calcium
hydride prior to use.  Submitters and checkers purchased diphenylphosphine (99%) from
Strem and transferred it through a cannula to a dry Schlenk tube under nitrogen to
prolong reagent life.  The submitters purchased iodine (≥99%) and sodium carbonate
(99%) from Aldrich and used as received.  The checkers purchased iodine (puriss. p. a.)
and potassium hydroxide (puriss. p. a.) from Riedel-de-Haën (puriss. p. a.) and sodium
carbonate (99.5%) from Merck and used as received.
3. Submitters distilled tetrahydrofuran from sodium 9-fluorenone ketyl1 prior to
use.  Submitters and checkers used methylene chloride, toluene, and acetonitrile purified
by passage through an activated alumina column under argon.2  The submitters purchased
reagent grade acetone from EMD, and hexanes and methanol (both ACS grade) were
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purchased from Fisher and used as received.  The submitters used distilled water purified
with a Barnstead NANOpure Infinity UV/UF system.  The checkers used tetrahydrofuran
(VWR, HPLC-grade) dried using a Pure-SolveTM system.  Reagent grade acetone was
purchased from VWR, methanol (Baker analyzed) was purchased from J.T. Baker and
hexanes were distilled.
4. The evolution of hydrogen gas during the addition of sodium borohydride is
minor due to the adequate size of the reaction flask and the surface area of cooling.  This
is readily vented through the oil bubbler.
5. The initial reaction quench with methanol proceeds with vigorous gas evolution.
Methanol should be added dropwise until the intensity of gas evolution abates.
6. The reduction product, (S)-tert-leucinol, can be purified by distillation,3 but this
was not necessary for this application.  The material showed the following
characterization data: 1H NMR (400 MHz, CDCl3)  δ: 0.89 (s, 9 H), 2.49 (dd, J = 10.2,
3.9 Hz, 1 H), 3.19 (t, J = 10.2 Hz, 1 H), 3.70 (dd, J = 10.2, 3.9 Hz, 1 H).  This material
may also be purchased from commercial sources, but is less expensive in the amino acid
form. Similar amino acid reductions have appeared in Organic Syntheses.4
7. 2-Bromo-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-benzamide showed
the following characterization data: mp 117–118 °C from acetone/hexanes; Rf = 0.14 (2:1
hexanes/acetone); 1H NMR (500 MHz, CDCl3) δ: 1.03 (s, 9 H), 2.40 (br dd, J = 5.0 Hz, 1
H), 3.64–3.70 (m, 1 H), 3.91-3.97 (m, 1 H), 4.04–4.08 (m, 1 H), 6.20 (br d, J = 8.4 Hz, 1
H), 7.27 (ddd, J = 7.9, 7.9, 1.6 Hz, 1 H), 7.35 (dd, J = 7.5, 7.5 Hz, 1 H), 7.55 (dd, J = 7.6,
1.5 Hz, 1 H), 7.59 (d, J = 8.0 Hz, 1 H); 13C NMR (126 MHz, CDCl3) δ: 27.1, 33.8, 60.3,
63.0, 119.0, 127.6, 129.7, 131.3, 133.3, 137.9, 168.6; IR (ATR) 3223, 3065, 2961, 1627,
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1544 cm-1; HRMS (FAB+) m/z calc'd for C13H19NO2Br [M + H]+: 300.0599, found
300.0590; MS (FAB) m/z (relative intensity): 300 (100%), 185 (49%), 77 (21%); [α]D20
+17.3 (c 2.38, methanol); Anal. calc’d. for C13H18NO2Br: C, 52.01; H, 6.04; N, 4.67.
Found: C, 52.01; H, 5.95; N, 4.51.
8. In some cases the resulting filtrate was purified by silica gel flash
chromatography, eluting with a 3:1 →  2:1 hexanes/acetone gradient to afford an
additional 2–6% of an off-white amorphous solid that is spectroscopically identical to the
crystalline material.
9. Reaction progress can be monitored by TLC analysis (the checkers used
Polygram®SIL/UV254-TLC-plates from Macherey-Nagel) using 2:1 ethyl acetate/hexanes
as the eluent with UV visualization (Rf amide = 0.28, Rf mesylate = 0.43, Rf
bromooxazoline = 0.64).  Mesylate formation is typically complete upon final addition of
methanesulfonyl chloride, whereas cyclization to the bromooxazoline typically requires
ca. 5 h at 50 °C to complete.
10. Flash chromatography column dimensions: 3 cm diameter x 20 cm height of
silica gel (checkers used  “Silica Gel 60” (0.040–0.063 mm) from Merck), eluting with
200 mL of 9:1 hexanes/ethyl acetate, then 450 mL of 6:1 hexanes/ethyl acetate, collecting
ca. 20–25 mL fractions.  Fraction purity can be assayed by TLC (the checkers used
Polygram®SIL/UV254-TLC-plates from Macherey-Nagel) analysis using 4:1 hexanes/ethyl
acetate with UV visualization.  This method of purification removes color from the crude
material and a minor impurity at Rf = 0.33.
11. 2-(2-Bromophenyl)-4-(1,1-dimethylethyl)-4,5-dihydro-(4S)-oxazole showed the
following characterization data: mp 47–48 °C; Rf = 0.27 (4:1 hexanes/ethyl acetate); 1H
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NMR (500 MHz, CDCl3) δ: 1.00 (s, 9 H), 4.11 (dd, J = 10.2, 8.0 Hz, 1 H), 4.26 (dd, J =
8.3, 8.3 Hz, 1 H), 4.38 (dd, J = 10.2, 8.7 Hz, 1 H), 7.27 (ddd, J = 7.7, 7.6, 1.9 Hz, 1 H),
7.33 (ddd, J = 7.5, 7.5, 1.1 Hz, 1 H), 7.63 (dd, J = 8.0, 0.9 Hz, 1 H), 7.66 (dd, J = 7.6, 1.3
Hz, 1 H); 13C NMR (126 MHz, CDCl3) δ: 26.0, 34.1, 69.0, 76.8, 121.9, 127.1, 130.3,
131.3, 131.5, 133.7, 162.8; IR (ATR) 2958, 1660, 1476, 1358, 1095, 1022, 959 cm-1;
HRMS (FAB+) m/z calc'd for C13H17NOBr [M + H]+: 282.0493, found 282.0488; MS
(FAB) m/z (relative intensity): 282 (100%), 224 (10%), 183 (17%), 77 (12%); [α]D20
–48.9 (c 3.77, hexane); Anal. calc’d. for C13H16NOBr: C, 55.33; H, 5.72; N, 4.96. Found:
C, 55.37; H, 5.70; N, 4.84.
12. Submitters sealed the Teflon valve and placed the sealed flask in a 110 °C oil
bath protected with a blast shield.  Reactions performed with minimal stirring or that
cease to stir result in incomplete conversion.  The preferred stirring rate of the coupling
reaction is ca. 700 setting (ca. 700 rpm) on an IKAmag RET basic stir/hot plate (a range
between 500–800 rpm is sufficient).  Additionally, the color of the reaction becomes an
intense yellow within 5–10 minutes of heating.  The color of the inorganic base then
dominates as it turns to light gray, and finally to a dark maroon/purple color after several
hours.
13. The reaction typically requires 21 h to reach complete conversion.  Reaction
progress can be monitored by TLC analysis (the checkers used Polygram®SIL/UV254-
TLC-plates from Macherey-Nagel) using 4:1 hexanes/diethyl ether as the eluent
(developed twice) with UV visualization (Rf bromooxazoline = 0.17, Rf reduced
oxazoline = 0.27, Rf tert-ButylPHOX = 0.33, Rf Ph2PH = 0.51).
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14. Fritted glass funnel (Por. 3, pore size 15–40 µm), 4 cm diameter x 5 cm height)
filled with 16 g of Celite.
15. Submitters dissolved the pale yellow semi-solid in a minimal amount of
dichloromethane (ca. 40 mL) and diethyl ether (ca. 50 mL).
16. Flash chromatography column dimensions: 5 cm diameter x 16 cm height of
silica gel, (checkers used “Silica Gel 60” (0.040-0.063 mm) from Merck).  Checkers
eluted with 500 mL of 24:1 hexanes/diethyl ether, then 400 mL of 9:1
dichloromethane/diethyl ether, collecting ca. 50 mL fractions. Fraction purity can be
assayed by TLC (the checkers used Polygram®SIL/UV254-TLC-plates from Macherey-
Nagel) analysis using 4:1 hexanes/diethyl ether with UV visualization.  The mixture of
products may contain reduced arene, starting bromooxazoline, and desired (S)-tert-
ButylPHOX, depending on the extent of reaction (Note 12).
17. As the percentage of desired (S) -tert-ButylPHOX in the crude mixture
increases, the oil readily solidifies upon concentration under reduced pressure.  To
decrease the time required to induce crystallization, this oil can then be dissolved in
diethyl ether and further concentrated.  Additionally, acetonitrile efficiently promotes
crystallization of (S)-tert-ButylPHOX in concentrated solutions.
18. If the reaction is pushed to completion, the material obtained from this simple
purification is typically quite pure (no impurities were detected by 1H NMR analysis of
the crude oil).  If the purity is unsatisfactory, this crystalline material can be recrystallized
with hot acetonitrile.  A typical recrystallization is performed as follows: in an
experiment run on 20.0 mmol scale, 7.033 g (18.15 mmol) of crude product was
dissolved in a minimal amount (ca. 8–10 mL) of boiling acetonitrile and allowed to cool
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slowly to ambient temperature.  The crystals are then filtered and washed with ca. 15–25
mL of hexanes, then dried under high vacuum to yield 6.613 g (17.07 mmol, 85.3%
yield) of white blocks.  This material is analytically pure by 1H NMR and all other
spectroscopic data (see Note 19).
19. In a run carried out on half-scale, 3.49 g of (S)-tert-ButylPHOX was obtained
(90% yield). (S)-tert-ButylPHOX showed the following characterization data; mp
113–114 °C from acetonitrile; Rf = 0.33 (4:1 hexanes/diethyl ether); 31P NMR (162 MHz,
CDCl3) δ: –5.49 (s); 1H NMR (400 MHz, CDCl3) δ: 0.73 (s, 9 H), 3.88 (dd, J = 10.2, 8.2
Hz, 1 H), 4.01 (dd, J = 8.3 Hz, 8.3 Hz, 1 H), 4.08 (dd, J = 10.2, 8.5 Hz, 1 H), 6.87 (ddd, J
= 7.7, 4.0, 0.8 Hz, 1 H), 7.33–7.21 (m, 11 H), 7.36 (apparent dt, J = 7.6, 1.3 Hz, 1 H),
7.94 (ddd, J = 7.7, 3.7, 0.9 Hz, 1 H); 13C NMR (101 MHz, CDCl3) δ: 25.8, 33.6, 68.3,
76.7 (overlaps with CHCl3-rest-signal, detected in DEPT135-experiment), 128.0, 128.3
(d, JCP = 5.9 Hz), 128.2 (2 lines), 128.5 (d, JCP = 9.7 Hz), 129.8 (d, JCP = 3.1 Hz), 130.3,
132.0 (d, JCP = 19.7 Hz), 133.6 (d, JCP = 20.2 Hz), 134.1, 134.3 (d, JCP = 21.0 Hz), 138.3
(d, JCP = 9.7 Hz), 138.5 (d, JCP = 12.6 Hz), 138.8 (d, JCP = 25.5 Hz), 162.7 (d, JCP = 2.7
Hz); IR (ATR) 3069, 2955, 2897, 2866, 1653, 1583, 1475, 1433, 1354, 1090, 1024, 955,
742, 669, 580, 511 cm-1; HRMS (FAB+) m/z calc'd for C25H27NOP [M + H]+: 388.1830,
found 388.1831; MS (EI) m/z (relative intensity): 388 (1%), 372 (9%), 330 (55%), 302
(100), 228 (6), 183 (12); [α]D20 –75.2 (c 0.925, CHCl3); Anal. calc’d. for C25H26NOP: C,
77.50; H, 6.76; N, 3.62. Found: C, 77.22; H, 6.82; N, 3.57.  The enantiomeric excess of
(S)-tert-ButylPHOX can be determined by analytical supercritical fluid chromatography;
this was performed using a Berger Analytix SFC (Thar Technologies) equipped with a
Chiralcel® OJ-H column (4.6 mm x 25 cm) obtained from Daicel Chemical Industries,
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Ltd. and a diode array detector.  The assay conditions are 10% ethanol, 35 °C, 2 mL/min
flow rate, with visualization at 210 nm (optimal), retention times: (R) enantiomer = 4.67
min, (S) enantiomer = 5.17 min.  The minor (R) enantiomer can not be detected from SFC
analyses of ligand prepared from the reported procedure, and is therefore >99% ee.  This
crystalline material is stable indefinitely at ambient temperatures in a closed container
under an atmosphere of nitrogen or argon.
A6.3 DISCUSSION
This synthesis of (S )- ter t -ButylPHOX (4-(1,1-dimethylethyl)-2-[2-
(diphenylphosphino)phenyl]-4,5-dihydro-(4S)-oxazole) is a modification of our
previously reported procedure.5  Several improvements have been implemented that
facilitate large-scale preparation of this ligand.  Recrystallization of 2-bromo-N-[(1S)-1-
(hydroxymethyl)-2,2-dimethylpropyl]-benzamide obviates the previous need for flash
column chromatography.  Subsequent oxazoline formation is now accomplished via
mesylate displacement with improved efficiency and yield.  The use of methanesulfonyl
chloride enables rapid mesylate formation at milder temperatures, and aqueous reaction
workup is favored over the previous method, where incomplete hydrolysis of p-
toluenesulfonyl chloride complicated purification.  The copper(I) iodide-catalyzed
phosphine coupling6 has been optimized to maximize the efficiency of the reaction by
minimizing the use of catalyst and diamine ligand, as well as reducing the quantities of
phosphine, cesium carbonate, and solvent.  Finally, a procedure to purify (S)-tert-
ButylPHOX is described, using a simple silica gel plug, followed by crystallization with
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acetonitrile (or recrystallization when necessary), to afford the ligand as a white
crystalline solid in four steps from (L)-tert-leucine in excellent overall yield (71.9–80.4%
over four steps).
The phosphinooxazoline7 (S)-tert-ButylPHOX is a chiral P/N-ligand useful for an
array of organometallic transformations, including alkylations,7,8 desymmetrizations of
meso-anhydrides,9 Heck react ions,10 hetero-Diels–Alder cycloadditions,11
Meerwein–Eschenmoser Claisen rearrangements,12 and hydrogenations.13  Our laboratory
has recently described its use as a uniquely effective ligand for the palladium-catalyzed
asymmetric decarboxylative allylation5,14 and protonation15 of prochiral ketone enolates.
This synthesis of (S)-tert-ButylPHOX highlights improvements of a general and efficient
strategy to access PHOX ligands of varied structure and electronics in substantial
quantities (Figure A6.1).5b
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Figure A6.1  PHOX derivatives prepared via this protocol
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APPENDIX 7
Optimized Large-Scale Procedure for
Enantioselective Tsuji Allylation†
A7.1 PROCEDURE
A7.1.1 1-METHYL-2-OXO-CYCLOHEXANECARBOXYLIC ACID 2-
PROPENYL ESTER
Caution!  This procedure should be carried out in an efficient fume hood due to the
evolution of hydrogen gas during the reaction.  Appropriate precautions should be taken
to avoid inhalation or direct contact with iodomethane or allyl alcohol.  The former is a
known carcinogen, and the latter is a potent toxin due to its in vivo metabolism to
acrolein, a known carcinogen.
                                                 
† This work was carried out in collaboration with Michael R. Krout and the procedures herein have been
published in Org. Synth.  Some of the data contained in this procedure were collected by the Org. Synth.
checkers (C. Ebner, and A. Pfaltz, University of Basel) during the normal Org. Synth. review process.  See:
Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Org. Synth. 2009, 86, 194–211.
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Scheme A7.1  Substrate synthesis
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A 500-mL, single-necked, round-bottomed flask equipped with a large magnetic stir
bar (38 x 8 mm) is charged with 50.0 g of pimelic acid (313 mmol, 1.00 equiv), 156 mL
of toluene, and 63.9 mL of allyl alcohol (939 mmol, 3.00 equiv) (Note 1).  The mixture is
stirred vigorously to create a uniform suspension, and 297 mg of p-toluenesulfonic acid
monohydrate (1.57 mmol, 0.005 equiv) is added.  A Dean–Stark trap and a water-cooled
condenser with a two-tap Schlenk adapter connected to a bubbler and an argon/vacuum
manifold (Note 2) are affixed to the flask, and the resulting suspension is heated to reflux
(120 °C oil bath temperature).  The mixture in the flask soon became homogeneous.
After 16 h at reflux, approximately 11 mL of water had accrued in the Dean–Stark trap.
The vessel is cooled to ambient temperature and the solution is transferred to a separatory
funnel (500 mL).  The organic solution is washed successively with saturated aqueous
sodium bicarbonate (3 x 15 mL) and brine (2 x 15 mL) and then dried over anhydrous
magnesium sulfate (6 g).  After filtration through cotton, the organic solution is
concentrated by rotary evaporation under vacuum (60 °C, 15 torr) and then the last traces
of solvent are removed under high vacuum (0.15 torr) to yield 72.3–74.6 g of diallyl
pimelate (301–311 mmol, 96–99% yield) as a slightly yellow-colored, free-flowing
liquid.  GC analysis indicated >99% purity (Note 3).
A flame-dried, three-necked, 1-L flask equipped with a glass stopper, a water-cooled
reflux condenser with a two-tap Schlenk adapter connected to a bubbler and an
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argon/vacuum manifold (Note 2), a rubber septum, and a magnetic stir bar is charged
with 13.2 g of 60% sodium hydride (331 mmol, 1.10 equiv) and tetrahydrofuran (250
mL) (Note 1).  The flask is immersed in a water bath (22 °C) and a solution of 72.2 g of
crude diallyl pimelate (301 mmol, 1.00 equiv) in 50 mL of tetrahydrofuran is added in a
steady stream via cannula during the course of 5 min.  Some moderate bubbling
(hydrogen evolution) of the reaction mixture is observed during the addition.  Following
the addition, the suspension is heated to 40 °C and then stirred for 10 h (Note 4)
whereupon the reaction mixture turned to a clear, yellowish solution.  Once the starting
material is consumed (based on TLC, Note 5), 24.3 mL of neat iodomethane (391 mmol,
1.30 equiv) (Note 1) is added to the mixture, which became a white suspension.  After an
additional 15 h at 40 °C, the mixture is cooled to ambient temperature (22 °C) and water
(60 mL) is added carefully via syringe over the course of 9 min to obtain a clear,
yellowish solution.  The mixture is transferred to a 1-L, single-necked, round-bottomed
flask, the THF is removed by rotary evaporation under vacuum (40 °C, 150 torr) (Note
6), and the remaining solution is transferred to a separatory funnel (500 mL) and diluted
with ethyl acetate (100 mL).  The phases are separated and the aqueous phase is extracted
with ethyl acetate (3 x 75 mL).  The combined organic extracts are washed with brine (1
x 50 mL) and dried over anhydrous magnesium sulfate (5 g).  After filtration through
cotton, the organic solution is concentrated by rotary evaporation under vacuum (40 °C,
75 torr) to yield a yellow liquid.  The material is purified by short-path distillation until
the first drop of the distillate turned yellow to give 52.9–53.0 g (270 mmol, 90% yield)
(Note 7) of a clear, colorless liquid boiling from 69–72 °C/0.08 torr.  GC analysis found
>99% product purity (Note 8).
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A7.1.2 (2S)-2-METHYL-2-(2-PROPEN-1-YL)-CYCLOHEXANONE
Scheme A7.2  Enantioselective decarboxylative allylation
O Pd2(dba)3
(S)-tert-ButylPHOX
THF, 30 °C
O
O
O
86% ee
A flame-dried, 50-mL, conical flask equipped with a rubber septum is charged with a
portion of 1-methyl-2-oxo-cyclohexanecarboxylic acid 2-propenyl ester, placed under
vacuum (0.06 torr) for 60 min to remove any dissolved gases, and then backfilled with
argon.  A 1-L, three-necked, round-bottomed flask is equipped with a stir bar, two rubber
septa, and a two-tap Schlenk adapter connected to a bubbler and an argon/vacuum
manifold (Note 2).  The apparatus is flame-dried under vacuum and backfilled with dry
argon (three cycles).  After cooling the flask to ambient temperature, 435 mL of
anhydrous tetrahydrofuran (Notes 1 and 9) is added and the flask is immersed in a 30 °C
water bath.  A twelve-inch needle is inserted through one of the septa and used to bubble
dry argon gas through the liquid for 30 min.  The needle is removed and then 1.02 g of
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3, 1.11 mmol, 0.0125 equiv) and 1.03
g of (S)-tert-ButylPHOX (2.67 mmol, 0.030 equiv) (Note 1) are added.  The mixture
immediately became opaque and took on a golden brown color.  This mixture is stirred at
30 °C for 30 min (Note 10).  Subsequently, neat 1-methyl-2-oxo-cyclohexanecarboxylic
acid 2-propenyl ester (17.5 g, 89.03 mmol, 1.00 equiv) from the conical flask is added via
syringe in a dropwise fashion to the catalyst mixture over the course of 10 min.
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When the transfer is complete, the syringe is rinsed successively with two 5 mL
portions of anhydrous tetrahydrofuran into the reaction mixture.  Upon addition of the
substrate to the catalyst mixture, the color changed to olive green.  The mixture is
maintained at 30–32 °C for 22–23 h (Note 11), when TLC indicated complete
consumption of the starting material (Note 12).  The olive green-colored mixture is then
passed through a pad of silica gel (5 cm diameter x 5 cm height) and rinsed with diethyl
ether (200 mL).  The bright yellow filtrate is concentrated by rotary evaporation under
vacuum (150 torr, 40 °C) (Note 13).  The liquid is then transferred to a 50-mL round-
bottomed flask and distilled through a short path apparatus into a receiving flask
immersed in an ice water bath to provide 11.5–12.8 g (75.7–84.2 mmol, 85–95% yield)
of (S)-2-allyl-2-methylcyclohexanone as a clear, colorless liquid boiling from 91–93
°C/16 torr that is analytically pure based on standard techniques (Note 14).  Analysis of
this material by GC on a chiral stationary phase found 86–87% enantiomeric excess
(Note 15).  In a reaction that gave 85% yield after distillation, additional product was
obtained by subjecting the material remaining in the distillation pot to flash
chromatography on silica gel (Notes 16 and 17), which provided an additional 1.14 g of
product (7.50 mmol, 8% yield), also of 86% ee, for a combined yield of 12.64 g (83.2
mmol, 93% yield) (Note 18).
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A7.1.3 E N R I C H M E N T  O F  ( 2S)-2-METHYL-2-(2-PROPEN-1-YL)-
C Y C L O H E X A N O N E  V I A  ( 2E)-2-[(2S)-2-METHYL-2-(2-
PROPENYL)CYCLOHEXYLIDENE]-HYDRAZINECARBOXAMIDE
Scheme A7.3  Increase of ee by means of semicarbazone derivative
O 1. semicarbazide•HCl
    NaOAc, H2O
2. recrystallization
3. 3 N HCl (aq), Et2O
O
86% ee 98% ee
Into a 250-mL, pear-shaped flask is added 5.58 g of sodium acetate (68.0 mmol, 1.00
equiv), 8.38 g of semicarbazide hydrochloride (74.8 mmol, 1.10 equiv), 75 mL of
purified water (Note 1), and a large magnetic stir bar.  The solution is stirred until all of
the solids dissolved.  At this point, 10.34 g of neat 2-allyl-2-methylcyclohexanone (68.0
mmol, 1.00 equiv) is added via syringe.  When the addition is complete, a two-tap
Schlenk adapter connected to a bubbler and an argon/vacuum manifold (Note 2) is
attached and the mixture is heated to 60 °C for 14 h (Note 19).  The thick slurry is
vacuum filtered (water aspirator) directly through filter paper on a porcelain Büchner
funnel and rinsed with water (2 x 20 mL).  The white solid is dried for 30 min on the
funnel, transferred to a 250-mL round-bottomed flask, which then is immersed in a 50 °C
water bath.  The white solid is dried under vacuum (0.3 torr) until a constant mass of 12.2
g (58.3 mmol, 86% yield) is achieved (about 8 h).  At this point, the semicarbazone is
found to have 90–91% ee (measured by reverting to the ketone, Note 20).
A stir bar is added to the flask and the solids are suspended in 150 mL of toluene with
mixing at approximately 400 rpm.  After a water-cooled reflux condenser is attached to
the flask, the mixture is then heated to 110 °C (bath temperature) in an oil bath. After a
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few minutes at this temperature, the solids dissolve completely to afford a clear colorless
solution (Note 21).  Heating is discontinued and the stirred mixture is allowed to cool to
ambient temperature (20 °C) overnight while still immersed in the oil bath (Note 22).
The cooled heterogeneous mixture is vacuum filtered (water aspirator) through filter
paper on a porcelain Büchner funnel.  The solids are rinsed with toluene (2 x 10 mL) and
then dried on the filter for 15 min (Note 23).  The solids are transferred to a 250-mL pear-
shaped flask and dried under vacuum (0.3 torr) until a constant mass of 10.8–10.9 g
(51.7–52.2 mmol, 76–77% yield, 89–90% recovery) is observed.  This material is found
to have 98–99% enantiomeric excess (measured by reverting to the ketone, Note 20).
A 250-mL pear-shaped flask containing a magnetic stir bar and 10.5 g of
semicarbazone (50.2 mmol) and 40 mL of diethyl ether is stirred to suspend the solids.
To the suspension is added 20 mL of 3 N aqueous hydrochloric acid (Note 1).  No
appreciable heat evolution is observed.  The mixture is stirred vigorously for 3 h at
ambient temperature (20 °C), at which time all of the solids had disappeared and two
clear colorless phases are observed.  The biphasic mixture is transferred to a 100-mL
separatory funnel and the phases are separated.  The aqueous phase is extracted with
diethyl ether (3 x 10 mL).  The combined organic layers are then washed successively
with saturated sodium bicarbonate (2 x 5 mL), water (1 x 5 mL), and brine (2 x 5 mL).
The organic phase is dried over anhydrous magnesium sulfate (1 g) and then filtered
through cotton and concentrated by rotary evaporation under vacuum (150 torr, first at 20
°C, then at 40 °C to remove the last traces of solvent) to provide 7.62–7.63 g (50.1–50.2
mmol, >99% yield) of (S)-2-allyl-2-methylcyclohexanone of 98% ee (Notes 14 and 15).
GC analysis demonstrates the product is formed in >99% product purity (Note 24).
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A7.2 NOTES
1. Pimelic acid (≥99%, Fluka), allyl alcohol (≥99%, Sigma-Aldrich), p-
toluenesulfonic acid monohydrate (ACS reagent, ≥98.5%, Sigma-Aldrich), toluene
(Baker ultra resi-analyzed, J.T. Baker), solid sodium bicarbonate (tech grade, Brenntag
Schweizerhall AG), magnesium sulfate (tech. grade, Brenntag Schweizerhall AG),
sodium hydride (60% dispersion in mineral oil, Acros), iodomethane (Reagent Plus, 99%,
Sigma-Aldrich), tris(dibenzylideneacetone)dipalladium (Pd2(dba)3, Strem), sodium
acetate (puriss. p.a., ACS reagent, anhydrous, ≥99.0% (NT), Fluka), semicarbazide
hydrochloride (99%, Alfa Aesar), and hydrochloric acid (36−38 wt%, J.T.Baker), were
purchased and used as received.  Checkers purchased purified water (for HPLC, Fluka),
submitters used water purified with a Barnstead NANOpure Infinity UV/UF system.
Ethyl acetate (tech. grade, Brenntag Schweizerhall AG) was distilled prior to use, diethyl
ether (tech. grade, Brenntag Schweizerhall AG) was distilled and passed through an
activated alumina column under nitrogen prior to use,1 tetrahydrofuran (HPLC grade,
Fisher) was distilled from sodium 9-fluorenone ketyl2 or passed through an activated
alumina column under argon prior to use.  The ligand (S)-tert-ButylPHOX was prepared
using our accompanying procedure in Organic Syntheses.3,4
2. A two-tap Schlenk adapter connected to a bubbler and an argon/vacuum manifold
is illustrated in Yu, J.; Truc, V.; Riebel, P.; Hierl, E.; Mudryk, B. Org. Synth. 2008, 85,
64–71.
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3. The esterification product, diallyl pimelate, may be distilled (bp
134–135 °C/0.2 torr), but this is not necessary for this application.  Distillation of a
separate sample of diallyl pimelate led to significant loss of material to unidentified
polymeric byproducts formed in the distillation flask, and distillation is therefore not
recommended.  Product purity was measured by GC using a CE Instruments GC 8000
Top equipped with a Restek Rtx-1701 column (30.0 m x 0.25 mm) and a flame ionization
detector using a method of 100 °C isothermal for 5 min, then ramp 13 °C/min to 240 °C,
then 240 °C isothermal for 5 min with 60 kPa He carrier gas flow.  The retention time for
the product was 17.85 min.  No further signals were observed by the checkers, and
therefore a product purity of 98% was assigned with >99% yield.  Submitters reported
observation of a predominant but unidentified impurity with slightly shorter retention
time than the product.  The product exhibited the following characteristics: 1H NMR
(400 MHz, CDCl3) δ: 1.33–1.40 (m, 2 H), 1.66 (apparent quintet, J = 7.7 Hz, 4 H), 2.34
(t, J = 7.6 Hz, 4 H), 4.57 (apparent dt, J = 5.7, 1.4 Hz, 4 H), 5.23 (apparent dq, J = 10.4,
1.3 Hz, 2 H), 5.30 (apparent dq, J = 17.2, 1.5 Hz, 2 H), 5.91 (ddt, J = 17.2, 10.4, 5.7 Hz,
2 H); 13C NMR (101 MHz, CDCl3) δ: 24.7, 28.7, 34.1, 65.1, 118.3, 132.4, 173.3; IR (neat
film, NaCl) 3086, 3025, 2942, 2866, 1733, 1648, 1456, 1421, 1378, 1272, 1173, 1086,
991, 932, 734 cm–1; MS (FAB, NBA) m/z (%) 242 (11), 241 (100, [M+H]+), 183 (85),
137 (31), 136 (14), 125 (53), 77 (10), 69 (12), 41 (59), 39 (12); HRMS (EI) m/z calc'd for
C13H20O4 [M]+: 240.1362, found 240.1355; TLC (Hex/EtOAc = 4:1) Rf = 0.46. Anal calcd
for C13H20O4: C 64.98, H 8.39, found C 65.28, H 8.38.
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4. Submitters reported 7 h at 22 °C and an additional 4 h at 40 °C until all starting
material was consumed. After this time the checkers did not observe full conversion by
TLC analysis using the TLC method described in Note 5.
5. The progression of the cyclization may be monitored by TLC analysis using 20%
ethyl acetate in hexanes as eluent with KMnO4 staining (submitters used p-anisaldehyde
staining): Rf diallyl pimelate = 0.46, Rf cyclized intermediate = 0.58–0.77 (broad, also
UV active), Rf alkylation product = 0.56. The detection of diallyl pimelate is often
obscured by the cyclized intermediate.
6. Following the submitters’ procedure, THF was not removed before diluting with
ethyl acetate. In the checkers’ hands no phase separation took place under these
conditions.
7. Submitters reported 67% yield and 92% purity.
8.  Using the GC method described in Note 3, 1-methyl-2-oxo-
cyclohexanecarboxylic acid 2-propenyl ester has a retention time of 14.77 min.  The
distilled material contains a small amount (<1% by GC) of uncyclized pimelate and <1%
of an unidentified byproduct (retention time of 14.61 min).  Submitters report observation
of 6% of uncyclized diallyl pimelate and 2% of unidentified byproduct, which does not
significantly affect the subsequent step.  Out of this mixture analytically pure material
may be obtained by flash chromatography on silica gel using a gradient of 1.5 → 4%
diethyl ether in hexanes as eluent.  GC response factors between 1-methyl-2-oxo-
cyclohexanecarboxylic acid 2-propenyl ester and diallyl pimelate were determined with
purified products to confirm these ratios, however assuming a 1:1 response factor gave
the same ratios.  The product showed the following characterization data: 1H NMR (400
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MHz, CDCl3) δ: 1.30 (s, 3 H), 1.43–1.50 (m, 1 H), 1.59–1.78 (m, 3 H), 1.98–2.05 (m, 1
H), 2.42–2.54 (m, 3 H), 4.58−4.66 (m, 2 H), 5.24 (dd, J = 10.4, 0.8 Hz, 1 H), 5.31 (dd, J
= 17.2, 1.4 Hz, 1 H), 5.83−5.93 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ: 21.4, 22.7,
27.6, 38.3, 40.8, 57.3, 65.9, 119.0, 131.6, 172.9, 208.2; IR (neat film, NaCl) 3442, 3082,
2939, 2866, 1719, 1648, 1452, 1377, 1336, 1301, 1259, 1212, 1160, 1121, 1084, 1062,
1038, 977, 936, 854, 816, 767, 668, 599 cm–1; MS (EI, 70 eV) m/z (%) 196 (26, [M]+),
168 (18), 139 (12), 138 (23), 137 (26), 127 (44), 111 (27), 110 (14), 109 (48), 83 (30), 82
(23), 81 (100), 69 (34), 67 (16), 55 (56), 43 (22), 41 (85), 39 (24); HRMS (EI) m/z calc'd
for C11H16O3 [M]+: 196.1099, found 196.1096; TLC (Hex/EtOAc = 4:1) Rf  = 0.56. Anal
calcd for C11H16O3: C 67.32, H 8.22, found C 67.17, H 8.15.
9. The substrate concentration (0.2 M) described herein yields product of slightly
lower enantiomeric excess (about 1% lower) than the previously reported, optimized
conditions (0.033 M in substrate).  For smaller scale where overall quantity of solvent is
less important, the lower substrate concentration is recommended.
10. The complexation time prior to adding substrate is important to the overall
reaction.  Shorter or longer complexation times led to lower product yield and incomplete
substrate conversion.
11. Submitters reported 26 h reaction time.
12. Although the reaction produces an equivalent of carbon dioxide, the evolution of
this byproduct is not visually apparent during the reaction.  The reaction is readily
evaluated by TLC analysis using 10% diethyl ether in pentane as eluent with KMnO4
staining (submitters used p-anisaldehyde staining): Rf dibenzylideneacetone = 0.24 (also
UV active), Rf β-ketoester = 0.33, Rf product = 0.46.
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13. Care should be taken to ensure that the moderately volatile product is not lost
during concentration of the filtrate.  However, if a substantial amount of solvent remains,
distillation of the product does not occur smoothly. At 150 torr and 40 °C,
tetrahydrofuran and diethyl ether are easily removed and product is not lost.
14. The distilled material showed the following analytical data: 1H NMR (400 MHz,
CDCl3) δ: 1.06 (s, 3 H), 1.54–1.61 (m, 1 H), 1.65–1.90 (m, 5 H), 2.23 (apparent ddt, J =
13.9, 7.3, 0.9 Hz, 1 H), 2.33−2.40 (m, 3 H), 5.01–5.06 (m, 2 H), 5.69 (apparent ddt, J =
16.6, 11.1, 7.4 Hz, 1 H); 13C NMR (101 MHz, CDCl3) δ: 21.2, 22.8, 27.5, 38.7, 38.9,
42.1, 48.6, 118.0, 133.9, 215.5; IR (neat film, NaCl) 3393, 3076, 2933, 2864, 1706, 1451,
1124, 995, 913 cm–1; MS (EI, 70 eV) m/z (%) 152 (31, [M]+), 137 (36), 123 (29), 109
(60), 108 (27), 95 (33), 94 (21), 93 (69), 83 (49), 82 (16), 81 (31), 79 (21), 69 (14), 68
(17), 67 (66), 55 (100), 53 (13), 41 (50), 39 (25); HRMS (EI) m/z calc'd for C10H16O [M]+:
152.1201, found 152.1204; TLC (Pentane/Et2O = 9:1) Rf = 0.46. Anal calcd for C10H16O:
C 78.90, H 10.59, found C 78.86, H 10.48; optical rotation following enrichment (Part
C): [α]D21.0 –47.0 (c 2.30, dichloromethane, 98% ee).
15. GC analyses were performed with a Fisons Instruments HRGC Mega2 series
equipped with a Chiraldex G-TA column (30.0 m x 0.25 mm) and a flame ionization
detector.  The assay conditions for 2-allyl-2-methylcyclohexanone are 100 °C isothermal,
60 kPa H2 carrier gas flow, retention times: major (S) enantiomer = 14.15 min, minor (R)
enantiomer = 17.09 min.  The absolute configuration was established by X-ray
crystallographic analysis of a semicarbazone derivative bearing a substituent with known
absolute configuration.5
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16. Column chromatography: 5 cm diameter x 10 cm height, eluting with 10%
diethyl ether in pentane, 100 mL forerun, collecting 30 mL fractions.  Product appeared
in fractions 9−20.  See Note 12 for TLC conditions.  For smaller scale preparations, it is
often convenient to perform chromatography directly rather than distilling the product.
17. In the reaction that gave 95% yield after distillation, TLC (see Note 12) of the
distillation residue showed only traces of product.  Therefore no flash chromatography
was performed.
18. Submitters reported 76% yield after distillation and an additional 11% from flash
chromatography for an overall yield of 87%.
19. Semicarbazone formation begins before the addition of ketone is complete,
although conversion at room temperature is sluggish.
20. To ensure an accurate ee value, the powder was mixed thoroughly prior to
measurement.  The enantiomeric excess was determined by suspending a small amount of
semicarbazone (approximately 10 mg) in a biphasic mixture of diethyl ether (1 mL) and 2
N aqueous hydrochloric acid (1 mL) at ambient temperature.  After 30 min of stirring, all
of the solids had dissolved and the organic layer was separated, dried briefly over
anhydrous magnesium sulfate, filtered through cotton, and the filtrate concentrated by
rotary evaporation.  The residue was then dissolved in tert-butyl methyl ether and
analyzed by GC (see Note 15 for separation conditions).  The semicarbazone was
homogeneous according to the proton and carbon NMR spectra, and appears to be a
single geometric isomer.  However a correct elemental analysis could not be achieved.
The following properties were observed: mp 190–191 °C (toluene, 98% ee); 1H NMR
(400 MHz, CDCl3) δ: 1.09 (s, 3 H), 1.41–1.48 (m, 1 H), 1.53–1.71 (m, 5 H), 2.14–2.25
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(m, 2 H), 2.32–2.39 (m, 2 H), 5.00 (apparent d, J = 3.5 Hz, 1 H), 5.03 (s, 1 H), 5.68–5.9
(m, 1 H), 8.29 (s, 1 H); 13C NMR (101 MHz, CDCl3) δ: 21.2, 22.9, 24.7, 26.1, 38.7, 41.6,
43.1, 117.3, 134.9, 157.3, 158.7; IR (neat film, NaCl) 3465, 3243, 3198, 3074, 2967,
2860, 1695, 1665, 1567, 1477, 1374, 1111, 1078, 991, 909 cm–1; MS (EI, 70 eV) m/z (%)
209 (35, [M]+), 194 (44), 168 (15), 165 (100), 151 (33), 150 (70), 149 (23), 148 (10), 135
(48), 134 (28), 125 (95), 108 (36), 107 (15), 98 (35), 96 (21), 95 (18), 93 (33), 91 (18), 82
(12), 81 (63), 80 (14), 79 (30), 77 (12), 67 (42), 55 (30), 53 (17), 44 (11), 41 (48), 39
(14); HRMS (CI, CH4) m/z calc'd for C11H20N3O [M + H]+:  210.1606, found 210.1599;
[α]D21.0 –50.5 (c 1.91, methanol, 98% ee).
 21. At the reported concentration, the hot toluene solution is not saturated.  The
additional solvent helps maintain efficient stirring as the crystallization progresses and
the viscosity of the mixture increases.  The additional solvent does not significantly affect
the efficiency of product recovery.
22. Stirring during the crystallization process is very important to the efficiency of
the ee improvement.  For example, two separate 300 mg portions of semicarbazone with
89% ee were recrystallized from hot toluene (about 3 mL) with and without stirring.
Although product recovery was comparable for either procedure (81% and 80%,
respectively), the unstirred crystallization provided semicarbazone of 93% ee while the
stirred crystallization provided semicarbazone of 96% ee.  Either procedure yields the
product as very fine needles.
23. Concentration of the filtrate by rotary evaporation provided an additional
1.24−1.32 g (10−11% recovery) of semicarbazone.  GC analysis of the corresponding
ketone found 20−26% ee for this material (see Note 20).
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 24. Using the GC method described in Note 3, 2-allyl-2-methylcyclohexanone has a
retention time of 11.43 min.
A7.3 DISCUSSION
The Dieckmann cyclization protocol employed here is a modification of a similar
procedures developed by Tsuji and coworkers6 and Fuchs and coworkers.7  This
improved procedure allows preparation of racemic allyl β-keto ester substrates in two
steps with a single purification.  Importantly, the single-pot cyclization/alkylation is an
improvement over our previously reported method that required solvent exchange.8  The
Dieckmann protocol is useful for the preparation of a number of substituted allyl β-keto
esters by varying the electrophile.  Possible substituents include alkyl, benzyl, substituted
benzyl, and alkenyl.9  Other more sensitive substituents may be introduced by quenching
the intermediate β-keto ester enolate with aqueous acid and then alkylating the resulting
β-keto ester under more mild conditions (e.g., K2CO3, acetone, 50 °C).8  In this manner,
the β-keto ester enolate may undergo conjugate addition, aldol, or fluorination reactions
with appropriate electrophilic components.8  The β-keto ester substrates are useful not
only for enantioselective decarboxylative allylation, but also for enantioselective
decarboxylative protonation reactions generating α-tertiary cycloalkanones.9  Alternative
methods for synthesis of β-keto ester substrates include acylation of ketones with diallyl
carbonates,8 allyl cyanoformates,8,10 allyl chloroformates,11 or allyl 1H-imidazole-1-
carboxylates.12
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The enantioselective decarboxylative allylation method from allyl β-keto esters,8,13
based on non-enantioselective transformations pioneered by Tsuji and Saegusa,14
represents a substantial advance in asymmetric allylation since prior methods15 required
that the putative prochiral enolate intermediate16 be stabilized by an electron-withdrawing
group (e.g., esters or aryl groups) or contain only a single acidic site.17,18  To highlight the
previous deficiency in the literature, 2-allyl-2-methylcyclohexanone had not been
prepared in high enantiomeric excess prior to our work since few alternative synthetic
methods are available.19  Related enantioselective transformations for the conversion of
allyl enol carbonates and silyl enol ethers to α-quaternary cycloalkanones, also based on
earlier work by Tsuji,20 have been developed by our group5,21 and others.22  However, β-
keto ester substrates are often preferable due to the straightforward synthesis and ease of
substrate handling.  The procedure reported herein has been optimized for large-scale
preparation and features lower catalyst loading and higher substrate concentration than
our previously reported work.  These changes have minimal impact on the efficiency and
selectivity observed in the reaction.  Improvements to purification include conditions for
distillation of the product and an improved protocol for conversion to the corresponding
semicarbazone derivative.  Conditions for recrystallization of the semicarbazone
derivative are also reported, and provide access to highly enantioenriched 2-allyl-2-
methylcyclohexanone.
The scope of this transformation8 and the related transformation of allyl enol
carbonates and enol silanes5,21 has been demonstrated to include alkyl, alkenyl, aryl,
ethereal, siloxy, halogen,23 ketone, ester, and nitrile substituents.  Additionally, the ring
may be appended, unsaturated, enlarged, or substituted with heteroatoms.  The delivered
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allyl group may be substituted at the internal position.  Cascade allylation has also been
performed to generate two quaternary stereocenters.  Good levels of enantioselectivity are
observed throughout these variations and products may be obtained in 55–99% yield and
80–94% ee (Figure A7.1).5,8,21
Figure A7.1  Ketones prepared via enantioselective decarboxylative allylation5,8,21
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The non-enantioselective Tsuji allylation reaction has been used sparingly in total
synthesis efforts.24  Since the development of asymmetric variants, however,
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enantioselective decarboxylative allylation has functioned as a key asymmetric step in the
synthesis of the natural products (+)-dichroanone,25 (+)-elatol,26 (+)-laurencenone B,26
(–)-cyanthiwigin F,27 (+)-carissone,28 and (+)-cassiol29 as well as in an approach to the
natural product zoanthenol30 (Figure A7.2).  Other useful transformations of the product
(S)-2-allyl-2-methyl cyclohexanone include elaboration to various [6.5]- and [6.6]-fused
bicycles and oxidation to a caprolactone derivative (Figure A7.3a).5  Spirocyclic systems
are accessible by employing Grubbs’ olefin metathesis catalysts31 with α,ω-dienes17,21,26
(Figure A7.3b). Dioxanone products may be cleaved to access acyclic keto diols and α-
hydroxy esters (Figure A7.3c).
Figure A7.2  Synthetic targets accessed via enantioselective decarboxylative allylation
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Figure A7.3  (a) Derivatives of 2-allyl-2-methylcyclohexanone.6 (b) Spirocycles accessible via ring-
closing metathesis.18,22,27 (c) Cleavage of dioxanones to access acyclic products.22
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The following notebook cross-reference is included to facilitate access to the
original data obtained for the compounds presented in this thesis.  All notebooks and
spectroscopic data are stored in the Stoltz group archives.
Compound Notebook ID
98 DCBXXII_71
105 DCBXXII_51
106 DCBXXII_061
107 DCBXXIII_265
110 DCBXXII_MeSi
124 DCBXVI_241
125 DCBXVI_195
126 KTIII033
127 KTIII_021
128 KTI_261
129 RMM-CYPHOX
130 KTII_225
131 KTIII_023
132 KTIII_025
135 KTIII_223
136 DCBXIV_107
137 KTIII_221
138 DCBXVIII_299
139 KTIII_213
140 KTIII_215
141 KTIII_231
142 DCBXV_99
143 DCBXIV_165
145 DCBXIV_233
146 DCBXV_45
148 DCBXXII_201
149 DCBXXII_109
150 DCBXXIII_97
151 DCBXXII_133
153 DCBXXII_135
154 DCBXXII_229
155 DCBXXII_115
156 DCBXXII_105
157 DCBXXIII_51
Compound Notebook ID
158 DCBXXIII_103
159 DCBXVI_227
161 DCBXXII_079
162 DCBXXIII_49
163 DCBXXIII_287
164 DCBXXIII_297
165 DCBXXVIII_295
166 DCBXXIII_223
168 DCBXXIII_209
169 DCBXXIII_219
170 DCBXXIII_159
171 DCBXXVIII_301
172 DCBXXVIII_299
173 DCBXXVIII_303
182 DCBXV_259
185 DCBXXII_183
186 DCBXXIII_263
187 KTI_265
188 KTII_075
189 KTIII_191
190 DCBXV_283
191 DCBXVI_153
192 DCBXXIII_301
193 ECKI_61
194 DCBXXIII_251
196 DCBXV_285
197 DCBXXIII_259
209 DCBXXII_247
210 DCBXXII_123
211 DCBXXII_193
212 DCBXXII_91
213 DCBXXIII_93
214 DCBXXII_199
215 DCBXVII_047
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Compound Notebook ID
216 DCBXVII_075
217 DCBXV_249
218 DCBXXII_89
219 DCBXXIII_35
220 DCBXXIII_95
222 DCBXXIII_273
223 DCBXXIII_073
224 DCBXXIII_81
225 DCBXXII_295
226 DCBXXIII_79
227 DCBXXIII_33
235 JTMVI-161B
237 JTMVI-151B
241 JTMVI-85C
242 AMH-I-159
244 DCBXXIV_101
248 JTMVII-35C
249 JTMVII-63B
250 JTMVII-39E
251 JTMVII-89B
252 JTMVII-37D
253 JTMVII-73B
254 DCBXXIV_297
255 JTMVII-57B
256 JTMVI-121D
257 JTMVI-177B
258 DCBXXIV_295
259 DCBXXV_59
260 AMH-I-225
261 AMH-I-229
262 DCBXXIV_151
263 AMH-XI-233
264 JTMVII-31C
265 DEW-III-281
266 JTMVII-81B
271 AMH-II-159
272 AMH-III-061-C2
274 AMH-V-075
275 AMH-V-073
276 JTMVII-283B
278 JTMVII-287B
279 AMHV-127
280 JTMVII-291B
281 AMHV-133
Compound Notebook ID
293 JTMVI-217B
294 DCBXV_231
295 DCBXV_233
306 AMH-III-055B
307 DCBXXIV_121
308 JTMVI-105B
309 JTMVI-99B
310 AMH-XI-227
311 JTMVI-213B
312 JTMVI-215B
317 DEW-III-039
318 DCBXXV_37
326 AMH-II-035
327 AMH-II-037B
328 JTMVII-273B
329 JTMVII-189B
330 JTMVII-245B
331 AMH-V-067
332 JTMVII-275B
333 AMH-V-065A
335 AMH-III-61
498 JTMIX-163B
629 JTMIX-105B
640 JTMIX-157C
643 JTMIX-107B
644 JTMIX-109C
646 JTMIX-209B
648 JTMIX-203B
650 JTMVII-249B
739 CD-III-127
740 CD-III-59
741 CD-II-111
742 CD-III-131
743 CD-II-65
744 CD-II-89
747 JTMXIV-075B
748 CD-II-101
749 CD-III-91
750 CD-III-85
751 CD-III-93
753 CD-III-65
753 CD-III-189
754 CD-III-73
756 CD-III-149
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Compound Notebook ID
760 JTMXIV-073B
761 JTMXIV-079B
762 CD-II-149
763 CD-III-139
767 CD-III-103
1032 Subject Index
Subject Index
Cassiol,
320–322, 640, 650–651, 660, 849–856
Catalytic cycle,
55–57, 663, 734, 841
Cross-over,
333–334, 345, 348, 426, 661–663
Decarboxylation,
55, 315–316, 328–330, 343, 347, 592, 628, 635, 656, 677, 681, 685–686, 695, 703,
705, 724, 839
Decarboxylative,
25, 62, 74, 315–316, 318–324, 387, 585–587, 620, 635–636, 643, 647, 663, 668, 679,
686, 704, 714–715, 724, 840, 910, 912
Desymmetrization,
38, 834–835
Diastereomer,
14, 24, 26–28, 315, 323, 345, 628, 638, 643, 646, 658, 683, 686–687, 691–692,
Diastereoselective,
5, 15, 18, 20, 645, 649,
Deuterium labelling,
11, 420–426, 701, 723, 764–766, 780, 333–334
Dynamic kinetic resolution,
Subject Index 1033
316, 829, 835–836
Enantioconvergent,
315–317, 344, 635, 640, 656, 715, 724, 829, 835–843, 908
Enolate,
21–25, 39–42, 55–56, 62–65, 312–314, 319, 325–333, 585–589, 618–621, 625–629,
635–638, 656–659, 662–664, 677–682, 684–686, 689–690, 694–697, 703–706, 715,
724, 838–840,
Kinetic resolution,
315, 635, 829–834
Mechanism,
11, 25, 21, 56, 65, 324–337, 585–590, 625, 631, 661–664, 679–680, 688, 694–696,
701, 705, 722–724, 732–734, 837–838, 842
Meso,
24, 638, 646, 686, 834
Olefin metathesis,
24, 59, 61, 647, 649, 660,
Oxidation,
59, 320, 632, 642–643, 649–650, 659, 680–681, 830–834, 836–837, 854
Oxidative addition,
12, 41, 55–56, 327–328, 585, 628, 635, 734
Pharmaceutical,
4, 8, 319, 642
1034 Subject Index
Platencin,
908–913
Prochiral,
39–40, 312, 316–317, 324–328, 586, 589–590, 619, 678, 684–685, 828, 844
Quaternary stereocenters,
8, 15–16, 18, 21, 23, 26, 28–29, 38–40, 48, 52–54, 59–60, 312, 316, 322, 585–586,
618–622, 637–638, 644, 647, 660, 693, 714, 724, 839, 850, 909
Racemic,
13–14, 24, 51, 314–317, 635, 637, 640, 642, 645, 656, 680, 689, 693, 698, 715–716,
724–726, 828, 830–844, 909
Rate-determining,
328, 330, 415
Reduction,
3–4, 9, 24, 648, 686–688, 760, 831, 837, 854, 914,
Reductive elimination,
327, 337, 589, 723, 734
Retrosynthesis,
1, 12–13, 24, 850, 909–912
Stereoablation,
25, 317, 635, 693, 715, 828–844
Stereoisomer,
24–25, 322, 646, 677, 691
Subject Index 1035
Stereomutation,
316–317, 343, 835–836
Stoichiometric,
4, 56, 585, 631, 655, 683–684, 687–689, 696, 698, 834, 840, 842, 854
Total synthesis,
2, 8, 13, 16, 26, 28, 322, 638, 641, 644, 646–651, 839, 849–856,
Transition state,
22, 315, 327, 329, 346, 589–590, 593, 679, 685, 690
X-ray,
54, 58, 134, 327, 328, 337, 587, 646, 658, 679, 913–914, 943
1036 Comprehensive Bibliography
Comprehensive Bibliography
Aboulhoda, S. J.; Henin, F.; Muzart, J.; Thorey, C. Tetrahedron Lett.  1995, 36,
4795–4796.
Aboulhoda, S. J.; Hénin, F.; Muzart, J.; Thorey, C.; Behnen, W.; Martens, J.; Mehler,
T. Tetrahedron: Asymmetry 1994, 5, 1321–1326.
Aboulhoda, S. J.; Létinois, S.; Wilken, J.; Reiners, I.; Hénin, F.; Martens, J.; Muzart,
J. Tetrahedron: Asymmetry 1995, 6, 1865–1868.
Adair, G. R. A.; Williams, J. M. J. Chem. Commun. 2007, 2608–2609.
Agnello, E. J.; Laubach, G. D. J. Org. Chem. 1960, 82, 4293–4299.
Akutagawa, S.; Tani, K.  Asymmetric Isomerization of Allylamines.  In Catalytic
Asymmetric Synthesis; Ojima, I., Ed.; Wiley-VCH: New York, pp. 145–161 (2002).
Albéniz, A. C.; Catalina, N. M.; Espinet, P.; Redón, R. Organometallics 1999, 18,
5571–5576.
Allin, S. M.; Gaskell, S. N.; Elsegood, M. R. J.; Martin, W. P. Tetrahedron Lett.
2007, 48, 5669–5671.
Amere, M.; Lasne, M.-C.; Rouden, J. Org. Lett. 2007, 9, 2621–2624.
Aoyama, Y.; Araki, Y.; Konoike, T. Synlett 2001, 9, 1452–1454.
Apparu, M.; Tiba, Y. B.; Leo, P.-M.; Fagret, D. Eur. J. Org. Chem. 2000, 1007–1012.
Applied Homogeneous Catalysis with Organometallic Compounds: A Comprehensive
Handbook in Three Volumes; Cornils, B.; Herrmann, W. A., Eds.; Wiley-VCH:
Weinheim, Germany, 2002.
Arp, F. O.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 10482–10483.
Arterburn, J. B. Tetrahedron 2001, 57, 9765–9788.
Comprehensive Bibliography 1037
Asymmetric Catalysis on Industrial Scale: Challenges, Approaches and Solutions;
Blaser, H.-U., Schmidt, E., Eds.; Wiley-VCH: Weinheim (2004).
Austin, J. F.; Kim, S.-G.; Sinz, C. J.; Xiao, W.-J.; MacMillan, D. W. C. Proc. Natl.
Acad. Sci. U.S.A. 2004, 101, 5482–5487.
Austin, J. F.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 1172–1173.
Avalos, M.; Babiano, R.; Cintas, P.; Jiménez, J. L.; Palacios, J. C. Tetrahedron:
Asymmetry 1997, 8, 2997–3017.
Baba, S. E.; Sartor, K.; Poulin, J.; Kagan, H. Bull. Soc. Chim. Fr. 1994, 131,
525–533.
Baba, S. E.; Sartor, K.; Poulin, J.; Kagan, H. Bull. Soc. Chim. Fr. 1994, 131,
525–533.
Bäckvall, J.-E.; Nordberg, R. E. J. Am. Chem. Soc. 1981, 103, 4959–4960.
Bäckvall, J.-E.; Nordberg, R. E.; Björkman, E. E.; Moberg, C. J. Chem. Soc., Chem.
Commun. 1980, 943–944.
Bäckvall, J.-E.; Nordberg, R. E.; Vågberg, J. Tetrahedron Lett. 1983, 24, 411–412.
Bäckvall, J.-E.; Nordberg, R. E.; Wilhelm, D. J. Am. Chem. Soc. 1985, 107,
6892–6898.
Bagdanoff, J. T.; Ferreira, E. M.; Stoltz, B. M. Org. Lett. 2003, 5, 835–837.
Bagdanoff, J. T.; Stoltz, B. M. Angew. Chem., Int. Ed. 2004, 43, 353–357.
Bakale, R. P.; Lopez, J. L.; McConville, F. X.; Vandenbossche, C. P.; Senanayake, C.
H. US Patent 6140529, 2000.
Baldwin, J. E.; Adlington, R. M.; Marquess, D. G.; Pitt, A. R.; Porter, M. J.; Russell,
A. T. Tetrahedron 1996, 52, 2515–2536.
1038 Comprehensive Bibliography
Balegroune, F.; Grandjean, D.; Lakkisb, D.; Matt, D. J. Chem. Soc., Chem. Commun.
1992, 1084–1085.
Banks, R. E.; Lawrence, N. J.; Popplewell, A. L. J. Chem. Soc., Chem. Commun.
1994, 343–344.
Barco, A.; Benetti, S.; De Risi, C.; Marchetti, P.; Pollini, G. P.; Zanirato, V.
Tetrahedron: Asymmetry 1997, 8, 3515–3545.
Bates, H. A.; Farina, J.; Tong, M. J. Org. Chem. 1986, 51, 2637–2641.
Baur, M. A.; Riahi, A.; Hénin, F.; Muzart, J. Tetrahedron: Asymmetry 2003, 14,
2755–2761.
Becker, H.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 448–451.
Behenna, D. C.  PhD thesis, California Institute of Technology (U.S.A.), 2006.
Behenna, D. C.; Stockdill, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2007, 46,
4077–4080.
Behenna, D. C.; Stockdill, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2008, 47,
2365–2386.
Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 15044–15045.
Bélanger, É.; Cantin, K.; Messe, O.; Tremblay, M.; Paquin, J.-F. J. Am. Chem. Soc.
2007, 129, 1034–1035.
Bélanger, É.; Houzé, C.; Guimond, N.; Cantin, K.; Paquin, J.-F. Chem. Commun.
2008, 3251–3253.
Bélanger, É.; Pouliot, M.-F.; Paquin, J.-F. Org. Lett. 2009, 11, 2201–2204.
Bhattacharya, A.; Dolling, U.-H.; Grabowski, E. J. J.; Karady, S.; Ryan, K. M.;
Weinstock, L. M. Angew. Chem., Int. Ed. 1986, 25, 476–477.
Comprehensive Bibliography 1039
Bienaymé, H. Tetrahedron Lett. 1994, 35, 7383–7386.
Blanchet, J.; Baudoux, J.; Amere, M.; Lasne, M.-C.; Rouden, J. Eur. J. Org. Chem.
2008, 5493–5506.
Boeckman, R. K., Jr.; Liu, Y. J. Org. Chem. 1996, 61, 7984–7985.
Boger, D. L. Key Ring Forming Reactions. Modern Organic Synthesis: Lecture
Notes, TSRI Press: La Jolla, CA, 1999; pp 273–281.
Bonifácia, V. D. B. Synlett 2004, 1649–1650.
Bonjoch, J.; Linares, A.; Bosch, J. Heterocycles 1987, 26, 2165–2174.
Bouillon, G.; Schank, K. Chem. Ber. 1980, 113, 2630–2635.
Boyd, E.; Coumbarides, G. S.; Eames, J.; Hay, A.; Jones, R. V. H.; Stenson, R. A.;
Suggate, M. J. Tetrahedron Lett. 2004, 45, 9465–9468.
Braun, M.; Laicher, F.; Meier, T. Angew. Chem., Int. Ed. 2000, 39, 3494–3497.
Braun, M.; Meier, T. Angew. Chem., Int. Ed. 2006, 45, 6952–6955.
Braun, M.; Meier, T. Synlett 2006, 661–676.
Braun, M.; Meier, T.; Laicher, F.; Meletis, P.; Fidan, M. Adv. Synth. Catal. 2008,
350, 303–314.
Buisson, D.; Azerad, R. Tetrahedron: Asymmetry 1996, 7, 9–12.
Buono, F.; Tenaglia, A. J. Org. Chem. 2000, 65, 3869–3874.
Buono, G.; Chiodi, O.; Wills, M. Synlett 1999, 377–388.
Burger, E. C.; Barron, B. R.; Tunge, J. A. Synlett 2006, 2824–2826.
Burkhardt, E. R.; Bergman, R. G.; Heathcock, C. H. Organometallics 1990, 9, 30–44.
Burns, A. C.; Forsyth, C. J. Org. Lett. 2008, 10, 97–100.
1040 Comprehensive Bibliography
Byers, P. K.; Canty, A. J.; Skelton, B. W.; Traill, P. R.; Watson, A. A.; White, A. H.
Organometallics 1992, 11, 3085–3088.
Carbery, D. R.; Donohoe, T. J. Chem. Commun. 2004, 722–723.
Carpenter, N. E.; Kucera, D. J.; Overman, L. E. J. Org. Chem. 1989, 54, 5846–5848.
Caspi, D. D.; Ebner, D. C.; Bagdanoff, J. T.; Stoltz, B. M. Adv. Synth. Catal. 2004,
346, 185–189.
Cazeau, P.; Duboudin, F.; Moulines, F.; Babot, O.; Dungogues, J. Tetrahedron 1987,
43, 2075–2088.
Chang, C.-I.; Chang, J.-Y.; Kuo, C.-C.; Pan, W.-Y.; Kuo, W.-Y. Planta Med. 2005,
71, 72–76.
Chang, C.-I.; Chien, S.-C.; Lee, S.-M.; Kuo, Y.-H. Chem. Pharm. Bull. 2003, 51,
1420–1422.
Charette, A. B.; Lebel, H. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N.,
Pfaltz, A., Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 2, pp 581–603.
Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000,
122, 3783–3784.
Cheon, C. H.; Yamamoto, H. J. Am. Chem. Soc. 2008, 130, 9246–9247.
Christoffers, J.; Baro, A. Adv. Synth. Catal. 2005, 347, 1473–1482.
Christoffers, J.; Mann, A. Angew. Chem., Int. Ed. 2001, 40, 4591–4597.
Clausen, A. M.; Dziadul, B.; Cappuccio, K. L.; Kaba, M.; Starbuck, C.; Hsiao, Y.;
Dowling, T. M. Org. Process Res. Dev. 2006, 10, 723–726.
Colombo, M. I.; Rúveda, E. A. J. Braz. Chem. Soc. 1998, 9, 303–312.
Comprehensive Bibliography 1041
Colombo, M. I.; Zinczuk, J.; Bohn, M. L.; Rúveda, E. A. Tetrahedron: Asymmetry
2003, 14, 717–725.
Colombo, M. I.; Zinczuk, J.; Mischnea, M. P.; Rúveda, E. A. Tetrahedron:
Asymmetry. 2001, 12, 1251–1253.
Comprehensive Asymmetric Catalysis, Vol. I–III; Jacobsen, E. N., Pfaltz, A.,
Yamamoto, H., Eds. Springer-Verlag: Berlin (2000).
Comprehensive Asymmetric Catalysis, Supplement 1 & 2; Jacobsen, E. N., Pfaltz, A.,
Yamamoto, H., Eds. Springer-Verlag: Berlin (2004).
Coppola, G. M.; Schuster, H. F.  α-Hydroxy Acids in Enantioselective Syntheses,
Wiley-VCH, Weinheim, 1997.
Corey, E. J. Angew. Chem., Int. Ed. 2002, 41, 1650–1667.
Corey, E. J.; Andersen, N. H.; Carlson, R. M.; Paust, J.; Vedejs, E.; Vlattas, I.;
Winter, R. E. K. J. Am. Chem. Soc. 1968, 90, 3245–3247.
Corey, E. J.; Bakshi, R. K.; Shibata, S.; Chen, C.-P.; Singh, V. K. J. Am. Chem. Soc.
1987, 109, 7925–7926.
Corey, E. J.; Cheng, X.-M.  In The Logic of Chemical Synthesis, Wiley: New York,
1–91 (1995).
Corey, E. J.; Guzman-Perez, A. Angew. Chem., Int. Ed. 1998, 37, 388–401.
Corey, E. J.; Guzman-Perez, A.; Loh, T.-P. J. Am. Chem. Soc. 1994, 116, 3611–3612.
Corey, E. J.; Helal, C. J. Angew. Chem., Int. Ed. 1998, 37, 1986–2012.
Cory, R. M.; Chan, D. M. T.; Naguib, Y. M. A.; Rastall, M. H.; Renneboog, R. M. J.
Org. Chem. 1980, 45, 1852–1863.
1042 Comprehensive Bibliography
Coumbarides, G. S.; Eames, J.; Ghilagaber, S.; Suggate, M. J. Tetrahedron Lett.
2004, 45, 9469–9474.
Coumbarides, G. S.; Eames, J.; Scheuermann, J. E. W.; Sibbons, K. F.; Suggate, M.
J.; Watkinson, M. Bull. Chem. Soc Jpn. 2005, 78, 906–909.
Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797–1842.
Cozzi, P. G.; Hilgraf, R.; Zimmermann, N. Eur. J. Org. Chem. 2007, 36, 5969–5994.
Criegee, R.; Marchand, B.; Wannowius, H. Justus Liebigs Ann. Chem. 1942, 550,
99–133.
Crimmins, M. T. Chem. Rev. 1988, 88, 1453–1473, and references therein.
Culkin, D. A.; Hartwig, J. F. J. Am. Chem. Soc. 2001, 123, 5816–5817.
Culkin, D. A.; Hartwig, J. F. Organometallics 2004, 23, 3398–3416.
Dai, X.; Nakai, T.; Romero, J. A. C.; Fu, G. C. Angew. Chem., Int. Ed. 2007, 46,
4367–4369.
Davidson, D.; Bernhard, S. A. J. Am. Chem. Soc. 1948, 70, 3426–3428.
Davies, H. M. L.; Beckwith, R. E. J. Chem. Rev. 2003, 103, 2861–2903.
Dawson, G. J.; Frost, C. G.; Martin C. J.; Williams, J. M. J.; Coote, S. J. Tetrahedron
Lett. 1993, 34, 7793–7796.
de Meijere, A.; Diederich, F. (eds.)  Metal-Catalyzed Cross-Coupling Reactions Vols.
1 & 2 (Wiley-VCH, Weinheim, 2004).
De Mico, A.; Margarita, R.; Parlanti, L.; Vescovi, A.; Piancatelli, G. J. Org. Chem.
1997, 62, 6974–6977.
Denissova, I.; Barriault, L. Tetrahedron 2003, 59, 10105–10146.
Denmark, S. E.; Beutner, G. L. Angew. Chem., Int. Ed. 2008, 47, 1560–1638.
Comprehensive Bibliography 1043
Denmark, S. E.; O’Connor, S. P. J. Org. Chem. 1997, 62, 584–594.
Denmark, S. E.; Wilson, T. W.; Burk, M. T.; Heemstra, J. R., Jr. J. Am. Chem. Soc.
2007, 129, 14864–14865.
Depew, K. M.; Marsden, S. P.; Zatorska, D.; Zatorski, A.; Bornmann, W. G.;
Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11953–11963.
Detalle, J.-F.; Riahi, A.; Steinmetz, V.; Hénin, F.; Muzart, J. J. Org. Chem. 2004, 69,
6528–6532.
Diels, O.; Alder, K. Justus Liebigs Ann. Chem.1928, 460, 98–122.
Dolling, U.-H.; Davis, P.; Grabowski, E. J. J. J. Am. Chem. Soc. 1984, 106, 446–447.
Donde, Y.; Overman, L. E. In Catalytic Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.;
Wiley-VCH: New York, 2000; pp 675–697.
Donnely, D. M. X.; Finet, J.-P.; Rattigan, B. A. J. Chem. Soc. Perkin Trans. 1 1993,
1729–1735.
Donohoe, T. J.; Freestone, G. C.; Headley, C. E.; Rigby, C. L.; Cousins, R. P. C.;
Bhalay, G. Org. Lett. 2004, 6, 3055–3058.
Douglas, C. J.; Overman, L. E. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5363–5367.
Dounay, A. B.; Humphreys, P. G.; Overman, L. E.; Wrobleski, A. D. J. Am. Chem.
Soc. 2008, 130, 5368–5377.
Dounay, A. B.; Overman, L. E. Chem. Rev. 2003, 103, 2945–2963.
Dounay, A. B.; Overman, L. E.; Wrobleski, A. D. J. Am. Chem. Soc. 2005, 127,
10186–10187.
Doyle, A. G.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2007, 46, 3701–3705.
Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 62–63.
1044 Comprehensive Bibliography
Doyle, M. P. In Catalytic Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley-VCH:
New York, 2000; pp 191–228.
Drago, C.; Caggiano, L.; Jackson, R. F. W. Angew. Chem., Int. Ed. 2005, 44,
7221–7223.
Drexler, H.-J.; You, J.; Zhang, S.; Fischer, C.; Baumann, W.; Spannenberg, A.;
Heller, D. Org. Process Res. Dev. 2003, 7, 355–361.
Drucker, D.; Easley, C.; Kirkpatrick, P. Nat. Rev. Drug Discovery 2007, 6, 109–110.
Du Feu, E. C.; McQuillin, F. J.; Robinson, R. J. Chem. Soc. 1937, 53–60.
Dua, S.; Taylor, M. S.; Buntine, M. A.; Bowie, J. H. J. Chem. Soc. Perkin Trans. 2
1997, 1991–1997.
Duhamel, L.; Duhamel, P.; Plaquevent, J.-C. Tetrahedron: Asymmetry 2004, 15,
3653–3691.
Duhamel, P.; Cahard, D.; Poirier, J.-M. Chem. Soc., Perkin Trans. 1 1993,
2509–2511.
Duhamel, P.; Cahard, D.; Quesnel, Y.; Poirier, J.-M. J. Org. Chem. 1996, 61,
2232–2235.
Eames, J.; Mitchell, H. J.; Nelson, A.; O’Brien, P.; Warren, S.; Wyatt, P. J. Chem.
Soc., Perkin Trans. 1 1999, 1095–1103.
Eames, J.; Weerasooriya, N. Tetrahedron: Asymmetry 2001, 12, 1–24.
Ebner, D. C.; Novák, Z.; Stoltz, B. M. Synlett 2006, 3533–3539.
Ebner, D. C.; Trend, R. M.; Genet, C.; McGrath, M. J.; O’Brien, P.; Stoltz, B. M.
Angew. Chem., Int. Ed. 2008, 47, 6367–6370.
Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem., Int. Ed. Engl. 1971, 10, 496–497.
Comprehensive Bibliography 1045
Eliel, E. L.; Wilen, S. H.; Mander, L. N. In Stereochemistry of Organic Compounds,
Wiley: New York, 1994; pp 965–971.
Enders, D.; Bockstiegel, B. Synthesis 1989, 493–396.
Enders, D.; Breuer, I.; Drosdow, E. Synthesis 2005, 3239–3244.
Enders, D.; Grondal, C. Angew. Chem., Int. Ed. 2005, 44, 1210–1212.
Enders, D.; Narine, A. A.; Toulgoat, F.; Bisschops, T. Angew. Chem., Int. Ed. 2008,
47, 5661–5665.
Enders, D.; Voith, M.; Lenzen, A. Angew. Chem., Int. Ed. 2005, 44, 1304–1325.
Enquist, Jr., J. A.; Stoltz, B. M. Nature 2008, 453, 1228–1231.
Erkkilä, A.; Majander, I.; Pihko, P. M. Chem. Rev. 2007, 107, 5416–5470.
Evans, D. A.; Fitch, D. M.; Smith, T. E.; Cee, V. J. J. Am. Chem. Soc. 2000, 122,
10033–10046.
Evans, D. A.; Johnson, J. S. In Comprehensive Asymmetric Catalysis; Jacobsen, E.
N., Pfaltz, A., Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 3, pp 1177–1235.
Evans, D. A.; Wu, J. J. Am. Chem. Soc. 2003, 125, 10162–10163.
Evans, P. A.; Nelson, J. D. J. Am. Chem. Soc. 1998, 120, 5581–5582.
Evarts, J.; Torres, E.; Fuchs, P. L. J. Am. Chem. Soc. 2002, 124, 11093–11101.
Farina, V.; Reeves, J. T.; Senanayake, C. H.; Song, J. J. Chem. Rev. 2006, 106,
2734–2793.
Fehr, C. Angew. Chem., Int. Ed. 2007, 46, 7119–7121.
Fehr, C. Angew. Chem., Int. Ed. Engl. 1996, 35, 2566–2587.
Ferreira, E. M.; Stoltz, B. M. J. Am. Chem. Soc. 2001, 123, 7725–7726.
1046 Comprehensive Bibliography
Fillion, E.; Fishlock, D.; Wilsily, A.; Goll, J. M. J. Org. Chem. 2005, 70, 1316–1327.
Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594–4595.
Fogliato, G.; Fronza, G.; Fuganti, C.; Lanati, S.; Rallo, R.; Rigoni, R.; Servi, S.
Tetrahedron 1995, 51, 10231–10240.
France, S.; Guerin, D. J.; Miller, S. J.; Lectka, T. Chem. Rev. 2003, 103, 2985–3012.
Frisch, A. C.; Beller, M. Angew. Chem., Int. Ed. 2005, 44, 674–688.
Frost, C. G.; Penrose, S. D.; Lambshead, K.; Raithby, P. R.; Warren, J. E.; Gleave, R.
Org. Lett. 2007, 9, 2119–2122.
Fuji, K. Chem. Rev. 1993, 93, 2037–2066.
Garg, N. K.; Caspi, D. D.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 9552–9553.
Garg, N. K.; Caspi, D. D.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 5970–5978.
Garg, N. K.; Caspi, D. D.; Stoltz, B. M. Synlett 2006, 3081–3087.
Garg, N. K.; Stoltz, B. M. Chem. Commun. 2006, 3769–3779.
Gaspert, B.; Halsall, T. G.; Willis, D. J. Chem. Soc. 1958, 624–628.
Gassman, P. G.; Harrington, C. K. J. Org. Chem. 1984, 49, 2258–2273.
Gelman, D.; Jiang, L.; Buchwald, S. L. Org. Lett. 2003, 5, 2315–2318.
Genêt, J.-P.; Jugé, S.; Achi, S.; Mallart, S.; Ruiz-Montès, J.; Levif, G. Tetrahedron
1988, 44, 5263–5275.
Gilchrist, T. L.; Sanchez Romero, O. A.; Wasson, R. C. J. Chem. Soc., Perkin Trans.
1 1989, 353–359.
Girard, C.; Kagan, H. B. Angew. Chem., Int. Ed. 1998, 37, 2922–2959.
Glorius, F.; Pfaltz, A. Org. Lett. 1999, 1, 141–144.
Comprehensive Bibliography 1047
Goodwin, N. T.  Ph.D. Thesis, California Institute of Technology, Pasadena, CA, July
2006.
Graening, T.; Hartwig, J. F. J. Am. Chem. Soc. 2005, 127, 17192–17193.
Graening, T.; Schmalz, H.-G. Angew. Chem., Int. Ed. 2003, 42, 2580–2584.
Grennberg, H.; Langer, V.; Bäckvall, J.-E. J. Chem. Soc., Chem. Commun. 1991,
1190–1192.
Gribble, G. W.  The Diversity of Naturally Produced Organohalogens.  In Natural
Production of Organohalogen Compounds; Gribble, G. W., Ed.; The Handbook of
Environmental Chemistry, Vol. 3, Part 3P; Springer: Berlin, 2003, pp 1–15.
Grover, P. T.; Bhongle, N. H.; Wald, S. A.; Senanayake, C. H. J. Org. Chem. 2000,
65, 6283–6287.
Guillaneux, D.; Zhao, S.-H.; Samuel, O.; Rainford, D.; Kagan, H. B. J. Am. Chem.
Soc. 1994, 116, 9430–9439.
Guiry, P. J.; Saunders, C. P. Adv. Synth. Catal. 2004, 346, 497–537.
Guo, M.; Minuti, L.; Taticchi, A.; Wenkert, E. J. Org. Chem. 1989, 54, 6138–6140.
Gupta, P.; Fernandes, R. A.; Kumar, P. Tetrahedron Lett. 2003, 44, 4231–4232.
Guthrie, J. P. Can. J. Chem. 1978, 56, 2342–2354.
Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1973, 38, 3244–3249.
Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615–1621.
Hamada, T.; Chieffi, A.; Åhman, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124,
1261–1268.
Hamashima, Y.; Somei, H.; Shimura, Y.; Tamura, T.; Sodeoka, M. Org. Lett. 2004, 6,
1861–1864.
1048 Comprehensive Bibliography
Hanessian, S.; Griffin, A. M.; Rozema, M. J. Bioorg. Med. Chem. Lett. 1997, 14,
1857–1862.
Hansch, C.; Leo, A.; Taft, R. W. Chem. Rev. 1991, 91, 165–195.
Hargaden, G. C.; Guiry, P. J. Chem. Rev. 2009, 109, 2505–2550.
Hargrave, J. D.; Herbert, J.; Bish, G.; Frost, C. G. Org. Biomol. Chem. 2006, 4,
3235–3241.
Harrington-Frost, N.; Leuser, H.; Calaza, M. I.; Kneisel, F. F.; Knochel, P. Org. Lett.
2003, 5, 2111–2114.
Harrowven, D. C.; Dainty, R. F. Tetrahedron 1997, 53, 15771–15786.
Hashimoto, S.-i.; Komeshima, N.; Koga, K. J. Chem. Soc., Chem. Commun. 1979,
437–438.
Hayashi, T.; Kanehira, K.; Hagihara, T.; Kumada, M. J. Org. Chem. 1988, 53,
113–120.
Hayashi, T.; Konishi, M.; Fukushima, M.; Kanehira, K.; Hioki, T.; Kumada, M. J.
Org. Chem. 1983, 48, 2195–2202.
Hayashi, T.; Konishi, M.; Fukushima, M.; Mise, T.; Kagotani, M.; Tajika, M.;
Kumada, M. J. Am. Chem. Soc. 1982, 104, 180–186.
Hayashi, U. In Cycloaddition Reactions in Organic Synthesis; Kobayashi, S.;
Jorgensen, K. A., Eds.; Wiley-VCH: New York, 2002; pp 5–56.
Hayashida, J.; Rawal, V. H. Angew. Chem., Int. Ed. 2008, 47, 4373–4376.
Heathcock, C. H.; Ellis, J. E.; McMurry, J. E.; Coppolino, A. Tetrahedron Lett. 1971,
12, 4995–4996.
Heck, R. F. Acc. Chem. Res. 1979, 12, 146–151.
Comprehensive Bibliography 1049
Heimgartner, H.; Zsindely, J.; Hansen, H.-J.; Schmid, H. Helv. Chim. Acta 1973, 56,
2924–2945.
Helmchen, G. J. Organomet. Chem. 1999, 576, 203–214.
Helmchen, G.; Pfaltz, A. Acc. Chem. Res. 2000, 33, 336–345.
Helmchen, G.; Steinhagen, H.; Reggelin, M.; Kudis, S. In Selective Reactions of
Metal-Activated Molecules; Werner, H., Schreier, P., Eds.; Vieweg Verlag: Wiesbaden,
1998; pp 205–215.
Hénin, F.; M’boungou-M’passi, A.; Muzart, J.; Pete, J.-P. Tetrahedron 1994, 50,
2849–2864.
Hénin, F.; Muzart, J. Tetrahedron: Asymmetry 1992, 3, 1161–1164.
Hénin, F.; Muzart, J.; Pete, J.-P.; M’boungou-M’passi, A.; Rau, H. Angew. Chem.,
Int. Ed. Engl. 1991, 30, 416–418.
Henning, H. G.; Stemplinger, G.; Rothe, K. Liebigs Ann. Chem. 1992, 8, 813–816.
Herath, K. B.; Attygalle, A. B.; Singh, S. B. J. Am. Chem. Soc. 2007, 129,
15422–15423.
Herrinton, P. M.; Klotz, K. L.; Hartley, W. M. J. Org. Chem. 1993, 58, 678–682.
Hills, I. D.; Fu, G. C. Angew. Chem., Int. Ed. 2003, 42, 3921–3924.
Hino, T.; Nakagawa, M.  Chemistry and Reactions of Cyclic Tautomers of
Tryptamines and Tryptophans.  In The Alkaloids Vol 34 (ed. Brossi, A.) 1–75 (Academic
Press, San Diego, 1988).
Hirao, T.; Fujii, T.; Ohshiro, Y. Tetrahedron 1994, 50, 10207–10214.
Hirata, T.; Shimoda, K.; Kawano, T. Tetrahedron: Asymmetry 2000, 11, 1063–1066.
Hodous, B. L.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 10006–10007.
1050 Comprehensive Bibliography
Hodous, B. L.; Ruble, J. C.; Fu, G. C. J. Am. Chem. Soc. 1999, 121, 2637–2638.
House, H. O.; Roelofs, W. L.; Trost, B. M. J. Org. Chem. 1966, 31, 646–655.
Hoveyda, A. H.  Asymmetric Catalysis in Target-Oriented Synthesis.  In Stimulating
Concepts in Chemistry; Vögtle, F., Stoddart, J. F., Shibasaki, M., Eds.; Wiley-VCH:
Weinheim, 145–160 (2000).
Hsiao, Y.; Rivera, N. R.; Rosner, T.; Krska, S. W.; Njolito, E.; Wang, F.; Sun, Y.;
Armstrong, J. D., III; Grabowski, E. J. J.; Tillyer, R. D.; Spindler, F.; Malan, C. J. Am.
Chem. Soc. 2004, 126, 9918–9919.
Huerta, F. F.; Minidis, A. B. E.; Bäckvall, J.-E. Chem. Soc. Rev. 2001, 30, 321–331.
Hughes, D. L.; Dolling, U.-H.; Ryan, K. M.; Schoenewaldt, E. F.; Grabowski, E. J. J.
J. Org. Chem. 1987, 52, 4745–4752.
Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 106, 2875–2911.
Ijima, Y.; Matoishi, K.; Terao, Y.; Doi, N.; Yanagawa, H.; Ohta, H. Chem. Commun.
2005, 877–879.
Irie, O.; Fujiwara, Y.; Neomoto, H.; Shishido, K. Tetrahedron Lett. 1996, 37,
9229–9232.
Jaouen, G.; Meyer, A. J. Am. Chem. Soc. 1975, 97, 4667–4672.
Jayasuriya, H.; Herath, K. B.; Zhang, C.; Zink, D. L.; Basilio, A.; Genilloud, O.;
Diez, M. T.; Vicente, F.; Gonzalez, I.; Salazar, O.; Pelaez, F.; Cummings, R.; Ha, S.;
Wang, J.; Sing, S. B. Angew. Chem., Int. Ed. 2007, 46, 4684–4688.
Jensen, K. B.; Thorhauge, J.; Hazell, R. G.; Jørgensen, K. A. Angew. Chem., Int. Ed.
2001, 40, 160–163.
Juaristi, E.; Soloshonok, V. A. (eds)  Enantioselective Synthesis of  β-Amino Acids
(Wiley & Sons, Hoboken, 2005).
Comprehensive Bibliography 1051
Jun, S. Y.; Zheng, J.-C.; Lee, D. Angew. Chem., Int. Ed. 2008, 47, 6201–6203.
Kacprzynski, M. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 10676–10681.
Kagan, H. B. Synlett 2001, 888–899.
Kagan, H. B.; Fiaud, J. C. in Topics in Stereochemistry, Vol. 18 (Eliel, E. L., ed.),
Wiley & Sons, New York, 1988, pp 249–330.
Kasu, H.; Ozako, S.; Kawamatsu, S.; Takatsu, S.; Ishii, M.; Tsunoda, T. Heterocycles
2001, 55, 847–850.
Kawatsura, M.; Hartwig, J. F. J. Am. Chem. Soc. 1999, 121, 1473–1478.
Kawazoe, K.; Yamamoto, M.; Takaishi, Y.; Honda, G.; Fujita, T.; Sezik, E.;
Yesilada, E.; Phytochemistry 1999, 50, 493–497.
Kayaki, Y.; Koda, T.; Ikariya, T. J. Org. Chem. 2004, 69, 2595–2597.
Kazmaier, U. Curr. Org. Chem. 2003, 7, 317–328.
Kazmaier, U.; Stolz, D.; Krämer, K.; Zumpe, F. L. Chem.–Eur. J. 2008, 14,
1322–1329.
Keinan, E.; Roth, Z. J. Org. Chem. 1983, 48, 1769–1772.
Keith, J. A.; Behenna, D. C.; Mohr, J. T.; Ma, S.; Marinescu, S. C.; Oxgaard, J.;
Stoltz, B. M.; Goddard, W. A., III. J. Am. Chem. Soc. 2007, 129, 11876–11877.
Keith, J. A.; Oxgaard, J.; Goddard, W. A., III. J. Am. Chem. Soc. 2006, 128,
3132–3133.
Keith, J. M.; Nielsen, R. J.; Oxgaard, J.; Goddard, W. A., III. J. Am. Chem. Soc. 2005,
127, 13172–13179.
Kerr, M. S.; Read de Alaniz, J.; Rovis, T. J. Org. Chem. 2005, 70, 5725–5728.
1052 Comprehensive Bibliography
Kim, B. M.; Kim, H.; Kim, W.; Im, K. Y.; Park, J. K. J. Org. Chem. 2004, 69,
5104–5107.
Kim, S.; Cho, C. H.; Lim, C. J. J. Am. Chem. Soc. 2003, 125, 9574–9575.
Kirby, G. W.; McGuigan, H.; McLean, D. J. Chem. Soc., Perkin Trans. 1 1985, 9,
1961–1966.
Kirmansjah, L.; Fu, G. C. J. Am. Chem. Soc. 2008, 129, 11340–11341.
Kiso, Y.; Tamao, K.; Miyake, N.; Yamamoto, K.; Kumada, M. Tetrahedron Lett.
1974, 15, 3–6.
Kitamura, M.; Kasahara, I.; Manabe, K.; Noyori, R.; Takaya, H. J. Org. Chem. 1988,
53, 708–710.
Kitching, W.; Sakakiyama, T.; Rappoport, Z.; Sleezer, P. D.; Winstein, S.; Young, W.
G. J. Am. Chem. Soc. 1972, 94, 2329–2335.
Klein, A.; Miesch, M. Synthesis 2006, 2613–2617.
Kolb, H. C.; Van Nieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94,
2483–2547.
Kollmar, M.; Goldfuss, B.; Reggelin, M.; Rominger, F.; Helmchen, G. Chem. Eur. J.
2001, 7, 4913–4927.
Kollmar, M.; Steinhagen, H.; Janssen, J. P.; Goldfuss, B.; Malinovskaya, S. A.;
Vázquez, J.; Rominger, F.; Helmchen, G. Chem.–Eur. J. 2002, 8, 3103–3114.
Krishnan, S.; Bagdanoff, J. T.; Ebner, D. C.; Ramtohul, Y. K.; Tambar, U. K.; Stoltz,
B. M. J. Am. Chem. Soc. 2008, 130, 13745–13754.
Krishnan, S.; Stoltz, B. M. Tetrahedron Lett. 2007, 48, 7571–7573.
Krout, M. R.; Mohr, J. T.; Stoltz, B. M. Org. Synth. 2009, 86, 181–193.
Comprehensive Bibliography 1053
Kuettner, E. B.; Keim, A.; Kircher, M.; Rosmus, S.; Strater, N. J. Mol. Biol. 2008,
377, 386–394.
Kukula, P.; Matousek, V.; Mallat, T.; Baiker, A. Chem.–Eur. J. 2008, 14, 2699–2708.
Kukula, P.; Matousek, V.; Mallat, T.; Baiker, A. Tetrahedron: Asymmetry 2007, 18,
2859–2868.
Kuwano, R.; Ito, Y. J. Am. Chem. Soc. 1999, 121, 3236–3237.
Kuwano, R.; Uchida, K.-i.; Ito, Y. Org. Lett. 2003, 5, 2177–2179.
Kuwano, R.; Uchida, K.-i.; Ito, Y. Org. Lett. 2003, 5, 2177–2179.
Larock, R. C.; Hightower, T. R.; Kraus, G. A.; Hahn, P.; Zheng, D. Tetrahedron Lett.
1995, 36, 2423–2426.
Larsen, A. O.; Leu, W.; Oberhuber, C. N.; Campbell, J. E.; Hoveyda, A. H. J. Am.
Chem. Soc. 2004, 126, 11130–11131.
Larsson, A. L. E.; Persson, B. A.; Bäckvall, J.-E. Angew. Chem., Int. Ed. 1997, 36,
1211–1212.
Laue, S.; Greiner, L.; Woelfinger, J.; Andreas, L.  Adv. Syn. Catal.  2001, 343,
711–720.
Lauktien, G.; Volk, F.-J.; Frahm, A. W. Tetrahedron: Asymmetry 1997, 8,
3457–3466.
Le Marquand, P.; Tam, W. Angew. Chem., Int. Ed. 2008, 47, 2926–2928.
Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2006, 128, 15604–15605.
Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta 2006, 39, 79–87.
Leow, D.; Lin, S.; Chittimalla, S. K.; Fu, X.; Tan, C.-H. Angew. Chem. Int. Ed. 2008,
47, 5641–5645.
1054 Comprehensive Bibliography
Levine, S. R.; Krout, M. R.; Stoltz, B. M. Org. Lett. 2008, 11, 289–292.
Li, B.-J.; Jiang, L.; Liu, M.; Chen, Y.-C.; Ding, L.-S.; Wu, Y. Synlett 2005, 603–606.
Liang, G.; Trauner, D. J. Am. Chem. Soc. 2004, 126, 9544–9545.
Lin, W.-H.; Fang, J.-M.; Cheng, Y.-S. Phytochemistry 1996, 42, 1657–1663.
Lin, W.-H.; Fang, J.-M.; Cheng, Y.-S.; Phytochemistry 1995, 40, 871–873.
Linton, E. C.; Kozlowski, M. C. J. Am. Chem. Soc. 2008, 130, 16162–16163.
Liu, S.; Müller, J. F. K.; Neuburger, M.; Schaffner, S.; Zehnder, M. J. Organomet.
Chem. 1997, 549, 283–293.
Lloyd-Jones, G. C.; Pfaltz, A. Angew. Chem., Int. Ed. 1995, 34, 462–464.
Low, J. J.; Goddard, W. A., III. J. Am. Chem. Soc. 1986, 108, 6115–6128.
Low, J. J.; Goddard, W. A., III. Organometallics 1986, 5, 609–622.
Lu, Z.; Ma, S. Angew. Chem., Int. Ed. 2008, 47, 258–297.
Lubell, W. D.; Kitamura, M.; Noyori, R. Tetrahedron: Asymmetry 1991, 2, 543–554.
Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. Chem.,
Int. Ed. 2001, 40, 1456–1460.
Luh, T.-Y.; Leung, M.-k.; Wong, K.-T. Chem. Rev. 2000, 100, 3187–3204.
Luo, Y.-R. Handbook of Bond Dissociation Energies in Organic Compounds, CRC
Press, Boca Raton, FL, 2007.
Lutz, R. P. Chem. Rev. 1984, 84, 205–247.
Ly, T.; Krout, M. R.; Pham, D. K.; Tani, K.; Stoltz, B. M.; Julian, R. R. J. Am. Chem.
Soc. 2007, 129, 1864–1865.
Comprehensive Bibliography 1055
Lydon, K. M.; McKervey, M. A. In Comprehensive Asymmetric Catalysis; Jacobsen,
E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: New York, 1999; Vol. 2, pp 539–580.
M. S. Sigman, D. R. Jensen, Acc. Chem. Res. 2006, 39, 221–229.
Ma, J.-A. Angew. Chem., Int. Ed. 2003, 42, 4290–4299.
Ma, S.; Han, X.; Krishnan, S.; Virgil, S. C.; Stoltz, B. M. Angew. Chem., Int. Ed.
2009, 48, 8037–8041.
Maiti, S.; Achari, B.; Banerjee, A. K. Synlett 1998, 129–130.
Maki, B. E.; Chan, A.; Scheidt, K. A. Synthesis 2008, 1306–1315.
Mandai, T.; Imaji, M.; Takada, H.; Kawata, M.; Nokami, J.; Tsuji, J. J. Org. Chem.
1989, 54, 5395–5397.
Mander, L. N.; Sethi, S. P. Tetrahedron Lett. 1983, 24, 5425–5428.
Marinescu, S. C.; Nishimata, T.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2008, 10,
1039–1042.
Marinovic, N. N.; Ramanthan, H. Tetrahedron Lett. 1983, 24, 1871–1874.
Marshall, J. A.; Fanta, W. I. J. Org. Chem. 1964, 29, 2501–2505.
Marten, B.; Kim, K.; Cortis, C.; Friesner, R. A.; Murphy, R. B.; Ringnalda, M. N.;
Sitkoff, D.; Honig, B. J. Phys. Chem. 1996, 100, 11775–11788.
Martin, S. F. Tetrahedron 1980, 36, 419–460.
Martín-Matute, B.; Edin, M.; Bogár, K.; Bäckvall, J.-E. Angew. Chem., Int. Ed. 2004,
43, 6535–6539.
Maruoka, K. (ed.) Asymmetric Phase Transfer Catalysis (Wiley-VCH, Weinheim,
2008).
1056 Comprehensive Bibliography
Maruoka, K. In Catalytic Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.;  Wiley-VCH:
New York, 2000; pp 467–491.
Mase, N.; Tanaka, F.; Barbas, C. F., III. Angew. Chem., Int. Ed. 2004, 43, 2420–2423.
Masumoto, S.; Suzuki, M.; Kanai, M.; Shibasaki, M. Tetrahedron 2004, 60,
10497–10504.
Masumoto, S.; Suzuki, M.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2002, 43,
8647–8651.
Matoishi, K.; Ueda, M.; Miyamoto, K.; Ohta, H. J. Mol. Catal. B: Enzym. 2004, 27,
161–168.
Matsuda, I.; Komori, K.-i.; Itoh, K. J. Am. Chem. Soc. 2002, 124, 9072–9073.
Matsumoto, K.; Tsutsumi, S.; Ihori, T.; Ohta, H. J. Am. Chem. Soc. 1990, 112,
9614–9619.
McFadden, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 7738–7739.
McKennon, M. J.; Meyers, A. I.; Drauz, K.; Schwarm, M. J. Org. Chem. 1993, 58,
3568–3571.
Meldrum, A. N. J. Chem. Soc. 1908, 93, 598–601.
Mendez, M.; Cuerva, J. M.; Gomez-Bengoa, E.; Cardenas, D. J.; Echavarren, A. M.
Chem.–Eur. J. 2002, 8, 3620–3628.
Mermerian, A. H.; Fu, G. C. Angew. Chem., Int. Ed. 2005, 44, 949–952.
Mermerian, A. H.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 4050–4051.
Meyers, A. I.; Williams, D. R.; Druelinger, M. J. Am. Chem. Soc. 1976, 98,
3032–3033.
Comprehensive Bibliography 1057
Meyers, A. I.; Williams, D. R.; Erickson, G. W.; White, S.; Druelinger, M. J. Am.
Chem. Soc. 1981, 103, 3081–3087.
Michelin, R. A.; Facchin, G.; Uguagliati, P. Inorg. Chem. 1984, 23, 961–969.
Mitsuhashi, K.; Ito, R.; Arai, T.; Yanagisawa, A. Org. Lett. 2006, 8, 1721–1724.
Miyamoto, K.; Hirokawa, S.; Ohta, H. J. Mol. Catal. B: Enzym. 2007, 46, 14–19.
Miyamoto, K.; Ohta, H. Eur. J. Biochem. 1992, 210, 475–481.
Miyaoka, H.; Kajiwara, Y.; Hara, M.; Suma, A.; Yamada, Y. Tetrahedron:
Asymmetry 1999, 10, 3189–3196.
Miyashita, M.; Sasaki, M.; Hattori, I.; Sakai, M.; Tanino, K. Science 2004, 305,
495–499.
Mohr, J. T.; Behenna, D. C.; Harned, A. M.; Stoltz, B. M. Angew. Chem., Int. Ed.
2005, 44, 6924–6927.
Mohr, J. T.; Ebner, D. C.; Stoltz, B. M. Org. Biomol. Chem. 2007, 5, 3571–3576.
Mohr, J. T.; Hong, A. Y.; Stoltz, B. M. Nature: Chemistry, 2009, 1, 359–369.
Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Nature 2008, 455, 323–332.
Mohr, J. T.; Krout, M. R.; Stoltz, B. M. Org. Synth. 2009, 86, 194–211.
Mohr, J. T.; Nishimata, T.; Behenna, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2006,
128, 11348–11349.
Mohr, J. T.; Stoltz, B. M. Chem.–Asian J. 2007, 2, 1476–1491.
Momose, T.; Toyooka, N.; Nishio, M.; Shinoda, H.; Fujii, H.; Yanagino, H.
Heterocycles 1999, 51, 1321–1343.   
Mongin, F.; Desponds, O.; Schlosser, M. Tetrahedron Lett. 1996, 37, 2767–2770.
Morisson, V.; Barnier, J. P.; Blanco, L. Tetrahedron 1998, 54, 7749–7764.
1058 Comprehensive Bibliography
Morita, M.; Drouin, L.; Motoki, R.; Kimura, Y.; Fujimori, I.; Kanai, M.; Shibasaki,
M. J. Am. Chem. Soc. 2009, 131, 3858–3859.
Moss, R. J.; Wadsworth, K. J.; Chapman, C. J.; Frost, C. G. Chem. Commun. 2004,
1984–1985.
Muñoz-Muñiz, O.; Quintanar-Audelo, M.; Juaristi, E. J. Org. Chem. 2003, 68,
1622–1625.
Muzart, J.; Hénin, F.; Aboulhoda, S. J. Tetrahedron: Asymmetry 1997, 8, 381–389.
Nagai, K.; Davies, T. A.; Dewasse, B. E.; Jacobs, M. R.; Appelbaum, P. C. J.
Antimicrob. Chemother. 2001, 48, 365–374.
Nagasampagi, B. A.; Dev, S.; Rai, C.; Murthy, K. L. Tetrahedron 1966, 22,
1949–1976.
Nájera, C.; Sansano, J. M. Chem. Rev. 2007, 107, 4584–4671.
Nakamura, M.; Hajra, A.; Endo, K.; Nakamura, E. Angew. Chem., Int. Ed. 2005, 44,
7248–7251.
Nakasako, M.; Obata, R.; Okubo, R.; Nakayama, S.; Miyamoto, K.; Ohta, H. Acta
Crystallogr. Sect. F, 2008, 64, 610–613.
Navarre, L.; Darses, S.; Genet, J.-P. Angew. Chem., Int. Ed. 2004, 43, 719–723.
Navarre, L.; Martinez, R.; Genet, J.-P.; Darses, S. J. Am. Chem. Soc. 2008, 130,
6159–6169.
Negishi, E.-i.; de Meijere, A. (eds.)  Handbook of Organopalladium Chemistry for
Organic Synthesis Vol. 1 (Wiley & Sons, New York, 2002).
Nelson, H. M.; Stoltz, B. M. Org. Lett. 2008, 10, 25–28.
Nelson, H. M.; Stoltz, B. M. Tetrahedron Lett. 2009, 50, 1699–1701.
Comprehensive Bibliography 1059
Netherton, M. R.; Fu, G. C.  Palladium-Catalyzed Cross-Coupling Reactions of
Unactivated Alkyl Electrophiles with Organometallic Compounds.  In Topics in
Organometallic Chemistry: Palladium in Organic Synthesis; Tsuji, J., Ed.; Springer: New
York, 85–108 (2005).
Neuville, L.; Chastanet, J.; Zhu, J. Tetrahedron Lett.  1999, 40, 7087–7090.
Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew.
Chem., Int. Ed. 2002, 41, 1668–1698.
Nicolaou, K. C.; Toh, Q.-Y.; Chen, D. Y.-K. J. Am. Chem. Soc. 2008, 130,
11292–11293.
Nicolaou, K. C.; Tria, G. S.; Edmonds, D. J. Angew. Chem., Int. Ed. 2008, 47,
1780–1783.
Nicolaou, K. C.; Vassilikogiannakis, G.; Mägerlein, W.; Kranich, R. Angew. Chem.,
Int. Ed. 2001, 40, 2482–2486.
Nielsen, R. J.; Goddard, W. A., III. J. Am. Chem. Soc. 2006, 128, 9651–9660.
Nielson, R. J.; Keith, J. M.; Stoltz, B. M.; Goddard, III, W. A. J. Am. Chem. Soc.
2004, 126, 7967–7974.
Nishimura, T.; Hirabayashi, S.; Yasuhara, Y.; Hayashi, T. J. Am. Chem. Soc. 2006,
128, 2556–2557.
Nishimura, T.; Katoh, T.; Takatsu, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc.
2007, 129, 14158–14159.
Noyori, R.; Kitamura, M.; Ohkuma, T. Proc. Natl. Acad. Sci. U.S.A. 2004, 101,
5356–5362.
Noyori, R.; Tokunaga, M.; Kitamura, M. Bull. Chem. Soc. Jpn. 1995, 68, 36–56.
Nugent, W. A.; RajanBabu, T. V.; Burk, M. J. Science 2002, 259, 479–483.
1060 Comprehensive Bibliography
Ogilvie, W.; Bailey, M.; Poupart, M.-A.; Abraham, A.; Bhavsar, A.; Bonneau, P.;
Bordeleau, J.; Bousquet, Y.; Chabot, C.; Duceppe, J.-S.; Fazal, G.; Goulet, S.; Grand-
Maître, C.; Guse, I.; Halmos, T.; Lavallée, P.; Leach, M.; Malanfant, E.; O’Meara, J.;
Plante, R.; Plouffe, C.; Poirier, M.; Soucy, F.; Yoakim, C.; Déziel, R. J. Med. Chem.
1997, 40, 4113–4135.
Ohmori, N. J. Chem. Soc., Perkin Trans. 1 2002, 755–767.
Ohtsu, H.; Iwamoto, M.; Ohishi, H.; Matsunaga, S.; Tanaka, R. Tetrahedron Lett.
1999, 40, 6419–6422.
Overman, L. E. Pure Appl. Chem. 1994, 66, 1423–11430.
Overman, L. E.; Larrow, J. F.; Stearns, B. A.; Vance, J. M. Angew. Chem., Int. Ed.
2000, 39, 213–215.
Overman, L. E.; Paone, D. V.; Stearns, B. A. J. Am. Chem. Soc. 1999, 121,
7702–7703.
Pal, S.; Mukhopadhyaya, J. K.; Ghatak, U. R. J. Org. Chem. 1994, 59, 2687–2694.
Palomo, C., Oiarbide, M., García, J. M. Chem.–Eur. J. 2002, 8, 37–44.
Paquette, L. A.; Sauer, D. R.; Cleary, D. G.; Kinsella, M. A.; Blackwell, C. M.;
Anderson, L. G. J. Am. Chem. Soc. 1992, 114, 7375–7387.
Paras, N. A.; MacMillan, D. W. C. J. Am. Chem. Soc. 2001, 123, 4370–4371.
Pastor, I. M.; Yus, M. Tetrahedron 2001, 57, 2371–2378.
Patil, N. T.; Yamamoto, Y. Synlett 2007, 1994–2005.
Peer, M.; de Jong, J. C.; Kiefer, M.; Langer, T.; Rieck, H.; Schell, H.; Sennhenn, P.;
Sprinz, J.; Steinhagen, H.; Wiese, B.; Helmchen, G. Tetrahedron 1996, 52, 7547–7583.
Pellissier, H. Tetrahedron 2003, 59, 8291–8327.
Comprehensive Bibliography 1061
Perdew, J. P.; Burke, K.; Ernzerhof, M. Phys. Rev. Lett. (Erratum) 1997, 78, 1386.
Perdew, J. P.; Burke, K.; Ernzerhof, M. Phys. Rev. Lett. 1996, 77, 3865–3868.
Persson, B. A.; Larsson, A. L. E.; Ray, M. L.; Bäckvall, J.-E. J. Am. Chem. Soc. 1999,
121, 1645–1650.
Petrova, K. V.; Mohr, J. T.; Stoltz, B. M. Org. Lett. 2008, 11, 293–295.
Pictet, A.; Spengler, T. Ber. Dtsch. Chem. Ges. 1911, 44, 2030–2036.
Piers, E.; Harrison, C. L.; Zetina-Rocha, C. Org. Lett. 2001, 3, 3245–3247.
Poisson, T.; Dalla, V.; Marsais, F.; Dupas, G.; Oudeyer, S.; Levacher, V. Angew.
Chem., Int. Ed. 2007, 46, 7090–7093.   
Poisson, T.; Oudeyer, S.; Dalla, V.; Marsais, F.; Levacher, V. Synlett 2008, 16,
2447–2450.
Prakash, G. K. S.; Beier, P. Angew. Chem., Int. Ed. 2006, 45, 2172–2174, and
references therein.
Quaternary Stereocenters: Challenges and Solutions for Organic Synthesis,
Christoffers, J., Baro, A., Eds.; Wiley: Weinheim, 2005.
Raheem, I. T.; Thiara, P. S.; Jacobsen, E. N. Org. Lett. 2008, 10, 1577–1580.
Raheem, I. T.; Thiara, P. S.; Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007,
129, 13404–13405.
Ramachary, D. B.; Barbas, C. F., III Chem.–Eur. J. 2004, 10, 5323–5331.
Rapado, L. P.; Bulugahapitiya, V.; Renaud, P. Helv. Chem. Acta 2000, 83,
1625–1632.
Rautenstrauch, V. Bull. Soc. Chim. Fr. 1994, 131, 515–524.
Rayabarapu, D. K.; Tunge, J. A. J. Am. Chem. Soc. 2005, 127, 13510–13511.
1062 Comprehensive Bibliography
Reisman, S. E.; Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130,
7198–7199.
Revial, G.; Jabin, I.; Redolfi, M.; Pfau, M. Tetrahedron: Asymmetry 2001, 12,
1683–1688.
Revial, G.; Pfau, M. Organic Syntheses; Wiley & Sons: New York, 1998; Collect.
Vol. 9, pp 610–618.
Reynolds, N. T.; Rovis, T. J. Am. Chem. Soc. 2005, 127, 16406–16407.
Rueping, M.; Theissmann, T.; Raja, S.; Bats, J. W. Adv. Synth. Catal. 2008, 350,
1001–1006.
Ryu, D. H.; Corey, E. J. J. Am. Chem. Soc. 2003, 125, 6388–6390.
Sakai, T.; Matsuda, A.; Tanaka, Y.; Korenaga, T.; Ema, T. Tetrahedron: Asymmetry
2004, 15, 1929–1932.
Sato, M.; Ban, H.; Kaneko, C. Tetrahedron Lett. 1997, 38, 6689–6692.
Sato, M.; Hisamichi, H.; Kaneko, C.; Suzaki, N.; Furuya, T.; Inukai, N. Tetrahedron
Lett. 1989, 30, 5281–5284.
Sato, Y.; Sodeoka, M.; Shibasaki, M. J. Org. Chem. 1989, 54, 4738–4739.
Satyanarayana, T.; Abraham, S.; Kagan, H. B. Angew. Chem., Int. Ed. 2009, 48,
456–494.
Sawamura, M.; Nagata, H.; Sakamoto, H.; Ito, Y. J. Am. Chem. Soc. 1992, 114,
2586–2592.
Sawamura, M.; Sudoh, M.; Ito, Y. J. Am. Chem. Soc. 1996, 118, 3309–3310.
Saxton, J. E. (ed.)  Indoles. Part Four. The Monoterpenoid Indole Alkaloids (Wiley &
Sons, New York, 1983).
Comprehensive Bibliography 1063
Schaefer, C.; Fu, G. C. Angew. Chem., Int. Ed. 2005, 44, 4606–4608.
Schlosser, M. Organometallics in Synthesis, Wiley-VCH, New York, 1996.
Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953–956.
Schöllkopf, U. Pure Appl. Chem. 1983, 55, 1799–1806.
Schulz, S. R.; Blechert, S. Angew. Chem., Int. Ed. 2007, 46, 3966–3970.
Schwarzenbach, G.; Felder, E. Helv. Chim. Acta, 1944, 27, 1044–1060.
Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 128, 1086–1087.
Seitz, T.; Baudoux, J.; Bekolo, H.; Cahard, D.; Plaquevent, J.-C.; Lasne, M.-C.;
Rouden, J. Tetrahedron 2006, 62, 6155–6165.
Senanayake, C. H.; Fang, Q. K.; Grover, P.; Bakale, R. P.; Vandenbossche, C. P.;
Wald, S. A. Tetrahedron Lett. 1999, 40, 819–822.
Senanayake, C. H.; Jacobsen, E. N.  Chiral (Salen)Mn(III) Complexes in Asymmetric
Epoxidations: Practical Synthesis of cis-Aminoindanol and Its Application to
Enantiopure Drug Synthesis.  In Process Chemistry in the Pharmaceutical Industry (ed
Gadamasetti, K. G.) 347–368 (Marcel Dekker, New York, 1999).
Seto, M.; Roizen, J. L.; Stoltz, B. M. Angew. Chem., Int. Ed. 2008, 47, 6873–6876.
Shaw, S. A.; Aleman, P.; Vedejs, E. J. Am. Chem. Soc. 2003, 125, 13368–13369.
Sheffy, F. K.; Godschalx, J. P.; Stille, J. K. J. Am. Chem. Soc. 1984, 106, 4833–4840.
Sheffy, F. K.; Stille, J. K. J. Am. Chem. Soc. 1983, 105, 7173–7175.
Shen, X.; Wu, Y.-K.; Zhang, F. Chin. J. Chem. 2002, 20, 1439–1444.
Sherden, N. H.; Behenna, D. C.; Virgil, S. C.; Stoltz, B. M. Angew. Chem., Int. Ed.
2009, 48, 6840–6843.
Shibasaki, M.; Yoshikawa, N. Chem. Rev. 2002, 102, 2187–2209.
1064 Comprehensive Bibliography
Shim, J.-G.; Nakamura, H.; Yamamoto, Y. J. Org. Chem. 1998, 63, 8470–8474.
Shimizu, I.; Yamada, T.; Tsuji, J. Tetrahedron Lett. 1980, 21, 3199–3202.
Shiraga, Y.; Okano, K.; Akira, T.; Fukaya, C.; Yokoyama, K.; Tanaka, S.; Fukui, H.;
Tabata, M. Tetrahedron 1988, 44, 4703–4711.
Shultz, C. S.; Krska, S. W. Acc. Chem Res. 2007, 40, 1320–1326.
Sibi, M. P.; Asano, Y.; Sausker, J. B. Angew. Chem., Int. Ed. 2001, 40, 1293–1296.
Sibi, M. P.; Coulomb, J.; Stanley, L. M. Angew. Chem., Int. Ed. 2008, 47,
9913–9915.
Sibi, M. P.; He, L. Synlett, 2006, 689–692.
Sibi, M. P.; Patil, K. Angew. Chem., Int. Ed. 2004, 43, 1235–1238.
Sibi, M. P.; Tatamidani, H.; Patil, K. Org. Lett. 2005, 7, 2571–2573.
Singh, S. B.; Herath, K. B.; Wang, J.; Tsou, N. N.; Ball, R. G. Tetrahedron Lett.
2007, 48, 5429–5433.
Singh, S. B.; Jayasuriya, H.; Ondeyka, J. G.; Herath, K. B.; Zhang, C. W.; Zink, D.
L.; Tsou, N. N.; Ball, R. G.; Basilio, A.; Genilloud, O.; Diez, M. T.; Vicente, F.; Pelaez,
F.; Young, K.; Wang, J. J. Am. Chem. Soc. 2006, 128, 11916–11920.
Slomczynska, U.; Kaminski, Z. J.; Leplawy, M. T. Bull. Pol. Acad. Sci. Chem.  1991,
39, 85–88.
Slomp, G., Jr.; Johnson, J. L. J. Org. Chem. 1958, 80, 915–921.
Smidt, S. P.; Menges, F.; Pfaltz, A. Org. Lett. 2004, 6, 2023–2026.
Smith, A. B.; Cho, Y. S.; Friestad, G. K. Tetrahedron Lett. 1998, 39, 8765–8768.
Snyder, S. A.; Corey, E. J. J. Am. Chem. Soc. 2006, 128, 740–742.
Comprehensive Bibliography 1065
Sodeoka, M.; Tokunoh, R.; Miyazaki, F.; Hagiwara, E.; Shibasaki, M. Synlett 1997,
463–466.
Södergren, M. J.; Andersson, P. G. J. Am. Chem. Soc. 1998, 120, 10760–10761.
Son, S.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 2756–2757.
Stanton, S. A.; Felman, S. W.; Parkhurst, C. S.; Godleski, S. A. J. Am. Chem. Soc.
1983, 105, 1964–1969.
Stavber, S.; Zupan, M. Tetrahedron Lett. 1996, 37, 3591–3594.
Stecher, H.; Faber, K. Synthesis 1997, 1–16.
Steinhagen, H.; Reggelin, M.; Helmchen, G. Angew. Chem., Int. Ed. Engl. 1997, 36,
2108–2110.
Stetter, H.; Kuhlmann, H. Chem. Ber. 1976, 109, 2890–2896.
Stewart, I. C.; Ung, T.; Pletnev, A. A.; Berlin, J. M.; Grubbs, R. H.; Schrodi, Y. Org.
Lett. 2007, 9, 1589–1592.
Stork, G.; Baine, N. H. J. Am. Chem. Soc. 1982, 104, 2321–2323.
Stork, G.; Brizzolara, A.; Landesman, H.; Szmuszkovic, J.; Terrell, R. J. Am. Chem.
Soc. 1963, 85, 207–222.
Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775–1776.
Stork, G.; van Tamalen, E. E.; Friedman, L. J.; Burgstahler, A. W. J. Am. Chem. Soc.
1951, 73, 4501.
Streuff, J.; White, D. E.; Virgil, S. C.; Stoltz, B. M., submitted for publication.
Sugiura, M.; Nakai, T. Angew. Chem., Int. Ed. Engl. 1997, 36, 2366–2368.
Suh, Y.-G.; Kim, S.-A.; Jung, J.-K.; Shin, D.-Y.; Min, K.-H.; Koo, B.-A.; Kim, H.-S.
Angew. Chem., Int. Ed. 1999, 38, 3545–3547.
1066 Comprehensive Bibliography
Sundberg, R. J.  Indoles (Academic Press, San Diego, 1996).
Taber, D. F.; Meagley, R. P.; Doren, D. J. J. Org. Chem. 1996, 61, 5723–5728.
Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986, 108, 7408–7410.
Takemoto, T.; Fukaya, C.; Yokoyama, K. Tetrahedron Lett. 1989, 30, 723–724.
Tambar, U. K.; Ebner, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128,
11752–11753.
Tani, K.; Behenna, D. C.; McFadden, R. M.; Stoltz, B. M. Org. Lett. 2007, 9,
2529–2531.
Tani, K.; Stoltz, B. M. Nature 2006, 441, 731–734.
Tannor, D. J.; Marten, B.; Murphy, R.; Friesner, R. A.; Sitkoff, D.; Nicholls, A.;
Ringnalda, M.; Goddard, W. A. , III; Honig, B. J. Am. Chem. Soc. 1994, 116,
11875–11882.
Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2003, 125, 11204–11205.
Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558–10559.
Taylor, M. S.; Jacobsen, E. N. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5368–5373.
Terao, Y.; Ijima, Y.; Miyamoto, K.; Ohta, H. J. Mol. Catal. B: Enzym. 2007, 45,
15–20.
Terao, Y.; Miyamomoto, K.; Ohta, H. Appl. Microbiol. Biotechnol. 2006, 73,
647–653.
Tewari, S. C.; Rastogi, S. N. Indian J. Chem., Sect. B 1979, 17B, 281–285.
The Oxford English Dictionary, (J. Simpson and E. Weiner, Eds.), 2nd ed., Oxford
University Press, Oxford, 1989.
Tian, G.; Boyle, P. D.; Novak, B. M. Organometallics 2002, 21, 1462–1465.
Comprehensive Bibliography 1067
Tiefenbacher, K.; Mulzer, J. Angew. Chem., Int. Ed. 2008, 47, 2548–2555.
Tiefenbacher, K.; Mulzer, J. Angew. Chem., Int. Ed. 2008, 47, 6199–6200.
Tiefenbacher, K.; Mulzer, J. J. Org. Chem. 2009, 74, 2937–2941.
Tokuda, O.; Kano, T.; Gao, W.-G.; Ikemoto, T.; Maruoka, K. Org. Lett. 2005, 7,
5103–5105.
Trend, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 4482–4483.
Trend, R. M.; Stoltz, B. M. J. Am. Chem. Soc. 2008, 130, 15957–15966.
Trimitsis, G.; Beers, S.; Ridella, J.; Carlon, M.; Cullin, D.; High, J.; Brutts, D. J.
Chem. Soc., Chem. Commun. 1984, 1088–1089.
Trost, B. M. Acc. Chem. Res. 1996, 29, 355–364.
Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1–14.
Trost, B. M. J. Org. Chem. 2004, 69, 5813–5837.
Trost, B. M. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5348–5355.
Trost, B. M.; Ariza, X. Angew. Chem., Int. Ed. Engl. 1997, 36, 2635–2637.
Trost, B. M.; Bream, R. N.; Xu, J. Angew. Chem., Int. Ed. 2006, 45, 3109–3112.
Trost, B. M.; Bunt, R. C.; Lemoine, R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000,
122, 5968–5976.
Trost, B. M.; Chan, D. M. T. J. Am. Chem. Soc. 1979, 101, 6429–6432.
Trost, B. M.; Chan, D. M. T. J. Am. Chem. Soc. 1979, 101, 6432–6433.
Trost, B. M.; Cramer, N.; Bernsmann, H. J. Am. Chem. Soc. 2007, 129, 3086–3087.
Trost, B. M.; Cramer, N.; Silverman, S. M. J. Am. Chem. Soc. 2007, 129,
12396–12397.
1068 Comprehensive Bibliography
Trost, B. M.; Hachiya, I. J. Am. Chem. Soc. 1998, 120, 1104–1105.
Trost, B. M.; Jiang, C. Synthesis 2006, 369–396.
Trost, B. M.; Lee, C. In Catalytic Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.;
Wiley-VCH: New York, 2000; pp 593–649.
Trost, B. M.; Li, Y. J. Am. Chem. Soc. 1996, 118, 6625–6633.
Trost, B. M.; Radinov, R.; Grenzer, E. M. J. Am. Chem. Soc. 1997, 119, 7879–7880.
Trost, B. M.; Schroeder, G .M.; Kristensen, J. Angew. Chem., Int. Ed. 2002, 41,
3492–3495.
Trost, B. M.; Schroeder, G. M. Chem.–Eur. J. 2005, 11, 174–184.
Trost, B. M.; Schroeder, G. M. J. Am. Chem. Soc. 1999, 121, 6759–6760.
Trost, B. M.; Schroeder, G. M.; Kristensen, J. Angew. Chem., Int. Ed. 2002, 41,
3492–3495.
Trost, B. M.; Silverman, S. M.; Stambuli, J. P. J. Am. Chem. Soc. 2007, 129,
12398–12399.
Trost, B. M.; Stambuli, J. P.; Silverman, S. M.; Schwörer, W. J. Am. Chem. Soc.
2006, 128, 13328–13329.
Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395–422.
Trost, B. M.; Verhoeven, T. R. J. Am. Chem. Soc. 1980, 102, 4730–4743.
Trost, B. M.; Verhoeven, T. R. J. Org. Chem. 1976, 41, 3215–3216.
Trost, B. M.; Xu, J. J. Am. Chem. Soc. 2005, 127, 17180–17181.
Trost, B. M.; Xu, J. J. Am. Chem. Soc. 2005, 127, 2846–2847.
Trost, B. M.; Xu, J. J. Org. Chem. 2007, 72, 9372–9375.
Comprehensive Bibliography 1069
Trost, B. M.; Xu, J.; Reichle, M. J. Am. Chem. Soc. 2007, 129, 282–283.
Trost, B. M.; Xu, J.; Schmidt, T. J. Am. Chem. Soc. 2008, 130, 11852–11853.
Trost, B. M.; Yong, L. J. Am. Chem. Soc. 1996, 118, 6625–6633.
Trost, B. M.; Zhang, Y. J. Am. Chem. Soc. 2006, 128, 4590–4591.
Trudeau, S.; Morken, J. P. Tetrahedron 2006, 62, 11470–11476.
Tsuda, T.; Chujo, Y.; Nishi, S.-i.; Tawara, K.; Saegusa, T. J. Am. Chem. Soc. 1980,
102, 6381–6384.
Tsuji, J. Acc. Chem. Res. 1969, 2, 144–152.
Tsuji, J. New J. Chem. 2000, 24, 127–135.
Tsuji, J. Proc. Jpn. Acad. Ser. B 2004, 80, 349–358.
Tsuji, J. Pure Appl. Chem. 1982, 54, 197–206.
Tsuji, J. Pure Appl. Chem. 1986, 58, 869–878.
Tsuji, J. Pure Appl. Chem. 1989, 61, 1673–1680.
Tsuji, J. Pure Appl. Chem. 1999, 71, 1539–1547.
Tsuji, J. Tetrahedron 1986, 42, 4361–4401.
Tsuji, J.; Minami, I. Acc. Chem. Res. 1987, 20, 140–145.
Tsuji, J.; Minami, I.; Shimizu, I.  Tetrahedron Lett. 1983, 24, 1793–1796.
Tsuji, J.; Minami, I.; Shimizu, I. Chem. Lett. 1983, 1325–1326.
Tsuji, J.; Minami, I.; Shimizu, I. Tetrahedron Lett. 1983, 24, 1793–1796.
Tsuji, J.; Minami, I.; Shimizu, I. Tetrahedron Lett. 1983, 24, 4713–4714.
Tsuji, J.; Nisar, M.; Shimizu, I,; Minami, I. Synthesis 1984, 12, 1009.
Tsuji, J.; Nisar, M.; Shimizu, I. J. Org. Chem. 1985, 50, 3416–3417.
1070 Comprehensive Bibliography
Tsuji, J.; Yamada, T.; Minami, I.; Yuhara, M.; Nisar, M.; Shimizu, I. J. Org. Chem.
1987, 52, 2988–2995.
Tsuji, Y.; Funato, M.; Ozawa, M.; Ogiyama, H.; Kajita, S.; Kawamura, T. J. Org.
Chem. 1996, 61, 5779–5787.
Tunge, J. A.; Burger, E. C. Eur. J. Org. Chem. 2005, 1715–1726.
Ukai, T.; Kawazura, H.; Ishii, Y.; Bonnet, J. J.; Ibers, J. A. J. Organomet. Chem.
1974, 65, 253–266.
Umemoto, T.; Fukami, S.; Tomizawa, G.; Harasawa, K.; Kawada, K.; Tomita, K. J.
Am. Chem. Soc. 1990, 112, 8563–8575.
Uno, T.; Watanabe, H.; Mori, K. Tetrahedron 1990, 46, 5563–5566.
Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 9228–9229.
VanRheenen, V.; Kelly, R. C.; Cha, D. Y. Tetrahedron Lett. 1976, 17, 1973–1976.
Varseev, G. N.; Maier, M. E. Angew. Chem., Int. Ed. 2009, 48, 3685–3688.
Vedejs, E.; Kruger, A. W. J. Org. Chem. 1998, 63, 2792–2793.
Vedejs, E.; Kruger, A. W.; Suna, E. J. Org. Chem. 1999, 64, 7863–7870.
Veya, P.; Floriani, C.; Chiesi-Villa, A.; Rizzoli, C. Organometallics 1993, 12,
4899–4901.
Vicente, J.; Arcas, A.; Fernández-Hernández, J. M.; Bautista, D. Organometallics
2001, 20, 2767–2774.
Vigneron, J. P.; Dhaenes, M.; Horeau, A. Tetrahedron 1973, 29, 1055–1059.
Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman, G. L.; Weinkauff, D. J.
J. Am. Chem. Soc. 1977, 99, 5946–5952.
von Matt, P.; Pfaltz, A. Angew. Chem., Int. Ed. Engl. 1993, 32, 566–568.
Comprehensive Bibliography 1071
von Nussbaum, F.; Brands, M.; Hinzen, B.; Weigand, S.; Häbich, D. Angew. Chem.,
Int. Ed. 2006, 45, 5072–5129.
Waalboer, D. C. J.; Schaapman, M. C.; van Delft, F. L.; Rutjes, F. P. J. T. Angew.
Chem., Int. Ed. 2008, 47, 6576–6578.
Wang, B.; Wu, F.; Wang, Y.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2007, 129,
768–769.
Wang, C.; Tunge, J. A. Org. Lett. 2005, 7, 2137–2139.
Wang, J.; Kodali, S.; Lee, S. H.; Galgoci, A.; Painter, R.; Dorso, K.; Racine, F.;
Motyl, M.; Hernandez, L.; Tinney, E.; Colletti, S. L.; Herath, K.; Cummings, R.; Salazar,
O.; Gonzalez, I.; Basilio, A.; Vicente, F.; Genilloud, O.; Pelaez, F.; Jayasuriya, H.;
Young, K.; Cully, D. F.; Singh, S. B. Proc. Nat. Acad. Sci. USA 2007, 104, 7612–7616.
Wang, J.; Soisson, S. M.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.;
Parthasarathy, G.; Tang, Y. S.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya,
H.; Ondeyka, J. G.; Herath, K. B.; Zhang, C. W.; Hernandez, L.; Allocco, J.; Basilio, A.;
Tormo, J. R.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S. H.; Michael, B.;
Felcetto, T.; Gill, C.; Silver, L. L.; Hermes, J. D.; Bartizal, K.; Barrett, J.; Schmatz, D.;
Becker, J. W.; Cully, D.; Singh, S. B. Nature, 2006, 441, 358–361.
Wang, Y.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2006, 128, 3928–3930.
Wanner, M. J.; van der Haas, R. N. S.; de Cuba, K. R.; van Maarseveen, J. H.;
Hiemstra, H. Angew. Chem., Int. Ed. 2007, 46, 7485–7487.
Watanabe, N.; Ogawa, T.; Ohtake, Y.; Ikegami, S.; Hashimoto, S.-i. Synlett 1996,
85–86.
Weix, D. J.; Hartwig, J. F. J. Am. Chem. Soc. 2007, 129, 7720–7721.
1072 Comprehensive Bibliography
White, D. E.; Stewart, I. C.; Grubbs, R. H.; Stoltz, B. M. J. Am. Chem. Soc. 2008,
130, 810–811.
Wiese, B.; Helmchen, G. Tetrahedron Lett. 1998, 39, 5727–5730.
Wijnberg, J. P. B. A.; Vader, J., de Groot, A. J. Org. Chem. 1983, 48, 4380–4384.
Williams, J. M. J. Synlett 1996, 705–710.
Wiskur, S. L.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 6176–6177.
Wolinsky, J.; Novak, R.; Vasileff, R. J. Org. Chem. 1964, 29, 3596–3598.
Woodward, R. B.; Bader, F. E.; Bickel, H.; Frey, A. J.; Kierstead, R. W. J. Am.
Chem. Soc. 1956, 78, 2023–2025.
Wu, M. H.; Hansen, K. B.; Jacobsen, E. N. Angew. Chem., Int. Ed. 1999, 38,
2012–2014.
Xu, F.; Armstrong, J. D., III; Zhou, G. X.; Simmons, B.; Hughes, D.; Ge, Z.;
Grabowski, E. J. J. J. Am. Chem. Soc. 2004, 126, 13002–13009.
Yamada, C. M.; Dellinger, D. J.; Carruthers, M. H. J. Am. Chem. Soc. 2006, 128,
5251–5261.
Yamago, S.; Nakamura, E. Org. React. 2002, 61, 1–217.
Yamamoto, A.; Ito, Y.; Hayashi, T. Tetrahedron Lett. 1989, 30, 375–378.
Yamamoto, Y. J. Organomet. Chem. 1999, 576, xi–xiii.
Yamashita, D.; Murata, Y.; Hikage, N.; Takao, K.-i.; Nakazaki, A.; Kobayashi, S.
Angew. Chem., Int. Ed. 2009, 48, 1404–1406.
Yamashita, Y.; Odashima, K.; Koga, K. Tetrahedron Lett. 1999, 40, 2803–2806.
Yan, X.-X.; Liang, C.-G.; Zhang, Y.; Hong, W.; Cao, B.-X.; Dai, L.-X.; Hou, X.-L.
Angew. Chem., Int. Ed. 2005, 44, 6544–6546.
Comprehensive Bibliography 1073
Yanagisawa, A.; Ishihara, K.; Yamamoto, H. Synlett 1997, 411–420.
Yanagisawa, A.; Kikuchi, T.; Watanabe, T.; Kuribayashi, T.; Yamamoto, H. Synlett
1995, 372–374.
Yanagisawa, A.; Touge, T.; Arai, T. Angew. Chem., Int. Ed. 2005, 44, 1546–1548.
Yanagisawa, A.; Touge, T.; Arai, T. Pure Appl. Chem. 2006, 78, 519–523.
Yates, P.; Eaton, P. J. Am. Chem. Soc. 1960, 82, 4436–4437.
Yoon, T. P.; Jacobsen, E. N. Science 2003, 229, 1691–1693.
Yoshikai, K.; Hayama, T.; Nishimura, K.; Yamada, K.; Tomioka, K. J. Org. Chem.
2005, 70, 681–683.
Yoshikai, K.; Hayama, T.; Nishimura, K.; Yamada, K.-i.; Tomioka, K. Chem. Pharm.
Bull. 2005, 53, 586–588.
You, S.-L.; Dai, L.-X. Angew. Chem., Int. Ed. 2006, 45, 5246–5248.
You, S.-L.; Hou, X.-L.; Dai, L.-X.; Cao, B.-X.; Sun, J. Chem. Commun. 2000,
1933–1934.
You, S.-L.; Hou, X.-L.; Dai, L.-X.; Zhu, X.-Z. Org. Lett. 2001, 3, 149–151.
Yu, W.; Jin, Z. Tetrahedron Lett. 2001, 42, 369–372.
Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6, 3217–3219.
Zhang, A.; RajanBabu, T. V. J. Am. Chem. Soc. 2006, 128, 5620–5621.
Zhang, K.; Peng, Q.; Hou, X.-L.; Wu, Y.-D. Angew. Chem., Int. Ed. 2008, 47,
1741–1744.
Zhao, X.; Liu, D.; Xie, F.; Zhang, W. Tetrahedron 2009, 65, 512–517.
Zheng, W.-H.; Zheng, B.-H.; Zhang, Y.; Hou, X.-L. J. Am. Chem. Soc. 2007, 129,
7718–7719.
1074 Comprehensive Bibliography
Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 14726–14727.
Zoute, L.; Audouard, C.; Plaquevent, J.-C.; Cahard, D. Org. Biomol. Chem. 2003, 1,
1833–1834.
About the Author 1075
About the Author
Justin Thomas Mohr was born in Anchorage, Alaska in 1980.  He was educated
through the Anchorage public school system, first at Inlet View Elementary School and
later at Romig Junior High School and West Anchorage High School.  His interest in the
physical sciences was piqued early in his education.  The author participated in the band
and theater programs in addition to competing with the school’s riflery and soccer teams.
The author graduated from the Anchorage School District summa cum laude in 1999.
In 1999, the author matriculated at Dartmouth College in Hanover. NH.  The
author focused his scientific interests on chemistry largely due to the guidance of
Professor Robert S. Cantor.  The author began performing laboratory research in 2001
under the supervision of Professor Gordon W. Gribble.  These studies, in collaboration
with Professor Cantor, sought to develop synthetic strategies for the synthesis of long-
chain n-polyols and their use as anesthetics.  The author was the recipient of a Beckman
Fellowship from 2002–2003 to fund this research.  While at Dartmouth, the author was
also involved in the management of the student-run commercial radio stations WFRD and
WDCR.  In 2003, the author received his A. B. degree cum laude (with honors in
chemistry) with a major in chemistry and a minor in theater.
In July of 2003, the author joined Professor Brian M. Stoltz’ group at the
California Institute of Technology.  The author explored the utility of chiral palladium
enolates for enantioselective reactions pertinent to target-directed synthesis.  His time at
Caltech was highlighted by the birth of his daughter, Marie Elise, in 2008.  The author
defended his PhD thesis in June of 2009 and will pursue postdoctoral research with
Professor Gregory C. Fu at the Massachusetts Institute of Technology.
